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PRESIDENT'S
ESSAY
GENES and POLITICS
The science of Genetics arose to study the transmission of physical characteristics from parents
to their offspring. When closely studied, much variation exists for virtually any characteristic, say,
in size or color, among the members of all species, be they flies, dogs, or ourselves, the
members of the Homo sapiens species. The origin of this variability long fascinated the scientific
world, which already in the 19th century asked how much of this variation is due to
environmental causes (nurture) as opposed to innate hereditary factors (nature) that pass
unchanged from parents to offspring. That such innate heredity exists could never be
realistically debated. One need just look at how characteristics in the shape of the face pass
through families. Ascribing, say, the uniqueness of the Windsor face to nurture as opposed to
nature goes beyond the realm of credibility.
Genes as the Source of Hereditary Variation Both within and
between Species
The key conceptual breakthrough in understanding the nature component of variation came in
the mid 1860s from the experiments of the Austrian monk and plant breeder, Gregor Mendel
(1822-1884). In his monastery gardens he created, by self-breeding, strains of peas that bred
true for a given character like pea color or pod shape. Then he crossed his inbred strains with
each other and observed how the various traits assorted in the progeny pea plants. In his
seminal scientific paper, published in 1865, Mendel showed that the origin of this hereditary
variability lay in differences in discrete factors (genes) that pass unchanged from one plant
generation to another.
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Most importantly, he showed that each pea has two sets of these factors, one coming from
the male parent, the other from the female. Some of those factors are expressed when present in
only one copy (dominant genes), whereas others become expressed only when two copies, one
from each parent, are present (recessive genes). Mendel's results later were used by the Danish
botanist, Wilhelm Johannsen (1857-1927), to make the important distinction between the
physical appearance of an individual (its phenotype) and its genetic composition (genotype).
Mere examination of a plant's physical appearance need not reveal its genetic composition.
Recessive genes present in only one copy can be identified only by further genetic crosses.
Mendel further made the equally important observation that genes do not necessarily stay
together when the male and female sex cells are formed. Instead, they often independently
assort from each other, giving rise to progeny with sets of features very different from those of
either parent.
Mendel's work, done before the behavior of chromosomes during cell division was
understood, almost had to lay unappreciated until the turn of the century, when three plant
breeders working on the European continent, Correns, De Vries, and Tschermak, independently
rediscovered the basic rules for hereditary transmission, which today we call Mendel's Laws. It
was not until 1890 that the sex cells were found to possess only half the number of
chromosomes present in adult cells. Fertilization through combining the haploid N number of
chromosomes of the sperm with the haploid N number of the egg restores the 2N diploid
chromosome number of adult plants and animals. Except for those special chromosomes that
determine sex, adult cells contain two copies of each distinct chromosome, each of which is
exactly duplicated prior to the cell division. With the basic facts of chromosome behavior so
established for both ordinary cell division (mitosis) and sex cell formation (meiosis), the
rediscovered laws of Mendel were given a chromosomal basis by the American, Walter Sutton.
Perceptively, he noted in 1903 that the segregation patterns of Mendel's genes exactly parallel
the behavior of chromosomes during the meiotic cell divisions that produce the male and female
sex cells (The Chromosomal Theory of Heredity). During the next several decades, an ever-
increasing number of genes were found to have precise locations along specific chromosomes.
In essence, each chromosome came to be seen as a linear collection of genes running between
its two ends.
Genes first were of interest because they were the source of the variability between the
members of a species, but they soon began to be appreciated more properly as the source of
information that gives an organism its unique form and function. Its collection of genes (its
genome) is what gives each organism its own unique developmental pathway. A dog is a dog, a
bacterium a bacterium, etc., because of the information carried by their respective genomes.
Gene duplication prior to cell division thus must be based on a very accurate copying process.
Otherwise, there would be no constancy of genetic information and of the development
processes they make possible. Correspondingly, genetic variation arises when genes are not
accurately copied (mutated) and give rise to changed (mutant) genes.
Hereditary Variability Generated by Changes in Genes (Mutation)
Underlies Evolution by Natural Selection
As soon as the first spontaneous gene mutations became known, they were perceived as the
obvious source of the new genetic variants necessary for Darwinian Evolution by "survival of the
fittest." Many more dysfunctional than more functional genes, however, resulted from random
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mistakes in the gene copying process. Thus, the rate at which the gene-copying process makes
mistakes is likely also to be under strong evolutionary pressure. If too many spontaneous
mutations occur, none of the mutant-gene-bearing organisms are likely to develop and produce
viable offspring. Correspondingly, too low a mutation rate will not generate sufficient gene
variants to allow species to compete effectively with those species evolving faster because of
their more frequent generation of biologically fitter offspring.
Eugenic Solutions for Human Betterment
The coming together of Darwinian and Mendelian thinking immediately raised the question of the
applicability of the new science of genetics to human life. To what extent was human success
due to the presence in their recipients of good genes that led to useful biological traits like good
health, social dependability, and high intelligence? Correspondingly, how many individuals at
the bottom of the human success totem pole were there because they possessed gene variants
perhaps useful for earlier stages in human evolution but now inadequate for modern urbanized
life? Social Darwinian reasoning viewed the sociocultural advances marking humans' ascent
from the apes as the result of continual intergroup and interpersonal strife, with such competitive
situations invariably selecting for the survival of humans of ever-increasing capabilities. Social
Darwinism came naturally to the monied products of the industrial revolution, a most prominent
one being the talented statistician, Francis Galton (1822-1911). Early in his career, he wrote the
1869 treatise Hereditary Genius, later coining the term "eugenics" (from the Greek meaning well-
born) for studies that would bring about improvements of the human race through the careful
selection of parents.
Clever though he was, and able to take comfort that he was Charles Darwin's (1809-1882)
cousin, Galton's eugenic prescriptions offered no basic improvement on the long-attempted
practice of seeing that offspring from families of attainment married into families of similar high
function. In this way, supposed good germ plasm would not be diluted by inputs of putative bad
heredity. But whether Galton was promoting reality, as opposed to an unjustified prejudice
against the vulgarity of the lower classes, had no way of being even half-tested before the arrival
of Mendelian analysis. So the eugenics movement naturally became galvanized by the new laws
of Mendelian heredity. But immediately, their hopes had to be tempered by the fact that human
genetics never would have the power of other forms of genetics where genetic crosses could be
made as well as observed. For better or worse, the eugenicists' main research tool had to be
hopefully well-collected, multi-generational pedigrees of physical and mental traits that passed
through families from one generation to the next. Toward that end, Galton, then already 84, co-
authored in 1906 the book Noteworthy Families, an index to kinships in near degrees between
persons whose achievements are honorable and have been publicly recorded.
Initially, there were hopes that simple Mendelian ratios would characterize the inheritance of
a broad-ranging group of human traits. But in addition to the limitations brought about through
the inability to confirm genetic hypotheses through genetic crosses, many of the studied traits
appeared in too few families for appropriate statistical analysis. Particularly difficult to analyze
were progeny traits not present in either parent. Conceivably, individuals had inherited one copy
of the same recessive gene from each parent. Such tentative conclusions became more
convincing when the respective traits, like albinism, were found more often in highly inbred,
isolated populations where marriages of cousins were frequent.
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Easier to assign as bona fide genetic determinants were dominant-acting genes that need be
inherited from only one parent for their presence to be felt. Once Mendelian thinking had
appeared, the inheritance mode of Huntington's Disease, the terrible neurological disease that
leads to movement and cognition disorders, was quickly ascertained as a dominant gene
disorder. Similar clear genetic attributions could be assigned to traits, such as red-green color
blindness and hemophilia, which preferentially appear in males but which are never passed on
to their own male offspring. This is the behavior of a trait caused by a gene present on the X sex
chromosome, two copies of which are present in females but only one in males, whose sexuality
is determined by the Y chromosome.
Important as these diseases of the body were to the individuals and families of those so
afflicted, the main focus of early 20th century eugenicists soon moved to potential genetic
causations for disabilities of the mind, embracing a wide spectrum of manifestations from
insanity through mental defectiveness, alcoholism, and criminality, to immorality. With
poorhouses, orphanages, jails, and mental asylums all too long prominent features of the most
civilized societies, eugenicists with virtually religious fervor wanted to prevent more such
personal and societal tragedies in the future. They also desired to reduce the financial burdens
incumbent on civilized society's need to take care of individuals unable to look after themselves.
But in their evangelical assertions that genetic causations lay behind a wide variety of human
mental dysfunctions, the early eugenically focused geneticists practiced sloppy, if not downright
bad, science and increasingly worried their more rigorous geneticist colleagues.
American Eugenics: Sloppy Genetics for the Legitimation of
Class Stratification
The most notable American eugenicist, whose conclusions went far beyond his facts, was
Charles B. Davenport (1866-1944), who parlayed his position as Director of the Genetics
Laboratory at Cold Spring Harbor, New York, to establish in 1910 a Eugenics Record Office
using monies provided by the widow of the railway magnate E.H. Harriman. In his 1911 book
Heredity in Relation to Eugenics, pedigrees were illustrated for a wide-ranging group of putative
hereditary afflictions ranging from bona fide genetic diseases, such as Huntington's disease and
hemophilia, to behavioral traits of much less certain hereditary attribution, such as artistic ability
and mechanical ability with reference to shipbuilding. With so little then known about the
functioning of the human brain, Davenport's early rush to associate highly specific
accomplishments of the human brain to specific genetic determinants could not automatically
be dismissed as nonsense. In today's intellectual climate, however, a predilection for genes that
predispose individuals to city life as opposed to rural life would not be the way to an academic
career. But, even his fellow early eugenicists must have regarded, as more wartime patriotism
than science, his 1917 claim that a dominant gene for thalassophilia predisposed its recipients
to careers as naval captains.
In addition to its family pedigree assembly and archival roles, the Cold Spring Harbor
Eugenics Record Office frequently counseled individuals with family backgrounds of genetic
diseases, particularly when they were considering marriage to blood relatives. Many such
seekers of help must have been misled by advice that never should have been given,
considering that era's limited power for meaningful genetic analysis. Worries about insanity were
a major concern, where manic-depressive disease was seen to move through some families as if
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it were a dominant trait. In contrast, schizophrenia had more aspects of a recessive disease.
Yet, even with today's much more powerful human genetics methodologies, we still do not know
the relative contribution of dominant versus recessive genes to these two major psychoses or
any other form of mental disease.
The Eugenics Record Office's pre-World War II message was that insanity usually expressed
itself only when genes predisposing it were inherited from both parents. If this were so, siblings
of individuals displaying mental instability were at risk of being carriers of insanity-provoking
genes. Since recessive genes for insanity would be silently passing through many families,
marriage to any individual with mentally disturbed siblings was not prudent. Even more certainly,
marriage should be avoided between individuals having severe mental illness in both parents. In
those days, when no effective medicines existed for any form of psychiatric illness, most families
bearing mental disease not surprisingly kept this knowledge as secret as possible. There must
have been many couples, perhaps over-worried about producing mentally disturbed offspring,
who chose not to have children.
The eugenicists predictably were concerned about mentally unstable individuals marrying
those with similar disturbances. Also of obsessive concern to them were individuals with feeble-
mindedness, where Davenport believed that recessive genes were also involved. With his
certainty that all children of two feeble-minded parents would be defective, he wrote of the "Folly,
yes the crime, of letting two such persons marry." In his mind, the inhabitants of rural poorhouses
were there largely because of their feeble-mindedness, and he considered one of our nation's
worst dangers to be the constant generation of feeble-minded individuals by the unrestrained
lusts of parents of similar conditions.
It was to stop such further contaminations of the American germ plasm that Davenport,
already as early as 1911, saw the need for state control of the propagation of the mentally
unstable or defective. Initially, he did not favor adoption of state laws allowing for their
compulsory sterilization, an idea then considered wise and humane by much of that era's
socially progressive elite. Clearly somewhat sexually repressed (obsessed?), he feared that with
pregnancy no longer a worry, the sexual urges of the sterilized, mentally unstable impaired
might cause more harm to society than even the procreation of more of their kind. Instead, he
wanted mentally impaired women to be effectively segregated (imprisoned?) from the impaired
of the opposite sex until after they passed the age of procreation. This prescription, however,
was totally unrealistic and the American eugenics movement as a whole enthusiastically
promoted the compulsory sterilization legislation that spread to 30 states by the start of World
War II.
If the eugenics movement had focused its attention predominately on genetic afflictions that
truly disabled its recipients, we might now be able to look back at it as a mixture of sloppy
science and well-intentioned but kooky naiveté. Photos of the Eugenics Booths of 1920s State
Farm Fairs are virtually laughable. In them can be seen "fitter families" displayed near the pens
at which prize cattle were shown. The thought that sights of their earnest faces would lead to
preferential procreation of more of the same now stretches our credulity. In contrast, the words
and actions of Harry P. Laughlin, Davenport's close associate and Superintendent of the
Eugenics Record Office, today can only make our minds flinch.
Pleased that his ancestors were traceable to the American Revolution, Laughlin shared
Davenport's belief that the strengths and weaknesses of national and religious groups were
rooted in genetic as well as in cultural origins. While, at least in public, Davenport wrote that no
individual should be refused admission to the United States on the basis of religious group or
national origin, Laughlin stated as scientific fact before appropriate Congressional bodies that
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the new Americans from Eastern and Southern Europe were marked by unacceptable amounts
of insanity, mental deficiency, and criminality. Although he lacked any solid evidence, he
nonetheless promoted the belief that the newest immigrants to our shores were much more likely
to be found in prisons and insane asylums than were the descendants of earlier waves of
English, Irish, German, and Scandinavian settlers. Even though the then-current postwar hysteria
against unrestrained immigration by itself might have led to the 1924 legislation, there is no
doubt that Laughlin's testimony tilted the composition of the future immigrants to Northern
Europeans.
With legislation in place, Davenport no longer had to fear that "the population of the United
States will on account of the great influence of blood (genes) from South-Eastern Europe rapidly
become darker in pigmentation, smaller in stature, more mercurial, more attached to music and
art, given to crimes of larceny, kidnapping, assault, murder, rape, and sex immorality and less
given to burglary, drunkenness, and vagrancy than were the original English settlers." Through
propagating such racial and religious prejudices as scientific truths, the American eugenics
movement was, in effect, an important ally of the ruling classes, many of whose privileges
inevitably came through treating those less fortunate as inherently unequal.
Using the First IQ Tests to Justify Racial Discrimination within
the United States
The emergence of intelligence measuring reinforced the belief of America's prosperous people
that their wealth reflected their respective family's innate intellectual superiority. The French
psychologist, Alfred Binet (1857-1911), was the first person to try to systematically measure
intelligence, responding to a 1904 request from the French government to detect mentally
deficient children. The resulting Binet-Simon tests crossed the Atlantic by 1908, being first
deployed in the United States by Henry Goddard in New Jersey at a training school for feeble-
minded boys and girls. Soon afterward, he went on to test 2000 children with a broad range of
mental abilities. Initially, there was considerable public opposition to the testing of "normal"
individuals because of the test's first use on the feeble-minded. Within only a few years,
however, revised Binet-Simon tests, more appropriate for precocious children, were prepared by
Lewis Ternan (1877-1956) at Stanford University. These so-called IQ (Intelligence Quotient)
tests were soon employed during World War I on hundreds of thousands of army draftees. Their
main function was not to weed out mental defectives, but to assign recruits to appropriate army
roles. Those administering the tests, led by the noted psychologist Robert M. Yerkes (1876-
1956), claimed they were seeing native intelligence independent of the recruit's environmental
history. Yet, clearly, many of the questions or arithmetic problems would be more easily
answered by those with extensive schooling and possessing a broad vocabulary. Not
surprisingly the non-English-speaking recruits just off the immigration boats tested badly,
allowing a test leader to privately confide to Davenport, "we are well on the right track in our
contention that the germ plasm (now) coming into the country does not carry the possibilities of
that arriving earlier." Such "objective test data" further convinced the eugenicist world that not
only was mental deficiency genetically determined, but so was general intelligence.
Although black men from urban areas tested higher than white southern rural men, their IQ
scores were significantly lower than their white equivalents from the same communities. Given
today's realization that intelligence measurements virtually by necessity have cultural biases, the
comparative data assembled from the army recruits had little real meaning. In many ways, it was
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like comparing oranges with apples. Nonetheless, the data summarized in Psychological
Examining in the United States Army were used to justify the discriminatory segregation laws
that effectively made America's black population second-class citizens. Genetic inequalities
across so-called race boundaries were taken for granted, and 29 states maintained laws against
black-white intermarriages often using the argument that the superior white germ stock would be
diluted with inferior genes.
Although eugenics had its origin in England, it never affected the national consciousness
there as it did in the United States. With social class stratification so long a characteristic feature
of British life, the ruling classes had no need of further justification for their privileged existence.
To a lesser but real extent, social inequalities also were taken-for-granted features of most
European countries, many of which still had royal families and their attendant aristocracy.
Enthusiastic prewar eugenics movements nonetheless sprang up all over the continent,
extending even to Southern America and Japan in the 1920s. Everywhere, the chief adherents
were the professional middle class, naively proselytized into believing that genetic thinking
could soon lead to human beings with heightened hereditary capabilities. Although the
continent's eugenicists frequently used the now unacceptable term 'race hygiene' for their
movement, their ways for the betterment of human heredity for the most part in no way infringed
upon preexisting human liberties. Offered as the future panacea was the standard package of
marriage between genetically healthy individuals, with correspondingly strong disapproval of
marriage for individuals bearing obviously bad genes like those leading to Huntington's Disease.
Only in two European countries, Germany and Sweden, was legislation enacted for obligatory
sterilization of individuals thought to be the bearers of disabling genes.
Nazi Eugenics (Race Hygiene): A Murderous Ménage a Trois of
Bad Genetics, Racial Anthropology, and Psychiatry at the Beckon
of Hitler and Himmler
Although it was the Hitler-led Nazi government that quickly passed the 1933 Eugenic
Sterilization Law, the broadly based German eugenics movement of the 1920s laid the ground
work. Then it was embraced by a spectrum of political thought, much of it totally respectable by
the ethical standards of those days. The Germany of that time was a nation undergoing a great
moral crisis brought on by its humiliating defeat in the World War. Its four awful years of trench
warfare had killed a significant fraction of its better younger men and left it vulnerable to the
hyperinflation that wiped out much of the savings of its professional middle class. Unlike
England or France, Germany as a world power had only a fleeting existence, and the German
people then saw the need to somehow reinvigorate themselves. The eugenicists' vision that
human beings' futures lie in their genes struck a receptive chord in the immediate postwar
German psyche. Even in the postwar chaos of its Weimar government, human genetics gained
strong governmental support. Genetics quickly became a high-quality science in Germany, with
Berlin becoming one of the world's leading centers for genetics. Study of supposed genetic
differences between the so-called races was vigorously promoted, with it being accepted as
fact that the commercial colonization of the world by major countries in Europe and the United
States reflected the inherent superiority of the Nordic people's genes for intelligence and
strength of moral purpose. Anthropological-based research had strong genetic components,
with genes being perceived as the crucial element determining human behavior.
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In total contrast, genetic explanations for human successes were not favorably received in
the Soviet Union, whose communist doctrines emphasized social, as opposed to genetic,
causation for the currently existing inequalities between humans. Already by the mid 1930s,
eugenic thinking had become strongly inimical to Russian Communist policymakers, who
increasingly favored the Lamarckian explanations (inheritance of acquired characteristics) of
Trofim Lysenko (1898-1982), its homegrown agriculturist, over the foreign-originating Morgan-
Mendelian analysis of heredity. Those pursuing genes within the Soviet Union soon were putting
not only their careers, but also their lives at risk. The great American geneticist, Herman J. Muller
(1890-1967), whose left-wing views led him to leave Texas and come to Russia in 1933,
effectively ended his Soviet career when, in 1936, he compared Lamarckian thinking to alchemy,
astrology, and shamism.
Seeking backing for the putative superiority of the Caucasian race, Adolf Hitler (1889-1945),
while imprisoned in 1924 for the failed Munich putsch, read Menschliche Erblichkeitslehre and
Rassenhygiene (The Principles of Human Heredity and Race Hygiene), a leading German
genetic text of the time coauthored by E. Baur, Eugen Fischer, and Fritz Lenz. Enveloped by an
uncritical eugenic perspective, it strongly reinforced Hitler's view of Germans as the master race
that justifiably should rule the world. If, however, the Germans were indeed the master race, the
Nazis had to explain their nation's humiliating defeat in the Great War and its subsequent
devastating hyperinflation.
A perfidious scapegoat was needed, and here Hitler drew upon the long-existing, anti-
Semitic feelings of many German people. Long segregated in rural enclaves dating back to the
Middle Ages, Jews became effectively part of Germany's commercial and professional life only
by the middle of the 19th century. Gravitating especially to the professions where their talents
could more easily prevail over still-existing prejudices, Jewish importance in German commerce
and professional life soon became disproportionate to their numbers, creating jealousies that
inevitably fanned preexisting anti-Semitism. Clearly, much of this Jewish success reflected its
religion and its respect for the intellect as opposed to oft revelatory-based opinions of their
Christian equivalency. Their anti-Semitic opponents, however, saw the Jews' upward trajectory
as manifestation of inherent immoralities that let them take unfair advantage of the more honest
Christian Germans.
Until the arrival of Mendelian thinking, German anti-Semites never consistently decided
whether their enemy was the Jews themselves or their religion. If their failure to acknowledge
Christ was the problem, Jews who converted posed no further threat to Christian civilization. But
if their reputed unscrupulous behavior and sexual licentiousness reflected innate hereditary
qualities, their presence within Christian societies threatened their country's moral resolve, if not
its very existence. Assertions by eugenicists that gene differences lay behind human behavioral
differences were thus made to order for Nazi needs. From the 1933 start of their absolute rule,
the Nazi propaganda machine ruthlessly portrayed Jews and Communists as the two main
villains blocking the ultimate triumph of National Socialism. No words were vile enough to
express their hatred for the genes that supposedly let Germany's one million Jews steal for
themselves the monies and jobs of the honest Germans, or their horror of the Communists who
wanted to redistribute monies from those who worked hard to those not able or willing to take
care of themselves. Treated with equal contempt by the Nazis, but of less importance because
of their much smaller numbers (30,000), were the Gypsies. Because of their wandering,
supposed sexually unrepressed life styles, and their lack of respect for property, the German
Gypsies were regarded by Nazi anthropologists as descendants of peoples of primitive
etiological origin who had mated repeatedly with the German criminal, asocial subproletariat. So
considered, the further breeding of this mixed blood people must be stopped.
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Sterilization of the Mentally Unfit as a Prelude to More Broadly Based
Wartime Genocide
Gypsies, however, were not specifically targeted under the 1933 Eugenics Law that mandated
compulsory sterilization for schizophrenia, manic-depressive psychoses, hereditary epilepsy,
Huntington's Chorea (Disease), hereditary blindness, hereditary deafness, severe physical
deformity, and severe alcoholism. Tribunals of Hereditary Health, consisting of a judge, a
government medical officer, and an "independent" physician, made the resulting decisions
where the individuals concerned often knew they were at risk only when called before its
members. With appeals extremely difficult, these psychiatrist-led verdicts between 1934 and
1939 led to some 400,000 compulsory sterilizations, many to noninstitutionalized persons. These
reputedly hereditary-damned individuals were further subjected to a subsequent 1934 law
forbidding persons with serious mental disturbances from marrying. A year later, legislation
specifically affecting Jewish marriages came through the 1935 "Nuremberg Decrees" for the
protection of German blood and health. They forbade not only marriages, but also sexual
intercourse between the so-called German and Jewish races.
Concomitant with these eugenic actions was the assembly of vast record collections
documenting individual hereditary-biological characteristics. To the Reich Kinship Bureau were
referred decisions as to the origin of individuals with potential partial Jewish blood. Many such
anthropological "expert conclusions" were made using only photos of the putative fathers.
However, with the census of 17 May 1939 providing supposed "confidential" information of any
Jewish grandparent, the Nazis, as the war started, felt they had a firm handle on the Jewish
blood within their midst. So encouraged, later that year Professor Eugen Fischer, this time
responding to coal barons of the Ruhr, wrote, When a people wants somehow or other to
preserve its own nature, it must reject alien racial elements and when they have already
insinuated themselves, it must suppress and then eliminate them. The Jew is such an alien..."
With the war on, the German government, seeing no reason to waste scarce resources to
keep what they considered genetically inferior peoples alive, proceeded to what it termed an
"euthanasia policy of mercy killing." In a one-sentence letter postdated 1 September 1939, Hitler
himself wrote, "Reich leiter Bouhler and Dr. Brandt are entrusted with responsibility of extending
the rights of specifically designated physicians such that patients who are judged incurable after
the most thorough review of their condition which is possible can be granted mercy killing." So
authorized, 3000 mental patients in occupied Poland were summarily shot by storm troopers. In
the Reich itself, where German citizens were involved, somewhat more formal procedures were
used. Questionnaires were distributed to the mental hospitals, where they were completed in
their capacity as experts by nine Professors of Psychiatry assisted by 39 other medical doctors.
For their labors, they were paid 5 pfennigs (the cost of a cigarette) per questionnaire when they
processed more than 3500 per month, but up to 10 pfennigs when fewer than 500
questionnaires per month were processed. The patients so selected for "euthanasia" had their
respective questionnaires marked with a cross. Subsequently, carbon monoxide supplied by
I.G. Farben was used for the elimination process. Before the killings stopped in the fall of 1941,
some 94,000 mental patients had been killed. Subsequently, covert "euthanasia" by starvation,
drugs, and failure to treat infectious diseases led to only 15% (40,000 persons) of Germany's
prewar mental hospital population remaining alive at the war's end.
The primary reason for the supposed stopping of mental patient "mercy killings" was the need
to transfer the personnel trained in killing by gas to the concentration camps, primarily in Poland
(e.g., Auschwitz), to which most German Jews and gypsies had already been deported. With the
decision already taken to invade the Soviet Union, a conference was held in March 1941 in
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Frankfurt at the Institute for the Investigation of the Jewish Question. At this conference, Dr.
Gross, the head of the Race Policy Institute of the Nazi party, stated, "The definitive solution must
involve the removal of Jews from Europe and he demands sterilization of quarter Jews." In an
October letter to Himmler, Oberdiensleiter Brack of the Fuhrer's chancellery wrote that there are
no objections to doing away (gassing) Jews who are unfit for concentration camp work. Less
than a month later, Rosenberg, theoretician and minister of the occupied eastern territories,
before representatives of the German press, announced the Final Solution of the Jewish
Question, revealing plans, still to be kept secret, for the eventual mass murder of all European
Jews, including the six million then living in the Soviet Union. The gas chambers so used were in
no way restricted to Jews and Gypsies, with Soviet prisoners of war being victims of the first
uses of Zyklon B (hydrocyanic acid) at Auschwitz. Anxious to give their racial extermination
policies "scientific" justification, Himmler later in 1943 specified in a decree that only physicians
trained in anthropology should carry out selection for killing and supervise the killings
themselves in extermination camps. Some quarter Jews were to be spared, but not those with
Jewish facial features who should be treated as half Jews. By the war's end, five to six million
European Jews were so killed, the majority by the gassing procedures that the Nazis' co-opted
human geneticists, psychiatrists, and anthropologists thought appropriate for individuals bearing
genes inimical to the best interests of the German people.
With the liberation first of Poland and then Germany, the full horror of the racially based
genocide policies of National Socialism quickly became known, generating even further disgust
for the pseudoscientific theories of race superiority and purity that underpinned Nazi ideology.
Anyone subsequently calling himself a eugenicist put his reputation as a decent moral human at
risk. In fact, before the war even started, eugenics in the United States already was being
perceived more as a social than a scientific movement. Already in 1930, the leaders of the
Carnegie Institute of Washington had been told that its Cold Spring Harbor Eugenics Record
Station practiced sloppy if not dishonest science. But with its founder Charles Davenport nearing
retirement, it was allowed to expire more slowly than in retrospect it should have. Its doors
closed only when Milos lav Demerec became director of the Department of Genetics in 1942.
There thus was the embarrassment of Harry Laughlin's receipt in 1936 of an honorary degree
from the University of Heidelberg in recognition of his contributions to racial hygiene.
Undoubtedly pleased that eugenics, then fading in the United States, was becoming even more
ascendant in Germany, Laughlin went to New York to receive his diploma from the German
Diplomatic Counsel.
Eugenics, a Dirty Word, as the Search for the Chemical Nature
of the Gene Begins
By the time I first came to Cold Spring Harbor for the summer of 1948, accompanying my Ph.D.
supervisor Salvador Luria, then a professor at Indiana University, the Eugenics Record Office
had been virtually expunged from its consciousness. Only in the library was its ugly past
revealed through the German journals of the 1920s and 1930s on Human Genetics and Race
Hygiene. No one that summer showed any interest in human genetics as a science or toward the
general question of how much of human behavior reflects nature as opposed to nurture. Instead,
genetic research there focused on the fundamental nature of genes and their functioning. It was
not that human genetic diseases had suddenly become unimportant to its director, Milos lav
Demerec. But there was general agreement both by the year-round staff and the many summer
visitors that until the chemical identity of the gene was elucidated and the general pathways by
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which it controlled cell structure and functioning were known, it was premature to even
speculate how genes contributed to human development and behavior.
Then, much sooner than anyone expected, the gene was revealed in 1953 to be DNA. The
genetic code was established by 1966, and gene expression was seen to be controlled by DNA-
binding regulatory proteins between 1967 and 1969. Genetics, happily then, had no reasons to
intersect politics, except in Russia, where the absurdity of its Lamarckian philosophy became
painfully more clear to its intelligentsia with every new major advance in molecular genetics.
These major genetic breakthroughs were largely accomplished using the simple genetic
systems provided by bacteria and their viruses that go under the name phages. By 1969, phage
had become so well understood genetically that it became possible to create specific phage
strains cleverly engineered to carry specific bacterial genes from one bacterial strain to another.
Yet, seeming more ashamed than pleased with their neat science, James Shapiro and Jonathan
Beckwith of Harvard Medical School held with much fanfare a press conference to announce
that their new way to isolate specific genes was on the pathway to eugenically motivated genetic
engineering of human beings. Knowing of the left-wing views of their "Science for the People"
group, I, like most of my colleagues in the Boston region, saw their self-denunciations as
manifestations of unrepentant leftist fears that further genetic research would render inviable the
Communist dogma that assigned all social inequalities to capitalistic selfishness. Shapiro then
moved (temporarily) to Cuba to regain his ideological purity.
Although the phage transductional system developed by Shapiro and Beckwith proved not to
be a forerunner for eventual human genetic engineering, this was not true for the much more
powerful and general "recombinant DNA" methodologies that Herbert Boyer and Stanley Cohen
developed 4 years later, in 1973, just 20 years after the discovery of the double helix. Their new
procedures allowed the isolation (cloning) of specific genes, through their insertion into tiny
chromosomes (plasmids) that could be moved from one cell to another. At roughly the same
time, unexpectedly powerful new ways to determine the exact sequences of the four letters (A,
G, T, and C) of genetic messages were worked out by Fred Sanger in Cambridge, England, and
by Walter Gilbert and Alan Maxam at Harvard. Together, using these two new techniques, the
exact structure of any gene could eventually be determined, given the appropriate facilities and
resources.
The resulting recombinant DNA era, however, despite all the promises it held for major
scientific advances, did not immediately take off. It initially stalled because of fears that among
the many new forms of DNA created in the laboratory would be some that would pose
unacceptable dangers to life as it now exists. In particular was the fear that highly pathogenic
new forms of viruses and bacteria would be created. To give time to assess such potential
dangers scientifically, a scientist-initiated moratorium on recombinant DNA research was
declared in 1975. Effectively, it blocked virtually all recombinant DNA research for the next 2
years, and research concerned with cancer, where worries were expressed that a cancer gene
might become bacterially transmitted, was held up for 2 more years.
During the moratorium, governmental committees were set up in the United States and in
various European countries to assess the potential dangers from recombinant DNA
experimentation in relation to its potential benefits for biology, medicine, and agriculture. No
plausible scientific reasons for stopping such research emerged, and such committees, often
containing public as well as scientific representatives, invariably concluded that in the absence
of any quantifiable potential dangers, it would be irresponsible not to move ahead with
experiments that could dramatically change the nature of biology. In retrospect, these decisions
to move ahead were always the correct ones. For example, cancer research and our knowledge
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of the genetic basis of the immune system, would effectively be back in the scientific middle
ages if the enlightenments made possible through recombinant DNA had not occurred.
To my knowledge, moreover, not one case of recombinant DNA-induced illness has since
occurred. No person has been so killed, nor has even one case of serious illness been attributed
to recombinant DNA, nor do we know of any case where the release into nature of any
recombinant DNA-modified organism has led to any known ecological disaster. This is not to say
that someday a recombinant DNA-induced disease or ecological upset will not occur. Today,
however, there is certainly no logical reason for not exploiting recombinant DNA procedures as
fast as possible for human betterment.
Ideological and Value-based Oppositions to Recombinant DNA Research
Although there was no evidence of danger from recombinant DNA, there soon arose much
visible and sometimes regretfully effective opposition to recombinant DNA research. Here the
distinction should be made between objections from scientists who understand the technical
issues involved and opposition from groups of public citizens who, though not understanding
the science involved, nonetheless oppose much to all recombinant DNA research. Although
some initial opposition arose from scientists whose own DNA research was not going well,
virtually all the continuing scientific opponents at their heart had political hang-ups. As leftists,
they did not want genes involved in human behavioral differences and feared that the onslaught
of scientific advances that would follow from the unleashing of recombinant DNA might
eventually allow genes affecting mental performance to be isolated and studied.
As a member of the Harvard Biology Faculty between 1975 and 1977, I watched in despair
when "Science for the People" successfully assisted the public members of the Cambridge,
Massachusetts, City Council to block recombinant DNA research at our Biological Laboratories.
Later, I asked Salvador Luria, who was then at Massachusetts Institute of Technology and who
knew that his left-wing friends were putting forth scientifically dishonest statements, why he
never publicly criticized them. His reply was that politics was more important than science. This
remark has long haunted me, as my own career owes much to the generous way he shared his
great scientific talents with me at the beginning of my scientific career. But as a Jew, who had to
flee first his native Italy and then France for the eventual safety of the United States, Luria's left-
wing political affinities were understandable, and I'm lucky I never had to so choose.
Specific political ideologies, however, are not the cause of the prolonged and sometimes
effective opposition to recombinant DNA from parts of the general public, particularly in
German-speaking regions. With professional agitators like Jeremy Rifkin playing important roles
in heightening these public fears, such leadership would never have been effective if their
audiences were at emotional ease with the gene and the geneticists who study it. The concept
of genetic determinism is inherently unsettling to the human psyche, which likes to believe that it
has some control over its fate. No one feels comfortable with the thought that we, as humans,
virtually all contain one to several "bad" genes that are likely to limit our abilities to fully enjoy our
lives. Nor do we necessarily take pleasure in the prospect that we will someday have gene
therapy procedures that will let scientists enrich the genetic makeups of our descendants.
Instead, there has to be genuine concern as to whether our children or their governments
decide what genes are good for them.
Genetics as a discipline must thus strive to be the servant of the people, as opposed to these
governments, working to mitigate the genetic inequalities arising from the random mutations that
generate our genetic diseases. Never again must geneticists be seen as the servants of political
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and social masters who need demonstrations of purported genetic inequality to justify their
discriminatory social policies. On the whole, I believe that genetics still commands broad
respect in the United States and in much of Europe, despite the efforts of the recombinant DNA
opponents to portray the genetic manipulations underlying the biotechnology industry as money-
driven actions done at the expense of the public's health and the world's environment.
Unfortunately, genetics and geneticists remain much less highly respected in Germany. There
even today the most benign of recombinant DNA experiments remain controversial and subject
to needless regulation. Propagation of genetically engineered plants is routinely sabotaged, with
the mere practice of human genetics regarded as a criminal act by extremists on the left.
This German dislike for the gene and its human-directed manipulations is easily assignable
to their Nazi eugenics past. The vile actions then done in the name of the gene hover as almost
permanent nightmares never erasable from their national identity. As human beings, never sure
that the world is immune from further such depraved behavior, we should never let this awful
past slip from our consciousness. At the same time, the whole civilized world will suffer if today's
German geneticists are unfairly thought to be cut from the same material that clothed those
German geneticists, anthropologists, and psychiatrists who not only assisted the Nazi eugenic
efforts, but promoted them as scientific-based necessities for German progress.
Part of today's problem may lie in the postwar fate of Hitler's biological conspirators. Naively
as outsiders we long assumed that they would have all been treated as potential if not real war
criminals, with even those of only slight guilt losing all further opportunities for academic
existence. But as the German geneticist, Benno Muller-Hill, courageously pointed out in his 1984
book, Todlicle Wissenschaff (Murderous Science, Oxford University Press 1988), there was no
attempt by the German academic community to find out what truly happened. Instead, it was
academically dangerous in Germany to explore the half-truths that allowed many key
practitioners of Nazi eugenics to resume important academic posts. A number of professors who
early joined the Nazi Party or SS and were directly involved with its genocide programs
committed suicide, but there were many Nazi-assisting scientists, successfully claiming that they
were only apolitical advisors, who slid quietly back into academic prominence.
The most damning example was that of Professor Otmar von Verschuer, who actively helped
the Nazis-first at the Kaiser Wilhelm Institute of Anthropology under Professor Eugen Fischer
and later at his own Institute of Human Genetics in Frankfurt. Involved in distinguishing Jews and
part-Jews, he later closely collaborated with his former assistant, the now-notorious Joseph
Menge le, then doing "scientific" research at Auschwitz. After the war, he nonetheless was
appointed to be Professor of Human Genetics at the University of Munster. Equally disturbing
was the postwar appointment of Fritz Lenz as head of an institute for the study of human heredity
at the University of Gottingen, Germany's most distinguished university. Although clearly a very
competent scientist, he was a major advisor for laws on euthanasia between 1939 and 1941, as
well as author of a 1940 memorandum, "Remarks on resettlement from the point of view of
guarding the race."
The postwar 1949 exoneration of von Verschuer occurred despite knowledge of the 1946
article in Die New Zeit accusing him of studying eyes and blood samples sent to him from
Auschwitz by Joseph Menge le. Yet a committee of professors, including Professor Adolf
Butenandt, later the head of the Max Planck Gesellschaft (the postwar name for the Kaiser
Wilhelm Gesellschaft), concluded that von Verschuer, who possessed all the qualities
appropriate for a scientific researcher and teacher of academic youth, should not be judged on
a few isolated events of the past. I find it difficult to believe that the Butenandt committee had
gone to the trouble of reading his article published in the Volkischer Beobachter 1-8-42. In it he
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wrote, 'Never before in the course of history has the political significance of the Jewish question
emerged so clearly as it does today. Its definitive solution as a global problem will be
determined during the course of this war.' Now there may be more reason to remember
Professor Butenandt for his part in the von Verschuer whitewash than for his prewar Nobel prize
for research on the chemistry of the estrogen sex hormone.
Genuine Human Genetics Emerges from Recombinant DNA Methodologies
Long holding back the development of Human Genetics as a major science was the lack of a
genetic map allowing human genes to be located along the chromosomes on which they reside.
As long as conventional breeding procedures remained the only route to gene mapping, the
precise molecular changes underpinning most human genetic diseases seemed foreordained to
remain long mysterious. The key breakthrough opening a path around this seemingly
insuperable obstacle came in the late 1970s when it was discovered that the exact sequence
(order of the genetic letters A, G, T, and C) of a given gene varies from one person to another.
Between any two individuals, roughly 1 in 1000 bases are different, with such variations most
frequently occurring within the noncoding DNA regions not involved in specifying specific amino
acids. Initially most useful were base differences (polymorphisms) which affected DNA cutting
by one of the many just discovered 'restriction enzymes' that cut DNA molecules within very
specific base sequences.
Soon after the existence of DNA polymorphisms became known, proposals were made that
they could provide the genetic markers needed to put together human genetic maps. In a 1980
paper, David Botstein, Ron Davis, Mark Scolnick, and Ray White argued that human maps could
be obtained through studying the pattern through which polymorphisms were inherited in the
members of large multigenerational families. Those polymorphisms that stay together were likely
to be located close to each other on a given chromosome. During the next 5 years, two groups,
one led by Helen Donis-Keller in Massachusetts, the other led by Ray White in Utah, rose to this
challenge, both using DNA from family blood samples stored at CEPH (Centre d'Etude du
Polymorphisme Humain), the mapping center established in Paris by Jean Dausset. By 1985,
the mutant genes responsible for Huntington's Disease and Cystic Fibrosis (CF) had been
located on chromosomes 4 and 7, respectively.
By using a large number of additional polymorphic markers in the original chromosome 7
region implicated in CF, Francis Collins' group in Ann Arbor and L.C. Tsui's group in Toronto
located the DNA segment containing the responsible gene. Its DNA sequence revealed that the
CF gene coded for a large membrane protein involved in the transport of chloride ions. The first
CF mutant they found contained three fewer bases than its normal equivalent and led to a
protein product that was nonfunctional because of its lack of a phenylalanine residue.
The Human Genome Project: Responding to the Need for Efficient Disease
Gene Mapping and Isolation
Although the genes responsible for cystic fibrosis. and Huntington's Disease were soon
accurately mapped using only a small number of DNA polymorphic markers, the genes behind
many other important genetic diseases quickly proved to be much harder to map to a specific
chromosome, much less assign to a DNA chromosomal segment short enough to generate
hopes for its eventual cloning. All too obviously, the genes behind the large set of still very badly
understood diseases like Alzheimer's disease, late-onset diabetes, or breast cancer would be
mapped much, much sooner if several thousands more newly mapped DNA polymorphisms
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somehow became available. Likewise, the task of locating the chromosomal DNA segment(s) in
which the desired disease genes reside would be greatly shortened if all human DNA were
publicly available as sets of overlapping cloned DNA segments (contigs). And the scanning of
such DNA segments to look for mutationally altered base sequences would go much faster if the
complete sequence of all the human DNA were already known. However, to generate these
importantly new resources for human genetics, major new sources of money would be needed.
So, by early 1986, serious discussions began as to how to start, soon, the complete sequencing
of the 3 x 109 base pairs that collectively make up the human genome (the Human Genome
Project or HGP).
Initially, there were more scientific opponents than proponents for what necessarily would be
Biology's first megaproject. It would require thousands of scientists and the consumption of
some $3 billion-like sums. Those disliking its prospects feared that, inevitably, it would be run by
governmental bureaucrats not up to the job and would employ scientists too dull for assignment
to this intellectually challenging research. Out of many protracted meetings held late in 1986 and
through 1987, the argument prevailed that the potential rewards for medicine as well as for
biological research itself would more than compensate for the monies the Human Genome
Project would consume during the 15 years then thought needed to complete it. Moreover,
completion of each of the two stages-the collection of many more mapped DNA markers and
the subsequent ordering of cloned DNA segments into long overlapping sets (contids)-would
by themselves greatly speed up disease gene isolation.
Always equally important to point out, the 15 years projected to complete the Human
Genome Project meant that its annual cost of $200 million at most would represent only 1-2% of
the money spent yearly for fundamental biomedical research over the world. There was also the
realization that some 100,000 human genes believed sited along their chromosomes would be
much easier to find and functionally understand if genome sequences were first established for
the much smaller, well-studied model organisms such as Escherichia coli, Saccharomyces
cerevisiae, Caenorhabditis elegans, and Drosophila melanogaster. Thus, the biologists who
worked with these organisms realized that their own research would be speeded up if the
Human Genome Project went ahead.
The American public, as represented by their congressional members, proved initially to be
much more enthusiastic about the objectives of the Human Genome Project than most
supposedly knowledgeable biologists, with their parochial concerns for how federal monies for
biology would be divided up. The first congressionally mandated monies for the Human Genome
Project became available late in 1987, when many intelligent molecular geneticists still were
sitting on the fence as to whether it made sense. In contrast, Congress, being told that big
medical advances would virtually automatically flow out of genome knowledge, saw no reason
not to move fast. In doing so, they temporarily set aside the question of what human life would
be like when the bad genes behind so many of our major diseases were found. Correctly, to my
mind, their overwhelming concern was the current horror of diseases like Alzheimer's, not seeing
the need then to, perhaps prematurely, worry about the dilemmas arising when individuals are
genetically shown at risk for specific diseases years before they show any symptoms.
Genome Ethics: Programs to Find Ways to Ameliorate Genetic Injustice
The moment I began in October 1988 my almost 4-year period of helping lead the Human
Genome Project, I stated that 3% of the NIH-funded component should support research and
discussion on the Ethical, Legal, and Social Implications (ELSI) of the new resulting genetic
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knowledge. A lower percentage might be seen as tokenism, while I then could not see wise use
of a larger sum. Under my 3% proposal, some $6 million (3% of $200 million) would eventually
be so available, a much larger sum than ever before provided by our government for the ethical
implications of biological research.
In putting ethics so soon into the Genome agenda, I was responding to my own personal fear
that all too soon critics of the Genome Project would point out that I was a representative of the
Cold Spring Harbor Laboratory that once housed the controversial Eugenics Record Office. My
not forming a genome ethics program quickly might be falsely used as evidence that I was a
closet eugenicist, having as my real long-term purpose the unambiguous identification of genes
that lead to social and occupational stratification as well as to genes justifying racial
discrimination. So I saw the need to be proactive in making ELSI's major purpose clear from its
start-to devise better ways to combat the social injustice that has at its roots bad draws of the
genetic dice. Its programs should not be turned into public forums for debating whether genetic
inequalities exist. With imperfect gene copying always the evolutionary imperative, there
necessarily will always be a constant generation of the new gene disease variants and
consequential genetic injustice.
The issues soon considered for ELSI monies were far-ranging. For example, how can we
ensure that the results of genetic diagnosis are not misused by prospective employers or
insurers? How should we try to see that individuals know what they are committing themselves to
when they allow their DNA to be used for genetic analyzing? What concrete steps should be
taken to ensure the accuracy of genetic testing? And when a fetus is found to possess genes
that will not allow it to develop into a functional human being, who, if anyone, should have the
right to terminate the pregnancy?
From their beginnings, our ELSI programs had to reflect primarily the needs of individuals at
risk of the oft tragic consequences of genetic disabilities. Only long-term harm would result in
the perception of genetics as an honest science if ELSI-type decisions were perceived to be
dominated either by the scientists who provided the genetic knowledge or by the government
bodies that funded such research. And since women are even in the distant future likely to
disproportionately share the burden of caring for the genetically disabled, they should lead the
discussions of how more genetic knowledge is to come into our lives.
Human Hesitations in Learning Their Own Genetic Fate
With the initial distribution of American genome monies and the building and equipping the
resulting genome centers taking 2 years, the Human Genome Project in its megaphase did not
effectively start until the fall of 1990. Decisions to go ahead by funding bodies in the United
States helped lead to the subsequent inspired creation of Genethon outside Paris by the French
genetic disease charity, Association Francaise contre les Myopathies (AFM), as well as the
building of the now immense Sanger Centre, just south of Cambridge, England, by the British
medically oriented charity, the Wellcome Trust. Now effectively 7 years into its projected 15-year
life, the Human Genome Project has more than lived up to its role in speeding up genetic
disease mapping and subsequent gene cloning. It quickly made successful the search for the
gene behind the Fragile X syndrome that leads to severe mental retardation in boys
preferentially affected by this sex-linked genetic affliction. The molecular defect found was an
expansion of preexisting three-base repetitive sequences that most excitingly increase in length
from one generation to the next. The long mysterious phenomenon of anticipation, in which the
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severity of a disease grows through subsequent generations, was thus given a molecular
explanation. Then at long last, in 1994, the gene for Huntington's Disease was found. Its cause
was likewise soon found to be the expansion of a repetitive gene sequence.
While the mapping to a chromosome per se of any disease gene remains an important
achievement, the cloning of the disease gene itself is a bigger milestone. Thus, the 1990 finding
by Mary Claire King that much hereditary breast cancer is due to a gene on chromosome 17 set
off a big gene-cloning race. With that gene in hand, there was a chance that its DNA sequence
would reveal the normal function of the protein it codes for. In any case, it gives its possessors
the opportunity to examine directly the DNA from individuals known to be at risk for a disease to
see whether they had the unwanted gene. Thus, when in 1993 the chromosome 17 breast
cancer gene (BRAC1) was isolated by Myriad, the Utah disease gene-finding company, it could
inform women so tested for BRAC1 whether or not they had the feared gene.
Initially, concerns were voiced that unbridled commercialization of this capability would all
too easily give women knowledge they would not be psychologically prepared to handle. If so,
the ethical way to prevent such emotional setbacks might be to regulate both how the tests were
given and who should be allowed to be tested. I fear, however, that a major reason behind many
such calls for regulation of genetic testing is the hidden agenda of wanting to effectively stop
widespread genetic testing by making it so difficult to obtain. Now, however, calls for
governmental regulation may fall on increasingly deaf ears. To Myriad's great disappointment, it
appears that the great majority of women at 50% risk of being breast cancer gene carriers don't
want to be tested. Rather than receive the wrong verdict, they seem to prefer living with
uncertainty. Likewise, a very large majority of the individuals at risk for Huntington's Disease are
also psychologically predisposed against putting themselves at risk of possibly knowing of their
genetic damnation.
Although we are certain to learn in the future of many individuals regretting that they
subjected themselves to genetic tests and wishing they had been more forewarned of the
potential perils of such knowledge, I do not see how the state can effectively enter into such
decisions. Committees of well-intentioned outsiders will never have the intimate knowledge to
assess a given individual's psychological need, or not, for a particular piece of scientific or
medical knowledge. In the last analysis, we should accept the fact that if scientific knowledge
exists, individual persons or families should have the right to decide whether it will lead to their
betterment.
Inarguable Existence of Genes Predisposing Humans to
Behavioral Disorders
The extraordinarily negative connotations that the term eugenics now conveys is indelibly
identified with its past practitioners' unjustified statements that behavioral differences, whether
between individuals, families, or the so-called races, largely had their origins in gene
differences. Given the primitive power of human genetics, there was no way for such broad-
ranging assertions to have been legitimatized by the then methods of science. Even the
eugenically minded psychiatrists' claims that defective genes were invariably at the root of their
mental patients' symptoms were no more than hunches. Yet, it was by their imputed genetic
imperfection that the mentally ill were first sterilized and then, being of no value to the wartime
Third Reich, released from their lives by subsequent "mercy killings."
But past eugenic horrors in no way justify the "Not in Our Genes" politically correct outlook of
many left-wing academics. They still spread the unwarranted message that only our bodies, not
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our minds, have genetic origins. Essentially protecting the ideology that all our troubles have
capitalistic exploitative origins, they are particularly uncomfortable with the thought that genes
have any influence on intellectual abilities or that unsocial criminal behavior might owe its origins
to other than class or racially motivated oppression. Whether these scientists on the left actually
believe, say, that the incidence of schizophrenia would seriously lessen if class struggles ended,
however, is not worth finding out.
Instead, we should employ, as fast as we can, the powerful new techniques of human
genetics to find soon the actual schizophrenia predisposing genes. The much higher concor-
dance of schizophrenia in identical versus nonidentical twins unambiguously tells us that they
are there to find. Such twin analysis, however, reveals that genetics cannot be the whole picture.
Since the concordance rates for schizophrenia, as well as for manic-depressive disease, are
more like 60%, not 100%, environmental predisposing factors must exist and, conceivably, viral
infections that affect the brain are sometimes involved.
Unfortunately, still today, the newer statistical tricks for analyzing polymorphic inheritance
patterns have not yet led to the unambiguous mapping of even one major schizophrenic gene to
a defined chromosomal site. The only convincing data involve only the 1% of schizophrenics
whose psychoses seemingly are caused by the small chromosome 22 deletions responsible
also for the so-called St. George facial syndrome. Manic-depressive disease also has been
more than hard to understand genetically. Only last year did solid evidence emerge for a major
predisposing gene on the long arm of chromosome 18. This evidence looks convincing enough
for real hopes that the actual gene involved will be isolated over the next several years.
Given that over half the human genes are thought to be involved in human brain development
and functioning, we must expect that many other behavioral differences between individuals will
also have genetic origins. Recently, there both "reckless personalities"
and "unipolar depressions" associate with specific polymorphic forms of genes coding for the
membrane receptors involved in the transmission of signals between nerve cells. Neither claim
now appears to be reproducible, but we should not be surprised to find some subsequent
associations to hold water. Now anathematic to left-wing ideologues is the highly convincing
report of a Dutch family, many of whose male members display particularly violent behavior.
Most excitingly, all of the affected males possess a mutant gene coding for an inactive form of
the enzyme monoamine oxidase. Conceivably having too little of this enzyme, which breaks
down neurotransmitters, leads to the persistence of destructive thoughts and the consequential
aggressive patterns. Subsequent attempts to detect in other violent individuals this same mutant
gene have so far failed. We must expect someday, however, to find that other mutant genes that
lead to altered brain chemistry also lead to asocial activities. Their existence, however, in no way
should be taken to mean that gene variants are the major cause of violence. Nonetheless,
continued denials by the scientific left that genes have no role in how people interact with each
other will inevitably further diminish their already tainted credibility.
Keeping Governments Out of Genetic Decisions
No rational person should have doubts whether genetic knowledge properly used has the
capacity to improve the human condition. Through discovering those genes whose bad variants
make us unhealthy or in some other way unable to function effectively, we can fight back in
several different ways. For example, knowing what is wrong at the molecular level should let us
sometimes develop drugs that will effectively neutralize the harm generated by certain bad
genes. Other genetic disabilities should effectively be neutralized by so-called gene therapy
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procedures restoring normal cell functioning by adding good copies of the missing normal
genes. Although gene therapy enthusiasts have promised too much for the near future, it is
difficult to imagine that they will not with time cure some genetic conditions.
For the time being, however, we should place most of our hopes for genetics on the use of
antenatal diagnostic procedures, which increasingly will let us know whether a fetus is carrying a
mutant gene that will seriously proscribe its eventual development into a functional human
being. By terminating such pregnancies, the threat of horrific disease genes continuing to blight
many families' prospects for future success can be erased. But even among individuals who
firmly place themselves on the pro-choice side and do not want to limit women's rights for
abortion, opinions frequently are voiced that decisions obviously good for individual persons or
families may not be appropriate for the societies in which we live. For example, by not wanting to
have a physically or mentally handicapped child or one who would have to fight all its life
against possible death from cystic fibrosis, are we not reinforcing the second-rate status of such
handicapped individuals? And what would be the consequences of isolating genes that give rise
to the various forms of dyslexia, opening up the possibility that women will take antenatal tests to
see if their prospective child is likely to have a bad reading disorder? Is it not conceivable that
such tests would lead to our devoting less resources to the currently reading-handicapped
children whom now we accept as an inevitable feature of human life?
That such conundrums may never be truly answerable, however, should not concern us too
much. The truly relevant question for most families is whether an obvious good to them will come
from having a child with a major handicap. Is it more likely for such children to fall behind in
society or will they through such affliction develop the strengths of character and fortitude that
lead, like Jeffrey Tate, the noted British conductor, to the head of their packs? Here I'm afraid
that the word handicap cannot escape its true definition-being placed at a disadvantage. From
this perspective, seeing the bright side of being handicapped is like praising the virtues of
extreme poverty. To be sure, there are many individuals who rise out of its inherently degrading
states. But we perhaps most realistically should see it as the major origin of asocial behavior that
has among its many bad consequences the breeding of criminal violence.
Only harm, thus, I fear will come from any form of society-based restriction on individual
genetic decisions. Decisions from committees of well-intentioned individuals will all too often
emerge as vehicles for seeming to do good as opposed to doing good. Moreover, we should
necessarily worry that once we let governments tell their citizens what they cannot do
genetically, we must fear they also have power to tell us what we must do. But for us as
individuals to feel comfortable making decisions that affect the genetic makeups of our children,
we correspondingly have to become genetically literate. In the future, we must necessarily
question any government which does not see this as its responsibility. Will it so not act because
it wants to keep such powers for itself?
The Misuse of Genetics by Hitler Should Not Deny Its Use Today
Those of us who venture forth into the public arena to explain what Genetics can or cannot do
for society seemingly inevitably come up against individuals who feel that we are somehow the
modern equivalents of Hitler. Here we must not fall into the absurd trap of being against
everything Hitler was for. It was in no way evil for Hitler to regard mental disease as a scourge
on society. Almost everyone then, as still true today, was made uncomfortable by psychotic
individuals. It is how Hitler treated German mental patients that still outrages civilized societies
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and lets us call him immoral. Genetics per se can never be evil. It is only when we use or misuse
it that morality comes in. That we want to find ways to lessen the impact of mental illness is
inherently good. The killing by the Nazis of the German mental patients for reasons of supposed
genetic inferiority, however, was barbarianism at its worst.
Because of Hitler's use of the term Master Race, we should not feel the need to say that we
never want to use genetics to make humans more capable than they are today. The idea that
genetics could or should be used to give humans power that they do not now possess, however,
strongly upsets many individuals first exposed to the notion. I suspect such fears in some ways
are similar to concerns now expressed about the genetically handicapped of today. If more
intelligent human beings might someday be created, would we not think less well about
ourselves as we exist today? Yet anyone who proclaims that we are now perfect as humans has
to be a silly crank. If we could honestly promise young couples that we knew how to give them
offspring with superior character, why should we assume they would decline? Those at the top
of today's societies might not see the need. But if your life is going nowhere, shouldn't you seize
the chance of jump-starting your children's future?
Common sense tells us that if scientists find ways to greatly improve human capabilities,
there will be no stopping the public from happily seizing them.
April 25, 1997 James D. Watson
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DIRECTOR'S
REPORT
Throughout many critical periods in the history of the Laboratory, there have been times when a
decision to embark on a new research direction has been facilitated by the assembly of a small
number individuals who share a common interest. Typically, the new research endeavor has
focused around the interests of one or two scientists who provide a complementary approach to
a single important problem. Coupled with the recruitment of these young scientists, the
Laboratory helps foster interest in the research by establishing courses and meetings so that the
new field becomes widely accessible to the broader scientific community. In this way, vigorous
new areas of research at Cold Spring Harbor have emerged and more often than not, they have
had great impact on biological research in general.
One of the most spectacular examples was the congregation at Cold Spring Harbor in the
1940s of scientists who believed that studying bacteria and the bacterial viruses known as
bacteriophages would offer unique insights into the nature of inheritance and of life itself. Made
possible by the ravages of war in Europe and the resultant exodus of brilliant young scientists
from war-torn countries to the United States, Milislav Demerec (Director 1941-1960) assembled
a group of investigators at Cold Spring Harbor who became known as the phage group.
Principle among these were Max Delbruck, Salvador Luria, and Alfred Hershey, resident
summer scientists at Cold Spring Harbor. Hershey later accepted one of Demerec's new
appointments to the full-time scientific staff. This effective mix of permanent Laboratory faculty
and visiting summer scientists ushered in a new era of biological discovery, the precursor to the
field now known as molecular biology. Facilitating the expansion of the new research was the
establishment of advanced courses at the Laboratory for scientists who wanted to join in on the
exciting new opportunities.
A repeat of this phenomena occurred when Jim Watson was appointed Director in 1968 and
began to assemble the DNA tumor virus group. The huge expansion of funding for cancer
research following the declaration in 1971 of the "War on Cancer" and the exciting opportunities
made possible with the ushering in of the recombinant DNA era in 1973 were welcome
developments that further boosted research at Cold Spring Harbor. Here again, an interesting
mixture of new young staff scientists and visitors to the Laboratory brought new technologies
and a research focus that caused a renaissance within the institution. Remarkably, this new
research direction was accomplished by the appointment of young scientists who were at the
earliest stages of their careers.
Many alumni from that era have gone on to continue their careers throughout the U.S. and
numerous other countries as some of the most prominent scientists in the broad field of
molecular biology. Most came to the Laboratory immediately after completion of their doctorates
and many of these were later promoted to the scientific staff. I was fortunate to have the
opportunity to come to Cold Spring Harbor as a Postdoctoral Fellow in 1979 when the tumor
virus program was in full swing. Even though some of the earlier scientists had by then moved
on to other institutions that wanted tumor virus research of their own, the constant recruitment of
young new talent ensured a vigorous research program. The Laboratory was a dynamic and
expanding place, with a balance of established, but still young, scientists coupled with newer
recruits that hoped to join in on the excitement of the day. I was also happy to be given the
opportunity to continue my studies on the replication of adenovirus DNA that were started when I
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was a graduate student in Australia, even though no one was at Cold Spring Harbor working on
this topic at the time. The Laboratory was, and remains today an attractive place for Postdoctoral
Fellows to pursue research in an environment that offered fantastic research capabilities and a
large measure of freedom to follow one's interests. Summer visitors in residence also added to
the variety of research life, although with today's dual income families, this aspect of science at
Cold Spring Harbor is becoming all too difficult to continue.
The success of the tumor virus program set the seeds for expansion of the Laboratory into
other research areas that were partially related to the immediate focus of the 1970s. The
philosophy of bringing a number of investigators together to attack a particular biological
problem was repeated many times over. The assemblage of the 'yeast group' to study the
control of mating-type and the developmental control of gene expression by DNA transposition
in the late 1970s and the early 1980s resulted in ensuring that the Laboratory was one of the
preeminent institutions in the world that studied yeast genetics. This expansion also helped other
research groups to begin to exploit the power of yeast genetics in their own research programs.
The establishment of the yeast group was preceded by the Laboratory's holding a postgraduate
course on the molecular biology and genetics of yeast that was begun in 1970 by Gerry Fink
and Fred Sherman, a course that is still taught each year. In this case, the course had an impact
on the future science at the Laboratory, rather than the other way around. The completion this
year of the sequence of the entire genome of the yeast Saccharomyces cerevisiae, the first
eukaryotic genome to be sequenced, ensures that this organism will remain an attractive model
for understanding the more complex mammalian cells.
More recently, the outstanding success of the Laboratory's neurobiology research program
that is devoted to understanding cognition derives from decisions in 1990 and 1991 to bring
together young scientists who all have a common interest in learning and memory. Following in
the tradition of the Laboratory, it was also decided to focus on a genetic approach to the
complexity of brain function. There was much concern among our advisors that a genetic
approach to understanding cognition would not work, but our belief in the program and in the
young scientists, coupled with the ability to find the necessary funds to support the
establishment and operating costs over the first critical three or four years, has resulted in a
remarkable program. Just as other successful programs have in the past, we must now ensure
that the learning and memory program can continue to expand and evolve. Part of this can be
achieved by the establishment of new postgraduate courses at the Laboratory to foster new
technologies and expansion of the research to other institutions. This year saw the introduction
of a course on Mouse Behavioral Analysis as an important addition to our rich stable of courses
on neurobiology. This course will couple genetic and behavioral techniques that were foreign to
each other a short while ago.
Our history suggests that the bringing together of a number of talented, young investigators
who share a common interest creates a research environment that transcends the sum of the
individual research programs. It also helps enormously to have scientists who develop their
independent research careers at the Laboratory so that they more easily fit into the Cold Spring
Harbor style of science. It is by no accident that all of our scientific staff were recruited to the
Laboratory at the early stages of their independent research careers. It is also exciting to
witness the development of these individuals and their research programs, some of which will
forever change the Laboratory.
Flexibility to pursue new research areas has been one of the key ingredients to the success
and high productivity of the Laboratory. While we regret that our highly successful scientists get
lured to senior positions in universities, the Laboratory takes the opportunity to appoint bright
young investigators who come here and develop their own programs at the cutting edge of
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research. Thus, a healthy mixture of senior faculty positions together with an influx of new blood
seems to be essential for our continued success.
In 1986, one aspect of this approach was formalized when the Laboratory began the Cold
Spring Harbor Fellow program. Modeled in part after the Junior Fellows program at Harvard, it is
intended to offer opportunities for very talented research scientists who have just completed
their Ph. D. or M. D. degrees. These unique scientists work at the Laboratory for a period of
three years, unencumbered by the normal constraints of formal postdoctoral training in someone
else's laboratory. The Laboratory provides salary, technical support, and the necessary funds to
support research on a topic of the Fellow's choosing, sometimes in collaboration with existing
faculty members, but more often than not, independent of research that involves collaboration.
Each of the Cold Spring Harbor Fellows appointed to data has been highly successful. Two
former Fellows, Adrian Krainer and Carol Greider, completed highly successful fellowships and
were promoted to the scientific staff as independent faculty members. Both are now well
respected, senior scientists in their field. Two other former Fellows completed outstanding
research at the Laboratory but unfortunately, were then lured to universities; David Barford
returned to a faculty position at Oxford University and Eric Richards moved to a faculty position
at Washington University in St. Louis. Our initial intention was to have a single Fellow in
residence at any one time, but the success of this program suggests that we should expand the
number of Fellows in residence. Outstanding students can be nominated for appointment as a
Fellow at any time by scientists at universities.
Although tradition has it that recently graduated students will benefit from the ability to
perform postdoctoral research in someone else's laboratory, I believe that a few selected
students have the ability to continue their graduate studies as independent investigators. The
Cold Spring Harbor Fellows program offers this opportunity in a highly supportive research
environment. The success of this program is reflected by the fact that this year we appointed
two Cold Spring Harbor Fellows, Scott Lowe and Ueli Grossniklaus to the Laboratory faculty,
where they will be able to expand their research by recruitment of additional personnel.
This year also saw a reorganization of the structure of the faculty positions at the Laboratory.
This was done in part because the new appointments at the Assistant Investigator, Associate
Investigator, or Investigator level parallel similar appointments at research universities and the
Howard Hughes Medical Institute. Perhaps the most significant change was the appointment of
our new faculty to an initial five-year term, rather than the old three-year appointment. Although
this provides additional financial burdens on the Laboratory, it also offers these new
investigators the time to develop innovative research programs that may take some time to
develop. The constant recruitment of new investigators, with their accompanying start-up funds,
the need to renovate laboratories and to provide the necessary research equipment, taxes the
ability of the Laboratory to support such research, but in the long run, it is these new research
areas that often provide the focus for longer term stability.
It is with considerable pride that we reflect on the accomplishments of our alumni who very
often made their first important discoveries at the Laboratory. At the same time, the vigor of our
current research programs suggest that the Cold Spring Harbor style of doing science continues
to be productive.
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HIGHLIGHTS OF THE YEAR
Research Highlights
The Tumor Virus Program
Much to my satisfaction, the 1996 review of the Lab's the DNA Tumor
Virus Program Project Grant resulted in renewal of this funding for the
fifth time. As the term of the grant is five years, we enter our 26th year
with this Program Project Grant, good through the year 2001.
This grant was established 25 years ago by Jim Watson and Joe
Sambrook to use DNA tumor viruses to study cancer. In 1968, the Lab
changed direction toward the study of DNA viruses that infect mam-
malian cells. Jim recruited Joe Sambrook, among others, to pursue these
studies and in 1971 the first application was made for a large ($1 million)
program project grant. This program project continues to be a corner-
stone of cancer research at the Lab to this day. Over the years this grant
has supported the studies of Joe Sambrook, Richard Roberts, Robert
Tjian, Michael Botchan, Phillip Sharp, Louise Chow, Earl Ruley, Ed Har-
low, Terri Grodzicker, Michael Mathews, Yakov Gluzman, and myself, as
well as many others. It was this grant that supported Richard Roberts'
studies on split genes that resulted in his winning the Nobel Prize in 1993
with Phillip Sharp.
The Program Project continues to use DNA tumor viruses to probe
how normal cells become cancer cells and now includes Winship Herr,
Arne Stenlund, Adrian Krainer, Ryuji Kobayashi, and myself. Additional
components of cancer research recently added to the grant are studies
by Carol Greider into the involvement of telomerase in tumor progression
and a multifaceted approach aimed at understanding the mechanisms
and regulation of programed cell death (apoptosis) in cancer cells by
Scott Lowe (a former Cold Spring Harbor Fellow), and Yuri Lazebnik.
Apoptosis involves a mechanism-built into every cell-that will cause the
cell to self-destruct when it is triggered. This process is vital to
Yuri Lazebnik and Scott Lowe
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development, ridding organisms of unnecessary cells (i.e., webs from
human embryo fingers and toes, and tails from tadpoles as they become
frogs) and also by destroying damaged or diseased cells. Most conven-
tional cancer therapies work by triggering apoptosis, and Scott and Yuri
each study different aspects of this process.
Scott Lowe reported, early in the year, the discovery of an important
characteristic of the p53 gene-a known tumor suppressor. Cells at the
center of solid tumors usually die from hypoxia, a lack of oxygen that
results from the dense cellular overcrowding caused by the rampant cell
division that is characteristic of cancer. Some cells, however, survive in
these hypoxic conditions, and Scott, with Tom Graeber and colleagues
at Stanford University School of Medicine, has shown that it is the cells
with a p53 mutation that survive. Scott had shown previously that cells
with a p53 mutation are immune to the effects of conventional cancer
therapies. Together these studies provide a link between tumor growth
and resistance to cancer therapy; tumor cells which acquire p53 muta-
tions would survive hypoxic conditions and simultaneously become less
susceptible to cancer therapy.
Yuri Lazebnik, who studies the mechanisms involved in the execution
of programed cell death, has also focused on drug resistance in cancer
cells, and is looking for ways to by-pass this therapeutic obstacle. Be-
cause conventional cancer therapy typically triggers apoptosis by
damaging the cell to the point that it self-destructs, Yuri is trying to un-
derstand why this machinery is not active in some tumor cells despite the
presence of the cell death signal. In addition, he is trying to discover how
the latent signal in tumor cells can be activated.
Yuri uses an experimental cell-free system that he developed by
mixing cytoplasmic extract from a cell with purified nuclei. Howard
Fearnhead of Yuri's lab made an interesting observation in the cell-free
system. When he used an extract from normal cells there were no
changes to the nuclei, but the addition of an extract from untreated,
drug-resistant tumor cells caused apoptotic changes in the nuclei-they
began to fragment in the same way as nuclei in dying cells. This indi-
cated that drug-resistant cells have the apoptotic machinery, but they
cannot sense the triggering signal that is present. In collaboration with
Scott Lowe, Yuri's lab traced the origin of this signal and found that it is
generated by the very same oncogene that transformed the cell to be-
come drug-resistant. Yuri's lab is now working to further identify the
oncogene-generated activity. The hope is that this knowledge could be
used to find a way to selectively activate apoptosis in cancer cells.
Cell Cycle
Studies of the cell cycle are also an important component of cancer re-
search and this year cell cycle studies in yeast and in mammalian cancer
cells complimented one another. Bruce Futcher's lab has been working
to understand how the essential cyclin-dependent protein kinase (CDK)
complex (Cdc28 -Cln) controls commitment to cell division in yeast, a
popular model organism for cancer research. They were particularly in-
terested in how Cdc28-Cln promotes DNA replication. They knew of a
protein, Sicl , that inhibits other CDK protein kinases that are necessary
for DNA replication. Last year, postdoctoral researcher Brandt Schneider
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and graduate student Qing-Hong Yang in the Futcher lab showed that
the Cdc28-Cln complex places phosphates on Sic1, following which the
phosphorylated Sic1 is attacked by enzymes that digest the protein,
thereby allowing DNA replication to begin. In cells that have Sic1, the CIn
proteins were essential for replication. A striking observation was that
mutant yeast cells lacking Sic1 could commit to DNA replication and cell
division even when they lacked the Cln proteins. These results show that
the only essential activity of the Cln-like cyclins and the CDK partner
CDC28, is to control an inhibitor (sic1) of cyclin CDKs that regulate DNA
replication.
These studies complement David Beach's work on the cell cycle in
mammalian cells. Beach's lab and others have shown that the Retino-
blastoma protein (Rb), an important tumor suppressor which inhibits
entry into the cell cycle, is itself inhibited by the Cdk4-Cyclin D protein
kinase complex-which is similar to the yeast Cdc28-Cln complex.
Beach's lab has found that while Cdk4-Cyclin D is normally essential for
DNA replication, it is dispensable in mutants lacking Rb. Furthermore,
they have shown that another tumor suppressor protein, p16, regulates
Cdk4-cyclin D activity by functioning as a CDK inhibitor.
Many clinical studies have shown that the p16 tumor suppressor is
mutated in a wide variety of human cancers. In collaboration with Ron
DePinho's laboratory at the Albert Einstein College of Medicine, the gene
that encodes p16 has been mutated in a line of mice so that the mice no
longer express the protein. These mice develop tumors of various types
at a very high rate, providing proof of the role of p16 as a tumor suppres-
sor. These "knock-out" mice will provide a valuable animal model for the
study of human cancer therapy.
Phosphatases
In other cell cycle work, David Beach and Konstantin Galaktionov made
the important discovery of the regulatory target of the myc onco-gene.
That myc is an oncogene has long been known, as has its role in cell
cycle: the Myc protein is a driving force in cell division, and in partner-
ship with a protein called Max, can promote either oncogenic transforma-
tion (cancer) or apoptosis (programed cell death). Myc is known to be a
transcription factor for controlling gene expression, but the critical target
genes whose expression it regulates remained obscure. David and
Konstantin have found that the cdc25A protein is the target of Myc's
function. They were studying Cdc25A because their earlier studies in
yeast showed that it was an important CDK regulator, a so-called protein
phosphatase. Interestingly, elevated levels of cdc25A have been found
in a significant number of breast tumors and other cancers, making these
cell cycle components a prime target for anti-cancer drug discovery ef-
forts.
Nicholas Tonks' lab has continued to move forward in their work on
the role of protein tyrosine phosphatases (PTPases). These enzymes
catalyze dephosphorylation-the removal of phosphate groups from
molecules which have been phosphorylated by protein kinases. In 1994,
Nick and then-Cold Spring Harbor Fellow and X-ray crystallographer
David Barford determined the first three-dimensional structure of a
PTPase: the human PTPase 1B (PTP1B). The crystal structure of a
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molecule frequently sheds a great deal of light on how the molecule
might function-scientists can then see which domains are exposed on
the surface, where potential binding sites are located, etc. This informa-
tion can then be used to develop molecules that effectively block
specific actions or interactions. In 1995, Nick and David (by then at Ox-
ford University) built on their success with another "first:" they solved the
structure of PTP1B bound to a phosphorylated substrate (the molecule
on which an enzyme acts).
In order to accomplish this, Nick and Postdoctoral Fellow Andrew Flint
developed a mutant that would bind to its substrate but not dephos-
phorylate it, and David crystalized and solved the structure of the bound
pair. These structures of PTP1B demonstrated that the unique signature
motif that is the defining feature of the PTP enzyme family acts as a rigid
cradle structure that binds to the phosphate group on a target substrate.
The motif lies at the base of a cleft on the surface of the protein and
when the substrate binds, the cleft closes, locking the substrate within
the enzyme.
These studies are illuminating how a PTPase works; the next question
was with what does it work? It has long been thought that there were a
limited number of PTPases each of which dephosphorylated a great
many substrates. Nick and his colleagues suspected, and have now
shown, that PTPases are actually very selective. Together they have de-
veloped "substrate-trapping" mutants for a variety of PTPases, like the
one used to solve the structure of the PTP1B substrate complex. By ex-
pressing substrate-trapping mutants in cells, they can see which sub-
strates the phosphatases recognize. They have made the surprising dis-
covery that many PTPs examined in a physiological context are ex-
quisitely selective, binding consistently to only a small number of sub-
strates. This work has implications for the development of finely targeted
therapeutics, as phosphorylation and dephosphorylation are critical to
many cellular processes including cell growth, proliferation, and differen-
tiation.
Transcription Control
Another important cellular process is transcription-the formation of a
complementary strand of RNA based upon one of the two strands of
DNA. But the in vivo study of DNA transcription is difficult because basal
transcription factors are vital to cells' survival. Disruption of their function
can lead to cell death, making experimentation difficult. Two Cold Spring
Harbor scientists, Winship Herr and Nouria Hernandez, study the com-
ponents of this vital process and their interactions. Some transcription
factors, the proteins required to initiate or regulate transcription, recog-
nize the promoter region of the DNA where transcription begins. A key
regulatory element in the promoter region of the DNA is known as the
TATA box.
Both Winship and Nouria study the TATA box-binding protein (TBP)
and its interaction with other transcription factors. Winship's lab devel-
oped a new system to study the relationship between TBP and the tran-
scription factor TFIIB in human cells by building on the work of Kevin
Struhl of Harvard Medical School. Kevin developed an altered promoter
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(TGTA instead of TATA) and an altered TBP binding protein that was
engineered to match it. In this system, transcription continued to occur,
yet the potentially lethal consequences of disrupting the endogenous
transcription machinery were circumvented. Bill Tansey in Winship's lab
took this approach an important step forward: using this altered TGTA
box/TBP pair, they developed a new altered pair of basal transcription
factors-TBP and TFIIB-that works in concert with the original TGTA
box/TBP pair. This "sequential altered specificity" has enabled Winship's
group to study TFIIB in living cells, which was previously not possible in
human cells.
Nouria reported interesting results in her work on the interaction be-
tween TBP and another group of transcription factors, the small nuclear
RNA (snRNA)-activating protein complex (SNAP,), that binds to the U6
RNA polymerase III promoter. TBP consists of a conserved domain long
thought to be the only functional region of the protein, while it also con-
tains a non-conserved amino-terminal region long thought to be less, if at
all, useful. Nouria has shown that upon truncating the TBP protein to
eliminate the amino-terminal domain, the TBP bound much better to the
TATA box. In addition, truncation of the amino-terminal domain resulted
in strongly diminished binding of SNAlpc to its binding site next to the
TATA box on the DNA. Her results indicate two previously unknown roles
for the non-conserved region of TBP: inhibiting TBP's binding to the DNA
and interacting with another member of the transcription machinery
(SNAPc) to promote its binding to the U6 promoter. Hence, the presence
of this previously unrecognized component is essential to U6 transcrip-
tion.
Neurofibromatosis
In cancer studies at Cold Spring Harbor, the ras oncogene, first dis-
covered by Cold Spring Harbor's Michael Wigler and a group at MIT in
1981, has been the focus of much research. ras is critical to control of
growth and development in healthy cells, and when mutated contributes
to the formation of tumors. In an exciting interplay between cancer and
neuroscience research, a member of our neurobiology team discovered
a role for the Ras protein in processes of learning and memory. In related
research, the same lab also made an important discovery regarding
Neurofibromatosis (NF), a disease that causes learning disabilities in
children and tumors in adults.
In 1995 Yi Zhong showed that the ras pathway was a mediating factor
in the transmission of certain (G-protein-coupled) neurological impulses.
In 1996, Yi's studies moved toward the investigation of the relationship
between ras and the Neurofibromatosis type I (NF1) tumor suppressor
gene. NF1 is one of the most commonly inherited neurological disorders
in humans. The disease is characterized by tumors (frequently benign),
developmental abnormalities, including reduced height, and in many
patients (30-45%) specific learning disabilities.
The activity of ras determines the response of cells to a number of
signals, including growth factors, that mediate cell proliferation, growth,
and differentiation. ras activity can be inhibited by a number of proteins
including NF1. Since it is known that elevated ras activity causes cancer
in many human tissues, the diminished inhibition of ras activity in NF
patients may well contribute to the development of NF symptoms. How-
ever, the story has become even more interesting as Yi Zhong has dis-
covered that the NF1 protein also controls another biochemical pathway
in addition to inhibiting the activity of ras. Yi's lab obtained mutant
Drosophila that lacked the NF1 gene from Andre Bernards at the Massa-
chusetts General Hospital in Boston and uncovered a link between NH
and the cyclic AMP signaling pathway. The latter pathway was previously
shown by Tim Tully and Jerry Yin of CSH and others to control learning
and memory in Drosophila. Yi found that the NF1 defect could be
eliminated by providing small molecules that could activate the cyclic
AMP pathway. These results suggest these small molecules as candi-
date drugs for treatment of NF.
Alcino Silva, who has done important work with mice, has uncovered
a mouse model for the study of learning and memory deficits associated
with NF. He obtained a line of NF1+/-mice (one good copy of the gene
and one defective) from Tyler Jacks, a collaborator at MIT, and
demonstrated learning difficulties similar to those in human NF patients.
The development of a mammalian model for the NF disease is facilitating
extensive studies of NF that would not be possible in human subjects.
These mice will also be valuable in assessing the effects of drugs that af-
fect the cyclic AMP pathway. I am particularly pleased that these exciting
results on NF come so soon after the watershed meeting on NF research
held at the Banbury Conference Center in late 1995.
In another research project, Alcino continues to study the role of the
CREB protein, a target of cyclic AMP, in learning and memory in mice.
This year, he had the very exciting success of achieving behavioral res-
cue in CREB mutant, learning-impaired mice. He demonstrated con-
clusively that by modifying training regimens for the CREB mutants he
was able to overcome profound long-term memory deficits. In these
studies Alcino altered the number of training sessions and the length of
the rest interval between them. This work follows from the elegant studies
on the role of CREB in learning and memory by Tim Tully and Jerry Yin.
These examples of successful behavioral rescue through modified train-
ing have tremendous implications for the treatment of memory disorders.
Neuronal Learning
In other neurobiology research, Hollis Cline and Roberto Malinow have
made great strides in understanding the changes that take place in
synapses during development of the neuronal networks and during
learning and memory processing. Holly studies the development and
stabilization of neurons and synapses while Robert looks at the molecular
mechanisms involved in synaptic plasticity-that is, the changes that take
place at synapses during learning and the formation of memories.
Holly's laboratory at CSHL is one of a few laboratories in the world to
have succeeded in using confocal microscopy to observe changes in
live neurons over the course of several days. She uses high-speed mi-
croscopy techniques and Dil, a fluorescent dye, in anesthetized Xenopus
frog tadpoles. By watching neurons grow over time, this group has been
able to document some remarkable aspects of their development. They
saw and photographed developing neurons sending out axon branches
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like branches on a tree, but the surprising result of these studies was that
most branches extended by the developing neuron were also retracted,
in a process of reaching and withdrawing that continued for days, until
the cell established a set of extensions with which it was happy. The fac-
tors that determine which branches were stabilized in the end remain un-
der investigation.
Once a synapse (a connection between an axon and a receptor cell)
is formed, synaptic transmission, the passing of neurological impulses,
may begin. Holly and Robert found that newly formed synaptic connec-
tions use a type of glutamate receptor called the NMDA receptor. When
a synapse matures, it gains a second type of neurotransmitter receptor
known as AMPA receptors. They've determined that this process is de-
pendent on the entry of calcium into the cell and subsequent activation
of the enzyme CaMKII, which in turn stimulates the arrival of AMPA
receptors. The exciting result of subsequent experiments showed that
when CaMKII is inserted into a developing neuron, the cell then develops
characteristics of a mature cell-the branches stabilize and the synapses
acquire the second receptor, AMPA.
Robert's group studies the role of AMPA receptors in a process called
LTP, for long-term potentiation. LTP is the strengthening of a neural path-
way, a physiological change that takes place with repeated or very
strong impulses across a neural pathway. This group studies LTP in the
hippocampal region of the rat brain. The hippocampus is a region of the
mammalian brain that is implicated in learning and memory. It has been
shown that when the hippocampus is damaged, the ability to form long-
term memory is impaired; when it is destroyed on both sides of the brain,
the ability to form new memories is lost. As LTP is thought to be a critical
part of the learning and memory processes, this continued work into the
mechanisms of LTP should provide valuable insight into these vital brain
functions.
Grigori Enikolopov has expanded on his earlier finding that nitric
oxide (NO) acts as a regulator of cell proliferation and differentiation. Ini-
tially Grisha and Natalia "Natasha" Peunova showed that NO acts as a
molecular switch to tell neuronal precursor cells to stop dividing and to
begin developing into, and functioning as, nerve cells. In experiments
designed to test the role of NO in other cells in developing Drosophila,
Grisha, Natasha, and Boris Kuzin, a visiting scientist from Moscow, have
shown that NO also controls organ size during development of an intact
organism. Flies in whom the expression of NO was suppressed during
larval development displayed substantially larger organs including eyes,
wings, genitalia, and legs. The diameter of some leg segments has been
3-4 times that of normal flies, leading to the nickname "Schwartzenegger
flies," as they are affectionately known among lab staff.
Tim Tully and Jerry Yin's quest to isolate new genes involved in the
biology of memory was boosted this year by generous support from the
Hartford Foundation. The Hartford Foundation is concerned with issues
related to aging and is especially enthusiastic about the learning and
memory work. The long-term hope of this collaboration is that new genet-
ic information will yield a greater understanding of the causes of aging-
related memory dysfunction. As part of this effort, the Hartford Founda-
tion will also support two Banbury meetings-one in 1997 on cognitive
functioning and one in 2000 on aging and cognitive dysfunction.
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Plant Genome Research
This year, with strong support from Laboratory Board Chairman David
Luke III, Cold Spring Harbor scientists Richard McCombie and Rob
Martienssen entered into a global collaboration that is determined to se-
quence the entire genome of a flowering plant, Arabidopsis thaliana, by
the year 2004. Under a grant of $12.7 million from the National Science
Foundation (NSF), the Department of Energy (DOE), and the Department
of Agriculture (USDA), three U.S. groups, one European consortium, and
one Japanese laboratory have divided up the total genome in order to
organize a thorough project with no duplication of effort.
Arabidopsis is a popular model organism for plant genetics research.
It is a small plant in the mustard family, and has one of the smallest plant
genomes and the highest gene density so far identified in a flowering
plant.
There are three U.S. groups participating in the project: one is a con-
sortium of sequencing labs headed by Cold Spring Harbor and including
groups from Washington University, in St. Louis, Missouri, and Applied
Biosystems, Inc., located in Foster City, California. The other two U.S.
groups are The Institute for Genomic Research in Rockville, Maryland,
and the Consortium of Stanford University, University of Pennsylvania,
and University of California at Berkeley. Our overseas collaborators are
the European Scientists Sequencing Arabidopsis (ESSA), a 17-lab con-
sortium under the direction of Mike Bevan, of the John Innes Center, and
the Kazusa DNA Research Institute in Japan, headed by Satoshi Tabata.
The project will result in the first genome sequence of a higher plant
and will provide a complete catalog of all the genes involved in the plant
life cycle, from seed to flower and fruit. Results garnered by the
participants will be made available to the global plant research com-
munity almost immediately via the World Wide Web. The resulting knowl-
edge will have agricultural implications for virtually all crops, including
wheat and corn, and will be immediately applicable to all economically
important plant species.
These numerous and varied good results in our Labs have allowed us
to end the year on a very positive tide. As the new year begins, I can al-
ready see continued success coming from these research programs.
Symposium
The 61st annual Cold Spring Harbor Symposium on Quantitative Biology,
held May 29-June 5, marked the sixth time that the Symposium has
been dedicated to topics on neurobiology; beginning with The Neuron in
1952, followed by Sensory Receptors in 1965, The Synapse in 1975,
Molecular Neurobiology in 1983, and The Brain in 1990, heralding Presi-
dent Bush's "Decade of the Brain." Each of these meetings has rendered
a clearer understanding of the complex nature of the brain and nervous
system. This year's meeting, Function and Dysfunction of the Nervous
System, was no exception. Talks focused on integration of neural sys-
tems and diseases of the nervous system. Sessions on psychiatric dis-
eases, addiction, neurodegenerative diseases, Alzheimer's, learning and
memory, and neuronal dysfunction indicated strong potential for the ap-
plication to human disease. This Symposium parallels the Laboratory's
deep commitment to neurobiology.
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During the Symposium, the annual Dorcas Cummings Lecture was
given by Vilayanur S. Ramachandran, Professor of Neurosciences and
Psychology, Director of the Brain and Perception Laboratory, and Co-
director of the newly formed Center for Research on Brain and Cognition
at University of California, San Diego. His research focuses on an interest
in human visual perception and behavioral neurology (the study of
patients with focal brain damage). His talk, Illusions of Body Image in
Neurology: What they reveal of human nature, explored his most recent
interest, which examines behavioral correlates of neural plasticity includ-
ing phenomena such as "phantom limbs," anosognosia or "denial of
paralysis," and anorexia nervosa. Most of these syndromes have been
known since the turn of the century and treated as enigmatic curiosities
on which there has been little research done. Ramachandran has
brought them from the clinic to the laboratory and shown that an in-
tensive study of these patients can often provide valuable new insights
into the functional organization of the normal human brain. Nearly 300
supporters of the Laboratory, as well as the scientists attending the
symposium, attended the lecture.
The Reginald G. Harris Lecture, inaugurated in 1995 and named for
the former Laboratory director who initiated the CSH Symposium in 1933,
was presented by Richard Axel of the Center for Neurobiology and Be-
havior at the College of Physicians and Surgeons, Columbia University.
His talk entitled The Molecular Biology of Smell opened the Sensory Per-
ception session.
On the eighth and final day, Zach W. Hall, Director of the National In-
stitute of Neurological Disorder and Stroke at the NIH, delivered an elo-
quent and comprehensive summary. He talked about the dual role of
Cold Spring Harbor-first, symbolically, as the place where new science
begins, and secondly, as a place of unprecedented scientific excite-
ment. His summary was based on two major themes-the link between
behavior and biology, and the success of being able to attack brain dis-
ease in humans.
Banbury Conference Center
Banbury Center highlights DNA: The chemistry and biology of DNA are
fundamental to so much of our research and to biomedical research
throughout the world. It is remarkable that even after so many years of in-
tensive study, we are still discovering novel properties of the molecule
and intriguing aspects of its biology. In 1995, Rich Roberts and Xiaodong
Cheng, here at the Laboratory, described how an enzyme-DNA
methylase that modifies the activities of DNA alters the structure of the
double helix in a totally unexpected way. In the same way that an old-
fashioned juke box "flipped" a record out of the stack to be played, so the
enzyme makes accessible the base it is modifying by "flipping" it out of
the helix. The 1996 Banbury meeting DNA Base Flipping: How and Why
reviewed new evidence that "base flipping" may be not be restricted to
DNA methylases but may be a more general mechanism used by other
enzymes for interactions with DNA molecules as well.
Banbury Center hosted an historic meeting on the topic of telomerase
in 1994. Work in Carol Greider's lab at Cold Spring Harbor and other
laboratories has shown that telomere replication may play important roles
in both cancer and aging. Telomerase is the enzyme that is used by the
cell to sustain telomeres (the ends of chromosomes) and this field has
become a very "hot" area of research. The follow-up meeting in 1996,
Telomeres and Telomerase, drew many of the participants of the 1994
meeting together with researchers new to the topic. The 1996 meeting,
like the earlier meeting, provided an opportunity for the presentation and
discussion of new data, unpublished and controversial.
One of the most remarkable meetings of the year dealt with one of the
oldest problems in molecular biology: how RNA molecules are made
from the appropriate genes and at the appropriate times. The field has
reached a stage of development where critical review and synthesis are
needed, and the Banbury meeting Mechanisms of Transcriptional Initia-
tion succeeded in providing at least the critical review. The meeting was
notable for its organization, the schedule being developed as the meet-
ing progressed, with speakers being limited to just a few minutes and
just a few slides.
The Executives' Conference
This series of meetings continues to be a pleasant surprise. Each year
sets such high standards for the following year, that it is not clear how we
will be able to find new topics of sufficient interest. It is a measure of the
vitality and vigor of biomedical research that new subjects are continually
appearing. Human Development-a topic much in the news now with the
cloning of a sheep-was the topic for 1996, and covered human em-
bryonic development, the development of gender differences, and the
fertilization and manipulation of human embryos in vitro.
Education for Nonscientists at Banbury Center
Among the most influential meetings held at Banbury Center were those
funded by the Alfred P. Sloan Foundation for workshops on biomedical
research for Congressional staff and science journalists. In 1996, the
Federal Judicial Center in Washington, D.C. brought federal and state
judges to Banbury to learn about many aspects of science in the
courtroom. Topics ranged from the history and philosophy of scientific
practice to issues of direct application, such as the use of statistical evi-
dence and how courts understand risk assessment. Genetics was not
neglected, with talks on eugenics, genetics, and social implications of
the Human Genome Project. One issue that was raised repeatedly con-
cerned expert witnesses and how to establish their credibility in litigation
where fees for testimony speak very loudly.
In November, the Banbury Center hosted a workshop for science
journalists similar in format to previous meetings funded by the Sloan
Foundation. This time supported by funds from the Lab's Department of
Public Affairs, the title of the meeting was Genetics of Human Behavior.
Talks addressed genetic factors involved in such "behavioral" issues as
alcoholism, homosexuality, aggressive behavior, and learning and
memory. The meeting was a stimulating and educational experience for
more than 20 science writers.
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Board of Trustees
Individual trustees Charles Dolan, Owen Smith, and Henry Wendt as well
as scientific trustee Shirley Tilghman each concluded a full term on the
Board in 1996. I look forward to continued advice and interaction with
these friends and colleagues.
Mary D. Lindsay, a friend and advocate for more than 40 years and a
board member as often as the bylaws allow since 1971, has concluded
her most recent term. She had been a member of the Executive Com-
mittee since the early 1980s and since 1992 was vice chairman of the
Board. Over the years, Mary has served on most board committees.
Among her longest and most valued tenure was her active role on the
Building Committee. In November, the Board elected Mary Lindsay an
honorary trustee for life.
Most recently Mary's long-held commitment to the young scientists
and their families came to fruition in the establishment of child care here.
Ground breaking, demolition and renovation of the De Forest Stables has
begun to make way for what will become a fine facility to serve the
youngsters of our staff.
The election of five new individual trustees and one scientific trustee
in 1996 continues the strong board participation that the Laboratory has
grown to depend on C. Thomas Caskey, M.D., senior vice president of
research for Merck Research Laboratories in West Point, Pennsylvania,
not only brings his extensive research experience in mammalian
genetics and inherited diseases but his astute business acumen in the
area of biotechnology. Helen Dolan, longtime resident of nearby Oyster
Bay, continues to represent the ever charitable Dolan family, who con-
tinue to be close friends of the Laboratory. Lola Grace is a financial con-
sultant specializing in financial institutions and has already made a
tremendous contribution with her outstanding leadership of the Emanuel
Ax Gala in October and her avid encouragement of Lab partnerships
with local private and public schools. Lola continues the strong associa-
tion between the Grace family and our Board. Leon Polsky, a lawyer
residing in New York City, has extensive legal and judicial experience to
bring to the Laboratory. Mr. Polsky is the son-in-law of the late, revered
trustee Lita Annenberg Hazen. William Matheson, retired since 1992 after
practicing law in New York City for 42 years, has established with Mrs.
Matheson the Matheson Endowment for Neuroscience. The Mathesons
make their home in Florida.
I am happy to welcome once again Dr. Arnold Levine, who served as
a trustee from 1976-1980. Codiscoverer of the important p53 tumor sup-
pressor protein, he studies virus-induced oncogenesis and cancer biol-
ogy at Princeton University in the Department of Molecular Biology.
To trustee and dear friend Wendy Russell, we all extend our heartfelt
sympathy at the loss of her beloved husband Bill Russell. In the short
time that we knew Bill, it was clear that he had fast become the same
avid proponent of the Laboratory as is his enthusiastic wife.
Robertson Research Fund
The Robertson Research Fund was established by the Robertson family
of Lloyd Harbor in 1973. The initial gift from Charles Robertson was near-
ly $8 million and coincided with the transfer of the Robertson property on
Banbury Lane to the Laboratory. The site of our Banbury Conference
Center, this property is further supported by a maintenance fund, also
created by the Robertsons.
Two years later in 1975, the Banbury Fund-the Robertson family's
private foundation-established the Marie H. Robertson Memorial Fund to
support neuroscience research at Cold Spring Harbor. This year, the
Marie Robertson fund distributed $125,000 to support Tim Tully and his
work on learning and memory in Drosophila; a new postdoctoral resear-
cher for Alcino Silva, who studies learning and memory in mice; two
neurobiology seminars (given by Josh Gordon of University of California,
San Francisco and Menahem Segal of the Fogarty International Center in
Bethesda, Maryland); and a Banbury Meeting on Genetic Approaches to
Learning and Memory.
In 1996 the Robertson Research Fund-its value now up to $59 mil-
lion-distributed $1.8 million to basic research at Cold Spring Harbor.
These funds provided research program support directly to 20 scientists;
very important supplemental support for the Lab's postdoctoral follows;
and support for graduate students and our seminar program. These most
generous gifts continue to have a monumental impact on science at the
Laboratory.
Major Gifts
The Laboratory's research programs received strong support in 1996.
Plant research received a second substantial gift from Laboratory Board
Chairman David L. Luke III and his wife Fanny, who gave $362,250 to
Arabidopsis research. In 1995, Mr. Luke and Westvaco Corporation pro-
vided seed money of $290,000 to establish a plant sequencing project at
Cold Spring Harbor. This gift allowed the Lab to become a major player
in an important international collaboration to sequence the genome of the
plant Arabidopsis thaliana. In additional plant research support, Pioneer
Hi-Bred International, Inc. gave $80,000 to support Research Investigator
Joseph Colosanti.
The Arnold and Mabel Beckman Foundation supported structural
biologist Leemor Joshua-Tor with a $200,000 new investigator grant; the
Mellam Family Foundation provided $200,000 to Nick Tonks for his work
with PTPases; the Pew Scholars Program in the biomedical sciences
gave $200,000 to Tatsuya Hirano in a four-year scholarship for research
on the dynamics of chromosome structure; the Oliver S. & Jenny R.
Donaldson Charitable Trust gave $125,000 to Michael Hengartner for his
work on programed cell death; the Swartz Foundation gave $77,274 to
help establish a computational neurobiology research program at the
Laboratory; the Charles A. Dana Foundation supported Tom Marr in his
research into the genetic basis of manic-depressive illness with
$194,000; while Glaxo-Wellcome, Inc. gave $100,000 for postdoctoral
fellows working on cell cycle and apoptosis in laboratories headed by
Yuri Lazebnik, Michael Hengartner, and David Beach. 1 in 9: The Long
Island Breast Cancer Action Coalition gave $50,000 to Michael Wigler's
lab for breast cancer research; Mr. and Mrs. Alan Seligson gave $35,000
to the ongoing Andrew Seligson Memorial Fellowship; the Goldring Fam-
ily Foundation gave $30,000 for a Postdoctoral Fellow in my laboratory;
Oxnard Foundation donated $20,000 to muscular dystrophy research;
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and the Lauri Strauss Leukemia Foundation granted $15,000 to Nick
Tonks through their Felix Schnyder Memorial Fund.
Gifts to neuroscience research were numerous. We are particularly
grateful to Marjorie A. and William L. Matheson for establishing The Math-
eson Endowment Fund for Neuroscience with gifts totaling $2,869,227.
The John A. Hartford Foundation gave $320,082 to Tim Tully; Lita Annen-
berg Hazen Foundation provided $200,000 to Neurobiology research;
the McKnight Endowment Fund for Neuroscience gave $150,000 to Jerry
Yin, and the G. Harold and Leila Y. Mathers Charitable Foundation
donated $126,750 to Robert Malinow. New York Community Trust gifted
$60,000 to Alcino Silva, and the National Neurofibromatosis Foundation
granted Alcino $50,000, while the Volkswagen Foundation gave him
$32,808. Both the Helen Hoffritz Foundation gift of $20,000 and the Ep-
pley Foundation for Research gift of $15,000 went to support Holly
Cline's research into neuronal growth.
Badly needed equipment money was received from The Oliver S. &
Jenny R. Donaldson Charitable Trust, who gave $100,000 to Dick
McCombie for an automated DNA Sequencer (used in both cancer and
plant research), William and Maude Pritchard Charitable Trust who gave
$75,000 for neurobiology equipment, and the Slocum Estate gave $8,000
for other essential equipment.
In the earliest stages of fund-raising for the Cold Spring Harbor
Laboratory Advanced Imaging Facility and associated start-up costs, we
received in 1996 generous commitments of $300,000 from the William
Stamps Farish Fund and $250,000 from the Gladys and Roland Harriman
Foundation. The Lucille P. Markey Charitable Trust gave $500,000 to
Karel Svoboda, a young neurobiologist who will join us in 1997 as we be-
gin our new imaging effort.
The Emanuel Ax Gala was the most successful fund-raiser in Lab his-
tory. Major gifts to this event include the Anderson Group, $10,000; Mr.
and Mrs. Charles Dolan, $10,000; Mrs. Oliver R. Grace, $10,000; Mr. and
Mrs. John S. Grace, $5,000; J.P. Morgan and Co., Inc., $5,000; Mr. and
Mrs. Edwin S. Marks, $5,000, Mr. and Mrs. William R. Miller, $5,000, Mr.
and Mrs. Thomas A. Saunders III, $5,000, Mr. and Mrs. Douglas A. Soref,
$5,000. A complete list of contributions to the gala may be found in the
financial section at back.
Donations to the Second Century Endowment Fund included
$393,000 from the estate of Eric Ridder, $50,000 from the Banbury Fund,
$49,960 from Henry Wilmerding, and $43,871 from Robert L. Garland by
way of a contribution to the pooled income fund.
Carol Large, chairman of the capital campaign for the Mary D. Lind-
say Child Care Center held a marvelous kick-off luncheon on September
18 for a very enthusiastic committee. By the end of 1996, more than
$620,000 had been raised. Board members, CSHL Association directors,
and members of the committee were responsible for contributing nearly
half toward the $1-million goal. Individuals and foundations have shown
their support for Lab families with generous donations: Edwin Marks,
$185,553; The Weezie Foundation, $75,000; Mr. and Mrs. Robert G. Mer-
rill, $54,380; Anonymous, $50,000; Mr. and Mrs. David L. Luke III,
$50,000; Mrs. John H. Livingston, $26,468; David H. Koch Charitable
Trust, $25,000; Mr. and Mrs. James M. Large, $20,000; Dr. and Mrs.
James D. Watson, $20,000; Schiff Foundation, $15,000; Dickey Family,
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$12,000; Mr. and Mrs. Peter 0. A. Solbert, $10,171; G. Morgan Browne,
$10,000; Hyde and Watson Foundation, $10,000; Mr. and Mrs. Robert V.
Lindsay, $10,000; Mrs. Donald A. Straus, $10,000; Mr. and Mrs. Howard
Phipps, Jr., $10,000; Mr. Arthur C. Merrill, $7,500; Mr. and Mrs. Henry
Wendt, $7,500; Mr. and Mrs. John P. Cleary, $5,000; Mr. and Mrs. Ed-
ward H. Gerry, $5,000; and Mr. and Mrs. Robert D. Lindsay, $5,000. A
complete list of donors may be found in the financial section of this
report.
DNA Learning Center
The DNALC received its 100,000th visitor in 1996. While this would be a
yearly or even quarterly statistic for a large science center, the numbers
alone do not tell the whole story. Half of all visitors, overwhelmingly
precollege students from the New York metropolitan area, participated in
a two-to-three hour laboratory experience. Visitation has tripled since
opening in 1988-to 22,720 students, teachers, and families in 1996. Also
over this period, the lab clientele has shifted from almost entirely high
school students to more than half middle school students. Lab field trips
were increased by 30% in 1996 by adding more afternoon sessions for
middle school students. However, with double or triple booking virtually
every school day between October 1 and June 15, the Bio2000
Laboratory has reached saturation. The DNALC's educational reach was
further expanded with the opening of its own World Wide Web site
(http://darwin.cshl.org). By year's end the site was receiving more than
10,000 "virtual" visitors per month, including representatives from more
than 50 countries.
In September, the DNALC celebrated the opening of the McClintock
Exhibit, a tribute to the late Barbara McClintock and the Nobel Prize-
winning work that she did during five decades at Cold Spring Harbor.
The display consists of a recreation of Barbara's laboratory bench and
includes original equipment, books and personal effects that had been
archived since Barbara's death in 1992. It also includes a biography, her
awards, and a video tape of Barbara's acceptance speech at the Nobel
Ceremony in Stockholm in 1983.
The enthusiasm for DNALC programs was matched by the excep-
tionally strong support of Long Island businesses represented on the
Corporate Advisory Board. This body, chaired by John Leahy of Chase
Manhattan Bank, raised $147,000 in support of the DNALC's programs
for local students. This contribution equaled 17% of 1996 operating
costs. Looking toward the DNALC's 10th anniversary in 1997, we will
have to consider ways to insure that it maintains its position as the
world's leader in gene education. This will include enlarging the DNALC
facility, expanding genetic information available at its WWW site, and
convincing the state government to accept some responsibility in provid-
ing annual support for this unique New York resource.
Scientific Honors
Carol Greider and her work on telomerase have received considerable
recognition in recent months. In addition to a good deal of attention from
the popular press, Carol has been lauded by several prestigious organi-
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zations. She was awarded the American Society for Cell Biology's
(ASCB) first Glenn Foundation Award. The American Society for
Biochemistry and Molecular Biology (ASBMB) honored Carol with the
Schering Plough Award, an award reserved for researchers who are
within ten years of receiving their Ph.D. Perhaps most exciting, and in-
deed challenging, was her appointment by President Clinton to the newly
established National Bioethics Advisory Commission (NBAC). This ap-
pointment came just in time to allow Carol to be a guiding force in decid-
ing how the Clinton administration will deal with ethical issues related to
the cloning of mammals.
David Beach, highly respected for his work in understanding control
of the cell division cycle and its implications for cancer, was elected this
year a Fellow of the Royal Society-the United Kingdom's prestigious na-
tional academy of science. Founded in 1660, the Society promotes im-
provements in natural knowledge. David attended the admission day
ceremony in London on June 6 and received the certificate of fellowship.
Michael Hengartner, a young apoptosis researcher, was awarded the
Pharmacia Biotech Prize for Young Scientists. Sponsored by the Amer-
ican Association for the Advancement of Science (AAAS), this honor
recognizes outstanding molecular biologists at the earliest stage of their
careers.
Structural biologist Leemor Joshua-Tor, who arrived at Cold Spring
Harbor in late 1994, received the Beckman Young Investigator Award.
Leemor uses X-ray crystallography and biochemistry to study the struc-
ture and function of cellular proteins and enzymes.
And finally, the Laboratory was honored when the Long Island divi-
sion of the American Cancer Society bestowed its special Excellence in
Research Award on the Laboratory for its "leading edge research pro-
gram in cancer biology.'
Cold Spring Harbor Laboratory Press
Eight books and two videos were published this year. Notable new titles
included the Symposium volume on Protein Kinesis and two new
volumes in the CSHL Monograph series. DNA Replication in Eukaryotic
Cells, edited by Melvin DePamphlis, is composed of three sections (con-
cepts, proteins, and systems) so it serves as an introduction to this im-
portant topic for scientists-in-training and as a core reference work for
experienced investigators. Epigenetic Mechanisms of Gene Regulation,
edited by Vincenzo Russo, Robert Martienssen, and Arthur Riggs, dis-
cusses our current understanding of the observation first made by Bar-
bara McClintock in maize, that heritable changes in gene function cannot
all be explained by changes in DNA sequence. The mechanisms un-
derlying these phenomena are reviewed in the many species in which
they are now known to occur. Also notable was the reissue of an ex-
panded edition of Horace Freeland Judson's absorbing history of the de-
velopment of molecular biology, The Eighth Day of Creation. The addi-
tional material in this edition includes challenging essays on the lives and
scientific contributions of Rosalind Franklin and Erwin Chargaff.
In December, Nancy Ford, the book program's managing editor, an-
nounced her decision to retire after 24 years' of extraordinary service to
the Laboratory. She played a leading role in the creation of the book
Trudy Calabrese Cathy Soref John Cleary
publishing program at Cold Spring Harbor and is remembered with af-
fection and admiration by many of the authors and editors with whom she
produced so many outstanding contributions to the scientific literature.
The journal program continued to strengthen. All three journals had
increased circulation and the impact factor of Genes & Development
rose for the eighth consecutive year, placing it among the six most in-
fluential science journals in the world.
Cold Spring Harbor Laboratory Association
The Cold Spring Harbor Laboratory Association, under the skillfull leader-
ship of President John Cleary, again enriched the Laboratory with its
many activities. Three dynamic and enthusiastic directors were elected
to the CSHL Association in 1996: Trudy Calabrese, Tony Kemper, and
Cathy Soref. Tony and Cathy have contributed greatly to the growth and
continued success of the Next Generation Initiative (NGI) while Trudy put
her efforts toward raising funds for the capital campaign for our child
care center and developing new contacts for our annual membership
drive.
The NGI program has generated new and renewed interest in the
Lab. The focus of this program is to encourage people in their thirties
and forties to become interested in science at the Lab and to encourage
new membership in the CSHL Association. At an NGI lecture on January
19, 1997, I presented an overall view of our research program and his-
tory and Tim Tully described the newest findings in learning and memory
in Drosophila. Following the program, five private dinner parties were
given, echoing the very successful dinner parties held annually since
1954 following the Dorcas Cummings lecture.
The traditional and highly regarded Symposium Dinner Parties were a
notable success under the 1996 leadership of Vernon Merrill, a director
of the Association. Twenty-two hosts and hostesses opened their homes
to personal guests, visiting and Lab scientists for an evening of excep-
tional food and lively intellectual exchange.
The Association's annual membership total of well over $600,000 was
gratifying in light of the fact that a major capital campaign for the child
care center and the Emanuel Ax benefit were under way concurrent with
the fall membership drive.
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Allen Oliff, M.D., executive director of Cancer Research at Merck Re-
search Laboratory, addressed the Association members at their Annual
Meeting in February. His lecture, Anti-cancer Agents Directed Against
Oncogene Targets, provided an enlightening discussion of the long and
complicated process involved in turning basic scientific knowledge into
therapeutic clinical treatments.
The Association orchestrated a variety of other special events during
the course of the year. On May 5, a concert by pianist and writer, Carol
Montparker, was complimented by an exhibition of the works of Stan
Brodsky, noted artist and teacher. This provided a double treat for the
Association members and friends who attended.
On October 13, our good friend Dr. Cynthia J. MacKay and Dr. Peter
Gouras, her collaborator from Columbia-Presbyterian Hospital, presented
a much-needed discussion of macular degeneration, the number one
cause of legal blindness in people over 65 in the United States. The lec-
ture drew an inquisitive audience to hear about retinal cell transplanta-
tion, a new treatment for this debilitating affliction. A lively question and
answer session followed; this lecture made a valuable contribution to our
friends and neighbors.
On November 17, 1996, Dr. David Grimaldi, Curator and Chairman of
the Department of Entomology at the American Museum of Natural His-
tory, presented an informative lecture on Amber: A Scientific Renais-
sance, to a packed house of adults and children. His focus was on both
the history and biology of this ancient resin. Afterward, Dr. Grimaldi
remained in the lobby to sign copies of his book, Amber: Window to the
Past, and to continue answering individual questions from the guests
about their own pieces of amber.
Also in November, this year's Major Donor Cocktail Party was gra-
ciously hosted by former Laboratory trustee Owen Smith and his wife
Bernadette in their beautiful home, Whispering Laurels, for major donors
and Laboratory scientists.
President's Council
The President's Council was formed three years ago in an effort to bring
together a small group of individuals interested in science and the work
at Cold Spring Harbor Laboratory. Members of the President's Council
provide support for the Cold Spring Harbor Fellows program through an
annual commitment of $25,000. This funding is critical to the Lab's con-
tinued initiative to attract top young scientists fresh from their Ph.D.
studies. These fellowships allow new researchers to pursue their own re-
search, rather than assisting in the laboratory of an established scientist.
A major feature of the Council is an annual meeting that brings to-
gether this select group of leaders from business, finance, and science
to discuss the latest developments in genetic research and biotechnol-
ogy. The Council's 1996 meeting, held May 17-18, commenced with
lunch on Friday at Ballybung, the home of Jim and Liz Watson, and was
followed by thought-provoking lectures on learning and memory by Drs.
Tom Marr and Alcino Silva of Cold Spring Harbor Laboratory. The key-
note speaker, Dr. Barry Gordon, Associate Professor of Neurology and
Cognitive Science at John Hopkins University Medical School, opened
the evening session with his talk on Remembering and Forgetting. Satur-
day's highlights included lectures by Dr. Eric Kandel, Howard Hughes
Medical Institute and Columbia University; Dr. Tim Tully, Cold Spring
Harbor Laboratory, Dr. Paula Tallal, Center for Molecular and Behavioral
Neuroscience, Rutgers University; and Dr. Earl Hunt, University of Wash-
ington. The mix of minds-leaders in the business world and in the
scientific community-evoked interesting insights as well as provocative
discussions. The meeting ended on Saturday with the guests gathering
once again at Ballybung for a parting luncheon.
Members of the President's Council include Christopher Alafi, Alafi
Capital; Abraham Appel, Appel Consultants; Peter L. Bloom, General At-
lantic Partners; James T. Conneen, A.T. Hudson & Co.; Michel David-
Weill, Lazard Freres & Co.; Frederick Frank, Lehman Brothers, Inc.; Leo
A. Guthart, ADEMCO; Charles E. Harris, Harris & Harris Group, Inc.;
Walter B. Kissinger, Long Island Research Institute; Donald A. Pels,
Pelsco, Inc.; George B. Rathmann, ICOS Corporation; Hubert J. P.
Schoemaker, Centocor, Inc.; James H. Simons, Renaissance Tech-
nologies Corp.; and Sigi Ziering, Diagnostic Products Corporation.
A Very Special Benefit
On October 13, 1996 renowned concert pianist Emanuel Ax provided a
most memorable evening. In addition to surpassing all previous events in
its success as a fund-raiser, the evening was a spectacular musical,
culinary, and visual experience. The outstanding performance of Mr. Ax
and a formal dinner for the 350 attendees were enhanced by the
dramatic decorations brought in for the event. Shelley Galehouse King
Broven's faux art added the finishing touches. Gala Chairman Lola
Grace, with co-chairmen Hope Laps ley, Carol Large, and Cathy Soref
and a committee of 75 pulled off a stellar event, which raised over
$134,000, with great style.
Concerts
Grace Auditorium was the setting for many other musical performances
during our meeting season. On April 27, at the meeting on zebrafish,
Emanuel Ax
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pianist Max Levinson performed a moving and enjoyable piano recital.
This concert was sponsored by a gift from Dr. Mark Ptashne.
Young Artists concerts included violinist Joseph Lin on August 17, ac-
companied by Benjamin Loeb on piano and held during the Cancer
Genetics meeting. On August 24, Todd Palmer, clarinetist, and Margaret
Kampmeier, pianist, performed during Bacteria and Phage, and Mikhail
Yanovitsky gave a piano concert on September 7 during Translational
Control. In addition, Andrew Russo, an invited guest of Liz Watson, per-
formed a piano recital in the intimate Davenport Music Room on Septem-
ber 22.
Child Care Realized
A long-held desire to provide child care to our staff is finally a reality.
Several hurdles were cleared in 1996-the Village Board approved our
plan for the renovation of the De Forest Stables at the north end of Bung-
town Road. A ground breaking on June 23, complete with golden shovel
and balloons, was attended by Village and Laboratory Trustees as well
as our Laurel Hollow neighbors and members of our extended Lab fam-
ily. Among the speakers were Sheri Lucero from Centerbrook Architects
and Mimi Leshin, recently retired director of the Long Island/National Em-
ployee Assistance Providers Inc., and an expert on child care in the
workplace.
A Laboratory committee, chaired by Cheryl Sinclair, director of human
resources, comprised of scientists, trustees, staff, and outside experts,
was charged with recommending appropriate child care. After exhaus-
tive research which included impromptu site visits, interviews and com-
parative proposals, the committee recommended the selection of Rain-
bow Chimes, Inc. This child care provider was established in 1980 under
the leadership of Kathleen Roche, R.N., founder and executive director
and Laura Ludlum, associate director since 1985. Rainbow Chimes pro-
vided site consultation, family orientation, and workshops for youngsters
both here at the Labortory and at their location in Huntington. Kathleen
Roche and her team bring the right kind of flexibility and quality needed
by our Lab families. The Mary D. Lindsay Child Care Center will be open
to our infants, toddlers and pre-schoolers in summer 1997. The dedica-
tion is planned for June 21, 1997.
Gavin Borden Visiting Fellow
The Gavin Borden Visiting Fellow pays tribute to the late Gavin Borden,
founder of Garland Publishing. Included in Garland's list are textbooks
for graduate students, the most successful of which is the popular
Molecular Biology of the Cell by Alberts et al. The Borden Fellow is
chosen each year by our graduate students, and speaks to and visits
with the students and staff. This year's Visiting Fellow was Martin Raff, an
author of MBC and professor of biology at the University College of
London. He opened his talk with warm reflections on time spent with
Gavin Borden, who died most prematurely at only 52 years of age, then
went on to offer an eloquent discussion of the control of cell numbers
during development. Using the central nervous system as an example,
glial cells specifically, Raff explored the many components that must be
in place for proper control of cell division and differentiation. The evening
lecture was followed by a dinner in the Clarkson dining room. The follow-
ing day, Dr. Raff met in seminar with the graduate students.
Undergraduate Research Program
The Laboratory's summer Undergraduate Research Program (URP), in-
itiated in 1959, has matriculated 462 students, affectionately known as
URPs. Many have gone on to productive careers in the biological
sciences. The program exposes students to hands-on experimental ap-
proaches to science and to a greater degree of understanding of the is-
sues involved in biochemistry, genetics, and in molecular and cellular
biology.
In 1996, administration of this program passed from Assistant Director
Winship Herr, who ran the program for the last 10 years, to scientist
Michael Hengartner.
Twenty-two students were chosen from more than 280 applicants for
this year's Undergraduate Research Program. On March 7, 1996 the Lab
received a $1 million gift to the URP endowment from Burroughs
Wellcome. In addition to the Wellcome Fund, the 1996 program was sup-
ported by Jephson Educational Trust, Cornelius N. Bliss Memorial Fund,
Share -It- Now -Foundation, Nathan Springer, Donald J. Sutherland, Dr. Ira
Herskowitz, Angus P. McIntyre, David B. Kaback, and the Qosina Corpo-
ration. A list of the students, their schools, mentors and research projects
may be found in the Undergraduate Research Program section of this
annual report.
Partners for the Future (PFF)
Through this program, designed to introduce high school students to the
world of basic research, the Lab welcomed five teenagers again this
year. The students work October through March with scientist mentors
from the Lab, on original research projects. I am pleased to welcome
Cablevision as the first corporate partner for the PFF program, and am
Martin Raff
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grateful for their forethought in establishing this partnership. This year
their corporate sponsorship funded Sophia Virani of Herricks High
School, who worked with Hong Ma on plant genetics. The other
participants, their high schools, and Lab mentors are: Jana Steiger,
Oyster Bay High School (with Peter Nest ler); David Nussbaum, Half Hol-
low Hills High School West (Michael Regulski); Robert Wlodarczyk,
Hauppauge High School (John Connolly); and Maddalena Pizzirusso,
Sewanhaka High School (Erich Grotewold).
Project WISE
For the second consecutive year, Cold Spring Harbor Laboratory took
part in Project WISE-Women in Science and Engineering. Orchestrated
by SUNY Stony Brook and funded by a grant from the National Science
Foundation, the project involves several Long Island institutions-SUNY,
CSHL, Brookhaven National Laboratory, and the American Association of
University Women-each helping to expose bright young women to the
world of science. The program for female high school students requires
the student's participation during each of her four high school years-9th
through 12th grade. The Lab instructs the 10th graders in molecular biol-
ogy and genetics, offering a foundation upon which they can build a fu-
ture in technology and the sciences.
Mary Horton of our Grants Department ably managed our involvement
in this ambitious program, which includes two trips to the DNA Learning
Center, dinners with Lab scientists, and visits to CSHL labs. Mentors in
1996 were staff investigators Holly Cline and Michael Hengartner; post-
doctoral fellows Karen Buchkovich, Alyson Kass-Eisler, Michele Cleary,
and John Horton; and research technician Stephanie Smith.
Educational Outreach
The Laboratory's responsibility to local private and public schools con-
tinues to expand through Lab tours, nature walks, chats on the internet
with and lectures by Lab scientists.
Eastwoods School pre-K children visited Xiaodong Cheng's X-ray
crystallography lab, the third grade learned about Tim Tully's flies, and
their eighth graders worked with combinatorial chemist Peter Nest ler and
postdoctoral researcher John Horton. In addition, each class took at
least one historical tour and an annual hunt along our beaches. The Inter-
school Exchange, a consortium of local private schools made up of
Eastwoods, Port ledge, Friends Academy, Holy Child, Greenvale and
Buckley Country Day School, is a group who shares community
resources. CSHL Association director Cathy Soref has been coordinating
the Lab's contribution to this group as a scientific resource. As well,
Friends Academy shared a special evening program with Lab staff
Alyson Cass Eisler, Brandt Schnieder and Mona Spector which included
e-mail follow up with those scientists.
For West Side School, within the Cold Spring Harbor School District,
we conducted three Science Nights. At each event a CSH scientist ad-
dressed a group of elementary school children and their parents and
teachers. On April 1, visiting scientist Sandy Williams presented Heart At-
tack? Genes to the Rescue. On May 20, Alcino Silva talked to a group
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about learning and memory in mice, and Carol Greider ended the series
on June 17, discussing You and Your Chromosomes.
For the second year, we cooperated with Cold Spring Harbor High
School as they hosted a group of Japanese high school students and
their teachers. The group spoke little English, but worked with a Japa-
nese English teacher as translator. When the vocabulary for a scientific
tour of Cold Spring Harbor Lab was beyond the translator's vocabulary,
we were fortunate to have the help of research investigators Akila
Mayeda and Shou Waga, and postdoctoral researcher Kyoko Hidaka,
who discussed our history, science, and educational programs with the
group.
Other tours included Westbury Friends School (Westbury), Sacred
Heart Academy (Hempstead), Greenvale School (Glen Head), and as-
sorted other schools and universities. For each of these tours we ask two
or more scientists to take a break from their research and show the stu-
dents and teachers around their laboratory. Our scientists are gracious
hosts to these groups and their participation enriches the experience for
our visitors.
Winterthur Visit
On June 19, our trustee Wendy Russell, a member of Winterthur Museum
and Gardens, helped arrange for the Lab to be part of a special
Winterthur visit to Long Island's North Shore. Their schedule included
Old Westbury Gardens, the Planting Fields Arboretum, the model railroad
and gardens of Mr. and Mrs. Henry Harris, Jr., as well as private gardens
of local garden club members. Here at the Lab they visited our DNA
Learning Center, heard from lab scientists, and took a tour by car of the
grounds.
(Photo by M. Cyril Morris)
Advocates for Cancer Research
Our relationship with the very dynamic grass roots organization 1 in 9:
The Long Island Breast Cancer Action Coalition continues to flourish, as
does Mike Wigler's research that they help support. Susan Cooper and
Wendy Goldstein again attended the annual Michael Scott Barish Sand
Soccer Tournament in Long Beach, where hundreds of children play
soccer to support the work of 1 in 9. More than a dozen Lab staff took
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part in their walk-a-thon in Eisenhower Park on May 19, at which Nassau
County Executive Tom Gulotta dedicated the Garden of Hope in memory
of the founding members of 1 in 9 who lost their battle with breast can-
cer. At their second annual black-tie dinner dance at the Seawane Club
in Hewlett Harbor, Jim Watson was honored in the good company of New
York State Senator Joseph L. Bruno, Nassau County Executive Thomas
S. Gulotta, and proactive union leader Joseph Scalamandre. During this
elegant event, 1 in 9 president Geri Barish presented the Laboratory with
a $50,000 check toward the 1 in 9 grant in support of cancer reseach in
the Wigler lab. We were honored to be there and continue to be deeply
grateful for their support.
Capital Projects
Our buildings and grounds staff (the new Facilities department), housed
for many years in the garage-style buildings facing the harbor on the
Lab's lower roadway, has officially outgrown its space. To that end, we
have completed renovation of the former Kurahara House and begun
construction of two adjacent barns approved for construction by the Vil-
lage of Laurel Hollow on June 17, 1996. This new complex, located at the
north end of the campus west of Bungtown Road, will consolidate all
facilities, functions and staff, including painters, landscapers, security,
electricians, grounds keepers, plumbers and others. The Richards Com-
plex is named for former director of buildings and grounds Jack
Richards, who continues to serve part-time as director of construction.
Bungtown Road was once again paved in 1996. While it is, in fact, a
public road, the Lab has for many years maintained, plowed and other-
wise cared for our "main road." This is a benefit to the Lab and our neigh-
bors alike.
Record Snow
The early months of 1996 were marked by the most profound snowfall in
the history of the Laboratory. On the eighth day of January, the "Blizzard
of 96" deposited more than 20 inches of snow into 50 mph winds, closing
schools throughout the area and many local roads. While most
Laboratory staff stayed home for a "snow day," dedicated members of
our Facilities Department braved the elements and traveled to the Lab to
clear walks and roads on Lab grounds, and mechanics arrived to assure
support for labs where research continued through the storm. On April
10, yet another foot of snow blanketed the grounds during the twentieth
snow storm of the season, making the winter of '95/96 the snowiest on
record. The Facilities staff worked tirelessly to keep the campus safe and
clear, and for this we are most appreciative.
Long-Term Service
At a festive poolside celebration at Banbury Center, Bill Keen, our comp-
troller who has kept the Laboratory financially responsible year after year,
celebrated 25 years with not a single adverse institutional audit report.
Bill calmly manages the complex nature of our funding with skill and
Top row: John Maroney, Bruce Stillman,
James D. Watson, Rodney Chisum, Peter Stahl
Middle row: Bill Keen, Pat Kurfess, Dorothy Brown
Front row: Roberta Salant, Elizabeth Ritcey, Phil Renna
humor. John Maroney, assistant administrative director/manager of com-
mercial relationship, also marked a quarter century of service. John be-
gan in 1971 as a laboratory technician for James Lab, where he learned
the buying skills necessary for a 1975 promotion to the Lab's purchasing
manager. In 1982 John assumed the position of assistant administrative
director. In 1989 he earned his law degree, which he applies to his
biotechnology licensing responsibilities.
Chief accountant Guy Cozza, groundsman Joseph Ellis, administra-
tive assistant Roberta Salant, assistant director of facilities Peter Stahl,
and media maker in Demerec Lab Margaret Wallace each celebrated 20
year milestones.
The Press' senior technical editor Dotty Brown; James lab aide Rod-
ney Chisum; senior scientist David Helfman, who was overseas on sab-
batical for most of the year; grants specialist Pat Kurfess; carpenter
Joseph Pirnak; senior photo technician Phil Renna, and editorial coor-
dinator Liz Ritcey each celebrated 15-year anniversaries with the Lab.
The evening ended with a presentation of gifts to honor each person's
service.
Changes in Scientific Staff
Turnover in scientific staff is to be expected in a rigorous and dynamic
scientific research institution such as Cold Spring Harbor Laboratory.
This year, after more than two decades at Cold Spring Harbor, senior
scientist Mike Mathews left us for the University of Medicine and
Dentistry of New Jersey (UMDNJ) in Newark, where he accepted a posi-
tion as Professor and Chairman of the Department of Biochemistry and
Molecular Biology. Mike arrived here in 1974 as an early member of the
'tumor virus group" and was studying diverse aspects of regulation of
gene expression in recent years. I was most fortunate to work with him as
a Postdoctoral Fellow when I first came to the Laboratory and I wish him
well in his new position. Also, Venkatesan "Sunder" Sundaresan left after
ten years of plant research with us. Sundar was instrumental in establish-
ing the current plant genetics research program at the Lab. Together
with Rob Martienssen he developed the use of Barbara McClintock's
transposons from maize to study plant development and gene expres-
Mike Mathews
(Photo by Susan Cooper)
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sion in Arabidopsis. Sunder has gone on to become Director of the In-
stitute of Molecular Biology at National University of Singapore.
Kim Arndt, an Associate Investigator who studied cell cycle in yeast
and had been with us since 1988, left for a position as Principal Scientist
with Wyeth-Ayerst Research Laboratory in Pearl River, New York. Staff
Associate Akiya Watakabe left David Helfman's lab to join the faculty of
the National Institute for Basic Biology in Okazaki, Japan.
Ronald Pruzan, visiting scientist from Geron Corporation, wrapped up
his stay in Carol Greider's lab. He has returned to Geron, the biotech
company in Menlo, California that is working to develop Carol's work on
telomerase into clinical applications.
Arrivals
We had ten new visiting scientists join our staff this year. One, Clifford
Yen, did postdoctoral research here in Rich Roberts' lab in 1978-1982
and is now looking at genetic mutations in human cancers using RDA
(representational difference analysis) in Michael Wigler's lab. Daniel
Bush came for his sabbatical from USDA-ARJ and the University of Il-
linois to do plant research with Rob Martienssen; Ai-Ping Dong, from
Northeast Normal University in China, is working with X-ray crystallog-
rapher Xiaodong Cheng; Satoshi Kida came from the University of Tokyo
to study learning and memory in Alcino Silva's lab; Umberto Piarulli ar-
rived from the Organicae Industrie le in Milano, Italy, to work in com-
binatorial chemistry with Peter Nest ler. Grigori Enikolopov has been host-
ing several visiting scientists-Vladimir Scheinker came from C.P.G., Inc.
in Lincoln Park, New Jersey, to study the role of nitric oxide in differentia-
tion, and Olga Zatsepina came to join her husband Boris Kuzin, who has
been a visiting scientist in Grisha's lab intermittently since 1994.
Venkatesan Sundaresan had two visiting scientists studying plant
genetics with him in 1996-Wei-Cai Yang from Wageningen University in
the Netherlands and De Ye from Institute of Molecular Agrobiology in
Singapore.
As usual, we also had a great infusion of youthful intellect. Twenty-
three labs took in one or more new postdoctoral researchers this year, for
a total of 33. Fourteen new graduate students also joined labs at Cold
Spring Harbor.
Promotions
Promotions this year included plant geneticist Ulrich "Ueli" Grossniklaus,
who studies plant reproductive biology and development; cancer resear-
chers Greg Hannon, who studies cell cycle, and Scott Lowe, who studies
apoptosis and cancer therapy resistance; X-ray crystallographer Rui-
Ming Xu; and genome computer scientist Michael Zhang. Each was
promoted to Assistant Investigator.
Postdoctoral Departures
The following postdoctoral researchers moved on during 1996. Some
went on to accept new positions elsewhere, others are continuing their
postdoctoral research. Four departed from David Beach's lab; two to
continue postdoctoral research-James Hudson at the Institute of Child
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Health in London; and Koji Okamoto at Columbia University in New
York-and two to research positions: Maureen Caligiuri as a scientist with
Mitotix, Inc. in Cambridge, Massachusetts and Johannes Hofmann as a
staff scientist at the Basel Institute of Immunology in Switzerland. Two of
Mike Mathews' researchers-Tsafrira Pe'ery and Yegnanarayana
Ramanathan-accompanied him to UMDNJ while two others went on to
continued postdoctoral research elsewhere: Huey-Jane Liao to SUNY
Stony Brook Pathology Department and Mingsong Liu to University of
California at San Francisco, Department of Medicine. Chantal Autexier
and Karen Buchkovich left the Greider lab-Chantal to become a senior
fellow at BioChem Pharma, Inc. in Chomedey, Canada and Karen to a
Research Assistant Professorship at University of Illinois at Chicago;
Michael Berg left the Stenlund lab to become a researcher at the
Swedish University of Agricultural Sciences; and Hui-Zhi Cai left Ryuji
Kobayashi's lab. Paul Kaufman and Rong Li departed from my lab-Paul
to become a Staff Scientist for Lawrence Berkeley National Laboratory
and Assistant Professor at the University of California-Berkeley and
Rong to an Assistant Professorship at the University of Virginia, Depart-
ment of Biochemistry in Charlottesville. Angus Wilson left the Winship
Herr lab to assume an Assistant Professorship at NYU Medical Center in
New York. Kim Arndt's lab saw two postdoc departures: Flavio Della Seta
went on to become Maitre de Conference for the French University, In-
stitute of Molecular Genetics in Montpellier, and May Luke is now a
scientist with Berlex Biosciences in Richmond, California; Andrew Flint
finished his postdoc in Nick Tonk's lab and has accepted a position as
staff scientist in and
with him went his wife, postdoc Catherine Flanagan of Hong Ma's. Mario
Gimona and Constance Temm-Grove both left David Helfman's lab-
Mario to become group leader at the Austrian Academy of Sciences, In-
stitute of Molecular Biology and Connie to accept a position as research
specialist at the University of Arizona Department of Animal Science in
Tuscon. Qing Gu left the Martienssen lab to continue postdoctoral re-
search at University of Tennessee in Knoxville; Akemi Hanamura
returned to Japan from the Krainer lab; Kyoko Hidaka finished her post-
doctoral work in Bruce Futcher's lab and went on to become a staff
scientist at the National Cardiovascular Center Research Institute in
Suita, Japan; and Yan-Fen Hu went from Nick Tonks' lab to continue
postdoctoral research at the University of Virginia in Charlottesville.
Nouria Hernandez's lab said good-bye to two postdoctoral research-
ers-Renu Mital is continuing postdoctoral studies at the Austrian Acad-
emy of Sciences, Institute of Molecular Biology in Salzburg and Frank
Pessler is now a medical student at the Ph.D./M.D. program at SUNY
Stony Brook. Yukiko Mizukami of Hong Ma's lab is now a visiting postdoc
at the University of California at Berkeley in the Department of Plant Biol-
ogy; Juhan Sedman of Arne Stenlund's lab accepted a position as a re-
search scientist at the Estonian Biocentre in Tarfu, Estonia; Barbara
Steiner left Bruce Futcher's lab to a continued postdoc at the Zentral In-
stitut Mr Seelische Gesundheit in Ludwigshafen, Germany; Henry Tobin
left the Tully lab and Marie-Luce Vignais left the Gilman lab for continued
postdoctoral research at the Institute of Molecular Genetics in
Montepelier, France. Wei Wen and Scott Woody also went on to addi-
tional postdoctoral research-Wei from the Wig ler lab to NYU Medical
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Center in New York and Scott from the Sundaresan lab to University of
Wisconsin at Madison.
Graduate Students
Many of our graduate students finished their Ph.D.s and have gone on to
do their postdoctoral research: from Kim Arndt's lab Andrea Doseff com-
pleted her Ph.D. and is now a postdoctoral researcher here in Yuri
Lazebnik's lab and Charles Di Como went to do postdoctoral research at
Columbia University in New York. Suzana Atanasoski earned her degree
from University of Zurich while working in Winship Herr's lab and has
returned to Switzerland. Hai Rao and Kim Gavin earned degrees while
doing graduate studies in the my lab-Hai went to a postdoctoral position
at the California Institute of Technology in Cal Tech Division of Biology in
Pasadena and Kim continues part-time postdoctoral research in my lab
and is assistant editor of Genes & Development, Dezhi Liao went from
the Malinow lab to become a Howard Hughes Medical Institute (HHMI)
postdoctoral researcher at Johns Hopkins University in Baltimore and
Deborah Taylor went from the Mathews' lab to University of Southern Cal-
ifornia School of Medicine in Los Angeles. Kathy O'Neill received her
Ph.D. and went from Mike Wiglers' lab to a postdoctoral fellowship in
Richard Hynes' lab at MIT, and Qing-Hong Yang earned her degree in
Bruce Futcher's lab and has gone on to medical school at University of
California at San Francisco. Vincenzo Cestari, a graduate student on
rotation in the Silva lab, is now a Ph.D. student at University of Rome in
Italy.
A Busy Time Ahead
The diversity of the programs at the Laboratory is quite remarkable and I
believe the high quality of our research and education is self-evident.
Yet, we do not rest on past accomplishments for very long. Only five
short years after a considerable expansion of the research at the
Laboratory into the exciting area of learning and memory, we find that we
are in desperate need of more laboratory space for this program. To take
full advantage of the great successes in understanding some of the
molecular underpinnings of learning and memory, it has become obvious
that we should incorporate new experimental approaches. One such ap-
proach is imaging neurons and their function in an intact brain. To visual-
ize neuronal function in live animals would be an enormous benefit, but
achieving this goal will require the construction of a new research build-
ing to house an imaging center and further technical developments. Hav-
ing already recruited Dr. Karel Svoboda, a physicist-turned-
neurobiologist, to join our faculty in the summer of 1997 and spearhead
this new direction, plans are well under way for a handsome imaging
building. This project will also enable us to increase the teaching space
for the courses, particularly those courses that focus on imaging of the
brain. The approval of a new zoning ordinance by the Village of Laurel
Hollow early in 1996 will enable careful plans for this project and others
to progress.
As I look to the immediate future, there will be opportunities to change
the direction of the Laboratory in addition to the expansion of our neuro-
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science program. A clear opportunity has emerged from the exciting new
developments in human cancer genetics, making it necessary to streng-
then our research on cancer cell biology and animal physiology. Further-
more, with the modern technologies that are available, it is certain that
academic institutions that focus on basic research, such as the
Laboratory, should play important roles in taking the basic research to
the clinic. Gone are the days when our science rattled around in the
scientific literature for some time before it was *picked up' by those more
clinically inclined. By judicious choice of collaborations with clinical cen-
ters and the biotechnology industry, the gap between our fundamental
discoveries and human health should be very narrow indeed.
As an institution, it is imperative that we prepare for such eventualities
by continuing to recruit the best young people, provide them with the ap-
propriate facilities, and identify partners with whom we can best
synergize. Each of these endeavors is very time consuming on its own,
but all are well worth the effort in the long run. In short, life in and around
the Laboratory will not be leisurely in the immediate future.
April 22, 1997 Bruce Stillman, Director
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ADMINISTRATION
Newsday recently titled a lead editorial "The World Comes to Cold Spring Harbor"- and so it
does, with record numbers of visiting scientists and students, and with representatives of
government, the judiciary, the press, and the general public. They come to interact with the staff
here and to learn from the multi-faceted research and education programs. In so doing, they
help make Cold Spring Harbor what must surely be the most interesting place in the world today
at the vanguard of genetics.
Last year was a particularly good time to visit and to work at the Lab. There was a remarkable
flow of discovery-from new cancer genes, to the molecular basis of long-term memory, to
flowering intricacies in plants. Meetings and courses on the main campus represented the
cutting edge of science, and Banbury Center, the CSHL Press, and the DNA Learning Center
added richness and diversity to an already overflowing mix.
It was also a satisfactory year from the administrative standpoint, with good financial results.
Revenues reached a new high of $45,215,000 and a small surplus of $59,000 was achieved
after allowing for approximately $3 million of depreciation. It was not necessary to utilize any
portion of the $1,150,000 of designated reserves set aside in previous years to defray start-up
expenses of the neuroscience program and for any research funding shortfalls. There were,
however, some significant variations in several areas of Laboratory operations. The CSHL Press
incurred an unanticipated deficit of $258,000, despite higher than projected sales of already
published titles. The shortfall was due to the inability to meet scheduled year-end publication
dates for a number of new books and lower than expected journal advertising revenues. A
reorganization program to deal with these problems was instituted shortly after year-end and
already shows positive indications for 1997. The deficit at the Press was more than offset by
better than anticipated financial results at the main Lab, which benefited from higher investment
income and indirect cost recovery from grants; and also from lower than budgeted costs in
several administrative departments. Before depreciation, 1996 operations generated positive
cash flow of $3,047,000, the best since $3,066,000 in 1992. Over the past 8 years, Laboratory
operations have generated more than $20 million of positive cash flow, which has been invested
primarily in renewing and improving infrastructure, modernizing laboratory facilities, and
acquiring new scientific equipment.
Not surprisingly, it becomes more difficult each year to repeat the good financial results to
which we have become accustomed. Limits on government funding for science, and intense
competition for available grants, have been accompanied by reductions in government
reimbursement for overhead. Categories of costs such as computer services and scientific
secretarial salaries are no longer fully reimbursed and must be paid for from in-house
institutional funds. Housing subsidies for young scientists seeking an acceptable living standard
here on the expensive North Shore of Long Island now total nearly $170,000 per year. The Lab
will be subsidizing its new on-grounds child care center, due to open in mid-1997, and will have
to provide for substantial start-up costs. Although we are exempt from most federal, state, and
local taxes, the Laboratory makes substantial voluntary payments to local villages in recognition
of services provided, and to the local school district on behalf of the children of staff living in on-
grounds tax-exempt housing. Such payments made from institutional funds last year were
approximately $155,000.
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To deal with such financial realities, it is imperative to maintain the lean and relatively low-
cost administrative structure which for many years has characterized the Lab, while being
certain that the extensive services required by a world class scientific staff continue to be
provided at a commensurate level. We are making substantial investments in facility
modernization, which will reduce costs in future years. A good example is the now halfway
completed $1.7 million program to replace the outdated HVAC systems in Demerec Laboratory
and in Bush Auditorium, and also the lighting and electric drive systems in these and many of
our other buildings. Overall, this project should generate energy savings of more than $300,000
per year and pay for itself entirely in less than six years' time.
Revenue enhancement provides a good counterbalance to increasing costs and we continue
to encourage David Stewart, director of Meetings and Courses, and his staff to extend the now
several-year effort to increase use of our much expanded and improved meetings and teaching
facilities by adding new meetings and courses appropriate to the character and mission of the
Laboratory. Each year, the number of participating scientists rises, providing significant new
revenues.
Very important also has been the success of technology transfer under the very capable
leadership of John Maroney. In 1996 for the first time, royalty-derived income was nearly $2
million and has become a significant source of support for the science program. This is a matter
of satisfaction, but paradoxically also of concern, in that one very important patent, accounting
for more than half of all royalty-derived income, will expire in the year 2000. There will be new,
but probably more modest, sources of royalty income by then. In addition, the Laboratory now
has growing holdings of stock in biotechnology companies, received in return for granting
various rights to Lab-developed intellectual property. The Laboratory now holds equity positions
of varying sizes in ten such companies based in whole or in part on Lab technology. Back in
1992, the Laboratory's Board of Trustees established the Science Fund as an integral part of the
Lab's endowment, into which are placed all such stock holdings to be accumulated and used
eventually for the support of the science program. For the first time, in 1996, the Lab's financial
statements include a conservative valuation for such holdings of $2,672,000. Five of the
companies have now completed IPOs and have public markets. While in most instances the
Lab's percentage ownership of each company is relatively small, it is a significant indication of
the value of CSHL technology that these 10 companies together have an overall public and
private market capitalization of just over $1 billion.
Nineteen ninety-six was another outstanding year for the Laboratory's endowment, which
collectively includes the Robertson and Cold Spring Harbor Funds and is our primary source of
internal funding for science. With the bull market of recent years continuing to drive equity
markets to record levels, the year-end combined values of the Robertson Research and Cold
Spring Harbor Funds approached $130 million, which when offset by the Lab's $30 million of
outstanding tax-exempt debt, represents a total of nearly $100 million, an amount we could only
dream about just a few years ago. As in the past, the endowment includes a balanced mix of
investments in equities, fixed income securities, and short-term instruments. Total return for 1996
was a shade less than 16%, ahead of the benchmark index, which rose 14.9%. As in past years,
the firm of Miller Anderson & Sherrerd, now a subsidiary of Morgan Stanley & Co., provided
outstanding investment management. During 1996, considering the substantial growth of the
funds, the Finance & Investment Committee of the Laboratory, headed by John Reese,
conducted a search for additional investment managers. Effective July 1, the Committee
appointed two, the Vanguard Prime Cap Fund and Essex Investment Management Company,
Inc., to provide additional expertise in the growth equity areas of the portfolios. U.S. Trust
Company continues to provide excellent management for our short-term investments. As in the
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past, the annual drawdown policy for the endowment was maintained at a conservative average
of less than 3.5% of market value. This policy, together with good investment management, has
enabled the endowment to grow over the years at a rate sufficient to provide an offset for
inflation and for expanded science programs.
Late last year, the Buildings & Grounds Department, under the leadership of Art Brings,
director of facilities, initiated its happily anticipated move into the new Richards Buildings &
Grounds Facility. Named to honor Jack Richards, now our still very active director of special
projects, the new facility includes modern central administrative offices and a conference room
fashioned from the shell of the previous residence of Mitsu Kurahara, which was purchased by
the Lab in 1992. It is flanked on either side by two new barnlike buildings which will house the
various trade shops and the storage facilities needed for supplies and equipment. Well hidden
from nearby meadows and from Bungtown Road are the necessary areas for parking of cars
and heavy equipment, for refuse processing, and for storing various grounds and building
supplies. By late summer of 1997, the entire Richards facility should be complete and in use by
the Department.
A second major 1996 project was the adaptive reconstruction of the de Forest Stables for use
as the new Mary D. Lindsay Child Care Center. With an eventual capacity of up to 50 infants,
toddlers, and preschoolers, the new Center will add significantly to the quality of life for young
laboratory families. The Center will be managed by Rainbow Chimes, Inc., an experienced child
care operator from Huntington, New York, who plan to utilize the most forward-looking method-
ologies of child care and teaching curricula.
Other important buildings and grounds projects included a change from secondary to
primary metering of the Lab's electric power, resulting in estimated cost savings of $150,000 per
year, and improved reliability and redundancy of the system, thanks to the addition of a second
electric feed from a second substation. Ballybung, the new President's house, was added to the
Lab's internal electrical grid. Demerec & James laboratories, Robertson & Hooper houses, and
Cabins 1-6 all received new high efficiency boilers for heat and hot water.
In Beckman Center, a new storage area was created for course equipment and new shops
for machining, equipment service, and HVAC were built. Other areas of Beckman were
reconfigured to provide room for a new MR facility and for installation of a new mass
spectrometer.
The upstairs guest rooms, bathrooms and the central hallway of Blackford Hall were
extensively renovated and redecorated, greatly improving these 90-year old overnight bachelor
accommodations for meetings guests. In Grace Auditorium the former computer center office
and repair shop was converted into a new full-service bookstore, the operation of which was
subcontracted to Barnes & Noble College Bookstores, Inc. It is now a pleasure to see the many
visiting scientists at the Lab meetings and courses congregating in the attractive and spacious
new facility to view the wide variety of general science books and the latest publications of the
CSHL Press. The old bookstore and copier room were converted to additional office space for
Meetings and Courses. The network operating center for information services was extensively
renovated to improve the efficiency and reliability of the Laboratory's computer system.
Doubleday House, severely damaged by fire early in the year, was fully restored and returned to
residential use. Last but not least, the Lab's radioactive materials license and animal care
accreditation were successfully renewed on a timely basis, completing a year of
accomplishment by the B&G staff, which never fails to amaze us.
Public Affairs and Development, capably directed by Susan Cooper, was also very active
and successful in areas of much importance to the Laboratory. Foremost was the increased
coverage of Lab research obtained in key national and local media. Newspapers such as the
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Wall Street Journal, New York Times and Newsday carried prominent articles describing cancer-
related discoveries in the labs of David Beach, Mike Wig ler and Carol Greider, and new insights
regarding the molecular basis of long-term memory from the labs of Tim Tully, Jerry Yin, and
Alcino Silva. ABC, CBS, and Cablevision News 12 all ran TV coverage of ongoing in-lab
research; and more recently, following the publicity surrounding the cloning of the sheep Dolly,
there was a televised discussion of bioethics with Jan Witkowski, director of Banbury Center.
Much effort was also directed toward further improving relations with the local community. A
new newsletter, The Lab Next Door, described the lectures, concerts, and other events of public
interest offered free of charge to the community by the Lab; and also reported the extensive
science educational programs and other assistance made available to local public and private
schools on a voluntary basis by our staff.
Development focused primarily on the difficult triple play of asking more-or-less the same
constituency of donors to participate in a capital campaign, major benefit, and the annual fund,
all in a single year. The capital campaign, for the benefit of the Lindsay Child Care Center, now
has pledges exceeding $800,000 and it is clear that the goal of $1 million will be
exceeded-owing much to the outstanding leadership of chairman Carol Large and vice-
chairman Deborah Solbert. The Emanuel Ax benefit, led by chairman Lola Grace, was both a
spectacular artistic and financial success, providing $136,000 for the benefit of the
Undergraduate Research Program endowment. The CSHL Association's Annual Fund, led by
president John Cleary, amazed us all by raising $608,000 and nearly matching the record
$662,000 total of the previous year, despite the other demands placed on its almost 700
members.
The Corporate Advisory Board of the DNA Learning Center, chaired by Jack Leahy, once
again achieved a record level of support, providing $151,000, or nearly 19 percent of the
DNALC's annual budget. These funds were raised through a combination of the Third Annual
CSHL Golf Tournament, chaired by Horst Saalbach of Festo Corporation and held at Piping
Rock Club, and by a successful Annual Fund spearheaded by the very able Laura Hundt. The
DNALC has become the Lab's most important outreach program to the public and the CAB is
indispensable in providing for its financial viability.
It is always with special regret that we view the departure of someone we have come to count
on as much as Barbara Wang, our assistant controller, who moved to Connecticut with her
family. We were fortunate indeed in having Kathy Didie of the Grants Department ready and
willing to assume Barbara's responsibilities, and already we are sure that she was an excellent
choice to be our new assistant controller.
Also noteworthy during 1996 were the successful negotiations conducted by our controller,
Bill Keen, leading to a new three-year indirect cost rate with the Department of Health & Human
Services. Although the new rate continues the gradual downtrend of recent years in the amount
of overhead the Laboratory may recover on government grants, it is an acceptable rate which
continues to provide urgency to our efforts to further reduce costs wherever possible. As always,
we are indebted to Bill for his very able management of Lab finances.
The same may be said each year of the fine leadership provided by the heads of our other
administrative departments: Susan Schultz in Grants, Cheryl Sinclair in Human Resources, and
Phil Lembo in Purchasing. In addition, we are most fortunate in the very comprehensive and
effective library services provided by Margaret Henderson and her staff, and for the substantial
upgrading and rationalization that has been brought to Information Services by Gerry Latter and
his hardworking department. Nor must we overlook the generous and efficient assistance that
Roberta Sa lant provides each year for the needs of the Trustees and of John Maroney and
myself.
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Looking forward to 1997, we are particularly pleased with the much improved relations with
our neighbors in the Village of Laurel Hollow. The new projects undertaken by the Lab, such as
the Child Care Center and the Building & Grounds Facility, have been processed expeditiously
and fairly by the Village in conformity with the new zoning ordinance. Together, we and the
Village have a better understanding of each other's needs and concerns and are determined to
go forward in the most constructive manner possible.
The present year will mark the transition of a number of extraordinarily productive scientists
from the Lab to other institutions. Their departure and the cost of recruiting replacements will
place a substantial financial burden on the Lab, and in that regard makes the balance of this
year and 1998 more financially uncertain than is usually the case. While we are saddened by
these departures, this sort of transition has been historically typical of the Lab and has
traditionally resulted in a new influx of young scientists who often experience the most
productive periods of their scientific careers while at CSHL. They will surely continue to astound
us with their discoveries, which are as often unexpected as they are unpredictable.
G. Morgan Browne
Administrative Director
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Nicholas Carpino, R. Sanders Williams, Hong Ma
Arne Stendlund, Patricia Springer, Viola Ellison
Tatsuya Hirano, Leemor Joshua-Tor,
Chi-Ping Yin, Daniel Hoeppner
TUMOR VIRUSES
The Tumor Virus section uses viruses to probe cell function and to understand the processes af-
fected during cell transformation. Two members, Arne Stenlund and Bruce Stillman, study DNA
replication of papillomavirus and SV40, respectively. The Stillman laboratory complements studies
of SV40 DNA replication with studies of cellular DNA replication in human and yeast cells. Winship
Herr, Adrian Krainer, and Michael Mathews study control of gene expression in human cells, includ-
ing the control of transcription, pre-mRNA splicing, and translation. Yuri Lazebnik and Scott Lowe
(see CSHL Fellows Section) study how programmed cell death or apoptosis is regulated in normal
and cancer cells, and how changes in the regulation of apoptosis influence the response of cancer
cells to chemotherapy. Jacek Skowronski studies virus/host-cell interactions with human im-
munodeficiency virus, probing how the viral protein Nef disrupts multiple aspects of signal transduc-
tion in T cells. The vitality of this section is exemplified by the strength of the DNA tumor virus pro-
gram project which covers much of the research in this section. This program project turned 25 this
year and was provided renewed funding for another five years with high praise.
DNA SYNTHESIS
B. Stillman R.S. Williams
S. Waga
C. Bolwig
J. Chong
G. Cullmann
V. Ellison
M. Hidaka
M. lizuka
P. Kaufman
R. Li
C. Liang
J. Mendez
K. Shibahara
A. Verreault
M. Weinreich
K. Gavin
Our laboratory has focused on the mechanism and
regulation of genome duplication in eukaryotic cells.
Traditionally, we have studied the replication of
simian virus 40 (SV40) and have used this system to
elucidate the mechanism of DNA replication in cells.
This research, however, is increasingly moving
toward understanding the replication of cellular
DNA, and in the last year, this shift in focus has
progressed further. We now take a combined
biochemical and genetic approach to understanding
the replication of DNA in cells and the process of
concomitant assembly of the replicating DNA into
chromatin. To facilitate the biochemistry, we have
concentrated on the production of recombinant vec-
tors for producing proteins, a time-consuming yet, we
believe, productive approach in the long term. In
parallel, recent studies have focused on genetic
studies to identify the proteins that are necessary for
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H. Rao
L. Zou
M. Waga
P. Wendel
C. Driessens
replication and chromatin assembly, expecting that
the two complementary approaches will yield greater
insight into the problems at hand. In the yeast, this
has been greatly facilitated by the completion of the
sequence of the entire Saccharomyces cerevisiae
genome in the early part of 1996 and the ever-
increasing presence of cDNA sequences in the human
genome databases.
Mechanism and Control of DNA
Synthesis at the Replication Fork
G. Cullmann, V. Ellison, R. Li, M. Waga, S. Waga
Loading proteins onto the DNA is one of the rate-
limiting steps in the replication of DNA, and two
FIGURE 1 Subunit assembly of the human replication factor
C. Shown above are the subunit interactions important for
RFC complex assembly. Although all five subunits are re-
quired for DNA synthesis, a subcomplex of p36, p37, and
p40 is sufficient for ATPase activity. The stability of p140 in
the complex is dependent on the p38 and p40 subunits,
whereas p40 requires p36 for maintenance in the complex.
proteins that perform this function after the initial un-
winding of the DNA at the replication origin are the
proliferating cell nuclear antigen (PCNA) and the
replication factor C (RFC). These proteins have func-
tional counterparts in bacteria and some of the bac-
terial phages, as well as in the more recently charac-
terized genome of an archaebacteria. RFC, a clamp-
loading protein and DNA-dependent ATPase, loads
PCNA onto the DNA so that it encircles the double
helix. PCNA then functions as a docking protein for
the incoming DNA polymerase 8, and, together, pol 8
and PCNA function as a processive polymerase.
We have isolated all of the S. cerevisiae RFC sub-
unit genes and have begun a combined biochemical
and genetic analysis of their function. In addition, we
have cloned the five subunits of human RFC in
recombinant baculoviruses and expressed the proteins
in infected insect cells. These proteins, when ex-
pressed individually or in combination, can be used
for studying the function of RFC and the subunit-
subunit interactions. Using these proteins, we have
identified the protein-protein interactions that occur
in the RFC complex (Fig. 1). The recombinant RFC
is as active as the protein purified from human cells,
and it has been possible to purify complexes that con-
tain less than the five subunits and discover the role
of individual proteins in RFC function. For example,
the four small subunits form a complex and have
DNA-activated ATPase activity, which was surpris-
ing since many have pointed out that the large RFC
subunit has DNA-binding activity.
We continue to study the interaction of RFC and
PCNA with the cyclin-dependent kinase (CDK) in-
hibitor, p21CIPI. We have shown that p21CIPI blocks
PCNA-dependent DNA polymerase activity and thus
inhibits SV40 DNA replication in vitro. Surprisingly,
p21c1P1 does not inhibit PCNA-dependent DNA
repair. The fact that p21 cl" binds CDK cyclins sug-
gests a link between cell cycle control of DNA repli-
cation and proteins at the replication fork. We have
demonstrated that PCNA can load onto a template
DNA in an RFC-dependent manner in the presence of
p21CIP1, and interestingly, p21CIPI is also bound to
the DNA, presumably via an interaction with PCNA.
This suggests that the inhibition of DNA replication
is caused by p21c1PI blocking an interaction with the
polymerase or that it blocks polymerase function.
The effect of the CDK cyclins on this reaction is
being investigated, which may provide insight as to
why the protein kinases form links to PCNA via
Chromatin Assembly
P. Kaufman, K. Shibahara, A. Verreault
The SV40 DNA replication system has yielded inter-
esting insight into the mechanism of the replication-
coupled assembly of the histones onto the newly
copied DNA, a process that needs to occur to dupli-
cate the chromosome in each cell cycle. We have
demonstrated that a chromatin assembly factor called
CAFI is required for the assembly of histones onto
DNA, in addition to the DNA replication proteins,
the four core histones H2A, H2B, H3, and H4, and
other as yet uncharacterized proteins. CAFI consists
of three subunits of molecular masses of 150, 60, and
48 kD. We reported last year the cloning of the genes
encoding the three subunits of CAFI and the recogni-
tion that there existed a protein that was very related
to the CAFI p48 subunit. This protein, called p46, is
89% identical and 95% similar to the p48 protein, but
it does not associate in vivo with the other CAFI sub-
units. In addition to its role as a CAFI subunit, the
p48 subunit turned out to be identical to a component
of another protein complex, the human histone deace-
tylase enzyme, as shown by Stewart Schreiber's lab-
oratory (Harvard Medical School).
A clue to the role of p46 came from studies in Rolf
Sternglanz's laboratory (SUNY, Stony Brook) and
Dan Gottschling's laboratory (Fred Hutchinson Can-
cer Center) on the acetylation of histones. Histone
acetylation has been shown to be coupled to
replication-dependent assembly of histones onto the
DNA during genome duplication in the S phase of the
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FIGURE 2 Protein complexes containing a family of histone
interacting subunits. The human p46 and p48, as well as the
yeast Cac3p and Hat2p, form a small subfamily of related
WD40-repeat proteins. p48 and Cac3p are part of CAF1 or
the human histone deacetylase. p46 and Hat2p are subunits
of the histone H4 acetyltransferase enzyme.
cell cycle and with silencing of gene transcription in
various organisms, including the silent mating-type
genes and genes that are located near telomeres in S.
cerevisiae. A relative of the human p46 and p48
proteins was found to be a subunit of the yeast
histone H4 B-type acetyltransferase. This enzyme
acetylates two lysine residues near the amino
terminus of the histone. These lysine residues are
known to be important for transcriptional silencing
and to be acetylated in newly assembled chromatin
during DNA replication. The yeast acetyltransferase
contains two subunits, Hatlp and Hat2p, the latter
being a p46/p48-related protein (Fig. 2).
In previous studies, we have purified the human
and Drosophila CAFI proteins and shown them to
have a similar subunit composition. This year, we
have purified the S. cerevisiae CAF1 protein complex
by complementation of the SV40-based DNA repli-
cation-dependent chromatin assembly reaction in
vitro. The yeast CAF1 contains three subunits and the
genes encoding these have been called CACI, CAC2,
and CAC3, encoding the p150, p60, and p48 func-
tional homologs, respectively. The CAC3 gene prod-
uct is related in sequence to the acetyltransferase sub-
unit Hat2p (Fig. 2).
Deletion of each of the CAC genes separately or in
combination resulted in viable cells that had two in-
teresting defects. They were sensitive to ultraviolet
irradiation, which induces nucleotide excision repair,
but not to y-irradiation, which induces double-strand
break repair. This was of interest to us because in a
collaboration with Genevieve Almouzni's laboratory
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in France, human CAF1 was shown to function in
chromatin assembly associated with UV-induced
nucleotide excision repair.
The deletion of the CAC genes also produced an-
other interesting phenotype. Deletion of any of the
CAC genes strongly reduces silencing of genes ad-
jacent to the telomeres of chromosomes. The dele-
tions result in an unstable epigenetic state near the
telomeric DNA because some cells in the population
contain a telomere-linked gene that is fully silenced,
whereas others have the gene fully transcribed.
Normally, in a wild-type strain, the telomeres repress
transcription of a nearby gene. It is possible that the
replication-coupled assembly of chromatin at the
telomeres is necessary for maintaining a stable
chromatin structure at the telomeres that can be in-
herited from one cell generation to the next. The
CACI gene is identical to RLF2 (Raplp localization
factor-2; identified in Judith Berman's laboratory,
University of Minnesota, St. Paul), a gene required
for the normal distribution of the telomere-binding
Raplp within the nucleus. Raplp is known to be re-
quired for teromeric silencing.
Together, these data suggest that CAFI has a role
in assembly of chromatin in vivo but that the
replication-coupled assembly is not essential. This
must mean that there is another chromatin assembly
pathway in the cell that can ensure the inheritance of
chromosomes but cannot maintain epigenetically in-
herited states of chromatin. The identification of a
family of related proteins as subunits of a chromatin
assembly factor, a histone deacetylase and a histone
acetyltransferase, suggests that these proteins might
function as histone targeting proteins or histone
chaperones. The emergence in the last year of both
histone acetyltransferases and deacetylase, both those
described here and others that are implicated in gene
regulation, suggests that this modification of proteins
will be an important regulatory mechanism for chro-
matin dynamics.
Cell Chromosome Replication
C. Bolwig, J. Chong, K. Gavin, M. Hidaka, M. lizuka,
C. Liang, J. Mendez, H. Rao, M. Weinreich,
P. Wendel, R. S. Williams, L. Zou
During the last year, we have expanded our studies
on the mechanism of initiation of DNA replication in
the yeast S. cerevisiae. In the last year, we have iso-
lated and sequenced a new gene, called CDC45, that
is involved in the initiation of DNA replication, and
we now are studying the function of Cdc45p and its
interactions with other initiation proteins.
A mutant CDC45 was originally isolated as a sup-
pressor of a mutation in CDC46, a gene that encodes
one of the minichromosome maintenance (MCM)
proteins. There are six MCM proteins that are certain
to be required for initiation of DNA replication in all
eukaryotic species examined to date. CDC45 was
known to interact genetically with at least two of the
six MCM genes in yeast. We therefore cloned the
wild-type CDC45 gene by complementation of the
cold-sensitive mutant. The resulting gene was se-
quenced and was shown to encode a novel protein
that had no significant similarity to other proteins in
the database, except for a protein from Usti lago that
had also been implicated in control of DNA replica-
tion in that organism. We have demonstrated using
genetic methods that CDC45 interacts not only with
the MCM genes, but also with the genes encoding
subunits of the origin recognition complex (ORC).
ORC is the initiator protein that binds to origins of
DNA replication in yeast and facilitates the initiation
of chromosomal DNA replication. This work implied
that Cdc45p may mediate an interaction between the
MCM proteins and ORC which is bound to origins of
DNA replication in the cell's chromosomes. Studies
Alter anaphase
or Early GI
in other laboratories have demonstrated that the
MCM proteins have a critical role in licensing the
replication origins so that they are competent for a
new round of initiation of DNA replication. This
licensing occurs in late mitosis or early G, as cells
enter the new cell cycle.
To follow up on these studies, we have cloned
CDC45 into a recombinant baculovirus vector for ex-
pression in insect cells and have recently completed
the expression of all six MCM proteins in baculo-
virus vectors so that they may be simultaneously ex-
pressed in insect cells. Using this technology, we
have also demonstrated previously the expression of
the six subunits of ORC and have reconstituted the
functional ORC complex in baculovirus-infected
cells. Using these reagents, we plan to continue our
studies on the interaction of Cdc45p with ORC and
the MCM proteins and study their roles in initiation
of DNA replication.
Other studies have led to the identification of other
proteins that interact with ORC. The four subunits of
the DNA polymerase a/primase complex have been
cloned into recombinant baculoviruses and a func-
tional protein complex has been expressed in insect
cells. The protein has been purified to homogeneity
and shown to have both DNA polymerase and DNA
primase activities, just like the native protein purified
from yeast. We have shown by a variety of methods
Window of opportunity
Late GI
Activation
atGI -S
S phase
G2 and up to
Metaphase
FIGURE 3 Proposed model for the chromosome replica-
tion cycle in eukaryotes. This model is based on the
work of many investigators. The initiator protein ORC is
bound to the chromosomes throughout the cell cycle.
The ordered assembly of the prereplication complex
(pre-RC) containing ORC, Cdc6p, and the MCM pro-
teins occurs during a window of opportunity that is
defined by the state of cyclin-CDK activity. Initiation of
replication requires cyclin-CDK and Cdc7p-Dbf4p ac-
tivities. After initiation, a post-RC is formed and cyclin-
CDK activity blocks assembly of the pre-RC.
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that the polymerase a/primase complex interacts with
ORC in cells and in vitro by direct protein-protein in-
teractions. This work is of particular interest because
it suggests that ORC may attract the polymerase
a/primase complex to the origins of DNA replication
by direct protein-protein interactions, thereby facili-
tating synthesis of RNA primers that would actually
initiate DNA replication.
In previous studies, we have identified the CDC6
gene by suppression of ORC mutants. We have now
gone on to show that the CDC6-encoded protein
(Cdc6p) is a key regulator of initiation of DNA
replication. Analysis of novel mutations in theCDC6
gene have demonstrated that Cdc6p controls the com-
petency of replication complexes to initiate DNA
replication. One mutant that we have isolated, cdc6-
3, causes promiscuous initiation of DNA replication
throughout the cell cycle so that initiation is no
longer limited to once in every cell division cycle and
to S phase.
Knowledge of the mechanism of initiation of DNA
replication in yeast is now quite advanced (Fig. 3).
The yeast studies provide a guide for our ongoing
studies on the initiation of DNA replication in human
cells. Three different cDNAs encoding three of the
human ORC protein subunits have been identified,
and we are currently studying the proteins with which
they interact. In the last year, we have also identified
the human cell encoded CDC6-related protein
(HsCdc6p) and have shown that it is absent in non-
proliferating cells but is present in the nucleus of
proliferating cells. The cloning of the gene and
cDNAs encoding the protein have suggested that the
transcription of the gene is controlled directly by the
E2F transcription factors that are in turn controlled
by the retinoblastoma tumor suppressor protein. The
discovery of the HsCdc6p and ORC subunits in hu-
man cells suggests that the mechanism of initiation of
DNA replication may be very similar in mammalian
cells and yeast.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund M. Berg C. Sanders
J. Sedman G. Chen
E. Gillitzer A. Lee
T. Sedman S. Kivimae
The papillomaviruses infect and transform the basal
epithelium in their hosts, inducing proliferation of the
cells at the site of infection. The resulting tumors are
in most cases benign and will usually regress after
some time, but certain types of human papilloma-
viruses (HPVs) give rise to tumors that are prone to
progress toward malignancy, especially frequently
cervical carcinoma. In total, HPV DNA can now be
found in biopsies from approximately 80% of all cer-
vical carcinomas.
A key impediment to the study of papillomavi-
ruses has been the inability to define a simple in vitro
cell culture system for HPVs, largely due to the fact
that these viruses normally require specialized differ-
entiating cells that only with great difficulty can be
generated in cell culture. Therefore, a bovine papil-
lomavirus (BPV-1) has become the prototype virus
for the papillomavirus group largely because a con-
venient cell culture system exists for this virus. In
this cell culture system, viral gene expression, on-
cogenic transformation, and viral DNA replication
can be studied. The DNA replication properties of
papillomaviruses show some unique and interesting
characteristics. As a part of their normal life cycle,
these viruses can exist in a state of latency character-
ized by maintenance of the viral DNA as a multicopy
plasmid in infected cells. The copy number of the
viral DNA appears to be tightly controlled and the
viral DNA is stably inherited under these conditions.
This system therefore provides a unique opportunity
to study plasmid replication in mammalian cells.
In previous years, we have reported the develop-
ment of a short-term replication assay that has
enabled us to define the viral components that are re-
quired for viral DNA replication. More recently, we
have directed our attention toward detailed biochemi-
cal analysis of the replication process. We are study-
ing the biochemical properties of the two viral
proteins (El and E2) that are required for viral DNA
replication. We are also studying how these two
proteins interact with the ori and with each other to
generate initiation complexes. From these studies, we
now have a relatively clear picture of the roles of the
El and E2 proteins in replication. El has all the char-
acteristics of an initiator protein, including on recog-
nition, DNA-dependent ATPase activity, and DNA
helicase activity. El can also function to unwind a
supercoiled plasmid that contains the on sequence.
The E2 polypeptide, whose function has remained
more elusive, appears to serve simply as a specificity
factor for El. Through physical interactions with
both El and the ori, E2 can provide sequence
specificity in the formation of the initiation complex.
Our attention has now turned toward elucidation of
the precise biochemical events that precede initiation
of replication at the origin of replication, i.e., binding
of the initiator to the ori, the initial opening of the
DNA helix, and the assembly and loading of the El
replication helicase at the replication fork. Our
studies indicate that the assembly of a preinitiation
complex is a multistep process involving the ordered
assembly of El molecules to generate different com-
plexes with differing activities that in turn serve to
recognize the ori, destabilize the double helix at the
ori, and function as the replication helicase.
Binding of the El and E2 Proteins
to the Origin of Replication
J. Sedman, T. Sedman, E. Gillitzer
The smallest sequence element from BPV that can
direct initiation of replication in vivo (ori) is approxi-
mately 60 nucleotides long. This sequence contains
three different, separable, elements. Two of these ele-
ments have known functions and constitute the bind-
ing sites for the viral El and E2 proteins, respective-
ly. The third element has been termed the A+T-rich
region and its function is unknown. We have devel-
oped a series of assays to study the binding of El and
E2 to the ori sequence to determine the requirements
for binding and for formation of productive replica-
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tion complexes. By a combination of DNase protec-
tion, gel retardation, and interference assays, we have
established that El is capable of binding to the on in
at least two different forms, either together with E2 to
form an El-E2-ori complex or by itself to form an
oligomeric El-ori complex. The El-E2-ori complex
is formed by cooperative binding of El and E2 to ori
and requires low concentrations of El. Formation of
the El -ori complex requires higher concentrations of
El and forms on the same ori sequence, but does not
require E2 or E2-binding sites for its formation. To
determine which of these complexes are important
for replication in vivo, we have generated a large
number of point mutations in the ori. These mutants
have been tested for their ability to form the two dif-
ferent complexes and for replication. Interestingly,
the results show very clearly that both the ability to
form the El-E2-ori complex and the ability to form
the El-ori complex are important for replication ac-
tivity in vivo. The simplest interpretation of these
results is that the assembly of a complex that is com-
petent to initiate DNA replication is a stepwise reac-
tion where the El-E2-ori and the El -ori complexes
represent intermediates.
An important factor in elucidating the function of
the two different El-containing complexes that can
form on the on is to understand the specific composi-
tion of the complexes and the stoichiometry of bind-
ing. This information is also important to determine if
a precursor-product relationship exists between the
two complexes. We have therefore performed molec-
ular mass determinations of the two different El-
ViikkA111
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FIGURE 1 A schematic model for binding of El in the El-
E2-ori complex and the trimeric El -ori complex. The El
molecule in the E1 -E2-ori complex binds on one face of the
DNA helix. In the trimeric El -ori complex, one El molecule
is bound in the same position as in the El-E2-ori complex,
whereas the two additional El molecules are bound on the
two other faces of the helix to complete a structure that en-
circles the DNA helix.
66
containing on complexes using a combination of gly-
cerol gradient centrifugation and gel filtration using
cross-linked El complexes. The results of these
studies show that El in the absence of E2 binds to the
on as a trimer. The formation of the trimer is induced
by the presence of the specific binding site for El and
does not occur in the absence of DNA. Interestingly,
this trimer of El is topologically linked to the ori
DNA, indicating that El forms a ring-like structure
that encircles the DNA. In the presence of E2, El
binds as a monomer to the same binding site. High
resolution footprinting as well as interference analy-
sis demonstrates that this monomer of El binds in an
identical position as one of the El molecules in the
trimeric complex, making it likely that the El-E2-ori
complex is a precursor for the trimeric El-ori com-
plex. On the basis of these experimental results, we
can draw a schematic model for binding of El in the
two different forms (Fig. 1).
El Forms a Hexameric Structure
That Has DNA-dependent ATPase
and DNA Helicase Activity
J. Sedman
As mentioned above, the El protein has been
demonstrated to have DNA helicase activity and also
DNA-dependent ATPase activity. All DNA-depen-
dent DNA helicases to date have been shown to have
nucleotide hydrolysis capacity. To identify the form
of El that has ATPase activity, we assembled El un-
der conditions used for ATPase assays and sedimen-
ted the material on a glycerol gradient. When the gra-
dient was assayed for ATPase activity, interestingly,
the activity was found to sediment as a discrete peak
with a relative molecular mass of approximately 400
kD, which is substantially larger than either the El-
E2-ori complex or the trimeric El -ori complex that
we have analyzed previously. Further analysis of this
form of El using gel filtration has revealed that the
relative molecular weight of this complex is con-
sistent with a hexameric form of El. This same com-
plex also has DNA helicase activity, indicating that
hexameric El is the active replication helicase. These
results, in conjunction with the two different El com-
plexes that we have previously identified, indicate
that El is capable of forming several different com-
plexes with different replication-related biochemical
activities.
Functional Interactions between
the El and E2 Proteins
M. Berg, G. Chen, S. Kivimae
In most eukaryotic replicons that have been studied,
binding sites for transcription factors constitute a part
of the cis-acting sequences required for replication
activity. In the majority of cases, including, for exam-
ple, SV40, polyomavirus, and ARS elements from
Saccharomyces cerevisiae, this auxiliary activity can
be supplied by various transcriptional trans-activators
with little apparent specificity. A similar requirement
exists also for papillomavirus replicons; however,
only the virus-encoded transcription factor E2 can
serve as an auxiliary factor for replication. The re-
quirement for E2 in replication of BPV extends
beyond a mere requirement for E2 bound to the ori:
A physical interaction with El is also required. This
interaction can be detected as cooperative binding of
the two proteins to the ori, when the respective bind-
ing sites are located in the correct position relative to
each other. Because the E2 proteins are well con-
served between different papillomaviruses and have a
conserved overall structure, we tested E2 proteins
from other papillomaviruses for interaction with BPV
El and for DNA replication. E2 from HPV-11 failed
to interact with BPV El in either of these assays.
This observation presented us with an opportunity to
map the regions of E2 that were required for this in-
teraction by construction of chimeric BPV/HPV-11
E2 proteins. This approach has a distinctive ad-
vantage over conventional mutagenesis in that the
overall structure of the protein can be maintained. We
have used this procedure to generate a large number
of chimeric E2 proteins. These chimeras were tested
for their ability to interact physically with BPV El in
a biochemical assay and for the ability to support
replication in vivo. The results from these experi-
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ments have revealed a more complex situation than
we had anticipated. We find that multiple regions
both from the amino-terminal trans-activation do-
main of E2 and from the carboxy-terminal "hinge"
and DNA-binding domain cooperate to generate a
strong interaction with E 1. We also find that the in-
teraction between the El and E2 proteins appears to
take place in a two-step process where an initial weak
physical interaction between El and the DNA-
binding domain of E2 allows a stronger, productive
interaction between El and the activation domain of
E2. Furthermore, we can also show that the differen-
tial specificity that is observed with E2 proteins from
different papillomaviruses is a result partly of dif-
ferences in on structure, indicating that the formation
of a productive interaction between El and E2 that
will result in initiation of DNA replication is highly
dependent on the position of the El- and E2-binding
sites relative to each other.
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We study the mechanisms of transcriptional regula- mechanisms. In particular, we study interactions be-
tion in eukaryotes, and use viruses to probe these tween the herpes simplex virus (HSV) transcriptional
regulatory protein VP16 and its cellular targets.
When HSV infects cells, VP16, a virion protein, is
released into the infected cell, whereupon it associa-
tes with two cellular proteins-the transcription factor
Oct-1 and the cell-proliferation factor HCF-on
VP16-responsive elements in HSV immediate-early
(IE) promoters. Formation of this VP16-induced
complex results in activation of transcription of the
HSV IE promoters.
Our studies continue to focus on three general
areas: (1) the study of how activators such as VP16
and the basal transcriptional machinery interact to
stimulate transcription, (2) the mechanisms of forma-
tion of the VP16-induced complex, and (3) the cel-
lular functions of the VP16-associated protein HCF.
Enhancer Function
C. Hinkley, P. Reilly, W. Tansey, X. Zhao
Enhancers are promoter elements that can stimulate
transcription even when positioned at great distances
from the transcriptional start site. To study enhancer
function, we examine how enhancer-binding ac-
tivators stimulate transcription through interactions
with the basal transcriptional machinery assembled
on core promoter elements. In vivo, it is difficult to
study how the basal transcriptional machinery
responds to activators because the basal factors are
highly conserved, ubiquitously expressed, and proba-
bly essential proteins; there is thus no direct way to
study basal factor mutants within a cellular context.
To circumvent these limitations, we have taken an
altered-specificity approach, using genetically tagged
basal factors to analyze parallel, manipulable, tran-
scription complexes within the cell. Figure 1 demon-
strates how, by linking two such altered-specificity
interactions together in sequence, we can study how
two basal factors, TBP and TFIIB, function in human
cells.
Our approach begins with a mutation in the TATA
box of a reporter gene, in which the wild-type TATA
sequence is changed to TGTA. As shown in lanes 1
and 2, this mutation disrupts activity of the reporter
gene. Expression of a form of the TATA-box binding
protein TBP (called TBPAS), which, unlike its wild-
type counterpart, can bind to the "TGTA" box, sup-
presses this reporter mutation and restores near wild-
type levels of reporter activity (lane 3). The recent
solution of the TATA box-TBP-TFIIB cocrystal
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FIGURE 1. Sequential altered-specificity interactions permit
analysis of TFIIB function in vivo. The figure shows an
RNase protection analysis of internal reference and reporter
transcripts after transient expression in human He La cells
(see text for details).
structure enabled us to extend our in vivo analyses to
include TFIIB. Out of the many TBP-TFIIB contacts
revealed in the structure, we noticed that a glutamic
acid at position 284 (E284) of TBP makes a polar
side-chain-side-chain interaction with an arginine at
position 169 (R169) in TFIIB. We first showed that
changing E284 of TBP to an arginine (TBPASE284R)
disrupts TBP function in vivo (lane 4). We then
found that a TFIIB molecule with the complementary
mutation-R169 changed to glutamic acid TFIIB
(TFIIBR169E)-can suppress this defect in TBP (lane
5), restoring wild-type levels of promoter activity.
These manipulations between TBP and TFIIB es-
tablish a three-way "sequential altered-specificity"
TATA-TBP-TFIIB array that now links TFIIB ac-
tivity to an output from the reporter gene, allowing
TFIIB mutants to be analyzed in vivo. The array has
also let us probe how TBP and TFIIB function to-
gether to support transcriptional activation. Although
many activation domains use the TBPT -FIIB interac-
tion in vivo, we have found that the known
TBP-TFIIB interaction is apparently not involved in
response to a glutamine-rich activation domain from
the transcription factor Spl: This activation domain is
relatively insensitive to the E284R mutation in
TBPAS and nonresponsive to the TFIIBRi69E sup-
pressor. This surprising result suggests that transcrip-
tional activation in vivo can be achieved through the
differential reliance on interactions between core
components of thd basal machinery.
Viral Trans-activation
D. Aufiero, R. Babb, M. Cleary, C. Huang,
C. Hunt-Grubbe
We study the structure and function of the VP16-
induced complex and compare that complex to cel-
lular complexes formed by Oct-1 with a basal tran-
scription complex and a cell-specific coregulatory
protein. We continue to examine how the VP16
protein of different herpesviruses is able to associate
with the same Oct-1 and HCF molecules but form
VP16-induced complexes of differing DNA-binding
specificities. For example, the VP16 protein of bo-
vine herpesvirus (BHV) can form a complex with hu-
man Oct-1 and HCF on BHV VP16-response ele-
ments, but this BHV VP16-induced complex does not
recognize HSV VP16-response elements; in contrast,
the HSV VP16 protein forms a complex on HSV
VP16-response elements but not a BHV VP16-re-
sponse element. By performing transcription assays
in vivo, we have shown that the differing specificities
of VP16-induced complex formation by BHV and
HSV VP16 protein translate into differing specific-
ities of promoter activation. These studies show how
a single transcriptional regulatory protein such as
Oct-1 can acquire different regulatory potentials
through association with coregulators of differing
DNA recognition specificities, in this case the VP16
proteins.
Oct-1 itself displays a remarkable degree of
flexibility in how it recognizes cis-regulatory ele-
ments, and we continue to investigate how flexible
DNA-binding specificity is achieved. The structure of
the Oct-1 DNA-binding domain-a POU domain-
has offered an explanation for how Oct-1 can bind to
a variety of different sequences. It is a bipartite
DNA-binding domain, consisting of two separate
DNA-binding structures-a POU-specific (POUs)
domain and POU-homeo (POUH) domain-tethered
by a flexible linker. The bipartite nature of the POU
domain suggested that the POU DNA-binding struc-
tures might adopt different conformations on the
DNA.
To study how the two POU DNA-binding struc-
tures bind to different regulatory sites, we adapted, in
collaboration with Shannon Pendergrast (Hernandez
Laboratory), a protein-to-DNA cross-linking strategy
developed by by S. Pendergrast and R. Ebright at the
Waksman Institute. They showed that a photoacti-
vatable cross-linker could be covalently attached to a
specific cysteine in a DNA-binding protein and used
to cross-link the protein to DNA. The site of cross-
linking could then be mapped on the DNA. We used
this method to create cross-linkers that are specific
for particular domains within a protein, by placing
the photoactivatable cross-linker on either the POUs
domain or the POUH domain. By using such domain-
specific cross-linkers, we showed that the two POU
DNA-binding structures do indeed position them-
selves differently on different binding sites.
To our suprise, we also learned that on one type of
HSV IE promoter VP16-responsive element, the
structure of the POU domain is dynamic, being able
to adopt at least two very different conformations on
a single binding site. These results raised an intrigu-
ing question: If the Oct-1 POU domain can adopt
multiple conformations on a single VP16-responsive
site, is VP16 able to form a complex with either con-
formation? To answer this question, we developed a
"cross-linking interference" strategy. In this experi-
ment, we cross-linked the POU domain to the VP16-
responsive site before forming a VP16-induced com-
plex. By cross-linking the POU domain to the DNA,
we effectively fixed the position of a POU DNA-
binding structure to the DNA and then asked if the
cross-linked species could still form a VP16-induced
complex. The results show that although sensitive to
cross-linking of the POUF, domain, VP16 is insensi-
tive to the position to which the POUs domain is
cross-linked. Thus, multiple conformations of the
POU domain are able to form a VP16-induced com-
plex.
Cellular Functions of HCF
M. Boutros, R. Freiman, Y. Liu, A. Wilson
We continue to study in ever-increasing detail the
role of HCF in uninfected cells. HCF is a family of
polypeptides, ranging in size from 110 kD to 150 kD,
which results from proteolytic cleavage of a large
precursor protein of approximately 300 kD at a series
of centrally located 26-amino-acid repeats called the
HCF repeats. Curiously, the resulting amino- and
carboxy-terminal HCF fragments remain associated
with one another after cleavage.
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Although HCF is a collection of large polypep-
tides, only the amino-terminal 380 residues of HCF
are required to associate with VP16 and stabilize
VP16-induced complex formation. This region con-
sists of six repeats related to repeats found in the
Drosophila protein Kelch and other proteins. We
refer to the repeats in HCF as the HCFKEL repeats. In
other proteins, HCFKEL-like sequences form a
propeller-like structure in which each repeat forms a
four-stranded 13-sheet, representing one blade of the
propeller. This propeller-like structure is also found
in the I3-subunit of heterotrimeric G proteins and is
involved in conformation-specific recognition of the
a subunit of the heterotrimeric G proteins. We
hypothesize that HCF may likewise associate with a
specific conformation of VP16 and by doing so stabi-
lize the VP16-induced complex.
In uninfected cells, HCF is involved in cell
proliferation. T. Nishimoto and colleagues (Kyushu
University) isolated a hamster cell line that has a tem-
perature-sensitive defect in cell proliferation caused
by a missense mutation in the HCF gene. The mis-
sense mutation that causes the HCF defect lies within
the amino-terminal VP16-interaction domain, and we
showed that this mutation affects the ability of VP16
to activate transcription and associate with HCF.
These results indicate that VP16 targets a part of the
cell machinery important for cell proliferation and
lead us to hypothesize that VP16 mimics a cellular
cofactor of HCF function involved in cell prolifera-
tion. Perhaps by mimicking such a factor, VP16 is
able to gauge the cell cycle status of the infected cell
and allow the virus to make an appropriate response,
either growing lytically or residing latently for many
years within the host.
A Genetic Analysis of Transcriptional
Synergy in Yeast
M. Tanaka
In the past year, my research has focused on a genetic
analysis of cooperative DNA binding by activators
and of synergy in transcription. I have previously
reported that activator binding to a promoter is
cooperative in vivo, consistent with an earlier report
on in vivo binding of the yeast activator GAL4. This
cooperative binding is possibly a general basis for
70
generating a high degree of binding-site synergy in
transcriptional activation; a two-site promoter shows
an approximately 30-fold higher level of transcription
than the single-site promoter in my system in yeast.
The low level of transcription from the single-site
promoter allowed me to isolate yeast mutants in
which the activity of the single-site promoter is en-
hanced, presumably through more effective activator
binding to a single binding site. In many of the
mutants I isolated, the activity of the multiple-site
promoter is relatively unaffected. As a result, the
binding-site synergy of transcription seen in wild-
type cells is nearly lost in these mutants.
A complementation test has shown that the muta-
tions are recessive, indicating that loss of function of
a wild-type gene(s) leads to specific enhancement of
the single-site promoter activity. This, in turn, sug-
gests that the function of the wild-type gene(s) is to
repress specifically the single-site promoter, probably
through selective inhibition of DNA binding. Togeth-
er, these results imply that negative regulation is criti-
cal in generating binding-site synergy in transcrip-
tional control.
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MECHANISMS OF CONSTITUTIVE AND
ALTERNATIVE PRE-mRNA SPLICING
RNA splicing is a required step in the expression of
most eukaryotic protein-coding genes. The selection
and pairing of authentic splice sites within the
spliceosome occur with a very high degree of fidelity,
which requires that limited and dispersed sequence
information present throughout introns and exons be
precisely interpreted. The expression of many cellular
and viral genes occurs via alternative splicing, which
involves substantial flexibility in the choice of splice
sites, allowing the expression of multiple protein
isoforms from individual genes. The choice of
alternative splice sites is commonly regulated to alter
gene expression, either tissue-specifically or in
response to a developmental program or to ex-
tracellular signals.
Both constitutive and alternative splicing mechan-
isms involve multiple protein components, as well as
RNA components that are part of small nuclear
ribonucleoprotein (snRNP) particles. Our lab has
focused on the identification, purification, and
molecular characterization of protein factors that are
necessary for the catalysis of splicing and/or for the
regulation of alternative splice site selection.
A major portion of our efforts has been devoted to
the characterization of three families of RNA-binding
proteins: the SR proteins, exemplified by SF2/ASF;
the heterogeneous nuclear RNP (hnRNP) A/B pro-
teins, of which the best characterized is hnRNP Al;
and the more recently discovered SF7 factors. Indi-
vidual SR proteins function as essential constitutive
splicing factors and are also involved in constitutive
or regulated enhancer-dependent splicing. In addi-
tion, they modulate alternative splicing in vivo or in
vitro in a concentration-dependent manner. This ac-
tivity is antagonized by hnRNP A/B proteins to
modulate alternative 5' splice site selection and by
SF7 proteins to determine alternative 3' splice site
selection.
ROLE OF THE STRUCTURAL DOMAINS OF SR
PROTEINS IN SUBNUCLEAR LOCALIZATION,
ALTERNATIVE SPLICING IN VIVO, AND GENERAL
SPLICING IN VITRO
SR proteins are required for constitutive pre-mRNA
splicing and also regulate alternative splice site selec-
tion in a concentration-dependent manner. They have
a modular structure that consists of one or two RNA-
recognition motifs (RRMs) and a carboxy-terminal
RS domain. J. Caceres transiently overexpressed
epitope-tagged wild-type or domain-deletion mutants
of SF2/ASF, SRp40, SC35, and SRp20 proteins in
HeLa cells to study the role of the constituent
domains of these SR proteins in cellular distribution,
subnuclear localization, and regulation of alternative
splicing (in collaboration with T. Misteli and D.
Spector, CSHL, and with G. Screaton, Oxford). In-
direct immunofluorescence microscopy showed that
the RS domain of SF2/ASF is neither necessary nor
sufficient for targeting to the nuclear speckles and
that SF2/ASF contains redundant, additive nuclear
localization signals in both RRMs and in the RS
domain. Striking differences were observed between
SF2/ASF, which has two RRMs, and two SR proteins
with a single RRM (SC35 and SRp20), since in the
latter proteins, the RS domain is both necessary and
sufficient as a subnuclear targeting signal to the
speckles. This was shown by transiently expressing
tagged chimeric proteins comprising the nucleoplas-
mic core domain, which localizes in the cytoplasm,
and the RS domain of SF2/ASF or of SRp20. The
former protein localized diffusely in the nucleus,
whereas the latter was found in the nuclear speckles.
Cotransfection studies using the above constructs
and alternatively spliced reporter genes were carried
out to determine the role of individual domains in
alternative splice site selection. As expected from
previous in vitro studies, the RS domain of SR
proteins is not required for the concentration-
dependent switch between alternative 5' splice sites.
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RRM2 of SF2/ASF has an important role in alterna-
tive splicing specificity; deletion of this domain
results in a protein that although active in alternative
splicing, has altered specificity in 5' splice site selec-
tion. Thus, whereas the intact protein or SF2/ASF
lacking RRM1 promotes use of the adenovirus E1A
13S 5' splice site, SF2/ASF lacking RRM2 promotes
use of the 12S 5' splice site. These results demon-
strate the modularity of SR proteins and the impor-
tance of individual domains for their cellular localiza-
tion and alternative splicing function in vivo.
A. Mayeda has also been studying the role of indi-
vidual SR protein domains in enhancer-dependent
splicing and in general splicing (in collaboration with
S. Chandler and X.-D. Fu, University of California,
San Diego, and with G. Screaton, Oxford). The sub-
strate specificity of the SR proteins SF2/ASF and
SC35 was studied using a l- globin pre-mRNA,
which can be spliced in the presence of either protein,
an HIV-tat pre-mRNA, which splices with SF2/ASF
but not with SC35, and an IgM pre-mRNA, which
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splices with SC35 but not with SF2/ASF. Initial
studies using a commitment assay showed that the in-
dividual domains of SF2/ASF and SC35 behave as
functional modules. Whereas the carboxy-terminal
RS domains of these proteins are interchangeable, the
substrate specificity of the proteins is defined by their
RRMs, of which two are present in SF2/ASF and one
in SC35. RRM2 of SF2/ASF cannot function alone in
splicing, but it can act positively or negatively-
depending on the substrate-to modify the specificity
of RRM2. Therefore, multiple RRMs in SR proteins
act coordinately to achieve a unique spectrum of pre-
mRNA substrate specificities.
STRUCTURE AND FUNCTION OF hNRNP A/B PROTEINS
We have continued to characterize several human
hnRNP A/B proteins, which A. Mayeda previously
showed to function in alternative splice site selection
by antagonizing SR proteins. In collaboration with S.
Munroe (Marquette University), A. Mayeda
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FIGURE 1 hPrp18 is required for the second step of human pre-mRNA splicing. (A) lmmunodepletion
of hPrp18 from HeLa cell nuclear extracts. A western blot probed with anti-hPrp18 showing untreated
HeLa cell nuclear extract (lane 1), the same extract depleted with antibodies from preimmune serum
(lane 2), or with antibodies against hPrp18 (lane 3). The positions of hPrp18 and of a cross-reacting 55-
kD protein are indicated. hPrp18 was identified by its exact comigration with hPrp18 made in E. coli; 4
1.tg of total protein was loaded in each lane. (8) Time course of pre-mRNA splicing in the presence and
absence of hPrp18. Splicing of 13-globin pre-mRNA was carried out using the extracts described in
panel A. untreated (lanes 1-4), pre-immune depleted (lanes 5-8), and hPrp18-immunodepleted (lanes
9-12) HeLa-cell nuclear extracts. For lanes 13-16, purified recombinant hPrp18 (with a His tag) was
added to the hPrp18-depleted extract for the splicing assay. The reactions were allowed to run for the
times shown (in minutes) at the top of each lane. The positions of the lariat-exon 2 intermediate, pre-
mRNA, mRNA, intron, and exon 1 intermediate (listed from top to bottom) are shown.
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showed that both RRMs and the carboxy-terminal
glycine-rich domain of hnRNP Al are required for
alternative splicing function. Interestingly, the two
RRMs, which are closely related in sequence, are not
functionally equivalent. Duplication of one of the
domains and deletion of the other results in fully
functional protein, whereas the reciprocal construct is
inactive. Swapping the position of the RRMs results
in a protein with weak activity. Current experiments
are aimed at identifying specific residues responsible
for the differences between the two RRMs. These ex-
periments will be guided by the structure of both
RRMs together, as recently determined by our col-
laborator R.-M. Xu here at the Laboratory.
RNA-binding studies carried out by I. Watakabe, a
former technician, and by A. Hanamura, a former
postdoc, showed that hnRNP A 1 and A2 bind to re-
lated sequences with high affinity, recognizing a
short motif within a suitable larger context. This
high-affinity binding requires both RRMs of hnRNP
Al, and the carboxy-terminal domain is also required
for stable interaction. Sequence-specific binding cor-
relates well with alternative splicing function; in con-
trast, A. Mayeda previously showed that general
RNA binding is not sufficient for activity (in col-
laboration with S. Munroe).
IDENTIFICATION AND CHARACTERIZATION
OF A HUMAN SPLICING FACTOR INVOLVED IN
CATALYTIC STEP 2
D. Horowitz identified a human splicing factor re-
quired for the second step of pre-mRNA splicing.
This 343-amino-acid protein, called hPrpl8, is 30%
identical to the yeast splicing factor Prp18, which is
involved in the second step of pre-mRNA splicing in
Saccharomyces cerevisiae and is a component of the
U5 snRNP. In HeLa cell extracts immunodepleted of
hPrpl8, the second step of pre-mRNA splicing is
abolished (Fig. 1). Splicing activity is restored by the
addition of recombinant hPrpl8, demonstrating that
this factor is required for the second step. The hPrpl8
protein is tightly bound to the spliceosome only dur-
ing the second step of splicing. hPrpl8 is required for
the splicing of several pre-mRNAs, making it the first
general second-step splicing factor found in humans.
Splicing activity can be restored to hPrpl8- depleted
HeLa cell extracts by yeast Prp18, showing that im-
portant functional regions of the proteins have been
conserved. However, hPrpl8 cannot functionally re-
place yeast Prp18, either in vivo or in vitro. A 90-
amino -acid region near the carboxyl terminus of
hPrpl8 is strongly homologous to yeast Prp18 and is
also conserved in rice and nematodes. The homology
identifies one region important for the function of
both proteins and may define a new protein motif. In
contrast to yeast Prp18, hPrpl8 is not stably associa-
ted with any of the snRNPs. A 55-kD protein that
cross-reacts with antibodies against hPrpl8 is a con-
stituent of the U4/U6 and U4/U6U5 snRNP particles
and has been purified for sequencing and further
characterization.
PURIFICATION AND CHARACTERIZATION OF A
SPLICING-COMPLEMENTING FACTOR
We are continuing to purify and characterize addi-
tional protein factors that are essential for one or both
RNA cleavage-ligation reactions. M. Murray frac-
tionated a HeLa cell nuclear extract and obtained a
fraction in which a single, or a limited number of, re-
quired component(s) has been separated from known
protein splicing factors and snRNPs. This fraction is
required to complement cruder fractions containing
the remaining essential components, thus defining a
novel activity required for cleavage at the 5' splice
site and lariat formation. This activity is termed SCF1
(splicing-complementing factor 1). Extensive purifi-
cation of SCF1 led to a polypeptide of approximately
75 kD and several smaller polypeptides, all of which
are closely related, based on microsequence (in col-
laboration with R. Kobayashi, CSHL). Isolation and
expression of full-length SCF1 cDNAs and further
characterization of the protein are in progress.
SPLICING OF PRE-mRNAS WITH NONCONSENSUS
SPLICE SITES
Q. Wu has been studying the biochemistry of splicing
of a very small class of introns with unique 5' and
3' splice sites that do not conform to the consensus
sequences. Whereas most introns begin with GT and
end with AG, the noncanonical introns begin with AT
and end with AC and are therefore known as AT-AC
(or AU-AC) introns. A dozen or so examples are now
known, and these introns share highly conserved 5'
splice site and presumptive branch site elements, in
contrast to most metazoan introns, which have
degenerate 5' splice site and branch site elements.
Recent work by the labs of R. Padgett and J. Steitz
demonstrated that AT-AC introns are spliced by a
pathway that involves several minor snRNAs-U12,
U4atac, U6atac, and probably U 1 1, as well as the
major snRNA U5. It appears that the AT-AC and
GT-AG spliceosomes are mechanistically similar,
with Ull, U12, U4atac, and U6atac performing func-
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tions that are closely related to those of Ul, U2, U4,
and U6, respectively, whereas U5, which is thought
to interact primarily with exon sequences flanking the
splice sites, appears to function in both pathways. Q.
Wu optimized conditions for splicing the AT-AC in-
tron of the human skeletal muscle sodium channel a-
subunit pre-mRNA in He La cell nuclear extracts. In
contrast to previous in vitro splicing experiments
with a different pre-mRNA, splicing of the sodium
channel intron did not require prior inactivation of
one or more major snRNAs. RNase cleavage experi-
ments showed that this reaction required U12,
U4atac, and U6atac snRNAs, but not Ul, U2, U4, or
U6 snRNAs. Interestingly, when the pre-mRNA sub-
strate included a few nucleotides of the downstream
conventional 5' splice site, the reaction was marked-
ly stimulated, and this stimulation was dependent on
intact Ul snRNA. This observation shows that exon-
definition interactions can take place between AT-
AC and GT-AG spliceosomes, and similar to exon
definition interactions between adjacent conventional
introns, the bridging process involves Ul snRNA
bound at the downstream 5' splice site.
More recently, Q. Wu has been characterizing a
small subclass of AT-AC introns, whose members
lack the highly conserved consensus sequences. Inter-
estingly, several of the sodium channel genes contain
both kinds of AT-AC introns, as well as conventional
introns. The divergent subclass of AT-AC introns ap-
pears to splice via the conventional pathway, with the
involvement of the major snRNAs. Previous muta-
genic analysis of conventional introns showed that al-
though G to A mutation at the first position and G to
C mutation at the last position abolish splicing, the
double mutant is active, suggesting that a non-
Watson-Crick base-pairing interaction between the
first and last bases may be important for splice site
recognition or proofreading. The preceding experi-
ment shows that such introns also occur naturally and
appear to splice by the conventional pathway. This
raises the interesting questions of why AT-AC in-
trons are so rare, and how AT-AC introns are com-
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mitted to the AT-AC versus the GT-AG splicing
pathways.
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PROTEIN SYNTHESIS
M.B. Mathews S. Brand M. Liu
M. Greenberg L. Manche
S. Gunnery J. Nussbaum
B. Lee T. Pe'ery
H.-J. Liao
Y. Ramanathan
D. Taylor
Q. Wang
P. Wendel
Gene expression in human cells is controlled by
many mechanisms acting at a variety of levels. The
research in our laboratory explores several different
systems which exemplify this diversity of regulatory
processes. Some of these involve viral genes that in-
teract with and modulate cellular pathways, imping-
ing on processes such as cellular growth control and
viral multiplication. The following paragraphs sum-
marize the progress made in 1996 on each topic.
With the closure of the Protein Synthesis laboratory
in the fall, this was a short year at CSHL for most of
us. Although some stayed on in other laboratories or
moved elsewhere, the core of the group migrated
across the Hudson to New Jersey Medical School,
our sense of excitement and anticipation somewhat
muted as we looked back over the buildings, lawns,
and estuary that had become a second home. Among
the highlights of the year, Debbie Taylor successfully
defended her Ph.D dissertation and moved as a post-
doc to the University of Southern California. We now
look forward to Ben Lee completing his degree in the
next few months, before returning to Stony Brook to
fulfill the requirements for his M.D.
Regulation of PCNA
B. Lee, M. Liu, P. Wendel, M.B. Mathews
Activation of the DNA replication machinery is an
important part of the process of neoplastic cellular
transformation, and the regulation of human prolifer-
ating cell nuclear antigen (PCNA) expression by the
multifunctional adenovirus E1A oncogene products
represents an informative system for examining the
molecular mechanisms underlying transformation.
PCNA is a highly conserved protein and an essential
component of eukaryotic DNA replication and cell
cycle complexes. The adenovirus ElA 243R on-
coprotein can induce expression of the PCNA
promoter through a cis-acting element termed the
PERE (PCNA -ElA responsive element). The PERE
contains a sequence homologous to an activating
transcription factor (ATF) motif, and we previously
demonstrated that the transcription factor ATF-1 is a
major component of PERE-protein complexes.
We have now identified an additional PERE-
binding protein, the transcription factor CREB, and
shown that it forms heterodimers with ATF-1 at this
site. CREB, but not ATF-1, is able to mediate trans-
activation of a minimal PCNA-CAT reporter by E1A
243R in vivo. Further analysis revealed that the tran-
scriptional coactivator, the CREB-binding protein
CBP, also associates with PERE-related complexes.
Like CREB, CBP is able to mediate a strong trans-
activation response to ElA 243R at the PCNA
promoter. Significantly, wild-type ElA fails to trans-
activate the PCNA promoter through a CREB mutant
protein which does not bind to CBP. Moreover, ElA
mutants deficient in their abilty to interact with CBP
also fail to transactivate the PCNA promoter through
either CREB or CBP. These findings support a model
whereby ElA 243R transactivates the PCNA pro-
moter via a CBP-CREB-PERE pathway. In more
general terms, the data outline a paradigm in which
ElA 243R can target and transactivate specific DNA
promoter sequences.
Regulation of HIV-1
Gene Expression
T. Peiery, Y. Ramanathan, M. Greenberg,
M.B. Mathews
The essential HIV-1 protein Tat stimulates transcrip-
tion from the HIV promoter, located in the viral long
terminal repeat (LTR). Tat seems to act, at least in
part, at the level of transcriptional elongation to over-
come premature transcriptional termination. It has
been reported that Tat binds to a cellular kinase
called TAK (the Tat-associated kinase) which phos-
phorylates the CTD (carboxy-terminal domain) of
75
RNA polymerase II (pol II). Since phosphorylation of
CTD is known to occur during the elongation step of
transcription, it appears likely that Tat functions by
recruiting TAK which then phosphorylates the CTD
of pol II.
We undertook the identification of TAK and the
exploration of its role in HIV transactivation. Initial
attempts to purify TAK employed conventional
separation procedures: Fractions were assayed for
their ability to phosphorylate a synthetic peptide con-
taining three repeats of the CTD heptamer. While de-
veloping the purification protocol, we realized that
TAK's chromatographic behavior resembled that of a
Drosophila transcription factor known as P-TEFb
(positive transcription elongation factor-b). More-
over, TAK and P-TEFb both display sensitivity to the
inhibitor DRB. David Price and his colleagues at the
University of Iowa showed recently that Drosophila
P-TEFb possesses a CTD kinase activity that is asso-
ciated with its role as a processive elongation factor.
Drosophila P-TEFb consists of two polypeptide
chains. The small subunit was cloned and found to
have similarity to cyclin-dependent kinases. Its hu-
man homolog, identified in a sequence database, ex-
hibits 70% identity to the Drosophila protein.
Through our collaboration with the Price laboratory,
we identified TAK with human P-TEFb kinase by
several criteria. First, anti-P-TEFb antibodies react
with chromatographic fractions containing TAK ac-
tivity, and extracts depleted with antibodies to P-
TEFb exhibit a dramatic reduction in the TAK ac-
tivity. Furthermore, P-TEFb appears to be the only
kinase that interacts with Tat. In addition, the interac-
tion between Tat and TAK requires an intact Tat
transactivation domain, and a similar requirement ex-
ists for the interaction of Tat with P-TEFb. Finally,
the inhibitors DRB and H-8 block CTD phosphoryla-
tion by TAK and P-TEFb in a similar fashion. The
human P-TEFb kinase appears to participate in
several different complexes in human cells. We are
currently examining these assemblies with a view to
understanding its roles in Tat transactivation and in
the uninfected cell.
RNA Polymerase Ill
Termination Signals
S. Gunnery, P. Wendel, M.B. Mathews
Observations reported last year led us to reevaluate
the nature of the signals required for transcriptional
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termination by RNA polymerase III (pol III). We
found that one of two runs of T residues inserted into
a chimeric gene transcribed by pol III, VA-Tat, was
not recognized as a termination signal, even though it
met the known requirements for such signals. Two
possible explanations were considered. First, the
proximity of the T stretch to the promoter element
might prevent recognition since it is placed less than
30 nucleotides from the B box of the VA RNA,
promoter. Second, the sequence context of the T
stretch might be critical, notwithstanding its close
match with the optimum context for the efficient
termination of 5S RNA gene transcription reported
earlier.
The first possibility was eliminated by drawing the
termination signal of the wild-type VA RNA, gene
nearer to the B box and assaying termination ef-
ficiency. Termination was unimpaired both in vivo
and in vitro when the separation was reduced to as
little as 14 nucleotides, leading us to consider the se-
quence context of the termination signal. In the
Xenopus 5S RNA gene, a run of four or more Ts is
effective if present in a GC-rich sequence context;
two or more consecutive A residues within three
nucleotides preceding or following the Ts are
deleterious to termination. Since the T stretch in the
VA-Tat mutant complies with this context yet fails to
cause termination, it is possible that the sequence re-
quirements for the two pol III genes are different.
There are two conserved sequence elements upstream
of the termination signal that are conserved among
different VA RNA genes, GNG lying two to six
nucleotides upstream of the T stretch and a pair of
nucleotides adjacent to the T stretch that are most
often Cs. Site-directed mutagenesis revealed that
removal of Gs from the first conserved sequence ele-
ment increased the efficiency of termination and that
As were not inhibitory. Similarly, introduction of A
residues in place of the two Cs had no effect on
termination, whereas their replacement with Gs
reduced the efficiency of termination dramatically.
Applying these observations to the VA-Tat mutant,
we showed that removal of the Gs upstream of the
run of Ts improved the efficiency of termination
40-50-fold.
This study indicates that the proximity to the
promoter elements does not have any effect on the ef-
ficiency of the termination signal, whereas the se-
quence surrounding the Ts is crucial. Evidently, the
sequence context requirement for termination of
transcription varies among the classes of pol III
genes.
Translational Control and
Host-Viral Interplay
S. Brand, H.-J. Liao, L. Manche, J. Nussbaum,
D. Taylor, Q. Wang, M.B. Mathews
The protein kinase PKR is an important regulator of
cell activity. In addition to its well-known roles in
translation (mediated by phosphorylation of the
protein synthesis initiation factor eIF2) and the
interferon-induced antiviral response, it has been im-
plicated in the control of cell growth, transformation
and differentiation, apoptosis, and signal transduc-
tion. Last year, we identified seven sites that become
autophosphorylated when the enzyme is activated in
vitro by double-stranded RNA (dsRNA) and estab-
lished roles for some of them in the activation of the
kinase both in vivo and in vitro. Consistent with pub-
lished reports that PKR can act as a tumor suppres-
sor, we have now shown that elimination of some of
the phosphorylation sites converts PKR to a form that
transforms 3T3 cells. Moreover, the transformed cells
are tumorigenic in nude mice.
Although regular dsRNA, presumably of viral
origin, is assumed to be the enzyme's natural ac-
tivator, PKR can also be activated by highly struc-
tured (but not perfectly duplexed) RNAs such as that
of the hepatitis delta virus genome. Characterization
by RNase protection analysis of the binding site for
PKR on this activator showed that the enzyme inter-
acts with a region of the RNA equivalent to about
65-70 base pairs. Similar analysis of the binding site
on adenovirus VA RNA1, an inhibitor of PKR activa-
tion, revealed a protected region equivalent to only
about 25 base pairs. These observations provide evi-
dence supporting a model for PKR activation that in-
volves dimerization as a prelude to intermolecular
autophosphorylation.
We are presently testing this model further and
characterizing the interactions of PKR with cellular
RNA activators and substrates. In addition, we have
begun to address the function of a second small
adenoviral transcript called VA RNA. Although
similar to VA RNA1 in many respects, and tran-
scribed from a neighboring gene, VA RNAH does not
effectively block PKR activation. To address its func-
tion, we are studying two cellular proteins (other than
PKR) that interact with VA RNA. The proteins
were purified, partially sequenced, and identified
through database searches as a helicase and a DNA-
binding protein. Examination of the nature and con-
sequences of their interactions with VA RNA!t is un-
der way.
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MOLECULAR MECHANISMS OF APOPTOSIS
Y. Lazebnik A. Doseff J. Rodriguez
L. Faleiro Y. Xu
H. Fearnhead
Our laboratory studies the molecular mechanisms of
apoptosis. Apoptosis is a fundamental biological pro-
cess critical for the development of organisms and for
maintaining tissue homeostasis. Consequently, dereg-
ulation of apoptosis contributes to diseases such as
cancer and neurodegenerative disorders. The emerg-
ing view of apoptosis is that diverse regulatory path-
ways activate a conserved execution machinery that
carries out cell disassembly. Although this execution
machinery is poorly understood, it appears that an es-
sential component are caspases (formerly known as
ICE-like proteases), a family of cysteine proteases.
Caspases are activated at the onset of apoptosis and
preventing this activation prevents cell death. We
study which caspases are involved in apoptosis, how
they are activated, and how this activation leads to
cell death. Our long-term goal, however, is to deter-
mine whether the apoptotic machinery can be used to
kill cancer cells selectively.
Identification of Caspases
Involved in Apoptosis
L. Faleiro [in collaboration with R. Kobayashi,
Cold Spring Harbor Laboratory]
The key observation linking caspases to apoptosis
was the finding that CED-3, a protein essential for
apoptosis in Caenorhabditis elegans, is a caspase.
This finding prompted the search for the mammalian
equivalent of CED-3. However, although only one
caspase is known in C. elegans, ten caspases have
been identified in humans. The diversity of human
caspases raised the question of which caspases are in-
volved in apoptosis. Of the human caspases, only
interleukin-10 converting enzyme (ICE), which pro-
cesses cytokines during inflammatory response, has a
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well-established function. To find which caspases are
involved in apoptosis is critical both for an under-
standing of apoptosis and for developing therapeutic
strategies that target this process.
We developed an approach to identify directly the
pool of caspases activated in apoptotic cells. Cas-
pases are expressed as precursors that must be pro-
teolytically processed to become active enzymes.
This processing yields three polypeptides, a prodo-
main, a small subunit, and a large subunit which con-
tains the catalytic cysteine. The two subunits associ-
ate to form the active protease and both contribute to
the catalytic activity. It has been known that peptide
inhibitors that mimic caspase substrates and in-
activate caspases by binding to the catalytic cysteine
can block apoptosis. However, the identity of the
caspases inhibited remained elusive since peptide in-
hibitors have broad specificity and can inactivate
multiple caspases. We have used peptide inhibitors
tagged with biotin as affinity labels and developed an
approach to simultaneously detect and identify multi-
ple labeled caspases by their mobility in two-dimen-
sional polyacrylamide gels. This approach provides a
snapshot that identifies the caspases activated in
apoptotic cells, estimates their relative abundance,
and indicates their posttranslational modifications.
Using tumor cells as a model, we have found that
CPP32 (caspase 3) and Mch2 (caspase 6) are the
major active caspases in apoptotic cells and are ac-
tivated in response to distinct apoptosis-inducing
stimuli and in all cell lines analyzed. Both CPP32 and
Mch2 are present in apoptotic cells as multiple active
species. In a given cell line, these species remained
the same irrespective of the apoptotic stimulus used.
However, the species of CPP32 and Mch2 detected
varied among cell lines, indicating differences in
caspase processing. These results pointed at CPP32
and Mch2 as two major caspases involved in apo-
ptosis and also demonstrated that more than one
caspase is activated in apoptotic cells. We will focus
on determining how CPP32 and Mch2 are activated
and what they do to bring about cell death.
The approach that we developed relies solely on
the biochemical activity of caspases and does not
depend on caspase primary sequence, cell type, or the
signal inducing apoptosis, making this approach
widely applicable for identifying active caspases in-
volved in apoptosis.
Oncogene-dependent Apoptosis
in Extracts from Drug-resistant Cells
H.O. Fearnhead [in collaboration with
Scott W. Lowe, Cold Spring Harbor Laboratory]
The failure to eliminate cancer cells effectively and
selectively is a major problem of cancer therapy.
Nonetheless, most mammalian cells, including those
that give rise to cancer, have an intrinsic machinery
whose function is to carry out cell suicide. Activation
of this execution machinery results in apoptosis, a
comprehensive process that can quickly eliminate
large numbers of cells without triggering adverse
The efficiency of
such killing prompts the examination of the apoptotic
execution machinery as a potential tool for killing
cancer cells.
Indeed, many anticancer drugs kill cells by activat-
ing the apoptotic machinery. However, this killing is
inefficient as activation is indirect. The direct effect
of these drugs is cell damage, such as DNA breaks or
cell cycle aberrations, which then triggers signaling
pathways that activate the execution machinery and
eventually leads to cell death. However, a cancer cell
may fail to die not because the drug does not induce
cell damage but because the information about this
damage fails to reach the execution machinery of
apoptosis. In principle, agents that directly activate
the execution machinery should bypass alterations
which prevent apoptosis and kill cells that are other-
wise resistant to cancer therapy. However, how to ac-
tivate the apoptotic machinery in cancer cells directly
and, most importantly, selectively is not clear.
During the last year, we tested whether drug-
resistant oncogenically transformed cells retain intact
apoptotic machinery. To do so, we used cell-free sys-
tems of apoptosis, a model that we developed pre-
viously. In such systems, extracts from apoptotic
cells induce apoptotic changes in isolated nuclei
(apoptosis in vitro), whereas extracts from untreated
cells do not. Like apoptosis in vivo, apoptosis in vitro
requires caspase activity, which is absent in extracts
from untreated cells. As an example of drug-resistant
cells, we used the 293 cell line, which was derived
from human kidney cells by transformation with
adenovirus DNA. 293 cells are unable to activate
components of the apoptotic machinery-the ICE-like
proteases (caspases)-following treatment with an
anticancer drug.
Remarkably, extracts from untreated 293 cells
spontaneously activated caspases and induced apop-
tosis in a cell-free system, indicating that drug-
resistant cells have not only the apoptotic machinery,
but also its activator. Comparing extracts from cells
with defined genetic differences, we showed that this
activator is generated by the adenovirus El A on-
cogene and is absent from normal cells. We provided
preliminary characterization of this oncogene-gener-
ated activity (OGA) and showed that partially pur-
ified OGA activates caspases when added to extracts
from untransformed cells.
Our results suggest that a basis for selective activa-
tion of caspases in cancer cells may lie in the
mechanisms intrinsic to carcinogenesis. A number of
oncogenes other than El A, when expressed in cells,
induce apoptosis. However, transformed cells may
survive and give rise to cancer because apoptosis is
suppressed, for example, by overexpression of Bcl -2,
an inhibitor of apoptosis. Such suppression not only
promotes the survival of cancer cells, but also confers
resistance to chemotherapeutic drugs that kill by in-
ducing apoptosis. Whether the pro-apoptotic activity
of oncogenes is abolished by proteins such as Bcl -2
or whether it becomes latent was not known. Our
results argue that OGA is present in transformed
cells, although in a latent form. We suggest that
agents that link OGA to caspases in cells would kill
tumor cells otherwise resistant to conventional cancer
therapy. As this killing relies on an activity generated
by an oncogene, the effect of these agents should be
selective for transformed cells. Purification of OGA,
which is under way, should identify this activity and
provide a clue as to whether it can be used to kill
transformed cells.
Regulation of Caspases
A. Doseff, J. Rodriguez, Y. Xu
Although caspases are considered a central part of the
apoptotic machinery, how these proteases are regu-
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lated is not known. We address the regulation of
caspases by determining possible posttranslational
modifications of these enzymes, identifying proteins
that interact with caspases, and revealing their cel-
lular localization. A major effort was made during
last year in generating tools required to utilize these
approaches. We obtained a set of monoclonal
antibodies to CPP32 and are in the process of produc-
ing antibodies to other caspases. Some of anti-CPP32
antibodies can efficiently immunoprecipitate CPP32
from cell extracts. We began to exploit these unique
reagents for several lines of experiments: to analyze
whether CPP32 undergoes posttranslational modifi-
cations other than proteolysis and to identify proteins
interacting with CPP32.
To identify proteins interacting with caspases, we
also continued to exploit the two-hybrid system. This
approach resulted in identification of multiple poly-
peptides that interact with the prodomain of CPP32
but not with the catalytic subunits. The relevance of
these polypeptides to the function of CPP32 in apo-
ptosis remains to be identified.
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski S. Bronson A. lafrate
Y.-N. Chang M. Lock
M. Greenberg T. Swigut
AIDS is invariably associated with the depletion of
the regulatory subset of T cells that express the CD4
protein on their cell surface. These CD4* T lympho-
cytes are the principal infected cells in human im-
munodeficiency virus (HIV) infection, which sug-
gests that viral infection may be a lethal event for
these cells. Our main interest is in understanding the
molecular mechanisms underlying the pathogenesis
of AIDS and, in particular, in understanding the func-
tional consequences of the interactions between viral
proteins and the cellular regulatory machinery.
In the last year, our work has focused on the func-
tions of the Nef proteins encoded by both HIV and
the simian immunodeficiency virus (SIV). Evidence
from the SIV/rhesus monkey animal model of human
AIDS, and evidence from individuals infected with
HIV-1, indicates that Nef is critical for AIDS
pathogenesis since disease does not develop in indi-
viduals that harbor nef-defective viruses. The func-
tion(s) of Nef that is critical for pathogenesis in vivo
is not known, and understanding these functions has
been a major focus of studies in our laboratory in the
past several years.
Nef is not required for the viral life cycle under
laboratory conditions, and therefore its function has
been difficult to study. We found previously that Nef
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has several effects when expressed in cultured cells.
In particular, Nef modulates several aspects of signal
transduction machinery in T lymphocytes. We have
defined the amino acid residues important for these
functions and have disrupted the individual functions
of the Nef protein. These studies revealed that Nef is
involved in several separate interactions with the host
cell machinery. Next, we have been using the SIV-
rhesus monkey model of human AIDS to determine
whether these interactions are important for the func-
tion of Nef in vivo (in collaboration with Frank
Kirchhoff, University of Erlangen, Germany). Final-
ly, during the last year, we initiated experiments
designed to identify and clone the cellular proteins
that interact directly with Nef and mediate its effects
on cellular signaling. These experiments will provide
a framework with which to manipulate Nef function
in vivo.
SEPARATE FUNCTIONS OF NEF DISRUPT TWO
ASPECTS OF T-CELL ANTIGEN RECEPTOR FUNCTION
Two major effects on cell function have consistently
been observed with natural nef alleles. One effect is
to induce alterations in cellular signal transduction
and the other is to down-regulate surface expression
of the CD4 molecule. The ability of Nef to alter sig-
nal transduction has been shown by a block to
interleukin-2 (IL-2) gene induction in T cells, and we
have recently shown that Nef blocks the CD69 gene
induction that follows stimulation via the T-cell
antigen receptor (TCR) in Jurkat T cells. The ability
of Nef to down-regulate CD4 surface expression is
likely to be important for the pathogenic process,
since the CD4 molecule forms part of the viral recep-
tor and is also a critical component of the TCR sig-
naling machinery.
We developed a new rapid assay to measure simul-
taneously the effects of Nef on two aspects of the
TCR machinery, CD4 expression and CD69 gene in-
duction. In this assay, expression of Nef in Jurkat T
cells results in a dramatic reduction in CD4 surface
expression and also results in a block to the induction
of CD69 following TCR stimulation. This assay
permitted us to characterize a large number of natural
nef alleles isolated from HIV-1-infected individuals
and of mutant Nef proteins. We found that the
abilities of Nef to alter both CD4 expression and
TCR signaling are conserved with natural Nef
proteins derived from HIV-1-infected individuals and
from AIDS patients, and therefore these two func-
tions are clearly important for viral replication in
vivo and for pathogenesis.
Since CD4 is a component of the T-cell signaling
apparatus, the two effects of Nef on the TCR could
merely reflect two consequences of a single interac-
tion. To address this possibility, we analyzed a large
number of mutant Nef proteins. These studies identi-
fied mutations that selectively disrupted the effect of
Nef on CD4 expression, or on TCR signaling, in-
dicating that these two functions of Nef reflect sepa-
rate interactions. We also found that the effect of Nef
on TCR signaling in Jurkat T cells does not require
the association of Nef with a serine kinase from the
PAK family, which abundantly associates with many
SIV and HIV-1 Nef proteins.
The observation that two separate functions of Nef
target different aspects of TCR machinery is intrigu-
ing. It is possible that these effects reflect the re-
directing of certain key components of the T-cell sig-
nal transduction machinery by Nef to enhance viral
replication and/or a coordinated effort to alter the
normal pattern of T-cell responses for the advantage
of the virus. In particular, the modulation of TCR sig-
naling by Nef could alter a range of T-cell responses,
including functional activation and programmed cell
death, both of which could have important roles in
the immunodeficiency virus life cycle in vivo.
FUNCTIONAL ORGANIZATION OF THE HIV-1
NEF PROTEIN
Analysis of a large number of mutant HIV-1 Nef
proteins allowed us to identify those amino acid
residues in Nef required for the effects on CD4 ex-
pression and on TCR signaling and to determine that
these two effects reflect separate functions of the Nef
protein. Mutations that had selective effects on the
ability of Nef to down-regulate CD4 expression
mapped to two regions within the Nef molecule, one
region in the amino-terminal third of the molecule
and the other within a short region in the carboxy-
terminal part of the Nef molecule (see Fig. 1). The
ability of Nef to block TCR signaling was selectively
abolished by mutations in the central part of Nef
molecule. This part is highly conserved both among
HIV-1 natural isolates and among the other primate
lentiviruses. In particular, the effect of Nef on TCR
sinaling was abolished by mutating the elements in
Nef that are important for the association of Nef with
SH3 domains. We propose that Nef interferes with T-
cell signaling as a result of an SH3 domain-mediated
interaction.
Within the last year, the nuclear magnetic reso-
nance (NMR) and crystal structures of HIV-1 Nef
were solved. Examination of these structures showed
that the amino acid residues that affected the ability
of Nef to down-regulate CD4 expression mapped to
the two disordered loops in the Nef structure, one in
the amino-terminal portion of Nef and one in the
carboxy-terminal portion of Nef. In contrast, muta-
tions that disrupted the effect of Nef on TCR signal-
ing mapped to the highly structured core of the Nef
molecule. Our observations indicate that Nef is in-
volved in several molecular interactions that are re-
quired for Nef to down-regulate expression of the
CD4 molecule and to block TCR signaling. At least
two interactions involving the disordered loops in
Nef are required for the effect of Nef on CD4 expres-
sion. Additional interactions mediated by the Nef
core are required for blocking TCR signaling. These
observations provided a framework to assess the con-
tribution of the individual interactions of Nef for
pathogenesis and to begin to identify the cellular
partners for these interactions.
HIV-1 AND SIV NEF HAVE SIMILAR FUNCTIONAL
ORGANIZATION
Expression of SIV Nef in Jurkat T cells, like the ex-
pression HIV-1 Nef, induced down-regulation of
CD4 expression and blocked TCR signaling. We per-
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FIGURE 1 Schematic representation of HIV and SIV Nef proteins. The disordered domains
of HIV-1 Nef spanning amino acids 1-67 and 149-178 are represented by a line and
designated Loop 1 and Loop 2, respectively. The structured regions of the HIV-1 Nef core
spanning residues 68-148 and 179-206 are represented by solid bars (derived from NMR
and crystal structures) (Grzesiek et al., Cell 85: 931-942 [1996]; Lee et al., Nat. Struct.
Biol. 3: 340-345 [1996]). The amino-terminal myristoy-lation is also shown (I). Conserved
structural elements of the SlVmac239 Nef protein that show at least 65% amino acid
identity with NA7 Nef are represented by gray bars (amino acids 98-180 and 209-220).
The remaining mac239 Nef sequences, spanning residues 1-97,181-208,221-263, show
less then 15% amino acid identity with the homologous regions of NA7 Nef and are
represented by open bars.
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formed a similar mutagenic analysis of SIV Nef both
to establish further the degree of functional conserva-
tion between HIV-1 and SIV Nef proteins and to de-
velop mutant SIV Nef proteins that could be used for
in vivo experiments. This analysis revealed that HIV-
1 and SIV Nef proteins have similar functional orga-
nization. Mutations that selectively disrupted the ef-
fect of SIV Nef on CD4 expression mapped to the
regions in SIV Nef that correspond to the location of
the disordered domains in the HIV-1 Nef molecule
(Fig. 1). Mutating residues in the central region of
SIV Nef, in contrast to mutating the corresponding
residues in HIV-1 Nef, had no effect on the ability of
Nef to block TCR signaling. This result was surpris-
ing, since the sequences in this region are so highly
conserved, and suggested that the two core domains
may interact differently with their cellular targets. To
investigate this interesting possibility further, we are
currently mapping the sequences in SIV Nef that are
required for the blocking of TCR signaling. Experi-
ments are also in progress to assess the importance of
the interactions required for CD4 down-regulation in
vivo.
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THE ASSOCIATION OF SIV NEF WITH P62 PAK-LIKE
KINASE IS NOT REQUIRED FOR THE INDUCTION OF
AIDS IN RHESUS MONKEYS
Several HIV-1 and SIV Nef proteins associate with a
p62 serine-threonine kinase related to the PAK fam-
ily kinases. This family of kinases is regulated by
small G proteins, and they are involved in diverse
cellular processes including responses to external sig-
nals and responses to stress. To address the possible
link between the association of Nef with the PAK-
related kinase and Nef's role in AIDS pathogenesis
was of considerable interest.
In the course of structure-function analysis of the
SlVmac239 Nef protein, we identified a double
amino acid substitution in Nef (P104A, P107A) that
selectively disupted the association of Nef with the
PAK-like kinase activity yet did not have a detectable
effect on the ability of Nef to down-regulate surface
CD4 expression or to block the induction of CD69
antigen in response to TCR stimulation. Pro lines 104
and 107 are located in the central conserved region of
the molecule, and they comprise a putative SH3
domain-binding motif. To test whether the associa-
tion of Nef with p62 is important for the induction of
AIDS, we collaborated with S. Lange and F. Kirch-
hoff at the University of Erlangen (Germany), who
constructed a variant mac239 SIV that encoded the
mutant Nef protein (P104A, P107A) unable to associ-
ate with the p62 phosphoprotein.
Interestingly, infection of two rhesus monkeys
with the variant SIV resulted in AIDS and rapid death
in each of the infected animals. Interestingly, no re-
versions were observed in the majority of nef se-
quences isolated from different time points during in-
fection and from lymphatic tissue at the time of
death. These observations indicate that the associa-
tion of SIV Nef with the p62 PAK family kinase is
not important for AIDS in SIV-infected rhesus
monkeys and is surprising since this interaction is
conserved for both SIV and HIV Nef proteins.
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MOLECULAR GENETICS OF EUKARYOTIC CELLS
This section comprises labs that study a diverse set of cellular phenomena, including structure,
signal transduction, and cancer, using mainly, but not exclusively, molecular and genetic ap-
proaches. David Spector's group studies the structure of the nucleus and the dynamic distribution
of mRNA splicing factors using electron and fluorescent microscopy. David Helfman's lab studies
the cellular cytoskeletion, especially the variety of isoforms of tropomyosins, their origins, and their
specific contribution to cellular phenotypes. Linda Van Aelst's laboratory continues the study of
small GTPases such as Ras and Rac: their roles in cellular physiology and signal transduction, and
the identification and dissection, by genetic means, of their protein partners. Nick Tonks and his
colleagues study the role of protein phosphatases and their substrates and modulators on the sig-
nal transduction pathways that regulate growth and differentiation. Michael Wigler's group identifies
and analyzes the genes and loci that are mutated in human cancer, and studies signal transduc-
tion in humans and yeasts. Michael Hengartner's laboratory explores the components of the pro-
grammed cell death pathway in the nematode C. elegans, and have begun to use that model
genetic organism to study memory, learning, and neural cell functioning.
MAMMALIAN CELL GENETICS
M. Wig ler C. Yen
M. Hamaguchi
M. Nakamura
D. Esposito
R. Lucito
D. Dong
W. Wei L. Rodgers B. O'Conner
K. O'Neill M. Riggs T. Chen
J. Stolarov J. Brodsky A. Bug lino
H. Tu J. Douglas A. Solanki
K. Chang J. Troge A. Triger
Y. Han
Research in the our lab is divided into three efforts.
The first and oldest part is the study of Ras signal
transduction pathways. Mutant Ras were the first hu-
man oncogenes discovered, and homologs of the Ras
genes are found throughout eukaryotic evolution. Our
original and major objective was to understand the
targets of these small GTPases, but now that we have
identified the main Ras target in the budding yeast
Saccharomyces cerevisiae (Toda et al., Cell 40: 27
[1985]), two targets in the fission yeast Schizosac-
charomyces pombe (Wang et al., Mol. Cell. Biol. 11:
3554 [1991]; Van Aelst et al., Proc. Natl. Acad. Sci.
90: 6213 [1993]; Chang et al., Cell 79: 131 [1994]),
and multiple targets in mammalian cells (Van Aelst
et al., Mol. Cell. Biol. 11: 3554 [1993]; Cold Spring
Harbor Symp. Quant. Biol. 59: 181 [1995]; White et
al., Cell 80: 533 [1995]; J. Biol. Chem. 271: 16439
[1996]) including the Raf protein kinase, our objec-
tive has been to understand how the Ras pathways are
organized.
The second part is the application of genomic anal-
ysis to the discovery of mutations underlying human
pathology, with a special emphasis on cancer. This
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section is an outgrowth of RDA (representational dif-
ference analysis) that was developed here in col-
laboration with Nikolai Lisitsyn (Lisitsyn et al.,
Science 259: 946 [1993]), now at the University of
Pennsylvania School of Medicine. Several novel ge-
netic lesions have been discovered in breast cancer,
and one new tumor suppressor gene identified in col-
laboration with the laboratory of Ramon Parsons at
Columbia University College of Physicians & Sur-
geons (Li et al. 1997).
We have initiated similar efforts to identify genetic
lesions in infants with de novo mutations causing a
variety of syndromes.
The third part is the exploration of the utility of en-
coded combinatorial synthesis for the discovery of
biologically active molecules. This research is an out-
growth of the development of this methodology in
collaboration with Clark Still, at the Department of
Chemistry, Columbia University (Ohlmeyer et al.,
Proc. Natl. Acad. Sci. 90: 10922 [1993]). In col-
laboration with Peter Nest ler (CSHL), formerly of the
Still lab, we are determining whether we can discover
branched peptidic molecules with high affinities for
specific peptides and specific regions of proteins. The
longer-term objective is to find low-molecular-weight
agonists and antagonists of signal transduction path-
ways.
Ras Signaling
K. O'Neill, J. Stolarov, H. Tu, K. Chang
In the budding yeast S. cerevisiae, Ras proteins
modulate adenylyl cyclase, and Ras is in turn modu-
lated by a guanine nucleotide exchange catalyst,
Cdc25 (Broek et al., Cell 48: 789 [1987]; Powers et
al., Mol. Cell. Biol. 9: 390 [1989]), and proteins that
accelerate Ras GTP hydrolysis, the Ira proteins
(Tanaka et al., Mol. Cell. Biol. 9: 757 [1989]). Three
clear problems remain: How are the Iras and Cdc25
modulated; what other protein(s) is modulated by
Ras; and how does Ras modulate adenylyl cyclase?
We are focusing on the latter problem for now. In
particular, we have been investigating the role of
Cap, an adenylyl-cyclase-associated protein (Field et
al., Cell 61: 319 [1990]), that is required for the ac-
tivation of adenylyl cyclase by Ras in vivo but not,
apparently, for in vitro reconstituted systems (Field et
al., Cell 61: 319 [1990]; Fedor-Chaiken et al., Cell
61: 329 [1990]; Wang et al., Mol. Cell. Biol. 12:
4937 [1997]).
Cap is a bifunctional protein that has been fairly
well conserved in evolution (Gerst et al., Mol.
Biol. 11: 1248 [1991]; Kawamukai et al., Mol. Cell.
Biol. 3: 167 [1992]; Gieselmann and Mann, FEBS
Lett. 298: 149 [1992]). The carboxyl terminus is re-
quired for cytoskeletal function and binds actin,
whereas the amino terminus, required for adenylyl
cyclase function, binds cyclase. We discovered that
the amino terminus of the mammalian Cap binds
talin, a central cytoskeletal component, and that the
amino terminus of yeast Cap also binds a talin
homolog, Sla2. We find that these interactions, and
the Sla2 protein itself, are required for yeast cells to
be responsive to activated Ras. We speculate that
these interactions (adenylyl cyclase with Cap, and
Cap with Sla2) may be required to facilitate the inter-
action between adenylyl cyclase and Ras but have not
ruled out other mechanisms. (For example, we would
not exclude the possibility that Ras, in its activated
state, facilitates the interaction of adenylyl cylase
with these components.) In any event, these interac-
tions may serve as a mechanism by which the as-
sembly of cytoskeletal components control the as-
sembly of signal transduction components and may
serve as a model for the anchorage-dependent control
of cell proliferation, a fundamental property of norm-
al mammalian cells that is lost upon their neoplastic
transformation.
In the fission yeast S. pombe, Ras is required for
normal sexual differentiation and cell shape (Fukui
and Kaziro, EMBO J. 4: 687 [1985]). The target for
the latter function is probably Scdl (Chang et al.,
Cell 79: 131 [1994]) and for the former both Scdl
and the Byr2 protein kinase (Chang et al., Cell 79:
131 [1994]; Wang et al., Mol. Cell. Biol. 11: 3554
[1991]). Byr2 is a member of the S. pombe MAP
kinase module, that conserved triad of protein kinases
that is a repeating refrain in so many eukaryotic sig-
naling pathways. Byr2 is the functional homolog of
the mammalian Raf protein kinase, and its substrate
is Byrl, the functional and structural homolog of
mammalian MEK. We have recently been focusing
on the mechanism of the regulation of Byr2, as an
ideal model system for understanding the control of
MAP kinase modules in general, and have made
rapid progress.
elm I Byr2-Reg
Byr2-Cat
Models for Byr2 Activation
FIGURE 1 We have assembled a model for the activation of
Byr2. This model is consistent with our data but is neither
complete nor necessarily correct. Byr2 recognizes GTP-
bound Ras1, associated with membrane. In this cellular
region and through this association, Byr2 encounters other
components necessary for its activation, including Shk1,
also found in this region through its association with Ras
(Chang et al., Cell 79: 131 [1994]; Marcus at al., Proc. Natl.
Acad. Sci. 92: 6180 [1995]). Upon encountering an ac-
tivated form of Shk1, Byr2 assumes an open configuration.
In the presence of Ste4, which is a leucine zipper protein
capable of homodimerization, the open configuration of
Byr2 dimerizes, leading to its autophosphorylation and ac-
tivation.
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Byr2 has an amino-terminal regulatory domain and
a carboxy-terminal catalytic domain. The amino-
terminal domain has a binding site for Ras, Ste4 (a
leucine zipper protein required for sexual function),
and the catalytic domain. These binding sites have
now been defined, and mutants in each have been ob-
tained. Cells containing a mutant Byr2 unable to bind
Ste4 act as though the Ste4 protein is not present;
cells containing a mutant Byr2 unable to bind Ras act
as though Ras-deficient; and cells containing a
mutant Byr2 with impaired catalytic/regulatory inter-
action act as though they have a constitutively ac-
tivated Byr2 kinase. These studies confirm that Ras
and Ste4 are required for Byr2 function and suggest
that the regulatory domain acts as an inhibitor for the
catalytic domain.
Using the two-hybrid system of Fields and Song
(Nature 340: 245 [1989]), we have been able to
demonstrate that mutations which disrupt regulatory/
catalytic interaction actually open up the configura-
tion of Byr2 so that it is able to bind its substrate
Byrl. Using this as an assay for the open configura-
tion, we have now shown that the Shkl protein
kinase (Marcus et al., Proc. Natl. Acad. Sci. 92: 6180
[1995]), the S. pombe homolog of S. cerevisiae
Ste20, also required for sexual differentiation, can in-
duce this confirmational change, presumably by
phosphorylating Byr2. Since Ste20 bears the same
genetic relationship to the S. cerevisiae sexual differ-
entiation MAP kinase module as does Shkl in S.
pombe, and these kinases are structurally conserved
in evolution, this control mechanism may represent a
conserved feature in the regulation of these modules.
Figure 1 illustrates one possible model that in-
corporates our present understandings in a consistent
manner.
Genomic Analysis
C. Yen, M. Hamaguchi, M. Nakamura,
D. Esposito, R. Lucito, Y. Han
We have been applying RDA to the analysis of hu-
man breast cancer, seeking to find loci that undergo
either gene copy amplification or homozygous dele-
tion. This work has been performed in collaboration
with Larry Norton at the Memorial Sloan Kettering
Cancer Institute, Scott Power's laboratory at the
Amplicon Corporation, the laboratory of Ramon Par-
sons at Columbia University, and Richard McCom-
bie's DNA sequencing group here at the Laboratory.
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A number of procedural and technical issues had
to be addressed or learned in order to conduct this
work properly, involving the procurement of tissue,
sorting of cancers by nuclear ploidy, performing
RDA on minute amounts of DNA, verification of
probe status in the absence of genomic Southern blot-
ting due to limiting material, developing the infra-
structure for chromosomal mapping, screening YAC
and BAC libraries, establishing banks of cell lines
and xenografts, "immortalizing" DNAs through rep-
resentations, exon trapping, automated sequencing,
loss of heterozygosity mapping, informatics for mas-
sive data storage and retrieval, and so on. We are still
in the midst of the technical developments to ac-
company and fully exploit the power of RDA and the
enormous bank of fixed specimens that have been ar-
chived at various medical centers. What we have
learned can be applied to other cancer types as well.
The easier part has been to search for amplified
loci. Nearly two dozen distinct loci have been identi-
fied that become amplified in human breast cancer. In
aggregate, about 95% of aneuploid tumors are ampli-
fied at at least one of these loci, and many tumors
contain multiple amplified loci. Only a few of these
loci contain known oncogenes, such as erb-2, c-myc
and cyclin D, so the majority should contain new
genes that become activated and contribute to breast
cancer. Of particular interest in this regard, we have
found by careful analysis that amplification near
several loci, such as erb-2 and c-myc, probably con-
stitutes multiple and distinctly separate sites of
amplification, suggesting the presence of nearby
genes whose amplification may be functionally
linked. It is our intention to define the genes that are
overexpressed from these loci to help us narrow the
field of possible breast cancer oncogene targets.
We have also identified more than a half dozen
loci that appear to undergo homozygous loss. Such
loci are likely to contain tumor suppressor genes.
Among the loci found in this way was the locus for
p15 and p16. In principle, because homozygous loss
tends to occur over small chromosomal regions, the
finding of the suspected tumor suppressor gene is
greatly facilitated. In fact, the identification of Brca-2
was facilitated by RDA, although not by us (Schutte
et al., Proc. NatL Acad. Sci. 92: 5950 [1995]). In col-
laboration with Ramon Parsons at Columbia, we
determined that the vast majority of loci we have
identified by RDA in breast cancer are centers for
loss of heterozygosity, consistent with the idea that
they contain major new tumor suppressors.
One of the loci we identified and mapped to
chromosome 10q23 was further analyzed by our col-
laborator Ramon Parsons, who identified a gene, we
now call Pten, by exon trapping (Li et at. 1997). Sub-
sequent analysis confirmed that the coding region for
this protein is frequently mutated in advanced breast,
brain, and prostate cancers. Five considerations make
this an especially exciting discovery.
First, the protein has homology with protein
phosphatases. Since protein kinases were among the
first oncogenes identified, it is highly gratifying to
finally find an enzyme that removes phosphate
groups from proteins as a tumor suppressor. Second,
Pten has homology with cytoskeletal proteins, sug-
gesting it may play a part in cell-cell or cell-matrix
interactions. For example, it might play a part in in-
vasiveness, metastasis, or "ancorage-independent"
growth. Third, Pten appears to be involved in many
cancers, and with high frequency, suggesting it has
an important and common role in cancer etiology.
Fourth, loss of heterozygosity at the site of Pten ap-
pears to correlate with the transition from benign to
malignant growths, suggesting it plays a part in an es-
pecially critical step in neoplasia. Fifth, work from
the Parson's lab indicates that hemizygous loss of
Pten appears to be the cause of a rare inherited
predisposition to neoplasia called Cowden's disease.
The methodology we have developed for the anal-
ysis of mutation in cancers can also be applied to dis-
orders in humans caused by de novo mutation within
the germ line. In essence, we can look for genetic
alterations present in a child that are not found in ei-
ther parent. A large number of rare but profound dis-
orders have been recognized by medical geneticists
and attributed to de novo mutation, but there may
also be cases that underlie frequent but more subtle
disorders, such as schizophrenia and autism, that
have not generally been considered to arise this way.
We are in the process of developing the tools to at-
tack such problems. If we are successful, our meth-
ods may provide an alternate and perhaps more effec-
tive manner to approach certain human disease than
the widely used but cumbersome and costly methods
of segregation analysis.
Encoded Combinatorial
Synthesis
D. Dong
Chemists can now prepare vast numbers of chemical
compounds by the combinatorial method of split
synthesis (Furka et al., Int. J. Pept. Prot. Res. 37: 487
[1991]; Lam et al., Nature 354: 82 [1991]). Utilizing
encoding, investigators can further identify active
molecules and rapidly learn their structure. The foun-
dation for this was established in 1993 by our col-
laboration with Clark Still at Columbia University
(Ohlmeyer et al., Proc. Natl. Acad. Sci. 90: 10922
[1993]). In collaboration with Peter Nest ler here at
the Laboratory, we are using this methodology to
study the combining power of branched peptidic
molecules. In particular, we are searching for
branched peptides that are capable of recognizing
linear peptides and specific peptide epitopes in pro-
teins. If successful, such approaches should enable us
to find affinity reagents for protein molecules to
detect, enhance, or diminish their function. We have
found some promising molecules that appear to inter-
act with the CAAX motif of Ras and inhibit the
farnesylation of Ras. These leads and ideas will be
put to more rigorous testing.
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SIGNAL TRANSDUCTION
L. Van Aelst B. Boettner N. Carpino
M. McDonough M. Marin
R. Packer
Our research interest is the study of the signal trans-
duction pathways involved in cell growth control and
the manner in which intracellular signaling is altered
in transformed cells. Our work is focused on two
major topics. The first is to investigate the role of the
small GTPases Ras and Rac in signal transduction.
These proteins have been demonstrated to have a
central role in the signal transduction pathways that
mediate such diverse biological phenomenon as
transformation, mitogenesis, metastasis, transcrip-
tional activation, and cytoskeletal organization. Our
major objective is to uncover the molecular mechan-
isms by which the Ras and Rac proteins exert these
effects. The second is the functional characterization
of p62d°k, a constitutively tyrosine-phosphorylated,
Ras-GAP-associated protein detected in chronic
myelogenous leukemia (CML) progenitor cells.
Ras and Rac Signaling Pathways
B. Boettner, M. McDonough, R. Packer,
L. Van Aelst
The importance of Ras in tumorigenesis has been
well documented. Cellular Ras genes have been
found to be frequently activated by mutation in a
wide variety of human cancers. Since our discovery
of the serine/threonine kinase Raf as a critical
downstream target of Ras required for Ras-mediated
cell transformation, evidence that additional func-
tions of Ras contribute to mammalian cell trans-
formation has been obtained. Ras effector domain
mutants, Ras(V12,G37) and Ras(V12,C40), which
were defective for Raf binding and activation
retained the ability to induce potent tumorigenic
transformation of some strains of NIH-3T3. The na-
ture of these Raf-independent pathways remains un-
clear. Interestingly, we isolated a Ras-binding
protein, AF6, which is still able to interact with the
Ras(V12, C40) mutant. AF6 has been previously de-
scribed in a single example as a fusion partner for
ALL1 in acute lymphoblastic leukemias (Prasad et
al., Cancer Res. 53: 5624 [1993]). We determined
that the first 160 amino acids of AF6 were sufficient
for Ras binding. The carboxyl terminus of AF6 con-
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tains an unc-104-like kinesin, class-V myosin ho-
mologous domains, and a GLGF repeat, suggesting a
role in signaling from cell-cell junctions. We are cur-
rently investigating a role of AF6 in Ras-mediated ef-
fects on transformation, mitogenesis, and morpho-
genesis. Furthermore, we are determining whether
AF6 localizes at cell-cell contact sites. Searching
protein databases with AF6 as query, we found that
the Drosophila Canoe protein showed a high degree
of similarity and indeed turned out to interact with
activated Ras in vitro as well. Canoe has previously
been described as a downstream component in
Drosophila Notch signaling (Miyamoto et al. Genes
Dev. 9: 612 [1995]), thus participating in regulation
of adhesive cell-cell interactions for determination of
various cell fates in developmental processes.
Whether AF6 could be of relevance for vertebrate
Notch function will be investigated.
Compelling evidence has been provided which in-
dicates that Rac is an essential component of Ras-
induced malignant transformation. Furthermore, it
has been demonstrated that activated mutant forms of
Rac are able to induce tumorigenic transformation of
rodent fibroblasts. Rac can also confer an invasive
phenotype and metastatic potential to lymphocytes
and may therefore be involved in multiple aspects of
cell growth control. Despite this evidence indicating
a role of Rac in tumorigenesis and metastasis, little is
known concerning the normal functioning of the Rac
proteins. One of the first functions attributed to Rac
was its involvement in the reorganization of the actin
cytoskeleton induced by growth factors and constitu-
tively active Ras(RasV12). More recently, Rac has
been demonstrated to activate the transcription fac-
tors SRF and c-Jun. Although the mechanism by
which Rac activates SRF is not known, the Rac-
induced activation of c-Jun is mediated by the c-Jun
amino-terminal kinase (JNK). Understanding the
functions of Rac and Rac-interacting proteins will be
essential to elucidate the role of Rac in tumori-
genesis, invasiveness, and metastasis.
Our major objective is to dissect the physiological
roles of Rac and identify its interacting proteins and
to further characterize the proteins that mediate the
activity of Rac. Using the yeast two-hybrid system,
we succeeded in isolating two novel genes, POR1
and POR2, and have begun to characterize them. We
demonstrated that PORI plays a part in Rac-induced
cytoskeletal rearrangements. More recently, in col-
laboration with C. Shorey-D'Souza (Washington
University School of Medicine, St Louis), we ob-
tained evidence for the involvement of PORI in
ARF6-mediated actin rearrangements. ARF6 GTPase
belongs to the ARF family and has been shown to
regulate trafficking and the organization of in-
tracellular membrane, most likely by eliciting the
targeted delivery of intracellular membrane to the cell
surface. A role for POR1 in membrane trafficking is
presently under investigation. The function of POR2
is at present unknown.
To dissect the different functions of Rac, we made
use of different Rac mutants obtained in a genetic
screen for mutant forms of Rac which associated dif-
ferently from one another to different Rac effector
proteins. Specifically, we isolated mutant Rac pro-
teins that could discriminate among the Rac targets,
PAK (an Ste20-related p21-activated kinase) and
POR1, in the two-hybrid system. A mutant of acti-
vated Rac, RacV12,H40 (where V12 indicates Val-12
and H40 indicates His-40), was isolated which was
defective in binding to PAK but not to PORI. This
mutant failed to stimulate PAK and JNK1 activity but
retained its ability to induce membrane ruffling and
to mediate transformation. A second mutant, RacV
12,L37 (where L37 indicates Leu-37), which binds
PAK but not PORI, was able to induce JNK activa-
tion but failed to induce membrane ruffling and to
mediate transformation. These results indicate that
the growth promoting activity of Rac is not depen-
dent on signals contributed by the JNK MAP kinase
pathway. Furthermore, they indicate that the activa-
tion of the JNK MAP kinase pathway and the
reorganization of actin cytoskeleton occur via distinct
effector systems. Further characterization of Rac-
interacting proteins and mutant analysis will be re-
quired to define the pathways leading to Rac-induced
transformation and invasiveness.
Functional Characterization of p62dok
N. Carpino, M. Marin, L. Van Aelst
[in collaboration with R. Kobayashi, Cold Spring
Harbor Laboratory, and B. Clarkson, Memorial
Sloan-Kettering Institute, New York]
The presence of a constitutively tyrosine phosphory-
lated, RasGAP-associated 62-kD protein (p62) was
detected within chronic myelogenous leukemia
(CML) progenitor cells. CML is a clonal disorder of
the hematopoietic stem cell, characterized by the
Philadelphia chromosome, in which exons of the
ABL proto-oncogene become linked to the BCR gene
on chromosome 22. The result is a chimeric protein
termed p210bcr-ably with deregulated tyrosine kinase
activity. Recently, N. Carpino et al. purified and
cloned the cDNA of p62, which they designated
p62dok (Carpino et al., Cell 82: 197 [1997]). p62dok
is a novel protein and has the features of a signaling
molecule.
We have observed that p62dok becomes rapidly
tyrosine-phosphorylated in hematopoietic cells in re-
sponse to c-Kit ligand, in fibroblasts in response to
insulin, and in v-src-transformed cells, implying a
general role for it in signal transduction pathways in-
volved in cell growth control. Our major objective is
to elucidate the functional role of p62d°k We have
initiated studies to determine the kinase(s) respons-
ible for p62 tyrosine phosphorylation in normal, un-
transformed cells. With regards to CML, we have
evidence that p62dok is a direct substrate of
p210bcr-abl. In collaboration with R. Kobayashi, we
are presently identifying the in vivo sites of tyrosine
phosphorylation of p62dok by BCR-ABL, as well as
the sites of tyrosine phosphorylation on p62dok fol-
lowing c-Kit ligand and insulin stimulation. The as-
sociation of p62dok with Ras GAP is suggestive for a
role of p62dok in the Ras signal transduction pathway,
possibly by affecting the function of GAP. To ad-
dress this, we are currently measuring the catalytic
activity of GAP toward Ras and the GTP/GDP ratio
of Ras in the presence of unphosphorylated and
tyrosine-phosphorylated p62. Furthermore, we are
setting up conditions to investigate a role for p62 in
Ras and tyrosine-kinase-mediated transformation and
are screening for p62-interacting proteins.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL OF
CELLULAR SIGNALING RESPONSES
N.K. Tonks A.M. Bennett
M.A. Daddario
R.L. Del Vecchio
A.J. Garton
M.J. Gutch A.A. Samatar
K.R. LaMontagne T. Tiganis
M.P. Myers S.H. Zhang
S.N. Mamajiwalla
The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes. Our lab is particularly interested in the role
of tyrosine phosphorylation in transducing an extra-
cellular signal into an intracellular response, such as
proliferation or differentiation. Protein phosphory-
lation is a reversible, dynamic process in which the
net level of phosphate observed in a target substrate
reflects not only the activity of the kinases that
phosphorylate it, but also the competing action of
protein phosphatases that catalyze the dephosphory-
lation reaction.
We study the expanding family of protein tyrosine
phosphatases (PTPs) that, like the kinases, comprise
both transmembrane receptor-linked forms and non-
transmembrane cytosolic species and represent a
major family of signaling enzymes. The structures of
the PTPs indicate important roles in the control of key
cellular functions. We are utilizing a variety of
strategies to characterize the normal physiological
function of several members of the PTP family.
During the last year, Andrew Flint and Yan Fen Hu
completed their postdoctoral studies and took up posi-
tions at Charybidis Corporation and the University of
Virginia, respectively. We were joined by Mike
Myers as a postdoctoral fellow.
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Identification of PTP Substrates
A.J. Flint, A.J. Garton, K.R. LaMontagne,
M.P. Myers, T. Tiganis
The identification of substrates of PTPs is an essential
step toward a complete understanding of the
physiological function of members of this enzyme
family. In 1995, in collaboration with David Barford
(Oxford University), we determined the crystal struc-
ture of PTP1B on a complex with a phosphotyrosyl
peptide substrate. From this structure, we defined
several residues in the enzyme that were important for
substrate recognition and catalysis. We have now
characterized the function of these residues further by
site-directed mutagenesis. Through this approach, we
have generated a form of PTP1B that maintains a high
affinity for substrate but does not catalyze dephos-
phorylation effectively, i.e., we have converted an ex-
tremely active enzyme into a "substrate trap." Further-
more, the residue that is mutated to generate the
substrate-trapping mutant is the invariant catalytic
acid (Asp-181 in PTP1B) that is conserved in all
members of the PTP family. Therefore, this has af-
forded us a unique approach to identification of
physiological substrates of PTPs in general. Following
expression, the mutant PTP binds to its physiological
substrates in the cell but, because it is unable to
lin- 15(n765ts) X lin-15(n765) X; cshp(op194) 11
FIGURE 1 The C. elegans multivulva phenotype conferred by lin-15 loss-of-function (If) mutation is
suppressed by cshp(op194). LIN-15 normally functions as a negative regulator of LET-23, an EGF
RTK receptor tyrosine kinase homolog. lin- 15(lf), mutations confer a multivulva phenotype due to
enhanced LET-23 activity during vulval development (left). A loss-of-function mutation in the SH2
domain-containing tyrosine phosphatase, cshp (op194), suppresses the lin- 15(lf) multivulva
phenotype (right), providing genetic evidence that cSHP participates in regulating LET-23 initiated
signals during vulval development. (Closed arrows) pseudovulvae; (open arrows) position of the
functional vulva.
dephosphorylate the target, the mutant and substrate
become locked in a stable, "dead-end" complex. This
complex can be isolated by immunoprecipitation and
associated proteins identified by immunoblotting
with antibodies to phosphotyrosine (pTyr). In addi-
tion, immunoblotting lysates of cells expressing the
mutant PTP with antibodies to pTyr can be used to
identify proteins whose phosphorylation state is
altered as a consequence of expression of the mutant.
We have now initiated such an approach to substrate
isolation with intriguing results.
SUBSTRATE SPECIFICITY OF PTP1 B
When expressed in COS cells, the substrate trapping
mutant of PTP1B forms a complex with four proteins
from the spectrum of phosphotyrosyl proteins. One of
these is the receptor for epidermal growth factor
(EGF), which is one of the family of ligand-activated
receptor PTKs. One of the others, p70, appears to be
a substrate for the Src PTK, since its phosphorylation
state is enhanced in cells expressing the v-Src on-
cogenic PTK. As would be expected for an interac-
tion between a PTP and its substrates, the association
is disrupted by the active site-directed inhibitor
vanadate, and for the EGF receptor, the interaction
absolutely requires receptor autophosphorylation.
Furthermore, from immunofluorescence studies, the
D181A mutant of PTP1B, which is targeted to the
endoplasmic recticulum (ER), appeared to retain the
endogenous EGF receptor in an intracellular com-
plex, suggesting that one important function of
PTP1B may be to prevent the inappropriate, ligand-
independent activation of newly synthesized EGF
receptors in the ER.
We have also extended our analysis of PTP1B
function in the context of the human disease chronic
myelogenous leukemia (CML). CML is a clonal dis-
order of the hematopoietic stem cell characterized by
the Philadelphia chromosome (Ph) in which the c-Abl
proto-oncogene on chromosome 9, encoding a PTK,
becomes linked to the bcr gene on chromosome 22.
This results in the production of a fusion protein
termed p210 bcr-abl, the PTK activity of which is en-
hanced relative to c-Abl. Expression of p210 bcr-abl
produces the abnormal patterns of tyrosine phos-
phorylation that result in the dysfunctional matura-
tion of the hematopoietic stem cell that is the charac-
teristic of CML. Therefore, CML represents one of
the best defined examples in which aberrant tyrosine
phosphorylation is the underlying cause of a human
disease. In contrast to the extensive characterization
of the PTK and its effects on cell function, relatively
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little is known about the nature of the PTPs that may
modulate p210 bcr-abl-induced signaling. We have
demonstrated that in cells expressing p210 bcr-abl,
including a cell line derived from a patient with
CML, the expression of PTP is enhanced specfi-
cally severalfold. The effect on expression of PTP1B
requires the kinase activity of p210 bcr-abl and oc-
curs rapidly, concomitant with maximal activation of
a temperature-sensitive mutant of the PTK, suggest-
ing that this may reflect a compensatory change to
the presence of the oncoprotein PTK rather than a
long-term adaptive response of the cell. Specificity in
this response is illustrated by the fact that although
the levels of PTP1B were increased following expres-
sion of p210 bcr-abl, we did not detect an increase in
several other PTPs including TC-PTP, the most
closely related homolog of PTP1B. Furthermore,
specificity in the response was also evident from the
perspective of the PTK in that there was no change in
PTP1B levels in Rat-1 fibroblasts expressing v-Abl,
which shares the same catalytic domain as p210 bcr-
abl, or transformed by v-Myc, illustrating that the
alteration in the levels of the phosphatase was not a
general response to cellular transformation.
Our data suggest that PTP may function in a
cellular context as a regulator of p210 bcr-abl-
induced signaling events. It is known that p210 bcr-
abl autophosphorylates on Y177 and that this serves
as a docking site for the adaptor protein Grb2 and
functions to assemble the multiprotein complex that
triggers the Ras-MAP kinase cascade, a step that has
been implicated strongly in transformation. Using an
AP-1/Ets reporter construct to measure the activation
of the Ras/MAP kinase cascade by p210 bcr-abl in a
cellular context, we have shown that PTP 1 B was
capable of antagonizing p210 bcr-abl-induced signal-
ing. Specificity in the response is reflected in the fact
that PTP did not inhibit transcriptional activation
of the same reporter by v-Abl, suggesting that Y177
in p210 bcr-abl is a major target for the PTP. Further-
more, expression of TC-PTP or PTP-PEST did not
effect p210 bcr-abl-induced signaling, as measured
by this transcriptional activation assay.
Signaling by p210 bcr-abl was also inhibited by a
"substrate-trapping" mutant of PTP1B, PTP1B-
D181A, suggesting that a critical substrate in the sig-
naling pathway was being held in a complex with this
mutant and being rendered nonfunctional. As ob-
served for the active PTPs, this mutant of PTP1B did
not affect induction of the reporter gene by v-Abl,
and an equivalent mutant of PTP-PEST did not in-
hibit signaling by p210 bcr-abl. Upon coexpression in
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COS cells, PTP1B-D181A formed a stable complex
with p210 bcr-abl but not v-Abl, despite the fact that
the latter was expressed abundantly and was tyrosine-
phosphorylated. Furthermore, we have shown that the
interaction between p210 bcr-abl and PTP1B-D181A
blocked by more than 90% the association of the
PTK with Grb2, suggesting that Y177 in p210 bcr-abl
is a major target of PTPIB. Disruption of the interac-
tion with Grb2 is the most likely mechanism of in-
hibition of p210 bcr-abl-induced activation of an AP-
1/Ets reporter by wild type and substrate-trapping
mutant forms of PTP1B. Therefore, the selectivity
observed in the up-regulation of PTP1B levels in
response to expression of p210 bcr-abl is reflected in
the selectivity of PTPIB in antagonizing p210 bcr-
abl-induced signaling. These data are consistent with
a function of PTP1B as an antagonist of p210 bcr-abl
signaling in vivo, and we are currently testing
whether the effects of the PTP are sufficient to
abrogate the transforming potential of this onco-
protein PTK.
IDENTIFICATION OF SUBSTRATES FOR PTP-PEST
PTP-PEST is a ubiquitously expressed, cytosolic,
mammalian PTP which exhibits high specific activity
in vitro. As such, one might anticipate that PTP-
PEST could exert a considerable influence on the
tyrosine phosphorylation status of a wide variety of
proteins in vivo. We initially identified a prominent
130-kD tyrosine-phosphorylated protein in pervana-
date-treated HeLa cell lysates which was preferential-
ly dephosphorylated by PTP-PEST in vitro. We ob-
served that substrate-trapping forms of PTP-PEST as-
sociated in stable complexes exclusively with the
same 130-kD protein, which was identified as
30cas by immunoblotting. Tyrosine-phosphoryl-
ated p130cas is a signaling intermediate implicated in
a wide variety of cellular processes, including on-
cogenic transformation, B-cell activation, and mito-
gen- and cell-adhesion-induced signaling; PTP-PEST
is therefore potentially involved in the regulation of
these processes through the specific dephosphoryl-
ation of p130cas.
We have also begun to investigate the molecular
mechanisms underlying the specificity of the interac-
tion between PTP-PEST and p130cas and have identi-
fied a high-affinity interaction between the SH3
domain of p130cas and a proline-rich sequence
(P335PPKPPRT) within the carboxy-terminal seg-
ment of PTP-PEST. Mutation of Pro-337 within this
sequence to alanine significantly impairs the ability
of PTP-PEST to recognize tyrosine-phosphorylated
p130cas as a substrate, without qualitatively affecting
the selectivity of the interaction. Thus, the highly
specific nature of the interaction between PTP-PEST
and p130cas appears to result from a combination of
two distinct substrate recognition mechanisms; the
catalytic domain of PTP-PEST contributes specificity
to the interaction with p130cas, whereas the SH3
domain-mediated association of p130cas and PTP-
PEST dramatically increases the affinity of the inter-
action. The involvement of the noncatalytic segment
of PTP-PEST in the selection of p130cas as a sub-
strate is a novel example of an emerging paradigm in
tyrosine-phosphorylation-dependent signaling pro-
cesses, in that substrate specificity of both protein
tyrosine kinases and phosphatases is frequently in-
fluenced by the noncatalytic segments of these en-
zymes, offering a versatile mechanism for restricting
each enzyme to specific roles in tyrosine-phosphory-
lation-dependent signaling pathways.
THE EGF RECEPTOR AND SHC ARE SUBSTRATES
FOR TCPTP
The substrate-trapping mutants have also been used
to compare the specificity of PTP1B with its closest
homolog, TCPTP, in a cellular context. Alternative
splicing of the TCPTP mRNA generates two forms of
the enzyme that differ at their extreme carboxyl
termini but share the same catalytic domain that is lo-
cated at the amino terminus of the molecule. One of
these forms, 48-kD TCPTP, is targeted to the ER and,
like PTP1B, trapped the EGF receptor. Immuno-
fluorescence studies revealed that expression of the
D182A mutant of TCPTP caused an accumulation of
EGF receptor in the ER. However, it did not trap the
lower Mr substrates of PTP1B, particularly a promi-
nent pTyr protein of 60 kD. The second form of
TCPTP, of Mr 45,000, localizes to the nucleus. When
cells expressing D182A 45k TCPTP are treated with
EGF, the phosphatase exits the nucleus and can be
isolated in a complex with the EGF receptor. How-
ever, unlike 48k TCPTP, this form of TCPTP also
traps Shc and additional pTyr proteins of 64k and
50k. Interestingly, in this case, the EGF receptor did
not accumulate in the ER, but expression of D182A
45k TCPTP appeared to block endocytosis of the
receptor. The effects on signaling are currently being
ascertained. These data illustrate that even closely re-
lated PTPs exhibit substrate specificity in a cellular
context and suggest that control of subcellular loca-
tion may be a critical element in determining such
specificity.
Identification of
Regulators
of PTP Function
R.L. Del Vecchio, S.N. Mamajiwalla,
A.A. Samatar, T. Tiganis and S.H. Zhang
In general, the structure of PTPs can be described in
terms of a conserved catalytic domain to which is
fused on either the amino- or carboxy-terminal side a
noncatalytic segment that serves a regulatory func-
tion and can be used to distinguish individual PTPs.
It is now apparent that PTPs are regulated at multiple
levels. We have been characterizing a number of
protein-protein interactions involving members of the
PTP family that may be important in regulating ac-
tivity directly or indirectly through control of sub-
cellular distribution.
REGULATION OF CYTOPLASMIC PTPs
By affinity chromatography, using GST-TCPTP fu-
sion proteins, we have isolated three cytoplasmic
proteins of 120 kD, 116 kD, and 97 kD that interact
with TCPTP. The p120 protein associated with
residues 377-415 from the carboxyl terminus of the
48-kD form of TCPTP, whereas the recognition site
for p97 and p116 was mapped to residues en-
compassing the TCPTP nuclear localization sequence
(NLS). The TCPTP NLS was shown to be bipartite
requiring two clusters of basic residues for efficient
nuclear translocation. p116 and p97 associated with
residues within basic clusters I and II, indicating a
direct correlation between binding and nuclear local-
ization. Sequence analysis of p97 identified it as the
nuclear import factor p97 (importin 0) which is an es-
sential component of the nuclear import machinery.
We found that TCPTP coimmunoprecipiated with the
nuclear import factor p97 from cell lysates and that
purified recombinant p97 and TCPTP interacted
directly in vitro. In a direct comparison, the TCPTP
NLS precipitated p97 and p116 from cell lysates,
whereas the SV40 T-antigen and nucleoplasmin NLS
did not. These results suggest that TCPTP may be
targeted to the nucleus by a distinct process which
may involve the direct interaction of p97 and possib-
ly p116 with the basic clusters of its bipartite NLS.
Moreover, these results demonstrate that the carboxy-
terminal segment of TCPTP contains docking sites
for interaction with proteins that may function to
target the enzyme to defined intracellular locations
and in the process regulate TCPTP function.
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A second example involves PTPH1, a human PTP
that has homology with the band-4.1 superfamily of
cytoskeletal-associated proteins. We have found that
PTPH1 interacts with the protein 14-3-3 in vivo. 14-
3-3s are a family of highly conserved acidic proteins
of 30 kD that are involved in control of mitogenic
signaling, cell cycle, and transformation and have
been shown to interact with a number of important
signaling proteins. As observed for other interactions
involving 14-3-3, the association with PTPH1 is
phosphorylation-dependent. We have identified two
novel serine phosphorylation sites in PTPH1 that
serve as the major 14-3-3-binding-sites but are dis-
tinct from the consensus binding motif identified to
date. Our results raise the possibility that 14-3-3 may
function as an adaptor molecule in the regulation of
PTPH1 and may provide a link between Ser/Thr and
tyrosine-phosphorylation-dependent signaling path-
ways.
RECEPTOR PTPs AND
CELL CONTACT
We have been characterizing PTP[I, a receptor PTP
with structural similarity to the immunoglobulin su-
perfamily of cell adhesion molecules. Our studies
have illustrated that PTI3p, interacts with the cad-
herin/catenin cell adhesion complex at adherens junc-
tions in vivo. This interaction appears to be dynamic;
conditions that lead to tyrosine phosphorylation of
the cadherin/catenin complex correlate with disrup-
tion of the interaction with PTPli. This observation is
provocative because tyrosine phosphorylation of the
cadherin/catenin complex has been observed under a
variety of physiological conditions potentially con-
tributing to transformation and metastasis. It appears
that PTPII, may provide the regulatory balance to this
phosphorylation event, thus maintaining the cad-
herin/catenin complex in its functional, dephosphory-
lated state.
A second receptor PTP that has been linked to cell
contact phenomena is DEP-1 (density enhanced PTP-
1), the surface expression of which is increased as
cells in culture approach confluence. Recent studies
have shown that expression of DEP-1 in 293 cells in-
duced cell cycle arrest in G and profound cytoskele-
tal changes that culminated in the cells rounding up
and floating off the dish. This effect, which is
specific for DEP-1, suggests that the PTP may act
upon cytoskeletal targets, and we are currently trying
to identify and characterize these substrates.
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Dual Specificity Phosphatases
and Growth Control
A. Bennett
We are focusing on MKP-1, a highly selective
phosphatase that dephosphorylates and inactivates
members of the MAP kinase family of enzymes in
vivo. The MAP kinases have been implicated as com-
mon and essential components of signaling pathways
induced by diverse stimuli, suggesting that MKP-1
will be a crucial, central player in the control of cell
function. We have been using MKP-1 as a molecular
probe with which to examine physiological functions
of the MAP kinases. Skeletal muscle differentiation
is a coordinated process initiated by the activation of
muscle-specific transcription factors, accompanied by
irreversible cell cycle withdrawal. The myoblast cell
line, C2C12, proliferates in high serum but differen-
tiates into multinucleated myotubes upon mitogen
deprivation. We have investigated whether the deci-
sion between either proliferation or differentiation in
C2C12 myoblasts is determined by the level of MAP
kinase activity. Within 24 hours following serum
deprivation, MyoD, the muscle-specific transcription
factor, was induced in C2C12 myoblasts concomitant
with the down-regulation of Erk2 (MAP kinase) ac-
tivity. To determine whether inhibition of MAP
kinase activity by MKP-1 in C2C12 myoblasts is suf-
ficient to induce MyoD, we generated stable C2C12
myoblast lines expressing MKP-1 (C2MKP1) under a
tetracycline-repressible promoter. C2MKP1 myo-
blasts overexpressed MKP-1 by up to threefold upon
removal of tetracycline, resulting in the inhibition of
Erk2 kinase. Under conditions of high serum where
C2MKP1 myoblasts fail to express either MyoD or
myosin heavy chain (MHC), MKP-1 overexpression
caused the up-regulation of MyoD and MHC expres-
sion. Myotube formation, however, was not ob-
served. Thus, inhibition of MAP kinase activity by
MKP-1 is sufficient to initiate the biochemical, but
not the morphological, myogenic phenotype. These
results also suggest that the initiation of C2C12
myogenesis may be determined by the coordinate ac-
tions of MAP kinase and MKP-1.
A Genetic Analysis of PTP Function
M. Gutch
We are using the nematode Caenorhabditis elegans
as a model system for a genetic analysis of PTP func-
tion. The experiments are being performed in col-
laboration with Michael Hengartner's lab here at
Cold Spring Harbor. An attractive feature of C.
elegans is that many of the properties of its signaling
pathways are conserved with those found in mam-
mals. Thus, the lessons learned in C. elegans should
be applicable to humans. Our strategy has been first
to use reverse genetics, using the C. elegans endog-
enous transposon Tcl to create gene knock-outs and
thereby PTP-deficient nematodes. One C. elegans
PTP we are focusing on is a homolog of the mam-
malian SHPs. This C. elegans PTP contains two SH2
domains at the amino terminus followed by a PTP
catalytic domain and a short carboxy-terminal tail.
Disruption of this gene by the transposon Tcl
resulted in a completely penetrant, zygotic semi-
sterile/maternal-effect-lethal phenotype with ab-
normal oocyte maturation. A second PTP we targeted
for disruption is a transmembrane PTP containing ex-
tracellular FNIII repeats and two intracellular PTP
catalytic domains. A BLAST search revealed highest
sequence similarity to the mammalian transmem-
brane PTP LAR. Targeted disruption of this gene
resulted in embryonic lethality and morphologically
abnormal nematodes. Future experiments will utilize
classical forward genetics to identify enhancers/sup-
pressors of the PTP knock-out phenotype.
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THE CYTOSKELETON IN NORMAL AND TRANSFORMED CELLS
D.M. Hellman C. Berthier
C. Chen
M. Gimona
J. Grossman
J.P. Liu
M. Meyer
A. Rai
M. Selvakumar
Y.-C. Wang
A. Watakabe
The research in our lab is focused on the expression,
structure, and function of cytoskeletal components in
normal and transformed cells. One interest of our lab
is the relationship between the cytoskeleton, malig-
nant transformation, and tumor suppression. We have
also been interested in understanding how specific
actin assemblies are organized and regulated. How
the assembly of cytoskeletal structures is regulated by
extracellular signals via molecules such as rho, rac,
and cdc42 and how it is altered by transformation are
under investigation. Why different cell types express a
specific set of structural components is still not well
understood. One possibility is that the dynamic and
stable macromolecular assemblies that are character-
istic of a specific cell type, e.g., stress fibers, con-
tractile ring, and filopodia in fibroblasts or sarco-
meres in skeletal muscle, will require specific iso-
forms of given structural proteins as well as regula-
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tory proteins for their proper maintenance and regula-
tion. In some cases, isoform diversity arises via alter-
native RNA splicing. We are investigating the cellu-
lar function of the cytoskeletal protein isoform diver-
sity generated by alternative RNA splicing. To study
the organization and regulation of various actin con-
taining structures, we are using a number of experi-
mental systems derived from fibroblasts, neurons,
epithelial cells, and muscle cells. In a related series of
experiments, we are studying the mechanisms re-
sponsible for tissue-specific and developmentally
regulated patterns of alternative RNA splicing.
During the year, three members of our group
moved on to new positions. Mirjam Meyer finished
her Diploma studies and has started her doctoral
work at the Max Planck Institute in Berlin, Germany.
After 2 years of postdoctoral study, Mario Gimona
returned to the Institute of Molecular Biology,
Salzburg, Austria. Akiya Watakabe has taken a staff
position at the National Institute for Basic Biology,
Okazaki, Japan. During most of 1996, I was on sab-
batical. Beginning in March, I studied with Professor
Jean-Claude Perriard at the Swiss Federal Institute of
Technology, Zurich, Switzerland, and then in Octo-
ber I spent an additional 6 months working with
Professors Avri Ben-Ze'ev, Benjamin Geiger, and
Alexander Bershadsky at the Weizmann Institute of
Science, Israel. Below is a summary of our studies
during the past year.
Forced Expression of Tropomyosin 2
or 3 in v-Ki-Ras-transformed Fibroblasts
Results in Distinct Phenotypic Effects
M. Gimona, D.M. Helfman
Transformation of cells in tissue culture results in a
variety of cellular changes including alterations in
cell growth, adhesiveness, motility, morphology, and
organization of the cytoskeleton. Morphological and
cytoskeletal changes are perhaps the most readily ap-
parent features of transformed cells. Although a num-
ber of studies have documented a decrease in the ex-
pression of specific tropomyosin (TM) isoforms in
transformed cells, it remains to be determined if the
suppression of TM synthesis is essential in the estab-
lishment and maintenance of the transformed pheno-
type. To address the roles of different TM isoforms in
transformed cells, we have examined the effects of
expressing specific TM isoforms in transformed cells
using a Kirsten-virus-transformed cell line (ATCC
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NRK 1569) as a model system. In contrast to normal
fibroblasts, the NRK 1569 cells contain reduced
levels of TM-1 and undetectable levels of TM-2 and
TM-3. These cells have a rounded morphology and
are devoid of stress fibers. Employing expression
plasmids for TM-2 and TM-3, stable cell lines were
established from the NRK 1569 cells that express
these isoforms individually. We demonstrate that ex-
pression of TM-2 or TM-3 leads to increased cell
spreading accompanied by the formation of identifi-
able microfilament bundles, as well as significant
restoration of well-defined vinculin-containing focal
adhesion plaques, although expression of each
isoform exhibited distinct properties. In addition,
cells expressing TM-2, but not TM-3, exhibited
contact-inhibited cell growth and a requirement for
serum. Experiments are in progress to further under-
stand the molecular mechanisms by which expression
of specific TM isoforms leads to changes in the
cytoskeleton and cell signaling.
Incorporation of GFP-Tropomyosin
Isoforms in Living Neonatal Rat
Cardiomyocytes: Nonmuscle TM-4
Requires Cooperative Interactions with
Other Low-molecular-weight Isoforms for
Thin-filament Binding
D.M. Helfman [in collaboration with Jean Claude Perriard,
Institute for Cell Biology, Swiss Federal Institute
of Technology, Zurich, Switzerland]
The ability of striated muscle (skeletal muscle a-TM)
and nonmuscle (fibroblast TMs 1, 2, 3, 4, 5, 5a, or
5b) isoforms of tropomyosin to incorporate into actin
filaments of neonatal rat cardiocytes (NRCs) and
fibroblasts was studied using GFP, VSV, and HA
epitope-tagged expression plasmids. All epitopes
were fused to the amino-terminal end of the TM
cDNA and analyzed following transient transfections.
The expressed fusion proteins were analyzed for I-
band incorporation in NRCS and incorporation into
microfilaments in fibroblasts. All isoforms, except
fibroblast TM-4, were able to incorporate into the I-
band of NRCs. In addition, cells that incorporated the
muscle or nonmuscle GFP-TMs into their sarcomeres
continued to beat and exhibited sarcomeric contrac-
tion, demonstrating that incorporation of the GFP-
TM did not interfere with myofibrilar function. In
contrast, all isoforms of TM analyzed, including TM
4, were able to associate with microfilaments in
fibroblasts. When TM-4 was cotransfected with other
low-molecular-weight isoforms of TM (TM-5, TM-
5a, and TM-5b), it was able to incorporate into sar-
comeres of NRCs. This result was not obtained when
TM-4 was cotransfected with high-molecular-weight
TMs (TM-2 or skeletal muscle a-TM). These data
demonstrate that the ability of TM-4 to bind to actin
filaments can be influenced by its interactions with
other low-molecular-weight TM isoforms. Further-
more, these studies demonstrate that GFP-TM can be
used to study thin-filament dynamics in muscle cells
and actin filament dynamics in nonmuscle cells.
Cytoskeletal and Adhesion
Proteins in Transformed Cells
D.M. Helfman [in collaboration with Avri Ben-Ze'ev,
Benjamin Geiger, and Alexander Bershadsky,
Weizmann Instiute of Science, Rehovot, Israel]
Malignant transformation is accompanied by a num-
ber of alterations in the cytoskeleton and cell adhe-
sion. Using an SV40-transformed human fibroblast
cell line, we investigated the distribution of adherens
junction molecules as well as the effects of express-
ing different isoforms of tropomyosin, caldesmon,
and small GTPases (rho, rac, and cdc42) on cell
shape, microfilaments, focal adhesions, tyrosine
phosphorylation, and adherens junctions. Different
isoforms of TM were found to exhibit distinct
phenotypic effects on the actin cytoskeleton. In addi-
tion, low-level expression of caldesmon led to en-
hanced formation of microfilament bundles, whereas
high-level expression led to disruption of microfila-
ment bundles and inhibition of ATP-driven con-
tractility. Expression of active rho, rac, and cdc42 led
to the formation of stress fibers, lamellopodia, and
filopodia, respectively, demonstrating that the cel-
lular targets for these signaling molecules were func-
tional in these transformed cells.
Distribution of TM isoforms in
Dynamic Actin-containing
Cytoskeletal Structures
C. Berthier
Several lines of biochemical evidence have suggested
that tropomyosin could be involved in the stabiliza-
tion of actin filaments. The multiplicity of TM iso-
forms in one single cell (e.g., seven isoforms per
fibroblast) raises the possibility that specific associa-
tions of given isoforms are required for the distinct
actin-based structures. This project was designed
with regard to the following questions: (1) Do dif-
ferent TM isoforms achieve their function by binding
to spatially distinct subsets of actin filaments, and (2)
how is the localization of the TMs restructured dur-
ing dynamic cellular events. We have constructed
chimeric genes encoding the different TMs fused at
their amino terminus to green fluorescent protein
(GFP). We have been able to establish stable cell
lines of 3T3 fibroblasts expressing these different fu-
sion proteins, and using GFP as a reporter, we are
currently investigating the subcellular distribution of
the GFP-TMs. Preliminary results suggest some dif-
ferences exist between the localization of different
GFP-TM fusions: High-molecular-weight TMs ap-
pear, for example, to be better incorporated into actin
stress fibers than low-molecular-weight TMs. What is
of particular interest is that this cellular system now
offers us the possibility to follow the dynamic behav-
ior of the GFP-tagged TMs, using fluorescence time-
lapse video recording of living cells. Experiments are
now in progress to characterize the dynamic localiza-
tion of the different TM isoforms during various cel-
lular motility events involving reorganization of the
actin cytoskeleton, such as protrusion of filopodia,
lamellipodia ruffling, forward movement, spreading
and assembly of stress fibers, and cytokinesis.
Using transfection of tagged proteins in cultured
cells followed by immunofluorescence, we are also
currently investigating the preferential localization of
the TM isoforms and the role of caldesmon in normal
and transformed cells. Preliminary results strongly
suggest that caldesmon helps the binding of the TMs
to actin filament bundles. We are in the process of
determining if caldesmon has a role in promoting the
binding of specific isoforms to actin filaments, as in
vitro results suggested. Several reports have shown
that expression of TMs is altered in transformed cell
lines, and we anticipate that our study will give new
insights into the role of TMs in the actin cytoskeleton
of cancerous cells.
Identification of Novel Tropomyosin
Binding Proteins
A.J. Rai
Tropomyosins (TMs) comprise a family of highly
conserved filamentous actin-binding proteins that
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have been identified in virtually all eukaryotic cells.
To date, there are four TM genes that have been char-
acterized in rat, and these give rise to at least 16 dif-
ferent isoforms. Expression of these isoforms occurs
in a tissue-specific manner. The function of TM is
best understood in striated muscle, where in conjunc-
tion with the troponin complex, TM regulates the
calcium-sensitive interactions that modulate actin
myosin-based contraction. Smooth muscle cells and
nonmuscle cells are devoid of a troponin complex,
and these cells express a multiplicity of different TM
isoforms, whose functions are poorly understood.
The system that we use for our investigations is that
of the rat fibroblast. These cells express at least seven
different isoforms of TM.
A plethora of genetic and biochemical data suggest
that different TM isoforms have different roles in the
cell. To delineate these specific functions in vivo, we
have sought to identify isoform-specific TM-binding
proteins. We have used several different approaches
to identify candidates that may serve these roles, in-
cluding affinity chromatography, coimmunoprecip-
itation, gel overlay, and the two-hybrid system. One
such protein that we have identified recently appears
to interact selectively with specific TM isoforms.
Current work suggests that this binding is dependent
on alternatively spliced regions of the TM molecule.
Future experiments are planned to further character-
ize this binding activity and to determine its physio-
logical relevance in the regulation of cytoskeletal dy-
namics. This work is not only of interest in basic
science, but also of clinical value, as it has long been
known that TM gene expression is selectively altered
in transformed cells. The identification and character-
ization of isoform-specific TM-binding proteins may
help us to understand how transformed cells maintain
their distinct state with reference to cytoskeletal dis-
organization and other aspects of the transformed
phenotype.
Exogenous Expression of Brain
Tropomyosin and Tropomodulin
Isoforms in Nonneuronal Cells
Reveals Their Actin-binding
Properties
A. Watakabe, D.M. Hellman
Whereas the roles of tropomyosin and tropomodulin
in skeletal muscle are well established, their roles in
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nonmuscle cells are relatively unknown. We have in-
vestigated the properties of neuronal isoforms of
tropomyosin and tropomodulin in biochemical and
transfection experiments. TMBrl and 3 are develop-
mentally regulated tropomyosin isoforms expressed
in neuronal cells. To examine their binding affinity
for F-actin, we produced recombinant TMBrs in bac-
teria and insect cells and carried out actin co-
sedimentation assays. We found that TMBrl and 3
poorly bind to F-actin, unlike other isoforms. To con-
firm this finding in cultured cells, we transfected
TMBrl and 3 into a rat fibroblast cell line NRK 1570
and examined whether they incorporate into actin-
based structures. Consistent with biochemical experi-
ments, the transfected TMBrs stayed mainly in the
cytoplasm, although we observed incorporation of
TMBrs into some actin-based structures. Surprising-
ly, when we used cardiac cells for transfection,
TMBrl incorporated efficiently into the sarcomeric
structure, whereas TMBr3 did not. This result sug-
gests that binding of tropomyosin to F-actin is con-
trolled not only by its intrinsic affinity to F-actin, but
also by the cellular environment. We also transfected
two different isoforms of tropomodulin into cardiac
cells. It was previously shown that E-tropomodulin is
localized at the pointed end of F-actin in sarcomeric
structure. We found that N-tropomodulin, which is
predominantly expressed in neurons, also locates at
the same position in sarcomere. This finding strongly
suggests that N-tropomodulin also has a pointed-end
capping activity as does E-tropomodulin.
Role of Exon Sequences in
Splice Site Selection
M. Selvakumar
Previous studies showed that the 3' splice site of
exon 6 (nonmuscle/smooth muscle exon) of 3-TM
can be utilized only if (1) a previous splicing event
joins exons 6 and 8 together or (2) we mutate either
the potypyrimidine tract at the 3' splice site of exon 6
to a poly(U) stretch or the 5 ' splice site of exon 6 to a
consensus sequence (Cs). Thus, we showed that both
the intron and exon sequences contribute to splice
site selection. Studies in other systems such as IgG
and troponin T have identified purine-rich motifs as
important exonic sequence enhancers (ESE). These
ESEs are believed to act as binding sites for splicing
factors such as SR proteins. Examination of se-
quences within exons 6 and 8 revealed the presence
of two ESEs in exon 6 (6-1, 6-2) and three ESEs in
exon 8 (8-1, 8-2, 8-3). Substitution mutations of these
motifs have shown that they are required for the 3'
splice site usage of exon 6. We also see that individu-
al motifs have different effects, with 6-1, 6-2, and 8-2
being the most robust ESEs. We used wild-type and
mutant exon sequences as probes for UV cross-
linking in an effort to look for RNA:protein interac-
tions. We see differences in binding efficiency for
several nuclear factors and are currently in the pro-
cess of identifying some of these proteins.
When pre-mRNAs containing multiple exons and
introns (exons 5 through 9) are used, the major splice
product detected in vitro unexpectedly skips exon 6.
We divided this long substrate into two with the first
half containing exons 5-6 and the second half con-
taining exons 6-7-8-9, with the focus being exon and
intron sequences in and around exon 6. We observed
that the ESEs in exon 6 substantially improve both
3' and 5' splice site usage when one of the splice
sites is weak. However, when both the splice sites are
strong (poly[U] and Cs), the ESEs are not required.
Thus, ESEs may have a role in bridging factors
across the exon and thereby stabilize interactions at
weak splice sites such as those commonly found in
alternatively spliced exons. We have also shown that
ESEs are required for exon 6 inclusion in vivo.
Regulation of a Muscle-specific
Exon in (3-TM Pre-mRNA
Y.-C. Wang, J.P. Liu
The rat 13-TM gene contains two pairs of mutually ex-
clusive exons which are alternatively spliced in a
tissue-specific manner. Exons 6 and 11 are included
in the isoform TM-1, which is expressed in non-
muscle and smooth muscle cells, whereas exons 7
and 10 are included in (3-TM produced in skeletal
muscle cells. We have used both in vitro and in vivo
experimental approaches to study the nuclear factors
and the cis-acting elements involved in the regulation
of alternative RNA splicing.
Using an in vitro splicing assay comprising the
293 cell (nonmuscle) nuclear extract complemented
by the mouse BC3H1 cell (muscle) nuclear extract,
we have identified an activity that promotes the splic-
ing of exons 5 to 7 in the muscle cell nuclear extract.
We are currently using such a complementation assay
and column chromatography to purify the factor(s)
that is responsible for this activity from muscle cell
nuclear extracts.
Although the cis-acting elements that are impor-
tant to suppress exon 7 in nonmuscle cells have been
delineated previously in HeLa cells, it is unclear
whether the same cis-acting elements are involved in
activation of exon 7 in skeletal muscle cells. To ad-
dress this question, we have transiently transfected a
TM minigene spanning exons 5 through 9 into mouse
3T3 (nonmuscle) and BC3H1 cells. Previous data
showed that exon 6, but not exon 7, was spliced in
HeLa cells. In addition, a low level of an aberrant
exon-skipping product (exon 5 directly spliced to
exon 8) was detected. When the minigene was trans-
fected into the mouse 3T3 fibroblast cells, similar
results were obtained. In contrast, in the differentiat-
ing BC3H1 muscle cells, exon 7 was now utilized.
Experiments are in progress to identify the cis-acting
elements required for use of the muscle-specific
splice.
The Mechanism of Blocking the
Utilization of a Skeletal Muscle
Exon in Nonmuscle Cells
C. Chen
By using the rat 13-TM gene, we are studying the
mechanisms involved in the regulation of alternative
splicing. Our previous data demonstrated that two
elements in both intron 6 and exon 7 were respon-
sible for the blocking of skeletal muscle exon 7 in
fibroblast. The intron regulatory element (IRE),
which is located downstream from intron 6, binds
polypyrimidine tract binding (PTB) protein and dis-
places the binding of a constitutive splicing factor U2
snRNP auxiliary factor to the polypyrimidine tract
(PPT), which results in the inability of U2 snRNP to
bind to the branch point sequence (BPS). The other
element identified is a sequence in skeletal-muscle-
specific exon 7. The mutation of this sequence
(named ex-1) resulted in the activation of exon 7.
This sequence is referred to as GRE, which stands for
guanine-rich element. The function of GRE is un-
known.
To simplify the system, to concentrate on the
99
GRE, and to increase the sensitivity of the functional
assay, a number of simple substrates have been gen-
erated and tested in vitro. A pair of simple substrates
designated p5-7 wild type and ex-1 mutant, which
consists of exon 5, intron 5, and exon 7, fulfilled the
requirement and have been chosen for further study-
ing the nature of GRE. At least three possibilities are
responsible for the activation of ex-1 mutation. One
possibility is that the mutation creates a strong exonic
enhancer. This is unlikley because two random se-
quence mutations of GRE activate exon 7 as well.
Another possibility is the ex-1 mutation disrupts a
putative secondary structure as demonstrated in the
chicken (3 -TM. This is also not the case because it did
not activate exon 7 when the complementary se-
quence, which was proposed to complement to the
GRE, was mutated; additionally, the splicing of exon
7 was not suppressed when the proposed secondary
structure was reformed by mutating both strands to
complementary sequences. The third possibility is the
binding of a suppressor disrupts the binding of anoth-
er constitutive splicing factor. To test this hypothesis,
UV cross-linking was used and a distinct protein
band, migrating at approximately 50 kD, was detect-
ed specifically to the wild-type RNA covering the
GRE. This activity was enriched, excised from the
protein gel, and subjected to microsequencing. We
are now in the process of further characterizing this
factor.
Analysis of a Multiprotein Complex
That Assembles on Cis-acting
Sequences Involved in Alternative
Splicing of (3-TM Pre-mRNA
J. Grossman, M. Meyer
We are using the rat 11 -TM gene as a model system to
study the mechanism of alternative splicing. Previous
studies have found that at least one protein, the poly-
pyrimidine-tract-binding protein (PTB), specifically
interacts with sequences upstream of exon 7 which
were shown to be involved in the alternative splicing
of t3 -TM pre-mRNA. To further study the role of
PTB in the regulated intron, monoclonal antibodies to
PTB were prepared. Anti-PTB antibodies did not in-
hibit the binding of PTB to RNA. To identify addi-
tional proteins that interact with sequences within the
pre-mRNA, two different assays were used: (1) 35S-
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Met-labeled nuclear extracts from He La cells were
mixed with nonbiotinylated RNAs and the RNA-
protein complexes were recovered by immunoprecip-
itation using monoclonal antibodies to PTB, and (2)
35S-Met-labeled He La nuclear extracts were mixed
with biotin-RNA containing intron 6 and the RNA-
protein complexes were recovered using streptavidin-
agarose beads. Identical patterns of proteins were ob-
served using both assays. When RNAs containing in-
tron 6 were coprecipitated with antibodies to PTB, a
novel set of proteins were found to coprecipitate. In
contrast, addition of RNAs containing introns 5 or 7
gave the same results as precipitations without RNA,
indicating that these RNAs are unable to form stable
complexes with PTB. These results are in agreement
with our previous studies demonstrating that PTB in-
teracts with sequences within intron 6, but not with
sequences in introns 5 and 7. Finally, analysis of the
proteins that assembled on introns 5, 6, or 7 using
biotin-RNA revealed a unique set of proteins that in-
teract with each of these sequences, indicating that
different heterogeneous nuclear ribonucleoproteins
(hnRNPs) are bound to different regions of the pre-
mRNA. Comparison of the proteins that assemble on
introns from the a-TM and (3 -TM genes that utilize
distant branch points revealed a common set of pro-
teins that assemble on these introns. These studies
identify a set of proteins, in addition to PTB, that are
most likely to be involved for distant branch point
usage.
PUBLICATIONS
Gimona, M., J. Kazzaz, and D.M. Heitman. 1996. Forced ex-
pression of tropomyosin 2 or 3 in vi-Ki-ras-transformed
fibroblasts results in distinct phenotypic effects. Proc.
Natl. Acad. Sci. 93: 9618-9623.
Temm- Grove, C.J., W. Guo, and D.M. Heitman. 1996. Low
molecular weight fibroblast tropomyosin 5 (TM-5): cDNA
cloning, actin-binding, localization, and coiled-coil inter-
actions. Cell Motil. Cytoskeleton 33: 223-240.
Watakabe, A., R. Kobayashi, and D.M. Heitman. 1996. N-
tropomodulin: A novel isoform of tropomodulin, identi-
fied as the major binding protein to brain tropomyosin.
J. Cell Sci. 109: 2299-2310.
In Press
Auerbach, D., B. Rothen-Ruthishauser, S. Bantle, M. Leu, E.
Ehler, D. Heitman, and J.C. Perriard. 1997. Molecular
mechanisms of myofibril assembly in heart. Cell Struct.
Funct. (in press).
Gimona, M., Z. Lando, Y. Dolginov, J. Vandekerchove, R.
Kobayashi, A. Sobieszek, and D.M. Heitman. 1997.
Calcium-dependent interaction of S100A2 with muscle
and nonmuscle tropomyosins. J. Cell Sot 110: 611-621.
Wang, J., M. Selvakumar, and D.M. Helfman. 1997. Splice
CELL BIOLOGY OF THE NUCLEUS
D.L. Spector S. Huang J. Silverman
P. Lorenz T. Howard
T. Misteli J. McCann
P. Mintz
Studies in our laboratory are focused on the structur-
al-functional organization of the mammalian cell
nucleus. Our research program evolves around under-
standing the nuclear organization of factors associat-
ed with pre-mRNA splicing and the RNA substrates
with which these factors interact. The microscopy
core facility has been used extensively over the past
year and numerous collaborations are under way with
the excellent technical expertise of Tamara Howard.
The Dynamics of Pre-mRNA
Splicing Factors in Living Cells
T. Misteli, D.L. Spector
Pre-mRNA splicing factors are distributed nonho-
mogeneously in the nucleus of mammalian cells. By
antibody labeling, they are concentrated in 20-40
distinct nuclear domains, termed speckles. The func-
tion of nuclear speckles is unknown. To investigate
the behavior of nuclear speckles in vivo, we have
visualized splicing factors in the nuclei of living
cells. Essential splicing factors were fused to the
green fluorescent protein (GFP). When expressed in
mammalian cells, the fusion proteins could easily be
detected by fluorescence microscopy in living cells.
The fusion proteins behaved identically to endogen-
ous pre-mRNA splicing factors and were functional
in vivo. Using time-lapse fluorescence microscopy,
the dynamic properties of splicing factors were ana-
lyzed. Nuclear speckles did not significantly alter
their position within the nucleus over long observa-
tion periods; however, the periphery of speckles ap-
peared highly dynamic as extensions formed from the
edge of speckles, and particles containing splicing
site selection and alternative splicing. In Eukaryotic
mRNA processing (ed. A. Krainer). IRL Press. (In
press.)
factors were frequently seen to associate with and dis-
sociate from speckles. These movements were strictly
dependent on ongoing RNA polymerase II transcrip-
tion and involved dephosphorylation/phosphorylation
events as they were sensitive to inhibitors of protein
kinases and protein phosphatases. To test whether
these extensions occurred directly in response to tran-
scriptional activation of particular genes, cell lines
were used that carry stably integrated inducible viral
genes. Upon transcriptional activation, pre-mRNA
splicing factors were released from speckles and ac-
cumulated at the sites of active transcription. These
observations suggest that pre-mRNA splicing factors
are highly dynamic within the interphase cell nucleus
and that they directly respond to transcriptional ac-
tivation of genes by relocation from speckles to active
genes. Further studies will address to what degree the
position of speckles within the nucleus is predeter-
mined and what determines the position of speckles
within the nucleus.
The molecular mechanisms for these redistribu-
tions are unknown, but they might involve protein
phosphorylation and dephosphorylation events. To ad-
dress the role of protein phosphatases, we have devel-
oped a permeabilized cell system in which mor-
phological redistributions of pre-mRNA splicing fac-
tors observed in vivo can be reproduced in vitro. We
have identified a serine/threonine phosphatase-I-like
activity as a factor in the modulation of the distribu-
tion of pre-mRNA splicing factors. From these obser-
vations, we propose a model in which a cycle of
phosphorylation and dephosphorylation determines
the localization of pre-mRNA splicing factors. We are
currently testing this model using biochemical means
to analyze the various phospho-isoforms of cellular
pre-mRNA splicing factors.
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FIGURE 1 Fluorescence and electron microscopic examination of the perinucleolar com-
partment. The PNC was observed by immunofluorescence in He La cells using an antibody
specifically recognizing PTB (arrowheads in A). At the electron microscopic level, the PNC
(arrowhead) can be observed to be composed of electron-dense, thick short strands
measuring 80-180 nm in diameter (B). These strands are surrounded by less elec-
tron-dense areas. Some of the strands are in direct contact with the surface of the
nucleolus (arrows in B). Bars: (A) 10 ikm; (B) 1 pm.
Distribution of Pre-mRNA
Splicing Factors and
Chromosomal Domains
J. Silverman (Undergraduate Research Program),
T. Misteli, D.L. Spector
The distribution or pre-mRNA splicing factors within
the nucleus is dependent on the overall level of tran-
scriptional activity of the cell. We set out to test
whether local differences in transcription levels
within the genome also had an effect on splicing fac-
tor distribution. Normal female cells contain two X
chromosomes, one of which is transcriptionally ac-
tive and the other transcriptionally inactive. The two
X chromosomes were visualized by chromosome
painting techniques, and at the same time, the essen-
tial splicing factor SC35 was detected by antibody
labeling. Using high-resolution confocal laser scan-
ning microscopy and statistical analysis, we have
been able to demonstrate that in the majority of cells,
the splicing factor SC35 was associated with only
one of the two X chromosomes and that the fre-
quency of association of SC35 with the inactive X
chromosome was about twofold lower than its fre-
quency of association with the transcriptionally ac-
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tive X chromosome. These observations indicate that
the distribution of pre-mRNA splicing factors is not
only dependent on the overall transcriptional level of
a cell, but also influenced by local differences in tran-
scription between particular regions of the genome.
Extending these findings, we have initiated studies on
the relative positioning of various chromosomes with
respect to each other in the interphase nucleus.
Dynamic Organization of the
Perinucleolar Compartment
S. Huang, D.L. Spector
The perinucleolar compartment (PNC) is a unique
nuclear structure, preferentially localized at the pe-
riphery of the nucleolus (Fig. 1). Several small RNAs
transcribed by RNA polymerase III (i.e., MRP RNA
and RNase P H1 RNA) and the polypyrimidine-tract-
binding protein (PTB, hnRNP I) have thus far been
identified in the PNC (Ghetti et al., Nucleic Acids
Res. 20: 3671 [1992]; Matera et al., J. Cell Biol. 129:
1181 [1995]; Lee et al., Proc. Natl. Acad. Sci. 93:
11471 [1996]). To further characterize the PNC, we
have extensively analyzed this structure in fixed cells
using light and electron microscopy, as well as in
living cells through time-lapse observations.
We have found, through the examination of a large
number of human cancer and normal cells, that PNCs
are much more prevalent in cancer cells than in
normal cells. The PNC prevalence varies among dif-
ferent cancer cell lines, suggesting that PNC preva-
lence may be correlated with the degree of malig-
nancy. When interphase He La cells were fixed and
examined using a monoclonal antibody specifically
recognizing PTB, we found that the number of PNCs
per nucleus appears to be consistent from parental
cells to daughter cells, suggesting that PNCs are
heritable through cell divisions. When cells were
preextracted using a nuclear matrix preparation
protocol, the PNC was found to be associated with
the insoluble fraction of the nucleus. The PNC dis-
sociates in early prophase and reforms at late
telophase in the daughter nuclei prior to the reentry
into the nuclei of all the PTB proteins. The reforma-
tion of the PNC in daughter cells does not require
new protein synthesis, suggesting that the newly
formed PNC is composed of proteins synthesized in
the previous cell cycle. The earliest detectable PNCs
at late telophase appear to be associated with
nucleolar organization regions (precursors of the
nucleolus). Immunoelectron microscopic examina-
tion using a monoclonal antibody specifically recog-
nizing PTB revealed that the PNC is in direct contact
with the surface of the nucleolus and that the im-
munolabeling of PTB appears to be heterogeneous
within the structure. A fusion protein between PTB
and green fluorescent protein (GFP) was generated to
visualize the PNC in living cells. Time-lapse studies
revealed that the size and shape of the PNC are
dynamic over time. To analyze the sequence requir-
ment for PTB to be localized in the PNC, deletion
mutants of the GFP-PTB fusion protein were generat-
ed. Results of these experiments showed that at least
three RRMs are required for the fusion protein to be
targeted to the PNC. As previous studies demon-
strated that three RRMs from either the carboxyl or
amino terminus of the protein are necessary and suf-
ficient for PTB to bind the pyrimidine-rich internal
ribosomal entry site (IRE) in virus-infected cells
(Kaminski et al., RNA 1: 924 [1995]), our results
would suggest that the RNA-binding capacity of the
PTB protein may be necessary for the protein to be
localized in the PNC. Studies are under way to ana-
lyze other components of the PNC and its function.
Intracellular Interactions and
Dynamics of Antisense
Oligonucleotides
P. Lorenz, D.L. Spector [in collaboration with
C.F. Bennett and B. Baker, ISIS Pharmaceuticals]
Antisense oligonucleotides designed to hybridize to
complementary regions in their target RNA bear a
great promise for use as specific molecular drugs. A
large variety of chemical modifications of the basic
nucleic acid structure have been introduced into
oligonucleotides to improve their efficacy, especially
to enhance their nuclease stability and binding af-
finity. Whereas the physicochemical properties of the
different types of oligonucleotides have been well
characterized, their cell biological behavior is far less
understood. Our studies are designed to gain insight
into the intracellular distribution of antisense oligo-
nucleotides in relation to their antisense activity. We
have set out to characterize the interactions of spe-
cific oligonucleotides with their target molecules as
well as with other cellular components. To do so, we
employ 18-20-mer oligonucleotides fluorescently
tagged at either terminus, and single cells are eval-
uated for antisense activity by fluorescence micros-
copy. Our basic administration method of the oligo-
nucleotides is microinjection into the cytoplasm or
nucleus of cells. Injected cells are side by side with
uninjected control cells, and microinjection permits
us to evaluate the potential of new antisense chem-
istries which are difficult to introduce into cells
otherwise.
We are currently using a model system in which
overexpressed rat tropomyosin (TM-1) is our target
RNA. The target gene and a control gene, the related
rat tropomyosins TM-4 or TM-5, are coinjected with
the oligonucleotide to be tested into HeLa cells. In-
hibition of expression of the target gene TM-1 while
still maintaining the ability to detect expression of the
control gene TM-4 or TM-5, by immunocytochemis-
try, denotes specific antisense activity in a particular
cell. Thus far, we have found two sequences in the
coding region of TM-1 that led to specific inhibition
of TM-1 expression. One sequence is located in exon
5 and the other in exon 9. The fact that the phos-
phorothioate modification but not the 2' propoxy
phosphodiester modification of the same oligonucleo-
tide sequence exerted antisense activity suggested
that the antisense effect is RNase-H-dependent.
During our studies of the intracellular dynamics of
oligonucleotides, we have established a new property
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of phosphorothioate-type oligonucleotides: Oligonu-
cleotides microinjected into nuclei underwent nucleo-
cytoplasmic shuttling. We have observed this phe-
nomenon after microinjection of the oligonucleotides
into one nucleus of naturally occurring binucleated
Ref-52 cells as well as in heterokaryon assays. Shut-
tling of phosphorothioate oligonucleotides could be
abolished by wheat germ agglutinin and by lowering
the temperature to 4°C. Therefore, it is a nuclear-
pore-mediated process that occurs by facilitated or
active transport. We are currently in the process of
characterizing in detail the involvement of ATP and
GTP, as well as known import/export systems for
proteins and RNAs.
Purification and Characterization
of Interchromatin Granule
Clusters
P. Mintz, D.L. Spector
In the past year, we have been focusing on the
purification of interchromatin granule clusters (IGCs)
that are enriched in pre-mRNA splicing factors.
These structures have been extensively characterized
at the immunocytochemical level. IGCs measure be-
tween 0.5 and 1 1AM in diameter and are composed of
20-25-nm granules that are interconnected by thin
fibrils. It has been proposed that the IGCs may serve
as storage and/or reassembly sites for splicing fac-
tors. Little information is known about the biochemi-
cal composition of the IGCs. Therefore, we have
used two different starting materials in trying to iso-
late the IGCs: He La tissue culture cells and mouse
liver cells. During the isolation procedure, the purity
of the IGCs and nuclear residue contamination were
monitored by light and electron microscopy.
We have been partially successful in purifying the
IGCs from both He La tissue culture cells and mouse
liver cells. The primary contamination, DNA, was
observed in the final stage of the purification proce-
dure. This is promising considering that more prob-
lematic nuclear contamination such as the nuclear
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lamina and internal nuclear matrix were not present
in the final fraction. To show that we have purified
the IGCs, immunogold labeling was performed with
the anti-3C5 antibody (recognizes the family of SR
proteins) on the purified IGC fractions and examined
using electron microscopy. We have observed struc-
tures (IGCs) labeled with the 3C5 antibody in con-
centrated areas. However, the labeling was not
homogeneous throughout the section. In many cases,
in a single section, there were one or two areas
labeled with the antibody and the majority of the
structures were not labeled. We have also performed
silver staining and Western blot analysis on all of the
fractions obtained throughout the purification steps.
We observed numerous bands in the various frac-
tions. The biochemical analysis is still ongoing, and a
more extensive biochemical analysis will be per-
formed once we are confident that we have isolated
pure IGCs. Our research is promising, and within the
next year, we hope to be able to purify the IGCs com-
pletely.
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GENETIC ANALYSIS IN CAENORHABDITIS ELEGANS
M. Hengartner S. Desnoyers J. Keller
T. Gumienny Q. Liu
D. Hoeppner S. Milstein
G. Parvilus (URP)
M. Spector
S. Tharin
Our laboratory uses the small nematode Caenorhab-
ditis elegans as a model organism for the study of
basic biological problems. The two main areas that
we are currently investigating are (1) programmed
cell death (apoptosis) and (2) nervous system func-
tion and development. Because important biological
processes are evolutionarily conserved, we believe
that the general rules that we find in C. elegans will
also apply to humans.
PROGRAMMED CELL DEATH
Programmed cell death (PCD, also known as apop-
tosis) is a mechanism used by multicellular organ-
isms to eliminate cells that are not needed or are
potentially dangerous. PCD has important roles in
animal development and homeostasis and occurs in a
wide variety of tissues in both vertebrates and in-
vertebrates. Proper control of PCD is crucial: Break-
down in the regulation of this process contributes to
the pathogenesis of a large number of diseases, in-
cluding cancer, autoimmunity, neurodegenerative
diseases, ischemic stroke, and myocardial heart in-
farct.
The nematode C. elegans provides an attractive
system for the study of PCD, as its development has
been extensively characterized and the animal is
readily amenable to genetic and molecular manipula-
tions. Hundreds of mutations that affect nematode
cell death have been isolated over the years. These
mutations identify over 16 genes that function in the
regulation and execution of apoptosis; these genes
define a genetic pathway for programmed cell death
in C. elegans. We and other investigators have pre-
viously shown that several of these C. elegans cell
death genes have homologs that perform similar
functions in mammalian apoptosis. This conservation
in sequence and function of cell death genes between
C. elegans and mammals strongly suggests that the
molecular mechanism for PCD has remained con-
served through evolution. Thus, the knowledge
gained about PCD in C. elegans promises to be
relevant to our understanding of apoptosis in human
development and disease.
Identification and Characterization of
CED-9-interacting Proteins
M. Spector, S. Desnoyers, D. Hoeppner
We have previously found that the cell survival gene
ced-9 is homologous to a family of apoptotic regula-
tors in mammals that include the genes bcl -2, bcl-x,
bax, and bak. The mechanism of action of these genes
is not known, but since neither CED-9 nor any of its
homologs have any obvious enzymatic function, it is
assumed that they act by interacting with other
proteins. In C. elegans, two good candidate targets are
the pro-apoptotic proteins CED-3 and CED-4: Both
are essential for programmed cell death and are
antagonized by CED-9. We therefore tested whether
these two proteins could interact with CED-9. Inter-
estingly, we found that CED-9 interacts physically
with CED-4, both in the yeast two-hybrid system and
in vitro. Mutations that reduce or eliminate ced-9 ac-
tivity also disrupt its ability to bind CED-4, suggest-
ing that this interaction is important for CED-9 func-
tion. Thus, CED-9 might control C. elegans cell death
by binding to and regulating CED-4 activity. Because
the pathway for programmed cell death is conserved
from C. elegans to mammals, we suspect that mam-
malian Bc1-2 family members might, in a similar fash-
ion, control apoptosis through interaction and regula-
tion of CED-4 homologs or analogs.
To complement these directed experiments, we
have also performed a general screen for C. elegans
proteins that interact with CED-9 in the yeast two-
hybrid system. We have identified several protein
fragments that appear to interact specifically with full-
length CED-9. We are in the process of further char-
acterizing these clones to determine their possible in-
volvement in apoptosis.
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Programmed Cell Death in the
C. elegans Germ Line
S. Milstein, T. Gumienny
PCD has a major role in the germ line. Germ cells are
by far the most common cell type to undergo PCD:
During development, 131 somatic cells die; in con-
trast, more than 300 germ cells die during adulthood.
Thus, during an animal's lifetime, more PCDs occur
in the germ line than in all the somatic tissues com-
bined. Most, but not all, mutations that affect PCD in
the soma also affect germ cell death. ced-3 and ced-4
are both required for germ cells to die, whereas ced-9
is required to protect oocytes from death: In the ab-
sence of ced-9, too many germ cells die, resulting in
sterility. In contrast, genes that affect PCD only in
specific somatic cells (such as the ces genes and egl-
1) do not affect germ cell death.
To understand how germ cells make the decision
between life and death, we are screening for muta-
tions that specifically affect PCD in the germ line. In
the last year, we have isolated a number of such mu-
tations, which we are now characterizing. We plan to
continue with our screens in the coming year, as none
of the approaches used so far have been saturated.
Genes Involved in the Engulfment
of Dying Cells
Q. Liu, T. Gumienny
Once a cell activates the apoptotic machinery, a num-
ber of downstream "subprograms" are activated, with
the goal of rapidly breaking down the cell and remov-
ing it from the body. These downstream programs are
responsible for the morphological and biochemical
changes that are characteristic of apoptotic cells. One
important subprogram results in the generation of sig-
nals that promote recognition and phagocytosis of the
dying cell by other cells.
Six genes have previously been shown to function
in this process in C. elegans. Genetic analysis has
suggested that these six genes identify two partially
redundant pathways. In the past year, we have identi-
fied several additional phenotypic criteria by which
these genes can be distinguished, strongly supporting
the original classification into two groups. We have
also made great progress in our effort to clone ced-6,
one of these engulfment genes. We have successfully
rescued ced-6 mutants with genomic DNA from a
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wild-type animal and have localized the rescuing ac-
tivity to a single genomic cosmid. We are now in the
process of determining which of the genes present on
this cosmid corresponds to ced-6. Finally, we have
identified a seventh gene involved in the engulfment
process (ced-12) and have begun to characterize it at
the genetic level.
Understanding the nature of the engulfment-pro-
moting signals and how they control phagocytosis
should significantly further our knowledge of the
events that surround and follow the activation of the
cell "deconstruction" program by the apoptotic cell.
Rapid recognition and phagocytosis of apoptotic cells
is also an important aspect of programmed cell death
in vivo, as unengulfed apoptotic bodies can undergo
secondary necrosis, leading to inflammation and pos-
sibly encouraging the development of autoimmune
disease.
NERVOUS SYSTEM FUNCTION AND
DEVELOPMENT
A second area under investigation in the lab is the
nervous system in C. elegans. The small size and rel-
ative simplicity of the nematode nervous system al-
lows us to address complex questions readily at the
genetic and molecular levels.
Development of a Tetracycline-
responsive System in C. elegans
S. Tharin, G. Parvilus
A tetracycline-responsive system for conditional gene
expression has recently been developed for use in
mammalian cells in culture and in transgenic mice.
Because such a conditional expression/repression
system would be useful for our studies of the nervous
system, we have been working toward adapting this
system for C. elegans. In our preliminary experi-
ments, we attempted to control gene expression in the
six touch cell neurons. Our system consisted of two
transgenes. The tetracycline-controlled trans-acti-
vator, which encodes a chimeric protein composed of
a portion of the tet repressor protein from Es-
cherichia coli fused to the transcriptional activation
domain of the viral protein VPI6, was placed under
the control of the mec-7 gene, which drives expres-
sion in the touch cells. The tetracycline-responsive
reporter consisted of lacZ placed under the control of
the pes-10 minimal promoter, upstream of which we
inserted many copies of the tet operator. We generat-
ed a large number of transgenic lines containing vari-
ous ratios of trans-activator and reporter constructs
and tested them for lacZ expression in the presence or
absence of the tetracycline analog dauxocycline. Al-
though our initial results with these lines were dis-
appointing (strong background staining, and little if
any specific staining), we are still bullish on this ap-
proach. We are now experimenting with different co-
injection markers and stronger promoters driving the
tetracycline-controlled trans-activator and hope to get
this system working in the coming year.
Learning and Memory
S. Tharin [In collaboration with J. Connolly and T. Tully,
Cold Spring Harbor Laboratory, and D. van der Kooy,
University of Toronto, Canada]
We have recently started a research program on the
molecular basis of associative learning and memory
in C. elegans. We are pursuing this project in col-
laboration with the Tully and van der Kooy labora-
tories. During the last year, we have made some
progress toward the development of a satisfactory
conditioning paradigm, which we will use to screen
for mutants defective in acquisition, short-term
memory, or long-term memory. Such mutants will
then be characterized at the behavioral, genetic, and
molecular levels.
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GENETICS
The inescapable news in the world of genetics during the last year was the announce-
ment of the cloning of a sheep in Scotland. Although this work was foreshadowed by
many years by that of Briggs and King in Indiana and of Gurdon at Cambridge who had
cloned amphibians, the near identical reproduction of a mammal galvanized the world's
press and invited the inevitable questions. Whether the cloning of humans will ever hap-
pen, except as a consequence of the fairly common natural accident of identical twins,
cannot be said. However, no technical advance has ever been left unexploited, that
mankind viewed to be in our best interest, whether at the time we were dead right or
dead wrong.
EUKARYOTIC CELL CYCLE CONTROL
D. Beach S. Allan
M. Caligiuri
A. Carnero
J. Chen
D. Conklin J. Hudson M. Serrano
K. Dai R. Maestro P. Sun
K. Galaktionov K. Okamoto J. Wang
J. Hoffman S. Salghetti L. Xie
During the course of the year, Maureen Caligiuri ac-
cepted a position as Scientist at Mitotix, Inc., in Cam-
bridge, Massachusetts; Johannes Hofmann went to
the IMP in Austria; Koji Okamoto joined Carol
Prives' lab at Columbia University; and Jim Hudson
accepted a lectureship at the Institute of Child Health
in London. We were joined by two new postdoctoral
fellows, Dr. Amancio Carnero and Dr. Jenny Wang.
Induction of the p16 Tumor
Suppressor in Response to
Oncogenic Stimuli
M. Serrano, D. Beach
The 6 ima a gene is a tumor suppressor mutated in a
wide variety of cancers. Protein p16 associates with
CDK4 and inhibits the G1 cyclin-dependent kinase
CDK4/cyclin D. We have previously shown that p16-
deficient mice are viable but are highly prone to
spontaneous and carcinogen-induced tumors, thus
directly implying a role for p16 in tumor suppression.
Little is known about the regulation of p16 or about
circumstances in which p16 might act to promote cell
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cycle arrest. An important clue to investigate the
regulation of p16 came from our observation that pri-
mary fibroblasts derived from p16-deficient mice can
be tumorigenically transformed by oncogenic ras,
whereas transformation of wild-type fibroblasts re-
quires an additional cooperating oncogene.
On the basis of the above observations, we have
hypothesized that p16 is induced by some signal or
condition specifically present during tumorigenesis,
but not during normal cell physiology. We have
found, in collaboration with Scott Lowe here at the
Laboratory, that expression of oncogenic ras in pri-
mary human or rodent cells induces the accumulation
of p53 and p16 and results in a permanent G1 arrest.
The arrest induced by ras is accompanied by, and is
phenotypically indistinguishable from, cellular senes-
cence. The causal role of p53 and p16 in mediating
this protective response is implied by the fact that
cells derived from p16-deficient mice or from p53-
deficient mice are permissive to the presence of on-
cogenic ras, and, indeed, these cells become mor-
phologically transformed upon introduction of ras.
We propose that p16 and p53 act to prevent cellular
transformation by abnormal mitogenic stimuli such
as oncogenic ras. This experimental system will al-
low us to analyze the regulation of p16 expression
and to dissect the relevant stimuli that induce p16. An
additional implication of these results is that cellular
senescence can be prematurely activated and is there-
fore not simply a reflection of the accumulation of
cell divisions.
cdc25 Cell Cycle
Phosphatase as a
Target of c-myc
K. Galaktionov, X. Chen, D. Beach
The c-Myc proto-oncogene (Myc) belongs to a fam-
ily of related genes implicated in the control of
normal cell proliferation and the induction of neo-
plasia. More recently, Myc has been implicated in the
induction of apoptosis or programmed cell death.
Myc-induced apoptosis is enhanced by growth factor
deprivation, and the oncogenic-apoptotic switch is
sensitive to the level of mitogenic stimulation. Myc,
in partnership with Max, forms a transcription factor.
Myc activity in cell cycle progression and apoptosis
requires the presence of both intact trans-activation
and Max-binding domains. Few transcriptional tar-
gets of Myc have been identified. Recently, it has
been shown that induction of Myc in growth-factor-
depleted cells causes rapid activation of the cyclin
E/cdk2 kinase without alteration in the abundance of
cdk2 or cyclin E. In this situation, although cdk2 is
inactive, it is phosphorylated at the essential Thr-160
residue prior to Myc induction, suggesting that ac-
tivation of cdk2 may be mediated either by dephos-
phorylation of the Thr-14 or Tyr-15 residues or by
loss of protein inhibitors such as p21, p27, or p16.
These observations prompted us to evaluate whether
cell cycle activators such as cdc25 genes might serve
as direct transcriptional targets of Myc.
Using cells expressing estradiol-inducible mycER
fusion protein, we have shown an increase in the
level of cdc25A RNA and protein closely following
induction of mycER with b-estradiol. On the con-
trary, cdc25A was not induced by the nononcogenic
mutant (A 105-143) of Myc. To investigate whether
the regulation of cdc25 by Myc might be direct, we
utilized a modified precipitation assay to search for
Myc/Max-binding sites within genomic human
cdc25A, B, and C DNA clones. The cdc25A gene
contains three Myc/Max-binding sites within the first
two introns. One putative Myc-binding site was
found in cdc25B. These can direct Myc-dependent
transcription from a heterologous promoter. Sur-
prisingly, in the absence of adequate levels of growth
factors, introduction of cdc25A into a responsive cell
line causes apoptosis. Myc-driven apoptosis was in-
hibited by cdc25A antisense oligonucleotides, sug-
gesting that cdc25A expression might be essential for
apoptosis under these experimental conditions. Final-
ly, inhibition of cdc25A expression using the cdc25A
genetic suppressor element (GSE) expressed from a
retroviral vector also resulted in the inhibition of
Myc-driven apoptosis. These findings suggest that
cdc25A is a physiologically relevant transcriptional
target of c-Myc.
Identification of Protein
Ubiquitin Ligases Involved
in the Proteolytic Degradation
of Cdc25 in Mammalian Cells
M. Caligiuri, D. Beach
The Cdc25 phosphatases are potential human on-
cogenes whose levels are elevated in a large number
of breast cancers. Understanding the biochemical me-
chanism of their regulation is therefore of fundamen-
tal importance. Cdc25 has been shown to be ubi-
quitinated in both fission yeast and mammalian cells
(Nefsky and Beach 1996; T. Kim and D. Beach un-
publ.). Polyubiquitination involves three successive
reactions in which ubiquitin is activated by the ubi-
quitin activating enzyme, El, in an ATP-dependent
reaction and then transferred via a thiolester bond to a
ubiquitin conjugating enzyme (UBC), E2. The
molecule of ubiquitin is then transferred through a
thiolester intermediate involving a ubiquitin protein
ligase, E3, to a lysine residue on the target protein.
The ubiquitinated products are then degraded by the
26S proteosome. The specificity of the reaction is
thought to be rendered by the interaction between the
E3 enzyme and the target protein.
The fission yeast pub) gene has been shown to be
involved in the ubiquitination of Cdc25 (Nefsky and
Beach 1996). Pub 1 shares a high degree of amino
acid sequence similarity with E6-AP, the E3 involved
in the ubiquitination of the p53 tumor suppressor. We
have used the sequence of pub) to search the ex-
pressed sequence tag database to identify human
genes that have homology with the active site region
of the E3 enzymes. In this way, we identified five
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new genes encoding human protein ubiquitin ligases,
hpubl through hpub5. The sequences obtained from
the database were then used to clone the correspond-
ing cDNAs by hybridization. The proteins encoded
by two of these genes, hpubl and hpub2, share a high
degree of amino acid sequence homology with yeast
Publ and were chosen for further analysis. Whereas
the sequence conservation between Publ and E6-AP
is confined predominantly to the carboxy-terminal
third of the protein in the so-called "hect domain,"
that with hPubl and hPub2 extends about 100
residues toward the amino terminus. Interestingly,
this region has been shown to be involved in the in-
teraction between E6-AP and the E6 protein and may
thus define an interaction domain for the Pub pro-
teins.
Using whole-cell extracts prepared from He La
cells, we have shown that recombinant human
Cdc25A can be ubiquitinated in vitro in the presence
of an ATP regenerating system. This assay utilizes
biotinylated ubiquitin for the visualization of poly-
ubiquitinated products with horseradish-peroxidase-
conjugated streptavidin. Titration of the extract al-
lowed the lower limit of the reaction to be defined.
We performed the reaction with a limiting amount of
extract and found that the addition of recombinant
El, hPub2, and UBC4 restored the polyubiquitination
of Cdc25A. We found that although the extract could
not be completely omitted from the reaction, it could
be titrated to the level at which polyubiquitination of
Cdc25 was not detected in the absence of UBC4 and
hPub2. These results suggest that hPub2, UBC4, and
an as yet unidentified protein(s) are involved in the
degradation of Cdc25. We believe that phosphoryla-
tion of Cdc25 may precede its degradation and that
the extract is supplying the protein kinase responsible
for this modification.
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GENETICS IN ANIMAL CELLS
G. Hannon P. Dong
Historically, many complex biological problems have
surrendered first to attacks that are uniquely available
in genetically tractable organisms. For example,
Drosophila provided the first clues to the role of
homeodomain proteins in regulating pattern forma-
tion during development, and the yeasts played a crit-
ical part in unraveling the basic mechanics of cell
cycle control. However, many biological questions
are best addressed directly in mammalian cells in
which genetic approaches have generally been lack-
ing. Efforts during the past year have focused on the
development of technologies that will allow genetic
approaches to be used in animal cells.
The genetic system that we have developed is con-
ceptually modeled upon the genetic techniques that
are available in yeast. These include (1) the ability to
deliver complex gene libraries, (2) the ability to dis-
tinguish those phenotypes that are created upon the
delivery of a specific gene from phenotypic variants
(revertants) that preexist in a cell population, (3) the
ability to efficiently recover genes from a phenotypi-
cally selected cell, and (4) the ability to reintroduce
recovered genes into cells to confirm their ability to
elicit a phenotype.
The design of the system had to compensate for
the unique difficulties of manipulating animal cells in
culture. Two major barriers have hindered past at-
tempts at genetics in animal cells. The first was the
inability to manipulate animal cells to create mutants.
Unlike yeast, animal cells do not offer the opportun-
ity of working with a haploid form, and unlike Dro-
sophila and Caenorhabditis elegans, crosses cannot
be used to create homozygous mutations in conveni-
ent genetic backgrounds. Therefore, the phenotypes
that are available in animal cells tend to be less
"tight" (i.e., to have a higher reversion rate) than
those that are available in a well-constructed yeast or
Drosophila mutant. The second problem was one of
mass. Although it is relatively straightforward to ana-
lyze a very large number of yeast cells, the ability to
screen animal cells is more limited.
A number of criteria had to be met to overcome
these problems. The efficiency of gene transfer into
animal cells had to be extremely high in order to al-
low the screening of high-complexity libraries with-
out the need to maintain impossibly large numbers of
cells. This criterion was met by the use of a retroviral
gene delivery system which could achieve rates of
stable gene transfer that routinely ranged from 10%
to 100%. Since retroviral gene transfer results in the
integration of a gene (provirus) into the host genome,
a mechanism to distinguish revertants from true
phenotypic rescues had to allow removal of the
provirus from the genome. This was accomplished by
the inclusion of recombinase target sites that flank
the integrated provirus. Thus, delivery of a recom-
binase to the genomic DNA in vivo allows excision
of the provirus which is lost from a proliferating cell
population by dilution. The excised provirus was
constructed to contain both a selectable marker and a
bacterial origin of replication. In this way, the ex-
cised virus could be recovered as a plasmid in bac-
teria. The design of the vector allows the excised
provirus to be used directly for the production of
retroviruses (in a retroviral packaging cell line that
we have constructed) for subsequent rounds of
screening.
Variations of our vectors have been designed both
for the delivery of sense expression libraries and for
the delivery of antisense fragment libraries. Both of
these vector configuations have been validated
through model genetic screens in which they per-
formed quite well. The genetic system is now being
applied to aspects of cellular growth control (such as
the control of cellular mortality) that have proven in-
tractable with conventional approaches.
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CELL CYCLE CONTROL IN SACCHAROMYCES CEREVISIAE
B. Futcher J. Donovan G. Sherlock
B. Elliott B. Steiner
K. Hidaka T. Volpe
M. Lessard H. Wijnen
B. Schneider
Our main interest continues to be the regulation of
Start and mitosis in S. cerevisae. We are most inter-
ested in the tethering of division to cell growth and in
the generation of the basic cell cycle oscillation. Many
key cell cycle events are regulated by protein kinase
complexes formed between Cdc28 and one of nine
cyclins. These fall into two broad groups: the G,
cyclins (Clnl, Cln2, and Cln3) that regulate Start and
the mitotic B-type cyclins (Clb 1, C1b2, Clb3, and
Clb4). Two other cyclins, C1b5 and C1b6, not only are
very important for DNA replication, but also have
roles at Start and perhaps also in early mitosis.
A second interest is yeast telomerase. We have
found telomerase activity in yeast and found that a
protein called Estl is associated with the activity. Last
year, we found a protein called Bdfl that binds to Estl
and affects telomere length and telomeric silencing.
We also found many mutants affecting yeast
telomeres.
Proteins Interacting with
the Mitotic Cyclins C1b2,
C1b3, and C1b5
J. Donovan
Two-hybrid screens have been done with the mitotic
cyclins C1b2, C1b3, and C1b5 to find interacting
proteins. A number of proteins have been found and
are being evaluated by other tests. These interacting
proteins may help control S phase and mitosis.
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Critical Thresholds of
G1 Cyclins for Start
B. Schneider
We are interested in knowing how much G, cyclin is
required for Start. Is Or will a
small amount suffice if given long enough to work?
As a first step, we constructed a strain with genotype
clnl cln2 cln3 GAL-CLN1 gall. In this strain, very
small amounts of galactose can be used to turn on the
GAL -CLNI construct, and the amount of expression is
proportional to the amount of galactose used. With
this titratable promoter system, we find that at certain
low levels of Cln expression, cells do not go through
Start even after many hours, whereas at slightly higher
levels of expression, Start occurs efficiently. This
strongly supports critical threshold models. An addi-
tional finding is that the critical threshold is much
lower in larger cells than in smaller cells. Thus, the
critical size threshold for Start may have two com-
ponents: First, as cells become larger, they express
more Cln, and second, as cells become larger, they re-
quire less Cln to pass through Start. The threshold
may decrease with increased size partly because the
amount of Sicl, a target of Cln-Cdc28 complexes,
decreases in abundance as G, progresses.
We have also investigated the relationship between
growth rate and Cln expression. Because Clns are un-
stable proteins, their steady-state abundance should
reflect their rate of synthesis, and thus there might be
less Cln at low growth rates. Analysis of cells grow-
ing at different rates shows that there is in fact a very
large difference, tenfold or more, in the amount of
CIn at different growth rates. For Start, slowly grow-
ing cells need much less CIn than do rapidly growing
cells. It seems that the threshold requirement for Cln
is quite variable under different conditions. We do
not yet understand the nature of the threshold, or why
it varies.
Substrates of Cdc28
G. Sherlock
We have done a computer screen of the S. cerevisiae
genome to find proteins with multiple clustered con-
sensus sites for Cdc28 phosphorylation. Many of the
proteins found in this screen are known to have a role
in the cell cycle. We are mutating the sites in some of
these proteins to see if there is a phenotype. So far,
we have examined site mutants in Cin8, a kinesin-
like motor protein; Chs2, a chitin synthase; and in a
number of proteins involved in DNA replication. The
DNA replication proteins include Orc2, Orc6, Cdc6,
Mcm3, and Cdc54 (which encodes an Mcm protein).
Some of the replication protein site mutants dramati-
cally decrease the efficiency of origin usage, and
some combinations of site mutants are lethal. This is
consistent with the idea that phosphorylation of these
sites, possibly by Cdc28, is important for regulation
of DNA synthesis.
In the future, we will see whether the observed
phenotypes are indeed due to a lack of phosphoryla-
tion or to other defects associated with the amino acid
change.
Analysis of WHI3,
a New Size Control
Gene
T. Volpe
The whi3 mutation was isolated some years ago, and
we are continuing its characterization. It contains an
RNA-binding motif, but otherwise has little similarity
to other proteins. Like other whi mutants, it gives a
small-cell phenotype. This seems to be because whi3
mutants overexpress CLNI and CLN2 G1 cyclins.
Overexpression of WHI3 turns off CLNI and CLN2
and is lethal. However, the level at which Whi3 inter-
feres with CLN expression is still unclear. Although
GAL-WHI3 does turn off CLNI and CLN2 expression
from their own promoters, it does not interfere with
CLNI or CLN2 expression from a GAL promoter.
Even so, neither GAL -CLNI nor GAL-CLN2 rescues
the lethality of GAL-WHI3. We examined the kinase
activity associated with CLN2 in a GAL-WI-113 strain
and found that it had an unusual array of substrate
proteins associated with it. A change in the CIn -
Cdc28 kinase complex may be the reason for the ef-
fects of GAL-WI-113. Whi3 may be used by the cell to
direct Cln-Cdc28 kinase to different targets. Some of
these may be involved in pseudohyphal growth, since
G. Fink and co-workers (pers. comm.) have found
that whi3 mutants are defective in pseudohyphal
growth.
Mechanisms of Transcriptional
Activation by Cyclin-Cdc28
Complexes
H. Wijnen
One effect of the Cln3-Cdc28 complex-perhaps the
only effect-is to induce transcription of a large fam-
ily of genes involved in the Gt /S transition. These in-
clude CLNI, CLN2, CLB5, CLB6, RNRI, and many
genes involved in DNA synthesis and cell wall
synthesis. We are trying to discover the mechanism
of induction. The promoters of the CLN3-inducible
genes all include binding sites for the Swi4 transcrip-
tion factor or for its close relative Mbpl. The Swi4
and Mbpl DNA-binding proteins each form a com-
plex with another protein called Swi6; these two
complexes are called the SBF or MBF transcription
factors, respectively. We have found that swi6
mutants are completely defective for CLN3-induced
transcription, and this argues that Swi6 is the direct
or indirect target for Cln3.
There are three ideas for how C1n3 might activate
Swi6 for transcription. First, Cln3-Cdc28 might
phosphorylate Swi6, which has several Cdc28 con-
sensus sites. This does not seem to be the case, be-
cause mutants of Swi6 lacking all Cdc28 sites have
no phenotype. Second, Cln3-Cdc28 might bind to
Swi6 and then, while bound, activate transcription by
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phosphorylating other molecules. So far, we have not
been able to detect Cln3-Swi6 interaction in im-
munoprecipitation experiments. Finally, Cln3-Cdc28
might phosphorylate and activate an activator of
Swi6 or it might phosphorylate and inhibit an in-
hibitor.
We have looked for high-copy suppressors of
mutants expressing very low levels of CLN3 to
screen for activators of Swi6. This screen has yielded
Phdl, a Swi6-like transcription factor, and Rmel,
which can activate transcription of CLN2, and a num-
ber of other genes, some of which may function as
co-activators of Swi6 with Cln3. Other genetic
screens are in progress to identify inhibitors of Swi6.
Telomerase
K. Hidaka, B. Steiner, M. Lessard
Last year, we showed that the Esti (Ever shorter
telomeres) protein was associated with telomerase ac-
tivity and with the yeast telomerase RNA.
To find other components of telomerase, we did a
two-hybrid screen with Estl that yielded 17 different
genes, most of which seem uninteresting. However,
one of the interactors, Bdfl, has telomere-related
phenotypes. Bdfl is a bromodomain protein and so
may be a component of chromatin. The bdfl mutant
has short telomeres and is defective in telomeric
silencing, but not defective in silencing at HML or
HMR. There is preliminary evidence of Bdfl-Estl in-
teraction in immunoprecipitation experiments. Al-
though Bdfl is not likely to be a catalytic component
of telomerase, it could help direct telomerase to the
chromosome ends or help regulate it in some way.
We have also screened for new mutants defective
in telomere addition and telomere maintenance.
Several hundred candidate mutants were obtained,
and several dozen of these show senescence. At least
some of these also show the continuous telomere
shortening phenotype of estl . These are now being
placed into complementation groups.
Finally, we have started a three-hybrid screen for
proteins interacting with the telomerase RNA. Im-
provements have been made to the three-hybrid
screen to improve specificity, and a number of inter-
esting proteins have been found that interact with
telomerase RNA, but not with control RNAs. These
are being tested as telomerase components.
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Cell Cycle Exit and
Stress Resistance
B. Elliott
Previously, we identified TPS2, which encodes
trehalose-6-phosphate phosphatase, as a gene needed
for stress resistance in yeast. Yeast are known to ac-
cumulate trehalose in response to stress, but it has
been controversial whether or not the trehalose is a
cause or an effect of the stress-resistant state. Our
tps2 mutant is stress-sensitive and accumulates much
less trehalose than a wild-type cell, but it also ac-
cumulates trehalose-6-phosphate (tre-6-P). Sugar
phosphates are often toxic, and tre-6-P is known to be
an inhibitor of glycolysis. Therefore, we considered
the possibility that the stress sensitivity of the tps2
mutant was due to accumulation of tre-6-P. We com-
pared tpsl mutants (which are defective in the first
step of trehalose synthesis and do not make tre-6-P)
with tpsl mutants and tpsl tps2 double mutants. All
three were stress-sensitive, but the tps2 single mutant
was significantly more sensitive than the other two.
Furthermore, a novel gene isolated as a partial sup-
pressor of tps2 encodes a phosphomutase, and par-
tially converts tre-6-P into trehalose. These results
suggest that while part of the stress sensitivity of tps2
is due to the accumulation of tre-6-P, another part is
genuinely due to the lack of trehalose. Thus, we be-
lieve trehalose is a stress-protectant.
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REGULATION OF GROWTH AND CELL CYCLE
COMMITMENT IN BUDDING YEAST
K.T. Arndt C.J. Di Como B. Guo
M. Luke C. Blegen
F. Della Seta
Our research mostly focuses on how growth signals
cause cells to grow and enter the cell division cycle.
For most eukaryotic cells, it is during Gt that deci-
sions are made as to whether or not to divide. For our
studies, we use the model organism Saccharomyces
cerevisiae, which is commonly called budding yeast.
Budding yeast cells that have executed the late Gt
event(s) termed Start are committed to initiate DNA
synthesis, form a bud, and divide. Start is the point
where growth signals and mating pheromones control
entry into the cell division cycle. The execution of
Start seems to require some threshold level of Gt
cyclin/CDC28 kinase activity, which is deterimined in
large part by the rate and levels at which the Gt
cyclin RNAs accumulate during late G1. However,
very little is known about the mechanisms that
determine if G1 cyclin RNAs accumulate and the rate
at which G1 cyclin RNAs accumulate.
Many cell cycle events are controlled by the
regulation of the phosphorylation of certain key pro-
teins. Protein phosphatases are proteins that remove
phosphate groups from phosphoserine, phosphothreo-
nine, or phosphotyrosine residues in other proteins. In
many cases, removal of the phosphate activates the
protein substrate. In other cases, removal of the
phosphate inactivates the protein substrate. Most of
our effort is focused on the SIT4 phosphatase. We
have found that SIT4, which is a type-2A-related
phosphatase, is required during G, for the execution
of Start, for bud formation, for the initiation of DNA
synthesis, and for spindle pole body duplication.
SIT4 is required for the execution of Start because it
is required for the expression of the CLN1 and CLN2
G5 cyclin genes. CLN1 and CLN2 proteins bind to
CDC28, thereby activating the kinase activity of
CDC28. When some threshold level of CLN/CDC28
kinase activity is achieved, Start is executed and the
cells are committed for DNA synthesis and the com-
pletion of the cell cycle. Our major goals are to
determine how growth signals control the ability of
SIT4 to promote Start and bud initiation and to
determine the downstream targets of SIT4 that func-
tion for Start and bud initiation.
Function and Regulation of
the SIT4 Phosphatase
during the Cell Cycle
F. Della Seta, M. Luke, C. J. Di Como,
R. Kobayashi, K.T. Arndt
SIT4 is a protein phosphatase catalytic subunit whose
levels are constant throughout the cell cycle. There-
fore, the activity of SIT4 might be regulated in the
cell cycle by association with regulatory subunits. In
Gt daughter cells, SIT4 exists mostly as monomeric
uncomplexed SIT4. During late Gt, at a time close to
Start (when SIT4 is required for Gt cyclin expres-
sion), SIT4 associates in separate complexes with
three high-molecular-mass phosphoproteins, termed
SAP155, SAP185, and SAP190 (Sit4-associated
protein, apparent mass in kilodaltons). Near or just
after mitosis, SIT4 is again found primarily as
monomeric uncomplexed SIT4.
SAP155 and SAP190 were purified, and R. Koba-
yashi obtained partial peptide sequences for both
proteins. This information was used to clone the
SAP155 and SAP190 genes. The predicted SAP155
and SAP190 proteins show no significant homology
with other proteins in the current databases. How-
ever, SAP155 and SAP190 are homologous to each
other, with about 30% identical amino acids over the
entire lengths of the proteins. Moreover, we also
identified two additional SAP genes in budding yeast
by homology: SAP185 from the budding yeast
genome project and another SAP gene by polymerase
chain reaction (PCR) using degenerate primers. We
have shown that SAP185 encodes a 185-kD protein
that associates with SIT4. We currently do not know
if SAP4 associates with SIT4, although we suspect
that it does. All four SAPs are acidic.
With the SAP genes in hand, we could determine if
the SAPs function positively with SIT4 (and turn
SIT4 on near Start) or if they function negatively
with SIT4 (and turn SIT4 off near Start). Three lines
of evidence show that the SAPs function positively
with SIT4. First, all four SAP genes in high copy
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number suppress the temperature-sensitive phenotype
of sit4-102 strains. Second, the phenotypic effects
due to the loss of all four SAP genes are identical to
the loss of SIT4. Third, in terms of the genetic inter-
actions with deletion of CLN3, BEM2, SIS2, or
PH085, the loss of the SAPs is the same as the loss
of SIT4. These findings indicate that the SAPs are re-
quired for SIT4's cellular function. The loss of the
SAPs is not at all similar to the effects due to over-
expression of SIT4.
By sequence similarity, the SAPs fall into two
groups: the SAP4/SAP155 group and the SAP185/
SAP190 group. The effects due to deletion of various
combinations of the SAP genes show that this se-
quence similarity is also a functional grouping of the
SAPs. Further analysis shows that the SAPs (and
hence SIT4 also) are providing two functions: one
function provided by SAP185 and SAP190 and an-
other function provided by SAP155 (perhaps along
with SAP4). Deletion of SAP185 by itself or deletion
of SAP190 by itself causes no decrease in the growth
rate of the cells. However, deletion of both SAPI 85
and SAP190 causes a slow growth rate phenotype.
Importantly, although either SAP185 or SAP190 on
either a low-copy-number cen plasmid or a high-
copy-number plasmid restored the growth rate of a
Asap185 Asap190 strain to wild type, neither SAP4
nor SAP155 could stimulate the growth rate of this
strain. Therefore, SAP155, even when overexpressed,
cannot provide the function provided by SAP185/
SAP190. In addition, the overexpression of SAP185
or SAP190 cannot stimulate the slow growth rate of
Asap155 strains. Therefore, the SAPs are providing at
least two cellular functions.
We have prepared antibodies that specifically
recognize SAP155, SAP185, or SAP190. With the
tools (antibodies and mutations in the genes) to ana-
lyze SAP155 and SAP190 in hand, we can now ad-
dress the following important questions. Do SAP155
and SAP190 regulate, positively or negatively, the
activity of SIT4 toward its in vivo substrates? Are
SAP155 and SAP190 substrates of SIT4? Interesting-
ly, SAP155, SAP185, and SAP190 become hyper-
phosphorylated in the absence of SIT4 function. How
is the association of SIT4 with SAP155, SAP185, and
SAP190 regulated? Via phosphorylation of the
SAPs? How do growth signals and cell cycle signals
regulate the association of SAP155 and SAP190 with
SIT4? We have found that the amount of the SAPs
that are associated with SIT4 is regulated not only by
cell cycle position, but also by cellular growth sig-
nals: by carbon source (glycerol/ethanol versus
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glucose), by the presence or absence of amino acids
in the growth medium, and during saturation of the
cultures. Possibly, the SAPs are involved in transduc-
ing nutrient growth signals via their association with
SIT4, thereby linking nutrient growth signals with G1
cyclin expression, bud formation, and other late G,
processes. The elucidation of such a signal transduc-
tion pathway will require the determination of how
the association of the SAPs with SIT4 is regulated
and what downstream processes are regulated by the
SAPs and SIT4.
SIT4 Is Required for G1
Cyclin Accumulation
K. Arndt, C.J. Di Como
SIT4 is required for the execution of Start because it
is required for the expression of the CLNI and CLN2
G1 cyclin genes. CLN1 and CLN2 proteins bind to
CDC28, thereby activating the kinase activity of
CDC28. When some threshold level of CLN/CDC28
kinase activity is achieved, Start is executed. During
early G1, the levels of CLNI and CLN2 RNAs are
very low. During late G1, the levels of CLNI and
CLN2 RNAs increase at a very rapid rate. The rate at
which CLNI and CLN2 RNAs increase is determined
in part by the activity of the CLN3 gene, which en-
codes a cyclin-like protein. Hyperactive alleles of
CLN3 cause a more rapid rate of increase of CLNI
and CLN2 RNA levels, whereas loss-of-function al-
leles of CLN3 cause a slower rate of increase.
Much evidence shows that CLN3 and SIT4 provide
additive pathways for the activation of CLNI and
CLN2 expression. In fact, mutation of both SIT4 and
CLN3 causes an essentially lethal effect. Moreover,
this lethal effect is due only to a defect in G1 cyclin
expression because it is completely cured by expres-
sion of CLN2 from a SIT4- independent promoter.
Like a sit4 mutation, a mutation in any gene required
in the SIT4 pathway for GI cyclin expression should
also be lethal in combination with a cln3 mutation.
We used the colony sectoring assay to isolate 400
mutants that could not grow in the absence of CLN3.
These mutants, termed ctr for CLN three requiring,
fell into 12 complementation groups. Previously, we
had analyzed CTR7 in the most depth. The CTR7
gene is the same gene as BCK2, which was originally
isolated as a gene that in high copy number can sup-
press the temperature-sensitive cell lysis defect of
mutations in the protein kinase C pathway. Our anal-
ysis had shown that BCK2 and CLN3 function in
pathways parallel to CLN1 and CLN2 G1 cyclin ex-
pression.
During the last year, we have focused on CTR9.
Cells lacking CTR9 are viable, but they grow slowly
at 30°C and are not able to grow at 37°C. Moreover,
at 30°C, the ctr9 mutants have a very strong defect in
the ability to accumulate CLN1 and CLN2 Gt cyclin
RNA in G1. Importantly, the slow growth rate of ctr9
mutants is dramatically stimulated to near wild-type
rates by expression of CLN2 protein from the ADH
promoter or the CLN1 protein from the GALL pro-
moter. Therefore, a primary defect in ctr9 mutants is
the inability to accumulate G, cyclins. Interestingly,
CTR9 has 33-amino-acid TPR repeats and is highly
similar to a mouse protein that interacts with SH2
domains. We suggest that CTR9 functions in a signal
transduction pathway leading to Gt cyclin expression
during Gt.
TAP42: An Essential 42-kD Protein
That Interacts with Both SIT4 and
the Type-2A Catalytic Subunits
C.J. Di Como, K.T. Arndt
To identify cellular substrates and/or regulatory sub-
units of SIT4, we isolated genes that, when present
on a high-copy-number plasmid, suppress the temper-
ature-sensitive phenotype of a sit4-102 mutant. From
this scheme, we isolated three genes. One gene is
SAP155, which encodes the 155-kD subunit of SIT4
(see above). High-copy-number SAP190 also sup-
presses the sit4 mutant, but we did not isolate
SAP190 from this screen because SAP190 is not pres-
ent in the high-copy-number library. The second gene
is HCS26. HCS26 encodes a Gt cyclin that binds not
to CDC28, but to the CDC28-related kinase PH085.
Other cyclins (CLN1, CLN2, ORFD, and CLB5) in
high copy number are not able to rescue the tem-
perature-sensitive phenotype of the sit4 mutant. In
addition, suppression of the sit4-102 strain by over-
expression of HCS26 requires PH085, suggesting
that an increase in the HCS26/PH085 kinase activity
is required. We have two models for the reason over-
expression of HCS26 does suppress, while over-
expression of CLN2 does not suppress, the sit4-102
mutant. In model 1, the HCS26/PH085 kinase can
phosphorylate substrates that CLN2/CDC28 cannot.
In model 2, the HCS26/PH085 kinase does not re-
quire SIT4 and the CLN2/CDC28 kinase does require
SIT4.
The third gene is a previously unidentified gene
which we term TAP42 (for two A phosphatase asso-
ciated protein) because it encodes a 42-kD protein
that associates with both SIT4 and the type-2A
catalytic subunit (we also isolated TAP42 as a gene
that in high copy number suppressed the temperature-
sensitive phenotype of a temperature-sensitive pp2a
mutant; see below). The TAP42 protein has similarity
to the mouse a4 protein, which becomes phosphory-
lated in response to activation of the T-cell receptor.
The budding yeast TAP42 gene is essential, and
germinating ADtap42 cells arrest as four to eight un-
budded cells. Immunofluorescence microscopy was
used to show that TAP42 is enriched in the nucleus,
but it is also present in the cytoplasm.
The association of TAP42 with SIT4 does not re-
quire the SAP proteins. Moreover, we have not been
able to find any TAP42 in SAP immunoprecipitates.
These findings show that TAP42/SIT4 complexes are
distinct from SAP/SIT4 complexes. In addition, asso-
ciation of TAP42 with PPH21 or PPH22 (the type-2A
PPase catalytic subunits) does not require TPD3 (an
A-like subunit) or CDC55 (a B-like subunit). Togeth-
er, these findings indicate that TAP42 interacts with
the catalytic subunit of SIT4 (a type-2A-related
PPase) and with the type-2A catalytic subunits and
that this interaction does not require any of the
known phosphatase subunits. Moreover, this TAP42
interaction is specific to these phosphatases because
TAP42 does not coimmunoprecipitate with the type-1
phosphatase catalytic subunit.
Genetic interactions and in vivo tests indicate that
TAP42 functions positively with SIT4 and with the
two PP2A catalytic subunits. We propose that the
TAP42/phosphatase interactions result in a new ac-
tivity, which is not present in TAP42 by itself and in
SIT4 or the PP2A catalytic subunits by themselves.
Possibly, TAP42 might direct the phosphatases to
dephosphorylate particular substrates.
Because rapamycin arrests cells in late G1, and
temperature-sensitive sit4 mutants arrest in late Gt,
we have been interested in a possible connection be-
tween SIT4 and the signaling pathway (TOR1/TOR2)
that is inhibited by rapamycin. Interestingly, similar
to the TOR mutants that give rapamycin resistance,
we have found that certain mutations in tap42 give
almost complete resistance to rapamycin. Moreover,
the interaction of TAP42 with the phosphatase
catalytic subunits is downstream from the TORI/
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TOR2 signaling pathway. Addition of rapamycin to
cells rapidly causes the dissociation of TAP42 from
SIT4 (but it does not decrease the association of
SAP155 or SAP190 with SIT4) and the dissociation
of TAP42 from the PP2A catalytic subunits (but it
does not dissociate TPD3 [A] and CDC55 [B] sub-
units from the type-2A catalytic subunit). This effect
is not a cell cycle position effect: The cells can be ar-
rested with hydroxyurea or nocodazole, and rapamy-
cin still rapidly dissociates TAP42 from SIT4 and the
PP2A catalytic subunits. Therefore, Tor function is
actively required to drive the association of TAP with
the PPases. Moreover, when the dominant rapamy-
cin-resistant TOR2R gene is present, addition of
rapamycin has no effect on the association of TAP42
with SIT4. This suggests that TOR function is needed
to cause the association of TAP42 with SIT4 and that
the TAP42/SIT4 interaction is a downstream process
in TOR signaling. Importantly, TAP42 dissociates
from the phosphatases when the cells reach stationary
phase. When stationary-phase cells are refed nutrient
growth signals (by diluting the cells into fresh me-
dium), TAP42 rapidly associates with SIT4 and with
the type-2A catalytic subunits. This association
precedes entry into S phase. Importantly, this growth-
signal-dependent association of TAP42 with the
PPases is prevented by rapamycin. In addition,
temperature-sensitive tap42 mutants have a strong
defect in the initiation of translation that appears to
be identical to that caused by the addition of rapamy-
cin. In addition, like the addition of rapamycin, loss
of TAP42 function results in the hyperaccumulation
of glycogen. In summary, TAP42/phos-phatase com-
plexes are part of the TOR signaling pathway, and
their formation is dependent on nutrient growth sig-
nals (Fig. 1). Future experiments will be directed at
further elucidation of the TAP42/phosphatase inter-
action for cell cycle progression.
Regulation of the HOG1
Stress-activated MAP
Kinase Pathway by TAP42
B. Guo, K.T. Arndt
To understand further how TAP42 functions, we used
the yeast 2-hybrid screen to identify TAP42-inter-
acting proteins. From our screen, we isolated 2A
phosphatase catalytic subunits (as expected) and two
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FIGURE 1 Model for TAP42 function.
additional genes. One was a novel 41-kD protein of
unknown function whose analysis is in progress. The
second TAP42-interacting gene was SSK2, which en-
codes a MAP kinase kinase kinase for the HOG1
pathway. The HOG1 pathway is required for rapid
adaptation to salt stress. Cells lacking HOG1 die
when osmotically stressed.
Interestingly, TAP42 interacts with the kinase
domain of SSK2. Temperature-sensitive tap42 strains
cannot activate the HOG1 MAP kinase at the non-
permissive temperature. Moreover, we have isolated
tap42 strains that are only salt-sensitive (i.e., they are
not temperature-sensitive and they grow normally at
30°C). These strains have a defect in the ability to ac-
tivate the HOG1 MAP kinase by salt stress. We used
the 2-hybrid system to show that one of the salt-
sensitive tap42 alleles encodes a TAP42 protein that
no longer interacts with SSK2. Therefore, at least one
function of TAP42 is to activate the HOG1 MAP
kinase via interaction with SSK2. Interestingly, addi-
tion of rapamycin rapidly causes the HOG1 MAP
kinase to be inactive. Possibly. TAP42/phosphatase
complexes link nutrient growth signals to the ability
of the HOG1 MAP kinase pathway to be activated by
salt stress.
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INITIATION AND TERMINATION OF TRANSCRIPTION IN HUMAN
snRNA GENES AND HIV-1
N. Hernandez T.L. Calhoun R. Mital F.C. Pessler
E. Ford V. Mittal C.L. Sadowski
R.W. Henry D.J. Morrison S. Sepehri
B. Ma P.S. Pendergrast M.-W. Wong
The human small nuclear RNA (snRNA) gene family
contains both RNA polymerase-II-transcribed and
RNA polymerase-III-transcribed genes. Yet, all
snRNA genes have very similar promoters, suggest-
ing that any difference may be important for the
determination of RNA polymerase specificity. The
RNA polymerase II snRNA promoters consist of a
proximal sequence element or PSE, which is suffi-
cient to direct basal levels of transcription in vitro,
and a distal sequence element of DSE, which en-
hances basal transcription. The RNA polymerase III
snRNA promoters contain, in addition, a TATA box
located downstream from the PSE, which works in
concert with the PSE to direct basal levels of RNA
polymerase III transcription. We know that it is the
presence of this TATA box that, in the context of the
human snRNA promoters, determines RNA polymer-
ase III specificity. Deletion of the TATA box in RNA
polymerase III promoters causes a switch to RNA
polymerase II transcription, whereas insertion of a
TATA box downstream from the PSE in an RNA
polymerase II snRNA promoter causes a switch to
RNA polymerase III transcription. We are interested
in identifying the factors that recognize the snRNA
promoter elements and participate in the formation of
the initiation complex, and in comparing them with
the factors required for RNA polymerase II transcrip-
tion from mRNA promoters and RNA polymerase III
transcription from typical RNA polymerase III pro-
moters with gene internal elements.
The human immunodeficiency virus type 1 (HIV-
1) promoter directs the synthesis of two classes of
RNA molecules: short transcripts that end premature-
ly at around position +60, and full-length transcripts.
In the absence of the viral trans-activator Tat, most
of the RNA molecules derived from the HIV-1
promoter are short, whereas in the presence of Tat,
most of them are full-length. The role of the short
transcripts is not clear, but several hypotheses have
been put forward: In particular, because Tat is an un-
usual activator that binds to an RNA target contained
within the short transcripts, one possibility is that the
short transcripts are synthesized to provide binding
sites for Tat. Another possibility is that the short
transcripts themselves have no role but that the abor-
tive transcription process that produces them serves
to keep the HIV-1 promoter in an open position ac-
cessible to activators and thus immediately reponsive
to any transcriptional stimulus. We are interested in
understanding how the short transcripts are formed,
and what their function is.
Characterization of the SNAP45
Subunit of SNAP,
C.L. Sadowski, R.W. Henry, R. Kobayashi,
N. Hernandez
The RNA polymerase II and III snRNA promoters
both contain a DSE, which serves as an enhancer of
basal transcription. Basal transcription is directed by
the PSE in the RNA polymerase II snRNA promoters
and by a combination of a PSE and a TATA box in
the RNA polymerase Ill snRNA promoters. The PSE
is recognized by a multisubunit complex that we refer
to as the SNAP complex (SNAPc). SNAI)c is com-
posed of at least four subunits, SNAP43, SNAP45,
SNAP50, and SNAP190, and associates with TBP.
We have previously isolated a cDNA corresponding
to the SNAP43 subunit. We have now isolated
cDNAs corresponding to the SNAP45 subunit, as
well as to the SNAP50 and SNAP190 subunits (see
below). The SNAP45 cDNA encodes a proline-rich
334-amino-acid protein. SNAP45 is specifically co-
immunoprecipitated in nondenaturing immunoprecip-
itations from nuclear extracts performed with anti-
SNAP43 antibodies, and reciprocally SNAP43 is spe-
cifically coimmunoprecipitated with anti-SNAP45
antibodies. Thus, these two proteins are part of the
same complex, although they do not appear to inter-
act directly with each other as determined by GST
pull-down experiments. However, both proteins inter-
act directly with TBP.
Immunodepletions of extracts with anti-SNAP45
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antibodies inhibit both RNA polymerase II and III
transcription of snRNA genes, whereas transcription
from the RNA polymerase II adenovirus 2 major late
promoter and from the RNA polymerase III VA,
promoter is unaffected. Thus, a SNAP45-containing
SNAP complex appears to be required specifically
for transcription of genes that contain a PSE, regard-
less of the RNA polymerase involved.
Characterization of the SNAP50
Subunit of SNAP,
R.W. Henry, B. Ma, C.L. Sadowski,
R. Kobayashi, N. Hernandez
We have recently isolated a full-length cDNA clone
corresponding to the 50-kD subunit of SNAP The
open reading frame predicts a 411-amino-acid se-
quence that contains two putative zinc-binding
domains. Depletion of extracts with anti-SNAP50
antibodies inhibits both RNA polymerase II and III
transcription of snRNA genes. Together with our pre-
vious results, this observation suggests that if two dif-
ferent SNAP complexes are required for RNA
polymerase H and III transcription from snRNA
promoters, they both contain the SNAP43, SNAP45,
and SNAP50 subunits. In-vitro-translated SNAP50
can be coimmunoprecipitated with in-vitro-translated
SNAP43, suggesting that these two subunits interact
with each other within the SNAP complex. UV cross-
linking experiments suggest that SNAP50 contacts
the DNA within the SNAP complex. Like recom-
binant SNAP43 and SNAP45, however, recombinant
SNAP50 cannot bind specifically to the PSE, sug-
gesting that the largest SNAI)c subunit is the DNA-
binding subunit of the complex.
Characterization of
the SNAP190
Subunit of SNAP,
M.-W. Wong, R.W. Henry, R. Kobayashi,
N. Hernandez
We obtained enough SNAP190 protein for micro-
sequencing and used the protein sequence informa-
tion to design degenerate oligonucleotides for PCR.
We obtained a probe, and by a combination of library
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screening and PCR, we have isolated a full-length
cDNA clone. SNAP190 is the DNA-binding subunit
of the SNAP complex, and we are analyzing how this
subunit recognizes the PSE.
Characterization of TFIIIB
R. Mital, R. Kobayashi, N. Hernandez
Typical RNA polymerase III promoters with gene in-
ternal elements recruit first TFIIIA and/or TFIIIC,
which can bind the DNA directly. This in turn allows
the recruitment of TFIIIB, which cannot bind to the
promoter on its own. TFIIIB is an essential RNA
polymerase III transcription factor in that it is thought
to contact and recruit RNA polymerase III directly. In
yeast, TFIIIB consists of three subunits: TBP and
BRFI, which are tightly associated, and the TFC5
gene product, which is more loosely associated with
the complex. In mammalian systems, however, the
composition of TFIIIB is less clear, although we have
shown before that the activity can be split biochemi-
cally into two fractions, one of which contains a TBP
complex. We have purified the TBP-containing com-
plex and shown that it consists of TBP and one asso-
ciated protein of 88 kD. The 88-kD protein was sub-
jected to microsequencing, and the protein sequence
information was used to design degenerate oligonu-
cleotides for PCR. A specific PCR probe was ob-
tained, which was then used to isolate a partial cDNA
clone. A full-length clone was then obtained by 5'
RACE. The predicted protein sequence reveals that
the 88-kD polypeptide corresponds to the human
homolog of yeast BRFI. Human BRF (hBRF) proba-
bly corresponds to TFIIIB90, a protein cloned by
R.G. Roeder and colleagues, although its predicted
amino acid sequence differs over a stretch of 67
amino acids from that reported for TFIIIB90 due to a
change of reading frame. Because these 67 amino
acids contain matches to two of our peptide se-
quences, we are confident that our sequence cor-
responds to the protein we purified.
We raised antipeptide antibodies against peptides
derived from various parts of the protein and used
these antibodies to examine the role of hBRF, if any,
in RNA polymerase III transcription from the human
U6 promoter. Some of our earlier results had sug-
gested that the TBP-containing complex contained in
the TFIIIB fraction might not be required for U6 tran-
scription. Indeed, we find that depletion of nuclear
extracts with anti-hBRF antibodies inhibited tran-
scription from the VA, promoter, a typical RNA
polymerase III promoter with gene-internal elements,
but had no effect on transcription from the U6
promoter. Furthermore, depletion with a mixture of
anti-TBP and anti-hBRF antibodies inhibited RNA
polymerase III transcription from both the VA, and
U6 promoters. However, whereas VA, transcription
was then restored only by addition of both recom-
binant TBP and hBRF, transcription from the U6
promoter could be reconstituted to higher than start-
ing levels by addition of just recombinant TBP. To-
gether, these results suggest that the TBP-hBRF com-
plex is not required for U6 transcription. It remains
possible that hBRF functions in U6 transcription in a
form that is not recognized by our antibodies, for ex-
ample, as part of another complex. This other com-
plex would then represent, however, a very small per-
centage of the total hBRF present in nuclear extracts,
as the depletions removed more than 98% of the
hBRF present in the extract, as judged from im-
munoblots.
The POU Domain
Potentiates the Binding
of the SNAP Complex
V. Mittel, M. Cleary, W. Herr, N. Hernandez
The DSE of the RNA polymerase II and III snRNA
promoters is characterized by the presence of an oc-
tamer motif which can recruit the transcription factor
Oct-1. Oct-1 is a POU domain protein whose DNA-
binding domain consists of a POU-homeo (POUH)
domain and a POU-specific (POUs) domain joined
by a flexible linker. On a probe containing an oc-
tamer motif and a PSE, the Oct-1 POU domain binds
cooperatively with SNAPC. The POU domain of the
pituitary transcription factor Pit-1, in contrast, does
not have this property. We used this observation to
test a number of Oct-1/Pit-1 POU domain chimeric
proteins for their ability to recruit SNAPc to the PSE.
We found that only chimeric proteins containing the
amino-terminal part of the Oct-1 POUs domain were
active. Further mutagenesis showed that exchange of
the glutamic acid at position 7 in the Oct-1 POUs
domain for its Pit-1 counterpart, an aspartic acid, in-
activated the ability of the Oct-1 POU domain to
recruit SNAPc to the PSE. Reciprocally, substituting
the arginine at position 7 in the Pit-1 POUs domain
with the glutamic acid present at the corresponding
position in the Oct-1 POUs domain imparted onto
Pit-1 the ability to recruit SNAPC. The abilities of
wild-type and mutant POU domains to enhance
snRNA gene transcription in vitro correlated directly
with their abilities to recruit SNAPc to the PSE.
These data suggest that the DNA-binding domain of
the Oct-1 activator contributes to transcription activa-
tion by recruiting SNAPc to low-affinity PSEs.
Characterization of the
Cooperative Binding of
Oct-1 and SNAP, to the DNA
E. Ford, N. Hernandez
The POU domain of the Oct-1 transcription factor
can recruit SNAPc to the PSE and activate snRNA
gene transcription in vitro. Yet, in vivo, Oct-1
domains outside of the POU domain activate snRNA
gene transcription. How do these domains function?
One possibility is that they simply increase recruit-
ment of SNAPc by the POU domain. To test this pos-
sibility, we compared full-length Oct-1 and the Oct-1
POU domain for their ability to recruit SNAPc to the
PSE. Although full-length Oct-1 was slightly more
active than the POU domain, the difference was small
and is therefore unlikely to account for the effect ob-
served in vivo. This suggests that activation by Oct-1
involves at least two steps: recruitment of SNAPc to
the PSE, and another step performed by Oct-1
domains outside of the POU domain.
We have characterized a PSE-binding complex
present in nuclear extracts, which we can detect by
electrophoretic mobility shift assay. This complex
contains both SNAPc and Oct-1, even though Oct-1
on its own cannot bind to the probe. Thus, SNAPc
can recruit Oct-1 to a probe which does not contain
an Oct-l-binding site. Nevertheless, we could not
detect binding of Oct-1 to SNAPc in the absence of
DNA. We therefore determined whether Oct-1 con-
tacts DNA in the complex. Indeed, Oct-1 contacts an
All' sequence present on the probe. ATI' (or AAT
on the other strand) constitutes part of the AAAT se-
quence recognized by the POUF, domain on a histone
H2B octamer site, suggesting that it may be contacted
by the POUH domain.
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TBP and SNAPc Bind Cooperatively
to the Human Basal U6 Promoter
V. Mittel, N. Hernandez
The basal U6 promoter consists of a PSE and a
TATA box located at a fixed distance downstream
from the PSE. The PSE recruits SNAI'c, whereas the
TATA box recruits the TATA-box-binding protein
TBP. TBP has been cloned from a number of species,
and sequence comparison reveals that the protein can
be divided into two domains: A very highly con-
served carboxy-terminal domain, and a nonconserved
amino-terminal domain. The carboxy-terminal do-
main performs all the functions so far attributed to
full-length TBP, including binding to the TATA box,
interacting with other basal transcription factors and
activators, and directing basal RNA polymerase II
transcription in vitro.
We have examined whether SNAI3c and TBP
might bind cooperatively to their respective binding
sites in the U6 promoter. We find that this is indeed
the case and that cooperative binding requires the
amino-terminal domain of TBP. This suggests that
one of the roles of the nonconserved amino-terminal
domain of TBP is in snRNA gene transcription by
RNA polymerase III.
Characterization of Human
RNA Polymerase III
S. Sepehri, N. Hernandez
To reconstitute RNA polymerase III transcription in a
completely defined system, we need highly purified
RNA polymerase HI. In addition, to study protein-
protein interactions that lead to the recruitment of
RNA polymerase III to specific promoters, we need
antibodies directed against human RNA polymerase
III. Such antibodies are presently not available. To
generate anti-human RNA polymerase III antibodies
that may be useful both for the purification of RNA
polymerase III and for the study of RNA polymerase
III recruitment, we have isolated a full-length cDNA
clone that encodes the largest subunit of RNA poly-
merase III. An antipeptide antibody directed against
part of the predicted amino acid sequence can im-
munoprecipitate an enzyme that is active in a non-
specific transcription assay and has the pattern of
resistance and sensitivity to different concentrations
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of a-amanitin typical of RNA polymerase III. We are
now characterizing protein-protein interactions be-
tween RNA polymerase III and different RNA poly-
merase III transcription factors.
Factors Required for snRNA
Transcription by RNA Polymerase II
T.L. Calhoun, N. Hernandez
The RNA polymerase II snRNA promoters require
the SNAP complex for transcription, but little is
known about which other factors are required. In con-
trast, all of the factors required for basal transcription
from the adenovirus 2 major late promoter, a typical
RNA polymerase II mRNA promoter, have been
identified, purified, and in most cases cloned. In col-
laboration with Dr. D. Reinberg and colleagues, we
are determining which of the general transcription
factors required for transcription from the adenovirus
2 major late promoter are also required for transcrip-
tion from RNA polymerase II snRNA promoters. We
are using antibodies directed against various general
transcription factors to deplete extracts and test
whether RNA polymerase II snRNA transcription is
affected. In the cases where it is, we then ask whether
addition of the recombinant factor can reconstitute
transcription. These experiments will provide an in-
sight as to which factors direct RNA polymerase II
transcription from snRNA promoters.
Identification and Purification
of FBI-1, a Factor That Specifically
Recognizes the 1ST
F.C. Pessler, P.S. Pendergrast, N. Hernandez
We have previously shown that formation of short
transcripts from the HIV-1 promoter depends on a
DNA element located in large part downstream from
the HIV-1 transcription start site. This element,
referred to as IST for "inducer of short transcripts" is
bipartite, with the 5' module being the most impor-
tant for 1ST activity. The biochemical role of IST is
not known, but we imagine that IST enhances the
recruitment of RNA polymerases that are not capable
of efficient elongation. Because 1ST is active in the
absence of any viral proteins, it must function by
recruiting a cellular factor. We have identified an
IST-binding factor (FBI-1) whose binding to wild
type and mutated versions of the 1ST correlates well
with short transcript formation. FBI-1 is therefore a
good candidate for a factor involved in the synthesis
of short transcripts. FBI-1 has been purified to near
homogeneity and consists of a single polypeptide
whose size is identical to that of a polypeptide that
can be specifically cross-linked to the 1ST in partially
purified fractions. This factor binds to several cellular
promoters that are known to be regulated at the level
of elongation and may therefore play a part in abor-
tive transcription from a number of cellular promot-
ers.
Isolation of cDNAs Corresponding
to FBI -1
D.J. Morrison, P.S. Pendergrast, R. Kobayashi,
N. Hernandez
As a first step toward the understanding of the role of
FBI-1, we have scaled up the purification of FBI-1
and obtained enough protein for microsequencing.
Searches of the expressed sequence tag (EST) data-
base revealed one EST whose predicted amino acid
sequence contained two of the peptide sequences ob-
tained from FBI-1. We used the EST as a probe to
screen a library and obtained a cDNA that encodes
a protein comigrating with endogenous FBI-1. This
suggests that the cDNA might be full-length. We
have raised antipeptide antibodies and are using these
reagents in an effort to understand the biochemical
function of FBI-1.
TBP Domains Required
for Tat Trans-activation
and 1ST Function
P.S. Pendergrast, D.J. Morrison, W.P Tansey,
M. Sheldon, N. Hernandez
The HIV-1 promoter generates two types of RNA
molecules, full-length transcripts and short trans-
cripts. The synthesis of the short transcripts depends
on the 1ST element. In the presence of the viral trans-
activator Tat, the synthesis of full-length transcripts
is up-regulated, whereas that of the short transcripts
is down-regulated. Thus, although 1ST appears to
stimulate the formation of transcription complexes
that are incapable of efficient elongation, Tat appears
to stimulate the formation of transcription complexes
that are capable of efficient elongation.
The HIV -1 promoter contains a TATA box. We
have used an in vivo assay to assess the role of TBP
in HIV-1 transcription and to test the effects of muta-
tions in TBP on synthesis of both short and full-
length transcripts. We found that TBP bound to the
TATA box is required for the synthesis of short and
full-length transcripts as well as for Tat trans-activa-
tion. Both the carboxy-terminal domain of human
TBP and full-length yeast TBP can replace full-
length human TBP for all of these processes. Muta-
tions in TBP affect formation of short and long trans-
cripts as well as Tat activation similarly, and these ef-
fects correlate with the previously described effects
of these mutations on binding of TBP to the TBP-
associated factor TAF,250. These results suggest
that although IST and Tat may stimulate the forma-
tion of different types of transcription complexes,
they use TBP similarly, most probably as part of the
TFIID complex.
Comparison of RNA-targeted and
DNA-targeted Transcriptional
Activators
P.S. Pendergrast, N. Hernandez
Tat is unique among transcription activators in that it
acts through an RNA target, the TAR element, con-
tained within the short transcripts. However, when
fused to the GALA DNA-binding domain, Tat can
also activate transcription from GALA-binding sites
on the DNA, raising the question as to why Tat is
directed to the RNA. We have compared RNA-
targeted activators and DNA-targeted activators in
their ability to activate the synthesis of full-length
transcripts and to repress the synthesis of short trans-
cripts from the HIV-1 promoter. We find that DNA-
targeted activators including DNA-targeted Tat ac-
tivate the synthesis of both short and long transcripts,
whereas the RNA-targeted activators Tat and a Rev-
VP16 fusion protein activate the synthesis of full-
length transcripts but repress the short transcripts.
Thus, repression of the short transcripts seems to be a
property unique to RNA-targeted activators, suggest-
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ing that repression of the short transcripts may be an
important function of Tat.
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TELOMERASE BIOCHEMISTRY AND REGULATION
C.W. Greider C. Autexier S. Buck M.A. Blasco
K. Buchkovich J. Hemish A. Kass-Eisler
S. Le B.-K. Oh R. Pruzan
S.K. Smith
Telomerase is a ribonucleoprotein polymerase that
synthesizes telomere repeats onto chromosome ends.
Evidence from yeast and mammalian cell culture sug-
gests that telomerase is required for telomerase length
maintenance. Telomerase activity is often not detect-
ed in human primary cells and tissues, whereas
tumor-derived cell lines and many tumor samples
contain detectable telomerase activity. The presence
of telomerase activity and short telomeres in tumors
suggested that inhibiting telomerase may be an effec-
tive cancer treatment. To understand both the bio-
chemistry of this unusual enzyme and the role of
telomerase in cancer, we are studying telomerase
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from Tetrahymena, human, and mouse. In the past
year, we have extended our in vitro studies of recon-
stituted Tetrahymena telomerase to human telomer-
ase to determine the essential regions of the human
telomerase RNA. We have also begun to dissect the
pathways that regulate telomerase in human cells
through understanding the cell cycle regulation in
white blood cells.
Finally, in collaboration with Dr. Ronald DePinho,
we generated a mouse that lacks telomerase activity.
This telomerase "knockout" mouse provides an essen-
tial tool to study the role of telomerase in mouse de-
velopment and in cancer.
Human Telomerase Reconstitution
C. Autexier, R. Pruzan [in collaboration
with W. Funk, Geron Corporation]
To dissect the human telomerase enzyme mechanism,
we developed a functional in vitro reconstitution as-
say. After removal of the essential 445-nucleotide hu-
man telomerase RNA (hTR) by micrococcal nuclease
digestion of partially purified human telomerase, the
addition of in-vitro-transcribed hTR reconstituted
telomerase activity. The activity was dependent on
and specific to hTR. Mutations in the hTR template
region generated the expected altered telomere se-
quence repeats in vitro. Using this assay, truncations
at the 5' and 3' ends of hTR identified a minimal
functional region of hTR (Fig. 1). Surprisingly, we
found that residues 1-44, 5 ' to the template region,
were not essential for activity, indicating that a mini-
mal functional region is located between residues 44
and 203. Mutagenesis of full-length hTR between
residues 170 and 179, 180 and 189, or 190 and 199
almost completely abolished the ability of the hTR to
function in the reconstitution of telomerase activity,
suggesting that sequences or structures within this
RNA
size hTR (nt)
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FIGURE 1 Functional analysis of 5 ' and/or 3' terminal dele-
tions of hTR. Telomerase activity was reconstituted with trun-
cations of human telomerase RNAs of various sizes as indi-
cated in the figure. RNA (2.5 pmoles) was added to reac-
tions shown in lanes 2-7. RNA (3 pmoles) was added to
reactions shown in lanes 8-10. Lanes 1-7 were exposed to
film for 2 days and lanes 8-10 for 5 days.
30-nucleotide region are required for activity, per-
haps by binding telomerase protein components.
Telomerase Regulation
during Entry into
the Cell Cycle
K. Buchkovich
Leukocytes, unlike many human somatic tissues,
have detectable telomerase activity. These cells pro-
vided a normal human cell type in which to study
telomerase. We studied the regulation of telomerase
activity and the telomerase RNA component as
leukocytes were stimulated to enter the cell cycle. In
primary human leukocytes stimulated with phyto-
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FIGURE 2 mTR-/- cell lines lack telomerase activity and ac-
tivity can be restored by reintroduction of the mTR gene. A
plasmid containing 5 kb of mouse genomic DNA that con-
tains the mTR gene and 3 kb of surrounding genomic DNA
was transfected into an mTR-/- cell line. As controls, telo-
merase activity was also measured in an mTR+/+ cell line
and an mTR-/- cell line transfected with an empty vector; 48
hr after transfection, S-100 extracts were prepared and as-
sayed for telomerase activity. As a control, telomerase ac-
tivity was also measured in an mTR4+ cell line. All of the ex-
tracts were pretreated (+) or not (-) with RNase before the
telomerase assay.
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hemagglutinin, telomerase activity increased greater
than tenfold as naturally quiescent cells entered the
cell cycle. The timing of the increase in telomerase
activity correlated with the increase in the percentage
of cells in S phase. Antibodies to the T-cell receptor
(TCR)/CD3 complex and the costimulatory CD28
receptor induced telomerase activity in a T-cell-
enriched population of cells. Rapamycin, an immuno-
suppressant that blocks TCR/CD3 signal transduction
pathways and Cdk2 activation, blocked telomerase
induction. Hydroxyurea, an inhibitor of S phase, did
not block Cdk2 kinase activity or telomerase activa-
tion. Analysis of several cell cycle markers including
Cdk2 kinase activity and cyclin E, and p27KiP1 by
Western blotting, indicated that rapamycin inhibited
cells in G, phase and hydroxyurea blocking cells in
early S phase, indicating that telomerase is activated
in G5 phase as T cells enter the cell cycle.
Generation of a Telomerase
"Knockout Mouse"
M. Blasco [in collaboration with Han-Woong
Lee and Ronald DePinho, Albert Einstein
College of Medicine]
To test whether telomerase is required for viability
and for tumor formation, we used homologous re-
combination to generate mice that were deleted for
the mouse telomerase RNA gene (mTR). Heterozy-
gous mice were initially generated that had one allele
of mTR replaced by the neomycin gene. The off-
spring from crossing mTR+/- together showed a 1:2:1
Mendelian distribution of wild-type (mT12+/+), het-
erozygous (mTR+/-), and null mice (mTR-/-), in-
dicating that the mouse telomerase RNA gene is not
essential for mouse development. To determine
whether the absence of mTR affects fertility, first-
generation (G,) mTR-/- mice were crossed to each
other and second-generation (G2) mTR-/- mice were
obtained in the expected numbers. Further mTR-/-
intercrosses generated third (G3), fourth (G4), fifth
(G5), and sixth (G6) generation null mice, indicating
that mTR is not essential for mouse development or
germ-line function.
Tissues and cell lines derived from telomerase null
mice lacked telomerase activity as measured by two
independent assays (Fig. 2). The absence of telomer-
ase activity in mTR-/- mouse embryo fibroblasts
(MEFs) and tissues indicates that the mTR gene is es-
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sential for mouse telomerase activity in vivo. To
determine if mTR-/- cells retain the ability to express
telomerase activity, we reintroduced the wild-type
gene into mTR--/- MEF cultures by transient transfec-
tion. Cell cultures transfected with the wild-type gene
had detectable telomerase activity, whereas cultures
transfected with an empty vector had no detectable
telomerase activity (Fig. 2). This in vivo reconstitu-
tion of telomerase indicates that the telomerase RNA
is the only component the cells lack for the expres-
sion of telomerase activity.
GENERATION OF ESTABLISHED CELL LINES FROM
MTR-/- MICE
To address the question of whether telomerase has a
role in cell immortalization and tumor formation, we
studied the ability of telomerase-negative (mTR-/-)
and telomerase-positive (mTR+/+) MEFs to generate
established cells lines using the 3T3 protocol. MEF
cultures from the first-generation knockout (GO and
mTR-/- cultures from G2, G3, and G4 generations of
knockout mice had growth rates similar to those of
the wild-type mTR+/+ cells for more than 200 genera-
tions. The telomerase null cultures generated estab-
lished cell lines after a period of slow growth known
as senescence or crisis at rates similar to those of
wild-type cells. This indicates that telomerase activity
is not required in mouse cells to escape senescence or
for the establishment of permanent cell cultures.
TRANSFORMATION AND TUMOR FORMATION IN THE
ABSENCE OF TELOMERASE ACTIVITY
To study the role of telomerase activation in mouse
tumors, we tested both primary and established
mTR-/- and mTR+/-1- cells for oncogenic transforma-
tion and tumor formation with SV40 T antigen plus
rasv 12. Foci from transfromed mTR-/- and mTR+/+
cells had a similar morphology and growth rate.
When injected into two different sites on a nude
mouse, the mTR-/- and mTR+/+ transformed cell
lines generated tumors of similar size. To look at the
effect of long-term in vivo absence of telomerase,
early-passage MEF cultures from G, mTR+/+ and
mTR+/- and G, G2, G3, and G4 mTR-/- mice were
transformed with adenovirus ElA and rasv12. Foci
were selected and 105 cells were injected into nude
mice. Tumors were generated from all of the mTR-/-
G,, G2, G3, and G4 cells (Fig. 3). Although there was
significant scatter in tumor size, there was no correla-
tion with the genotype or generation of mTR-/-
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FIGURE 3 Tumor formation in mTR*/+ and mTR-/- mice. Pri-
mary MEF cultures were derived from mTF3+4 (Wt), mTR+/-
(Het), and first (G.,), second (G2), third (G3), and fourth (G4)
generation mTR-1- mice. The cells were infected with a
retrovirus expressing El A and rasv12 and transformed.
Cells from the foci were injected into nude mice, and tumor
formation was measured after 46 days. The values shown
represent the average of four different injection sites for
each cell type.
animals (Fig. 3). These results indicate that telomer-
ase activity is not essential for tumor formation in
nude mice.
TELOMERE LENGTH IN TELOMERASE NULL CELLS
Telomerase activity is thought to be required for
telomere length maintenance in mammals. In human
cells, the terminal restriction fragment (TRF) contain-
ing the telomeric repeats is typically between 10 and
15 kb. However, the mouse laboratory species, Mus
musculus, used to generate the mTR-/- strain, has
telomeres ranging from 20 to 150 kb. The TRFs are
not resolved on conventional agarose gels and thus
pulsed-field gels have been used to estimate TRF
length. Surprisingly, using pulsed-field gels, we were
not able to detect significant telomere shortening in
mTR-/- MEFs compared to mT12+/-1- cells after grow-
ing the cells for more than 200 population doublings
in vitro. Furthermore, primary MEFs from mTR+/-
and mTR-/- from the Gt, G2, G3, and G4 generations
did not show any significant difference in telomere
length when compared to wild-type mT12+/+ DNA
(Fig. 4). The inability to detect telomere shortening
suggests that the rate of telomere shortening in the
absence of telomerase activity in M. musculus might
be slower than in human cells, and further passaging
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FIGURE 4 Telomere length in G1 -G4 mTIR-/- mice. South-
ern blot analysis of telomere restriction fragments from
mTR+/+, mT19+/-, and mTR-/- MEF cultures. Early-passage
MEF cultures were grown, and the cells were embedded in
agarose plugs. In the first three lanes, cells were derived
from animals that had been backcrossed to C57BL/6J for 5
generations before intercrossing to produce the embryos
used here. Lanes 4 and 5 represent the third- and fourth-
generation intercross of mTR-/- animals that had not been
extensively backcrossed.
will be needed to detect telomere shortening. Alterna-
tively, the apparent lack of telomere shortening in
mouse cells might reflect a telomerase-independent
mechanism for telomere maintenance. Yeast cells
deleted for the telomerase RNA gene that have a
wild-type recombination system generate rare "sur-
vivors" after loss of viability in culture. In these cells,
gene conversion allows lengthening of telomere
repeat tracts. If the rad52 gene is deleted, gene con-
version is severely reduced and survivors are not gen-
erated. In yeast undergoing recombination-mediated
telomere elongation, dramatic changes in telomere
length are seen. Strikingly, even in wild-type mice,
the rate of telomere length changes is extraordinarily
high, suggesting that perhaps recombination path-
ways may normally have a role in telomere main-
tenance in the mouse.
RELEVANCE TO HUMAN CANCER
Although mice provide a powerful tool for under-
standing cancer progression, there are some sig-
127
nificant differences in human and mouse biology that
may effect tumor growth. Two of the most relevant
differences for this study are the extremely long
telomeres in mice and the relative ease of im-
mortalization of mouse cells. Telomerase activation
is tightly correlated with immortalization in human
cells, whereas mouse cells immortalized readily in
the absence of telomerase. Whether this difference
represents a fundamentally different tumor suppres-
sor mechanism in human cells or is simply a slight
difference in control pathways remains to be estab-
lished.
The possibility that mouse cells easily activate or
perhaps normally utilize a telomerase-independent
mechanism of telomere maintenance is intriguing.
Evidence suggests that recombinational bypass path-
ways might occur in some human cell lines. Since
this alternative mechanism might provide an avenue
for human tumor survival, it will be essential to fully
understand the role of this pathway in both human
and mouse cells.
The fact that a mouse lacking telomerase can sur-
vive for more than six generations and the growth
rate of cells in vitro is not altered was surprising to us
and to most of our colleagues. However, unexpected
results are often the most interesting as they allow us
PLANT GENETICS
V. Sundaresan
R. Martienssen
E. Grotewold
to challenge our own assumptions and to refocus on
what our experiments are telling us about nature.
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Molecular Analysis of the
Maize Indeterminate Gene
J. Colasanti, Z. Yuan, V. Sundaresan
THE MAIZE INDETERMINATE GENE REGULATES
THE TRANSITION TO FLOWERING
Plants differ from animals in that most of their devel-
opment occurs postembryonically. This is accom-
plished by a population of undifferentiated stem cells,
the apical meristem, which gives rise to all parts of
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the plant after germination. The shoot apical meri-
stem generates the aerial parts of the plant. During
vegetative growth, the shoot apical meristem pro-
duces leaves and other vegetative structures, and dur-
ing reproductive growth, the shoot apical meristem
gives rise to structures such as flowers. A critical and
poorly understood event in the development of plants
occurs when the shoot apical meristem undergoes the
transition to reproductive growth. We have been
studying a mutant of maize, indeterminate (idl) that
is defective in the transition to reproductive develop-
FIGURE 1 The structure of the id1 gene is shown. Shaded areas represent the four exons, open boxes show the
introns; the large intron is 1.4 kb. Zinc finger motifs in exons 2 and 3 are represented by double circles. The in-
sertion site of the Ds2 transposon into the coding region of exon 3 is indicated.
ment, i.e., theshoot apical meristem of idl mutants
continues to produce leaves, therefore maintaining
the plant in a state of vegetative growth. Eventually,
given enough time, idl mutants will produce aberrant
floral structures with vegetative characteristics. Pre-
viously, we reported the isolation of the idl gene
from maize by transposon tagging. This year, we re-
port the complete structure of the idl gene and de-
scribe the expression pattern of idl during develop-
ment.
THE ID1 GENE STRUCTURE
The sequence of the idl gene shows that it has
similarities to zinc finger regulatory proteins from
other species, suggesting that idl may act as a tran-
scriptional regulator of other genes. The structure of
the idl transcribed region was determined by RT-
PCR. Primers based on the sequence of an idl
genomic clone were used to amplify portions of an
idl transcribed regions. Comparison of the amplified
regions to the genomic sequence showed that idl has
three introns and four exons (see Fig. 1). Exons 2 and
3 each contain a zinc finger DNA-binding motif; the
other parts of the deduced amino acid sequence show
no similarity to proteins in current databases. The
zinc finger motif domain, however, shows homology
with the Drosophila and human Kruppel genes and
was used to identify a family of genes in maize with
this motif. These have been designated id-like genes.
In addition, id-like genes have been identified in
other plant species, such as Arabidopsis and potato.
We are currently collaborating with Pioneer Hi-Bred
International to investigate the function of the id-like
genes.
THE 101 GENE IS EXPRESSED IN DEVELOPING LEAVES
Northern blot analysis was used to determine where
idl is expressed in the plant. Poly(A)+ mRNA was
isolated from different parts of maize plants at dif-
ferent times of growth, from soon after germination
to late in development when flowers have already
formed. Spatially, the idl gene is expressed only in
immature leaf tissue that has not expanded and is not
undergoing photosynthesis; i.e., it is absent in mature
leaves. Temporally, we have discovered that idl is
expressed at low levels soon after germination and
that expression increases as plants approach the
transition to flowering. After formation of the flow-
ers, the idl mRNA is detectable at low levels in post-
reproductive plants. Expression of idl is not found in
roots, stems, or floral tissues. More importantly,
Northern analysis and preliminary in situ hybridiza-
tion experiments show no detectable levels of idl in
the shoot apical meristem at any time during develop-
ment (see Fig. 2). This has significant implications
for the mechanism of idl gene function (see below).
bril REGULATES A TRANSMISSIBLE SIGNAL THAT
EVOKES THE TRANSITION TO FLOWERING
A large number of physiological studies from the last
70 years have demonstrated that two critical events
must occur for a plant to undergo the transition to
flowering: First, a signal is produced in the leaves
that is transmitted to the shoot apical meristem where
it elicits the flowering program, and second, the shoot
apical meristem must become competent to receive
the floral stimulus. Although many attempts have
been made to isolate a flower-inducing substance (or
"florigen"), no one has succeeded in identifying a
simple hormone-like substance that can cause the
cells of the shoot apical meristem to begin a program
of reproductive development. As reported in previous
Annual Reports, we have genetic evidence that idl
acts non-cell-autonomously, i.e., that the idl gene
product mediates the production of a signal that
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migrates from one part of the plant to another to carry
out its function. The expression pattern of idl de-
scribed above now provides molecular evidence that
the idl gene acts non-cell-autonomously, i.e., that it
is expressed in leaves where it regulates the produc-
tion of a substance(s) that migrates to the shoot apical
meristem to mediate the transition from vegetative to
reproductive growth. Current efforts are directed at
pin-pointing the temporal/spatial expression pattern
of the idl gene and at examining the location of the
IDI protein. Understanding the molecular signals that
invoke reproductive development will contribute to
the understanding of how this process occurs in
plants, as well as have potential commercial benefits
from the ability to manipulate reproductive timing in
crop plants.
Genetic Analysis of Embryogenesis
in Arabidopsis Using Enhancer Trap
and Gene Trap Transposon Tagging
S.T. Woody, V. Sundaresan
We have used the enhancer trap and gene trap
transposon tagging system developed at Cold Spring
Harbor Laboratory (Sundaresan et al., Genes Dev. 9:
1797 [1995]) to identify and characterize embryo-
specific gene expression in Arabidopsis. Nearly 1000
insertion lines generated by our laboratory and the
collaborating laboratories of Grossniklaus, Ma, and
Martienssen here at the Laboratory were screened for
patterns of GUS reporter gene expression during em-
bryogenesis. Three lines that displayed an embryo-
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FIGURE 2 Northern blot analysis with mRNA from mature leaf, immature leaf, root,
and apex from B73 maize plant with ten visible leaves. The same blot was probed
with an kit-specific probe, the maize cdc2 probe (which is highly expressed in tis-
sues with actively dividing cells), the hcf106 gene probe (expressed in leaves), and
a probe for an id-like gene, *p1'.
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specific GUS expression pattern are of particular in-
terest. In LENNY, GUS expression is first detected in
the lens-shaped cell of the hypophysis at the base of
globular-stage embryos and remains confined to it
throughout embryogenesis. In the mature embryo,
staining is present only in the central cells of the root
meristem. LENNY marks a specific cell lineage
within the basal domain of the embryo and provides
separate confirmation of the proposal that the central
cells are descendants of the lens-shaped hypophysial
cell (Dolan et al., Development 119: 71 [1993]). In
contrast, the expression specificity of COTDOT is
dynamic: Expression is first observed in cells near
the nascent shoot apical meristem of transition stage
embryos, but at later stages, GUS expression be-
comes more localized, becoming confined to vascular
cells of the embryonic root and ultimately to a subset
of cells in the root meristem and columella. Finally,
expression in a third insertion, JART, occurs in the
specialization zone of the root; expression is also ob-
served in the cotyledons. It was determined that the
insertional Ds element in JART is within an exon
downstream from the homeodomain of a member of
the GLABRA2 family of Arabidopsis homeobox
proteins. More detailed characterization of the above
three insertions and other insertion lines identified in
this screen is in progress.
Gene Trap Patterns during
Organogenesis in Arabidopsis
P. Springer, Q. Gu, D. Bush, R. Martienssen
The molecular mechanisms underlying the partition-
ing, outgrowth, and differentiation of lateral organs in
plants are largely unknown, but leaves, floral organs,
and cotyledons (seed leaves) may use the same basic
process, given that these organs can be interconverted
by homeotic mutations. Because of its highly reitera-
tive nature, leaf development is uniquely suited to
study organogenesis in plants. Unfortunately, many
mutations in genes required for leaf development
result in lethality or sterility because of their effects
on leaf-like organs in the embryo and in the flower.
This makes such mutations difficult or impossible to
identify in conventional genetic screens. We are
using enhancer trap and gene trap transposon
mutagenesis in the model plant Arabidopsis thaliana
to identify genes expressed in prepatterns in
meristems and leaf primordia (Sundaresan et al.,
Genes Dev. 9: 1797 [1995]). Using this approach,
genes can be identified by their expression patterns in
heterozygous (normal) plants even when disruption
results in an early lethal phenotype (Springer et al.,
Science 268: 877 [1995]). We have screened 1034
gene trap lines and 880 enhancer trap lines for
reporter gene expression in the seedling 9 days after
germination and have established a database contain-
ing these expression patterns. Approximately 45% of
enhancer traps (397) and 31% of gene traps (328)
show GUS expression. Figure 3 shows the number of
expression patterns that are specific to each individu-
al organ with respect to any two other organs. Ubiq-
uitous expression patterns are rather rare, represent-
ing about 6% of the total (43/725), and many of these
are artifactual insertions in the T DNA. Approximate-
ly 4% of the lines show reporter gene expression ex-
clusively in leaves or leaf primordia, whereas 4.5%
exhibit GUS expression specifically in other domains
of the shoot apex. Amplification and sequencing of
transposon insertion sites has revealed insertions into
FIGURE 3 A summary of staining pattern frequencies in 9-
day -old seedlings. The number of individual insertions that
result in reporter gene expression in each organ or com-
bination of organs is shown.
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a wide variety of genes. Insertions into two known
genes (the MADS box gene AGL8 and the ethylene
response gene hooklessl) have reporter gene expres-
sion patterns that are in close agreement with pub-
lished in situ hybridization data. We believe therefore
that this collection accurately reflects the proportion
of all expressed genes that are found in these tissues.
By extrapolation, several hundred genes may be spe-
cifically expressed in prepatterns in the shoot apex.
Molecular Genetics of
asymmetric leaves
in Arabidopsis
M. Curtis, R. Martienssen
The Arabidopsis mutant asymmetric rosette leaves
(as1) has variably lobed leaves with a drastically
altered proximodistal pattern, characterized by
altered spacing of hydathodes, trichomes, and veins
relative to the leaf margin. We are examining the in-
teraction of asl with several GT and ET lines which
have reporter gene expression patterns in the shoot
apical meristem and the leaf primordia. We have
identified several genes whose expression pattern is
altered in as] mutants, and an example is shown in
Figure 4A. Similarly, ET and GT lines with expres-
sion patterns in the stomata, the vasculature, stipules,
hydathodes, trichomes, and marginal epidermal cells
are being used to examine the position of these land-
mark structures in asl leaves. We are attempting to
clone the gene for asl using the gene-trap transposon
system. Ds transposable elements preferentially
transpose within 5 cM of their original location, and
one of the Ds starter lines (DsG1) has been mapped
FIGURE 4 Enhancer trap and gene trap reporter gene ex-
pression patterns. An enhancer trap reporter gene expres-
sion pattern at the base of the wild-type leaf (A) is severely
reduced at the base of asymmetric leaves at the same
stage (B). (C) An enhancer trap expression pattern confined
to leaf vascular tissues.
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to chromosome 2 less than 5 cM away from asl
(Sundaresan et al., Genes Dev. 9: 1797 [1995]). Ap-
proximately 40,000 F, seeds derived from more than
1500 Ac DsGI X as1 crosses have been produced.
Plants derived from these F, seeds are currently
being screened for new alleles of asl, caused by the
insertion of Ds, which will allow molecular cloning
of the locus. In parallel experiments, we have ob-
tained 135 recombinants around the as1 locus that
have allowed us to map asl to a single YAC. Com-
plementation of mutant plants with cosmid clones
from this region are currently under way using
Agrobacterium-mediated transformation.
Disruption of the AGL8 Gene
Prohibits Differentiation during
Arabidopsis Fruit Development
Q. Gu, R. Martienssen [in collaboration with
C. Ferrandiz and M. Yanofsky, Department of Biology
and Center for Molecular Genetics, University of
California at San Diego]
We have isolated an enhancer trap DsE insertion into
the 5 ' -untranslated region of the MADS box gene
AGL8 (agamous-like). GUS reporter gene expression
is found in the vascular tissue of the leaf and stem. In
the gynoecium, GUS expression is confined to all cell
layers of the carpel valve but is excluded from the
dehiscence zone, the replum, and septum tissues. Ex-
pression of the AGL8-coding region is abolished in
the mutant. The Arabidopsis fruit (the silique) is
derived from two fused carpels, which greatly
elongate after fertilization. Dehiscence takes place at
ripening to release the seeds. Plants homozygous for
the agl8 mutation have small congested siliques. In-
stead of an orderly dehiscence, seeds are trapped in
the silique and occasionally they prematurely burst
through the carpel wall. In addition, the cauline leaf
is noticeably broader as compared to that of the wild
type. The small carpel structure is due to a failure of
cellular differentiation after fertilization. Scanning
microscopy showed that several cell types are miss-
ing, including stomatal cells. Cell division and expan-
sion are disrupted in the carpel wall but continue in
the central septum tissue of the silique. Although the
only phenotype we can detect is in the fruit, expres-
sion at other stages of development suggests that
AGL8 may have a redundant function in these other
tissues. This possibility is being addressed in double-
mutant studies.
Characterization of the Prolifera
Gene in Arabidopsis
P. Springer, R. Martienssen
We have previously reported the cloning and charac-
terization of the PROLIFERA gene from Arabidopsis
(Springer et al., Science 268: 877 [1995]).
PROLIFERA was identified by a DsG (gene trap Ds
element) insertion, which led to reporter gene expres-
sion in dividing cells. PROLIFERA is closely related
to the CDC47 gene from Saccharomyces cerevisiae,
which is a member of the MCM2-3-5 gene family,
and is required for the initiation of DNA replication.
Consistent with this predicted essential function, dis-
ruption of PROLIFERA by the DsG element results
in megagametophyte and embryo lethality. This early
lethality masks any role PROLIFERA may have at
later stages of development. We have begun experi-
ments which will allow us to examine the role of
Prolifera throughout development. We have made
constructs containing a DsG element fused between a
strong constitutive promoter (CaMV 35S) and the
PROLIFERA gene in either the sense or antisense
orientation. In the absence of Ac, plants carrying one
of these constructs will express the GUS reporter
gene constitutively, under control of the 35S
promoter. In the presence of Ac, the DsG element
will excise in somatic sectors, resulting in loss of
GUS activity and the concomitant expression of the
Prolifera or anti -Prolifera gene. This will provide a
visual marker (loss of GUS activity) for the antisense
or overexpression sectors. In this way, we can exam-
ine whether cellular differentiation depends on cell
cycle progression in the developing leaf and root.
Using Gene Trap and Enhancer Trap
Screens to Identify Gene Products
That Regulate Resource Allocation
in the Plant's Vascular System
D. Bush (1), R. Martienssen
(1) Permanent address: Photosynthesis Research
Group, USDA-ARS Department of Plant Biology,
University of Illinois, Urbana
The leaf functions as the primary supplier of free en-
ergy and reduced carbon in higher plants. The leaf is
the so-called "source" tissue because it contains the
photosynthetic machinery that transforms light ener-
gy into useful biological energy and because most of
that captured energy is exported from the leaf (in the
form of sucrose and amino acids) to satisfy the
biochemical needs of nonphotosynthetic cells.
Likewise, the import-dependent tissues specialize in
other important processes, such as nutrient acquisi-
tion (roots) or reproduction (flowers). The develop-
ment of specialized tissue systems generates a need
for long distance transport, and the vascular system
of higher plants is the complex network of special-
ized cells that mediate this essential process. Several
gene trap and enhancer trap transposants have been
identified whose GUS expression pattern is restricted
to the vascular system in mature leaf tissue (Fig. 4B).
Since the principal activity of mature leaves is the ac-
quisition and export of sugars and amino acids, the
protein products encoded by these tagged genes may
be important contributors or regulators of this funda-
mental activity. Significantly, several of these trans-
posants exhibit mutant phenotypes that include
reduced size and slow growth. In addition to leaf ex-
pression patterns, other transposants have been iden-
tified whose GUS expression is localized in the vas-
cular tissue of the hypocotyl and/or roots of the plant.
Current efforts in this project are focused on obtain-
ing sequence information about the tagged genes and
on using thin sections of stained organs to identify
the cell-specific expression patterns.
Local Saturation Mutagenesis
of the Short Arm of
Arabidopsis Chromosome 4
C. Yordan, J. Montagu, P. Stavropoulos,
R. Martienssen, [in collaboration with M. Lodhi and
R. McCombie, Cold Spring Harbor Laboratory]
The Cold Spring Harbor Arabidopsis sequencing
consortium will be determining the complete nucleo-
tide sequence of the short arm of chromosome 4 (a 3-
Mb region) during the next 2-3 years (see report by
R. McCombie). We are attempting to saturate this
region with transposon insertions launched from the
prolifera gene, which lies near the center of this
region. By isolating DNA in pools from a collection
of such insertions, we can identify insertions into the
sequenced genes by amplifying pooled DNA with
primers from the sequence and primers from the DsG
transposable element (Das and Martienssen, Plant
Cell 7: 287 [1995]). Mobilization is accomplished by
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crosses to Ac transposase, followed by selection of
pooled F, progeny on culture plates supplemented
with naphthalene acetamide (NAM) which selects
against Ac, and kanamycin, which selects for the Ds,
either at prolifera or at a new location. We have ana-
lyzed a few hundred selections by Southern blotting,
amplification, and mapping against the YAC contig
from this region. Results suggest that insertion fre-
quencies are high enough for this procedure to be ef-
fective and that insertions typically fall within a few
hundred kilobases of the prolifera gene. Neverthe-
less, many thousands of selections need to be made to
saturate the region. A number of insertions result in
new patterns of reporter gene expression and in
mutant phenotypes, which are under investigation.
The iojap Gene in Maize
M. Byrne, R. Martienssen
iojap (ij) is a recessive nuclear mutation in maize that
affects the differentiation of mature chloroplasts from
undifferentiated organelles. The cytoplasmic in-
heritance of defective plastids from variegated ij
plants has been a textbook example of non-
Mendelian genetics for more than 50 years (Rhoades,
Cold Spring Harbor Symp. Quant. Biol. 11: 202
[1946]). Molecular cloning and preliminary biochem-
ical studies suggest that the maize Ij protein is associ-
ated with the 50S subunit of chloroplast ribosomes
(C.-D. Han and R. Martienssen, Annual Report
1994). Hypothetical proteins with sequence simi-
larities to Ij have been identified in a number of other
organisms, including Arabidopsis (M. Byrne and W.
Taylor, unpubl.). The maize and Arabidopsis se-
quences are 64% identical except for an amino-
terminal region that is predicted to be a transit pep-
tide cleaved during chloroplast import. Hypothetical
proteins from five bacterial species share between
23-36% identity and 50-57% similarity with the
maize Ij. In addition, a hypothetical protein in
Caenorhabditis elegans shares 21% identity (50%
similarity) with maize Ij and has all of the amino acid
residues absolutely conserved in the above se-
quences. The C. elegans protein has an amino-
terminal extension suggestive of a mitochondrial
transit peptide. However, there is no obvious lj
homolog in yeast. Bacterial overexpression of the
mature protein from maize and Arabidopsis has been
accomplished using His-tagged proteins, antibodies
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have been raised, and yeast 2-hybrid screens are
being used to identify interacting proteins.
Genetically, double mutants have been constructed
with other plastid ribosome mutants, and a number of
new alleles of maize lj have been generated using the
transposon Mutator. The phenotype of homozygous
ij -mum/ 7 plants is dependent on the activity of Mu
transposons, so that homozygous plants that have lost
Mu activity appear wild type. This suppressible ij al-
lele will provide a useful tool for cell lineage studies
because double mutants for ij-mum17 and the pig-
ment marker al -mum2 will be coordinately mosaic
for both genes in clonally derived sectors (Martiens-
sen and Baron, Genetics 136: 1157 [1994]). The ef-
fect of loss of Ij function can then be assessed in sec-
tors that are marked by loss of pigmentation.
Specification of Leaf Shape
and Leaf Cell Identity in
leafbladeless2 Mutants of Maize
N. Springer, R. Martienssen [in collaboration with
M. Timmermans and T. Nelson, Yale University]
leafbladeless2 is a recessive leaf mutant that arose in
a Robertson's Mutator line. The mutant phenotype is
suppressed in Mu-inactive stocks and in mosaic
plants, suggesting it was caused by the insertion of a
Mu transposable element. The first two leaves have
wild-type morphology, but in successive leaves, the
width and pigmentation of the blade becomes severe-
ly reduced until only a pale thread remains. Mor-
phological defects could be observed in very early
primordia by SEM, suggesting that fewer cells are in-
corporated into mutant leaf primordia. In leajblade-
less2 mutants, ectopic ligule will often form on the
abaxial surface of the leaf at the sheath-blade bound-
ary. Ectopic sheath fringes are also observed in some
plants, running parallel to the sheath margin, and
flanking patches of adaxial epidermal cell types on
the abaxial side. Residual mutant blade tissue has
fewer mesophyll cells and almost no intermediate
bundles. Lateral vascular bundles exhibit a chaotic
placement in the horizontal axis but appear to retain
wild-type polarity in the dorsoventral axis. The
pleiotropic phenotype suggests that Leafbladeless 2 is
required for leaf cells to adopt the appropriate
identity in response to axis specification in the early
primordia. It remains to be seen whether this reflects
an alteration in axis specification itself.
Hcf106 is an Ancient Conserved
Gene Required for Membrane
Protein Trans location
in Chloroplasts
A.M. Settles, D. Bush, R. Martienssen
[in collaboration with K. Cline, University
of Florida, Gainesville]
hcf106 mutant maize seedlings are pale green and are
deficient in a subset of chloroplast thylakoid mem-
brane protein complexes. Among other possibilities,
a defect in thylakoid protein targeting could lead to
the observed phenotype. Thylakoid protein targeting
in chloroplasts utilizes translocation pathways found
in bacteria, via the homologous receptors cpSecA and
cpFfh (Cline and Henry, Annu. Rev. Cell Dev.
12: 1 [1996]). In addition, a subset of thylakoid
proteins are targeted using a third pathway that re-
quires only a pH gradient across the thylakoid mem-
brane (the ApH pathway). hcf106 mutants accumulate
intermediates of known substrates for this targeting
pathway, suggesting that it may be defective
(Voelker and Barkan, EMBO J. 14: 3905 [1995];
Settles et al., CSHL Annual Report 1994). We have
adapted in vitro chloroplast import assays from pea to
maize, and we have found that hcf106 chloroplasts
are defective in targeting and processing of ApH-
dependent but not secA-dependent intermediates. One
interpretation of these results is that the pH gradient
is not sufficient in hcf106 mutants for ApH proteins
to be targeted. We have measured the pH gradient in
hcf106 thylakoids using radioactively labeled methyl-
amine as a tracer molecule. Although hcf106 mutants
have a reduced pH gradient when compared to wild
type, the hcf106 gradient is equivalent to that in thal
(cpSecA) mutant seedlings that still target ApH
proteins normally (Voelker et al., Genetics 145: 467
[1997]). These experiments suggest that HCF106 is a
component of the ApH targeting pathway. The
hcf106 -muml allele has been cloned by transposon
tagging, and antisera have been raised to an HCF106
fusion protein (Yonetani et al., CSHL Annual Report
1992). Chloroplast fractionation, chaotrope extrac-
tion, and protease protection experiments indicate
that HCF106 is primarily a thylakoid membrane
protein, with some localization to the inner en-
velopes. Database searches of bacterial genomes have
revealed homologous open reading frames in six bac-
terial species, including Escherichia coli and
cyanobacteria. To investigate the role of the E. coli
genes, we have generated transposon insertions into
this hypothetical operon. We are currently testing
these strains for secretion defects.
Mutator Tagging of Genes
Required for Pericarp
Pigmentation
W. Flood (Dowling College), E. Grotewold
Flavonoids are a very large class of small phenolic
molecules found in all plants. Flavonoids play a num-
ber of important biological functions, including plant
and flower pigmentation, sexual reproduction, protec-
tion against UV radiation, defense to attack by phyto-
pathogens, in symbiotic interactions between plants
and microbes, and in the regulation of plant hormone
transport. Most higher plants only accumulate 3-
hydroxy flavonoids and the derived pigments, the
anthocyanins (Fig. 5). Anthocyanin accumulation is
controlled in maize by two classes of regulatory
proteins (see Fig. 5): a Myb-domain containing class
(C1 and PI) and a basic helix-loop-helix (bHLH)
domain-containing class (which include the R and B
genes). Anthocyanin production requires the interac-
tion of a member of the Myb domain family and a
member of the bHLH domain family.
In addition to 3-hydroxy flavonoids and anthocya-
nins, maize and its close relatives (e.g., sorghum) ac-
cumulate 3-deoxy flavonoids and derived pigments,
which include the phlobaphenes. A single known ge-
netic factor, P (for pericarp pigmentation), controls 3-
deoxy flavonoid and phlobaphene biosynthesis. Little
is known about the biosynthesis of the P-regulated
phlobaphenes, which are restricted to the floral
organs of maize and some other grasses. The con-
spicuous pigmentation determined by P in the
pericarp (the pericarp is the modified ovary wall)
makes it an ideal system to identify additional genetic
factors required for this branch of flavonoid
biosynthesis. In addition to P, factors required for
pericarp pigmentation could include regulators of P
expression, modulators of the P regulatory function,
additional biosynthetic genes, or factors required for
normal pericarp development. We started a genetic
screen aimed at genetically identifying additional
genes required for the accumulation of the red
phlobaphene pigments in maize pericarps. We used
for that purpose the Mutator transposable element
system from maize. Mutator elements, different from
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FIGURE 5 Maize flavonoid biosynthetic pathway. Genes regulated by P or Cl/PI + R/B are indicated
with arrows.
the Ac transposable element that we used in previous
studies, have a very high rate of forward transposition
with no obvious preference for linked sites. Insertions
of Mutator in genes required for pericarp pigmenta-
tion should be evidenced by the characteristic and
easy-to-score pericarp variegation.
We have so far screened approximately 15,000
M3+M4 ears for variegated pericarps (the pericarp is
a maternal tissue, therefore the phenotype is only evi-
denced in the generation after the mutation occurred).
We have now identified more than 30 mutations that
give variegated pericarp. Allelism tests are under way
to determine how many different genes have been
targeted. The level and the type of variegation found
in these pericarps are very different from the patterns
given by Ac, as expected, given the differences in the
excision properties of Mutator and Ac. Preliminary
genetic and molecular data suggest that PAP1 (PAP
for pericarp altered pigmentation) corresponds to an
insertion (of Mutator?) in the large intron of P,
providing a control that the strategy used will yield
mutants in the P-regulated pathway. We are currently
characterizing other PAP mutants at the molecular
and genetic level.
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DNA-binding Properties of the
Maize Myb Domain Proteins
P and C1 and Modular Structure
of the Promoter of a
Commonly Regulated Gene
E. Grotewold [in collaboration with M. Sainz and
V. Chandler, University of Oregon]
The Myb domain proteins P and Cl independently
regulate branched maize flavonoid biosynthetic path-
ways (Fig. 5). Whether no other genetic factor has
been identified as needed for the P-regulatory func-
tion, Cl regulates transcription only in the presence
of the bHLH protein R. Our previous studies have
shown that P activates transcription of a1, a flavonoid
biosynthetic gene also regulated by Cl, by directly
interacting with al promoter elements, which are
bound with high affinity by P in vitro (haPBS, for
high-affinity P-binding sites). In addition, the DNA
sequences preferentially bound by P are very dif-
ferent from the sequences bound by animal Myb
proteins (Fig. 6) (Grotewold et al., Cell 76: 543
[1994]). Our more recent studies indicate that the cor-
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FIGURE 6 Graphic representation of the results of binding-site selection experiments, expressed as percentage of
times a particular nucleotide was found at each position. The proteins used in each case are indicated at the top of
each panel and the number of sequences analyzed is shown between brackets. Positions of the nucleotides from -4
to +3 were arbitrarily assigned. Favored residues selected for each position are shown below. N indicates that any
residue is accepted.
responding Myb domains are solely responsible for
the different in vitro DNA-binding preferences of P
and v-Myb and that residues outside the conserved
DNA-recognition helices are necessary for the dis-
tinct DNA-binding preferences of these two proteins
(Williams and Grotewold 1997).
We have recently determined that Cl binds to the
same elements as P in the al promoter, but with five
to ten times lower affinity (Sainz et al. 1997). The
low affinity of Cl for these binding sites was not im-
proved in vitro by the presence of an R/B protein. Cl
prefers binding to sequences very similar to those
bound by P, as indicated from the results of site-
selection experiments (Fig. 6). The consensus bind-
ing site for Cl indicates that Cl may have a slightly
broader DNA-binding specificity than P, consistent
with the larger number of flavonoid biosynthetic
genes regulated by Cl (Fig. 5). The highest DNA-
binding affinity of Cl is for the haPBS, indicating that
the DNA-binding domains of Cl and P have a funda-
mental difference(s) which does not allow Cl to bind
DNA with as high an affinity as P. In addition to the
haPBS, the al promoter contains low-affinity P-
binding sites (taPBS), which in vivo are as important
as the high-affinity sites for al activation by P (Sainz
et al. 1997). Promoters containing the IaPBS are also
activated by Cl and R, and Cl binds the laPBS with
an affinity similar to that of the haPBS. Thus, the al
promoter has a modular structure with cis-elements
bound by similar regulators with different affinities.
We are currently investigating the mechanisms by
which P and Cl regulate promoters containing solely
low-affinity binding sites for these proteins.
Identification of Additional
Factors Required for the
Regulatory Function of the
Myb Domain Proteins P and Cl
M. Pizzirusso [Partner for the Future], E. Grotewold
[in collaboration with Dr. Ronald Koes and Dr. Jos Mol,
Vrije Universiteit Amsterdam]
The regulatory function of transcriptional regulators
is often modulated by protein-protein interactions
with other cellular factors and by posttrancriptional
modifications. Besides the interaction of Cl with the
bHLH factor R, little is known about how these pro-
cesses may modulate the activity of the P and Cl
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Myb domain proteins. Current approaches used in
our laboratory aimed at identifying factors that physi-
cally interact with P and Cl include yeast two-hybrid
screenings and complementation experiments in
yeast. A new approach that we have taken consists of
investigating a number of mutations that affect
anthocyanin accumulation in Petunia. Some of the
corresponding genes have been isolated by Dr. Koes
and colleagues, and they do not match with genes
previously identified in maize. One such mutant is
An11. Several lines of evidence suggest that Anl 1
modulates the regulatory function of the Petunia Cl
ortholog Ant at the posttranscriptional level. The
Anl 1 protein is cytosolic and contains WD-40
repeats, consistent with a possible role of Anl 1 in a
signal transduction cascade that modulates Cl ac-
tivity. To investigate whether An 1 1 controls Cl func-
tion in maize, we isolated cDNA clones for the maize
Anll ortholog. As we continue the characterization
of the maize An11 gene, we have started screening
for Mutator insertions using a targeted mutagenesis
approach. The availability of a mutant in the maize
Anl 1 gene should allow us to investigate at what
level An 1 1 modulates Cl function.
Identification of Transposable
Element Insertions in Maize Genes
Encoding Myb Domain Proteins
with Novel Cellular Functions
P.D. Rabinowicz, Y. Sun, T. Litzi (URP Program),
E. Grotewold
Proteins containing the Myb DNA-binding domain,
originally identified in vertebrate Myb oncoproteins,
have been found in most eukaryotes, from yeast to
plants and animals. Mouse and human Myb domain
proteins have fundamental roles in cell cycle control
and in the proliferation and differentiation of hemato-
poietic cells, and several lines of evidence suggest a
role for Myb as a transcriptional regulator. So far,
fewer than ten Myb domain proteins have been iden-
tified in vertebrates. In sharp contrast with animal
cells, plants express more than 100 Myb domain pro-
teins, and a few were shown to regulate processes
such as the accumulation of secondary metabolism,
the determination of cell shape and cell fate, and the
control of pattern formation. The unique character-
istics of these processes suggest that the increase in
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Myb domain protein number in plants during evolu-
tion, compared to animals, may reflect their role in
the regulation of a number of cellular functions
specific to plants. To investigate the function of Myb
domain proteins in maize, we adapted a reverse
genetics approach, originally developed in Drosoph-
ila and later used in maize, to identify insertions of
Mutator transposable elements in families of genes
encoding Myb domain proteins. Oligonucleotides
from Mutator ends and from conserved regions in
Myb domains are used to amplify by PCR pools of
genomic DNA made from maize seedlings containing
active Mutator elements. In 120 PCRs, 3600 plants
(3600 seedlings planted in a 60 x 60 grid array) can
be analyzed. By labeling the end of the Mutator-
specific primer and analyzing the amplification prod-
ucts on sequencing-type polyacrylamide gels, we
minimize the problems associated with nonspecific
amplifications given by the degenerate Myb primers.
Labeled bands of identical sizes present in PCRs
from both dimensions of the grid constitute putative
insertions in Myb-homologous sequences, allowing
the immediate identification of the specific maize ear
from which the kernels were planted. Using this
strategy, more than ten putative insertions have been
identified. From three sequenced so far, one cor-
responds to an insertion of a Mutator element in a
putative intron of a novel myb gene. We are currently
investigating whether the presence of this insertion
cosegregates with a visible phenotype in the progeny
of plants containing the Mutator element inserted in
this gene.
Cloning of the Mixta Myb
Domain Protein from
Arabidopsis thaliana
P.D. Rabinowicz, G. Moriates (C.W. Post), E. Grotewold
A new area into which our research is moving is to
determine the mechanisms by which Myb domain
proteins regulate important plant developmental pro-
cesses, in addition to the biosynthesis of secondary
metabolites. Specifically, we are focusing on polar-
ized cell growth regulated by the Myb domain pro-
teins Mixta and GL1. The snapdragon Mixta protein
regulates petal cell shape (Noda et al., Nature 369:
661 [1994]), whereas the Arabidopsis GL1 protein is
required for the differentiation of epidermal cells into
trichomes (hair cells) (Marks, Curr. Biol 4: 621
[1994]). No target genes for Mixta or GL1 have yet
been identified, and little is known about the mech-
anisms used by plants to control cell shape, pre-
sumably by regulating the biosynthesis and/or polar-
ized transport of cell wall components. In plants, the
polarized transport of cell wall components to specif-
ic cell wall domains has fundamental developmental
implications in cell shape, cell differentiation, and
ultimately in pattern formation and morphogenesis.
Do the GL1 and Mixta proteins regulate different
aspects of the biosynthesis of specific cell wall com-
ponents, similarly as P and Cl regulate different
branches of flavonoid biosynthesis, or do they control
trafficking of cell wall components to particular cell
wall domains?
As a first step to answer this question, we cloned
the Mixta gene from Arabidopsis thaliana (A.t.
Mixta). A.t. Mixta contains a Myb domain 91%
identical to the Myb domain from the snapdragon
Mixta gene, but outside this region, the homology
drops significantly (Rabinowicz et al. 1996). We are
currently testing whether A.t. Mixta complements a
mutation in the Mixta gene from Petunia, a plant
more amenable to transformation than snapdragon.
A novel strategy to identify target genes for A.t.
Mixta has been devised. We obtained from the
Arabidopsis gene-trap and enhancer-trap collection at
CSHL lines with GUS staining patterns specific to
the petals, the tissue where Mixta is expressed. By
bombarding leaves from these plants with A.t. Mixta
expressed from a constitutive promoter, we are
screening for lines in which GUS activity is induced
by A.t. Mixta. This would indicate which plants con-
tain an insertion of the transposable element with the
reporter close to a gene downstream from A.t. Mixta.
Experiments are also currently under way to deter-
mine the effect of the ectopic expression of A.t.
Mixta in leaf epidermal cells and how mutations that
affect trichome formation interfere with Mixta func-
tion.
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ARABIDOPSIS FLOWER DEVELOPMENT
H. Ma J. Cruz K. Grace H. Huang
D. DeLagante S. Guha H. Katari
H. Fan A. Hameed D. Kwan
C. Flanagan Y. Hu R. Levin
D. Liu
J. Lyons
Y. Mizukami
D. Rosa
P. Rubinelli
S. Virani
M. Yang
We continue to probe the molecular mechanisms con- dopsis thaliana. Specifically, we focus on genes
trolling cell fates during development, using Arabi- regulating flower development. During the past
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several years, we have been characterizing the func-
tion of several members of the MADS-box gene fam-
ily, which has members in all major eukaryotic king-
doms. One of the genes that we study is the
Arabidopsis floral homeotic gene AGAMOUS (AG),
which is a critical regulator of both floral organ
identity and floral meristem identity. Many other
MADS-box genes were isolated molecularly and
designated as AGL for AG-Like.
In addition, we have isolated and characterized
three Arabidopsis mutant alleles in the FONI gene
(Floral Organ Number); these mutants have an in-
creased number of reproductive floral organs. Fur-
thermore, we are in the process of identifying new
genes required for flower development using enhan-
cer trap/gene trap transposon mutagenesis methods.
In addition, to isolate new genes that function during
late floral organ development, we have identified a
number of genes specifically expressed in carpels or
stamens. These genes are likely to be involved in cell
differentiation during late flower development, and
they provide molecular markers for specific cells or
tissues of the reproductive organs.
In 1996, we were joined by two new postdocs,
Ming Yang and Dehua Liu, in April and June, respec-
tively. Ming had just finished his Ph.D. at Ohio State,
where he studied Arabidopsis mutants defective in
cell division patterns in leaves, and Dehua was a
postdoc at the Noble Foundation in Oklahoma, where
he studied an enzyme involved in fatty acid biosyn-
thesis. We bid farewell to our postdocs Cathy Flana-
gan, who moved to the Seattle area with her husband
Andrew Flint, and Yukiko Mizukami, who went to
Berkeley to continue her research in the area of plant
reproductive development. Last year, as in previous
years, several undergraduate students participated in
our research. From SUNY at Stony Brook, Kristen
Grace and Julissa Cruz came to our lab in the spring
and continued in the summer, Harpreet Katari and
Robert Levin joined us in the summer, and Julissa
Cruz, James Lyons, Danielle DeLagante, and Sam it
Guha worked here in the fall; they participated in our
enhancer trap projects and transgenic plant work with
the AG and AGL genes. Aliyah Hameed from Bryn
Mawr returned for a second summer, working with
postdoc Hai Huang. David Kwan from Berkeley also
spent part of the summer working with Hua-Ying
Fan, a postdoc in our lab, to characterize the interac-
tion between AG and AGL s. Last spring, our Partner
for the Future, Dominik Rosa, a senior at Commack
High School, completed his work with Peter Rubin-
elli on stamen-specific cDNA clones. And last fall, a
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new Partner, Sophia Virani from Herricks High
School, started working on the analysis of stamen-
specific genes and the AGL1 gene. We gratefully ac-
knowledge the assistance of Upland Farms' manager
Tim Mulligan and his assistant Stan Schwarz.
Generation of New Enhancer
and Gene Trap Transposants
and Analysis of Floral
Expression Patterns
C.A. Flanagan, H.-Y. Fan, M. Yang, H. Katari,
J. Cruz, R. Levin, J. Lyons, D. Delagante,
S. Guha, Y. Hu, H. Ma
To identify new genes regulating Arabidopsis flower
development, we have continued to generate enhan-
cer trap/gene trap transposon insertional lines. We
have now generated about 2200 independent inser-
tional lines, or transposants. At the same time, we
have begun to characterize the transposants. We have
examined the expression patterns of the Ds-borne
GUS reporter gene in the first 900 transposants gen-
erated by the laboratories of Drs. Sundaresan, Mar-
tienssen, and Grossniklaus, and our lab. We have ex-
amined the staining patterns in the inflorescences, in-
dividual mature flowers, seed pods, and cauline
leaves (as a control for vegetative tissue). Overall,
about 20-30% of the transposant lines stain in the
flower. GUS staining was found in flowers at early,
intermediate, or late stages of development, and vari-
ous combinations of staining in different organs were
observed. In particular, patterns in the reproductive
organs and at intermediate to late stages are the most
common. On the other hand, truly constitutive ex-
pression was rare. Furthermore, there are many dif-
ferent patterns within single organs, reflecting cell- or
tissue-specific GUS expression. The characterization
of these and additional lines should allow us to iden-
tify many new genes functioning in flower develop-
ment.
AG-AGL Interactions Mediated
by the K Domain
H.-Y. Fan, Y. Hu, M. Tudor,
D. Kwan, H. Ma
Plant MADS domain regulatory proteins have a
region of moderate sequence similarity that has been
designated as the K domain, and its predicted coiled-
coil structure suggests a role in establishing a protein-
protein interaction. In vivo studies with the Arabi-
dopsis AGAMOUS (AG) protein have indicated that
the .K domain is important for AG function. Using a
bait fusion protein containing the K domain and the
carboxy-terminal region of AG in a yeast two-hybrid
selection, we found 156 clones that encode potential
AG-interacting proteins. These clones encode one of
four highly related MADS domain proteins: AGL2,
AGL4, AGL6, and AGL9. Additional analysis
showed that the K domain of AG alone was able to
bind the K domains of these AGLs. This binding was
further confirmed by immunoprecipitation experi-
ments using in-vitro-synthesized AG and AGL
proteins. These results strongly indicate that AG in-
teracts with AGL2, AGL4, AGL6, and AGL9. On the
basis of these results and previous observations, we
propose that AG function requires interaction with at
least one of these AGL proteins, and such interac-
tions contribute to the functional specificity of the
AG protein.
Phenotypic Analysis of Double
Mutants between fonl and Other
Floral Mutations
H. Huang, A. Hameed, H. Ma
We previously reported the isolation of an Arabi-
dopsis floral organ number mutant, fonl, and the
characterization of its phenotype (H. Huang and H.
Ma, 1993, 1994, 1995 Annual Reports). The fon]
single-mutant phenotype indicates that the FONT
gene regulates the duration of the floral meristem,
and the organization of floral organ primordia. To
test for genetic interaction between FONT and other
genes, we have generated and analyzed a large num-
ber of double mutants. The clavata (clv) mutations
are known to affect floral meristem activity. We
found that the clv] fonl, clv2 fonl, and clv3 fonl
double mutants all show similar phenotypes, having
more stamens and carpels than either fonl or clv
single mutants. These results indicate that FON1 and
CLV genes function in different pathways to control
the number of third and fourth whorl floral organs. In
addition, double-mutant phenotypes suggest that
FON1 does not interact with TERMINAL FLOWER]
(TFL1), APETALAI (AP1), APETALA2 (AP2), or
UNUSUAL FLORAL ORGAN (UFO). In contrast,
normal LEAFY (LFY) function is required for the ex-
pression of fonl phenotypes. In addition, FONT and
AGAMOUS (AG) both seem to affect the domain of
APETALA3 (AP3) function, which also affects the
formation of stamen-carpel chimera due to fonl
mutations. Finally, genetic analysis suggests that
FONT interacts with SUPERMAN (SUP), which also
regulates floral meristem activity.
Characterization of
Organ-specific cDNAs
P. Rubinelli, Y. Hu, S. Virani, D. Rosa, H. Ma
As described in previous Annual Reports, we have
been characterizing several cDNAs that are expressed
specifically or predominantly in anther or pollen.
Among these clones, APT27 encodes a putative
glucosidase with similarity to plant glucosidases that
convert inactive storage forms of the plant hormone
cytokinin to active forms. We have constructed Es-
cherichia coli expression plasmids to produce recom-
binant APT27 protein for in vitro biochemical
studies, which are in progress. At the same time,
several constructs have been made to test its function
in vivo using transgenic plants. We are currently gen-
erating transgenic plants. In addition, antisense trans-
genic plants are being produced to test the function of
a few other anther/pollen-specific genes.
Characterization of Male
Fertility Mutants
M. Yang, H. Ma
To identify and characterize new genes that control
the development of the male reproductive organ
stamen and male haploid generation (gametophyte)
pollen, we have searched for male sterile or low-
fertility mutants among the enhancer/gene trap
transposants. More than 20 candidates were found
thus far, and we have characterized two of these in
some detail. The first mutant, 218-181, has a reduced
fertility as indicated by a reduced seed set. The
mutant also has defects in floral organs, including
fused sepals and filaments. We found that the fila-
ment of the mutant stamens has about one-fourth the
normal length and that pollen development per se
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seems to be normal and the pollen grains are func-
tional. The fertility defect seems to be due to an in-
ability to deliver pollen grains to the stigma. The sec-
ond mutant, 1176-306, is a tight male sterile mutant.
The mutant also produces smaller petals. Microscopic
analysis indicates that pollen development and/or
release is affected. The mutant filament is about half
as long as the normal one and has about half as many
normal-sized cells as in wild type. Therefore, cell
division may be affected in the mutant filament and
possibly in the mutant petal. The sterility could be
due to the same cellular defects during pollen devel-
opment.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano M. Hirano
K. Kimura
A. Losada
Our laboratory is interested in understanding the
molecular mechanisms responsible for the dynamic
changes of higher-order chromosome structure during
the cell cycle. The experimental system we use is a
cell-free extract derived from Xenopus laevis (Afri-
can toad) eggs in which higher-order chromosome
structures can be reconstituted in vitro in a cell-cycle-
dependent manner. This unique system provides us
with both a simple procedure for chromosome isola-
tion and a powerful functional assay for chromosome
condensation. We previously identified major poly-
peptides of mitotic chromosomes assembled in this
cell-free system, which we referred to as Xenopus
chromosome-associated polypeptides (XCAPs). Our
initial efforts were focused on two of the XCAPs,
XCAP-C and XCAP-E, and we were able to demon-
strate that they have a key role in mitotic chromo-
some condensation in vitro. Both polypeptides belong
to an emerging family of putative ATPases, the SMC
(structural maintenance of chromosomes) family. The
family has expanded rapidly in the last 2 years since
its discovery, and it is now known that SMC proteins
are involved in many aspects of higher-order chromo-
some structure and function, including chromosome
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segregation, dosage compensation, and recombina-
tional DNA repair. During the past year, we purified
protein complexes (termed condensins) containing
XCAP-C and XCAP-E and found that three additional
components copurified with these polypeptides. We
completed cDNA cloning of the newly identified sub-
units and obtained basic information on DNA-binding
activities associated with condensins. We also ex-
tended our efforts to the identification and character-
ization of a second class of SMC protein complexes in
Xenopus egg extracts.
Molecular Characterization
of Condensin Subunits
T. Hirano, M. Hirano [in collaboration with
R. Kobayashi, Cold Spring Harbor Laboratory]
By immunoaffinity chromatography using anti-pep-
tide antibodies, we purified protein complexes con-
taining XCAP-C and XCAP-E from Xenopus egg ex-
tracts. Sucrose density gradient centrifugation of an
affinity-purified fraction revealed two major forms of
the complexes: The 8S form (termed 8S condensin) is
a heterodimer of XCAP-C and XCAP-E, whereas the
13S form (13S condensin) contains three additional
subunits. We found that the newly identified subunits
are identical to previously uncharacterized XCAPs,
XCAP-D2, XCAP-G, and XCAP-H. Both 8S and
13S condensins are targeted to chromosomes in a
mitosis-specific and phosphorylation-dependent man-
ner. Immunodepletion and addback experiments
showed that 13S condensin is absolutely required for
chromosome assembly in vitro. Our results also sug-
gested that 8S condensin has a minor contribution to
proper condensation of mitotic chromosomes.
We cloned cDNAs encoding the newly identified
three XCAPs and found that all of them are novel
proteins (Table 1). An initial database search identi-
fied homologs of yeast and humans, but no genetics
or biochemistry had been described in these homo-
logs. Very recently, however, an apparent homolog
of XCAP-H was identified from Drosophila melano-
gaster as a gene product, Barren, whose mutation
shows a defect in mitotic chromosome segregation in
early embryos. Although biochemical characteriza-
tion of Barren remains to be done, the mutant
phenotype and the chromosomal localization of Bar-
ren are totally consistent with the idea that it is a
component of 13S condensin in Drosophila. We
therefore anticipate that the structural organization
and individual subunits of condensins are highly con-
served among eukaryotes and that they play a funda-
mental part in chromosome condensation both in
vitro and in vivo. Moreover, we found a limited
TABLE 1 Subunits of the Two Different Classes of SMC
Protein Complexes
Molecular S. S. D.
Xenopus massa cerevisiae pombe melanogaster
Subunits of condensins
XCAP-C
XCAP-E
XCAP-D2
XCAP-G
XCAP-H
165 kD
140 kD
150 kD
130 kD
100 kD
Smc4pb
Smc2p
yes
yes
yes
Cut 3p
Cut14p
yes
Subunits of the XSMC1/3 complexes
XSMC1 160 kD Smclp
XSMC3 140 kD Smc3pb yes
2
2
Barren
Dcapb
Yes indicates that a putative homolog of unknown function has
been deposited in the databases.
a Determined by SDS-PAGE.
Named, but no functional analysis has been reported.
similarity between XCAP-H and DPY-26, a Caenor-
habditis elegans protein required for meiotic
chromosome segregation. Remarkably, in somatic
cells, DPY-26 is also involved in dosage compensa-
tion as a component of a protein complex containing
DPY-27, an SMC protein exclusively required for
dosage compensation. This result strengthens our pre-
vious proposal that the two apparently different chro-
mosomal events, chromosome condensation and dos-
age compensation, might share common molecular
mechanisms.
Biochemical Activities
of Condensins
K. Kimura, T. Hirano
Although we have demonstrated that condensins are
able to drive chromosome condensation in our cell-
free system, we do not know how they work in this
complex process. To understand condensin functions
at a mechanistic level, we are trying to identify
biochemical activities of purified condensins. We
have made three predictions for functions of this
novel class of protein complexes: (1) Since genes en-
coding SMC proteins have been found in several bac-
terial genomes, the primary target of condensins is
DNA, rather than eukaryote-specific chromatin com-
ponents (e.g., histones); (2) since condensins localize
to whole chromosomal arms, they are not likely to
exhibit strict sequence specificity for their DNA-
binding; and (3) since XCAP-C and XCAP-E contain
putative ATP-binding motifs, condensins must have
an activity that changes DNA structure in an ATP-
dependent manner. We tested these predictions by
using affinity-purified fractions containing 13S con-
densin. We found that the fractions contained a
DNA-binding activity as determined by a gel-retarda-
tion assay using nonspecific duplex DNA probes.
Competition experiments showed preferential bind-
ing to long DNA fragments compared with short ones
(e.g., 600 by vs. 100 bp). We also found that the 13S
condensin fractions exhibited higher affinity for
synthetic cruciform DNAs than for duplex DNAs
with the same sequences. Thus, 13S condensin might
recognize structured DNAs, such as DNA crossover
or bent DNA. Furthermore, preliminary experiments
suggested that 13S condensin was able to introduce
positive supercoils into a closed circular DNA in the
presence of topoisomerase I. The supercoiling reac-
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tion was ATP-dependent. We speculate that 13S con-
densin either wraps or overwinds DNA by utilizing
the energy of ATP hydrolysis, thereby inducing local
positive supercoiling of chromosomal DNA. Such
topological changes could lead to an accumulation of
torsional stress of DNA in adjacent regions, which in
turn contributes to higher-order structural changes of
chromatin fibers. Experiments to test this model are
now in progress.
Identification of a Second Class
of SMC Protein Complexes
A. Losada, M. Hirano, T. Hirano
The genome project of Saccharomyces cerevisiae
identified four members of the SMC family in this
organism, Smclp, Smc2p, Smc3p and Smc4p. Pre-
vious genetic studies showed that Smclp and Smc2p
are required for proper segregation of mitotic chro-
mosomes, whereas mutations in Smc3p and Smc4p
have not yet been reported. Since Smc2p and Smc4p
are most homologous to XCAP-E and XCAP-C, re-
spectively, we believe that the two yeast gene prod-
ucts function as core subunits of yeast condensins
(Table 1). This is consistent with the previous obser-
vation that a defect in chromosome condensation was
observed in smc2, but not in smcl. What then is the
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exact role of Smclp and Smc3p in chromosome
dynamics during mitosis? This question prompted us
to search for additional SMC polypeptides from
Xenopus egg extracts. On the basis of sequence
homology, we cloned cDNAs encoding XSMC1 and
XSMC3, Xenopus homologs of Smcl p and Smc3p,
respectively (Table 1). By raising specific antibodies
against these polypeptides, we found that XSMC1
and XSMC3 associate with each other in the extracts,
forming two distinct complexes with sedimentation
coefficients of 10S and 15S. Neither the 10S nor 15S
form contains condensin subunits. Conversely, nei-
ther XSMC1 nor XSMC3 associates with condensins.
By analogy to 13S condensin consisting of five sub-
units, it is likely that the 15S complex contains addi-
tional subunits besides XSMC1 and XSMC3. We are
now investigating the localization and functions of
these new protein complexes containing XSMC1 and
XSMC3. Preliminary results suggested that the
XSMC1/3 complexes are not required for chromo-
some condensation in our cell-free system. We ex-
pect that they might be involved in other processes
essential for proper segregation of mitotic chromo-
somes, for example, sister chromatid cohesion.
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STRUCTURE AND COMPUTATION
Scientists in this section are engaged in basic research and methodology development in gene
discovery and in gene and protein functional analysis. The program is comprehensive and has
major programs both in the experimental and computational aspects of gene discovery and in the
analysis and prediction of gene and protein structure and function. The main scientific thrust and
overall goals of this section are to develop and apply methods that
establish chromosomal position of heritable disease genes by linkage and segregation
analysis of affected families
automate high-speed DNA sequencing over long contiguous regions of genomic DNA
automate the detection of segments of genomic DNA sequences that have specific biologic
content
predict gene function by homology/analogy to existing sequences
isolate and characterize minuscule amounts of proteins for cloning genes using degenerate
PCR techniques
use X-ray diffraction patterns with crystalline proteins to determine their three-dimensional
structure with the goal of understanding their function
use combinatorial chemistry methods to screen for significant molecular interactions among
large arrays of molecules
COMPUTATION AND HUMAN GENETICS
T. Marr S. Cozza J. Helmich
D. Cuddihy T. Iwasaki
D. Gordon J. Lugert
E. Hackborn M. Mallison
J. Salit
A. Tracy
M. Zhang
GENOME TOPOGRAPHER SOFTWARE
The overall goal of our laboratory is to enhance the
capability of the genome topographer (GT) prototype
software for use as a high-quality software package
that addresses major informatics research require-
ments of the molecular biology and genetics research
and development communities. GT is a major soft-
ware package that we have been working on for
several years. We have major funding through the
National Institutes of Health (NIH) as a Human
Genome Informatics Research Resource and from
Genomica Corporation. This funding relationship be-
tween NIH and the private sector was strongly en-
couraged by the NIH Council. This software is
designed to be useful to users ranging from those in
large-scale production labs to those in smaller,
hypothesis-driven labs.
In recent years, many of the molecular details of
the structure of the human genome have become ap-
parent as a surge of research has produced new in-
formation about chromosome organization and genet-
ic and physical maps, and details about specific
chromosomal regions, gene sequences, and gene/
protein interactions. These types of information are
being used to drive research in several areas, much of
it medically oriented. Specifically, research into the
genetic basis of complex diseases is heavily in-
fluenced by these recent advances.
A disease is considered complex if it displays non-
Mendelian characteristics. In general, this is the result
of a disease phenotype being caused by the interac-
tion of multiple genetic and environmental factors.
More specifically, this may happen because different
mutations at a single locus give rise to clinically
similar phenotypes (allelic heterogeneity); mutations
at any one of a number of different loci cause clini-
cally indistinguishable phenotypes (locus heterogene-
ity); differences in expression of an allele depend on
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which parent transmitted it (genetic imprinting) or
expression of the gene is affected by the sex of the in-
dividual (sex limitation); expression of a mutant gene
causes disease in only some individuals (incomplete
penetrance); inheritance is strictly maternal (mito-
chondrial inheritance); expression of an allele
depends on interactions with other genes and envi-
ronmental factors (multifactorial inheritance); expan-
sion of trinucleotide repeats in coding or regulatory
regions of the gene alters its expression in a progres-
sive manner over several generations (anticipation);
the occurrence of environmentally induced nonherit-
able cases of a disease with a phenotype indistin-
guishable from the genetic version (phenocopies); or
novel mutations in a germ line or tissue cause disease
(sporadic cases). Complex disorders may also be
plagued by problems of uncertain diagnoses because
of the range of phenotypic variation and variable age
of onset.
In simplistic terms, it may be considered that there
are two types of complex diseases. The first would be
those that show a relatively high level of heritability
and that may be studied primarily by tracking a dis-
ease gene through generations of families that display
familial clustering. The second would be those that
are far more frequently the result of the accumulation
and interactions of somatic mutations. Here, molecu-
lar and biochemical analyses represent a feasible ap-
proach to study.
A group of diseases that fall into the first category
is the human psychiatric diseases. It has been demon-
strated through twin and family studies that many of
these diseases have a considerable genetic compo-
nent, which makes them reasonable candidates for
the genetic linkage. Many exhibit a bewildering array
of phenotypes, variable age of onset, heterogeneity,
polygenic inheritance, and incomplete penetrance.
These factors combined have made analysis of genet-
ic data difficult using the available technology and
have drastically slowed progress in disease gene lo-
calization. Many of these disorders are very prev-
alent in the population. For example, bipolar disorder
has an estimated prevalence of 1-2% in the general
population. Therefore, these diseases represent dif-
ficulties and medical expenses for a large segment of
the general population.
The other type of disease is typified by cancer, a
clearly complex disease characterized by uncon-
trolled or otherwise abnormal proliferation of cells.
The progression of the disease involves the escape of
a single cell from its normal proliferative controls,
clonal amplification of the altered cell and accumula-
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tion of secondary mutations, bypass of the organ-
ism's defenses that otherwise eliminate abnormal
cells, metastasis of the primary tumor to other parts
of the body, proliferation of the metastatic cells in
other organs and elimination of function in these
organs, and the development of multidrug resistance.
Current estimates of the number of genetic alterations
that are required for this full progression range from
three to five.
These disorders typify two poles of medical re-
search today and are used to guide the development
of GT as a useful computer tool. The new areas we
emphasized most strongly this past year are the gen-
eration of a linkage analysis workbench, the genera-
tion of a sequence analysis workbench, and the devel-
opment of specialized database tools that integrate in-
formation that might lead to novel breakthroughs or
novel experimental ideas in the study of collections
of genes and their products such as oncogenes. These
represent three facets of research where the applica-
tion of sophisticated computer technology will con-
tribute significantly. Although they are being devel-
oped separately, it must be stressed that the combina-
tion of such approaches and tools is the real strength
of GT, and the study of any disease should be facili-
tated by the use of one or more of them.
The development of the linkage analysis work-
bench will address the current technical difficulties
encountered in carrying out linkage, epidemiology,
and segregation analysis. The details of the design of
this package can be seen in the user manual overview
pages, but it has become increasingly clear that a real
need exists for the standardization, integration, and
simplification of computer-based approaches to these
analyses.
The study of diseases such as cancer is not as well
suited to linkage analysis techniques and would
benefit more from the integration and correlation of
data relating to cellular biology (for information on
the genetic, molecular, and biochemical basis of cel-
lular proliferation and invasion), immunology (for in-
formation on the body's defense mechanisms for
elimination of abnormal cells), and epidemiology (for
information on environmental risk factors and genetic
predispositions present in subpopulations).
The role of rapid and complete sequence analysis
in both genetic and sporadic lesion-based disease re-
search cannot be overstated. Sequence analysis be-
comes critical at the point where disease genes have
been identified and at the point where gene/gene in-
teractions are being assessed. Apart from annotating
the sequence of a new gene, sequence analysis
permits researchers to define functional families of
proteins that in turn provides some additional in-
formation about the biochemical interactions that un-
derlie the disease. From the results of database
searches, one may locate sequence motifs, make
functional predictions, and functionally delineate
protein families. Rapid iterative testing of slight vari-
ations of a motif to improve its specificity would be
one way to exploit sequence analysis methodologies
to augment the amount of information gained.
There is now a great need for the type of integra-
tive and analytical software that we are proposing to
develop. Currently, researchers must use several dif-
ferent sources of data to devise informative experi-
ments, such as the published scientific literature and
scientific meetings. They must be familiar with a
myriad of often difficult-to-use computer programs to
perform even relatively simple investigations into the
potentially relevant record of data or to perform
analyses on data that they have collected. Limitations
also apply to the interpretation of results, which
would be simplified and enhanced by allowing re-
searchers to see them in the context of what is cur-
rently known about the genomes of human and model
organisms. The consequence of the current situation
is that most biologists are not able to efficiently and
fully analyze their data and are likely missing crucial
new findings. The situation is exacerbated by an
ever-growing number of journals, scientific meetings,
specialized databases using ad hoc nomenclature,
data representational and computer access methods,
and analysis programs that have individual idiosyn-
cratic requirements.
Considering these facts, a major goal in the devel-
opment of the GT software has been to allow the user
to move from clinical assessment of disease pheno-
types, to genetic map, to physical map, to sequence
and function, and back to clinical assessment of
potential drugs using what appears to the user as one
computer program. Our work in 1996 extends this
idea to support the movement from sequence or link-
age analysis programs to stored genome data or the
movement from specialized databases to the general-
ly available public data servers with the same ease.
Of critical importance is the fact that GT will allow
researchers to maximally utilize the conservation of
genes and the chromosomal synteny of model organ-
isms, such as yeast and mouse, quickly and easily.
The additional data that are available from such
model organisms are currently not fully exploited by
many researchers and will likely provide critical in-
sights into existing data.
The next phase of the Human Genome Project
(HGP) is likely to be characterized by the availability
of (1) significant amounts of DNA sequence from hu-
man and model organisms, (2) physical maps of in-
creasing resolution with localized ESTs of the human
and mouse genomes using standardized, verifiable
mapping technologies, (3) high-density maps of poly-
morphic genetic markers for the human and mouse
genomes, and (4) major advances in methods for high
throughput genotyping, positional cloning and/or
exon trapping, and sequencing.
The methods and materials resulting from the HGP
are well suited to meet the challenges in the study of
complex human genetic diseases, which require the
ability to detect and sort out heterogeneous, polygen-
ic, and epistatic genetic effects, modulated by en-
vironmental factors. Scientific investigations into the
parts of the puzzles presented by these complex prob-
lems require application of state-of-the-art experi-
mental methodologies in the fields of genetics,
molecular biology, and biochemistry. It is our thesis
that gene finding, functional analysis, and efficacy
testing could be greatly accelerated using state-of-
the-art computer methodologies if (1) relevant data
were represented in a simple, reproducible, and
semantically integrated manner, (2) the timeliness of
the flow of such data between small, hypothesis-
driven research labs and large genome centers was
optimized, and (3) basic researchers were empowered
with "user-friendly," but technically powerful, tools
for computer-aided interpretation of the data. These
are the goals of our GT software project.
The software allows users to take full advantage
of the data being generated by International Human
Genome Programs. The scope of the software in-
cludes applications in clinical genetics and epidemi-
ology, statistical genetics, molecular biology, and
molecular genetics and biochemistry. The software
has been in field test at several locations since Octo-
ber 1996, and the first production release 1.0 of this
client-server based software, which is scheduled for
release in third quarter 1997, will allow users to carry
out the following:
1. Connect by internet/intranet to a central GT data-
base server for access to semantically integrated
collections of most of the large-scale data current-
ly generated by the international genome project.
Example data sources include the Whitehead/MIT
Center, GDB, Genethon, Sanger Center, Jackson
Lab Mouse Genome Database, and all of the nu-
cleotide and protein sequence databases at NCBI.
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2. Graphically display and execute queries for selec-
tively sifting through these large and sometimes
redundant data collections, retrieving results into
the GT client application, cut-and-paste results
into other client applications, such as word pro-
cessors, and print postscript graphics of a compre-
hensive collection of genetic, radiation hybrid,
and physical maps, including highly annotated
genomic sequences, for example.
3. Query and integrate results from the NCB! MED-
LINE and sequence databases using keywords
and/or by searching them using BLAST. In addi-
tion, for users with adequately equipped Unix
workstations, we provide the option to perform
rigorous sequence database searching and align-
ment studies using FASTA and a full dynamic
programming method developed at the Resource.
This latter option is particularly useful for STS
and EST analysis.
4. Transparently connect to multiple GT servers so
that users can go to original sources of data
(which use a GT server). Ultimately, GT will run
in a truly federated mode whereby the user is
capable of transparently running queries across
multiple geographically distributed databases of
mixed architecture.
5. Use GT experiment management capabilities for
managing, tracking, and assessing the quality of
large-scale DNA mapping and sequencing pro-
jects.
The first official test release of the GT software
was October 1996. It was installed and tested at six
laboratories representative of the wide range of users
intended for GT. Following the October 96 release
and after getting feedback from user sites and making
appropriate changes to the software, we released and
began installation of version 1.0 gamma of the GT
software in March 1997 to an expanded 15 test sites,
including three pharmaceutical companies, two bio-
tech companies, two private medical research labor-
atories, one government medical research laboratory,
and seven intermediate sized, academic molecular
biology and genetics research laboratories. We refer
to these 15 sites as "opinion leader" sites because
they all are major sites and involve opinion-leading
scientists. A full-featured user manual, administra-
tors' manual, and training guide have been written.
Perhaps the most exciting and largest technical ad-
vance in the underlying GT technology was the ar-
rival of our vendor-based technologies: (1) database
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federation technology available in the Gem Stone
database product, and thus in the GT server, and (2)
the Common Object Request Broker Architecture
(CORBA). The short- and long-term implications of
these technologies are wide ranging and include the
potential development of a Federation of GT database
servers and clients that are all transparently inter-
connected semantically, logically, and securely. This
could lead to the consolidation of the informatics
needs for data generation and distribution of as much
as is desired by the genome program management,
and perhaps as important, related programs taking ad-
vantage of genome program data.
For example, using a GT Federation system, it
would be possible to put a GT server in several hu-
man genome sequencing centers which will trans-
form clones from a sequence-ready physical map into
long sequences of genomic DNA. People at the
NCHGR Sequencing Center would probably be in-
volved in the further analysis and annotation of se-
quences by computer and some experiments. It would
be useful to have a great deal of peer-reviewed
scientists at other sites analyzing these sequences as
well, because of the difficulty in automated feature
extraction from mammalian sequences. Federated GT
servers and clients could be transparently integrated
to many such sites. Furthermore, suppose that a peer-
reviewed scientist (e.g., NCI study section) is study-
ing sequence polymorphisms in large collections of
oncology patients and their tumors pathologies. A GT
server and client could be provided and transparently
intergrated into the growing Federation as well. None
of the growing or incrementally increasing knowl-
edge base need always be available for perusal by
others on the Federation network, or the public in
general using GT security tools, but rather only after
the data and metadata have undergone some agreed
upon release mechanism. This is only one scenario
using this powerful new database Federation technol-
ogy. The new CORBA interface opens up other, but
equally powerful, possibilities.
We have been working with two different new
releases of CORBA, one at the server level and one at
the client level. So far, we have concluded that the
server-level implementation is the most sound given
the state of CORBA technologies as a whole. The
CORBA implementation that Gem Stone supplies
with their release 5.1 product provides an industry
standard ORB (such as standards are) and supports
language interfaces including Smalltalk, Java, C,
C++, and HTML. For our own development process,
this allows us to use CORBA for all network-based
computing, such as our compute server applications,
using a very sophisticated application program inter-
face that includes queueing, security, failure, and
most asynchronous network processing using indus-
try-standards. We have developed some of these our-
selves in the past. More importantly is that CORBA
opens up GT to outside developers so that they can
write their own applications against GT without inter-
action with the GT development team. It also means
that both HTML and Java based browsers can be
written using the GT databases for the data server,
without using the GT client at all.
The Genetic Basis of
Manic-Depressive Illness
A Charles A. Dana Foundation Consortium among Cold
Spring Harbor Laboratory, Johns Hopkins University, and
Stanford University.
T. Marr (1), J.R. De Paulo (2), C.J. Friddle (3), D. Botstein (3),
M. Gschwend (3), R.J. Koskela (3), M.G. McInnis (2), F.J.
McMahon (2), D.A. Meyers (2), S.G. Simpson (2), O.C. Stine
(2), D. Gordon (1), J.D. Watson (1)
(1) Cold Spring Harbor Laboratory, Structure and Computa-
tion Program
(2) Johns Hopkins University, School of Medicine, Depart.
ment of Psychiatry
(3) Stanford University, School of Medicine, Department of
Human Genetics
The Dana Consortium is formally coming to an end
in June 1997, but data analysis will be an ongoing ef-
fort at all of the contributing labs. Positive results
have now been repeatedly found on chromosome
18q. This may be the first such finding ever for a
gene involved in a complex human behavior.
Because of the expected complexity of the genetic
components of manic-depressive disorder (MDD), it
is essential that the clinical and experimental data
that provide the foundation of the genetic study be of
highest quality possible. Furthermore, because of the
lack of mathematical algorithms that are clearly supe-
rior, or perhaps even relevant, to detecting linkage
between phenotype and genotype for genetically
heterogeneous disorders, such as MDD is thought to
be, it is essential that the basic data be managed in a
computer system that allows for facile manipulation
and extensive, flexible analysis of the data. Finally,
again because of the lack of rigorous analytic tools, it
is essential to have a computer system that allows for
extensive manual, visually based exploratory analy-
ses.
These are the issues that Cold Spring Harbor Lab-
oratory has focused on in this collaboration, namely,
providing a rigorous data handling, manipulation, and
analysis computer platform for the ongoing and final
phases of the project. We have developed a software
system that addresses these issues, which will be crit-
ical to the next phase of the project, i.e., the analysis
phase. We will distribute our software to the col-
laborators after most of the basic data have been col-
lected and entered into the system, and analyses can
then proceed. As discussed with Dana officials at the
beginning of this project, the system we developed is
generally applicable to complex genetic systems and
is not specific to MDD and will therefore be useful to
potentially a large number of important genetic dis-
orders, including other neurologic disorders, cancer,
and hypertension.
The types of data that needed to be supported in
our project are extensive and include clinical data,
pedigree data, genotyping data, laboratory data con-
cerning locations and identities of cell lines and DNA
supplies, and related matters. We have developed an
integrated computer program that now is capable of
storing, manipulating, consistency checking, and
otherwise generally analyzing all of the relevant pri-
mary data resulting from the clinical and experimen-
tal efforts of the Dana Consortium. The software is
distributed on a CD ROM disk and can be easily in-
stalled by relatively novice computer users. The
client software runs equally well on Macintosh, PC,
and Unix computers. The database software runs on
PC computers running MS Windows NT or Unix sys-
tems.
Because there are no existing mathematical meth-
ods that are clearly superior to others or are known to
be singly effective in linkage studies in diseases that
are genetically heterogeneous, we have developed
new methods that determine linkage and/or enhance
current linkage methods. We have used mathematics
and statistics to provide analytic solutions to ques-
tions about distribution theory, power, and sample
size for linkage tests. We are currently applying these
methods to the Dana bipolar data under a range of ge-
netic models and parameter specifications.
For the data analysis portion, we have performed
the following: an exploratory data analysis of certain
genetic model-based and genetic model-free statistics
from current state-of-the-art linkage programs SAGE
SIBPAL (Tran et al., Sib-pair Linkage Program Ver-
sion 2.6. Part of S.A.G.E. Release Documentation
1384 [1994]), and GENEHUNTER (Kruglyak et al.,
Am. J. Hum. Genet. 58: 1347 [1996]). We have ap-
plied analysis of variance with markers and pedigree
effects, Tukey's one-degree-of-freedom test for
removable additivity, and transformation of the data
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to remove nonadditivity. We have run SAGE SIB-
PAL on the entire genome. Our findings agreed with
the results published by Stine et al. (Am. J. Hum.
Genet. 57: 1384 [1995]), namely, strongest evidence
for linkage was on chromosome 18, the pter (marker
D18S37). It is vitally important that data analysis of
the Dana families be continued. The findings of Stine
et al. were marginally significant, and our exploratory
data analysis in combination with our mathematical
computations will enable us to determine if the find-
ing is a true but weak finding or a false-positive find-
ing. Furthermore, our methods will enable us to
determine if other chromosomes suggest linkage to
bipolar illness.
We have studied the effects of allele frequency
variation on the outcome from linkage tests. A com-
mon practice among researchers performing linkage
studies is the use of equal allele frequencies as input
when reporting P-values from computer linkage pro-
grams. Ott (Am. J. Hum. Genet. 51: 283 [1992])
demonstrated that in the presence of untyped individ-
uals, falsely assuming equal allele frequencies tends
to lead to strong false-positive evidence for linkage in
parametric lod score analysis. To address the same
question in nonparametric tests, we (Gordon et al.
1997a) performed an analysis using a uniform prior
distribution of allele frequencies on the test results
from the linkage program SAGE SIBPAL, which
tests for proportion of alleles shared identical-by-
descent among affected siblings, and which also per-
forms the Haseman-Elston test. Our data were taken
from a NIMH bipolar study (Berritini et al., Proc.
Natl. Acad. Sci. 91: 5918 [1994]), specifically family
genotype data for the marker ACTHR112. As part of
our study design, we removed genotype information
from randomly selected parents in these pedigrees
and observed the effects that such missing data would
have on the test results. Our results showed that the
P-values resulting from equal allele frequencies
as input were never the most conservative. In fact,
for the Haseman-Elston test, at least 50% of the
P-values were larger than the equal-allele-
frequencies P-values (see Table IV in Gordon et
al. 1997a). In addition, we found that the SAGE
SIBPAL test for proportion of alleles identical-
by-descent among affected siblings showed a
greater percentage of suggested linkage with
decreasing parental genotype information,
whereas the Haseman-Elston test results produced
suggested linkage comparatively less frequently.
We will extend this work by performing a similar
analysis on simulated data in which the genetic
model is known, the true allele frequencies are
known, and complete genotype information exists
on all of the parents in the study.
Using mathematics, we have computed the first
four moments of a quadratic form when its input
variables are independent (Gordon et al. 1997b).
Given this hypothesis, we can approximate the
null distribution of any quadratic form of these
response variables and calculate significance
levels, perform power calculations, and develop a
deeper understanding of the properties of non-
parametric linkage tests such as the Haseman-
Elston test (Haseman and Elston, Behay. Genet.
1: 3 [1972]). Continuation of these studies is es-
sential for the eventual success of the project.
In Press
Gordon, D., S.J. Finch, A.L. Jacobs, N.R. Mendell, R.M.
Single, and T.G. Marr. 1997a. Association of
posterior p-values of S.A.G.E. SIBPAL Proportion-
IBD and Hase-man-Elston statistics for ACTH112.
Genet. Epidemiol. (in press).
Gordon, D., S.J. Finch, and T.G. Marr. 1997b. Third and
fourth cumulants of quadratic forms in random vari-
ables with finite first eight moments. (In press).
SEQUENCE-BASED ANALYSIS OF COMPLEX GENOMES
W.R. McCombie N. Dedhia A. Johnson
S. Granat N. Kaplan
J. Hoffman
The long-term goal of our lab is to utilize the latest
technology of automated DNA sequencing to de-
termine the correlation between structure and func-
tion in complex genomes. This involves generating
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genome sequence data as well as the development of
new tools to generate and analyze these data. This
summary is accordingly divided into development and
sequencing sections.
TECHNOLOGY DEVELOPMENT AND
IMPLEMENTATION
Software Development
N. Dedhia, W.R. McCombie
An important facet of successful large-scale sequenc-
ing is the ability to sequence a large number of
samples consistently. Tracking data flow in high-
throughput sequencing is important in maintaining a
consistent number of successfully sequenced sam-
ples, making decisions on scheduling the flow of se-
quencing steps, trouble-shooting problems at various
steps, and tracking the status of different projects. We
had already developed an informatics structure
capable of dealing with our previous data flow, but
our anticipated scale-up would require a more sophis-
ticated system. In addition, we wanted to use the
latest sequence assembly software and associated
tools to facilitate this important process. These tools
also required a different computational environment
from the one that we had. As a result, we decided to
perform a major reconstruction of our informatics in-
frastructure. We obtained several relevant Unix
scripts from our collaborators at the Genome Se-
quencing Center at Washington University. They de-
veloped these scripts to move and reformat sequenc-
ing data. Most of these scripts contained code
specific to the setup at Washington University. We
modified the code to fit the data flow system we were
designing. We used these scripts, the latest sequence
assembly software (PHRED and PHRAP from Phil
Green), and portions of our original data flow soft-
ware, to construct our new system. This system was
originally constructed so that the data processing op-
erations would be initiated by a Unix-based com-
mand line interface. This portion of the project has
been completed and the next step is to implement a
Netscape-based system that will place the entire pro-
cess of data flow monitoring and control under a
Web-based interface. This will simplify the user in-
terface significantly as well as link to our sequencing
group Intranet that is under development. Implement-
ing the mechanics of the process without the simple
interface, however, allowed us to increase signifi-
cantly our sequencing throughput while the interface
was still under development.
Once our data files are transferred to the Unix en-
vironment, the vector sequence and poor quality data
will be removed and the bases determined from the
ABI trace files using PHRED. The trace files and se-
quence files are then moved to the appropriate project
directories for assembly. We developed new scripts
for this step. Each sample name contains the name of
the 96-well plate that was used to process the sample
in the earlier steps of template preparation. We asso-
ciate each plate name with a particular project in a
simple database. This database is then queried auto-
matically and data are transferred to the appropriate
directory for assembly based on which clone the se-
quence was derived from. This entire process can be
done on large batches of sequences and requires little
human intervention. This frees between one and two
full-time people for other tasks compared to our ear-
lier data processing procedures. Moreover, this in-
formation is monitored so that the sequencing
throughput, success rate, and average read length of
the sequences can be determined on a daily, weekly,
and monthly basis with a simple command on the
Unix command line. We are also working to put this
type of quality control monitoring into our Intranet
and make it accessible over the Web.
The new Web-based software package we are de-
veloping is modular and designed to allow additional
unit operations to be added and tracked with ease.
The software can be interfaced with different base-
calling and assembly engines. Site-specific details are
sequestered and can be customized in a simple man-
ner. Access to the underlying relational database is
currently through the Perl DBI interface, thereby al-
lowing the use of different relational databases.
Development of a High-throughput
Sequencing Infrastructure
A. Johnson, N. Kaplan, S. Granat, J. Hoffman,
W.R. McCombie
A major part of our effort in 1996 was devoted to
scaling up our sequencing efforts. In the summer of
1996, we moved into a new lab in the Hershey build-
ing and roughly tripled our size. This required dif-
ferent project management methods than those used
for smaller projects. Much of this was in terms of
software development as described. However, sub-
stantial modifications to almost all of our laboratory
procedures were necessary to allow us to scale up the
sequencing and reduce the cost per base at the same
time.
Our template purification methods were complete-
ly changed both to allow higher throughput per per-
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son and to reduce cost. Previously, we were using a
robot to purify templates on columns, which pro-
duced one to two 96-well plates of templates per day
at a cost of about $1.50 per template. Although we
still use this method for some special applications, we
have switched our daily template preparation to an
alternate procedure (Mardis, Nucleic Acids Res. 22:
2173 [1994]). This procedure costs about $0.05 to
$0.10 per template, and one person can readily do
two to four 96-well plates per day. This change alone,
which saves us about $1.00 per template, will save us
about $75,000-100,000 in supply costs per year
given our current sequencing rate of 1500-2000
templates per week.
This new procedure, like all of those we in-
corporate, was first tested on a limited scale to
resolve problems, and then additional members of the
group were trained in the procedure in order to put it
into general use. We knew that the use of this
template procedure might also require a change in
some of our sequencing reaction chemistry. New dye,
labeled primers, and a new thermostable polymerase
became available in 1996 which, in theory, would
enable us to increase our sequencing efficiency and
would cost less than other commercially available
reagents. We implemented this new chemistry in the
same gradual way as the template preparation. These
reagents save us about $2.50 to $3.00 per reaction
over other commercially available reagents. Thus,
they provide about the same cost advantage as the
homemade reagents we had been using but substan-
tially free us from reagent preparation and quality
control issues created by using homemade reagent
kits for sequencing. In addition, because these re-
agents provide superior results, this has allowed us to
greatly reduce the time spent editing and finishing the
sequence (which is the most time-consuming part of
the sequencing process). As part of this development
process, we adapted these new reagents, called ener-
gy transfer primers and Thermosequenase, to the
Catalyst robot in our lab. We were one of the first to
accomplish this and made the procedure available on
our World Wide Web site for other researchers.
To meet our sequencing throughput requirements,
we implemented a number of new techniques to in-
crease efficiency. Chief among these was switching
all of our template production and sequencing reac-
tions to a 96-well format. This caused some difficulty
initially since the smaller volumes used make many
of the steps in sequencing more subject to difficulties
in mixing and pipetting. However, this change has
enabled us to use various tools such as 8-, 12-, and
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96-channel pipettors for many of the steps in the se-
quencing process. This saves us considerable time
given the large number of pipetting steps necessary in
a given week. These tools have enabled us to move
from 300-600 reactions per week to about 1500-
2000 reactions per week with about a twofold in-
crease in the number of people who actually carry out
the daily sequencing reactions. The other personnel
added to the group are involved in software develop-
ment, library construction, and various other tasks. In
a similar manner, we began carrying out many of the
steps in the sequencing process using reduced reagent
volumes. This allowed us to cut costs but initially
caused problems because reduced volume reactions
are inherently less robust than full volume reactions.
During the scale up, our success rates were erratic,
but they have now stabilized in the same range as that
seen in other large-scale sequencing labs. We are up-
grading several of our sequencers in the coming year
and anticipate that we will be able to increase our
throughput 20-40% with the same number of people
while maintaining the same success rates. This will
be due to the solid foundation we have built in the
past year by tearing down all of our procedures and
rebuilding the sequencing process with a higher ca-
pacity, higher efficiency target.
Genome Sequencing of
Arabidopsis thaliana
M. Lodhi, M. de la Bastide, N. Dedhia, T. Gottesman,
L. Gnoj, S. Granat, A. Hamad, A. Hasegawa, J. Hoffman,
A. Johnson, N. Kaplan, N. Shody, K. Schutz, S. Till,
R. Martiennsen, W.R. McCombie
We have formed a consortium with colleagues at the
Genome Sequencing Center at Washington Univer-
sity (GSC) and Applied Biosystems (ABE) to se-
quence a large region of the genome of the plant
Arabidopsis thaliana. We are also collaborating with
the European Scientists Sequencing Arabidopsis
(ESSA) to coordinate regions of the genome that we
will be sequencing. This project is part of a larger in-
ternational collaboration to sequence the entire
genome of this important model organism. The larger
collaboration is responsible for making sure that
regions of the genome are allocated to the sequencing
groups, such as ours, in an equitable and efficient
manner.
Our initial effort was a pilot project to sequence a
cosmid clone which we selected and which contained
the Prolifera gene from chromosome IV (Springer et
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al., Science 268: 877 [1995]). This clone was com-
pletely sequenced within the past year. Figure 1
shows the genes identified in this cosmid. We also
worked with our collaborators at the GSC and ABI to
sequence a bacterial artificial chromosome (BAC)
clone from the short arm of chromosome IV that was
provided to us by Ian Bancroft of ESSA. BAC clones
contain substantially more insert DNA than do cos-
mid clones (two to five times as much typically), and
we are switching our sequencing to BACs rather than
cosmids to increase our efficiency. It did, however,
take some time to learn protocols to deal with the
larger clones. This BAC clone (-115 kb) was nearly
completed in the past year. Two small, specific
regions of this clone have proven to be very difficult
to sequence, but the remainder of the clone has been
completed. Figure 2 shows a diagram of the genes
found within this clone.
To scale up our Arabidopsis sequencing program,
we began a major mapping effort. Scientists at the
John Innes Center determined a contig map of yeast
artificial chromosomes (YACs). We used these
clones to probe by hybridization high-density BAC
arrays and to select the BACs from those areas of the
genome. Once BACs are placed in "bins" based on
PROTEIN CHEMISTRY
R. Kobayashi H. Cai J. Kahler C. Kelley
P. Kearney G.J. Salas G. Binns
N. Carpino N. Poppito K. Wanat
Jennifer Kahler, Hui-Zhi Cai, and Camille Kelley left
our group this year, and Kimberly Wanat became a
new member. This summer, G. Jessica Salas spent 10
weeks with us as an URP (Undergraduate Research
Program). Two highlights of the year are that Nick
Carpino cloned a gene encoding GAP-associated p62
and we purchased a matrix-assisted laser desorption
ionization time-of-flight mass spectrometer funded by
a shared instrumentation grant from the National In-
stitutes of Health (NIH).
GAP-associated p62 in Chronic
Myelogenous Leukemia
N. Carpino, J. Kehler, B. Stillman, R. Kobayashi
[in collaboration with B. Clarkson, Memorial
Sloan-Kettering Cancer Center]
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their YAC hybridization data, our colleagues at the
GSC employ their high-capacity restriction digest
fingerprinting technology to align them with one an-
other and determine a "tiling path" of minimally
overlapping clones. The minimal BAC tiling path is
the sequencing substrate. This mapping has provided
sequencing targets sufficient for our needs until near
the end of 1997.
After obtaining these additional clones, we have
begun the sequencing of some of them. The shotgun
portion of the sequencing of one of these BACs
(10M13) was finished during 1996. With our mapped
clones and sequencing infrastructure in place, our
1997 target is to sequence 1-1.5 Mb of Arabidopsis.
Our fellow consortium members should combine to
sequence about the same amount based on the
mapped, sequence-ready templates; we are jointly de-
veloping for this project. We are releasing our
Arabidopsis sequencing data to the community in a
very rapid manner. We are also releasing preliminary
data through our World Wide Web site. This site can
be found at http: / /www.cshl.org/genseq. It will also
have the latest information on other aspects of the
Arabidopsis mapping and sequencing projects.
Characteristic of chronic myelogenous leukemia
(CML) is the presence of the chimeric p210bcr-ab
protein possessing elevated protein tyrosine kinase
activity relative to normal c-Abl tyrosine kinase.
Hematopoietic progenitors isolated from CML
patients in the chronic phase contain a constitutively
tyrosine phosphorylated protein that migrates at 62
kD by SDS-PAGE and associates with the p120 Ras
GTPase-activating protein (GAP). We have purified
p62d°k from a hematopoietic cell line expressing
p210ber-ab1 . 1:162d°k is a novel protein with features of
a signaling molecule. Association of p62d°5 with
GAP correlates with its tyrosine phosphorylation.
p62d°k is rapidly tyrosine phosphorylated upon ac-
tivation of the c-Kit receptor, implicating it as a com-
ponent of a signal transduction pathway downstream
from receptor tyrosine kinases.
Protein Chemistry
Core Facility
C. Kelley, N. Poppito, K. Wanat, G. Binns, R. Kobayashi
Collaboration with other scientists at Cold Spring
Harbor Laboratory continued as a major activity in
our laboratory. This year, we purchased an additional
piece of equipment to study protein structure (espe-
cially posttranslational modifications). An NIH
shared instrumentation grant was submitted in March
1995 and funded this year. Contributers are Ryuji
Kobayashi, David Beach, Adrian Krainer, Bruce
Futcher, Yuri Lazebnik, Carol Greider, Mike Ma-
thews, Sha Mi, Nouria Hernandez, Bruce Stillman,
Winship Herr, and Nicholas Tonks. The instrument, a
matrix-assisted laser desorption ionization time-of-
flight mass spectrometer, arrived at Cold Spring Har-
bor in October 1996. It is capable of analyzing the
molecular weight of peptides as low as 50 fmoles.
With this instrument, we have been able to identify in
vivo phosphorylation sites by analyzing peptide frag-
ments separated by high-performance liquid chroma-
tography (HPLC) to obtain partial amino acid se-
quences of purified protein. This state-of-the-art in-
strument has added a significant capability for struc-
tural analysis of protein to the laboratory, and its util-
ity has been growing as we spend more time this in-
strument.
In-gel Digestion for Internal
Sequence Analysis of Protein
Stained by Silver
H. Cai, N. Poppito, R. Kobayashi
Since internal sequence analysis of protein has an es-
sential role in a strategy of cloning a specific gene,
this technique has been extensively used at Cold
Spring Harbor since 1992. The method has been im-
proved further and optimized for protein stained with
silver. Our intensive study showed that the sensitivity
limit of our current in-gel digestion technique is 2
pmoles when we applied the technique on carbonic
anhydrase. Detailed conditions and method will be
published in 1997.
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MACROMOLECULAR CRYSTALLOGRAPHY
X. Cheng A. Dong W. Gong J. Horton
L. Jokhan Y. Liu T. Malone
K. Mc Cloy M. O'Gara R. Xu
X. Zhang
Our goal is to determine the structures of a number of
biologically important proteins, to atomic resolutions,
for a better understanding of their functions in cel-
lular processes.
Within the year of 1996, Karen Mc Cloy, a tech-
nician who was a part of the group for 4 years, left
the laboratory. Ruiming Xu was recognized with a
promotion to assistant investigator. Ruiming will
continue to study the structure of UP) and other re-
lated proteins and we wish him all the best. Lana Jok-
han obtained her master's degree and accepted a
position at Bristol-Myers Squibb. Two new postdoc-
toral researchers, Xujia Zhang and Weimin Gong,
and one visiting scientist, Aiping Dong, joined the
laboratory.
DNA Methylation
X. Cheng
DNA methyltransferases (Mtases) are found in or-
ganisms ranging from archaea and bacteria to plants
156
and mammals. In many of the archaea and bacteria,
these enzymes are components of restriction-modifi-
cation systems. Some Mtases have roles in many
eukaryotic cell processes including control of tran-
scription, genomic imprinting, mutagenesis, DNA
repair, and development. The DNA Mtases transfer a
methyl group from S-adenosyl-L-methionine (Ado-
Met) to a given position of a particular DNA base
within a specific DNA sequence. These Mtases
belong to two families: one (including MHhaI)
methylates the C5 ring carbon of cytosine yielding
5-methylcytosine (5mC), whereas the second family
(including MPvull and Dam) methylates the ex-
ocyclic amino group of cytosine or adeine yielding
either N4-methylcytosine (N4mC) or N6-methylade-
nine (N6mA).
Rotation of a DNA nucleotide out of the double
helix and into a protein-binding pocket ("base flip-
ping") was first found to occur with Hhal DNA
Mtase (Klimasauskas et al., Cell 76: 357 [1994]).
There is now evidence that a variety of proteins use
base flipping in their interactions with DNA. Al-
though the mechanism for base flipping is still not
clear because no intermediates have been character-
ized, we propose a three-step pathway: recognizing
the target site and increasing the interstrand phos-
phate-phosphate distance nearby, initiating the base
flipping by protein invasion of the DNA, and trap-
ping the flipped DNA structure (Cheng and Blumen-
thal 1996). Our laboratory is focusing on finding a
basis for flipping bases.
A Structural Basis for the
Preferential Binding
of Hemimethylated
DNA by Hhal Mtase
M. O'Gara [in collaboration with R.J. Roberts,
New England Biolabs, Inc.]
MHhal, a 5mC Mtase, has been structurally charac-
terized in complex with its DNA substrate in three
different methylation states: unmethylated, hemi-
methylated, and fully methylated. This year, the crys-
tal structure of MHhal complexed with nonpalin-
dromic duplex DNA containing a hemimethylated
recognition sequence, and with the cofactor analog
S-adenosyl-L-homocysteine (Ado Hcy), has been de-
termined. The structure provides an explanation for
the stronger affinities of DNA Mtases for hemimeth-
ylated DNA than for unmethylated or fully methyl-
ated DNA in the presence of AdoHcy.
The unmethylated target 2' -deoxycytidine flips
out of the DNA helix, and the CH group at position 5
makes van der Waals contacts with the sulfur atom of
AdoHcy. Selectivity/preference for hemimethylated
over fully methylated DNA may thus reflect interac-
tions among the chemical substituents (H or CH3) at
the C5 position of the flipped cytosine, protein, and
the bound AdoHcy. The 5- methyl -2' -deoxycytidine
on the complementary strand remains in the DNA
helix, with the methyl group almost perpendicular to
the carboxylate group of Glu-239, which is part of
the sequence-recognition loop. Thus, selectivity/
preference for hemimethylated over unmethylated
DNA appears to result largely from van der Waals
contacts between the planar Glu-239 carboxylate and
the methyl group of the 5- methyl -2' -deoxycytidine.
Furthermore, the positive electrostatic potential
originating from the bound AdoHcy extends to the
DNA phosphate groups flanking the flipped cytosine.
The increased binding to DNA by long-range elec-
trostatic interactions should also occur with the
methyl donor AdoMet.
Selenomethionyl Pvull Mtase
M. O'Gara [in collaboration with R.M. Blumenthal,
Medical College of Ohio]
We have a much more limited understanding of the
amino-Mtases (N6mA and N4mC). N4mC Mtases
were discovered only relatively recently, and to date
the gene sequences of fewer than a dozen have been
determined (in contrast to -45 5mC and -35 N6mA
Mtases). MPvull was the first N4mC Mtase for
which the nucleotide sequence of the gene and the
crystal structure (see below) were determined. The
Mtase methylates the internal cytosine of CAGCTG
sequences.
The method of multiwavelength anomalous dif-
fraction (MAD) of X-ray synchrotron radiation is
now routinely used to solve crystal structures. MAD
experiments demand the presence of a few anoma-
lous scatterers at fixed positions. We chose to in-
corporate selenium (Se) atoms as the anomalous scat-
terers. The standard approach to production of a
selenomethionine (SeMet) derivative protein is to ex-
press the protein in strains auxotrophic for Met. Ex-
pression of a SeMet derivative protein in such a strain
generally increases the chance for complete in-
corporation of SeMet. However, the MPvull-coding
plasmid was not moved into a strain auxotrophic for
methionine because we did not have an auxotrophic
strain that was McrBC-; expression of MPvull is
lethal unless the host strain is McrBC-. Instead, we
efficiently incorporated SeMet into MPvull, over-
expressed in an Escherichia coil methionine proto-
trophic strain, DH10B. To assess the level of SeMet
incorporation, mass spectrometry was carried out on
both intact and digested selenomethionyl MPvuII, in
collaboration with R. Kobayashi (CSHL).
Mass spectrometry analysis of selenomethionyl
MPvuII revealed three major forms that probably
differ in the degree of SeMet incorporation and the
extent of SeMet oxidation. Amino acid sequencing,
mass spectrometry analysis of SeMet-containing pep-
tides (products of a protease digestion), and crystal-
lographic analysis (see below) suggest that all nine
methionines have been substituted by SeMet; at least
three (Met-30, Met-51, and Met-261) were only par-
tially replaced and one (amino acid 261) was prefer-
entially oxidized.
Selenomethionyl MPvull was crystallized as a
binary complex of the methyl donor AdoMet in the
monoclinic space group P21. Two complexes were
present per asymmetric unit. The crystal, frozen at
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95°K, used for the MAD experiment diffracted to 3.3
A resolution. The MAD data were collected at three
different wavelengths corresponding to the inflection
point k1 and the peak k2 of the Se-containing crystal
absorption spectrum, and a third wavelength (.3) at
an energy of 852 eV above the peak position. The
anomalous and isomorphous difference Patterson
maps at the Harker section (v = 1/2) among data sets
collected at wavelengths kl, X2, and X3 showed a
number of peaks corresponding to possible Se sites
and cross-vectors.
The incorporation of Se Met in place of methionine
residues provides a general vehicle for phase deter-
mination as well as for polypeptide chain tracing. The
MPvull (amino acids 14-336) has nine methionines
out of 323 amino acids (2.8%), greater than the 1.7%
of averaged occurrence of methionine in proteins. On
the other hand, the presence of many Se sites poses
an exciting challenge for locating their positions and
for MAD applications.
Structure of Pvull
Mtase-AdoMet Complex
W. Gong, M. O'Gara [in collaboration with
R.M. Blumenthal, Medical College of Ohio]
There are a total of 18 possible Se sites per asym-
metric unit (9 per molecule). Thus far, a total of 12
sites (6 per molecule) have been manually deter-
mined from Patterson maps and confirmed by the
twofold noncrystallographic symmetry operator. The
geometrical relationship of the 12 Se atoms showed a
noncrystallographic twofold symmetry and this local
symmetry was consistent with the result of the self-
rotation function calculated between the two MPvuIl
molecules in the asymmetric unit. Among the other
three Se Met residues whose Se positions were not
determined, Se Met" (the amino-terminal methio-
nine) and SeMetim are located in disordered regions,
whereas the side chain of SeMet24t is flexible.
These 12 Se positions were used for MAD phases,
with a final figure of merit of 0.58 at 3.3 A resolu-
tion, using k1 -k3 and X2 -X3 isomorphous differences
and both X2 and X3 anomalous dispersions. The
phases were improved by solvent flattering and two-
fold molecular averaging. The initial MPvull model
was built at 3.3 A resolution and the final model was
refined at 2.8 A resolution with the crystallographic
R-factor of 0.19.
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Structurally, MPvuIl is folded into two broad
domains: a larger catalytic domain that contains the
active site and Ado Met-binding regions, and a small-
er DNA-recognition region (Fig. 1). The two domains
are connected by a flexible linker in the absence of
DNA. The catalytic domain shares the "consensus"
structural characteristics defined by the 5mC Mtase
MHhal, the N6mA Mtase MTaql, and a small
molecule Ado Met-dependent Mtase.
Bacteriophage T4 DNA
Adenine Mtase (Dam)
X. Zhang [in collaboration with S. Hattman,
University of Rochester]
Most of the known bacterial DNA Mtases are part of
restriction-modification systems, but there are some,
such as Dam, that have no corresponding cognate
endonuclease. Dam methylation is the only docu-
mented case of prokaryotic methylation involved in
the regulation of cellular processes. Dam methylates
the adenine in the sequence GATC, generating
N6mA. T4 Dam has a molecular mass of 30.4 kD,
exists as a monomer in solution, and is similar to bac-
terial type H DNA Mtases with respect to kinetic pa-
rameters.
The enzyme has been overexpressed and purified
to near homogeneity. The purification was a straight-
forward process. Bacterial cells were lysed, and the
cell debris was removed by centrifugation. The
resulting supernatant was loaded onto a DEAE-
cellulose (DE52) column, and the flow-through was
collected. This solution was then loaded onto a P11
phosphocellulose column, and the protein was eluted
with a linear gradient of NaCI. The peak was pooled
and then loaded onto a hydroxyapatite column or an
FPLC Mono S column. For purification of the Dam-
AdoHcy binary complex, Ado Hcy was added to the
protein to a final concentration of 0.2 mm and the
mixture was incubated on ice for 2 hours prior to
loading onto the last column. The resulting pure
protein-AdoHcy complex was then concentrated.
The availability of highly purified T4 Dam has fa-
cilitated our crystallization trials. A series of synthe-
tic oligonucleotides containing the GATC sequence,
but varying in length and nature of ends (Table 1),
were incubated with equimolar amounts of the puri-
fied and concentrated Dam-AdoHcy. The Dam-
AdoHcy-DNA ternary complexes were screened for
FIGURE 1 Schematic ribbon diagram of the MPvull structure. The bound Ado Met is a ball-and-stick
model.
crystallization by a sparse matrix using vapor diffu-
sion at 16°C with hanging droplets (6 1.11). Five of
nine complexes yielded crystals, but only two crys-
tals diffractd X-rays to a medium resolution: a 15-
mer with an T-overhang (15-T1') and a 12-mer with
blunt ends (12-blunt).
The crystals with the 15 -TT DNA attained a size
of about 0.3-0.4 mm in one day. Preliminary analysis
showed that the crystals were of the monoclinic space
group C2 and had unit-cell dimensions of a = 146 A,
b = 110 A, c = 96 A, and 13 = 107°, with four com-
plexes per asymmetric unit. The crystals with the 12-
blunt DNA exhibited irregular shape and twinning.
Microseeding and macroseeding were used to obtain
better crystals. The crystals diffracted X-rays to ap-
proximately 3.3 A using flash freezing and were of
the P21 space group with cell dimensions of a = 40.3
A, b = 115.7 A, c = 74.2 A, and p = 104°. There are
two complexes per asymmetric unit. Efforts to deter-
mine the structure of T4 Dam bound to this 12-blunt
DNA are currently under way, by conventional
TABLE 1 Oligonucleotides Screened for
Cocrystallization with T4 Dam-AdoHcy Complex
Name Sequence Cocrystals
10-blunt 5 ' -ACGGATCCGT-3 ' none
3 ' -TGCCTAGGCA-5 '
11-TT 5' -TCAGGATCCTG-3 ' long needle shape
3 ' -GTCCTAGGACT-5 ' diffract >10 A
12-blunt 5' -ACAGGATCCTGT-3 ' suitable for X-ray
3 ' -TGTCCTAGGACA-5 ' diffract >3.3 A
13-7. 5 ' -TCACGGATCCGTG-3 ' big, good shape
3 ' -GTGCCTAGGCACT-5 ' diffract >10 A
13-AA 5' -AACAGGATCCTGT-3 ' none
3 ' -TGTCCTAGGACAA-5 '
14-blunt 5 ' -CACAGGATCCTGTG-3 ' none
3 ' -GTGTCCTAGGACAC-5
15-TT 5 ' -TCACAGGATCCTGTG-3 ' big, good shape
3' -GTGTCCTAGGACACT-5 diffract >4.5 A
15-AA 5 -ACACAGGATCCTGTG-3 ' none
3 ' -GTGTCCTAGGACACA-5 '
16-blunt 5 ' -TCACAGGATCCTGTGA-3 ' big, good shape
3 ' -AGTGTCCTAGGACACT-5 ' diffract >6 A
The recognition sequence for Dam is in bold and underlined.
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heavy-atom methods (soaking the crystal in the solu-
tion of mercury methyl chloride or using iodinated
nucleic acid bases) and the MAD method of bromi-
nated nucleic acid bases.
Pvull Endonuclease
J. Horton [in collaboration with H.G. Nastri
and Paul D. Riggs, New England Biolabs, Inc.]
No discussion of restriction-modification systems
would be complete without considering their part-
ners, the DNA restriction enzymes or endonucleases.
Several years ago, this laboratory determined the
structure of Pvull endonuclease (RPvulI) with cog-
nate DNA (Cheng et al., EMBO J. 13: 3927 [1994]).
This type II restriction endonuclease from the
organism Proteus vulgaris cleaves DNA between the
central GC of its recognition sequence (5 ' -
CAGCTG-3 ' ) in an Mg++-dependent reaction, gen-
erating blunt-ended products. This year, two new
RPvuII structures are of peculiar interest: RPvull
complexed with iodinate cognate DNA (RPvull-
iDNA) and a mutant RPvuII(D34G) complexed with
cognate DNA. High-resolution data were collected
from crystals of these complexes at 1.78 and 1.59 A,
respectively. In studies of PvuII(D34G), where Asp-
34 is replaced by a glycine, the protein binds to the
canonical DNA sequence with the same affinity as
the wild-type but is catalytically deficient. Previous-
ly, the structure of the wild-type protein showed that
Asp-34 was involved in DNA recognition through
minor-groove contacts. Now it appears that Asp-34
must be involved with catalysis as well.
Our high-resolution RPvulI(D34G)-DNA struc-
ture shows clearly that it is not the conformation of
the protein that changes but that of the DNA. In par-
ticular, the DNA conformation is much different
where the RPvuII cuts the DNA as compared to the
wild-type RPvulI-DNA structure. In the RPvull
(D34G)-DNA complex, this local region takes on
more of an A-DNA conformation than a B-DNA con-
formation. Such differences in conformation of a lo-
cal region can alter the phosphate backbone surface
of the oligonucleotide and thereby position the target
scissile bond of the phosphate backbone differently.
Often, the importance of water molecules in mac-
romolecular recognition is overlooked. High-resolu-
tion macromolecular structures yield much informa-
tion about ordered water structure and corroborate its
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significance in this process. Fortunately, we can com-
pare, at comparable resolutions, the ordered water
molecules in the structures of RPvull (D34G)-DNA
and RPvull -iDNA, where the C of the central GC is
iodinated at the N4 position in the major groove and
approximates the methylated DNA. Our structure
comparison shows that an extensive, well-ordered
water network does not exist in RPvull -iDNA as it
does in RPvuII(D34G)-DNA. Additionally, it ap-
pears that two histidine residues (His-84 and His-85)
have two discrete conformations in the RPvuII-
iDNA structure. We surmise that these two His resi-
dues are locked into position through recognition of
the well-ordered water network found in the un-
methylated recognition sequence and are primed to
aide in efficient catalysis. Interestingly, in a recent
structure-function study by Nastri and Riggs, replace-
ment of His-84 with leucine resulted in a mutant
protein that had 1/100 of the specific activity of the
wild-type protein but bound with nearly the same af-
finity. Mutants of His-85 bound DNA with high af-
finity but their catalysis activity was seriously com-
promised or totally abolished. Perhaps the DNA "ap-
peared" methylated to these mutants and catalysis
could not efficiently be established.
VP16-induced Complex
Y. Liu [in collaboration with C. Huang and
W. Herr, Cold Spring Harbor Laboratory]
Last year, we reported the crystallization of the cen-
tral core region (amino acids 48-412) of VP16,
which is sufficient for VP16-induced complex forma-
tion but lacks the activation domain, and MIR phases
from two mercury derivatives. This year, we are
using an experimental approach to improve the ac-
curacy of the phases: the MAD method using SeMet
and pCMBS-derivative crystals. We have collected
Se-MAD data (at two wavelengths) and Hg-MAD
data (at two wavelengths) at the National Syn-
chrotron Light Source, Brookhaven National Labora-
tory, using beamline X12-C.
VP1648-412 contains ten methionines. We first
transformed a Met-autotrophic E. coli strain (DL41)
with the VP16 expression construct and then over-
expressed VP1648-412 protein in medium that sup-
plies SeMet to obtain the Se-containing proteins. The
purification procedures and crystallization conditions
of Se-containing VP1648-412 are the same as those for
the native VP1648-412. Incorporation of the Se atoms
in the crystals was monitored by assaying the Se ab-
sorption edge through X-ray fluorescence measure-
ments. The Se atoms will also help us to trace the se-
quence. In addition, we have collected two-wave-
length data from a pCMBS-soaked crystal (3 mm for
26 hours) at near the Hg L111 absorption edge. The
anomalous difference Patterson maps show strong
peaks corresponding to the three pCMBS sites. Ex-
periments are under way to improve the inter-
pretability of the electron density map.
UP1
R. Xu, L. Jokhan [in collaboration with A. Mayeda
and A. Krainer, Cold Spring Harbor Laboratory]
UP1, the amino-terminal domain of Al heterogene-
ous nuclear ribonucleoprotein (hnRNP Al), com-
prises two tandem RNA-recognition motifs. Both
motifs are necessary for efficient RNA binding and
for the alternative splicing activity of hnRNP Al. Hu-
man UP1 has been overexpressed in E. coli, purified
to near homogeneity, and crystallized in space group
P21 with unit cell dimensions of a = 37.94 A, b =
43.98 A, c = 55.64 A, and p = 93.9°. The crystal dif-
fracts X-rays strongly beyond 1.3 A resolution and a
native data set to 2.0 A has been completed. Diffrac-
tion data sets from platinum- and mercury-deriva-
tivized crystals have also been collected. The three-
dimensional structure of UP1 is presented in Dr. Xu's
section.
Beam line X26-C at the National
Synchrotron Light Source,
Brookhaven National Laboratory
J. Horton [in collaboration with M. Capel
and P. Siddons, Brookhaven National Laboratory]
Increasingly, it is becoming essential for biologists to
have easy access to a synchrotron beamline in order
to be successful in obtaining three-dimensional in-
formation for macromolecular structures. Synchro-
tron light sources provide X-rays that can be 10,000
times as intense as CSHL's X-ray generator. This in-
tensity allows better data to be collected not only
faster, but also from smaller crystals and usually to
higher resolution. Another advantage of synchrotron
light is that the experimenter can fine-tune its wave-
length; this allows for quicker solving of the "phase
problem" of crystallography.
In collaboration with the State University of New
York at Stony Brook (SUNY-SB) and the Biology
Department at Brookhaven National Laboratory
(BNL-Biology), we are converting beamline X26-C
at the National Synchrotron Light Source (NSLS) at
BNL for use in routine X-ray diffraction data collec-
tion from crystals of macromolecules. Previously,
this beamline had been used for the development and
application of X-ray microscopy techniques and for
Laue diffraction protein crystallography.
During the past year, we have acquired the neces-
sary equipment and have begun assembly of a con-
figuration that will offer CSHL structural biologists
excellent opportunities for data acquisition. We are
well under way to satisfying our immediate goals of
readying X26-C for our data collection requirements.
First, a new monochromator has been installed by the
NSLS staff (under P. Siddons) and the beamline has
been modified to accommodate it. This monochrom-
ator will have a high-energy resolution and a wide
energy range so that almost any usable X-ray wave-
length can adequately and accurately be reached.
Second, several pieces of equipment have been
purchased, adjusted, and tested in the past year: a
300-mm MAR Research imaging plate for data col-
lection; two Silicon Graphics computers for data
reduction; 22 gigabytes of disk storage; an 8-mm tape
subsystem for data backup; a PC workstation for
manipulation and monitoring of beamline hardware;
an Oxford Cryostream liquid-nitrogen cryostat for
freezing crystals during data collection; one working
and another large storage liquid nitrogen dewar for
the cryostat; and apparatus for automatic filling of the
working dewar. Much of this apparatus has been
modified for synchrotron use by the BNL-Biology
team (under M. Capel). This equipment has been
tested and used on beamline X25 by several experi-
enced crystallography groups, including CSHL's
groups (Cheng, Joshua-Tor, and Xu).
In the coming year, we plan to construct a
MAR/FAST hybrid diffractometer and install the
BNL-Biology software already written for a similar
hybrid at the X12-C beamline. These two steps will
allow us to align crystals accurately and routinely in
various orientations for measuring anomalous diffrac-
tion used in phase determination. Additionally, we
will establish and document the data-collection pro-
cedures peculiar to the new configuration of X26-C.
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When completed, X26-C should be as productive or
more productive than other beamlines dedicated to
macromolecular crystallography at NSLS.
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STRUCTURAL BIOLOGY
L. Joshua-Tor T. Messick
J. Rosenbaum
Our focus is to study the molecular basis for regu-
latory processes in terms of molecular recognition.
We are using tools of structural biology and bio-
chemistry in a combined approach to look at pro-
teins and protein complexes associated with these
processes. X-ray crystallography, our primary tech-
nique, enables us to get a very accurate three-dimen-
sional structure of our proteins and the interactions in
which they are involved. We use biochemistry to
study properties predicted by the structure and to
direct our structural studies in an iterative manner.
We are also combining information from molecular
biology and genetics in collaborative efforts to study
their functions. Our current efforts center around two
distinct themes: (1) the study of an evolutionarily
conserved family of oligomeric intracellular prote-
ases, the bleomycin hydrolases, and (2) structural
studies of transcription factor complexes. Here, we
are currently screening crystallization conditions.
THE BLEOMYCIN HYDROLASES
Resistance to antineoplastic drugs, whether intrinsic
or acquired, is a central problem in treatment of hu-
man cancers. Bleomycin hydrolase is a cysteine
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protease discovered by its ability to hydrolyze the
anticancer drug bleomycin and thus to limit its use in
cancer therapy. The recent discovery of homologs of
this intracellular hexameric 300-kD protein in yeast
and bacteria implies a conserved cellular function for
this protein. In humans, this protease is expressed in
all tissues tested and at elevated levels in several
tumors. In mice, expression is highest for newborn
mice and decreases with age. The crystal structure of
the yeast bleomycin hydrolase, Gal6, which we have
determined, has revealed several unique features of
these proteases. These include a ring structure with a
central channel where the six active sites can be ac-
cessed only from within the channel, a nucleic-acid-
binding activity, and an unusual positioning of the
completely conserved carboxyl terminus of the pro-
tein in its own active site cleft. The yeast protein binds
preferentially to single-stranded DNA or RNA with a
K, of 10 nM and to nicks in double-stranded DNA.
Moreover, its expression is regulated by galactose and
the Gal4 protein, and Gal6 itself acts as a repressor of
galactose-regulated genes. Clearly, bleo-mycin
hydrolase has complex cellular functions, consistent
with the increasing recognition of the important role
in general of intracellular proteases.
S. cerevisiae (GaI6, yBH, BLH1)
H. sapiens (Bleomycin hydrolase)
L. lactis (PepC)
L. helveticus (PepC)
L. delbruekii (PepC)
S. thermophilus (PepC)
446 453
...WDPMGALAK
...WDPMGALAE
...WDPMGALA
...WDPMGALAFKY
...WDPMGALAFDF
...WDPMGSLASK
FIGURE 1 A ribbon diagram of the active site cleft with the carboxy-terminal portion of the
polypeptide chain shown in stick representation occupying most of the active site cleft.
Shown is an overlay of the carboxy-terminal arms of the wild-type protein ingray and the
double mutant (active site cysteine replaced by an alanine residue and removal of the ter-
minal lysine) in black. The active site triad (Cys-73 for the wild type and Ala-73 for the
mutant, His-369 and Asn-392) as well as Gln-67, which stabilizes the oxyanion hole, are
also shown in stick representation and are labeled. The polypeptide chain moves toward
the active site triad in the mutant by approximately one residue by a hinge motion due to
Gln-450 at the center of the carboxy-terminal arm. The bulge this glycine forms in the wild
type straightens out in the mutant as depicted in the figure. This brings one of the carboxy-
terminal carboxylate oxygens to the oxyanion hole as it would be in the intermediate. This
is illustrated by a hydrogen bond (shown as a dashed line) between that oxygen and the
nitrogen of Gln-67. Another hydrogen bond forms between the other oxygen and the ac-
tive site histidine. A sequence alignment of this region is shown below. Note the variability
in sequence following the last alanine.
The Carboxyl Terminus of GaI6,
the Yeast Bleomycin Hydro lase,
a Molecular Ruler for Proteolysis
L. Joshua-Tor [in collaboration with W. Zheng and
S.A. Johnston, Southwestern Medical Center)
One of the more interesting features of this enzyme is
the carboxy-terminal arm and its role in proteolysis.
The carboxy-terminal arm of Ga16 extends into its
own active site cleft and structurally resembles pep-
tide inhibitors of papain. In this way, the carboxyl
terminus may serve as a regulator of enzyme activity.
The sequence is completely conserved in this region
(see Fig. 1) apart for the very last residues. We have
shown that for the yeast and human homologs, these
unconserved residues appear to be removed in the
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mature enzyme, most likely by an autocleavage pro-
cess, both of them terminating with an alanine as the
last residue of the polypeptide chain. In fact, if we
mutate the active site cysteine to an alanine in the
yeast enzyme, the terminal lysine is not removed and
is well ordered in the crystal structure we have solved
for this mutant (see below).
The positioning of the carboxy-terminal arm in the
active site cleft explains its amino peptidase activity
in vitro. On the basis of crystal structure of the yeast
enzyme, we propose that the substrate is positioned
such that its amino end is held by the carboxylate of
the carboxy-terminal arm in position for cleavage.
The geometry would be such that the amino-terminal
residue would be cleaved. This is consistent with the
observation that N-blocked peptides are not cleaved
by these enzymes. To test this hypothesis, several
mutants were prepared with various truncations at the
carboxyl terminus. We have shown that we can turn
the enzyme into an endopeptidase, cleaving a peptide
substrate at a predicted position. Thus, the carboxyl
terminus acts as a molecular ruler, resulting in an en-
zyme that has positional specificity, rather than se-
quence specificity. This is also consistent with the
observation that these enzymes have a rather broad
substrate sequence specificity.
A Hinge in the Carboxy-terminal
Arm of Gal6 Controls Autoproteolysis
L. Joshua-Tor, J. Rosenbaum [in collaboration with
W. Zheng and S. A. Johnston, Southwestern
Medical Center]
We are currently expressing these proteins as his-
tidine-tagged constructs in Escherichia coli. In this
manner, relatively high yields of purified protein can
be obtained in a two-step purification, and although
we have a TEV protease site, which would enable us
to remove the tag, we did not have to cleave the
histidine tag even for crystallization purposes. The
crystal structures of two mutants of the yeast enzyme
have been solved. In both mutants, the active site
cysteine was replaced with an alanine. In the first
mutant, which was solved at 2.05 A resolution, the
carboxy-terminal lysine was retained. This is in effect
a natural substrate for the protease since the enzyme
normally cleaves this residue off. In the second
mutant, which was solved at even higher resolution,
1.87 A, this lysine was intentionally removed as it is
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in the wild-type protein. Thus, a double mutant had to
be prepared to achieve the single effective change
compared with the wild-type protease. The quality of
the electron density maps obtained from these
mutants, the latter in particular, is such that even part
of the tag is observed in these crystal structures.
When comparing the two mutants with the wild-
type protein, a hinge is revealed in the carboxy-
terminal arm that appears to control the initial auto-
cleavage reaction necessary for obtaining the mature
protein. Most proteases have a site designed to bind a
negatively charged oxygen (an oxyanion) which is
present in the intermediate of the proteolytic cleavage
reaction (termed the "oxyanion hole"). A carboxylate
oxygen, being such a moiety, would naturally occupy
that site if it could reach it. The effect of removing
the sulfhydryl (SH) group from the active site
cysteine by substituting it with an alanine is that a
path is open for the carboxylate of the carboxyl
terminus to reach the "oxyanion hole." One of the
carboxylate oxygens in both mutants is sitting in that
oxyanion hole. For the second mutant, where the only
effective difference with the wild-type protein is a
substitution of the sulfhydryl group, this is exactly
the location of that group during the initial cleavage
reaction. From the superposition of this mutant with
the wild-type protein (see Fig. 1), it is clear that the
carboxy-terminal arm must move toward the active
site in order to occupy that site. To achieve this mo-
tion, a "bulge" in the polypeptide chain is straight-
ened out in what would resemble a hinge motion,
with a conserved glycine residue (G450) at the hinge
(see Fig. 1). A close examination of the angles in-
volved would predict that a glycine would be the only
amino acid that would allow this hinge motion.
The Human Bleomycin Hydro lase
L. Joshua-Tor, J. Rosenbaum [in collaboration with
H. Whelan and S. A. Johnston, Southwestern
Medical Center]
One of our goals is to understand the bleomycin
hydrolase activity of the enzyme which leads to drug
resistance. The human homolog is the more ap-
propriate target to study in this case, both as the free
protein and in complex with the drug. This could also
be beneficial in rational drug design for specific in-
hibitors that would block the bleomycin hydrolase ac-
tivity and possibly overcome drug resistance and thus
the efficacy of bleomycin as an anticancer agent.
Using an expression system in E. coli similar to the
one we used for the yeast homolog and mutants, the
recombinant human homolog is obtained in rea-
sonable yields and purified in a two-step procedure.
We were successful in our crystallization attempts
and are currently in the process of refining these con-
ditions.
ENCODED COMBINATORIAL LIBRARIES
H.P. Nest ler K. Charlston (Student) R. Liu
D.L. Dong R. Sherlock
J. Montagu (URP) J. Steiger (PFF)
Encoded combinatorial "One beadOne Structure" li-
braries have opened a new dimension for the study of
intermolecular interactions of low-molecular-weight
synthetic receptors with chemical and biological
ligands. We are employing combinatorial libraries to
identify molecules that specifically interfere with the
biological function of proteins of physiological im-
portance at specific functional sites. Hereby, we pur-
sue two different approaches: the search for selective
enzyme inhibitors that deactivate enzymes by binding
to their active site, and the quest for molecules that
bind proteins at specific epitopes on their surface and
block the access of other proteins interacting with
these epitopes.
Molecular Forceps from
Combinatorial Libraries
That Bind RAS Proteins
D.L. Dong, R. Liu, R. Sherlock [in collaboration with
M.H. Wig ler, Cold Spring Harbor Laboratory]
Our initial studies have shown that simple molecules
displaying two or more short peptide or peptide-like
chains (which we termed "molecular forceps") can
provide reasonable affinities and selectivities toward
peptide substrates. We are using libraries of molecu-
lar forceps to identify molecules that are able to bind
to the carboxyl terminus of RAS proteins (also
termed "CaaX-box") and prevent its farnesylation.
The famesylation of RAS has been shown to be a
crucial step in the activation of RAS as a signal
tranduction protein, and pharmaceutical trials have
shown that molecules that inhibit the farnesyl trans-
ferase, the farnesylating enzyme, are able to stop
tumor growth. The approach we follow outlines a new
paradigm for molecular biology, as we will attempt to
prevent a biological process not by inhibiting the en-
zyme connected with this process but by masking the
substrate with a synthetic molecule. To efficiently
target our molecular forceps toward the carboxyl
terminus of RAS, we use the isolated peptide se-
quence instead of the whole protein as substrate for
the screening of our libraries. The mole-cules selected
against the peptide epitope should bind RAS site-
specifically at the CaaX-box. Although there is
precedence that antibodies can be raised against pep-
tide epitopes in this fashion, it is unclear whether this
approach is suitable for the selection of synthetic
molecules. The carboxyl terminus of RAS is a suitable
test case for this novel approach as it is conforma-
tionally not restricted and should therefore be readily
accessible for the molecular forceps we intend to gen-
erate.
During the past 12 months, we generated a library
that contained two-armed and four-armed molecular
forceps. When we screened the library against the oc-
tapeptide derived from the CaaX-box of RAS, the
molecular forceps with four arms, although more flex-
ible than the two-armed forceps, predominated as in-
teracting molecules. This result suggests to us that we
will be able to compensate reduced molecular rigidity
by increasing the molecular size of our forceps. We
could show that the molecules selected for their bind-
ing toward the octapeptide also bind the whole
protein, establishing that we are able-at least in this
case-to select molecules that bind the protein by
screening a library against the epitope of interest. All
of the molecules that we selected, as well as
molecules selected against the whole protein, have
shown potential to impede the farnesylation of RAS,
and we are currently establishing that this retardation
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is caused by binding of the forceps to the CaaX-box
of RAS and not by coincidental inhibition of the
farnesyl transferase.
Combinatorial Libraries
for the Identification
of Enzyme Inhibitors
K. Charlston, J. Montagu, R. Sherlock [in collaboration
with A. Doseff, Y. Lazebnik, N. Tonks, Cold Spring
Harbor Laboratory, and C. Gennari and U. Piarulli,
University of Milano, Italy]
In the past year, we have engaged in the investigation
of using two families of amino acid derivatives for
the identification of enzyme inhibitors: sulfonamides
as potential inhibitors of proteases and phospho-
tyrosine mimics as inhibitors of protein tyrosine
phosphatases (PTPs). Both enzyme families are in-
volved in controlling cell fate and contain many
homologous enzymes. To elucidate the effects of
each individual member of these families requires
that the functionality of each individual enzyme be
abolished selectively. Because of the diversity of
compounds present in combinatorial libraries, we
hope to select molecules that selectively block the ac-
tion of the targeted enzymes while leaving homolo-
gous enzymes unaffected. Such inhibitors will be val-
uable tools for the dissection of biochemical path-
ways.
Sulfonamides have found widespread application
as antibiotics. They structurally mimic the transition
state of peptide hydrolysis, bind to proteolytic en-
zymes, but are not cleaved. Thus, the assumed mode
of biological activity is through inhibition of
proteolytic enzymes. Our collaborators in Milan have
developed a new class of sulfonamides, it- amino-
sulfon amino acids, that can be used as building
blocks for combinatorial libraries. During the last
year, we have begun to develop a library containing
regular peptides and peptides containing P-amino-
sulfon amino acids to identify inhibitors for prote-
ases. Phosphotyrosine mimics are known as inhib-
itors for PTPs. We have prepared one phospho-
tyrosine analog and incorporated it in a peptide and
established that this mimic binds to PTP-1B and in-
hibits its activity. The next step will be to include this
phosphotyrosine mimic in a peptide library to select
peptide sequences that inhibit PTP-1B selectively in
the presence of its homologs.
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Detection of His6- tagged Peptides
and Proteins on Beads and
Protein Gels
R. Liu, H.P. Nest ler, J. Steiger
The attachment of a hexa-histidine moiety ("His-tag")
to proteins is a standard means to purify these
proteins by affinity chromatography over a nickel
column, making use of the strong affinity of the His-
tag to the nickel bound to the column. We have de-
veloped a technique to use the His-tag for the screen-
ing of combinatorial libraries. Beyond its ability to
complex nickel ions, the His-tag also interacts with
other ions of transition metals, such as copper. Cop-
per(II) ions are essential to catalyze the Benzidine
Blue reaction, where the colorless substrate benzidine
(biphenyl-diamine) is oxidized by hydrogen peroxide
to yield a dark blue charge-transfer complex. When
applied for the screening of libraries, beads interact-
ing with the His-tagged ligands develop a brown
color which increases over time. As the setup of the
staining allows for the catalytic amplification of the
signal, the described technique allows the detection
of very small amounts of proteins as it is required for
the screening of combinatorial libraries. The use of
the described staining technique is not limited to the
screening of combinatorial libraries. We have adapt-
ed this staining for the detection of His-tagged
proteins in SDS-PAGE gels. As the His-tagged pro-
teins have a higher affinity toward copper than other
proteins, engineered and expressed His-tagged pro-
teins are stained predominantly in gels of protein
mixtures.
A Two-dimensional, Diagonal
SDS-PAGE Technique to Screen
for Protease Substrates
in Protein Mixtures
H.P. Nestler
Proteases have emerged during the last years as key
players in the execution of programmed cell death.
Many homologous proteases have been identified and
cloned. Yet, to understand the pathways the proteases
are involved in, and to elucidate the cellular cascades
they trigger, requires the identification of the in-
tracellular substrates processed by each protease.
Even the intensive efforts in genome sequencing and
cloning that yield new protein sequences every day
do not yield final answers to these questions. The oc-
currence of a cleavage motif in a protein sequence is
not sufficient for proteolytic susceptibility of the
protein, as the folding of the proteins may prevent ac-
cess of the protease to the substrate site. Indeed,
many proteins in their native conformation have been
shown to be resistant to proteolytic digestion.
Two-dimensional gel electrophoresis combined
with in-gel-proteolysis is a novel approach to screen
for protease substrates in protein mixtures: A mixture
of proteins, i.e., a cellular extract, is separated in a
SDS gel and the lanes are excised. The denatured
proteins in the gel stripes are renatured and digested
with the protease of interest. The electrophoretic de-
velopment into the second dimension under the same
conditions as the first dimension results in undigested
proteins appearing in a diagonal line, whereas the
products of the proteolytic cleavage separate from the
diagonal. The denaturation of the proteins with SDS
during the electrophoresis is necessary to ensure the
STRUCTURAL BIOLOGY
R.-M. Xu Y. Zhang
L. Jokhan
One of our main areas of interest is to understand the
structural basis of protein-RNA interactions using X-
ray crystallography. Currently, we focus on the struc-
ture determination of proteins involved in pre-mRNA
splicing, including hnRNP Al, SF2/ASF, and
U2AF65. A common feature of these proteins is that
they all contain several copies of RNA-recognition
motifs, and synergy between the RRMs is required
for stable and specific RNA-binding and for activity.
As a first step in understanding the RRM synergy
from a structural point of view, we have crystallized
and determined the crystal structure of UPI, the two-
RRM domain of hnRNP Al.
Structure Determination of UP1
P.M.. Xu, L. Jokhan [in collaboration with Adrian Krainer,
Cold Spring Harbor Laboratory]
Nascent transcripts of RNA polymerase II are bound
by a group of nuclear proteins, known as hetero-
electrophoretic separation by molecular weight,
which is required to achieve the alignment of un-
cleaved proteins in the diagonal of the two-
dimensional gel. The sequences of thus identified
protease substrates can later be determined by micro-
sequencing.
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geneous nuclear ribonucleoproteins (hnRNPs).
hnRNP Al, one of the most abundant hnRNP pro-
teins, has important roles in a number of cellular pro-
cesses, including packaging of pre-mRNA transcripts
in the nucleus, control of gene expression through
regulation of alternative 5' splice site selection, and
promoting annealing of complementary single-
stranded nucleic acids. In vitro experiments showed
that it can act as an RNA chaperone to ensure correct
folding of biologically active RNAs, such as ribo-
zymes and tRNAs. hnRNP Al has also been impli-
cated in transporting mature mRNA from the nucleus
to the cytoplasm. RNA-protein interactions are the
principal mechanism underlying each of these bio-
logical effects of hnRNP Al. Therefore, the deter-
mination of the structural basis by which hnRNP Al
interacts with RNA is important in understanding each
of these biological processes.
Human hnRNP Al is a 34-kD protein consisting of
a single polypeptide chain of 320 amino acids. An
amino-terminal proteolytic fragment spanning the first
196 amino acids and known as unwinding protein
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1 (UP1) comprises two RNA-recognition motif
(RRM) sequences separated by a short linker. The
carboxy-terminal region of hnRNP Al is rich in
glycine and includes several RGG repeats, which also
constitute an RNA-binding motif. Early studies
showed that both the amino-terminal UPI domain
and the carboxy-terminal glycine-rich domain are
capable of binding to nucleic acids, whereas the in-
tact protein exhibits more stable and highly coopera-
tive binding, with cooperativity being due to self-
association of the carboxy-terminal domain. Both the
UP1 domain and the carboxy-terminal domain are re-
quired for the alternative splicing activity of hnRNP
Al, and within the UPI domain, mutations in con-
served surface residues of either RRM abolish ac-
tivity, although general RNA binding is not substan-
tially affected. Purified hnRNP Al binds with high
affinity to short RNAs containing one or more copies
of the motif UAGGGA/U, although the physiological
significance of this high-affinity binding remains
controversial.
In the absence of bound RNA, UPI. was crystal-
lized in space group P21 with cell dimensions a =
38.0 A, b= 43.9 A, c= 55.8 A and (3 = 94.2°. The
unit-cell parameters suggest that there is one UP1
molecule per asymmetric unit in the crystal. The
crystal structure of UPI was determined by the clas-
sical MIR method to 1.9 A resolution. The crystal
structure of UPI shows that each RRM independently
adopts the characteristic RRM fold, consisting of a
four-stranded antiparallel (3- pleated sheet and two a
helices packed on one side of the (3- sheet. The two
RRMs in the UP1 structure are in close contact and
are positioned with the R sheets facing the same side
(Fig. 1).
The most significant and unexpected finding from
the UP1 structure is that the two RRMs are held to-
gether through two Asp-Arg salt bridges, which
FIGURE 1 Ribbon diagram showing the UP1 structure. The conserved RNP-2 and RNP-1 submotifs (p, and (33,
respectively) are shaded. The disordered portion of the linker connecting the two RRMs is shown in a dark color;
the amino terminus starts at Pro-7, and the carboxyl terminus ends at Ser-182. Amino acids involved in inter-RRM
salt-bridging and the conserved phenylalanines are shown as ball and stick models.
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result in juxtaposition of the four-stranded 13-sheet
from each RRM to form an extended RNA-binding
surface. The salt bridges observed may partially ac-
count for the observed salt sensitivity of RNA bind-
ing by both UP1 and hnRNP Al. Since the two salt
bridges in the UPI structure are partially exposed to
the solvent, it may be expected that a high-ionic-
strength environment could have a strong destabiliz-
ing effect on the packing of the RRMs, by disrupting
the Arg-Asp electrostatic interactions. Interestingly, it
has been observed that salt concentration can in-
fluence alternative splicing in vitro, with increasing
ionic strength having an opposite effect on alternative
5' splice site utilization as that of adding hnRNP Al.
The activation of proximal 5' splice sites upon in-
creasing salt concentration is consistent with destabi-
lization of hnRNP Al binding through disruption of
the inter-RRM salt bridges. The specific residues in-
volved in salt bridging between the two RRMs are
highly conserved among hnRNP A/B proteins but not
in more distantly related RRMs, strongly suggesting
that the structural basis for achieving a defined
orientation of the two RRMs relative to each other
has been phylogenetically conserved.
Although the present structure does not have
bound RNA, a great deal can be inferred about the
UPI -RNA interactions from the UPI structure, in
combination with previous biochemical studies of
hnRNP Al and UPI and with findings from struc-
tural studies of single RRM-RNA interactions in
other RNA-binding proteins. It is known that the
RRM 11-sheet provides a general RNA-binding plat-
form, and the conserved aromatic residues located in
the two central strands base-stack with single-
stranded bases of the bound RNA. These base-
stacking interactions are likely to be an evolutionarily
conserved mechanism of RRM-RNA interaction. Al-
though the conserved RRM features are crucial for
both general and sequence-specific RNA binding,
regions outside of the RRM may also have important
roles. In the UP1 structure, the linker connecting
RRMI and RRM2 appears to be flexible, and six
residues in the middle are disordered. Nevertheless,
the ordered residues in the structure place the linker
in a position highly likely to be involved in direct
RNA interactions. In addition, structural comparisons
of UPI with other RRM structures suggest that the
short amino-terminal 310 helix can potentially play a
prominent part in interacting with RNA.
Our next step will be to determine the co-crystal
structure with RNA, which will provide a precise pic-
ture of RNA-protein interactions by hnRNP Al.
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NEUROSCIENCE
Synergy abounds-among genes in a genome, among neurons in a brain, and among
neuroscientists at CSHL. This past year has witnessed impressive, important advances in
our understanding of the biochemical bases of learning and memory and of the mechan-
istic link between development and behavioral plasticity. Implications of this new insight
for the treatment and cure of learning disabilities are direct and immediate.
Malinow and company have begun to elucidate how a cellular form of memory-long-
term potentiation (LTP)-comes about. Young hippocampal neurons initially form synapses
that are "silent." Once they mature, however, postsynaptic depolarization coincident with
presynaptic activity produces an NMDA receptor-mediated calcium influx into the
dendrite. Increased levels of calcium activate a calcium-dependent kinase (CAMKII),
which presumably mediates the insertion of new AMPA receptors into the postsynaptic
membrane. AMPA receptors then respond to presynaptic release of glutamate even when
the postsynaptic membrane is not depolarized, thereby yielding an enhancement of
synaptic transmission. Amazingly, this same molecular mechanism may be involved in
activity-dependent synaptic stabilization during development of the brain. By imaging
neural growth in the frog optic tectum, Cline and workers have shown that newly formed
synaptic connections are glutamatergic but are unstable in immature neurons. As the
neurons mature, however, CAMKII expression increases and, consequently, NMDA
receptor-mediated neural activity converts silent synapses to more active ones again via
the appearance of AMPA receptors. These enhanced synapses then become more
stable. Thus, the conversion of immature, unstable synapses to mature stable synapses
appears to underlie both developmental and behavioral plasticity.
How do these immature neurons arise in the developing brain? Enikolopov and col-
leagues have been studying the effect of nitric oxide (NO)-a gaseous molecule which is
produced by nitric oxide synthase-on neural development. They first established in cell
culture that NO helps control a developmental switch from proliferation to differentiation of
neuronal precursor cells. More recently, they have obtained direct evidence for this devel-
opmental role of NO by assessing its function in vivo using both the fruit fly and frog model
systems.
Another important aspect of neurodevelopment concerns heritable learning dis-
abilities. In this context, Silva and colleagues have turned their attention to the
neurofibromatosis typel (NF1) gene, mutations in which produce learning disabilities (and
other defects) in children. They have shown that mutant mice carrying a knock-out of NF1
also display distinct learning disabilities, thereby establishing a model system with which
to study this heritable disease. Cellular studies have suggested that NF1 may function as
part of the Ras/Raf signal transduction pathway. Hence, Silva and coworkers also as-
sessed learning in mutant mice carrying a knock-out of the Ras-GRF exchange factor;
such mice also have learning defects. While studying cellular mechanisms of synaptic
plasticity in Drosophila, Zhong and coworkers discovered that peptidergic stimulation of
motor neurons induced both the Ras/Raf pathway and the cAMP pathway. In fact, coinci-
dent activation was required to produce changes in synaptic transmission. This observa-
tion, combined with results from the Silva group, prompted Zhong's group to study mutant
flies carrying disruptions of an NF1 homolog. They discovered these NF1 mutants to be
defective in synaptic transmission and associative learning. These results in mice and flies
have led both groups to investigate drug treatments that may ameliorate the learning dis-
abilities of NF1 mutants.
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MOLECULAR NEUROBIOLOGY OF LEARNING AND
MEMORY IN DROSOPHILA
T. Tully C. Jones S. Pinto
G. Bo !wig J. Christensen
M. Regulski B. Svedberg
J. DeZazzo K. Velinzon
J. Dubnau J. Connolly (Cambridge)
A. Wells (URP) D. Cain (PFF)
This past year, we have been consolidating our work
on the role of cAMP signaling in learning and
memory. In collaboration with Jerry Yin's lab, we are
developing new transgenic lines and behavioral train-
ing protocols to reveal further CREB's role in long-
term memory (LTM) formation. For these experi-
ments, we have used inducible transgenes to manipu-
late gene expression in time. We also have succeeded
in using enhancer-trap lines to manipulate gene ex-
pression in space, thereby demonstrating a role for
cAMP signaling in an identified anatomical structure
of the adult brain. To extend these gene manipula-
tions, we have begun to build a new genetic tool,
which will allow us to manipulate gene expression in
time and space.
dCREB2 Activator Is
Rate-limiting
for Enhanced LTM
T. Tully, J. Dubnau, B. Svedberg [in collaboration
with J. Yin, Cold Spring Harbor Laboratory]
Evidence from other model systems (Aplysia) has
suggested that the rate-limiting step in LTM induc-
tion is the cAMP-induced translocation of the protein
kinase A (PKA) catalytic subunit from the cytoplasm
into the nucleus. Whereas this situation, in fact, may
obtain during the acquisition phase of associative
learning, we considered it unlikely to be the case
once acquisition reached an asymptotic high. At such
a time, cAMP signaling would be expected to be
maximally activated and thus PKA translocation
would be well under way. What then is rate-limiting
for the induction of LTM after spaced training? We
addressed this question by quantifying enhanced
LTM in transgenic dCREB2-a (CREB activator) flies
that were heat shocked for different lengths of time.
We found that enhanced LTM was a direct function
C. Hogel (Wellington College)
T. Bridges (Eton College)
H. Solomon (PFF)
R. Wlodarczyk (PFF)
D. Nussbaum (PFF)
of the duration of heat shock. Thus, enhanced LTM
induction is rate-limited by the amount of transgenic
CREB activator expressed.
We also have begun to search for genes down-
stream from CREB that are transcriptionally regu-
lated during LTM formation. Parametric experiments
have determined that transcriptional changes of
150% can be detected via five RNA extracts from
adult heads. Both positive and negative controls have
been established, with extant genes known to be in-
volved in cellular or behavioral plasticity. Presently,
a screen for new genes will begin.
Identification of New
Genes Involved
with Associative Learning
T. Tully, C. Jones, S. Pinto, J. Christensen, G. Bolwig,
T. Bridges, J. DeZazzo, K. Velinzon, H. Solomon
[in collaboration with K. Broadie, University of Utah]
We continue our molecular genetic characterizations
of latheo, linotte, nalyot, golovan, and amnesiac. We
are studying various pleiotropic effects of latheo
mutations. In collaboration with Kendall Broadie at
the University of Utah, we have discovered that Lat
is expressed in embryonic blastoderms, in larval
neuroblasts, and in presynaptic terminals of the larval
neuromuscular junction and that latheo mutants show
an induced hyperexcitability at these synapses
(preliminary observations made by Yi Zhong,
CSHL). We have raised antibodies to Lio and now
are characterizing its expression pattern in adult
brains. Genetic complementation experiments have
established that the nalyot mutation lies in the Adf-1
transcription unit, which encodes a transcription fac-
tor. Similarly, the golovan mutations fail to comple-
ment other mutations in extra machrochaetae, a neg-
ative regulator of proneural transcription factors. Ex-
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periments are now under way to determine if these
new nuclear factors function during adult learning
and memory formation.
Characterization of Extant
Mutants in Signal
Transduction Pathways
T. Tully, C. Hogel, C. Jones, M. Regulski, J. DeZazzo,
D. Cain, D. Nussbaum [in collaboration with
C. O'Kane, Cambridge; M. Forte, Vollum Institute;
K. Kaiser, University of Glasgow]
We have extended our study of cAMP signaling dur-
ing olfactory associative learning in two important
ways. First, we successfully have detected a bio-
chemical defect in mutant PKA -RI adults: Whole-
head homogenates show higher than normal baseline
levels of PKA activity in the absence of any ex-
ogenous cAMP but normal PKA activity in 5 ton
cAMP. Although subtle, this biochemical defect is
consistent with the notion that the PKA-RI muta-
tion(s) either yields lower than normal levels of RI
protein or produces an dominant-negative mutant
protein. Evidence from Northern and Western blot
analyses suggests both. Second, we have used
enhancer-trap technology to limit expression of
dominant-negative mutant or wild-type stimulatory
subunits of G protein (Gs) to various anatomical
regions of the fly brain. When mutant G, is expressed
preferentially in mushroom bodies, olfactory associa-
tive learning is completely abolished, with no detec-
table effects on the transgenic flies' task-relevant
sensorimotor responses. When mutant Gs is ex-
pressed in the central complex (another anatomical
region of the fly brain that has been implicated in
learning), olfactory associative learning is normal.
Likewise, this learning is normal when wild-type Gs
is expressed in either brain region (Fig. 1). These data
demonstrate for the first time that cAMP signaling in
mushroom bodies is required for normal olfactory as-
sociative learning, a notion originally suggested by
the (preferential) expression patterns of dunce,
rutabaga, DCO, and RI.
We also have extended our studies of turnip
mutants, which were isolated as defective in olfactory
learning and are defective in phospholipid-dependent
protein kinase (PKC). We have shown that locomotor
reactivity is aberrant in turnip flies. Consequently,
these mutants show abnormal task-relevant sensori-
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FIGURE 1 Olfactory associative learning among wild-type
flies (+/+) or transgenic flies expressing enhancer-trap
C747 alone (P/+), mutant Gs protein along (G*/+), two dif-
ferent wild-type Gs proteins alone (G1/+ or G2/+), and both
C747 and wild-type Gs protein (P/G1 or P/G2) is similar. In
contrast, learning is completely abolished in transgenic flies
expressing both C747 and mutant Gs protein (P/G*). Similar
results were obtained with four other enhancer-trap lines
that also express transgenes preferentially in mushroom
bodies. Learning is normal, however, when mutant Gs is ex-
pressed in the central complex (data not shown).
motor responses, faster than normal habituation to ol-
factory cues, abnormally low dishabituation, and less
dark reactivity. Such effects preclude the notion that
turnip (and PKC activity) underlies olfactory associa-
tive learning in Drosophila.
We have generated antisera to dNOS and have
begun to characterize its pattern of expression in
Drosophila. Interestingly, it appears first expressed
during embryogenesis in a region of the midline from
which neuroblasts later differentiate. We now are
trying to disrupt dNOS to characterize the develop-
mental and behavioral effects of hypomorphic and
null mutations.
Finally, we have attempted to rescue the memory
defect of amnesiac mutations via induced expression
of "the Quinn ORF," a putative neuropeptide that M.
Feany and W.G. Quinn have reported to be encoded
by amnesiac. We see no rescue. Along with DNA se-
quence data from the 19A region, this observation
suggests that the amnesiac transcript may encode a
neuropeptide. Thus, we continue efforts to clone the
correct gene.
Behavioral Properties of Learning
and Memory in Normal and
Mutant Flies
T. Tully, J. Connolly, F. Wlodarczyk, K. Velinzon
[in collaboration with D. Yamamoto, Mitsubishi Kasei]
We continue to develop new training protocols to dis-
sect genetically the biobehavioral organization of
learning and memory. This year, we have modified
our Pavlovian discriminative conditioning procedure
to quantify conditioned excitation (produced by pair-
ing an odor with electroshock) versus conditioned in-
hibition (produced by pairing an odor with "no
shock"). Our data reveal properties of conditioned ex-
citation and inhibition similar to those in vertebrates.
Moreover, our behavioral analyses indicate that con-
ditioned inhibition is not produced by our discrimina-
tive procedure. Finally, we have discovered that con-
ditioned inhibition is normal but that conditioned ex-
citation is reduced in radish mutants. Thus, we have
genetically dissected these two opposing forms of as-
sociative learning.
We also have developed a new chemosensory
learning procedure for larvae. Initial learning levels
are similar between larvae subjected to either spaced
or massed training. Memory persists for at least 2
days after spaced training, however, but decays with-
in 2 days after massed training. Thus, even fruit fly
larvae show this fundamental (and ubiquitous) prop-
erty of memory formation. With this larval assay, we
will be able to study the effects of mutations on
learning in immature "flies" and then characterize the
development of adult associative learning.
New Genetic Tools
T. Tully, J. Dubnau, A. Wells
Several of the studies mentioned above capitalized on
the use of genetic tools in Drosophila that allow us to
manipulate gene function in either time (inducible
transgenes) or space (enhancer-trap-driven trans-
genes). Ideally, however, we want to manipulate gene
function in time and space. To accomplish this exper-
imental goal, we have begun to develop a new trans-
gene vector that incorporates both enhancer-trap-
driven expression and inducible expression.
Another current limitation in fly molecular genet-
ics concerns targeted mutagenesis of cloned (wild-
type) genes. The only method currently available is
site-selected P element mutagenesis, which is rela-
tively inefficient and labor-intensive. To solve this
problem, we are developing a molecular-genetic
method to enhance the frequency of homologous
recombination in fruit flies. If successful, this ap-
proach will allow replacements of wild-type DNA se-
quence with mutant sequences of various sorts.
Finally, our past efforts to identify new genes in-
volved with learning and memory have been forced
to rely on P element mutagenesis, primarily because
this approach yields morphologically and molecularly
tagged mutations, which then are more easily cloned.
P elements do not insert randomly into the genome,
however. Best estimates suggest that these transpos-
ons likely will disrupt only half of the 15,000 genes
in Drosophila. Chemical mutagenesis, in contrast,
mutates genes randomly but does not yield morpho-
logically tagged genes. Moreover, this approach
usually produces point mutations, which are next to
impossible to detect molecularly. To alleviate this
problem, we are developing a molecular method to
identify point mutations.
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LONG-TERM MEMORY FORMATION IN DROSOPHILA
J. Yin M. Belvin S. Till
B. Nyein (URP) J. Wallach
M. Stebbins H. Zhou
We are interested in the molecular biology of long-
term memory (LTM) formation. The available in-
formation, tools, and technologies that can be applied
to this problem vary from experimental system to
system, with each organism having unique ad-
vantages and disadvantages. We are trying to utilize
advantageous approaches, or develop complementary
ones, to exploit the relative strengths of the Dro-
sophila and mouse systems.
Upstream Activation
of CREB
S. Till, H. Zhou, J. Yin
We have initiated a reverse genetic approach to ana-
lyze the role of conserved phosphorylation sites in
the "P-box" domain of the Drosophila dCREB2 gene.
Phosphorylation sites that are conserved between the
mammalian cAMP-inducible transcriptional activa-
tors (CREB, CREM, and ATF-1) and the fly protein
have been mutated to alanine residues. These muta-
tions have been incorporated into both inducible acti-
vator (dCREB2-a) and blocker (dCREB2-b) isoforms
of the fly gene and transgenic lines have been made
and await behavioral testing. Previous work has
shown that when flies carrying the wild-type ac-
tivator transgene are given a single training trial,
there is a linear relationship between the amount of
induction and the amount of LTM that is formed, un-
til an asymptote is reached. Transgenic flies that are
given a subthreshold amount of induction require
more spaced training trials to reach this asymptote.
To test the effect of mutating a given phosphorylation
site on activator function, we will deliver sub-
threshold amounts of induction to wild-type and
mutant transgenic flies so that they express com-
parable amounts of protein, give them a single train-
ing trial, and compare their LTM levels. To test for
the involvement of a given phosphorylation site in
the requirement for a rest interval, we will give sub-
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threshold levels of induction followed by spaced or
massed training trials. Similarly, mutant blockers will
be tested for their effects on preventing LTM forma-
tion.
To complement our in vivo analysis of phosphory-
lation, we have begun to generate phospho-specific
antibodies directed against sites in dCREB2 of partic-
ular interest. We have two independent antibodies
directed against the phosphorylated Ser-133 residue,
whose phosphorylation is absolutely necessary, but
not sufficient, for CREB activation across all species.
This residue has been shown to be a target for a num-
ber of different signaling pathways, including protein
kinase A, Ca"-calmodulin kinase H and IV, and
CREB-kinase, which lies downstream from a neuro-
trophin-activated MAP kinase cascade. Currently, we
are examining this antibody on Western blots and tis-
sue sections in response to physiological, pharmaco-
logical, and genetic manipulations that should result
in phosphorylation of this residue. We have also
begun making a Ser-142 phospho-specific antibody,
but we have been hampered by our inability to phos-
phorylate efficiently the fly CREB protein on this
residue in vitro.
We have been using a mammalian Ser-142 phos-
pho-specific antibody to try to trap this species in
mammalian cells and hippocampal slices. Since we
believe that phosphorylation of this residue is directly
or indirectly responsive to CaM kinase II, we are
treating cells or slices with physiological stimuli or
pharmacological agents that should activate this path-
way. Using Western blot analysis of proteins, or im-
munohisotchemistry of cells, we are looking for evi-
dence that this residue can be phosphorylated.
The LTM Cells
J. Wallach, H. Zhou, J. Yin
We are continuing to characterize our transgenic flies
which carry CREB-responsive reporter genes. Two
different types of reporters have been made, those
that contain complex promoter fragments from puta-
tive "downstream" targets of activated CREB (Droso-
phila fos, tyrosine hydroxylase, and CREB) and those
that only contain reiterated CREB-binding sites
(CREs).
These insulated reporter flies have been examined
for their validity in reporting CREB-activated tran-
scription. With the simpler reporters, a 3x wild-type
CRE enhancer generates a much stronger signal than
a 3x mutant CRE enhancer, showing that the pattern
of staining which we see on adult head sections is
sensitive to mutations that decrease the binding af-
finity of the dCREB2 proteins at least 20-fold in
vitro. If the dCREB2-b inducible transgene is crossed
into the fly that contains the 3x wild-type CRE
reporter, expression from this transgene blocks
reporter activity, showing that the enhancer can be
responsive to fly CREB isoforms. However, neither
genetic or pharmacological manipulations have ever
resulted in up-regulation of reporter expression. Our
attempts to visualize LTM-specific staining of the
reporter have also not been successful to date. We are
currently investigating the reasons for our inability to
increase expression from the reporter and the reasons
for nonresponsiveness after behavioral training.
We have begun a parallel experiment in mouse.
Recently, it was shown that a simple 6x wild-type
CRE transgenic mouse can report meaningful respon-
ses to physiological stimulation in hippocampal slices
(LTP vs. L-LTP), and pharmacological intervention
in dissociated neuronal cells. We have made similar
lines of mice that contain reiterated CRE sites but
have incorporated the use of vertebrate "insulators" to
help alleviate position-dependent effects on expres-
sion. We are using fragments from the chicken globin
locus control region, which has been shown in trans-
genic settings to have "insulator" function. Insulation
is generally defined as position-independent, copy-
number-dependent expression. These mice are cur-
rently being characterized, in anticipation of testing
behavioral, physiological, and pharmacological stim-
ulations. The mouse system has the distinct advan-
tage that numerous behaviors are available for test-
ing, many of which have known anatomical require-
ments for memory formation based on ablation
studies. Part of our strategy is to select particular be-
haviors whose required anatomical regions show low
basal expression in our reporter mice, thus increasing
the chances of detecting new, training-induced stain-
ing.
Molecular and Genetic
Characterization of dCREB2
M. Belvin, B. Nyein, H. Zhou, J. Yin
One of the advantages of the fly system is the de-
creased amount of "molecular redundancy" among
families of molecules. In mammals, the CREB,
CREM, and ATF-1 genes have all been shown to be
capable of responding to similar transduction systems
to activate transcription from CRE-containing down-
stream genes, at least in cell culture systems. Another
level of complexity is added by the numerous alterna-
tively spliced forms which can be generated from the
CREB and CREM genes. It is unclear whether this
molecular richness is utilized in neurons, although it
seems very likely given that analogous, alternatively
spliced isoforms exist in both Drosophila and Aplysia
neurons. Thus, a real molecular description of the
events that occur on the dCREB2 gene in response to
LTM formation is a challenge, although less daunting
than the comparable description on the three mam-
malian genes.
We have begun to characterize the set of immuno-
responsive protein bands detected in endogenous
Drosophila head extracts on Western blots. Current-
ly, we detect a group of bands in the 12-50-kD range
that we suspect to represent endogenous protein
forms. These proteins will need to be isolated and
characterized biochemically before we can be sure of
their identity. We have made new antibodies to try to
sort out some of this complexity, although we have
not been able to generate an activator-specific serum
after a number of repeated efforts. Ultimately, we
will need a spatial description of the tissue distribu-
tion of these forms.
The other obvious advantage of the fly system is
the feasibility of doing forward genetics. We are very
interested in isolating a (probable) lethal mutation in
the dCREB2 gene, which will facilitate genetic,
molecular, and behavioral analysis of the role of this
gene in LTM formation and neuronal development.
In addition, the availability of a lethal mutation will
allow a strong screen for suppressors, which may,
depending on the molecular nature of the mutation,
reveal upstream and/or downstream interacting
genes.
In parallel, we have continued our examination of
the S162 mutation, a y-ray-induced lethal com-
plementation group which co-maps to the same X-
chromosome cytological location as a dCREB2
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probe. This mutation results in early larval lethality in
homozygous females and hemizygous males. How-
ever, this lethality can be partially rescued by the
dCREB2-b transgene, and almost full rescue is
achieved when the transgene is induced. The inter-
pretation of simple rescue experiments is complicated
by the fact that background (presumed) genetic
variability can also give partial rescue. This vari-
ability in partial rescue precludes the use of this
mutation in a simple suppressor screen. Therefore,
we are awaiting the first-level description of protein
isoforms in wild-type flies before returning to a
molecular description of the 5162 mutation. Our cur-
rent efforts to isolate a mutation in the dCREB2 gene
involve developing an easy visible screen for CREB
activity.
The initial attempt at an external, visible screen for
CREB activity utilized the white gene. The protein is
normally involved in the synthesis of the red eye pig-
ment found in wild-type eyes. The white gene shows
dosage sensitivity, with a linearity between the
amount of protein and the eye color over a sixfold
range. We created a series of insulated, 3x, 6x, and
9x CRE-white reporter flies where the white-coding
region was placed under the control of a simple
CREB-responsive promoter element, exactly like our
LTM cell reporters (see above). However, none of
these transgenic reporters were responsive to induc-
tion of the dCREB2-b transgenic blocker when they
were crossed together. Therefore, we have moved to
a luciferase-based reporter.
CRE-Luciferase Transgenic
Reporters
M. Belvin, H. Zhou, J. Wallach, J. Yin
Luciferase offers a number of advantages as a
reporter molecule, including reduced half-life as a
protein, ease of measurement in crude extracts,
ability to measure in a behaving fly, and sensitivity.
We have made 3x wild-type CRE luciferase trans-
genic reporter flies and measured luciferase activity
in crude total fly, total head, or total body extracts.
These measurements, while easy to carry out, have a
large amount of variability and therefore require mul-
tiple samples. However, when two independent trans-
genic lines are "entrained" on a strict 12 -hour
light:12-hour dark cycle, we find that the luciferase
activity shows periodicity, with a major peak in
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luciferse activity at dusk. More significantly, when
flies are entrained for 4-5 days and then put into a
24-hour darkness regimen ("free run"), the reporter
shows the same periodicity, indicating that this
CREB-responsive transcription is likely to be regu-
lated through the circadian system. Examination of
adult head sections with a luciferase antibody shows
that the spatial staining pattern is similar, if not
identical, to that of our 1- galactosidase reporters,
with heavy staining in the visual system (the eye,
lamina, and medulla).
We are testing the feasibility of this system as an
easy method to measure CREB activity, in anticipa-
tion of using it as a phenotype to score in a mutagenic
screen. Our understanding of the biology that regu-
lates the CRE-luciferase reporters might allow us to
use this reporter system as a method to screen for
mutations in aspects of the circadian clock, genes up-
stream of CREB in the circadian circuit, and in
CREB itself.
Neurotrophins in Drosophila
M. Stebbins
The neurotrophins are neuronal growth-factor-related
proteins that serve important functions in neuronal
differentiation, survival, target-directed outgrowth,
and cell-type determination. Recent data suggest very
strongly that certain neurotrophic factors, especially
brain-derived neurotrophic factor (BDNF), may also
have significant roles in modulating synaptic function
and plasticity-related growth processes. These mole-
cules are conserved across mammalian species, and
very recently, an invertebrate molecule was de-
scribed. Our goal is to determine if there is a con-
served family member in Drosophila and to utilize
flies to (1) place the function of these molecules in
the rich context of Drosophila neuronal development
and axon guidance, (2) begin to understand the com-
plex signaling pathways downstream from ligand
binding, (3) utilize fly genetics to identify interacting
genes, and (4) ask if they are involved in learning and
LTM formation.
To begin this process, we are looking for evidence
that conserved ligands or receptors exist in Drosoph-
ila. Two complementary experiments are being
pursued. First, we have made inducible transgenic
flies carrying truncated versions of the mammalian
trkA and trkB receptors. The truncated trkB receptor
is a naturally occurring splice variant that contains
just the extracellular ligand-binding domain and very
little of the intracellular signaling domain. Func-
tionally, it is a dominant-negative receptor. The trun-
cation in the trkA gene was made at approximately
the same point as the shortened trkB isoform. These
flies are currently being examined to see if induction
of the receptor results in any neuronal developmental
phenotype, which would suggest that there is an
endogenous fly protein that can be titrated by ectopic
overexpression of the mammalian receptor. These
reagents also allow us to test the inducible effects of
the transgene on learning and LTM formation.
To complement these experiments, the mammalian
proteins (NGF, BDNF, and NT-3) are being injected
into fly embryos, and the embryos are being exam-
ined for neuronal developmental defects. Phenotypes
in this assay would suggest that there are fly recep-
tors which are capable of recognizing mammalian
ligands. Taken together with the transgenic experi-
ments, we should be in a position to decide on which
neurotrophin or receptor to concentrate and have
functional information on approaches to cloning and
identifying the gene(s). We, and others, initially tried
to identify possible conserved genes using DNA-
based low-stringency approaches. cDNA clones for
trkA, trkB, trkC, NGF, BDNF, and NT-3 were used
unsuccessfully to screen Drosophila genomic South-
ern blots at varying levels of stringency. It is ex-
pected that some type of functional assay may have
to be employed to clone the trophic molecules or
their receptors.
Development of Spatial-Temporal
Inducible Strategies
M. Stebbin, H. Zhou, J. Yin
In Drosophila, we have begun adopting the tetra-
cycline-inducible system for spatially and temporally
regulated expression of genes. Transgenic flies are
being made that contain both the forward and reverse
systems, where the trans-activator is expressed ubiq-
uitously, to test the practical aspects of temporal
regulation. We are also putting the forward system
under a mushroom body enhancer-promoter, which
should delimit high-level expression of the trans-
activator to the anatomical region that is required for
learning. Finally, we are adopting the system so that
the currently available enhancer-trap lines (which ex-
press gal4 in defined areas of the adult brain) can be
used to drive expression of the trans-activator in
these regions. By layering on the enhancer trap sys-
tem to the tetracycline system, we should be able to
achieve reasonable spatial and temporal regulation of
expression with the large available collection of char-
acterized enhancer lines.
In mice, there have been recent reports of success-
ful use of the tetracycline system in the analysis of
behavior. However, one of the limitations that cur-
rently exists is the slow kinetics of induction for the
reverse system, since it relies upon withdraw! of
tetracycline. Preliminary information on the forward
system is that induction is faster, although it still re-
quires a couple of days to achieve reasonable levels
of the induced target gene product. We believe that
one major contributing factor to the kinetic problem
is that the trans-activator is expressed very poorly,
partly due to a cryptic splicing event that results in
nonfunctional RNA. We have removed this site, as
well as rebuilding the gene using mammalian codon
usage. Mice are currently being injected with various
transgenes to test these improvements. The CaM
kinase II promoter, whose high-level expression does
not begin until 3 weeks after birth and is delimited to
the forebrain, is being used to drive expression of the
forward trans-activator. In addition, the globin LCR
fragments are being used to insulate the target trans-
genes. If these fragments function as insulators, then
almost all independent lines of the target transgene
should be fairly equivalent in their response to the
trans-activator. This property would greatly reduce
the number of combinations of transgenes (trans-
activator and target) that would be needed to test for
any given gene which is being induced.
To facilitate analysis of trans-activator expression
both in flies and in mice, we have initiated antibody
production against the forward and reverse trans-
activators. Current versions of the tetracycline system
only use target reporter genes to measure trans-
activator function, since trans-activator expression is
very low. The only available data on trans-activator
expression in transgenic mice uses RT-PCR to detect
trans-activator RNA. We suspect that the cryptic
(nonproductive) splicing of the trans-activator gene
contributes to this problem.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong F. Guo J. Sheng
F. Hannan N. Wright
L. Luo
Our research interest is to understand the neural basis
of learning and memory. The approach undertaken is
to analyze Drosophila learning and memory mutants.
During last two decades, a number of Drosophila
mutants have been isolated on the basis of their poor
performance in a classic conditioning task. Some of
these mutations affect learning, whereas others affect
memory. Insights into the neural basis of learning and
memory may be gained if we can understand how the
functions of the nervous system are altered in these
mutants. Our research has been focused on two
aspects of the problem. First, we use these mutants to
dissect signal transduction pathways that may be im-
portant for learning and memory. This study has pro-
vided unexpected insights into biochemical processes
that may be important for learning and memory and
has identified new components for further genetic
manipulation of behavior. Second, we are developing
preparations for electrophysiological and Ca++ imag-
ing recordings of neuronal activity in the mushroom
body of the live fly brain. This effort has allowed us
to record, for the first time, neural activity in the cen-
tral nervous system in response to odors in live flies,
which provides a basis to examine neural coding of
olfaction and ultimately to investigate the neural
basis of olfactory-associated learning and memory in
flies.
Requirement of the NF1 Protein for
Activation of Rut- Adenylyl Cyclase
F. Guo, F. Hannan, Y. Zhong [in collaboration
with T. Inger and A. Bernards, Massachusetts
General Hospital]
The rut gene, isolated as a learning and memory
mutant, encodes a Ca++/CaM-sensitive adenylyl cy-
clase (Rut-AC). Biochemical study by M.S. Living-
stone has shown that Rut-AC is not involved in the
cAMP synthesis activated by monoamine trans-
mitters, such as dopamine, 5-HT, and octopamine.
Our electrophysiological study has revealed that Rut-
AC is involved in mediating neuropeptide transmis-
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sion. The pituitary adenylyl-cyclase-activating poly-
peptide (PACAP38)-like neuropeptide activates both
Rut-AC/cAMP/PKA and Ras/Raf pathways to modu-
late K+ currents synergistically. This result brought
our attention to the Ras/Raf pathway for its potential
role in learning and memory. To understand this
pathway better, we examined the effects of those
mutations that disrupt either activation or inactivation
of Ras activity. Among them, PACAP38 response
was eliminated by the mutations at the locus
homologous to the human neurofibromatosis type 1
(NF1) gene (Fig. 1).
Mutations in the NF1 gene lead to a common hu-
man genetic disorder that is identified by benign
tumors of the peripheral nerves, hyperpigmentation,
white matter lesions in the brain, learning disabilities,
and many other manifestations. The NF1 protein,
which contains a fragment similar to the GTPase ac-
tivating protein for Ras (Ras-GAP), stimulates the in-
trinsic activity of Ras-GTPase and therefore inhibits
biological activation of Ras. However, the NF1 pro-
tein may not act solely to regulate Ras; it may also
function as an effector mediating signaling important
for differentiation. The Drosophila homolog of NFl
is 60% identical to the human NFl protein over its
entire 2802-amino-acid length. Our study indicates
that the defective PACAP38 response in Drosophila
NFI mutants could not be explained by failure to
negatively regulate Ras activity. Instead, the defect is
caused by the blockade of activation of rut-encoded
adenylyl cyclase because the PACAP38 response
could be fully restored by supplying drugs that stimu-
late the cAMP pathway prior to the perfusion of
PACAP38 (Fig. 2).
The conclusion that NFl is a crucial component
for activation of the cAMP pathway is further sup-
ported by studying the developmental defect of NF1
mutants. The smaller body size of NF1 mutants
caused by reduced cell size was not rescued by
manipulating the Ras pathways, but by expressing
additional catalytic subunits of cAMP-dependent
protein kinase A (PKA). This finding leads to new in-
sights into mechanisms of G-protein-mediated signal
transduction and the pathogenesis, and possible the
treatment, of human type-1 neurofibromatosis.
control 2 min
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FIGURE 1 PACAP38-induced enhancement of K+ currents
is abolished in NF1 mutants. The arrow indicates focal ap-
plication of PACAP38 (5 pm). 'Control' current traces were
recorded before application of PACAP38. The time in sec-
onds after pressure-ejection of PACAP38 is indicated at the
top of the current traces.
Molecular Basis of Learning
Disability in NF1 Mutants
F. Guo
We are interested in examining learning and memory
in Drosophila NF1 mutants. First, NF1 patients and
NF1 mouse knock out display a learning disability.
Second, activation of adenylyl cyclase, which is
defective in the learning and memory mutant rut, is
regulated by NFl. Thus, Drosophila NF1 mutants
may serve as a model for understanding the molec-
ular basis of NFl-related learning disabilities and as a
control 3 min
PACAP38
wild type +Thrskol in
NFI'+forskolin
+forskolin
4 min 6 min
1
250 nA
20 ms
FIGURE 2 Restored PACAP38 response in NF1 mutants by
forskolin. Forskolin (10-100 [an) was applied to mutant cells
before perfusion of PACAP38.
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FIGURE 3 Learning defect in NF1 mutants. The per-
formance index is in a scale where i indicates a perfect
learning and 0 no learning. The learning score was obtained
by using Tully-Quinn and procedure.
model for the development of drug treatment for the
NF1 learning disability.
Greatly facilitated by the help from Tim Tully's
lab here at the Laboratory, we have been able to ob-
tain preliminary data showing that associative Team-
ing is defective (Fig. 3) in NF1 mutants, whereas the
peripheral sensory modalities related to learning be-
havior are near normal. We hypothesize that this
learning defect is caused by a blockade of activation
of rut-encoded adenylyl cyclase, as indicated in the
PACAP38 response, as well as other adenylyl
cyclases. The rut mutants have been isolated as a
learning and memory mutant. On the basis of this
hypothesis, we are testing whether the learning defect
10-16 10-9 10-6 10-7 10-6 10-5 10-4 10-6
(002+)
FIGURE 4 Basal level of adenylyl cyclase activity in NF1
mutants. Adenyljd cyclase activity was assayed by using
homogenized abdomen tissues of adult male flies.
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FIGURE 5 Intracellular recordings from mushroom body neurons of a live fly. A small patch of
cuticle was removed, and the opening was covered with saline. Mushroom bodies can be
visualized, via the opening, by the expression of GFP. The membrane voltage traces were re-
corded from one of these identified mushroom body neurons.
observed in NF1 mutants can be rescued by expres-
sing additional PKA catalytic subunits or by feeding
flies with forskolin, a drug that stimulates adenylyl
cyclase activity, bypassing the NF1 effect.
Ras-NF1 Complex in Activation
of Adenylyl Cyclase
F. Hannan, L. Luo
The eletrophysiological experiment presented earlier
indicates that NF1 is crucial for activation of aden-
ylyl cyclase, but it provides no clues as to how NF1
influences the activity of adenylyl cyclase. Because
the yeast protein, IRA, is distantly related to NF1 and
is involved in Ras-dependent activation of adenylyl
cyclase, we are testing the idea that activity of
adenylyl cyclase can be regulated by the Ras-NF1
complex. The cyclase activity was measured from
homogenized Drosophila tissues, and it was shown
that the basal level of cyclase activity was not af-
fected in NF1 mutants (Fig. 4). We are examining
how cyclase activity in wild-type flies and NF1
mutants is affected by additional Ras or mutant Ras.
Although preliminary data were very interesting, the
results were not consistent. We are now trying to find
conditions that give rise consistency.
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Recording and Imaging of Neuronal
Activity of Mushroom Body
N. Wright
The mushroom body (mb) is a distinct central ner-
vous system structure that is crucial for olfactory-
related associative learning in insects, including flies.
Electrophysiological recordings from mushroom
bodies in other large insects, such as the bee, have
provided rather exciting insights into the neural basis
of learning and memory. To utilize learning and
memory mutants of Drosophila for gaining further
understanding, we must first overcome the technical
difficulty of the small size of Drosophila brain and
neurons, which has previously prevented any physi-
ological studies of the fly central nervous system. We
have developed several preparations. First, the ac-
tivity of mushroom body neurons was recorded in-
tracellularly from a dissected whole brain, in which
mushroom body neurons were identified by expres-
sion of green fluorescence protein (GFP) in the
GAL4 enhancer-trap lines. This preparation may al-
low us to study synaptic plasticity of mushroom body
neurons. Second, the activity of mushroom body
neurons was recorded from a live fly (Fig. 5). Third,
to investigate the neural network properties that are
related to learning and memory, we are developing a
preparation that allows us to monitor the activities of
multiple mushroom body neurons by using Ca++ im-
aging. We have successfully obtained imaging of
neuronal activity in response to odor stimulation.
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CELLULAR MECHANISMS OF ACTIVITY-DEPENDENT
NEURONAL DEVELOPMENT
H. Cline N. Ali (URP) J. Edwards I. Rajan
R. Bari I. Miloslayskaya G.-Y. Wu
B. Burbach E. Nedivi D.-J. Zou
The lab is working toward an understanding of the
cellular and molecular mechanisms that control the
development of structure and function of the central
nervous system (CNS). We perform our studies using
the developing retinotectal projection of the frog
Xenopus. We use several approaches to this system
that allow us to assess and manipulate the coordinated
development of neuronal morphology and synaptic
transmission in the CNS. One approach is to use im-
aging of single retinal axons or tectal neurons in the
intact anesthetized animal to observe their mor-
phological development for up to 5 days in vivo with
time-lapse confocal microscopy. A second approach is
to use a whole-brain preparation to take whole-cell
patch-clamp recordings from neurons at different
stages in the process of maturation. We can record
from tectal neurons as they receive their first synaptic
contact from retinal afferents and track the develop-
ment of the synaptic connections as they mature. This
is one of the only experimental systems that permits
direct recordings of synapse formation and maturation
in the intact CNS. To manipulate the genetic and
protein components of the neurons, we use viral vec-
tors to deliver genes of interest into frog neurons. We
are now using this range of techniques to test the
hypothesized roles of synaptic activity and activity-
regulated proteins in the coordinated development of
the structure and function of the CNS.
Dynamic Growth of
Normal Axons
H. Stier, I. Miloslayskaya, S. Witte, H. Cline
Changes in neuronal structure can contribute to the
plasticity of neuronal connections in the developing
and mature nervous system; however, the expectation
that they would occur slowly precluded many from
considering structural changes as a mechanism un-
derlying synaptic plasticity that occurs over a period
of minutes to hours. We have taken time-lapse confo-
cal images of retinotectal axon arbors to determine the
time course, magnitude, and distribution of changes in
axon arbor structure within living Xenopus tadpoles.
Images of axons were collected at intervals ranging
from 3 minutes, 30 minutes, and 2 hours during total
observation periods up to 8 hours. Branch additions
and retractions in arbors imaged at 3- or 30-minute in-
tervals were confined to shorter branches. Sites of ad-
ditions and retractions were distributed throughout the
arbor. The average lifetime of branches was about 10
minutes. Branches of up to 10 itm could be added to
the arbor within a single 3-minute observation inter-
val. Observations of arbors at 3-minute intervals
showed rapid changes in the structure of branch tips,
including transitions from lamellar growth cones to
more streamlined tips, growth cone collapse, and re-
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extension. Simple branch tips were motile and ap-
peared to be capable of explor-atory behavior when
viewed in time-lapse movies. In arbors imaged at 2-
hour intervals during a total of 8 hours, morphologi-
cal changes included longer branches tens of microns
in length. An average of 50% of the total branch
length in the arbor was remodeled within 8 hours.
The data indicate that the elaboration of the arbor oc-
curs by the random addition of branches throughout
the arbor, followed by the selective stabilization of a
small fraction of the new branches and the retraction
of the majority of branches. Stabilized branches can
then elongate and support the addition of more
branches. These data show that structural changes in
presynaptic axons can occur very rapidly even in
complex arbors and can therefore play a part in forms
of neuronal plasticity that operate on a timescale of
minutes.
Calcium Imaging in
Retinal Arbors
J. Edwards, H. Cline
Now that we have documented the rates of mor-
phological changes in retinal axon arbors and in
growth cones, we have begun to test whether changes
in [Ca"]; correlate with neuronal growth and growth
cone navigation in vivo, and whether experimentally
decreasing [Ca"]; changes these aspects of neuronal
development. We have been able to image changes in
[Ca++]; in the growing axon arbors and growth cones
in vivo. Our initial experiments in this project indi-
cate that branch additions are spatially and temporal-
ly correlated with transient increases in local calcium.
More recent experiments have sought to determine
the mechanisms that regulate intracellular calcium in
retinal axon arbors. Continuing to work in the intact
animal, we have found that light stimulus to the eye
increases calcium in the axon terminals and that this
increase is blocked by antagonists of the nicotinic
acetylcholine receptor (nAChR) applied to the axon
terminals in the optic tectum. Twenty years ago, it
was reported that nAChR activity was required for
the normal development of the topographic projec-
tion from the retina to the optic tectum, but no me-
chanism for this action has been found. Our data sug-
gest that nAChR on retinal axon terminals can in-
fluence the topographic organization of the retinotec-
tal projection through a calcium-mediated change in
axon growth.
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Development of Glutamatergic
Retinotectal Synapses
G-Y. Wu, H. Cline In collaboration with
R. Malinow, Cold Spring Harbor Laboratory]
To examine the development of glutamatergic synap-
tic transmission in the vertebrate CNS, we developed
a preparation of the isolated intact tadpole brain
amenable to reliable single-fiber stimulation, whole-
cell recording and dye labeling, pharmacological con-
trol of the extracellular environment, and transient
expression with a recombinant viral vector. The tad-
pole optic tectum is particularly advantageous for the
study of neural development because new neurons
are constantly being generated in a proliferative zone
in the caudal region of the optic tectum. Neurons
from rostral tectum are chronologically older and
morphologically more complex than neurons in
caudal tectum, so that within a single preparation,
there exist neurons over a range of developmental
stages arranged along the rostro-caudal (RC) axis of
the tectum.
Calcium entry through the N- methyl -n- aspartate
(NMDA) receptor might trigger the stabilization of
synaptic connections and neuronal morphology, by
activating calcium-sensitive protein kinases, such as
calcium/calmodulin-dependent protein kinase type II
(CaMKII). CaMKII is a developmentally regulated
protein kinase implicated in control of neuronal
growth, synaptogenesis, and synaptic plasticity.
CaMKII is activated by calcium entry through
NMDA receptors and has several substrates relevant
to neuronal development, including cytoskeletal
proteins and the a-amino-3-hydroxy-5-methyl-4-iso-
xazole propionic acid (AMPA) receptor. We tested
the hypothesis that CaMKII activity in tectal neurons
may be part of the signal transduction pathway that
mediates activity-dependent changes in synaptic
physiology and neuronal structure.
Whole-cell recordings from optic tectal neurons in
Xenopus tadpoles were used to study the maturation
of a glutamatergic synapse. The first glutamatergic
transmission is mediated only with NMDA receptors
and is silent at resting potentials. More mature syn-
apses acquire transmission by AMPA receptors. This
maturational program is mimicked by postsynaptic
expression of constitutively active CaMKII. Newly
formed synapses may be silent unless sufficient
depolarization is provided by coincident activity
which could activate postsynaptic CaMKII, leading
to the appearance of AMPA responses.
Control of Neuronal Growth
G.-Y. Wu, D.-J. Zou, I. Rajan, I. Miloslayskaya,
B. Burbach, R. Bari, H. Cline
Developing neurons must coordinate their mor-
phological and functional development. If CaMKII
activity were involved in the activity-dependent con-
trol of neuronal growth as well as synapse matura-
tion, this might be a pathway by which neurons could
coordinate various aspects of their development. In
vivo time-lapse confocal images of retinal axons,
taken by D.-J. Zou, have demonstrated that elevated
tectal cell CaMKII activity results in retinal axons
that have simpler morphologies due to a selective
retraction of short branch tips. G.-Y. Wu tested
whether CaMKII activity might also control the mor-
phological maturation of tectal neurons using in vivo
time-lapse imaging and immunohistochemistry.
CaMKII is developmentally regulated in tectal
neurons. Neurons in which CaMKII activity was
elevated by viral expression of a constitutively active
CaMKII (tCaMKII) have more stable dendritic struc-
ture than control neurons. Inhibition of CaMKII in-
creased dendritic growth selectively in more nature
neurons, which express endogenous CaMKII.
These observations on neuronal morphology, taken
together with the electrophysiology data, in which it
appears that elevated CaMKII promotes the matura-
tion of synapses, suggest the following type of coor-
dinated regulation of neuronal structure and function:
When NMDA receptors are active and there is cal-
cium influx, the resultant increase in CaMKII activity
has two distinct effects on the tectal cell. One is to
promote the maturation of the synaptic physiology
and the other is to deter additional growth of the
dendrite at the local site where CaMKII activity was
elevated. As a result of the decreased branch addition
and branch extension in the tectal neurons, the retinal
axons retract the newly added short branch tips that
have failed to establish synaptic contacts with target
neurons. In our experiments, we increase CaM KlI ac-
tivity throughout the tectal cell, but in the normal
neuron, NMDA receptor activity, calcium influx, and
CaMKII activity would occur at discrete sites within
the arbor corresponding to sites of converging inputs.
This would result in highly localized control of
synapse maturation and neuronal growth.
This model suggests that glutamate receptor ac-
tivity will also influence tectal cell development. To
test this hypothesis, I. Rajan took in vivo time-lapse
images of single tectal neurons from normal animals
and from animals treated with pharmacological
blockers of the glutamate receptors, NMDA and
AMPA receptors, as well as the sodium channel
blocker tetrodotoxin. Her beautiful in vivo images
from the treated and control animals will help deter-
mine the role of glutamatergic activity on neuronal
development.
Development of New Recombinant
Viruses to Test Protein Kinase
Function In Vivo
D.-J. Zou, B. Burbach, H. Cline
To test the role of calcium-dependent signal transduc-
tion pathways involved in regulating the formation of
the retinotectal projection, we plan to decrease the ac-
tivity of several calcium-dependent endogenous en-
zymes in tectal neurons by expressing their specific
inhibitory peptides. We began by determining the
potency and specificity of peptide inhibitors on the
activity of endogenous enzymes by doing kinase as-
says in tadpole brain homogenates. With these funda-
mental biochemical data in hand, we then went on to
construct recombinant vaccinia viruses that encode a
variety of peptides which specifically inhibit endoge-
nous CaMKII or PKC. We have begun to test the ef-
fect of these reagents on the development of retinal
axon and tectal cell morphology.
Candidate Plasticity Genes
E. Nedivi, I. Rajan, H. Cline, R. Bari
[in collaboration with P. Worley, Johns
Hopkins University]
We have begun to test the potential function of
several activity-regulated genes, which were isolated
through differential screening techniques by E.
Nedivi in Y. Citri's lab at the Weismann Institute and
by P. Worley's group at Johns Hopkins University.
The candidate plasticity genes are regulated by
neuronal activity and during development. Initial ex-
periments indicate that expression of three candidate
plasticity genes using recombinant vaccinia virus
constructs results in three unique phenotypes with
respect to neuronal development. These promising
results indicate that the frog retinotectal system is an
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excellent system in which to test the postulated roles
of novel genes in activity-dependent neural develop-
ment and synaptic plasticity in vivo.
Control of Cell Proliferation
and Differentiation by NOS
N. Ali, H. Cline [in collaboration with N. Peunova and
G. Enikolopov, Cold Spring Harbor Laboratory]
N. Peunova and G. Enikolopov have shown that
nitric oxide (NO) functions as an intercellular signal
which triggers PC12 cells to switch from a proliferat-
ing state to a differentiated neuronal phenotype. We
have begun to test whether NO might perform such a
function in the developing optic tectum. Diaphorase
staining, which labels cells that contain nitric oxide
synthase (NOS), and NOS antibody immunostaining
demonstrate that NOS-containing cells are located in
the optic tectum just rostral to the caudomedial band
of proliferating cells. We treated tadpoles with NOS
inhibitors and labeled the population of proliferating
cells by BrdU incorporation, followed by immuno-
staining for BrdU. NOS inhibitors appear to increase
the number of BrdU-labeled cells in the optic tectum
and to change the distribution of BrdU-incorporating
cells. These results support the hypothesis that
endogenous NO may serve to control cell prolifera-
tion in the developing brain in vivo.
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THE BIOLOGY OF LEARNING AND MEMORY
A. Silva P. Chen
0. Carvalho
N.B. Fedorov
E. Friedman
K.P. Giese
J. H. Kogan
V. Cestari
J. Coblentz
R. Filipowski
P.W. Frank land
S. Kida
Our laboratory is studying how the brain processes
and stores information. Our strategy is to analyze the
behavior and electrophysiology of mice with specific
genetic modifications. Below is a summary of our re-
search efforts during the last year.
BEHAVIORAL AND ELECTROPHYSIOLOGICAL
ANALYSIS OF MICE WITH A POINT MUTATION IN
THE CALMODULIN-BINDING DOMAIN OF aCaMKII
At basal calcium levels, the unphosphorylated cal-
cium calmodulin kinase II (CaMKII) is inactivated in
less than 1 second, whereas autophosphorylated
184
CaMKII might remain active indefinitely. Remark-
ably, after autophosphorylation at Thr-286, the affin-
ity of the enzyme for Ca/CaM increases 1000-fold,
from a Kd of 15 nm to one of less than 20 pm, a change
that could have a significant impact on calcium-
depen-dent processes in cells. Previous biochemical
studies showed that the substitution of Thr-286 by
alanine in aCaMKII does not disturb enzyme function
at high Ca/CaM but blocks its ability to trap Ca/CaM,
and to remain active after Ca/CaM concentrations
return to basal levels. Using the Cre/Lox system (see
Fig. 1), we have generated this mutation in embryonic
stem cells and have derived mutant mice. Like the
homozygous null mutants, mice homozygous for this
point mutation have severe deficits in fear condition-
ing and in spatial learning (water maze). The water
maze deficits resemble those that we observed in
mice with ibotenic acid lesions of the hippocampus.
For example, both the hippocampal lesioned mice
and these point mutants can learn the visible-platform
test of the water maze, suggesting that they have the
required vision and motor coordination to perform
this task, whereas being profoundly impaired in the
spatial version of the task. Electrophysiological anal-
ysis showed that these mutants have normal synaptic
transmission and normal augmentation but that long-
term potentiation (LTP) is severely impaired at a
number of frequencies and paradigms tested. Our
results show that this LTP deficit is not due to either
an increase in inhibition, a prepotentiation of un-
tetanized synapses, or differences in release during
the tetanus. These results suggest that the postsynap-
tic autophosphorylation of this kinase is important for
LTP and also suggest a connection between the LTP
deficit of the mutants and their spatial learning ab-
normalities. We are currently studying the mechan-
isms that underlie the LTP deficits of these mutants,
as well as the impact of this deficit on the properties
of place cells and on other forms of plasticity, such as
that involving circadian rhythms and the develop-
ment of neocortical circuits.
PRESYNAPTIC FUNCTION AND LEARNING
AND MEMORY: STUDIES OF MICE WITH A
HETEROZYGOUS MUTATION FOR OCaMKII
AND MICE LACKING SYNAPTOPHYSIN
Studies in our laboratory have shown that mutations
that affect certain forms of short-term plasticity
without affecting LTP can disrupt learning and
memory. To extend these studies, in the last year, we
have analyzed mice mutant for two other presynaptic
proteins ((3CaMKII and synaptophysin). Mice hetero-
zygous for the pCaMKII gene are healthy and devoid
of obvious neurological abnormalities, such as sei-
zures and ataxia. Studies with the spatial version of
the Morris water maze using a variety of protocols
did not detect any abnormalities in these mutants.
Similarly, studies of cued and contextual fear con-
ditioning also did not detect any deficits in these
mutants. These results are in striking contrast with
the behavioral phenotype of the aCaMKII hetero-
zygote which show pronounced deficits in both the
water maze and contextual conditioning tests. To
determine whether 13CaMKII affected synaptic plas-
ticity, we have studied LTP and its reversal, paired-
pulse facilitation, and posttetanic potentiation. These
forms of plasticity also seem to be unaffected in these
mutant mice. However, the mutants appear to show
faster rates of synaptic depletion under continuous,
prolonged stimulation. Interestingly, it does not seem
that this increase in synaptic depletion compromises
the animal's ability to learn and remember, thus
demonstrating that not all deficits in synaptic func-
tion result in learning or memory deficits. The results
described suggest that the role of this kinase in syn-
aptic function is not critical for learning. Similarly,
studies in our laboratory have also shown that mice
devoid of synaptophysin perform normally in the
Morris water maze, suggesting that the loss of this
abundant presynaptic molecule (5% of protein in syn-
aptic vesicles) does not affect hippocampal-depen-
dent learning.
CREB AND MEMORY
CREB, the cAMP-responsive element-binding pro-
tein, is a transcription factor whose activity is modu-
lated by increases in the intracellular levels of cAMP
and calcium. Results from studies with Aplysia,
Drosophila, and mice indicate that CREB-mediated
transcription is required for long-term memory. Addi-
tionally, a recent study found that long-term memory
for olfactory conditioning can be induced with a
single trial in Drosophila expressing a transgenic
CREB activator, whereas in normal flies with pre-
sumably lower CREB-mediated transcription levels,
conditioning requires multiple spaced trials. This
result suggests that CREB-mediated transcription is
important in determining the type of training required
for olfactory conditioning in Drosophila. Interesting-
ly, studies with cultured neurons in Aplysia indicated
that removing a CREB repressor promoted the forma-
tion of long-term facilitation, a cellular model of non-
associative memory. We have recently confirmed
our previous results that mice lacking the a and A
CREB proteins (CREB"A-) have abnormal long-term
but not short-term memory tested in an ethologically
meaningful task (food preference task). Importantly,
spaced training can overcome the pro-found memory
deficits of CREB"A- mutants. Increasing the intertrial
interval from 1 to 60 minutes overcame the memory
deficits of the CREIVA- mice in three distinct behav-
ioral tasks: contextual fear conditioning, spatial learn-
ing, and socially transmitted food preferences. These
results indicate that manipulations of CREB function
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FIGURE 1 Social transmission of food preferences task. This behavioral task com-
prises three parts: (1) Demonstrator mice are given a distinctively scented food
(cued food). (2) The demonstrator mice are allowed to interact with "observer" mice,
during which the observer mice have the opportunity to smell the scented food on
the breath of the demonstrator mice. (3) Immediately or 24 hr after interaction with
the demonstrators, food-deprived observer mice are given a choice between two
scented foods: either the same scented food that the demonstrators had eaten
(cued) or another distinctively scented food (noncued).
can affect the number of trials and the intertrial inter-
val required for committing information to long-term
memory. Remarkably, this effect of CREB function
is not restricted to simple conditioning tasks-it also
affects complex behaviors such as spatial memory
and memory for socially transmitted food prefer-
ences.
aCaMKII IS REQUIRED FOR THE STABILITY
OF MEMORY
The studies described above show that CREB is re-
quired for memory. Animals with lower levels of
CREB learn but forget within hours. Many other
studies in a number of species have identified a vari-
ety of manipulations that affect memory tested within
minutes or hours after training. By comparison, little
is known about molecular processes that specifically
affect memory weeks and months after training. In
the last year, we have shown that the aCaMKII
heterozygous mutation disrupts spatial memory 3-10
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days after training without having a measurable effect
on memory tested 3 days after training. The delayed
time course of this effect suggests that the memory
instability is not due to a failure to synthesize new
proteins immediately after training. Rather, some
other consolidation process is compromised. For ex-
ample, the proposed transfer of memories from hip-
pocampus to neocortical areas may be disrupted by
this mutation. Alternatively, with lower levels of this
kinase, LTP or some other related process may be-
come unstable over time.
Interestingly, our previous studies had indicated
that the aCaMKII is also required for learning. These
mutants require more training than normal mice to
master the spatial version of the water maze.
Nevertheless, after extended training, these mice
master this task, and our results suggest that unstable
memory is not simply due to weaker learning that
fades away, since we obtained similar results with
different training paradigms (overtraining). Current-
ly, we are looking at the stability of in vivo hip-
pocampal LTP in these mutants.
ABNORMAL NEURONAL FIRING AND IMPAIRED
LEARNING IN Kv131.1- DEFICIENT MICE
Most of our studies have focused on how synaptic
plasticity affects learning and memory. However,
neurons express other plastic properties that may not
necessarily involve synaptic function but that could
nevertheless be required for learning and memory.
One example of this is K+ currents and their role in
spike dynamics. Thus, we have initiated a research
program designed to determine how changes in spike
dynamics affect learning and memory.
The modulation of rapidly inactivating voltage-
gated (A-type) K+ channels has previously been im-
plicated in frequency-dependent spike broadening
and in learning in invertebrates. To test for a similar
function of A-type channels in mouse brain, we have
deleted the K+ channel subunit Kvp1.1, which con-
fers A-type inactivation on mammalian Kvl channels
in vitro. In the last year, we have demonstrated that
the loss of Kv01.1 in mice leads to a substantial
decrease in the ratio of A-type versus delayed rec-
tifier current in hippocampal CAl pyramidal neurons.
This change resulted in reduced frequency-dependent
spike broadening. The amplitude of the Ca++- depen-
dent slow after hyperpolarization (sAHP) was also
reduced, being consistent with the idea that
frequency-dependent spike broadening controls the
Ca++ influx during a train of action potentials. The
behavioral analysis of the Kvp1.1-deficient mice
revealed an impairment in reversal learning in the
Morris water maze but not in the initial spatial learn-
ing. Additionally, 24-hour memory for socially trans-
mitted food preferences is also abnormal in the
mutants. These results indicate that Kv01.1 contrib-
utes to both A-type channel inactivation and fre-
quency-dependent spike broadening regulating neu-
ronal ca++ influx. These are key neuronal deter-
minants of spike dynamics, which may account for
the behavioral deficits we have shown in the mutant
mice.
IN VIVO ELECTROPHYSIOLOGICAL STUDIES OF
HIPPOCAMPAL PLACE CELLS IN MUTANT MICE
At the heart of the work carried out in our laboratory
is the connection between the behavioral and elec-
trophysiological phenotypes of mutant mice. How-
ever, most of our electrophysiological studies have
been restricted to the analysis of neurons in brain
slices. Measurements in brain slices are the ideal way
to study specific molecular and cellular mechanisms,
such as synaptic and channel function. However, it is
difficult to connect directly our electrophysiological
studies with the behavioral phenotypes of the mutant
mice because of the multisystem complexity of the
brain. Changes in cellular function can be more
directly connected with changes in circuit properties
than with alterations in behavior. Similarly, the be-
havior of an animal may be more easily explained on
the basis of circuit properties than with cellular biol-
ogy. Therefore, the understanding of circuit proper-
ties may bridge cellular mechanisms with behavior.
One way to study the properties of circuits is to col-
lect information about cell firing during behavior
with techniques that allow simultaneous recording
from multiple cells in a given circuit. For example,
single-unit recordings in the hippocampus found that
many cells seem to fire at higher frequencies when
the animal is in a specific place (place cells), as if
they were encoding a specific spatial location. Thus,
multiple in vivo recordings of cell firing allow us to
glimpse at the properties of cells in functioning
neuronal ensembles.
Mutant mice are ideal tools to explore the connec-
tion between cellular physiology (LTP, LTP, SLP),
circuit properties, and behavior. So far, single-unit
recordings have only been used in a few mutant
studies. The first were our collaborative studies with
neocortical single-unit recordings which were used to
study the impact of the loss of the aCaMKII on
neocortical plasticity. In these studies, single-unit
recordings were used to study responses to sensory
stimulation before and after periods of deprivation.
The results implicated this kinase in neocortical
plasticity, both in the somatosensory cortex and in the
visual cortex.
In the last year, Dr. Yoon Cho, previously in our
laboratory, and Dr. Howard Eichenbaum developed
electrophysiological methods for the study of place
cells in mice. Yoon's work shows that it is possible to
measure place cells in mice, a finding that has also
been reported recently by two other groups. Her find-
ings suggest that the relationship between place cells,
LTP, and memory is likely to be complex, since a
mutant lacking spatial learning and CAl LTP never-
theless showed nearly normal place cells, suggesting
that CA1 LTP is not essential for the establishment of
place cells in the CA1 region.
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THE INVOLVEMENT OF GRF IN LEARNING
AND MEMORY
Previous studies in our laboratory showed that the
mutation of the neurofibromatosis type 1 (NF1) gene
in mice resulted in specific impairments in the Morris
water maze: Spatial, but not visible, learning was af-
fected. Fear conditioning was also unaffected in the
NF1 mice. The NF1 gene product contains several
domains, one of which has GAP activity that stimu-
lates the inactivation of Ras. To test whether the
mutation of another Ras regulator thought to function
in the brain could also affect learning in a similar
way, we generated mice with a targeted disruption of
the exchange factor Ras-GRF. This Ras activator is
expressed preferentially in central neurons, and it is
activated by both calcium and cholinergic signals,
two stimuli involved in learning. Similar to the NF1
mice, the Ras-GRF mutants showed impairments in
spatial learning but not in fear conditioning. These
results suggest that the deregulation of Ras can lead
to learning impairments and that such deregulation
may account for the learning deficits in NFL Further-
more, the NF1 mutant mice may be a useful model to
study how the mutation of the NF1 gene causes learn-
ing disabilities in humans.
SOCIALLY TRANSMITTED FOOD PREFERENCES:
A NOVEL WAY TO TEST MEMORY IN MICE
Our laboratory is interested in hippocampal-depen-
dent memory mechanisms. However, there are not
many hippocampal-dependent tasks suitable to dis-
tinguish learning from memory deficits. Most
hippocampal-dependent learning tasks, such as the
water maze, involve multiple training sections, and
therefore it is problematic to separate effects on
learning and memory. Most of our memory studies
have used fear conditioning tasks because the animal
can learn with a single brief trial and the memory that
is triggered is long lasting. However, fear condition-
ing involves foot shocking (aversive), and it does not
reflect the natural behavioral repertoire of the mouse.
Thus, in the last year, we have adapted the social
transmission of food preferences test to mice. This
task had previously been developed in rats. This be-
havioral test task takes advantage of the fact that ro-
dents develop a natural preference for foods that they
have recently smelled on the breath of other rodents.
It allows us to test whether mutants have memory
deficits in a hippocampal-dependent test that involves
neither aversive stimuli, spatial learning, nor fear
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Part I- Demonstrator eats cued food
Demonstrator Cued Food
Part II- Demonstrator interacts with
observer
Demonstrator Observer
Part Observer is tested for food
preference
iiii,Cued Food
Observer IVNon-Cued Food
FIGURE 2 Generation of mice with a point mutation in the
aCaMKII gene. The 'knock in procedure we used has two
parts: In the first step, we transfected embryonic stem (ES)
cells with a construct containing the point mutation (Thr-286
substituted by an alanine) in the regulatory domain of the
aCaMKII gene. In the second step, ES cells with an
homologous integration of the aCaMKII construct were
transfected with a Cre recombinase plasmid. Expression of
Cre recombinase resulted in the deletion of the LoxP-
flanked neomycin gene.
conditioning. Importantly, this task exploits ethologi-
cally meaningful behaviors: the animals ability to
learn quickly and remember information pertaining to
social olfactory cues. The social transmission of food
preferences test takes place in three phases (Fig. 2):
First, "demonstrator" mice are given a distinctively
scented food (ground mouse chow with cinnamon or
cocoa). Second, the demonstrator mice are allowed to
interact with "observer" mice, during which the ob-
server mice have the opportunity to smell the scented
food on the breath of the demonstrator mice. Third, at
a given time later, the observer mice are given a
choice between the food that the demonstrator mice
had eaten or another novel food. Like rats, mice show
a preference for the food eaten by other mice, and the
memory for the food is stable through many days.
Remarkably, an interaction as brief as 5 minutes is
sufficient to trigger a memory that last many days.
During the last year, we have used this task to study
memory in a number of our mutants. With our help,
many other laboratories are now using this task for
the analysis of legrning and memory in mutants.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN
CENTRAL SYNAPSES
R. Malinow N. Dawkins. Z. Mainen H. Hinds (visiting MD-PhD Harvard/MIT student)
J. Esteban M. Maletic-Savatic C. Sano (visiting Japanese Medical Student)
Y. Hayashi A. Shirke S. Horie (visiting Japanese Medical Student)
T. Koothan S. Zaman
Our group addresses issues directed toward an under-
standing of learning and memory by studying the
physiology of synapses. We study synaptic transmis-
sion in rat brain slices which are complex enough to
show glimpses of emergent properties as well as
simple enough to allow hard-nosed biophysical scruti-
ny. We have also begun to focus on neurons and
synapses in cultured conditions. This allows us to
study cell biological details with greater control. It is
our philosophy that synapses have some key
properties whose understanding is possible and that
such an understanding will provide insight into
phenomena at higher levels of complexity.
Dendritic Exocytosis Is Mediated
by Activation of CaMKII
M. Maletic-Savatic
We continue to study a novel process we have dis-
covered in neurons: calcium-evoked dendritic ex-
ocytosis (CEDE). This process is likely to be involved
in the delivery of proteins to the surface membrane
and may control the make-up of synapses. We have
previously shown that CEDE is developmentally
regulated and is mediated by the actions of CaMKII
and have now found that intact microtubules are
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necessary for this process. We are currently investi-
gating the identity of the organelles that undergo ex-
ocytosis by using combined light and electron mi-
croscopy.
What Is the Effect of CaMKII on
Synaptic Transmission?
A. Shirke
We have previously shown that long-term potentia-
tion, a form of synaptic plasticity, is mediated by the
action of postsynaptic CaMKII. We have investigated
the possible downstream effects of CaMKII by inject-
ing an active form of CaMKII into neurons and deter-
mining the effects on glutamate receptor sensitivity to
neurotransmitter. We find that injection of CaMKII
into postsynaptic neurons increases synaptic trans-
mission as well as sensitivity to exogenously applied
neurotransmitter. Analysis of this increase suggests
that this is due to an increase in the number of recep-
tors, not an increase in the affinity of receptors. We
will investigate further how CaMKII can increase the
number of postsynaptic receptors. One possibility is
that receptors are delivered to a synapse through a
CEDE-like process.
LTP in Mice Lacking
aCaMKII
H. Hinds
We have studied LTP in mice lacking the a isoform
of CaMKII and find that LTP is diminished but not
absent. Thus, genetic background appears to deter-
mine the requirement for aCaMKII. We find that
LTP is exactly 50% of normal. Under various induc-
tion protocols, we obtain 50% of the normal LTP.
These observations make predictions regarding which
kinases are involved in LTP and at what stage in LTP
generation.
nisms involved? We are studying this using hetero-
logous expression of fusion proteins in cultured
neurons. We make recombinant glutamate receptors
fused to green fluorescent protein (GFP) to monitor
the mobility, association, and aggregation of synaptic
receptors.
Silent Synapses
R. Malinow
The synapses we study (which are similar to and
serve as a model for most excitatory synapses in the
vertebrate brain) use glutamate as the neurotransmit-
ter and have two types of postsynaptic glutamate-
sensitive receptors: AMPA-type and NMDA-type
receptors. These receptors differ in their activation
properties as well as their permeation (what they al-
low to pass into the cell once activated). AMPA-type
receptors need only glutamate to open, and NMDA-
type receptors require both glutamate and membrane
depolarization. Last year, we published direct evi-
dence that a large fraction of the synapses we study
have only NMDA-type receptors. These synapses
will thus be silent (even if transmitter is released)
when the postsynaptic cell is at resting membrane
potential (most of the time), because the postsynaptic
receptors will not open if only transmitter is released.
We have reached this conclusion by looking at failure
rates during transmission elicited when the post-
synaptic cell is held at hyperpolarized and depolar-
ized potentials. If there were AMPA-type receptors at
all synapses, the failure rates should be the same; we
find twice as many failures at hyperpolarized poten-
tials. This difference is not present if NMDA-type
receptors are blocked. This and several other pieces
of evidence indicate that there are synapses with only
NMDA receptors. We recently published several
lines of evidence that pure NMDA synapses add
AMPA receptors during LTP.
How Is the Number of Glutamate
Receptors in a Synapse Regulated?
Y. Hayashi, C. Sano, S. Horie
We have begun to investigate the cell biology of
glutamate receptors; i.e., how are receptors delivered
to the synapse, and what are the regulatory mecha-
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Developmental Progression
of Silent Synapses
R. Malinow [in collaboration with G.Y. Wu and
H. Cline, Cold Spring Harbor Laboratory]
We have looked at the developmental progression of
these pure NMDA synapses in the retino-tectal sys-
tern of the tadpole. We find that initial synapses are
pure NMDA and silent at hyperpolarized potentials.
During development, AMPA receptors are added. We
also find that increased postsynaptic CaMKII can
mimic this developmental maturation. These results
have led to a specific hypothesis of synapse forma-
tion and modulation of gain by LTP: We find that ini-
tial synapses form with only NMDA receptors. These
synapses will transmit information only if coactive
with other synapses (which have AMPA receptors).
If the pure NMDA-receptor synapses are potentiated
by LTP, they will now have AMPA receptors added
to them and will be able to transmit information
without the need for coactivation with other synap-
ses.
Appearance/Disappearance
during the Estrous Cycle?
S. Zaman
During the estrous cycle of the rat (5d), there is a
30% increase and decrease in the number of synaptic
contacts in the hippocampal CA1 region. We wish to
test the hypothesis that these transient synapses have
only NMDA receptor function. We are currently
measuring AMPA- and NMDA-mediated responses
in hippocampal slices from different stages in the
estrous cycle. Using the methods previously estab-
lished, we will be able to test directly if there are
more pure NMDA synapses during the time when,
anatomically, it is known that there are 30% increases
in synapses.
Immunohistological
Identification
of Silent Synapses
J. Esteban, T. Koothan
We have generated polyclonal antibodies that recog-
nize a putative extracellular domain of AMPA recep-
tors. We are currently testing if this antibody can be
used to detect synapses that have no AMPA recep-
tors. Our preliminary results indicate that there are
discrete regions in dendrites that are immunopositive
only when the plaman membrane is permabilized,
and not before permabilization. This is consistent
with the existence of synapses that have AMPA
receptors in intracellular regions and not on the sur-
face.
We will use a similar strategy to determine (1) if
there are indeed synapses (with presynaptic markers),
(2) if these regions contain NMDA receptors, and (3)
if the prevalence of such sites can be manipulated
with LTP.
Is Synaptic Transmission
in the Brain a Point
to Point Process?
Z. Mainen
Although the traditional view of a synapse is that
each presynaptic terminal releases transmitter that af-
fects receptors on a single postsynaptic spine, there
have been recent suggestions that this may not be so.
It could be that transmitter released from one pre-
synaptic terminal affects receptors on many nearby
synapses. This is made plausible by the observation
that some glutamate receptors (NMDA-type) have a
100-fold greater affinity for glutamate than other
receptors (AMPA-type). Thus, any spillover of
glutamate from one synapse could activate NMDA
receptors on nearby synapses. This would have
several important implications regarding information
transfer and mechanisms of plasticity (e.g., since
NMDA receptors need to be activated to induce
LTP). Furthermore, this view would make us reinter-
pret the findings regarding "silent synapses" de-
scribed above.
We have examined some of the evidence that has
been put forth by other groups supporting the spil-
lover model. These studies have used extensively a
putative indicator of presynaptic function: the coeffi-
cient of variation (CV) of synaptic responses. We
find that this measure is inadequate when applied to
NMDA responses. In particular, pure postsynaptic
changes (like partial inhibition of NMDA responses
with a high-affinity antagonist) produce robust
changes in CV of the NMDA re-sponse. We show
with experiments and detailed electrotonic models
that this inadequacy of the CV is due to voltage-
clamp errors. Therefore, conclusions based on CV of
NMDA responses, used by a number of groups to
argue for the spillover model, are nulled.
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Cell Biology of Presenilin 1,
a Protein Responsible for
Familiar Alzheimer's Disease
T. Koothan
A protein which when mutated is responsible for
50% of familial Alzheimer's disease, PS-1, was
recently cloned. Little is known regarding its cellular
distribution and function. We have generated poly-
clonal antipeptide antibodies directed against the
amino terminus (N) or postulated loop portion (L) of
this protein. Using Western blot analysis, we find that
this protein is cleaved in half and that this cleavage is
developmentally regulated. We have evidence that
this cleavage is controlled by calpain: Calpain in-
hibitors added to cells prevent cleavage and calpain
added to cell lysates promotes cleavage. We also find
that the PS-1 protein appears to form dimers. Using
immunohistochemistry, we find that PS-1 is ex-
pressed only in neurons, not glial cells. The loop por-
tion of the protein is localized in the lysosomes,
whereas the N portion is localized in the endoplasmic
reticulum. We plan to investigate the localization,
processing, and function of this protein in neuronal
function.
Electrophysiology of Transgenic
Mice Carrying Mutated Presenilin 1
S. Zaman [in collaboration with S. Sisodia,
A. Parent, D. Borchelt, Johns Hopkins University]
We have begun a collaboration with this group to
study the electrophysiology of mice expressing a
mutant form of PS-1 that is known to cause disease in
humans. Preliminary studies indicate that various
electrophysiological changes are aberrant in these
mice. We will continue to characterize these changes
and carry out experiments to determine the underly-
ing mechanisms.
In conclusion, we are continuing to elucidate the
basic mechanisms involved in central synaptic trans-
mission. Such an understanding is necessary to derive
a mechanistic flowchart of plastic processes. We also
continue to probe the role of different molecules, in-
cluding CaMKII and PS-1, in activity-induced and
developmental synaptic plasticity.
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SIGNAL TRANSDUCTION AND DIFFERENTIATION
G. Enikolopov S. John N. Peunova Y. Stasiv
P. Krasnov G. Ramanathan A. Weissmann
B. Kuzin V. Scheinker 0. Zatsepina
Our main interest lies in signals that link cell activity
with cell differentiation. In the past year, we have
concentrated most of our efforts on the role of nitric
oxide (NO) in development. We are testing a hy-
pothesis that NO acts as an antiproliferative agent
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and controls the balance between cell proliferation
and cell differentiation during normal development.
This project stems from our finding that NO is essen-
tial for neuronal differentiation of cultured cells. To
see if this holds true for the intact developing
organism, we started several projects with different
models of animal development. We have shown that
during Drosophila development, NO controls the cell
number and, eventually, the tissue development and
organ size of the developing fly. We are now focus-
ing on genetic and biochemical interactions of NO
with systems that control cell division and cell differ-
entiation in the developing organism. Another major
interest in the lab is protein trafficking in the
neuronal cell. We want to determine motifs that are
essential for trafficking of proteins to the terminals of
neuronal cells, with a goal of targeting chimeric
proteins to the nerve terminals.
Nitric Oxide Regulates Cell
Proliferation during
Drosophila Development
B. Kuzin, N. Peunova, V. Scheinker,
G. Enikolopov [in collaboration with I. Roberts,
Cambridge University]
Organ development requires a tightly controlled pro-
gram of proliferation followed by growth arrest and
differentiation and, often, programmed cell death.
The balance between the number of cell divisions and
the extent of subsequent programmed cell death in
imaginal discs of Drosophila larvae determines the
final size of organs and structures of the adult fly. We
have found that NO acts as an antiproliferative factor
and controls cell number during Drosophila develop-
ment. Nitric oxide synthase (NOS) gradually ac-
cumulates in imaginal discs of Drosophila and
reaches maximum levels at the end of the larval de-
velopment, when DNA synthesis and cell division in
most of the cells of imaginal discs and the brain slow
down. Inhibition of NOS in larvae results in surplus
cell proliferation and excessive growth of the seg-
ments of the body of the adult fly. In contrast, ectopic
overexpression of the NOS gene causes a decrease in
the number of cells and reduction in the size of some
segments. The distribution of affected segments in
the adult leg corresponds to the distribution of NOS
in the larvae, and the changes in segment size can be
directly correlated with changes in DNA synthesis in
imaginal discs after manipulations of NOS activity.
The results of BrdU labeling of imaginal discs sug-
gest that modulation of NOS activity directly affects
the number, but not the distribution, of cells in S
phase. However, in some imaginal discs (e.g., the eye
disk), we consistently detected an increase in the
number of cells in S phase after inhibition of NOS,
but the resulting adult eye usually appeared to be
normal. We studied the possibility that programmed
cell death counteracts excessive cell proliferation and
restores the normal number of cells in the eye during
metamorphosis. We tested whether the potential sur-
plus cell proliferation can be unmasked in the ab-
sence of programmed cell death. We used transgenic
flies in which programmed cell death in the develop-
ing eye was suppressed by recombinant p35, an in-
hibitor of apoptosis, to reveal excessive proliferation
after NOS inhibition. We found that under these cir-
cumstances, several cell types and structures are
overrepresented, the most noticeable change being an
overall increase of the size of the eye due to the in-
creased number of ommatidia. In addition, other cell
types (e.g., secondary and tertiary pigment cells, cone
cells, and cells of the bristles) proliferated after NOS
inhibition to levels higher that those achieved by
blocking apoptosis by p35. These data demonstrate
that the removal of the suppressive influence of NO
leads to an increased size of the adult organ, unless
this effect is masked by programmed cell death, and
indicate that the final cell number in the adult organ
is under dual control of both cell proliferation and
programmed cell death. Furthermore, these data pro-
vide independent support for the hypothesis that NO
directly regulates the cell number during develop-
ment.
We propose that production of NO is required dur-
ing embryonic development and during tissue regen-
eration in the adult organism for the proper control of
cell proliferation. The antiproliferative properties of
NO may be particularly important in situations in
which terminal differentiation of committed cells is
temporally separated from cell proliferation and is
strictly dependent on cessation of cell division. Given
the multiplicity of the NOS isoforms, their overlap-
ping tissue distribution, and the possibility that NO
can be transferred within the developing organism by
hemoglobin and thus supplied exogenously by the
mother, it is conceivable that any group of cells in the
embryo and fetus can be exposed to NO action.
Our current efforts are focused on dissecting ge-
netic interactions of NO during Drosophila develop-
ment. We use mutant and transgenic flies carrying
components of the retinoblastoma pathway to study
cross talk between the NO pathway and the general
cell cycle machinery in controlling the final size of
organs of the adult fly.
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Molecular Mechanisms of Nitric
Oxide Synthesis during
Drosophila Development
Y. Stasiv, G. Ramanathan, B. Kuzin,
G. Enikolopov [in collaboration with M. Regulski,
Cold Spring Harbor Laboratory]
It has been recently shown in our lab that manipula-
tion of NOS activity in Drosophila larvae results in
dramatic changes in the adult fly's organs (Kuzin et
al. 1996). This argues that NO controls the size of
body structures during Drosophila development.
Recently, a Drosophila NOS gene, dNOS1, was
cloned (Regulski and Tully, Proc. Natl. Acad. Sci.
92: 9072 [19951) that is active in adult Drosophila
brain and whose closest analog is mammalian
neuronal NOS. We sought to identify Drosophila
genes that are responsible for NO action in develop-
ment. We used several approaches to clone genomic
or cDNA copies of NOS-related loci. Our results sug-
gest that, in contrast to mammals, where NO is
synthesized by three different NOS genes, Dro-
sophila most probably has only one locus for NOS,
which is the analog of mammalian neuronal NOS.
However, different dNOS transcripts are expressed
during development. We have cloned one of them,
dNOS3. dNOS3 is expressed mainly in Drosophila
larvae. It arises as a result of alternative splicing
which results in early termination of translation and
synthesis of a 214-amino-acid-long protein, which
corresponds to the amino-terminal part of the dNOS1
protein. Currently, we are testing the possible func-
tional role of dNOS3 by coexpression with dNOS1 in
mammalian and Drosophila cell lines and by genera-
tion of transgenic lines expressing dNOS3 under the
control of inducible (heat shock) and tissue-specific
promoters.
NO and Xenopus Brain
Development
N. Peunova, G. Enikolopov [in collaboration
with H. Cline, Cold Spring Harbor Laboratory]
Our studies of Drosophila development have re-
vealed that synthesis of NO is essential for the
balance between proliferation and differentiation dur-
ing larval development, thus contributing to the final
size of organs of the adult fly. We are interested in
how conserved this mechanism of growth control is
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and whether it is similarly involved in vertebrate
morphogenesis. We chose Xenopus laevis as a model
organism for these studies, focusing our investigation
on the formation of the brain. Histogenesis of the
Xenopus brain begins with the folding of the neural
tube and continues until metamorphosis. New cells
are continuously produced in the ventricular zone of
the tadpole brain, and they undergo terminal differen-
tiation while moving outward of the ventricle. Using
cytochemical and immunochemical staining, we have
found that NOS is accumulated in maturing neurons,
suggesting that it may be involved in cessation of
proliferation of neural precursors. To test whether
NO has a causative role in establishing growth arrest,
we are trying to perturb NOS expression by introduc-
ing a slow-releasing plastic impregnated with NOS
inhibitors in the ventricle of the tadpole brain. Our in-
itial results suggest that NOS is directly involved in
control of cell proliferation and neuronal differentia-
tion in the developing vertebrate brain.
NO and Neuronal
Differentiation
N. Peunova, 0. Zatsepina, V. Scheinker
Our studies indicate that NO has a dual role during
nerve growth factor (NGF)-induced neuronal differ-
entiation of PC12 cells: First it acts as an antipro-
liferative agent, inducing growth arrest in dividing
cells, and thereafter, when growth arrest is firmly es-
tablished and the cells have undergone differentia-
tion, it helps suppress programmed cell death. Inhibi-
tion of NOS at early stages of NGF action, in yet un-
differentiated cells, results in continuous cell division
and suppression of differentiation, whereas in fully
differentiated PC12 cells, it leads to apoptosis. We
study mechanisms of this dual mode of action of NO.
To examine the contribution of different NOS
isoforms in these two phases of differentiation, we
followed the expression of various NOS genes by
Western blot analysis and by reverse transcrip-
tase-polymerase chain reaction (RT-PCR). Our
results suggest that differentiation of PC12 cells is
accompanied by a switch in expression of different
NOS isoforms. In particular, expression of the
neuronal isoform reaches maximal levels after
growth arrest was established and, perhaps, is more
directly associated with survival functions.
Protein Targeting to
Neuronal Cell Terminals
P. Krasnov, G. Enikolopov
The main aim of this project is to define the minimal
protein motifs sufficient for protein trafficking to the
terminals of neuronal cells. We want to use these
motifs in protein vectors to target chimeric proteins
capable of modulating signal transduction cascades to
the neuronal terminals. This may enable manipulation
of signaling events at the terminals without affecting
the rest of the cellular compartments. We have
chosen synaptotagmins as a starting material for a
targeting protein vector. Synaptotagmins belong to a
large family of evolutionary conserved proteins ex-
pressed predominantly in neuronal cells. Synaptotag-
mins are constituent components of synaptic vesicles
and large dense-core secretory vesicles, and some
synaptotagmin isoforms are highly enriched in neur-
onal cell terminals.
To define the structural elements of the synap-
totagmin molecule that are responsible for its target-
ing properties, we performed extensive deletion and
alanine scanning mutagenesis of rat synaptotagmin II
tagged with an influenza virus hemagglutinin (HA)
epitope. The mutants were transiently expressed in
NGF-differentiated PC12 cells and their intracellular
distribution was monitored by immunofluorescence
and subcellular fractionation using anti-HA anti-
bodies. We found that there are two structural ele-
ments of the synaptotagmin gene located near the
transmembrane domain and in the carboxy-terminal
domain, which are both necessary and sufficient for
targeting of the protein molecule to the terminal.
Mutations in the transmembrane region of synap-
totagmin abolishes its incorporation in the vesicles,
whereas deletions in the carboxy-terminal domain
disrupt its proper accumulation in the terminals of
neurites. This suggests that after the protein is in-
corporated in correct membrane compartments via its
amino-end region, the transport machinery utilizes
the signals at the carboxy-end of the molecule for
proper transport, retention, and eventual accumula-
tion at the terminal. Using alanine-scanning mutagen-
esis of the carboxy-terminal domain, we have identi-
fied two amino acids that are absolutely critical for
accumulation of synaptotagmin at the terminal. These
amino acids are conserved among all known synap-
totagmin isoforms, suggesting that different synap-
totagmins may have similar or common mechanisms
of targeting. We are currently using the delineated se-
quences to target exogenous proteins involved in sig-
nal transduction to the terminals of neuronal cells and
to search for interacting proteins which might partici-
pate in synaptotagmin's trafficking in the neuronal
cell.
We greatly appreciate the expert assistance of San-
tosh John in all of the described experiments.
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CSH LABORATORY JUNIOR FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Junior Fellow program to encourage independent
research by outstanding young scientists who, during their graduate studies, displayed exceptional
promise of becoming leading scientists of the future. The purpose of this program is to provide an
opportunity for these young scientists to work independently at the Laboratory for a period of up to
3 years on projects of their choice. Junior Fellows are provided with a salary, research support, and
technical assistance so that they can accomplish their goals free from other distractions. The inter-
action among research groups at the Laboratory and the program of courses and meetings on
diverse topics in molecular biology contribute to a research environment that is ideal for innovative
science by these Fellows.
Two previous Cold Spring Harbor Fellows, Dr. Adrian Krainer (1987) and Dr. Carol Greider
(1988), are currently members of the faculty at the Laboratory. Dr. David Barford, our Junior Fellow
since 1991, left in 1994 to go to Oxford University (Laboratory of Molecular Biophysics) as a univer-
sity lecturer. Dr. Ueli Grossniklaus joined us in 1994 from the Department of Cell Biology, University
of Basel, Switzerland. Dr. Scott W. Lowe, came from the Center for Cancer Research at the Massa-
chusetts Institute of Technology. Both Drs. Grossniklaus and Lowe were promoted to the faculty as
Assistant Investigators during this year so that they could expand their laboratories.
DEVELOPMENTAL GENETICS OF PLANT REPRODUCTION
U. Grossniklaus R. Baskar M. Hoeppner
N. Castiaux J. Moore
W. Gagliano J.-P. Vielle Calzada
Our research focuses on the characterization of the
molecular and genetic basis of plant reproduction, in
particular the formation of the female gametes. Un-
like in animals, where the meiotic products differen-
tiate directly into gametes, the spores of plants give
rise to multicellular haploid gametophytes that pro-
duce the gametes later in their development. In flow-
ering plants, the sexually dimorphic gametophytes
(micro- and megagametophytes) develop within the
reproductive organs of the flower. A single cell
within an ovule primordium differentiates into a
megaspore mother cell (MMC), undergoes meiosis,
and produces four megaspores, three of which die.
The fourth divides through three consecutive mitoses,
to form the embryo sac consisting of seven cells: the
egg cell, two synergids, three antipodals, and a
binucleate central cell. After double fertilization of
both the egg and the central cell, the ovule develops
into a seed. Although the seven cells of the megaga-
metophyte are of clonal origin, they develop along
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four alternative developmental pathways. The mole-
cular and genetic basis controlling female gameto-
genesis in plants are largely unknown. The highly
polar nature of the female gametophyte, its small
number of distinct cell types, and its closely coor-
dinated development with surrounding tissues of the
ovule make it an ideal system to study fundamental
aspects of plant development. The goal of our re-
search is to investigate the role of positional informa-
tion, cell lineage and cell-cell communication in plant
morphogenesis, and cellular differentiation. A better
understanding of the molecular mechanisms control-
ling megagametogenesis will not only yield import-
ant insights into fundamental concepts in plant devel-
opment, but also provide tools for the manipulation
of the reproductive system. We are particularly inter-
ested in applying our findings to the engineering of
apomixis, an asexual form of reproduction through
seeds. The introduction of apomixis into sexual crops
would have revolutionary implications for plant
breeding and agriculture, allowing for the immediate
fixation of any desired genotype and its indefinite
clonal propagation.
We would like to acknowledge the efforts of a
number of high school and undergraduate students
who assisted in our research. Hillel Sims, John F.
Kennedy High School, Bellmore, identified Arabi-
dopsis homologs of genes required for meiosis in
yeast; Paul Pultorak, SUNY Stony Brook, put some
of our insertional mutants onto the genetic map; and
Bill Wagner, Duke University, helped with the char-
acterization of mutants disrupting megagametogene-
sis.
Genetic Analysis of Plant
Reproduction by
Enhancer Detection
U. Grossniklaus, J. Moore, W. Gagliano,
J.-P. Vielle Calzada, M. Hoeppner, N. Castiaux,
FL Baskar [in collaboration with M. Lodhi
and R. McCombie, Cold Spring Harbor Laboratory]
To dissect female gametogenesis in plants, we are
performing a large-scale enhancer detection/gene trap
screen in Arabidopsis thaliana, a small crucifer that
has been widely adopted as a model system for plant
developmental biology and genetics. Enhancer detec-
tion and gene trap systems allow the identification of
genes based on their pattern of expression. The isola-
tion of genes expressed during megasporogenesis and
megagametogenesis will yield important insights into
the genetic control of plant reproduction. We are
using an enhancer/gene trap system based on the
Ac /Ds transposon of maize which was developed here
at the laboratory (Sundaresan et al., Genes Dev. 9:
1810 [1997]). The presence of a transposon at a locus
of interest greatly facilitates its subsequent molecular
and genetic characterization. During the past 3 years,
we generated about 4300 lines carrying single ran-
domly distributed enhancer detector/gene trap trans-
posons (transposants) by screening the progeny of
close to 22,000 plants for unlinked transposition
events. We have screened approximately 1500 of our
transposants for reporter gene expression in develop-
ing ovules and 5000 transposants for mutations that
disrupt female gametogenesis. The characterization
of transposants at various stages of reproductive de-
velopment is an ongoing long-term project in our
laboratory.
MOLECULAR CHARACTERIZATION OF
INSERTIONS BY TAIL PCR
To obtain molecular information on transposants that
were identified in our initial screens, we isolated
genomic fragments flanking the insertion site. We
adapted a novel polymerase chain reaction (PCR) -
based method, thermal asymmetric interlaced PCR
(TAIL PCR; Liu et al., Plant J. 8: 457 [1995]), to iso-
late genomic regions flanking the Ds insertions. We
designed three nested Ds primers each to isolate both
5' - and 3' -flanking regions. They are used in com-
bination with an arbitrary degenerate primer hybrid-
izing to many locations in the genome. Using unique
thermal cycling conditions and consecutive rounds of
PCR, it is possible to amplify specifically the
genomic fragment flanking the insertion site. We
have isolated flanking genomic regions for 87
transposants (93% success rate for the recovery of at
least one border fragment) using two different ar-
bitrary primers. Approximately 170 PCR products
representing 87 loci that show reporter gene expres-
sion in developing ovules or disrupt megagameto-
genesis were directly sequenced. We identified 27 in-
sertions into or nearby known genes or expressed se-
quence tags (ESTs) from Arabidopsis, 8 sequences
with significant homology and 12 sequences with
weak homology with other sequences in the data-
bases. Whereas many of the sequences showed
homology with ESTs of unknown function, others
were similar to genes encoding basic cellular factors
involved in metabolism, general transcription, and
translation. Importantly, we also identified genes en-
coding putative regulatory proteins involved in signal
transduction processes and transcriptional regulation
which may serve key regulatory functions in sexual
reproduction.
Developmental Alternatives
during Megasporogenesis
J.-P. Vielle Calzada, U. Grossniklaus
The alternation of generations is one of the major de-
velopmental changes in the life cycle of a flowering
plant. It involves the transition from a massive
diploid plant body into a structure composed of a
small number of highly organized haploid cells, the
gametophytes. This transition is initiated with the dif-
ferentiation of the MMC, followed by meiosis and
completed with the differentiation of the functional
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megaspore. There are numerous examples of devel-
opmental alternatives that lead to the formation of
unreduced gametes, one of the key components of
apomictic reproduction. The developmental versatil-
ity of megasporogenesis in flowering plants suggests
a flexible regulatory control, the genetic and
molecular basis of which is poorly understood. Only
a few mutations disrupting megasporogenesis have
been described, and genes functionally involved in
megaspore specification and the initiation of female
gametophyte development have yet to be isolated and
characterized. Genetic analysis suggests that the dif-
ferences between sexual and aposporous apomictic
reproduction may be determined by a regulatory
locus that directs somatic cells to form a female
gametophyte without undergoing meiosis. It has been
proposed that genes controlling apomixis may encode
proteins which normally function during megasporo-
genesis in sexual reproduction, but may have an
altered temporal and spatial pattern of expression in
apomictic ovules. A better understanding of the
molecular mechanisms underlying megasporogenesis
is required to induce developmental deviations that
resemble apomictic processes. To identify and clone
genes acting during megasporogenesis, we screen our
transposant collection for reporter gene expression in
early stages of ovule development. In a pilot screen,
we identified several lines that are characterized by
reporter gene expression in ovule primordia prior to
MMC differentiation, in megaspores undergoing
meiosis, or in highly restricted regions of the devel-
oping ovule. Of particular interest is a semisterile line
with polar expression restricted to proximal regions
of the nucellus, a domain implicated in megaspore
specification. The gametophytic control of this
phenotype indicates a requirement for the haploid
genome in late events of megasporogenesis. To con-
firm patterns of gene expression, we are currently es-
tablishing a high-resolution whole-mount in situ
hybridization procedure that will allow us to detect
signals at single-cell resolution in the ovule.
Dissection of Megagametophyte
Development by Insertional
Mutagenesis
J. Moore, W. Gagliano, U. Grossniklaus
Very few mutants affecting the gametophytic phase
of the plant life cycle have been described in the liter-
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ature, and the isolation and characterization of addi-
tional mutants will provide new insights into the ge-
netic regulation of this process. In more than 5000
transposants, we identified 178 mutants with reduced
fertility, suggesting a possible defect in megagameto-
phyte development or function. If a mutation affects
megagametogenesis, ovules carrying a defective fe-
male gametophyte arrest and do not develop into
seeds. Therefore, a plant heterozygous for an inser-
tion affecting megagametophyte development is ex-
pected to display a semisterile phenotype, since half
of the ovules will contain a gametophyte carrying the
mutant allele. Reduced fertility can result from poor
growth conditions, sporophytic female sterile muta-
tions with low penetrance, reciprocal translocations,
or mutations affecting the female gametophyte. These
different possibilities can be distinguished by a
segregation analysis of the kanamycin resistance
marker present on the Ds element. Insertional muta-
tions that disrupt megagametogenesis will show a
non-Mendelian segregation of the Ds element. We
characterized the segregation pattern of the kanamy-
cin resistance gene in 126 lines and identified 29
transposants with distorted segregation consistent
with a gametophytic defect and 30 additional lines
where gametophyte transmission was affected but
masked by a second element. These results suggest
that approximately half of the initially identified
mutants are closely linked to a Ds insertion (and
therefore likely to be tagged) and that about 1% of all
insertions affect gametophytic transmission.
We chose 19 lines carrying a single element and
displaying a consistent phenotype for further analy-
sis. The morphology of affected megagametophytes
was characterized in cleared specimens (Fig. 1). The
different mutants disrupted various aspects of mega-
gametophyte development such as free nuclear divi-
sions, nuclear migration and differentiation, eel -
lularization, and fertilization. We isolated and se-
quenced genomic regions flanking the insertion site
for all 19 transposants, and 13 of them showed
similarity to sequences deposited in the databases.
Three major classes of genes that are expected to
result in gametophyte lethality were identified: (1) in-
sertions in essential genes with basic metabolic func-
tions, for example, dTDP-glucose-4-6-dehydratase or
dihydrofolate reductase; (2) mutations in cell cycle
control genes, for example, a disruption of a subunit
of the origin recognition complex, Orc2; and (3) in-
sertions in genes with a putative regulatory function
controlling megagametogenesis and fertilization such
as insertions in genes that have homology with
FIGURE 1 Photomicrographs of embryo sacs in gametophytic mutants. (a) Ovule has been stained
with hematoxylin and cleared in methylbenzoate; (b-e) ovules have been cleared in Herr's solution.
(a) Wild type. (S) Synergid; (E) egg cell; (C) central cell; (A) antipodals. (b) ET 981. Abnormal posi-
tion and morphology of gametophyte nuclei. Cellularization is delayed and abnormal (arrowheads)
forming uncharacteristically large cells at both poles. (c) GT 790. Cells fail to form. Distribution and
differentiation of nuclei are aberrant. A sibling wild-type gametophyte at the free nuclear endosperm
(FNE) stage is shown. (d) GT 2633. Cellularized embryo sac. Pollen tube penetrated the synergid
but fertilization is impaired. The two sperm cells (arrowheads) remain in the degenerated synergid.
(e) GT 3347. A second nucleus (arrowhead) remains in the central cell. (b-c) Composite pictures
(different focal planes).
proteases, phosphatases, and other signal transduction
molecules.
Cell Specification
in the Female
Gametophyte
R. Baskar, J. Moore, W. Gagliano, U. Grossniklaus
The small number of clonally derived cell types in
the female gametophyte makes it an ideal system to
study cell specification processes in plants. By char-
acterizing genes that are specifically expressed in in-
dividual cells of the megagametophyte, we try to in-
vestigate the respective roles of positional informa-
tion, cell lineage, and cell-cell communication in cell
determination and differentiation. We have screened
close to 1500 transposants for reporter gene expres-
sion in mature ovules. Among the enhancer detector
transposants, approximately 5% show expression in
the female gametophyte. Whereas some of these
show expression in all cells of the megagametophyte,
others are specific to a subset of cells (e.g., the three
cells of the egg apparatus) or to individual cell types
such as the oocyte, synergids, and antipodals, sug-
gesting that they may be involved in cell specifica-
tion processes. We are particularly interested in the
specification and function of the egg cell. To date, we
have identified two transposants with expression in
the egg, neither of which displays an obvious mutant
phenotype. One of them carries an insertion in the
carboxy-terminal region of a cdc2-like kinase; the
second does not have significant similarity to other
proteins in the databases. We are currently isolating
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the promoter regions of these genes and will use them
for genetic cell ablation and the misexpression of
regulatory genes. Such experiments will yield impor-
tant insights into the mechanisms of cell specification
and allow us to probe the potential of the egg cell for
autonomous activation, an important component of
apomictic reproduction.
Polyspermic Fertilization
Events in Maize
U. Grossniklaus, N. Castiaux
In flowering plants, two pairs of cells participate in
the fertilization process. One of the two sperm cells
delivered by the male gametophyte fuses with the egg
to form the zygote, whereas the second fuses with the
central cell and gives rise to the primary endosperm.
Due to the inaccessibility of plant gametes, the fertil-
ization process itself has not been studied extensive-
ly. Most animal species studied prevent the union of
more than two haploid cells and have evolved sys-
tems to prevent polyspermy. In many animal species,
a transient fast block to polyspermy is established by
the depolarization of the egg membrane within mil-
liseconds after the binding of the first sperm, and a
second more permanent block is then generated by
enzymatic changes in the egg membrane and the sur-
rounding extracellular matrix. Although in vitro fer-
tilization experiments suggest that the plant egg com-
pletes its cell wall within minutes after fertilization
(Kranz et al., Plant J. 8: 9 [1995]) thereby preventing
further fertilization events, it is not known whether
plant gametes prevent polyspermy by a fast block.
We tested whether multiple sperms can participate in
the fertilization of the central cell in maize. The cen-
tral cell is binucleate and forms the triploid endo-
sperm after fertilization. Normal endosperm develop-
ment strictly requires the presence of maternal and
paternal genomes in a ratio of 2:1, any deviation from
this ratio resulting in kernel abortion. We crossed
tetraploid females with a mixture of pollen from two
different diploid males carrying distinguishable
endosperm markers. In this cross, only kernels with
endosperm containing two paternal genomes will ful-
ly develop. This is achieved if two sperm cells partic-
ipate in the fertilization event with the central cell or
if an aberrant meiosis produces diploid sperms. In
175 crosses, we recovered 26 full-sized kernels carry-
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FIGURE 2 Full-sized kernels derived from a cross between
a tetraploid female and a mixture of pollen from two diploid
males. (a) Kernel carrying two paternal copies of the R-nj
marker pigmenting the crown; (b) kernel carrying two pater-
nal copies of R-st yielding a spotted pattern; (c) kernel
derived from a polyspermic fertilization event carrying both
the R-nj and R-st markers originating from two different
paternal plants.
ing the endosperm markers from both male parents,
and 166 carried one of the two markers (Fig. 2).
Since we only detect half of the polyspermic events
in such a cross, about one quarter of the full-sized
kernels (52/192) are derived from events where two
sperm cells participated in the fertilization of the cen-
tral cell. These results clearly demonstrate that
polyspermy occurs in vivo and may explain the rela-
tive tolerance of plants to polyploidization and
hybridization.
Functional Analysis of medea,
a Gametophytic Maternal
Effect Mutant
U. Grossniklaus, J.-P. Vielle Calzada,
M. Hoeppner, W. Gagliano
We continued our characterization of medea (mea), a
gametophytically controlled mutant that affects the
subsequent sporophytic generation. We had shown
that mea is a gametophytic maternal effect embryo-
lethal mutant: Seeds derived from mea eggs abort ir-
respective of the paternal contribution and gene
dosage. Our genetic characterization of mea sug-
gested that it affects either a maternally expressed
cytoplasmic factor or an imprinted gene expressed
from the maternal allele. To better characterize the
mea phenotype, we compared the morphology of mea
and wild-type seeds in cleared and sectioned
specimens. Early stages of mea embryogenesis were
indistinguishable from wild type, with the first dif-
ferences becoming apparent at the globular stage. Al-
though morphogenesis in wild-type embryos pro-
ceeds to the heart stage, mea embryos remain
globular for an extended period of time undergoing
additional cell divisions. By the time wild-type si-
blings have reached the cotyledonary stage and seed
maturation begins, mea embryos have proceeded to
the late heart stage but are much larger than wild-type
embryos of the corresponding stage: mea late heart
stage embryos have almost twice as many cell layers
(19.6 +/- 1.1) as compared to wild type (13.0 +/-
0.9). Despite this dramatic increase in size, mor-
phogenesis of mea embryos proceeds normally but is
delayed, producing giant heart stage embryos that
eventually die during seed desiccation. The develop-
ment of the endosperm is also affected, showing a
reduction of the rate at which nuclear division takes
place but normal morphogenetic progression. Taken
together, these results suggest that MEA regulates
growth during embryogenesis and seed development
without interfering with morphogenesis, which pro-
ceeds normally but slow.
To determine the function of the MEA wild-type
product, we investigated whether mea is a gain-of-
function or loss-of-function mutation. Since domi-
nance and recessiveness are defined as an interaction
of two alleles, this question cannot be addressed in
haploid gametophytes. We constructed tetraploid
plants carrying a mutant mea allele which allowed us
to analyze seeds derived from diploid megagameto-
phytes carrying two, one, or no mutant mea allele.
This analysis showed that mea behaves as a recessive
mutation and thus that the wild-type function of MEA
is to restrict proliferation during embryogenesis. Our
findings provide strong support for a theory proposed
by Haig and Westoby (Am. Nat. 134: 147 [1989])
which explains parent-of-origin-dependent regulation
of embryo size as the outcome of a conflict between
parental genomes over the allocation of nutrients
from the mother to its offspring. The theory predicts
that parentally controlled loci (imprinted genes or
cytoplasmic factors produced prior to fertilization)
should influence the growth rate of the embryo, with
paternally expressed genes promoting growth and
maternally expressed genes tending to reduce it. mea
is the first single gene mutation in plants providing
strong support for this theory: The mea phenotype is
under strict gametophytic maternal control, and mea
embryos are characterized by increased proliferation
and delayed differentiation. We have isolated genom-
ic regions flanking the mea insertion and have recent-
ly identified a rare cDNA in a floral library. We are
currently characterizing the structure and function of
mea at the molecular level.
Arabidopsis Mutants Displaying
Apomictic Traits
U. Grossniklaus, R. Baskar [in collaboration with
R. Pruitt and S. Lolle, Harvard University]
Seeds are generally considered to be the result of sex-
ual reproduction. In more than 400 apomictic species,
however, seeds form independent of fertilization.
Gametophytic apomixis can be interpreted as a short-
circuiting of the sexual pathway where meiosis is im-
paired or absent, and an unreduced cell produces a
mature female gametophyte. The apomictic egg cell
develops autonomously to produce clonal seeds. We
have previously established a powerful screen to
identify Arabidopsis mutants that allow seed devel-
opment in the absence of fertilization. Such mutants
display certain aspects of apomictic reproduction, and
their identification and characterization constitute an
important step toward the engineering of apomixis in
sexual species. Taking advantage of a temperature-
sensitive male sterile mutation isolated in R. Pruitt's
laboratory, we performed a saturation screen for
mutants that allow seed pod development under
restrictive conditions. Among the more than 15,000
mutagenized plants, we identified close to 500 puta-
tive mutants which are currently being rescreened at
Harvard. We expect to recover several distinct
phenotypic classes: (1) suppressors of male sterility
allowing the production of functional pollen, (2)
revertants of the male sterile mutation, and (3)
pseudo-suppressors that allow seed development in
the absence of fertilization. Based on rescreening the
first 126 putative mutants, we expect that about one
third of them belong to class III, displaying com-
ponents of apomicitc reproduction, for example,
autonomous endosperm development and partheno-
genesis.
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REGULATION OF APOPTOSIS
S.W. Lowe M.E. McCurrach At. Lin
J. Polyakova A.V. Samuelson
T.M.F. Connor
Our research is based on the premise that apoptosis, a
genetically controlled form of cell death, provides a
natural defense against tumor development and un-
derlies the cytotoxicity of most current anticancer
drugs. Consequently, mutations that disrupt apoptotic
programs can cause tumor progression and resistance
to cancer therapy. Earlier studies identified the p53
tumor suppressor as an important regulator of apo-
ptosis and demonstrated that p53 mutations could
promote oncogenic transformation, tumor progres-
sion, and resistance to cytotoxic agents by reducing a
cell's apoptotic potential. Our current research is
aimed at elucidating how p53 promotes apoptosis and
characterizing p53-independent apoptotic pathways
that might function in tumor cells. We are also devel-
oping in vivo models to study the regulation of apop-
tosis in spontaneous mouse tumors. With Y. Lazeb-
nik here at the Laboratory, we are investigating how
p53 and other regulators of apoptosis affect activation
of the apoptotic "machinery" (i.e., the molecules
directly responsible for apoptotic cell death). In addi-
tion, we have begun a new direction, investigating
how cells respond to ras oncogenes and the con-
sequences of this response for multistep carcino-
genesis.
Modulation of
Chemosensitivity
A.V. Samuelson, At. Lin, M.E. McCurrach
One of the most confounding aspects of cancer
pharmacology is the molecular basis underlying the
"therapeutic index" of cytotoxic agents: Why are can-
cerous cells killed and most normal tissues spared?
Since most anticancer agents induce apoptosis, re-
sponsive tumors must be more susceptible to apo-
ptosis than most normal tissues. Evidence from our
laboratory and elsewhere suggests that alterations in
cellular susceptibility to apoptosis are tightly linked
to tumorigenesis. For example, normal fibroblasts are
resistant to drug-induced apoptosis but become ex-
tremely susceptible after having been made tumor-
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igenic by coexpression of the ElA and ras onco-
genes (Lowe et al., Cell 74: 954 [1993]). If these
tumorigenic cells have p.53 mutations, however,
cytotoxic agents are no longer able to induce apo-
ptosis efficiently. These observations suggest that
tumor cell chemosensitivity is determined, at least in
part, by the combined effects of oncogenic mutations
on apoptosis.
Our laboratory continues to use genetically manip-
ulated cells to mimic oncogenic changes occurring in
spontaneous tumors and to modulate cellular suscep-
tibility to apoptosis. We have shown that ElA is suf-
ficient to promote chemosensitivity in fibroblasts. Al-
though coexpression of a ras oncogene with ElA is
able to transform primary cells (i.e., make them
tumorigenic), ras does not prevent, and may in fact
enhance, apoptosis.
ElA binds a series of cellular proteins, including
p300/CBP, p107, p130, and pRb (the product of the
retinoblastoma tumor suppressor gene). We are in-
vestigating how ElA enhances apoptosis and chemo-
sensitivity and anticipate that this will direct us to
cellular activities involved in chemosensitivity. Our
results indicate that ElA's apoptotic activity requires
its ability to bind and inactivate pRb (but not p107 or
p130). However, this function is not sufficient; rath-
er, a separable ElA domain cooperates with Rb in-
activation to enhance cellular susceptibility to apo-
ptosis. We are currently characterizing this other ElA
function. Moreover, we are working closely with Y.
Lazebnik's laboratory to characterize El A's apo-
ptotic activity at the biochemical level.
p53 and Apoptosis
M.E. McCurrach, T.M.F. Connor, S.W. Lowe
Inactivation of p53-dependent apoptosis promotes
oncogenic transformation, tumor development, and
resistance to many cytotoxic anticancer agents; how-
ever, the mechanism whereby p53 promotes apo-
ptosis is poorly understood. p53 is a sequence-
specific binding protein that can regulate transcrip-
tion. One transcriptional target of p53 that may be
important for apoptosis is Bax, a cell death agonist
that has homology with the anti-apoptotic Bcl -2
protein. Forced overexpression of p53 increases Bax
expression in several cell types, and this increase cor-
relates with the induction of apoptosis. In addition,
the Bcl -2 and El B 19K proteins, which can inhibit
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FIGURE 1 Bax contributes to the p53 apoptotic program.
E1A-expressing MEFs of the indicated genotype were
treated with adriamycin and analyzed for apoptosis by co-
staining with FITC-annexin V and propidium iodide (PI) or by
staining with acridine orange. Annexin V binds phospho-
tidylserine. Apoptotic changes in membrane biochemistry
lead to increased concentration of phosphotidylserine on
the outer plasma membrane, where it becomes accessible
to annexin V. PI fluorescently stains late apoptotic cells that
have lost membrane integrity. Shown are dot plots from 2-
color flow cytometry: (lower left quadrant) viable; (lower right
quadrant) early apoptotic; (upper right) late apoptotic. Acri-
dine orange staining allows visualization of the chromatin
condensation characteristic of apoptotic cells. At doses of
adriamycin that kill wild-type but not p53-deficient cells (i.e.,
cell death is p53-dependent), bax deficiency leads to a par-
tial defect in apoptosis.
apoptosis induced by p53 overexpression, can physi-
cally associate with Bax. This raises the possibility
that these oncoproteins interfere with p53-dependent
apoptosis by antagonizing Bax function.
All of the studies mentioned above have relied on
forced overexpression of p53 or Bax to induce apo-
ptosis-circumstances that may not faithfully repro-
duce their normal activities. To determine whether
bax is required for p53-dependent apoptosis, the ef-
fects of bax deficiency were examined in primary
mouse embryo fibroblasts (MEFs) expressing the
El A oncogene, a setting where apoptosis is strictly
dependent on endogenous p53 (Lowe et al., Cell 74:
954 [1993]). Using this approach, we demonstrated
that bax can function as an effector of p.5.3 in
chemotherapy-induced apoptosis (Fig. 1) and contrib-
utes to a p53 pathway to suppress oncogenic trans-
formation. Furthermore, we showed that additional
p53 effectors participate in these processes. These
p53-controlled factors cooperate with Bax to promote
a full apoptotic response and their action is sup-
pressed by the Bcl -2 and El B 19K oncoproteins.
These studies demonstrate that Bax is a determinant
of p53-dependent chemosensitivity and illustrate how
p53 can promote apoptosis by coordinating the ac-
tivities of multiple effectors. We will continue to dis-
sect this pathway in the coming year.
p53-independent Apoptotic
Pathways
T.M.F. Connor, J. Polyakova, S.W. Lowe
Most cancers are treated using a combination of
anticancer agents, each with a distinct primary in-
tracellular target. This approach decreases the
likelihood that mutations in any one primary drug
target produce drug resistance and treatment failure.
However, it is now known that agents with distinct
primary targets can induce apoptosis through similar
mechanisms (e.g., p53 pathway). Under these cir-
cumstances, a single mutation that disrupts the apo-
ptotic pathway (e.g., p53 mutation) may produce
resistance to multiple agents. In principle, the full
benefits of combination therapy would be achieved
using agents that activate distinct apoptotic pathways.
Using our simple system of fibroblasts trans-
formed by E1A and ras, we have identified agents
that induce through the p53-apoptotic pathway and
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others that do not require p53 for apoptosis. As pre-
dicted, p53-dependent drugs act synergistically with
p53-independent agents to induce apoptosis. Using
MEFs deficient for specific genes and various cell
death inhibitors, we are genetically characterizing
these distinct pathways. We are also characterizing
the caspases activated in each pathway, and during
combination treatment (see below). We envision that
this system will provide a simple model for under-
standing "cross-talk" between apoptotic pathways.
Caspases in Cancer
J. Polyakova, T.M.F. Connor [in collaboration with
Y. Lazebnik and L. Falerio, Cold Spring Harbor Laboratory]
Proteases related to interleukin-1 15 converting en-
zyme, called caspases, are thought to be essential
components of the apoptotic "machinery" (i.e., the
molecules directly responsible for apoptotic cell
death). The importance of apoptosis in cancer argues
that components of this machinery may be tumor
suppressors and/or drug sensitivity genes. Since
proteolytic cleavage is essentially irreversible, cas-
pase activation may represent the last regulated step
in apoptosis. In this view, the endpoint of most, if not
all, cytotoxic anticancer drugs is caspase activation.
Consequently, most mutations that limit drug cyto-
toxicity act upstream of these proteases. If true, the
caspases represent attractive drug targets.
A major goal of our laboratory is to understand
how cell death regulators like p53 affect caspase ac-
tivation. First, with Y. Lazebnik, we are identifying
the caspases activated during p53-dependent and
-independent apoptosis in the well-defined MEF sys-
tem described above. Second, using viral caspase in-
hibitors or MEFs deficient for specific caspases, we
are studying the contribution of specific caspases to
various apoptotic pathways. We have shown that in-
activation of p53 or overexpression of cell death in-
hibitors such as El B 19K and Bcl -2 prevents caspase
activation. Multiple caspases are activated during
chemotherapy-induced apoptosis in MEFs, and dis-
tinct apoptotic pathways can use overlapping but
nonidentical sets of caspases. These studies under-
score the potential importance of caspases in cancer
therapy and may ultimately provide new insights into
how cell death regulators interface with the apoptotic
machinery.
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Multistep Carcinogenesis
S.W. Lowe, At. Lin, M.E. McCurrach [in collaboration
with M. Serrano and D. Beach, Cold Spring
Harbor Laboratory]
Cancer is a multistep process involving a series of ge-
netic changes and each enhances the growth or sur-
vival of developing tumor cells. Considerable prog-
ress has been made in identifying tumor-specific
mutations and how these mutations alter normal gene
function. For example, mutational activation of ras
results in a protein that constitutively transmits
mitogenic signals, and inactivation of p53 disrupts
cell cycle arrest or apoptosis. However, much less is
known about how these mutations interact to produce
the malignant phenotype. Why are these mutations
often found in the same tumors? Why does ras muta-
tion typically precede p53 mutation?
Perhaps the simplest model for studying the multi-
step nature of cancer involves oncogenic transforma-
tion of primary cells. Primary cells are genetically
normal and capable of only a limited number of cell
divisions in culture, after which they permanently ar-
rest by a process known as senescence. At low fre-
quencies, primary cells acquire mutations that disrupt
senescence, allowing these variants to be established
into "immortal" cell lines. Expression of oncogenic
ras typically "transforms" immortal cells to a tumor-
igenic state, but ras alone cannot transform primary
cells. However, primary cells are made tumorigenic if
ras is coexpressed with second oncogenes such as
ElA (a phenomenon known as "oncogene coopera-
tion") or when expressed in the absence of tumor
suppressors such as p53 and p16. When expressed
alone, these cooperating mutations (EIA, p53 loss,
p16 loss) facilitate the immortalization process.
We recently demonstrated that prolonged expres-
sion of oncogenic ras in primary fibroblasts induces a
permanent cell cycle arrest involving p53 and p16.
Remarkably, this arrest is indistinguishable from
senescence. Inactivation of either p53 or p16 prevents
ras-induced arrest in rodent cells, and ElA achieves a
similar effect in human cells. These observations sug-
gest that the onset of cellular senescence can be
prematurely activated in response to an oncogenic
stimulus. Inactivation of this senescence program, by
a cooperating oncogene or as a result of spontaneous
mutation, allows proliferation to continue unabated
and facilitates oncogenic transformation. Conse-
quently, premature senescence may be an important
safeguard against neoplasia.
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COLD SPRING HARBOR
MEETINGS AND COURSES
ACADEMIC AFFAIRS
The rapid pace of advances in cell and molecular biology as well as neurobiology have made communica-
tion and dissemination of new information and technologies critical. The academic program at Cold Spring
Harbor Laboratory is designed to address this need. The program comprises a wide-ranging series of
postgraduate laboratory and lecture courses, workshops, large meetings, and a summer research program
for undergraduates. The program now extends from a spring session of courses starting early in March
through a fall session of courses ending in November.
This year, 24 courses were held at the laboratory, including 19 laboratory courses that took place in the
Delbruck Laboratory and the Howard Hughes Medical Institute (HHMI)) teaching laboratories in the
Beckman Neuroscience Center. Five advanced neurobiology lecture courses were held at the Banbury
Conference Center.
Course instructors come from universities and research institutes around the world to teach at Cold
Spring Harbor and their creativity (and endurance) really make the courses work so well. Course
instructors, lecturers, and students are listed below. Several scientists who have contributed greatly by
teaching courses for several years will be retiring after this year, although we know that we can count on
them to give advice-and course lectures-in the future. In the spring session, these included Bruce Birren
and Doug Vollrath, instructors in the course on Cloning and Analysis of Large DNA Molecules, as well as
Rob Grainger and Hazel Sive, who taught Early Development of Xenopus laevis. The three-week summer
courses form the core of the academic program, and several instructors who have participated in first-rate
fashion over a period of years are retiring-namely, Richard Behringer and Ginny Papaioannou, who taught
Molecular Embryology of the Mouse; Jim Boulter, an instructor for Molecular Cloning of Neural Genes; Ken
Burtis, who taught in the Eukaryotic Gene Expression course; and Chris Kaiser, an instructor in the Yeast
Genetics course, as well as Bill Mobley, who taught in the Neurobiology of Human Neurological Disease
lecture course. Our thanks also go to retiring fall course instructors Paul Hough, Iris Mastrangelo, Ken
Jacobson, Claire Huxley, Mike Lovett, and Tom Marr.
The courses are supported by, and would not be possible without, a series of grants from federal and
private sources. The summer molecular genetics courses have been supported for many years by grants
from the National Institutes of Health and the National Science Foundation. A grant from the National
Institute of Mental Health that supports several of the neurobiology courses was renewed this year. A large
education grant from HHMI has provided stable support for the neurobiology program and has allowed the
Laboratory to begin and to expand its series of spring and fall courses. The Laboratory also has an award
from the Esther and Joseph A. Klingenstein Fund for the support of neurobiology courses. As has been the
case for several years, the Grass Foundation provided funds for scholarships for students in neurobiology
courses. A grant from the Department of Energy has also helped in the funding of the courses in Macro-
molecular Crystallography. In addition, the Laboratory receives valuable support from many companies
that donate supplies and lend equipment for the courses.
While sixteen meetings have been held at the Laboratory this year, the Symposium remains central.
This year's Symposium on Function and Dysfunction in the Nervous System brought together a broad array
of neurobiologists to discuss recent research. Other highlights of the year included a new meeting, Cancer
Genetics and Tumor Suppressor Genes, organized by Anton Berns, Terri Grodzicker, Ed Harlow, David
Livingston, Carol Prives, and Bert Vogelstein. The meeting, which was over-subscribed in its first year, em-
phasized connections between the functions of tumor suppressor genes and their loss or mutation in dif-
ferent cancers. Other meetings, which are often held in alternate years, covered topics ranging from the
Cell Cycle to Translational Regulation to Molecular Chaperones and the Heat Shock Response. The meet-
ings on Genome Mapping and Sequencing and Retroviruses continue on a yearly basis. This year, two
biotechnology meetings were held outside of the regular meetings season. These conferences, which
started off with one held on Optical Imaging of Gene Expression and Signaling in Living Cells, are overseen
by David Stewart and are expected to continue in future years. In all, over 5000 scientists attended the
meetings this year. Organizers and contributors to the meetings are listed below. The sources of support
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for these meetings come from the Laboratory's Corporate Sponsor program, NIH, NSF, DOE, and various
corporations and foundations. Grants helped scientists at all stages of their careers to attend the confer-
ences.
While graduate students, postdoctoral fellows, and faculty participate in the courses and meetings, the
Undergraduate Research Program (URP) provides an opportunity for college undergraduates to spend 10
weeks at the Laboratory during the summer. The program, headed by Michael Hengartner, allows students
to do research in the laboratories of staff scientists.
The large numbers of courses and meetings proceed with skill and efficiency, thanks to the collabora-
tive efforts of a large number of people at the Laboratory. The staff of the Meetings Office, headed by David
Stewart, Director of Meetings and Courses, coordinates the arrangements for all of the visiting scientists.
This enormous job, which seems to grow every year, is carried out not only extremely efficiently, but with
good humor as well. The staff, including Micki McBride, the Course Registrar, Nancy Weeks, Head Con-
cierge, Jim Koziol, Diane Tighe, Marge Stellabotte, Andrea Stephenson, Drew Mendelson, and Michael
Glaessgen, as well as staff from several other departments, are crucial to the success of the meetings and
courses. These include Herb Parsons, Ed Campodonico, and the audiovisual staff; Cliff Sutkevich and his
staff who set up and maintain course equipment; Edie Kappenberg, the course coordinator, Mary Horton of
the Grants Office; and Lee Martin of Cold Spring Harbor Laboratory Press.
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61st COLD SPRING HARBOR SYMPOSIUM
ON QUANTITATIVE BIOLOGY
Function and Dysfunction
in the Nervous System
May 29-June 5 282 participants
ARRANGED BY Bruce Stillman, Cold Spring Harbor Laboratory
It is inherent in our nature to want to understand all that is wrong, as well as what is right in the
biological systems that we study. Perhaps one of the most fascinating areas of biology where this
is applicable is the nervous system. Increasingly, progress in biology is influenced by the dis-
eases and maladies that afflict us. The decision to hold the 61st Symposium on Function and Dys-
function in the Nervous System was driven by the belief that in the near future will we learn an
enormous amount about how the nervous system works by simultaneously studying the diseases
that affect it. These studies, in parallel with other studies on the normal function of the nervous sys-
tem, will greatly advance neurobiology in much the same way that genetics of model organisms
has hastened unexpected and fundamental discoveries. The goal was to intermingle scientists in-
terested in the study of systems in neuroscience with those trying to understand how those sys-
tems fail, so that an overview of the problems in neurological diseases could be obtained. This
was a somewhat risky venture because neurobiology is as varied as biology itself, and the bring-
ing together of investigators with diverse interests can create a hodgepodge of science that does
not interest anyone. But the diseases of the nervous system are as fascinating as biology gets,
and it was well worth the
Some Symposia celebrate past accomplishments in fields of biology, but this one looked
mostly to the future, which we hope, and even expect, is an exciting one. We anticipate that this
Symposium will provide a stepping stone for future progress. The current meeting could not have
been organized without the great help of several colleagues, including Eric Kandel, Stan Prusiner,
Richard Axel, Conrad Gilliam, Gideon Dreyfuss, and Tony Movshon. The formal scientific program
consisted of 86 speakers and 94 poster presentations. The meeting attracted 282 participants.
Introductory talks on the first evening were from Michael Merzenich, Eric Kandel, Stan Prusiner,
Richard Price, and Ann Pulver. The second Reginald G. Harris Lecture was delivered by Richard
Axel, who presented his exciting work on olfaction. V.S. Ramachandran gave a fascinating Dorcus
Cummings Lecture on the illusions of the body image to our friends and neighbors, and was wide-
ly acclaimed.
Essential funds to run this meeting were obtained from the National Institute of Neurological
Disorders and Stroke and The DuPont Merck Pharmaceutical Company. In addition, the financial
help from the Corporate Sponsors of our program is essential for these meetings to remain a suc-
cess and we are grateful for their continued support. These sponsors are: Alza Corporation; Am-
gen Inc.; BASF Bioresearch Corporation; Becton Dickinson and Company; Boehringer Mannheim
Corporation; Bristol-Myers Squibb Company; Chiron Corporation; Chugal Research Institute for
Molecular Medicine, Inc.; Diagnostic Products Corporation; The Du Pont Merck Pharmaceutical
Company; Forest Laboratories, Inc.; Genentech, Inc.; Hoechst Marion Roussel, Inc.; Hoffmann-La
Roche Inc.; Johnson & Johnson; Kyowa Hakko Kogyo Co., Ltd.; Life Technologies, Inc.; Eli Lilly
and Company; Merck Genome Research Institute, Oncogene Science, Inc.; Pall Corporation; The
Perkin-Elmer Corporation, Applied Biosystems Division; Pfizer Inc.; Pharmacia & Upjohn, Inc.; Re-
search Genetics, Inc.; Sandoz Research Institute; Schering-Plough Corporation; Sumitomo
Pharmaceuticals Co., Ltd.; Wyeth-Ayerst Research; Zeneca Group PLC.
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L. Katz, J.-P. Changeux G. Enikolopov, E. Kandel, G. Fischbach N. Dwyer, H. Cline
J.-P. Changeux, C. Weissmann
PROGRAM
Welcoming Remarks: Bruce Stillman
Z. Hall
Introduction
Chairperson: W .M. Cowan, Howard Hughes Medical
Institute
Neurodegenerative Diseases
Chairperson: D.J. Selkoe, Harvard Medical School and
Brigham and Women's Hospital, Boston, Massachusetts
Addiction and Emotional Memory
Chairperson: J.R. De Paulo, Johns Hopkins University
Baltimore, Maryland
Alzheimer's Disease
Chairperson: D. Price, Johns Hopkins University Baltimore,
Maryland
Language and Visual Processing
Chairperson: D. HUbel, Harvard University, Boston,
Massachusetts
Channels and Receptors
Chairperson: J.A. Movshon, Howard Hughes Medical
Institute and Center for Neural Science, New York
Neuronal Survival and Signaling
Chairperson: H.T. Cline, Cold Spring Harbor Laboratory
Memory
Chairperson: E.R. Kandel, Howard Hughes Medical
Institute, Columbia University College of Physicians &
Surgeons, and New York State Psychiatric Institute
Prions
Chairperson: S.B. Prusiner, University of California, San
Francisco
Neuronal Degeneration and Synapse Function
Chairperson: M.E. MacDonald, Massachusetts General
Hospital, Boston
C. Bargmann, S. Strickland
Dorcas Cummings Lecture: "Illusions of body image in
neurology: What they reveal of human nature."
Speaker: V.S. Ramachandran, Dept. of Psychology and
Neurosciences Program, University of California, San
Diego
Perceptual Plasticity
Chairperson: L. Buck, Howard Hughes Medical Institute,
Harvard Medical School, Boston, Massachusetts
Reginald G. Harris Lecture: The Molecular Biology of Smell"
Speaker: A. Axel, Howard Hughes Medical Instittue and
Center for Neurobiology and Behavior, College of
Physicians & Surgeons, Columbia University, New York
Sensory Perception
Chairperson: R. Axel, Howard Hughes Medical Institute and
College of Physicians & Surgeons, Columbia University,
New York
Psychiatric diseases
Chairperson: A.E. Pulver, Johns Hopkins University,
Baltimore, Maryland
Neuronal Dysfunction
Chairperson: R.F. Margolskee, Mt. Sinai School of Medicine,
New York, New York
Rhythms
Chairperson: C. Bargmann, University of California, San
Francisco
Summary: Z.W. Hall, University of California, San Francisco
and National Institute of Neurological Disorders and
Stroke, National Institutes of Health, Bethesda, Maryland
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MEETINGS
Optical Imaging of Gene Expression and Signaling in Living Cells
March 15-March 17 194 participants
ARRANGED BY Steve A. Kay, Scripps Research Institute
Optical imaging technology and the development of new probes has provided biologists with un-
precedented opportunities to study the molecular basis of cell organization and function. Three
hundred scientists gathered over two days to discuss current achievements, but more importantly,
to further explore the interface between imaging technology and studies on the expression of the
genome. Intense interest has been placed on the use of green fluorescent protein (GFP) as a way
of genetially encoding a fluorescent probe within the cell.
The meeting started with a keynote address by Roger Tsien, UCSD, whose laboratory has
pioneered the development of color-shifted mutants of GFP. Furthermore, the use of GFP to
measure protein-protein interactions via fluorescence resonance energy transfer (FRET) was dis-
cussed, as was the announcement of the development of 13-lactamase as novel fluorescent marker
for gene expression in living cells. Throughout the meeting many impressive talks on the use of
GFP and its derivatives for studying live cell protein dynamics in Drosophila, yeast, mammalian,
and plant cells were presented. For those interested in transcriptional dynamics, several talks pre-
sented the use of luciferase imaging as the only available tool for looking at rapid changes in gene
transcription in living tissues and cells, including the mutation of beetle luciferases to produce new
colors (K. Wood, Promega Corp.). Many exciting developments in imaging technology were pre-
sented, such as the use of two-photon excitation in confocal microscopy, which appears to be one
of the most attractive methods for observing fluorescent probes in living samples. Spectacular
movies of chromosome dynamics during cell division were also presented, using 3d-
deconvolution microscopy techniques. Advances in NTMR microscopy were presented by Scott
Fraser, of Caltech, and this method clearly promises to be a powerful tool for studying live cell
events in tissues and embryos. The lectures were accompanied by a large group of posters des-
cribing a broad array of reporter gene and cellular imaging applications. Demonstrations of recent
advances in CCD detector technologies were provided by the main corporate sponsor,
Hamamatsu Photonics.
PROGRAM
Welcome Address: Bruce Stillman
Cold Spring Harbor Laboratory, Steve Key, University of
Virginia, Charlottesville
Keynote address: Roger Tsien, University of California, San
Diego
Advanced Imaging Technology and Reporter Measurement
Chairperson: Steve Kay, University of Virginia,
Charlottesville
Luciferase Applications
Chairperson: Scott Fraser, Caltech, Pasadena
Applications of Green Fluorescent Protein and its Derivatives
Chairperson: Richard Day, University of Virginia,
Charlottesville
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M. Westerfield R. Kimmel
Zebrafish Development and Genetics
C. Nusslein-Volhard
April 24-April 28 362 participants
ARRANGED BY Nigel Holder, King's College, London, United Kingdom
Nancy Hopkins, Massachusetts Institute of Technology
Phil Ingham, Imperial Cancer Research Fund, United Kingdom
Christiane Nusslein-Volhard, Max-Planck-Institut, Germany
Monte Westerfield, University of Oregon
The second biennial open-invitation meeting devoted to research on Zebrafish Development and
Genetics was held at Cold Spring Harbor Laboratory, April 24-28, 1996. The meeting focused on
the cellular, molecular, and genetic regulation of embryonic development and growth. Sessions
covered: (1) neural crest and head development, (2) axis formation, (3) morphogenesis and pat-
terning, (4) gene transfer, gene expression, and new methodologies, (5) genetic mapping, (6) in-
ductive interactions, (7) heart, blood and other organs, (8) CNS development and (9) a satellite
symposium on genomics. Additionally, a session on community issues provided an opportunity to
discuss common goals of the zebrafish research community and means of fostering communica-
tion and dissemination of the information and research reagents throughout the community. There
were 236 presentations.
This meeting was funded in part by the National Institute of Child Health and Human Develop-
ment (a division of the National Institutes of Health) and the National Science Foundation.
PROGRAM
Neural Crest and Head Development
Chairperson: J. Eisen, University of Oregon, Eugene
Synaptic Transmission
Chairperson: J. Kehoe, Foote Norma le Superieure, Paris,
France
Axis Formation I
Chairperson: C. Kimmel, University of Oregon, Eugene
Axis Formation II
Chairperson: M. Mullins, University of Pennsylvania School
of Medicine, Philadelphia
Morphogenesis and Patterning
Chairperson: D. Duboule, University of Geneva, Switzerland
Methodologies
Chairperson: N. Hopkins, Massachusetts Institute of
Technology
Mapping
Chairperson: J. Postlethwait, University of Oregon, Eugene
Inductive Interactions
Chairperson: C. Thisse, C.U. de Strasbourg, lllkirch, France
Heart, Blood, and Other Organs
Chairperson: M. Fishman, Massachusetts General Hospital,
Harvard Medical School
CNS Development I
Chairperson: S. Wilson, King's College, London, United
Kingdom
CNS Development II
Chairperson: S. Wilson, King's College, London, United
Kingdom
"Perspectives on the Zebrafish Genome"
Chairperson: L. Zon, Harvard Medical School, Howard
Hughes Medical Institute and Children's Hosital, Boston,
Massachusetts
Molecular Chaperones and the Heat-shock Response
May 1-May.5 384 participants
ARRANGED BY Costa Georgopoulos, University of Geneva, Switzerland
Susan Lindquist, University of Chicago
Richard Morimoto, Northwestern University
In addition to the detailed information now available on the structure and biophysical properties of
the chaperoning in bacteria and in the homologue, hsp60, in mitochondria, this meeting reflected a
renewed, more basic set of inquires: how proteins are folded, how unfolded proteins are recog-
nized, the number of substrate proteins per chaperone, and the role of nucleotide hydrolysis in
chaperone activities. A fascinating session covered questions of how proteins are imported and
folded in two major organelles: the endoplasmic reticulum (ER) and mitochondria. Convergence of
powerful genetic and biochemical tools has revealed a role for individual chaperones and
chaperone complexes in the processes of transport and folding. Studies on the question of
chaperone machines focused on hsp90, the small heat-shock proteins, and the hsp70 family. The
70s and 90s do not have size restrictions and have the ability to transiently and stably interact with
folding intemediates in the process of protein folding.
Questions on the regulation of chaperone gene expression addressed the bacterial transcrip-
tion factors (sigma 24 and sigma 32) and their sensing mechanisms for unfolded proteins. In
eukaryotes, transcriptional regulation is mediated by a family of heat shock factors that become ac-
tivated in response to different types of stress and lead to the selective induction of a select num-
ber of genetic loci. The link between the stress sensing apparatus and stress protein function is in
the protection of cells from molecular damage. These concepts may be relevant to diseases that
involve the appearance of misfolded proteins, including Alzheimer's or prion diseases which in-
volve cell death and in autoimmunity and infectious diseases. Manipulating the expression of stress
proteins may prove beneficial to protection of tissues during trauma, including surgery and
transplantation.
This meeting was funded in part by the National Science Foundation, Affinity Bioreagents, Inc.,
Bayer Corporation, Churchill Livingstone, F. Hoffman-LaRoche AG, Novo Nordish A/S, and
Stress Gen.
0. Bensaude, R. Morimoto
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A.P. Arrigo, A. Tissieres
C. Georgopoulas
PROGRAM
I. Yahan, G. Li
The Biology of Chaperonins and Protein Folding
Chairperson: E. Craig, University of Wisconsin, Madison
Cytosolic Chaperonins and Import and Folding of Precursor
Proteins
Chairperson: W. Neupert, Institut fur Physiologische Chemie
der Universitat Munchen, Germany
Unfolding Protein Response and the Role of Chaperones in
Protein Degradation
Chairperson: M.-J. Gething, University of Melbourne,
Australia
The Protein Folding Problem: Other Chaperones (hsp90,
dnaJ, small HSPs, Cis-Trans Prolyl Isomerases and
Protein Disulphide Isomerases)
Genome Mapping and Sequencing
Chairperson: J. Heitman, Duke University Medical Center
Stress Tolerance: Protecting Cellular Components from
Molecular Damage
Chairperson: F-U. Hartl, Howard Hughes Medical Institute
and Memorial Sloan-Kettering Cancer Center
Controlling Chaperone Expression and Activation
Chairperson: C. Gross, University of California, San
Francisco
The Role of Stress Response in Disease and Pathology
Chairperson: L. Hightower, University of Connecticut, Storrs
May 8-May 12 469 participants
ARRANGED BY David Bentley, Sanger Centre
Eric Green, National Institutes of Health
Philip Hieter, Johns Hopkins University
A strong tradition of excellence was continued at this ninth Cold Spring Harbor meeting on genome
mapping and sequencing. More than 260 abstracts were presented, reflecting a broad array of
topics relating to the analysis of genomes from a number of different organisms. The sessions cov-
ered such areas as physical mapping of human chromosomes, multi-organismal genomics, human
genetics and biology, mapping methods and technologies, gene discovery and transcript map-
ping, large-scale DNA sequencing, and bioinformatics.
Some of the recently established presentation formats were again utilized in an effort to provide
an appropriate forum for assimilating the large amounts of incoming genome mapping and se-
quencing data. A poster symposium featuring the major DNA sequencing groups allowed at-
tendees to get a glimpse of the people and strategies that will likely play key roles in sequencing
the human genome. Once again, projection-style, interactive computer demonstrations in Grace
Auditorium effectively showcased the critical new bioinformatics tools being developed for storing,
organizing, and analyzing genomic maps and sequences.
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D. Green, R. Waterston
C. Huxley, E. Green
G.J.B. Van Ommen, J. Weissenbach A. Chakravarti, J. Cuddihy, P. Hieter
A central theme of the meeting related to the initiation of large-scale sequencing of the human
genome. Various presentations focused on the important issues relating to this critical and exciting
phase of the Human Genome Project. These included the construction of sequence-ready maps,
the expansion of sequence production groups, the development of sequencing automation and
technologies, and the establishment of improved software for data analysis and handling.
Another major highlight of the meeting was the keynote talk given by Shirley Tilghman (Prin-
ceton University) titled "Lessons Learned, Promises Kept: A Biologist's Eye-view of the Genome
Project." Tilghman discussed the impact of genome research on the study of biology, including the
proven value of comparative genomic analysis (lessons learned) as a result of freely accessible
genomic data (promises kept). A summary of this talk was published in the journal Genome Re-
search (6:773-780, 1996).
With the anticipated developments in genome mapping and sequencing in the coming months,
next year's tenth anniversary meeting should be a particularly exciting and historic event.
This meeting was funded in part by the National Center for Human Genome Research, a divi-
sion of the National Institutes of Health.
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PROGRAM
Large-scale Physical Mapping
Chairpersons: R. Gibbs, Baylor College of Medicine,
Houston, Texas; J. Weissenbach, Genethon, CNRS, Evry,
France
Multi-organismal Genomics: Biological Insights
Chairpersons: P. Hieter, Johns Hopkins University,
Baltimore, Maryland; C. Huxley, Imperial College School
of Medicine, St. Mary's Hospital, London, United Kingdom
Computer Demonstrations I
Moderator: L. Hillier, Washington University School of
Medicine, St. Louis, Missouri
Human Genetics and Biology
Chairpersons: S. Brown, MRC Mouse Genome Centre,
Oxford, United Kingdom; A. Chakravarti, Case Western
Reserve University, Cleveland, Ohio
DNA Sequencing Poster Symposium
Chairpersons: D. Bentley, Sanger Centre, Cambridge,
United Kingdom; E. Green, National Institutes of Health,
Bethesda, Maryland
Computer Demonstrations II
Moderator T. Marr, Cold Spring Harbor Laboratory
ELSI Panel Discussion
Moderator: E. Jordan, National Institutes of Health,
Bethesda, Maryland
Informatics
Chairpersons: K. Buetow, Fox Chase Cancer Center,
Philadelphia, Pennsylvania; L. Hillier, Washington
University School of Medicine, St. Louis, Missouri
Mapping Methods and Technologies
Chairpersons: D. Burke, University of Michigan, Ann Arbor;
I. Dunham, Sanger Center, Cambridge, United Kingdom
Computer Demonstrations III
Moderator: K. Buetow, Fox Chase Cancer Center,
Philadelphia, Pennsylvania
Keynote Speaker Shirley Tilghman, Princeton University,
New Jersey
Gene Discovery and Transcript Mapping
Chairpersons: M. Boguski, National Institutes of Health,
Bethesda, Maryland; R. Kucherlapati, Albert Einstein
College of Medicine, Bronx, New York
Commercial Implications of Genomics Research
May 12-May 14 118 participants
ARRANGED BY Eric Roberts, Dillon, Read & Co. Inc.
David Stewart, Cold Spring Harbor Laboratory
This short conference on Commercial Implications of Genomic Research, sponsored jointly by the
Laboratory and the New York investment bank Dillon, Read & Co. Inc., brought leaders in the in-
vestment and financial communities to Cold Spring Harbor to learn from current leading prac-
titioners about the present state of knowledge and technology in genomics research. Participation
was by invitation only from both East and West Coast financial communities and also from abroad,
and included senior executives of biotechnology, pharmaceutical, and venture capital companies.
The meeting was relatively informal in style, and all the participants, scientists as well as execu-
tives, found it to be both intellectually stimulating and very enjoyable.
Eminent keynote speakers including Jim Watson, J. Craig Venter, Eric Lander, and Robert
Waterston were able to give a broad overall view of certain aspects of the field to a predominantly
lay, though informed, audience. The keynote talks set the scene for discussions of particular tech-
nologies given by senior researchers from leading biotech companies (both established and start-
up) who explained the science underlying their technology platforms in the context of the commer-
cial environment. Presentations were made by Incyte Pharmaceuticals, Gene Logic, Genome
Therapeutics Corporation, Exelixis Pharmaceuticals, Sequana Therapeutics, Human Genome
Sciences, Darwin Molecular Corporation, Genset, Amplicon Corporation, Genetics Institute, Mil-
lenium Pharmaceuticals, GenoMed, Myriad Genetics, Mercator Genetics, Genomica Corporation
and Progenitor. Two roundtable discussions on Intellectual Property (moderator Leslie Misrock,
Pennie & Edmunds) and Business Models in Genomics (moderator Cynthis Robbins-Roth) were of
considerable interest to the audience, while Kevin Kinsella's dazzling postbanquet multimedia
presentation provided an amusing personal and anecdotal history of the genome biotechnology
industry.
219
This conference is intended to be the template for an annual meeting bringing relevant sections
of the investment community to Cold Spring Harbor for an intensive and educational couple of days
every year to learn about and discuss some topic in modern biology. We hope that this event will
lead to a broader understanding of the underlying science on the part of investors, to the potential
benefit of biomedical research as a whole. There may also be reciprocal benefits in bringing to-
gether leading scientists from the biotechnology industry face-to-face with the major decision-
makers from the financial sectors.
We thank Dillon, Read & Co., Inc. for funding this meeting.
PROGRAM
Welcoming Comments J.D. Watson, Cold Spring Harbor
Laboratory
Keynote Address J.C. Venter, The Institute for Genomic
Research
Keynote Speaker E. Lander, Whitehead/MIT Center for
Genomic Research
R.W. Scott; R.A. Whitfield, lncyte Pharmaceuticals, Inc.
R.Kouri, Gene Logic, Inc.
R.J. Hennesey, J.P. Richards, Genome Therapeutics
Corporation
R. Barbier, J.-F. Formela, Exelixis Pharmaceuticals, Inc.
K.J. Kinsella, T.J.R. Harris, Sequana Therapeutics, Inc.
L. Misrock, Pennie & Edmunds
W.A. Haseltine, Human Genome Sciences, Inc.
Cell Cycle
G.D. Abbott, Darwin Molecular Corp.
P. Brandys, Genset, S.A.
P.G. Lowell, Amplicon Corporation
P. Gage, Genetics Instittue, Inc.
C. Robbins-Roth, BioVenture Publishing
Keynote Speaker B. Waterston, Washington University
H.F. Arader, Jr., Milennium Pharmaceuticals, Inc.
B.G. Atwood, P.L. Kilian, GenoMed, Inc.
P.D. Meldrum, M. Skolnick, Myriad Genetics, Inc.
E. Sigal, Mercator Genetics, Inc.
J.L. Rathmann, Genomica Corporation
D.B. Given, Progenitor, Inc.
May 15-May 19 385 participants
ARRANGED BY Fred Cross, Rockefeller University
Jim Roberts, Fred Hutchinson Cancer Research Center
The biennial cell cycle meeting is recognized internationally for its ability to bring together scientists
who study cell regulation in eukaryotes ranging from yeast to humans. Although the impact of cell
cycle research is being strongly felt in many other biological disciplines including developmental
biology and cancer biology, this year's cell cycle meeting marked a renewed emphasis on the
basic mechanisms of cell cycle regulation.
As in other years, scientists studying cell cycle regulation in yeast, Xenopus, Drosophila and
mammals were well represented. Once again, the striking phylogenetic conservation of cell cycle
regulatory mechanisms was readily evident. Adding to the picture were some initial forays into cell
cycle regulation in plants, a frontier that promises exciting discoveries in years to come. It was also
inescapably obvious to all in attendance that the methodologic barriers that separated cell cycle
studies in different organisms were finally breaking down. Yeasts no longer are the only organisms
for doing genetic analyses of cell cycle regulation; impressive studies of Drosophila and mouse
mutants provided major new insights into cell cycle regulatory mechanisms in higher eukaryotic
organisms. Additionally, biochemical studies of cell cycle proteins in yeast are now almost on equal
footing with parallel studies in other organisms. Highlighting this year's meeting was the growing
emphasis on and insight into the roles of proteolysis in cell cycle regulation. The regulated destruc-
tion of cyclin B during mitosis remains the paradigm for studying ubiquitin-dependent protein turn-
over during the cell cycle. The discovery of the anaphase-promoting complex (APC), the elucida-
tion of its role in the ubiquitination of cyclin B, its regulation during the cell cycle, and its possible
relationship to mitotic checkpoints were all major advances described at this meeting. Equally ex-
citing was the discovery and initial characterization of a complementary protein turnover pathway
operating at the transition from G, to S phase.
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The cell cycle conference brought together 385 scientists for the presentation of 65 talks, and
184 posters. It was another landmark meeting for the cell cycle field, and the participants all con-
tinued to look forward to equally exciting meetings in future years.
This meeting was funded in part by the National Institute (a division of the National Institutes of
Health) and the National Science Foundation.
PROGRAM
Keynote Address: T. Hunt, ICRF, Clare Hall Laboratories,
United Kingdom
CDK Regulation
Chairperson: D. Beach, Cold Spring Harbor Laboratory
Cell Cycle Initiation
Chairperson: T. Orr-Weaver, Whitehead Institute,
Cambridge, Massachusetts
Cell Cycle Completion
Chairperson: H. Pwinica-Worms, Washington University
School of Medicine, St. Louis, Missouri
Cell Cycle Transcription
Chairperson' L. Breeden, Fred Hutchinson Cancer
Research Center, Seattle, Washington
Cell Cycle Control
Chairperson: C. Sherr, St. Jude Children's Hospital,
Memphis, Tennessee
CDK Substrates
Chairperson: R. Deshaies, California Institute of Technology,
Pasadena
Coordination of Cell Cycle Events
Chairperson: T. Weinert, University of Arizona, Tucson
Cell Cycle Exit
Chairperson: S. Elledge, Baylor College of Medicine,
Houston, Texas
B. Clurman, R. Sheaff J. DiGregori, K. Knudsen, A. Koff
B. Kelly, B. Futcher
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Retroviruses
May 21-May 26 424 participants
ARRANGED BY Ronald Desrosiers, Harvard Medical School
Anna Marie Skalka, Fox Chase Cancer Center
The annual Retrovirus has become truly international, with many foreign participants attending.
Molecular aspects of both the pathogenesis and replication of these viruses were discussed. As in
the last few years, a significant proportion of the contributions focused on the human pathogen,
HIV. However, this comprehensive meeting is especially valuable in that it offers a unique op-
portunity to enhance our understanding of retrovirus molecular biology through comparing and
contrasting a variety of systems.
New information was forthcoming from many levels. For example, the pathogenesis sections in-
cluded not only new molecular details concerning infection with the well-studied human, primate,
murine, and avian viruses, but also some of the first glimpses of pathogenesis by novel
retroviruses that infect fish. In several cases, information about retroviral proteins is now available
at the atomic level. Participants learned of the solution of the X-ray crystal structure of the FIV dUTP
pyrophosphatase, and heard more important details concerning the structure and function of other
virion proteins. They also gained a new appreciation of the ways in which detailed structural in-
J. Elder, J. Lenz, S. Ross S. Goff, V. Prasad, J.D. Stoye
P. Jolicoeur, P. Pitha-Rowe
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J. Young, P. Bates
formation on the retroviral enzymes, reverse-transcriptase, protease, and integrase, is facilitating
the development of effective drugs to treat viral disease and also increasing our knowledge of the
enzymes' mechanisms. A final session highlighted the use of exciting new technologies and new
approaches to intervention, some of which may lay the groundwork for therapies of the future.
Contributions from Corporate Sponsors provided core support this this meeting.
PROGRAM
Pathogenesis (nonlenti)
Chairpersons.' P. Jolicoeur, Clinical Research Institute of
Montreal; J. Stoye, National Institute for Medical
Research, London
Pathogenesis (lenti)
Chairpersons: M. Martin, NIAID, National Institutes of Health;
R.C. Desrosiers, Harvard Medical School, New England
Regional Primate Research Center
Receptors/Entry/Uncoating
Chairpersons: J. Young, Harvard Medical School; P. Bates,
University of Pennsylvania
Reverse Transcription
Chairpersons: S. Hughes, ABL-Basic Research Program,
NCI-Frederick Cancer Research and Development
Center; M. Roth, University of Medicine and Dentistry of
New Jersey/RWJ Medical School
Integration and Other Early Events
Chairpersons: J. Leis, Case Western Reserve University
School of Medicine; G. Kalpana, Albert Einstein College of
Medicine
Transcription (Tat and Tax)
Chairpersons: J. Dudley, University of Texas, Austin;
J. Coffin, Tufts University School of Medicine
Posttranscription (Rev and CTEs)
Chairpersons: R. Katz, Institute for Cancer Research, Fox
Chase Cancer Center; M.-L. Hammarskjold, Myles H.
Thaler Center for AIDS and Human Retrovirus Research
and University of Virginia, Charlottesville
Other Regulatory Proteins and Elements
Chairpersons: M. Malim, Howard Hughes Medical Institute
and University of Pennsylvania School of Medicine;
J. Skowronski, Cold Spring Harbor Laboratory
Assembly, Processing, and Egress
Chairpersons: V. Vogt, Cornell University; R. Craven,
Pennsylvania State University School of Medicine
Interventions, Vectors, and New Technologies
Chairpersons: G. Pavlakis, ABL-Basic Research Program,
NCI-Frederick Cancer Research and Development
Center; H. Gottlinger, Dana-Farber Cancer Institute and
Harvard Medical School
Cancer Genetics and Tumor Suppressor Genes
August 14-August 18 429 participants
ARRANGED BY Anton Berns, The Netherlands Cancer Institue
Terri Grodzicker, Cold Spring Harbor Laboratory
Ed Harlow, Massachusetts General Hospital
David Livingston, Dana-Farber Cancer Institute
Carol Prives, Columbia University
Bert Vogelstein, Johns Hopkins University
Cancer Genetics and Tumor Suppressor Genes was a new meeting at the Laboratory. It was set up
to allow scientists to discuss their latest results on different aspects of cancer cell biology and to al-
low for extensive crosstalk concerning ideas and methodologies. The conference was, in fact, over-
subscribed, with 429 scientists meeting to present more than 300 talks and posters. Launched by a
keynote address by Richard Klausner, Director of the National Cancer Institute, the meeting pre-
sented an extensive range of work: from location and nature of mutations in different tumors to
properties of the p53 tumor suppressor gene. Many talks dealt with growth control of cancer cells,
and areas that received much attention included control of the cell cycle, apoptosis, and transcrip-
tional regulation of and by tumor suppressor genes. Animal models have provided much informa-
tion about tumorigenesis, and one session dealt with "knock-out" and transgenic mouse models.
The wide range of studies in this area was emphasized by presentations that dealt with tumor prog-
ression, angiogenesis, and metastasis. This new meeting was off to an exciting start and all ses-
sions found the lecture and poster halls packed with extensive discussions and exchanges of in-
formation.
This meeting was funded in part by the National Cancer Institute, a branch of the National In-
stitutes of Health.
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PROGRAM
Animal Models
Chairpersons: A. Berns, The Netherlands Cancer Institute,
Amsterdam; A. Bernstein, Samuel Lunenfeld Research
Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
Cell Cycle
Chairpersons: E. Harlow, Massachusetts General Hospital
Cancer Center, Boston; G. Vande Woude, NCI-Frederick
Cancer Research and Development Center, Maryland
Tumor Cell Biology
Chairpersons: B. Vogelstein, Johns Hopkins University,
Baltimore, Maryland; E. Fearon, University of Michigan
Medical Center, Ann Arbor
Transcriptional Regulation
Chairpersons: D. Livingston, Dana-Farber Cancer Institute
and Harvard Medical School, Boston, Massachusetts
C. Prives, Columbia University, New York, New York
p53
Chairpersons: A. Levine, Princeton University, Princeton,
New Jersey; C. Harris, National Cancer Institute, National
Institutes of Health, Bethesda, Maryland
Cancer Genetics
Chairpersons: B. Ponder, CRC Human Cancer Genetics
Research Group, Addenbrookes Hospital, University of
Cambridge, United Kingdom; L. Strong, University of
Texas System Cancer Center, Houston
Chromosome Behavior and Stability
Chairperson: C. Greider, Cold Spring Harbor Laboratory
Apoptosis
Chairpersons: E. White, Center for Advanced Biotechnology
and Medicine, Rutgers University, Piscataway, New
Jersey; R. Kolodner, Div. of Human Cancer Genetics,
Dana-Farber Cancer Institute, Boston, Massachusetts
T. Grodzicker, M. Green
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Poster session in Bush
C. Greider, S. Lowe
B. Vogelstein, D. Livingston
Molecular Genetics of Bacteria and Phages
August 20-August 25 207 participants
ARRANGED BY Carol Gross, University of California
Jeff Roberts, Cornell University Marorie Russel
This year's meeting was enhanced by invited scientists who chaired each of the sessions. Given
the diversity of session topics, their introductory remarks, providing general background informa-
tion and outlining unanswered questions in the field, were particularly valuable.
As usual, it required several sessions to cover multiple aspects of transcription and gene
regulation, but the increased activity in cell biology was notable. In the Signaling and Global Cir-
cuits and Cell Division and Development sessions, speakers used fluorescence microscopy to ex-
amine how cell-type-specific gene expression is established during sporulation in B. subtilis, and
how the sites of cell division are determined in E. coli. Then, in the Cell Surfaces & Secretion ses-
sion, we got the first insight into the role the eukaryotic Signal Recognition Particle homolog plays in
E. coli.
Sophisticated genetic and biochemical approaches were used to examine the architecture and
reaction mechanism of enzymes. One provided direct visualization of a repressor protein sliding
along a DNA molecule, looking for its binding site. Two elegant studies described a built in check-
point for the activity of a transposase; since a subunit bound to one site catalyzes recombination at
the other site, and subunits bound to two different sites form a single, shared catalytic domain,
catalysis can occur only when the distant sites have been brought together in the appropriate con-
figuration. Another presentation concerned the mechanism of protein splicing. Protein splicing may
be an arcane biological oddity, but the details of the mechanism, and the application to a new sys-
tem for protein purification based on the cleavage reaction, generated a great deal of excitement.
The scientific community had been puzzled for several years by reports that seemed to support
the Lamarkian idea that useful or "adaptive" mutations occur preferentially. A talk that presented
data contradicting this interpretation, along with an explanation for why "nonselected" (i.e., not use-
ful) mutations had not been detected previously, was enthusiastically received.
This meeting was funded in part by the U.S. Department of Energy.
P. Model, J. Lupski, C. Gross
1 A,
J. Wild, E. Calve, W. Szybakski
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T. Henkin, M. Russel, J. Roberts
PROGRAM
Signaling and Global Circuits
Chairperson: A.D. Grossman, Massachusetts Institute of
Technology
Cell Surfaces, Secretion, and Intercompartmental
Communication
Chairperson: J. Beckwith, Harvard Medical School
Cell Division and Development
Chairperson: L. Rothfield, University of Connecticut Health
Science Center
Regulation of Transcription Initiation
Chairperson: R.H. Ebright, Rutgers University
RNA Polymerase
Chairperson: A. Goldfarb, Public Health Research Institute,
New York
Mouse Molecular Genetics
Phage and Tricks
Chairperson: R. Hendrix, University of Pittsburgh
Post-initiation Control
Chairperson: T.M. Henkin, Ohio State University
The Bacterial Genome: Structure, Recombination, and
Transposition
Chairperson: T.A. Baker, Massachusetts Institute of
Technology
Replication and repair
Chairperson: K. Kreuzer, Duke University
Back to the Beginning-Sigma
Chairperson: S. Gottesman, National Institutes of Health
August 28-September 1 430 participants
ARRANGED Rosa Beddington, National Institute for Medical Research
Allan Bradley, Baylor College of Medicine
Robb Krumlauf, National Institute for Medical Research
Liz Robertson, Harvard University
The Mouse Molecular Genetics conference, held in alternate years at the EMBL, Heidelberg, at-
tracted the usual capacity crowd of international researchers. This meeting occupies a singularly
important niche, bringing together a large cohort of people working in diverse areas of mouse biol-
ogy. This year's conference was no exception, covering topics from genetic approaches (both tra-
ditional and new wave) to tumorigenesis and behavior.
The meeting was organized into eight sessions, each composed of two longer, invited
presentations in addition to eight shorter talks selected from the abstracts. The conference was
rounded out by the inclusion of a record-breaking 280 posters, presented in two afternoon ses-
sions, and made possible by the provision of additional tented accommodation. This volume of in-
formation considerably enhanced the scientific content of the meeting, even if the average
participant was left "staggering and "frazzled" by the wealth of new, and largely unpublished data.
Highlights of the platform presentations included important new mechanistic insights into the
process of X-chromosome inactivation, and the roles played by components of the activin signaling
pathway in mesoderm formation in the early embryo. A number of classic mouse mutations, includ-
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S. Dunwoodie, K. Anderson
ffi iti
E Robertson E. Holland
ing staggerer, beige and fused, have yielded up their molecular identities. Finally, a number of
presentations included significant, and long-awaited advances in strategies for generating condi-
tional mutations and binary systems to study cell fate. These topics, and many more, made for
lively discussion among the 430 participants. In all, a very stimulating and interactive meeting.
This meeting was funded in part by the National Science Foundation; and the National Institute
of Child Health and Human Development, the National Cancer Institute, and the National Institute of
Neurological Disorders and Stroke, branches of the National Institutes of Health.
PROGRAM
Genetics I
Invited Speaker: P. Avner, Institut Pasteur, Paris, France
Chairperson: N. Hastie, Western General Hospital,
Edinburgh, United Kingdom
Patterning
Invited Speaker: L. Buck, Howard Hughes Medical Institute
and Harvard University Medical School, Boston,
Massachusetts
Information Coding in the Olfactory System
Chairperson: C. Tabin, Harvard University Medical School,
Boston, Massachusetts
Tumorigenesis
Invited Speaker: R. Jaenisch, Whitehead Institute for
Biomedical Research, Cambridge, Massachusetts
DNA Methylation, Imprinting, and Cancer
Chairperson: A. Berns, The Netherlands Cancer Institute,
Amsterdam
Embryogenesis
Invited Speaker M. Yanagisawa, Howard Hughes Medical
Institute and University of Texas Southwestern Medical
Center, Dallas
Endothelin Pathway in Neural Crest Development
Chairperson: J. Rossant, Samuel Lunenfeld Research
Institute, Mount Sinai Hospital, and University of Toronto,
Canada
Signals and Receptors
Invited Speaker: R. Derynck, University of California, San
Francisco
"Epithelial immaturity in EGFR-/- mice"
Chairperson: S. Korsmeyer, Washington University School of
Medicine, St. Louis, Missouri
Neural Development
Invited Speaker: M. Bronner-Fraser, California Institute of
Technology, Pasadena
"Formation of Neural Crest"
Chairperson: M. Placzek, MRC, London, United Kingdom
Genetics II
Invited Speaker: J. Takahashi, Northwestern University,
Evanston, Illinois
"Genetics of Circadian Clocks in Mice"
Chairperson: F. Costantini, Columbia University College of
Physicians & Surgeons, New York
Organogenesis
Chairperson: C. Wright, Vanderbilt University School of
Medicine, Nashville, Tennessee
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Translational Control
September 4-September 8 430 participants
ARRANGED BY Richard J. Jackson, University of Cambridge, United K9ngsom
Michael B. Mathews, Cold Spring Harbor Laboratory and UMD-New Jersey Medical School
Marvin Wickens, University of Wisconsin, Madison
The Translational Control meeting, yet again, brought a significant increase in the number of
participants and of abstracts, indicative that interest in these topics is still blossoming and testifying
to the paramount importance of this meeting as the major international forum of the field. As in pre-
vious years, animal, plant and viral systems were very well represented, but, with a few notable ex-
ceptions, those interested in prokaryotic systems seem to have sadly abandoned this meeting,
which has the unfortunate consequence that ribosome structure and function was also poorly
represented. On the positive side, there was a very welcome increase in the number of presenta
tions dealing with developmental topics, with a particular upsurge in work on Drosophila em-
bryogenesis. Of particular significance is the growing appreciation that embryogenesis involves not
just specific mRNA localization but also a temporal control of maternal mRNA translation.
A major new area of discussion at this meeting was the structure, function, and regulation of the
eIF4F holoenzyme complex. Cleavage of the eIF4G component by picornavirus proteases indi-
cates that it serves a bridging function to bring together a number of important initiation factors:
elF4E, the cap-binding protein, binds to the N-terminal one-third of eIF4G; elF3 binds to the central
region; and the helicase eIF4A interacts with the C-terminus, at least in the case of mammalian
elF4G. In addition, at least in the case of yeast, the N-terminus of eIF4G interacts with Pablp, pro-
vided that the latter is bound to poly(A), which would promote physical interaction between the two
ends of the mRNA. Consistent with this is the fact that the normal pathway of mRNA degradation in
yeast involves first the shortening of the poly(A) tail, then decapping, and finally degradation by a
5' -3' exonuclease, but in mutants lacking Pablp, the decapping occurs prematurely without the
need for poly(A) tail shortening.
An unexpected finding is that mammalian cells have what seems to be an elF4G decoy, which
shares homology with the C-terminal two-thirds of elF4G, and appears to act as a negative
regulator of initiation. In livers of transgenic animals over-expressing apolipoprotein B-editing en-
zyme, this decoy is ablated as a result of hyper-editing of its mRNA, and the outcome is rampant
hepatocarcinoma. A related topic that was barely in its infancy at the last meeting is the impact of
M.B. Mathews, J. Atkins
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the major signaling pathway on translation initiation exerted via 4E-BPI, a protein which binds the
cap-binding initiation factor eIF4E and sequesters it from entry into the eIF4F holoenzyme complex.
Phosphorylation of 4E-BPI by the rapamycin-sensitive pathway inhibits its interaction with elF4E,
thus liberating the cap-binding protein for entry into the eIF4F holoenzyme complex, and hence in-
creasing initiation rates.
While the above may be regarded as the highlights, in a short report of this nature it is not pos-
sible to mention numerous examples of excellent work reported in other areas, and the meeting
certainly left the impression of good progress being made on many different fronts.
This meeting was funded in part by RiboGene, Inc., ICN Pharmaceuticals, Inc. Promega Corp.,
and Novagen, Inc.
PROGRAM
5' UTR Functions
Chairperson: A.P. Geballe, Fred Hutchinson Cancer
Research Center, Seattle, Washington
Poly(A), PABP AND 3' -5' Crosstalk
Chairperson: L. Gehrke, Massachusetts Institute of
Technology, Cambridge
Developmental Regulation
Chairperson: J. Kimble, University of Wisconsin, Madison
Regulation of Initiation
Chairperson: L.S. Jefferson, Pennsylvania State University,
Hershey
Workshop: Factors and Mechanisms
Chairperson: J.W.B. Hershey, University of California, Davis
Elongation and Termination
Chairperson: J.F. Atkins, University of Utah Medical School,
Salt Lake City
mRNA Stability and Turnover
Chairperson: L.E. Maquat, Roswell Paik Cancer Institute,
Buffalo, New York
Initiation Factors: Structure and Function
Chairperson: K.S. Browning, University of Texas, Austin
RNA-Protein Interactions
Chairperson: M.W. Hentze, EMBL, Heidelberg, Germany
Molecular Approaches to the Control of Infectious Diseases
September 9-September 13 157 participants
ARRANGFD BY Fred Brown, USDA, Plum Island Animal Disease Center
Dennis Burton, Scipps research Institute
Peter Doherty, St Jude Children's Research Hospital
John Mekalanos, Harvard University Medical School
Er ling Norrby, Karolinska Institute, Sweden
The 14th Annual Meeting on New Vaccines, now called Molecular Approaches to the Control of In-
fectious Diseases was held on September 9-13, 1996. As in previous years, the program had a
balance of talks describing the basic concepts underlying the eliciting of immunity against in-
fectious agents and those dealing with the application of these concepts to the design of new vac-
cines. The importance of structural studies was illustrated by John Skehel's talk on influenza
hemagglutinin and by the presentations of Don Wiley and Luc Teyton on the interaction of antigens
of with T-cell receptors. An intriguing talk by Marc van Regenmortel described the immunogenic
activity of peptides synthesized from D-amino acids by aligning the residues in the reverse order
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from that on the parent L-peptide. In such all-D-retropeptides, the side chains are oriented as in the
parent L-peptide; consequently, antibodies raised against the L-or all-D-retro forms cross-react
with both structures. In a practical application of this approach, the all-D-retropeptide correspond-
ing to the immunogenic loop of foot-and-mouth disease virus was shown to elicit protective
neutralizing antibodies. Pasteur and Landsteiner would have appreciated this approach.
It has been shown in several animal models that injection of the DNA coding for immunogenic
proteins and epitopes of infectious agents can evoke immunity. The mechanisms underlying these
observations are not well understood, but several papers presented indicated that these questions
are now being investigated. At the practical end of the spectrum Er ling Norrby's historical talk on
vaccination against measles illustrated how our understanding of the structure of the virus and its
immunogenic proteins has answered questions from the past and pointed the way forward in the
efforts being made to eradicate the disease.
As in the previous two meetings, the Albert Sabin Foundation lecture was included in the pro-
gram. On this occasion, Joe Melnick, who contributed so much to our understanding of
potiomyelitis infection and its control by vaccination, gave a historical review of our knowledge of
the virus. Salk and Sabin are the names that are remembered, but Joe and others made important
contributions in the 1950s which led to the two highly successful vaccines.
This report is also a farewell message. Since this will be the last year in which Cold Spring Har-
bor Laboratory will host a program on new vaccines, it is appropriate that we mention Bob
Chanock and Richard Lerner, the founders of the meeting in 1983, and the organizers of sub-
sequent meetings, Harry Ginsberg, Er ling Norrby, John Mekalanos, Dennis Burton, and Peter
Doherty. It has been a pleasure and an education to work with them and the staff at Cold Spring
Harbor Laboratory, particularly Dorothy Brown, Mary Cozza, and Inez Sialiano in Publications, Micki
McBride in the Meetings & Courses Office, and Herb Parsons of Public Affairs, who always ensured
that the meetings ran like clockwork. This meeting was funded in part by Pharmacia LKB Biotech-
nology.
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PROGRAM
Immunogenic Structures
Chairperson: D. Burton, Scripps Research Institute, La Jolla,
California
Keynote Speaker: J. Skehel; M. Van Regenmortel
DNA Immunization I
Chairperson: J. Tainer, Scripps Research Institute, La Jolla,
California
Keynote Speakers: M. Liu; J. Sadoff
Interaction of Antigens with the Immune System
Chairperson: P.C. Doherty, St. Jude Children's Research
Hospital, Memphis, Tennessee
Keynote Speakers: D. Wiley; L. Teyton
Bacterial Vaccines
Chairperson: J. Mekelanos, Harvard University Medical
School, Boston, Massachusetts
Keynote Speakers: J. Tainer; M. Blaser
Emerging Pathogens
Chairperson: F. Brown, Plum Island Animal Disease Center,
Greenport, New York
Keynote Speaker: C.J. Peters
DNA Immunization II
Chairperson: M. Liu, Merck Research Laboratories, West
Point, Pennsylvania
Parasite Vaccines
Chairperson: L.H. Miller, NIAID, National Institutes of Health
Keynote Speaker: L.H. Miller
Viral Vaccines
Chairperson: F. Brown, Plum Island Animal Disease Center,
Greenport, New York
Keynote Speaker: E. Norrby
Cytokines, Pathogenesis and Vaccines
Chairperson: M. Van Regenmortel, CNRS, IBMC,
Strasbourg, France
Keynote Speaker: L. Sher
Keynote Speaker: R. Germain
HIV-SIV
Chairperson: E. Norrby, Karolinska Institute, Stockholm,
Sweden
Keynote Speaker: J.G. Sodroski
Molecular Biology of Hepatitis B Viruses
September 18-September 22 249 participants
ARRANGED BY Robert E. Lanford, Southwest Foundation for Biomedical Research
Michael Nassal, University of Heidelberg, Germany
The annual meeting on Molecular Biology of Hepatitis B Viruses was held at the Cold Spring Harbor
until 1989 and this year marked the return of this international meeting to Cold Spring Harbor. Many
exciting new developments were presented on a variety of topics focusing on a virus that induces
chronic infections that represent the fourth leading cause of deaths due to infectious diseases
worldwide. A much greater emphasis is being placed on the interaction of the virus and viral
proteins with the host than was in recent years. Many new developments were reported regarding
processing and intracellular transport of viral transcripts and potentially involved host factors. New
methods were developed to better define the sequence and structural requirements for the epsilon
PNA sequence, which is involved in encapsidation of viral PNA as well as protein-primed initiation
of reverse transcription. Data demonstrating the interaction of cellular chaperone proteins with the
reverse transcriptase and the reconstitution of polymerase activity from individually expressed
domains were presented. Sequences involved in later steps of genomic replication are beginning
to be defined. Although the cell surface receptor for HBV still has not been identified, a cellular
protein that may represent a portion of the receptor complex has been characterized, and addi-
tional potential receptor candidates are being examined. Studies on the membrane topology and
amino acid sequences within the large-envelope protein needed for receptor binding were present-
ed. The mechanism of transcriptional activation by the X protein continues to be highly complex
due to the numerous interactions this protein has with cellular pathways. Studies in transgeneic and
knockout mice demonstrated that both perforin and FasL pathways are required for cytolytic viral
clearance, but that noncytolytic viral elimination by cytokines may be more or equally important. Al-
though new and promising nucleoside analogs were described for treatment of chronic infections,
the observation that long-term treatment with nucleoside analogs does not result in clearance of
covalently closed circular DNA from the nucleus indicates the difficulty of overcoming this obstacle
in order to clear chronic infections.
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This meeting was funded in part by a grant from the National Institute of Allergy and Infectious
Diseases and the National Cancer Institute, both branches of the National Institutes of Health. Con-
tributions from the following companies were provided to this meeting for travel grants for young
scientists: Glaxo Wellcome Inc., Merck Research Laboratories, Schering Plough Research Institute,
Bayer AG, Appolon Inc., Roche Products Ltd., Abbott Laboratories, Behringwerke AG, and
Boehringer Ingelheim GmbH.
PROGRAM
Transcription
Chairpersons: D.L. Johnson, University of Southern
California; Y. Shaul, Weizmann Institute of Science,
Rehovot, Israel
Replication
Chairpersons: D. Loeb, McArdle Laboratory for Cancer
Research, University of Wisconsin, Madison; P. Marion,
Stanford University School of Medicine, California
Structural Proteins/Receptors
Chairpersons:W. Gerlich, Justus Liebig University, Giessen,
Germany; J. Summers, University of New Mexico Cancer
Research and Treatment Center, Albuquerque
Seminar
M. Mathews, Cold Spring Harbor Laboratory
Interactions Between Viruses and the Host Translation
System
Regulatory Proteins
Chairpersons: H. Schaller, ZMBH, University of Heidelberg;
K. Koike, Cancer Institute, Tokyo, Japan
HCC
Chairpersons: C. Rogler, Marion Bessin Liver Research
Gene Therapy
Center, Albert Einstein College of Medicine, Bronx, New
York; M.A. Buendia, Institut Pasteur, Paris, France
Variants/HDV
Chairpersons: H. Will, Heinrich-Pette Institut, Hamburg,
Germany; J.L. Gerin, Georgetown University Medical
Center, Rockville, Maryland
Immunology/Pathogenesis
Chairpersons: F. Chisari, Scripps Research Institute, La
Jolla, California; A. Jilbert, University of Adelaide,
Australia
Workshop I: Receptors
Moderator: J. Pugh, Fox Chase Cancer Center,
Philadelphia, Pennsylvania
Workshop II: WHV
Moderator: P. Cote, Georgetown University, Rockville,
Maryland
Antivirals
Chairpersons: M. Melegari, Massachusetts General Hospital
Cancer Center and Harvard Medical School, Charlestown;
F Zoulim, INSERM 0271, Lyon, France
September 19-September 25 463 participants
ARRANGED BY Theodore Friedmann, University of California, San Diego
Richard Mulligan, Massachusetts Institute of Technology
Gary Nebel, University of Michigan
David Weatherall, University of Oxford
Cold Spring Harbor Laboratory hosted the third in its series of biennial meetings on human gene
therapy. Despite discouraging publicity accompanying a number of inconclusive clinical studies
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published since the 1994 meeting, there has been an explosion of interest and progress in the
field, and a growing conviction that truly beneficial clinical applications of gene transfer tech-
nologies will soon appear. This optimism was reflected by the fact that the meeting was very heavi-
ly oversubscribed. Of the many meetings on gene therapy, Cold Spring Harbors remains the only
one with an abstract-driven format and, therefore, continues to be the most accessible to the broad
gene therapy community, including students, fellows, and junior and senior investigators. While
results and progress in a number of ongoing clinical trials were presented, the program empha-
sized the molecular genetics and cell biology issues underlying approaches to human gene
therapy. The organizers are convinced that interest and progress in human gene therapy will grow
enormously in the very near future and that further meetings at Cold Spring Harbor will continue to
satisfy an important need in the scientific and medical communities.
This meeting was funded in part by the National Institute of Child Health and Human Develop-
ment; National Cancer Institute; National Institute on Aging; National Institute of Diabetes and Di-
gestive and Kidney Diseases; National Institute on Deafness and Other Communication Disorders;
National Institute of Dental Research; National Institute of Mental Health; and the National Institute
of Neurological Disorders and Stroke; all branches of the National Institutes of Health.
PROGRAM
Hematopoietic
Chairperson: D. Weatherall, University of Oxford, United
Kingdom
Cancer I
Chairperson: G. Nabel, Howard Hughes Medical Institute,
University of Michigan, Ann Arbor
National Gene Vector Laboratory Report
Chairperson: K. Cornetta, Indiana University, Indianapolis
Cancer II
Chairperson: A. Nienhuis, St. Jude Children's Research
Hospital, Memphis, Tennessee
Viral Vectors
Chairperson: R. Mulligan, Massachusetts Institute of
Technology, Cambridge
Learning and Memory
Non-viral Vectors
Chairperson: M.A. Liu, Merck Research Laboratories, West
Point, Pennsylvania
Aids
Chairperson: I. Verma, Salk Institute, La Jolla, California
Regulatory Issues
Chairperson: N. Wivel, University of Pennsylvania,
Philadelphia
Disease Models
Chairperson: T. Friedmann, University of California, San
Diego, La Jolla
Emerging Technology
Chairperson: J. Leiden, University of Chicago, Illinois
October 2-October 6 145 participants
ARRANGED BY Per Anderson, University of Oslo
Eric Kandel, Columbia University
Richard Thompson, University of Southern California
Susumu Tonegawa, Massachusetts Institute of Technology
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The third biennial meeting on Learning and Memory consisted of platform and poster presentations
and discussions of current research and concepts in the biological basis of memory. Study of the
biological bases of learning and memory is a most exciting field in neuroscience. Progress is cur-
rently very rapid, particularly at molecular, cellular, neural systems, and computational levels. Com-
monalties of mechanisms appear to be emerging from studies of gene expression, synaptic
plasticity (LTP and LTD) and processes of memory storage in invertebrate and vertebrate systems.
In particular, similar changes in the properties of membrane channels and intracellular second
messenger systems were identified in a number of different neural systens in both vertebrate and
invertebrate preparations. Discussions ranged from brain systems of memory in humans through
brain circuits and systems of memory, to brain plasticity in development, basic processes of learn-
ing and memory, mechanisms of synaptic plasticity, e.g., long-term potentiation (LTP) and long-
term depression (LTD), biophysical and molecular substrates of synaptic plasticity, to genetic ap-
proaches to mechanisms of memory.
A special focus of the meeting was on the use of mutant and transgenic mice to identify the
roles of gene expression of particular enzyme systems in synaptic plasticity and memory. The
"gene knockout" approach is new and very promising. There was much discussion about the pos-
sibility of developing localized, inducable, reversible knockout preparations.
The meeting was funded in part by the National Science Foundation.
PROGRAM
Higher Nervous System Function
Chairperson: L. Ungerleider, Laboratory of Brain and
Cognition, National Institute of Mental Health, National
Institutes of Health, Bethesda, Maryland
Brain Circuits and Systems of Memory
Chairperson: A. Graybiel, Dept. of Brain and Cognitive
Science, Massachusetts Institute of Technology,
Cambridge
Basic Processes of Learning and Memory
Chairperson: Y. Dudai, Weizmann Institute of Science,
Rehovot, Israel
Transition from Short- to Long-term Memory
Chairperson: F. Nottebohm, Rockefeller University, New
York
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Computational Models of Learning and Memory
Chairperson: E. Marder, Volen Center and Biology Dept.,
Brandeis University, Waltham, Massachusetts
Mechanisms of Synaptic Plasticity-LTP,LTD,
and Other
Chairperson: T. Carew, Dept. of Psychology, Yale
University, New Haven, Connecticut
Biophysics and Molecular Biology of Synaptic Plasticity and
Memory
Chairperson: J. Byrne, Dept. of Neurobiology and Anatomy,
University of Texas Medical School, Houston
Genetic Approaches to Mechanisms of Memory
Chairperson: A. Silva, Cold Spring Harbor Laboratory
Neurotrophins, Brain Plasticity, and Development
Chairperson: M.E. Hatten, Rockefeller University, New York
Differential Display and Related Techniques for Gene Discovery
October 6-October 9 410 participants
ARRANGED BY Peng Liang, Vanderbilt Cancer Center
Harold Robertson, Dalhousie University
The technique of differential display of mRNA following reverse transcription and polymerase chain
reaction (PCR) amplification was described initially in 1992 by Liang and Pardee. The closely-
related procedure of RNA fingerprinting by arbitrarily primed PCR (RAP-PCR) was developed at the
same time by McClelland and Welch. Cold Spring Harbor opted to host a meeting focusing on the
broad applicability of these related display techniques in a rapidly maturing field. In the first ses-
sion, Arthur Pardee and Michael McClelland described the development of differential display and
RAP-PCR. Next came sessions devoted to advances in the methodologies of differential display, in-
cluding techniques for reducing the false positives and for rapidly confirming that differentially dis-
played cDNA fragments are differentially expressed in the tissues or cells of interest. Several
groups reported respectively on nonradioactive differential display and on techniques allowing the
differential display of cDNA fragments in the 1.0-2.0 Kb range, thus increasing the likelihood of ob-
taining information on coding sequence. Two further sessions were devoted to applications of
these techniques to an amazingly broad range of biological problems that included forestry (the
study of wind stress in poplar trees), hematopoiesis, neurobiology, cardiology, cancer, immunol-
ogy, psychiatry, neuroendocrinology and many others. The final session focused on techniques
emerging from the general approach used in differential display and RAP-PCR, including the dis-
play of 3 -restriction fragments and expression monitoring by hybridization to high-density
oligonucleotide arrays. Highlights of the meeting included advances in differential display technol-
ogy (differential display of long cDNA fragments) and the emergence of new techniques based on
the concepts of differential display and RAP-PCR, including suppression subtractive hybridization
and the display of 3- restriction fragments of cDNA. The most dramatic presentation at the meeting
was the introduction of the DNA chip-screening technologies, which many believe will replace dif-
ferential displays and related technologies as the human genome project is completed.
Major funding for the meeting was provided by Beckman Instruments Inc. and Genomyx Corpo-
ration (in corporate partnership with Beckman Instruments Inc.). Additional financial support was
also provided by Clontech Laboratories, Inc., Gen Hunter Corporation, Merck and Company, Inc.,
Millennium Pharmaceuticals, NEN Life Science Products Division of DuPont, Qiagen Inc., and
SmithKline Beecham Pharmaceuticals.
H. Robinson, M. van Lookeren-Campagne, A. Pardee
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PROGRAM
Methodology I
Chairpersons: P. Liang, Vanderbilt Cancer Center,
Vanderbilt University School of Medicine, Nashville,
Tennessee; M. McClellend, Sidney Kimmel Cancer
Center, San Diego, California
Methodology II
Chairpersons: M. Erlander, R.W. Johnson Pharmaceutical
Research Institute, San Diego, California; J.A. Winkles,
American Red Cross, Holland Laboratory, Rockville,
Maryland
Applications I
Chairpersons: T. Ito, Human Genome Center, Institute of
Medical Sciences, University of Tokyo, Japan;
J. Guimares, DNAX Research Institute, Palo Alto,
California
Applications II
Chairpersons: G. Theissen, Max-Planck-Institut fur
Zfichtungsforschung, Cologne, Germany; M.E. Russell,
Harvard School of Public Health, Boston, Massachusetts
Emerging Techniques
Chairpersons: S.A. McCarthy, DNAX Research Institute,
Palo Alto, California; S. Weissman, Yale University School
of Medicine, New Haven, Connecticut
236
POSTGRADUATE COURSES
The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory is aimed at meet-
ing the special need for training in interdisciplinary subjects that are either so new or so specialized
that they are not adequately treated by universities. Our aim is to provide intensive study in the
most recent developments and techniques in these subjects and to prepare students to enter
directly into research in a particular area. To ensure up-to-date coverage of current research work,
we bring together a workshop staff from many laboratories around the world and supplement this
staff with a series of seminar speakers.
Advanced Genome Sequence Analysis
March 20-April 2
INSTRUCTORS
Chen, Ellson, Ph.D., Perkin Elmer Corporation
Gibbs, Richard, Ph.D., Baylor College of Medicine
McCombie, W. Richard, Ph.D, Cold Spring Harbor Laboratory
Wilson, Richard, Ph.D., Washington University School of Medicine
ASSISTANTS
Dear, Simon, The Sanger Center, United Kingdom
Heiner, Cheryl, Applied Biosystems, Inc.
Hoffman, Jane, Cold Spring Harbor Laboratory
James, Carolyn, University of Manchester, United Kingdom
Johnson, Doug, Washington University School of Medicine
McPherson, John, Washington University School of Medicine
Muzny, Donna, Baylor College of Medicine
Till, Sally, Cold Spring Harbor Laboratory
Zhu, Lin, Sequanna Therapeutics
Recent advances in the automation of DNA sequencing have opened new possibilities for the anal-
ysis of complex genomes at the DNA sequence level. This 2-week course provided intensive train-
ing in this rapidly evolving field. The course emphasized techniques and strategies for using auto-
mated sequences to sequence large, contiguous genomic regions. Students carried out all of the
steps in the sequencing process from preparing cosmid DNA to computer analysis of the finished
sequence. Topics included subclone library generation, large-scale template purification, sequenc-
ing reactions, gel analysis on automated sequencers, sequence assembly, gap filling, and conflict
resolution, Students worked in groups to sequence a large region of DNA. In last year's course, a
45-kb cosmid was sequenced (Gen Bank accession #U23729). Through this process the students
were trained in crucial project and data management techniques. A series of lecturers discussed
their applications of these techniques as well as alternate strategies for high-speed-automated
DNA sequencing.
Last year's speakers included C.T. Caskey, A. Dusterhoft, T. Marr, D. Smith, R. Smith, F.W.
Studier, B. Roe, R. Weiss, and J.D. Watson.
237
PARTICIPANTS
Clark, M., B.S., Ph.D., University of Cambridge School of
Medicine, United Kingdom
Coleman, D., B.S., University of Oxford, United Kingdom
Dumanski, J., M.D., Ph.D., Karolinska Institute, Sweden
Goff, S., B.S., Ph.D., CIBA, North Carolina
Hitte, C., B.S., M.S., CNRS, France
Kraemer, E., B.A., Ph.D., Washington University, St. Louis
Little, R., B.S., M.S., Eli Lilly & Co., Indiana
Ma, J., B.S., M.S., Millenium Pharmaceutical, Inc.,
SEMINARS
Chen, E., Perkin-Elmer Corporation. Ordered shotgun se-
quencing: Strategy to integrate mapping and large-scale
sequencing.
Gibbs, R., Baylor College of Medicine. Large-scale sequenc-
ing strategies for the human X chromosome.
Mathies, R., University of California, Berkeley. Energy-
transfer fluorescent primers for DNA sequencing and anal-
ysis.
McCombie, W.R., Cold Spring Harbor Laboratory. Strategies
and technologies for the analysis of complex genomes.
Metzger, M., Baylor College of Medicine, Houston. Develop-
Massachusetts
Khong, N.V., M.S., D.V.M., Vrije University, Brussels
Podlutsky, A., B.S., M.S., Karolinska Institute, Sweden
Reichard, R., B.S., M.S., SmithKline Beecham, Pennsylvania
Schmuck, K., B.S., Ph.D., Sandoz Pharmaceutical, Ltd., Swit-
zerland
Touchman, J., B.A., Ph.D., National Institutes of Health
Van Geel, M., M.S., Roswell Park Cancer Institute, New York
Vitale, D., B.S., Universita 'Federico Italy
ment of novel fluorescent dyes for quantitation of
heterogeneous HIV-1 populations using automated DNA
sequencing.
Roe, B., University of Oklahoma, Norman. Sequencing the
human genome: Lessons from the first 3 million banes.
Schwartz, D., New yuork University. New methods for optimal
mapping of large DNA clones.
Uhlen, M., Royal Institute of Technology, Stockholm. Auto-
mated sequencing of PCR products.
Wilson, R., Washington University, St. Louis. Genome analy-
sis by large-scale DNA sequencing.
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Cloning and Analysis of Large DNA Molecules
April 10-23
INSTRUCTORS
Abderrahim, Hadi, M.D., Ph.D., Centre d'Etudes du Polymorphism Humain, France
Birren, Bruce, Ph.D., Whitehead Institute/MIT Center for Genome Research
Riethman, Harold, Ph.D., Wistar Institute
Vollrath, Douglas, M.D., Ph.D., Stanford University
ASSISTANTS
Gros, Isabelle, Centre d'Etudes du Polymorphism Humain, France
Negorev, Dmitri, Medical College of Pennsylvania
Nguyen, Michael, Whitehead Institute/MIT Center for Genome Research
This course covered the theory and practice of manipulating and cloning high-molecular-weight
DNA. The course focused on the use of yeast artificial chromosome (YAC) and bacterial artificial
chromosome (BAC) cloning systems for library construction and techniques of pulsed-field gel
electrophoresis (PFGE). Lectures and laboratory work included an introduction to yeast genetics,
the isolation and manipulation of high-molecular-weight DNA from a variety of sources, and prepa-
rative and analytical PFGE. Clones were produced and characterized by several approaches in-
cluding library screening, contig assembly, long-range restriction and RecA-assisted restriction
endonuclease (RARE) cleavage mapping, and recovery of YAC ends. Lectures by outside
speakers on topics of current interest supplemented the laboratory work.
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Araya, Z., B.S., Uppsala University, Sweden
Cai, Li, B.S., Ph.D., Harvard Medical School /Children's Hos-
pital
Crooijmans, R., B.S., Wageningen Agricultural University,
The Netherlands
Diaz-Perez, S., B.S., Ph.D., University of California, Los
Angeles
Fielding, R., B.S., Chromaxome Corporation, San Diego, Cal-
ifornia
Hubner, N., M.D., University Hospital Benjamin Franklin,
Germany
Koike, G., M.D., Ph.D., Medical College of Wisconsin
SEMINARS
Doggett, N., Los Alamos National Laboratory. Physical map-
ping of chromosome 16: Methods, results, and lessons
learned.
de Jong, P., Rosewell Park Cancer Institute, Buffalo, New
York. Preparation of the PEC and BAC libraries for the hu-
man genome.
Gnirke, A., Mercator Genetics, Inc., Menlo Park, California.
Distance calibration of YAC-contig and STS maps by
RARE cleavage.
Mosser, J., B.S., Ph.D., CNRS, UPR 41, France
Nielsen, L.B., M.D., University of California, San Francisco
Santos, C., B.S., Ph.D., Universidad Publica De Navarra,
Spain
Soong, T.-W., B.S., Ph.D., National University of Singapore,
Singapore
Stoilov, I., M.D., University of Connecticut Health Center
Suchyta, S., M.S., Michigan State University
Van Lingen, B., B.S., Tufts University
Vantoai, T., B.S., Ph.D., United State Department of Agricul-
tural Research
Wiltshire, T., B.S., University of Tennessee
Hamilton, B., Whitehead Institute. Positional cloning of mouse
neurological mutations: Two examples.
McCombie, W.R., Cold Spring Harbor Laboratory. Strategies
and techniques for large-scale DNA sequencing.
Reeves, R., Johns Hopkins University. Structural and biologi-
cal genome analysis using YACs.
Wing, R., Texas A&M University. Evaluation of the BAC clon-
ing stystem for crop plants and progress toward mega-
based cloning of the tomato jointless gene.
Protein Purification and Characterization
April 10-23
INSTRUCTORS
Burgess, Richard, Ph.D., University of Wisconsin, Madison
Courey, Albert, Ph.D., University of California, Los Angeles
Lin, Sue-Hwa, Ph.D., University of Texas/M.D. Anderson Cancer Center
Mische, Sheenah, Ph.D., Rockefeller University
ASSISTANTS
Arthur, Terry, University of Wisconsin, Madison
Burke, Thomas, University of California, San Diego
Earley, Karen, University of Texas/M.D. Anderson Cancer Center
Gharandaghi, Farzin, Rockefeller University
Grabski, Tony, University of Wisconsin, Madison
Valentine, Scott, University of California, Los Angeles
This course was intended for scientists who were not familiar with techniques of protein isolation
and characterization. It was a rigorous program that included laboratory work all day and a lecture
with discussion session every evening. Each student became familiar with each of the major tech-
niques in protein purification by actually performing four separate isolations including (1) a regula-
tory protein from muscle tissue; (2) a sequence-specific, DNA binding protein; (3) a recombinant
protein overexpressed in E. coli; and (4) a membrane-bound receptor. A variety of bulk fractiona-
tion, electrophoretic, and chromatographic techniques were employed including precipitation by
salts, pH, and ionic polymers; ion exchange, gel filtration, hydrophobic interaction, and reverse-
phase chromatography; lectin affinity, oligonucleotide affinity, and immunoaffinity chromatography;
polyacrylamide gel electrophoresis and electroblotting; and high-performance liquid chromato-
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graphy. Procedures were presented for solubilizing proteins from inclusion bodies and refolding
them into active monomeric forms. Methods of protein characterization were utilized including im-
munological and biochemical assays, peptide mapping, amino acid analysis, protein sequencing,
and mass spectrometry. Emphasis was placed on strategies of protein purification and character-
ization rather than on automated instrumental analysis. Guest lecturers discussed protein structure,
modification of proteins, methodologies for protein purification and characterization, and applica-
tions of protein biochemistry to cell and molecular biology. Guest lecturers have included S. Darst,
J. Edsall, G. Guidotti, J. Kadonaga, A. Kornberg, D. Marshak, N. Pace, G. Rose, J. Rothman, and
B. Stillman.
PARTICIPANTS
Benito, M.-I., B.A., Stanford University
Brandriss, M., B.A., Ph.D., New Jersey Medical School
Coffey, R., B.A., M.D., Vanderbilt University Medical Center
Danziger, R., B.A., M.D., Columbia University College of
Physicians & Surgeons
Hoskins, S., B.S., Ph.D., City College of New York
Kaplan, M., B.A., Stanford University
Moore, S., B.S., Ph.D., National Cancer Institute, Frederick
Cancer Research Center
Nagel, T., M.D., University of California, San Francisco
SEMINARS
Burgess, R., University of Wisconsin, Madison. Overview of
protein purification, immunoaffinity purification.
Courey, A., University of California, Los Angeles. Transcrip-
tional regulation of dorsal/ventral pattern formation in
Drosophila.
Darst, S., Rockefeller University. Preparation and analysis of
proteins for structural studies: Applications to E. coli RNA
polymerase.
Edsall, J., Harvard University. Perspectives on 70 years of
protein purification.
Guidotti, G., Harvard University. Can insulin receptor function
as a monomer?
Kadonaga, J., University of California, San Diego. Transcrip-
Peris, M., B.S., University of California, Los Angeles
Romanowski, P., B.S., University of Cambridge, United King-
dom
Schiller, N., B.S., Ph.D., University of California, Riverside
Todd, A., B.S., McGill University, Canada
Valenzuela, M., B.S., Ph.D., Meharry Medical College
Van Lohuizen, M., B.S., Ph.D., Netherlands Cancer Institute,
The Netherlands
Visa, N., B.S., Ph.D., Karolinska Institute, Sweden
Xue, D., B.S., Ph.D., Massachusetts Institute of Technology
tion, chromatin, and purification of nuclear proteins.
Marshak, D., Osiris Therapeutics, Baltimore, Maryland.
Phosphorylation and regulation of cell growth,
Lin, S.-H., University of Texas/M.D. Anderson Cancer Center.
Purification of membrane proteins and cell adhesion
molecule, C-CAM.
Mische, S., Rockefeller University. Microanalytical protein
preparation and characterization.
Pace, N., Texas A&M University. Protein folding and stability.
Rothman, J., Memorial Sloan-Kettering Cancer Center,
Protein machinery of vesicular transport.
Stillman, B., Cold Spring Harbor Laboratory. Biochemical ap-
proach to understanding the replication of eukaryotic cells.
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Early Development ofXenopus laevis
April 12-21
INSTRUCTORS
Grainger, Robert, Ph.D., University of Virginia
Sive, Hazel, Ph.D., Whitehead Institute
ASSISTANTS
Doniach, Tabitha, University of California, San Francisco
Gamse, Joshua, Whitehead Institute
Kroll, Kristen, Harvard Medical School
This course provided extensive laboratory exposure to the biology, manipulation, and use of em-
bryos from the frog, Xenopus laevis. The course was suited for investigators who have had no ex-
perience with Xenopus and who have worked with Xenopus and wished to learn new techniques.
All students had current training in molecular biology and some knowledge of developmental biol-
ogy. The course consisted of intensive laboratory sessions, supplemented by daily lectures and
demonstrations from experts in both experimental and molecular embryology. Areas covered in-
cluded (1) care of adults and embryo isolation; (2) stages of embryonic development and anatomy;
(3) whole mount in situ hybridization and immunocytochemistry; (4) microinjection of eggs and
oocytes, including DNA constructs, mRNA and antisense oligonucleotides; (5) micromanipulation
of embryos, including explant and transplantation assays; and (6) use of cell cycle extracts, includ-
ing preparation of transgenic embryos.
Lecturers included Tabitha Doniach, Stephen Gould, Richard Harland, Janet Heasman, Ray
Keller, Kristen Kroll, Jonathan Slack, Jim Smith, and Mark Solomon.
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PARTICIPANTS
Ballard, W., Ph.D., CSIRO, Australia
Ben Asher, E., Ph.D., Weizmann Institute of Science, Israel
Gaudierei, S., Ph.D., University of Western Australia
James, C., Ph.D., University of Manchester, United Kingdom
Krall, J., B.S., Amersham Life Sciences, Inc., Cleveland, Ohio
Latinwo, L., Ph.D., Florida A&M University
Lau, C.H., B.S., M.S., National University of Singapore
McPherson, J., Ph.D., University of California, Irvine
Meyers, B., B.A., M.S., University of California, Davis
Myerson, J., B.S., M.S., Merck Research Laboratories
SEMINARS
Grainger, R., University of Virginia, Charlottesville. Xenopus
lens induction: From sense to sensibility.
Harland, R., University of California, Berkeley. Expression
cloning and the study of Xenopus neural induction.
Heasman, J., University of Minnesota School of Medicine.
Adhesion molecules and antisense oligonucleotide inhibi-
tion of function.
Keller, R., University of Virginia, Charlottesville. Xenopus
gastrulation.
Advanced Bacterial Genetics
Paricio, N., Ph.D., University of Valencia, Spain
Schramm, S., B.S., GenPharm International, Mt. View, Califor-
nia
Silvey, M., B.S., University of East Anglia, United Kingdom
Singh, R., Ph.D., National Research Council of Canada, Can-
ada
Tian, J., B.D., M.S., National Institute of Standards and Tech-
nology, Gaithersburg, Maryland
Young, A., Ph.D., Whitehead Institute for Biomedical Re-
search, Cambridge, Massachusetts
Sive, H., Whitehead Institute, Cambridge, Massachusetts.
Anteroposterior ectodermal patterning in Xenopus.
Slack, J., University of Bath, United Kingdom. Fibroblast
growth factor signaling during Xenopus development.
Smith, James, National Institute for Medical Research, United
Kingdom. Upstream and downstream of brachyury:
Xenopus mesoderm induction.
Solomon, Mark, Yale University. Cell cycle extracts and
analyzing the Xenopus cell cycle.
June 7-27
INSTRUCTORS
Bass ler, Bonnie, Ph.D., Princeton University
Manoil, Colin, Ph.D., University of Washington
Trun, Nancy, Ph.D., National Cancer Institute, NIH
ASSISTANTS
Darby, Creg, University of Washington
Faris, Jason, Princeton University
Peters, Joseph, University of Maryland at College Park
The laboratory course presented logic and methods used in the genetic dissection of complex pro-
cesses in bacteria. The methods presented included mutagenesis using chemical, physical, and
biological mutagens; mapping mutations using genetic and physical techniques; analysis of
cytoplasmic and membrane proteins using gene fusions; suppressor analysis; molecular cloning;
polymerase chain reaction; and epitope insertion mutagenesis. The course consisted of a series of
experiments designed to illustrate the genetic logic necessary to begin with a simple phenotype
and progress through a detailed characterization of a biological process. A key component of the
course was the use of sophisticated genetic methods in the analysis of "undomesticated" bacteria.
Invited lecturers described the use of genetic approaches to study processes in a variety of bac-
teria.
PARTICIPANTS
Canovas, D., B.S., University of Sevilla, Spain
Cook, G.M., M.S., Ph.D., King's College London, United
Kingdom
Kamili-Moghaddam, M., M.S., Uppsala University, Sweden
Lee, M.-A., B.S., Ph.D., Defense Medical Research Institute
Singapore
Leib ler, S., B.A., M.S., Ph.D., Princeton University
Lubys, A., B.S., Institute of Biotechnology, Lithuania
Nelson, D., B.S., Ph.D., University of California, Davis
Newman, D., B.A., Princeton University
SEMINARS
Kaiser, D., Stanford University School of Medicine. Ex-
tracellular signaling in Myxococcus.
Miller, V., University of California, Los Angeles, Studying Yer-
sina enterocolitica virulence factors.
Schuman, H., Columbia University. Genetic analysis of in-
tracellular multiplication by Lenionella pneurnophda.
Oethinger, M., M.D., Ph.D., Tufts University
Patarakul, K., M.D., Georgetown University Medical Center
Razatos, A., B.S., University of Texas
Rhee, J.H., M.D., Ph.D., Chonnam National University Medi-
cal School, Korea
Rinchik, E., Ph.D., Sarah Lawrence College
Venturi, V., Ph.D., International Center for Genetic Engineer-
ing & Biotechnology, Italy
Worley, M., B.S., Oregon Health Sciences University
Zhou, Z., B.S., Albert Einstein College of Medicine
Silhavy, T., Princeton University. Genetic analysis of protein
interactions in the translocation complex.
Wright, A., Tufts University School of Medicine. Genetic anal-
ysis of chromosome segregation in bacteria.
Young, R., Texas A&M University. The problem of bac-
teriophage lysis: It all comes out in the end!
Molecular Approaches to Ion Channel Biology
June 7-27
INSTRUCTORS
Caldwell, John, Ph.D., University of Colorado
Levinson, Rock, Ph.D., University of Colorado
Maue Robert, Ph.D., Dartmouth Medical School
ASSISTANTS
Koszowski, Adam, University of Colorado
Shah, Ruta, Dartmouth Medical School
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This intensive laboratory/lecture course introduced students to the multidisciplinary use of
molecular biological, biochemical, immunological, and electrophysiological approaches to the
study of ion channels. The laboratory focused on the cellular regulation of channel expression and
function. Hands-on exercises included characterization of regulatory elements that control tran-
scription of channel genes, identification of ion channel isoform transcripts and proteins, visualiza-
tion of channel distributions, and the biophysical analysis of channel isoform function in excitable
cells and tissues and in exogenous expression systems. Specific techniques employed included
PCR, Western blot, transient transfection and expression, immunocytochemistry, and patch clamp
analysis of ionic currents. Lectures covered the techniques employed while providing broad ex-
posure to current issues surrounding ion channel mechanisms and cellular expression. This course
was intended for advanced students, postdoctoral researchers, as well as independent investi-
gators with specific plans to apply the techniques taught to a defined problem, and participants
were encouraged to bring their preparations to the course for preliminary studies.
PARTICIPANTS
Angsuthanasombat, C., B.S., M.S., Ph.D., Mahidol University,
Thailand
Arazi, T., B.S., M.S., Weizmann Institute, Israel
Bautista, D., B.S., Stanford University
Benson, D., B.A., Ph.D., Mount Sinai School of Medicine
Harty, P., B.S., Ph.D., National Institutes of Health
Peter, D., B.S., Ph.D., Rockefeller University
Rose, C., B.S., Ph.D., Yale University School of Medicine
Sierralta, I., M.S., University of Calgary, Canada
Talukder, G., B.S., Stanford University
Tosetti, P., B.S., University of Pavia, Italy
Trevino, C., B.S., Ph.D., Universidad Nacional Autonoma de
Mexico
Zhu Y., B.S. Ph.D., New England Medical Center
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SEMINARS
Dawson, D., University of Michigan Medical School. The
CFTR C1 channel: Molecular basis of conduction and
gating.
Goldman, D., University of Michigan. Activity-dependent and
synapse-specific expression of nAChR genes during de-
velopment of the neuromuscular junction.
Green, W., University of Chicago. Assembly of ion channels.
Henderson, L., Dartmouth College. Sex and the single chan-
nel: GABA receptors in the rat hypothalamus.
Kusiak, J., National Institutes of Health. Transcriptional con-
trol of the NMDAR1 gene.
Mandel, G., State University of New York, Stony Brook.
Regulations of neuronal sodium channel genes through
transcriptional silencing.
Monyer, H., University of Heidelberg, Germany. Glutamate
receptor expression in individual neurons.
Role, L., Columbia University. Distribution and expression of
neuronal acetylcholine receptors in the brain.
Sargent, P., University of California, San Francisco. Structural
and functional diversity of nicotinic receptor families in the
brain.
Snutch, T., University of British Columbia, Canada. Molecular
aspects of calcium channel expression in the nervous sys-
TrtemMri mer, J., State Univesity of New York, Stony Brook.
Protein-protein interactions important in lc' channel func-
tion.
Molecular Embryology of the Mouse
June 7-27
INSTRUCTORS
Behringer, Richard, Ph.D., University of Texas/M.D. Anderson Cancer Center
Papaioannou, Virginia, Ph.D., Columbia University College of Physicians & Surgeons
CO-INSTRUCTORS
Koopman, Peter, Ph.D., University of Queensland, Australia
Magnuson, Terry, Ph.D., Case Western Reserve University
246
ASSISTANTS
Chapman, Deborah, Columbia University College of Physicians & Surgeons
Mishina Yuji, University of Texas/M.D. Anderson Cancer Center
This course was designed for biologists interested in applying their expertise to the study of mouse
embryonic development. Laboratory components provided an intensive introduction into the techni-
cal aspects of working with and analyzing mouse embryos, and lecture components provided the
conceptual basis for current research. Procedures that were described included isolation and cul-
ture of pre- and postimplantation embryos; oviduct and uterus transfer; formation of aggregation
chimeras; isolation of germ layers in gastrulation-stage embryos; establishment, culture, and genet-
ic manipulation of embryonic stem cell lines; in situ hybridization to whole mounts of embryos; im-
munohistochemistry; microinjection of DNA into pronuclei; and microinjection of embryonic stem
cell into blastocysts.
Last year's speakers were A. Bradley, M. Bronner-Fraser, A. Efstratiadis, B. Hogan, P. Koop-
man, T. Jessell, A. Joyner, R. Lovell-Badge, J. Mann, T. Magnuson, A. McMahon, A. Nagy, S.
Rastan, D. Solter, P. Soriano, P. Tam, D. Wilkinson, and R. Woychik.
PARTICIPANTS
Amieux, P., B.S., University of Washington
Cremona, 0., M.D., Yale University School of Medicine
Frenkel, P., B.A., M.D., Baylor College of Medicine
lzpisua-Belmonte, J.C., M.S., The Salk Institute
Jansson, S., M.S., University of Helsinki, Finland
Jones, M., B.S., Ph.D., Monash University, Australia
Larrain, J., B.S., Catholic University of Chile
Mahmood, R., B.S., Ph.D., Guy's Medical School,
SEMINARS
Behringer, R., M.D. Anderson Cancer Center/University of
Texas. Organization of pattern during mouse em-
bryogenesis.
Bradley, A., Baylor College of Medicine. Teratocarcinomas
and embryonic stem cells. Homologous recombination in
mouse embryonic stem cells.
Bronner-Fraser, M., University of California, Irvine. The neural
crest.
Efstradiatis, A., Columbia University College of Physicians &
Surgeons. Insulin-like growth factors in mouse develop-
ment.
Hammer, R., University of Texas Southwestern Medical Cen-
ter. Transgenic animals in biomedical research.
Jessell, T., Columbia University College of Physicians &
Surgeons. Patterning of the vertebrate nervous system.
Joyner, A., New York University Medical Center. Mouse
engrailed genes and patterning of the brain and limbs.
Koopman, P., University of Queensland, Australia. Sry and
sox gene function in the mouse.
Lovell-Badge, R., MRC, National Institute for Medical Re-
search, United Kingdom. Mammalian sex determination.
Sox genes and mouse development.
Magnuson, T., Case Western University. Role of eed during
mouse gastrulation.
Mann, J., Beckman Research Institute, City of Hope.
Genomic imprinting.
United Kingdom
Mallamaci, A., B.S., Ph.D., H. San Raffaele, Istituto di
Ricovero e Cura a Carattere Scientifico, Italy
Nix, D., B.S., M.S., University of Utah
Pepling, M., B.S., Ph.D., Carnegie Institute of Washington
Schaefer, L., B.A., Ph.D., Massachusetts General Hospital
Shiang, R., Ph.D., University of California, Irvine
St. John, M., B.S., Yale University School of Medicine
McMahon, A., Harvard University. Inductive mechanisms that
pattern the mouse embyro.
Nagy, A., Mount Sinai Hospital, Canada. Vasculogenesis in
the mouse embryo.
Papaioannou, V., Columbia University College of Physicians
& Surgeons. Mouse chimeras in experimental embryology.
Parada, L., University of Texas Southwestern Medical Center.
Role of neurotrophic factors during nervous system devel-
opment.
Rinchik, E., Sara Lawrence College. Mutagenesis.
Robertson, E., Harvard University. Nodal signaling during
gastrulation and axis formation in the mouse.
Rossant, J., Mount Sinai Hospital, Canada. Mouse
preimplantation development and implantation. Cell
lineage and inductive interactions in the early mouse em-
bryo.
Solter, D., Max-Planck Institute of Immunology, Germany.
Genomic imprinting.
Soriano, P., Fred Hutchinson Cancer Research Institute. In-
sertional mutagenesis in the mouse.
Tam, P., Children's Medical Research Institute, Australia.
Mouse postimplantation development. Cell lineage and
potency in the early mouse embryo.
Wilkinson, D., MRC, National Institute for Medical Research,
United Kingdom. Patterning of the vertebrate hindbrain.
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Genetic-Epidemiologic Studies of Complex Diseases
June 11-18
INSTRUCTORS
Neil Risch, Ph.D., Stanford University
Elizabeth Squires-Wheeler, Ph.D., Columbia University College of Physicians & Surgeons
This lecture course considered the difficulties in studying the genetic basis of complex disorders,
such as diabetes, cardiovascular disease, cancer, Alzheimer's disease, schizophrenia, and
epilepsy, with a particular emphasis on neuropsychiatric conditions. Discussions were held on
genetic-epidemiologic study designs, including family, twin, and adoption studies, as well as mode
of inheritance analyses, and their role in setting the framework for understanding the genetic and
nongenetic components of a disease.
A major focus was on the identification of specific gene effects using both linkage and associa-
tion analysis. Discussed was the efficiency and robustness of different designs for such analysis;
further considered was how evidence from genetic-epidemiologic studies informs both the design
and interpretation of molecular genetic studies. Recent discoveries of genes for both Mendelian
and non-Mendelian diseases guided the discussion of the various methodologic issues.
Past lecturers have included L. Eaves, D. Easton, B. Keats, K. Kidd, K. Merikangas, J. Ott, R.
Ottman, M. Pericak-Vance, G. Peterson, C. Sing, R. Spielman, B. Suarex , and J. Todd.
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PARTICIPANTS
Allison, D., B.A., Ph.D., Columbia University College of
Physicians & Surgeons
Anant, J., B.S., Ph.D., University of Texas Southwestern
Medical Center
Buchhalter, J., M.D., Ph.D., Oregon Health Sciences Univer-
sity
Collins, R., B.S., M.S., University of Oxford, United Kingdom
Egan, M., B.A., M.D., National Institutes of Health
Esnayra, J., B.A., University of California, San Diego
Ester ling, L., B.S., Ph.D., National Institutes of Health
Hoffer, M., B.S., Ph.D., Leiden University, The Netherlands
Lau, K.F., B.S., Ph.D., Sequana Therapeutics, La Jolla, Cali-
fornia
Lopes-Cendes, I., B.S., M.S., McGill University, Canada
SEMINARS
Bressman, S., Columbia University College of Physicians &
Surgeons. Dystonia.
Claus, E., Yale University. Breast cancer,
Honer, W., University of British Columbia, Canada.
Schizophrenia.
Keats, B., Louisiana State University Medical Center.
Mendelian principles and population genetics. Linkage
analysis I.
Litton, R., Yale University. Hypertension.
Merikangas, K., Yale University School of Medicine. Techni-
ques of family studies, Ascertainment and case identifica-
tion.
Meyer, J., Medical College of Virginia. Biometrical genetics,
Family and twin designs.
Orth, M., M.D., Ph.D., University of California, San Francisco
Pei, Y., M.D., University of Tornonto, Canada
Poda, M., B.S., M.S., Istanbul University, Turkey
Prat ley, R., B.S., M.D., National Institutes of Health
Rao, V.S., B.S., M.S., Ph.D., Boston University School of
Medicine
Satagopan, J., B.S., M.S., Ph.D., Memorial Sloan-Kettering
Cancer Center
Thomas, J., M.D., Ph.D., Millenium Pharmaceuticals, Inc.
Cambridge, Massachusetts
Turecki, G., M.D., McGill University, Canada
Vezzoni, P., M.D., Consiglio Nazaionale della Ricerche, Italy
Yap, E., B.S., M.D., Defense Medical Research Institute,
Singapore
Ott, J., Rockefeller University. Linkage analysis II.
Ottman, R., Columbia University School of Public Health.
Principles of genetic epidemiology.
Pericak-Vance, M., Duke University Medical Center.
Alzheimer's disease.
Petersen, G., Johns Hopkins University. Colon cancer.
Reich, T., Washington University School of Medicine. Al-
coholism.
Risch, N., Stanford University. Sib-pair and relative-pair de-
signs. Schizophrenia.
Spielman, R., University of Pennsylvania School of Medicine.
Transmission distortion test. Diabetes.
Squires-Wheeler, E., Columbia University College of
Physicians & Surgeons. Schizophrenia.
Neurobiology of Human Neurological Disease:
Mechanisms of Neurodegeneration
June 20-26
INSTRUCTORS
Gandy, Samuel, Ph.D., Cornell University Medical College
Mobley, William, Ph.D., University of California, San Francisco
Prusiner, Stanley, Ph.D., University of California, San Francisco
Why do neurons die in specific acute or chronic human neurological disorders? How do they die?
Does apoptosis characterize cell death in some of these disorders? Do different pathological
deaths share common mechanisms? What practical treatments can be contemplated?
This lecture course explored possible answers to these important questions. Recent advances
in neurogenetics and in molecular and cell biology have begun to shed light on the mechanisms
that underlie nervous system injury in disease states such as Alzheimer's disease, amyotrophic
lateral sclerosis, prion diseases, Huntington's disease, epilepsy, and stroke. Taking advantage of
small class size and extensive discussion, invited faculty lecturers examined critical issues in their
areas of expertise. Overviews were provided and course participants did not need to have famil-
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iarity with neurological diseases. The course focused principally on the specific hypotheses and
approaches driving current research. Emphasis was placed on the highly dynamic interface be-
tween basic and clinical investigation, including the interdependence of clinical research and dis-
ease model development, and the value of disease research in understanding the function of the
normal nervous system.
Lecturers have included D. Bredesen, D. Choi, V. Dawson, R. Edwards, N. Heintz, J.
McNamara, D. Price, C. Ross, D. Selkoe, S. Sisodia, and R. Tanzi.
PARTICIPANTS
Aguirre, T., B.S., M.S., Katholieke University of Leuven, Bel-
gium
Aleshkov, S., M.D., Ph.D., Boston University Medical Center
Ances, B., B.S., M.S., University of Pennsylvania
Bolwig, G., B.S., Ph.D., Cold Spring Harbor Laboratory
De Marco, S., B.S., M.S., Mayo Graduate School
Greenfield, J., B.A., Cornell University
Jarrott, B., B.S., Ph.D., Monash University, Australia
Jenkins, S.-A., B.A., University of California, Los Angeles
Lorenzetti, D., B.S., Ph.D., Baylor College of Medicine
Lutjens, R., B.S., M.S., Glaxo institute for Molecular Biology,
Switzerland
SEMINARS
Bredesen, D., La Jolla Cancer Research Foundation.
Thanatopsis: Principles emerging from the study of neural
apoptosis.
Choi, D., Washington University School of Medicine. Hunting-
ton's patient. Excitotoxicity.
Dawson, V., Johns Hopkins University School of Medicine.
Free radicals and oxidants: Mechanisms and pathways to
neurodegeneration.
Edwards, R., University of California, San Francisco.
Parkinson's disease.
Gandy, S., Cornell University Medical College. AD patient.
Regulation of amyloid metabolism.
Heintz, N., Rockefeller University. Ataxia telangiectasia: Cell
cycle checkpoints and neurodegeneration.
McNamara, J., Duke University Medical Center. Emerg-
Meier, J., B.S., Ph.D., McGill University, Canada
Morrison, B., B.A., Mount Sinai Medical School
Neuhaus, R., B.S., Schering AG, Germany
Opal, P., M.D., Ph.D., Northwestern University
Ri, Y., B.S., Albert Einstein College of Medicine
Rogove A., B.S., State University of New York, Stony Brook
Suopanki, J., B.A., M.S., University of Helsinki,Finland
Vali, S., B.S., University of California, Davis
Vassar, R., B.A., Ph.D., AMgen, Inc.
Wyoral, S., B.S., Columbia University College of Physicians &
Surgeons
Xu, R., B.S., M.S., AMgen, Inc.
ing insights into mechanisms of epilepsy.
Mobley, W., University of California, San Francisco.
Neurotrophic factors and neurologic disease. AD patient.
Prusiner, S., University of California, San Francisco. Prion
diseases,
Ross, C., Johns Hopkins University School of Medicine. Trip-
let repeat neurodengerative disorders: Focus on Hunting-
ton's disease.
Tanzi, R., Massachusetts General Hospital. Molecular analy-
sis of the four genes responsible for familial Alzheimer's
disease.
Selkoe, D., Harvard Medical School. Molecular pathogenesis
of Alzheimer's disease.
Sisodia, S., Johns Hopkins University School of Medicine.
Animal models of AD.
Computational Neuroscience: Vision
June 28-July 11
INSTRUCTORS
Heeger, David, Ph.D., Stanford University
Shadlen, Michael, Ph.D., University of Washington, Seattle
Simoncelli, Eero, Ph.D., University of Pennsylvania
ASSISTANTS
Boynton, Geoffrey, Stanford University
Teo, Patrick, Stanford University
Computational approaches to neuroscience have produced important advances in our understand-
ing of neural processing. Prominent successes have come in areas where strong inputs from
neurobiological, behavioral and computational approaches can interact. Through a combination of
lectures and hands-on experience with a computer laboratory, this intensive course examined
several areas, including feature extraction, motion analysis, binocular stereopsis, color vision,
higher-level visual processing, visual neural networks, and oculomotor function. The theme was
that an understanding of the computational problems, the constraints on solutions to these prob-
lems, and the range of possible solutions can help guide research in neuroscience. Students had
experience in neurobiological or computational approaches to visual processing. Some back-
ground in mathematics was beneficial.
Past lecturers have included E. Adelson, R. Andersen, H. Bulthoff, R. Desimone, R. von der
Heydt, N. Graham, E. Hildreth, P. Lennie, S. Lisberger, J. Malik, J. Maunsell, S. McKee, M. Morgan,
K. Nakayama, I. Ohzawa, W. Newsome, T. Poggio, T. Sejnowski, D. Sparks, K. Tanaka, S. Ullman,
and B. Wandell.
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PARTICIPANTS
Anzai, A., B.S., M.S., University of California, Berkeley
Bartlett, M., B.A., M.A., University of California, Davis
Candy, R., B.S., University of California, Berkeley
Chung, S., B.S., Northwestern University
Cottaris, N., B.S., University of California, Berkeley
Demb, J., B.A., Stanford University
Dodd, J., B.S., Oxford University, United Kingdom
Fine, I., B.A., University of Rochester
Fredericksen, E., B.S., M.S., Ph.D., McGill University, Cana-
da
Friedman-Hill, S., B.A., University of California, Davis
Handel, A., B.A., New York University
Heuer, H., B.A., University of California, Davis
Horwitz, G., B.S., Stanford University
SEMINARS
Adelson, E., Massachusetts Institute of Technology. Ele-
ments of early vision. Color constancy and light-
ness/brightness.
Brainard, D., University of California, Santa Barbara. Color.
Color constancy and lightness/brightness.
Dacey, D., University of Washington, Seattle. Retina.
Glimcher, P., New York University. Saccadic eye move-
ments.
Graham, N., Columbia University. Light adaption, pattern
detection, and masking. Texture.
Heeger, D., Stanford University. V1 model. Light adaption,
pattern detection, and masking. Visual stabilization and 3D
motion.
McKee, S., Smith-Kettlewell Research Institute. Stereo vision.
Miles, F., Laboratory of Sensorimotor Research National In-
Arabidopsis Molecular Genetics
Kenyon, G., B.A., Ph.D., University of Texas Medical School
Kraft, J., B.A., M.S., Ph.D., University of Colorado
Kukkonen, H., Ph.D., University of Wales Cardiff, United
Kingdom
Mareschal, I., B.S., M.S., McGill University, Canada
McAdams, C., B.A., Baylor College of Medicine
Nestares, 0., B.S., M.S., C.S.I.C. Institut de Optica, Spain
Olds, E., B.A., Stanford University
Philbeck, J., B.A., M.S., University of California, Santa Bar-
bara
Rappas, J., B.A., Harvard Medical School
Rosenholtz, R., B.S., M.S., Ph.D., NASA, Ames, Moffet Field,
California
Wichmann, F., B.A., Oxford University, United Kingdom
stitutes of Health, Bethesda. Visual stabilization. Visual sta-
bilization and 3D motion.
Movshon, J.A., New York University. V1 physiology. MT
physiology.
Maunsell, J., Baylor College of Medicine. Attention physiol-
ogy.
Palmer, J., University of Washington, Seattle. Attention
psychophysics.
Reid, C., Harvard Medical School. Geniculo-cortical path-
way.
Shad len, M., University of Washington, Seattle. MT physiol-
ogy. Motion psychophysics and models.
Simoncelli, E., University of Pennsylvania. MT model. Motion
psychophysics and models.
Wandell, B., Stanford University. Functional brain imaging.
July 1-21
INSTRUCTORS
Deng, Xing-Wang, Ph.D., Yale University
Last, Robert, Ph.D., Boyce Thompson Institute, Cornell University
Preuss, Daphne, Ph.D., University of Chicago
ASSISTANTS
Mayfield, Jake, University of Chicago
Osterlund, Mark, Yale University
Williams, Chad, Boyce Thompson Institute, Cornell University
This course provided an intensive overview of topics in plant growth and development, focusing on
molecular genetic approaches to understanding plant biology. It emphasized recent results from
Arabidopsis thaliana and other model plants and provides an introduction to current methods used
in Arabidopsis research. The course also demonstrated the use of microbial systems in plant re-
search, including Agrobacterium, E. coli, and S. cerevisiae. It was designed for scientists with ex-
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perience in molecular techniques or in plant biology who wish to work with Arabidopsis. The course
consisted of a vigorous lecture series, a hands-on laboratory, and informal discussions. Speakers
provided both an in-depth discussion of their own work and a review of their specialty.
Discussions of important topics in plant research were presented by the instructors and by in-
vited speakers. These seminars reviewed plant anatomy; plant development (including develop-
ment of flowers, roots, meristems, embryos, and the epidermis); perception of light and photomor-
phogenesis; responses to pathogens and to other environmental stresses; synthesis and function
of secondary metabolites and hormones; nitrogen assimilation; unique aspects of plant cell biology
(including the plant cytoskeleton, cell wall, and chloroplasts); the importance of transposons and
Agrobacterium for manipulating plant genomes; and current approaches to genome analysis.
The laboratory sessions provided an introduction to important techniques currently used in
Arabidopsis research. These included studies of Arabidopsis development, mutant analysis,
studies of epidermal features, in situ detection of RNA, histochemical staining and immunolabeling
of proteins, transformation with Agrobacterium, transient gene expression in protoplasts, expres-
sion of plant proteins in microorganisms, detection and analysis of plant pathogens, and tech-
niques commonly used in genetic and physical mapping.
Recent speakers included J. Bender, A. Britt, C. Chapple, J. Chory, G. Drews, J. Ecker, S.Y.
He, A. Lloyd, H. Ma, R. Martienssen, J. Medford, T. Mitchell-Olds, P. Quail, J. Schiefelbein, B. Stas-
kawicz, D. Stern, I. Sussex, T. Voelker, and V. Walbot.
PARTICIPANTS
Bueche, C., B.S., Institut fur Biologie, II, Germany
Cairney, J., B.S., Ph.D., Institute of Paper Science & Technol-
ogy, Atlanta, Georgia.
Carabelli, M., Ph. D., Centro Acidi Nucleici, CNR, Italy
Gosti, F., B.S., Ph.D., National Research Science Center,
France
Kent, M., B.S., University of Minnesota
Kodrzycki, R., B.S., Ph.D., Westvaco Corporation, South
Carolina
Larrinua, I., B.S Ph.D., Dowelanco Discovery Research, In-
diana
Matthews, Jr., W., B.S., M.S., University of California, River-
side
Queitsch, C., B.S., University of Chicago
Raventos, D., B.S., Ph.D., University of Copenhagen, Den-
mark
Venkataraman, S., B.S., Michigan State University
Weber, A., B.S., M.S., Harvard University
Yalpani, N., B.S., Ph.D., Pioneer Hi-Bred International, Inc.,
Iowa
Zeidler, M., B.S., M.S., Fu Berlin, Germany
Zik, M., B.S., M.S., Weizmann Institute of Science
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SEMINARS
Benfey, P., New York University. Root development.
Bush, D., University of Illinois, Urbana. Ion channels, trans-
port.
Cashmore, T., University of Pennsylvania. Light perception.
Chapple, C., Purdue University. Secondary metabolites.
Cherry, M., Stanford University. Arabidopsis resources/
AAtDB.
Dellaporta, S., Yale University. Transposons.
Deng, X.-W., Yale University. Photomorphogenesis.
Falco, C., E.I. Du Pont de Nemours, Wilmington, Deleware.
Genetic engineering in plants.
Glazebrook, J., University of Maryland. Plant defenses.
Hepler, P., University of Massachusetts. Plant cell biology.
Jofuku, D., University of California, Santa Cruz. Flower devel-
opment: In situ hybridization methods.
Keith, B., University of Chicago. Cloning genes by com-
plementation. Yeast methods for cloning genes.
Kindle, K., Cornell University. Chlamydomonas.
Last, R., Boyce Thompson Institute, Cornell University.
Plant stress responses. Amino acid biosynthesis.
Lloyd, A., University of Texas, Austin. The epidermis.
Ma, H., Cold Spring Harbor Laboratory. High-tech ap-
proaches to cloning Arabidopsis genes.
Martienssen, R., Cold Spring Harbor Laboratory. Enhancer
traps in Arabidopsis.
Meagher, R., University of Georgia. Gene machine and actin.
Peothig, S., University of Pennsylvania. Plant anatomy. Plant
development.
Preuss, D., University of Chicago. Male and female
gametophytes and fertilization.
Sederoff, R., North Carolina State University. Molecular anal-
ysis of plant genomes and QTLs.
Shena, M., Stanford University School of Medicine. The
Arabidopsis genome project.
Theologis, A., University of California, Berkeley. Hormones.
Walker, G., Massachusetts Institute of Technology.
Rhizobacterium.
Genetics of Behavior and Neurobiology of Drosophila
July 1-21
INSTRUCTORS
Taylor, Barbara, Ph.D., Oregon State University
Patel, Nipam, Ph.D., University of Chicago
Tully, Tim, Ph.D., Cold Spring Harbor Laboratory
ASSISTANTS
Duman Schee, Molly, University of Chicago
Larson, DeLaine, Oregon State University
This laboratory/lecture course was intended for researchers at all levels who want to use
Drosophila as an experimental system for studying behavior, physiology, and development. Daily
seminars introduced students to a variety of research topics and developed those topics by includ-
ing recent experimental contributions and outstanding questions in the field. Guest lecturers
brought original preparations for viewing and discussion and/or direct laboratory exercises and ex-
periments in their areas of interest.
The course provided students in hands-on experience with various wild-type and mutant prepa-
rations useful for studying behavioral and neurobiological questions: Larval and adult nervous sys-
tems are used for studying behavior and physiology; embryonic and metamorphosing nervous sys-
tems are used for studying development. Students were exposed to a variety of techniques, such
as genetic manipulations for generating and managing stocks, chromosomal in situ hybridization,
and embryo injections, providing a comprehensive introduction to modern experimental tools
specific for Drosophila.
In last year's course, behavioral emphasis was given to courtship, learning and memory, and
biological rhythms; physiological emphasis was given to the genetics and molecular biology of ex-
citability; and developmental emphasis was given to neurogenesis, axonal pathfinding, and synap-
togenesis.
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Last year's guest lecturers included A. Bieber, K. Blochinger, R. Cagan, M. Dickenson, B.
Ganetsky, J. Hall, V. Hartenstein, R. Hardie, H. Keshishian, K. Kaiser, G. Laurent, M. Kernan, I.
Meinertzhagan, L. Restifo, P. Taghert, C.-F. Wu, and Y. Zhong.
PARTICIPANTS
Andretic R., B.S., University of Virginia
Chouard, T., B.S., M.S., Ph.D., University of California, Los
Angeles
Gray, C., B.A., University of Virginia
Hammer le, B., B.S., Ph.D., Instituto Cajal, CSIC, Spain
Hoang B., B.S., University of Illinois
Hodge, J., B.S., Cambridge University, United Kingdom
Thomas M., B.S., M.S., University of Zurich, Switzerland
SEMINARS
Brand, A., Wellcome/CRC Institute, United Kingdom.
Determination and function of glia/midline cells.
Carlson, J., Yale University. Olfactory processing.
Ganetzky, B., University of Wisconsin. Introductory physiol-
ogy, ion channels.
Hartenstein, V., University of California, Los Angeles. Em-
bryonic development.
Jackson, R., Worcester Foundation for Biomedical Research.
Circadian behaviors.
Kernan, M., State University of New York, Stony Brook.
Mechanosensory systems.
Kolodkin, A., Johns Hopkins School of Medicine. Axon path-
finding.
Montell, C., Johns Hopkins School of Medicine. Visual sys-
tems.
Murphey, R., University of Massachusetts. Sensory systems
Mukhopadhyay, M., B.S., M.S., Mac Master University, Cana-
da
Schuldt, A.J., B.S., Cambridge University, United Kingdom
Wenniger, J., B.A., University of Pennsylvania
Wu, M., B.A., Baylor College of Medicine
Yu, H.-H., B.A, M.S., Johns Hopkins University School of
Medicine
and adult behaviors.
Patel, N., University of Chicago. Pattern forma-
tion/neurogenesis/evolution.
Sink, H., University of California, Berkeley. Development of
motor systems.
Restifo, L., University of Arizona. Metamorphosis and adult
development.
Robinow, S., University of Hawaii. Cell death.
Sokolowski, M., York University, Canada. Larval behaviors.
Taghert, P., Washington University School of Medicine.
Neuromodulators and neurotransmitters.
Taylor, B., Oregon State University. Reproductive behaviors
and the adult nervous system.
Tully, T., Cold Spring Harbor Laboratory. Learning and
memory.
Wu, C.-F., University of Iowa. Physiology of motor systems.
Molecular Cloning of Neural Genes
July 1-21
INSTRUCTORS
Boulter, James, Ph.D., University of California, Los Angeles
Darnell, Robert, Ph.D., Rockefeller University
Heintz, Nathaniel, Ph.D., Rockefeller University
Lai, Cary, Ph.D., Scripps Research Institute
CO-INSTRUCTORS
Elgoyhen, Ana Be len, Salk Institute
Kong, Hae-Young, University of Pennsylvania
Quinn, Anne Marie, Yale University
ASSISTANTS
Arnold, Donald, Rockefeller University
Okano, James, Rockefeller University
Zeltser, Lori, Rockefeller University
This intensive laboratory and lecture course was intended to provide neuroscientists at all levels
with an introduction to modern molecular neurobiology. The course consisted of daily laboratory
exercises, discussions on the practice of molecular biology, and a series of evening research semi-
nars by invited speakers. This lecture series emphasized the ways in which molecular techniques
studied in the laboratory have been successfully applied to the study of neural genes.
The laboratory portion of the course included a module on gene cloning and a module on the
analysis of neural gene expression. Gene cloning techniques included isolation and characteriza-
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tion of poly(A)+ RNA; synthesis of cDNA libraries; standard screening and expression screening of
cDNA libraries; analysis of cDNA clones, including phagemid rescue, restriction analysis, Southern
blotting, ligations, transformation, electroporation, and subcloning; and PCR analysis including
oligonucleotide design, synthesis, and purification, and PCR-based subtraction cloning. Gene ex-
pression studies included Northern blot analysis, RT-PCR analysis, in vitro transcription for RNase
protection, and in situ and mammalian gene targeting.
Last year's lecturers included S. Burden, A. Craig, R. Darnell, S. Fields, B. Hoffman, G. Lemke,
G. Mandel, P. Mombaerts, A. Quinn, and P. Worley.
PARTICIPANTS
Canzoniero, L., M.D., Ph.D., Washington University
Conn, P.J., B.S, Ph.D., Emory University
Dougherty, M., B.S., Ph.D., University Pierre & Marie Curie,
France
Hajihosseini, M., B.S., M.S., Ph.D., Pasteur Institute, France
Hall, J., B.S., Cambridge University, United Kingdom
Horton, A., B.S., University of St. Andrews, United Kingdom
Jasmin, L., M.D., Ph.D., Georgetown University Medical Cen-
ter
Jiang, H., B.S., M.S., Purdue University
Koentges, G., B.S, UMDS, Guy's & St. Thomas's
SEMINARS
Chao, M., Cornell University Medical School. Molecular clon-
ing of neural genes.
DeCamilli, P., Yale University School of Medicine. Molecular
mechanisms in synaptic vesicle endocytosis.
Du lac, C., Columbia University. Single-cell PCR analysis of
olfaction.
Eberwine, J., University of Pennsylvania. RNA-binding
proteins and neurologic disease.
Friedman, J., Rockefeller University. Genetic analysis of
neural disease genes.
Gaul, U., Rockefeller University. Visual development in verte-
brates.
Harlow, E., Massachusetts General Hospital Cancer Center.
Approaches to gene cloning in the brain.
Medical & Dental Schools, United Kingdom
Korade, Z., DVM., Ph.D., University of Pillsburgh
Korotzer, A., B.A., Ph.D., Colorado State University
Lander, C., B.A., Yale University
McKinnon, S., B.S., M.S., Ph.D., Johns Hopkins University
School of Medicine
Nicholson, L., B.S., M.S., Ph.D., Salk Institute, United King-
dom
Rosenmund, C., B.S., Ph.D., Max-Planck Institute, Germany
Yoon, C., B.A., Harvard Medical School
Hemmati-Brivanlou, A., Rockefeller University. Neural devel-
opment in amphibians.
Mombaerts, P., Rockefeller University. Targeting olfaction.
Nottebohm, F., Rockefeller University. Molecular approaches
to animal behavior.
Parada, L., University of Texas Southwestern Medical Center.
Gene analysis of trophic pathways.
Pfaff, S., Columbia University. Induction, expression, and
function of transcription factors in differentiating motor
neurons.
Worley, P., Johns Hopkins School of Medicine. Novel cellular
mechanisms in synaptic plasticity: Subtractive hybridiza-
tion and differential cloning strategies.
Neurobiology: Brain Development and Function
July 14-27
INSTRUCTORS
McKay, Ronald, Ph.D., National Institutes of Health
Schuman, Erin, Ph.D., California Institute of Technology
This lecture course presented both basic concepts and currently exciting research problems in
neurobiology. It focused on the methods now used to study the development and function of the
nervous system. Topics covered included gene expression, cell proliferation and tumor formation,
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neural induction, stem cells and lineage, neurite outgrowth, synaptic biochemistry and physiology,
positional information and maps, learning, sensory transduction and coding, transplantation, trans-
genic mice, and behavior. The advantages of different experimental systems from C. elegans to
primates were discussed. The main purpose of this course was to provide many opportunities to
discuss this rapidly expanding field with invited lecturers. The lectures provided a general introduc-
tion as well as a detailed analysis of current research for each topic. Individuals from a wide variety
of backgrounds and experience were encouraged to apply.
Past lecturers have included W. Bialek, D. Bredesen, D. Cleveland, A. Doupe, J. Hudspeth, R.
Jahn, D. Kaplan, L. Katz, R. Malinow, G. Matthews, M. Mayford, M. Meister, T. Movshon, D. Ts'0, L.
Reichardt, J. Rothman, J. Rubenstein, T. Sejnowski, T. Schwarz, M. Wilson, and C. Zuker,
PARTICIPANTS
Attix, S., B.S., University of California, Los Angeles
Bhattacharya, S., B.A., Ph.D., Stanford University
Blanquet, V., B.S., Ph.D., GSF-Forschungszentrum, Germany
Di Paolo, G., B.S., M.S., Glaxo Institute for Molecular Biology,
Switzerland
Gao, F.B., B.S., Ph.D., University College London, United
Kingdom
Gotoh, Y., B.S., M.S., Ph.D., Kyoto University, Japan
Grishchenko, E., B.S., Kiev National University, Ukraine
Gulisano, M., M.D., Ph.D., Scientific Institute H. San Raffaele,
Italy
Hargrave, M., B.S., University of Queensland, Australia
Hu, H., B.S., Ph.D., Case Western Reserve University
Jellie, A., B.S., M.S., Ph.D., University of Otago, New Zealand
Johansen, J., B.S., M.S., arolinska Institute, Sweden
Johansson, C., B.S., D.D.S., Karolinska Institute, Sweden
Joore, J., B.S., M.S., Ph.D., Netherlands Institute for Develop-
mental Biology, The Netherlands
Kohwi, Y., B.S., Ph.D., Burnham Institute
Krug, K., B.A., University Laboratory of Physiology, United
Kingdom
Margolis, R., B.A., M.D., Johns Hopkins University
Neophytou, C., B.A., MRC, University College London,
United Kingdom
Pizzorusso, T., B.S., Ph.D., Scuola Norma le Superiore, Italy
Price, S., B.A., Medical Research Council, United Kingdom
Salecker, I., B.S., Ph.D., University of California, Los Angeles
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SEMINARS
Burden, S., New York Medical Center. Signals regulating the
function of the neuromuscular junction.
de Camilli, P., Yale University School of Medicine. Molecular
mechanisms in synaptic vesicle endocytosis and recy-
cling.
Gerfen, C., National Institutes of Health. Functional organiza-
tion of the forebrain.
Greenberg, M., Children's Hospital, Harvard Medical School.
Neurotrophin and neurotransmitter regulation of gene ex-
pression and neuronal adaptive response.
Jahr, C., Oregon Health Sciences University. The time
course of glutamate's action in the synaptic cleft.
Kaplan, D., National Cancer Institute, FCRDC. Growth fac-
tors, receptors, and second messengers.
Kennedy, M., California Institute of Technology. Structure
and function of the postsynaptic density.
Laurent, G., California Institute of Technology. Olfactory
coding with oscillations.
Logothetis, N., Baylor College of Medicine. Object vision:
Neurophysiology and psychophysics in monkeys.
Malinow, R., Cold Spring Harbor Laboratory. Central synap-
tic transmission: Plasticity and development.
McKay, R., National Institutes of Health. CNS stem cells.
Eukaryotic Gene Expression
July 24-August 13
Montague, P.R., Baylor College of Medicine. Models of asso-
ciative learning and synaptic plasticity.
Raper, J., University of Pennsylvania. Control of growth
cones.
Rosenfeld, G., University of California, San Diego. Transcrip-
tion factors, co-activators, and co-repressors in neural de-
velopment.
Rothman, J., Memorial Sloan-Kettering Cancer Center. Mem-
brane fusion and synaptic transmission.
Rubenstein, J., University of California, San Francisco. Tran-
scriptional domains in the developing brain.
Schuman, E., California Institute of Technology. Signaling
and hippocampal synaptic plasticity.
Sternberg, P., California Institute of Technology. C. elegans
development and behavior.
Sudhof, T., University of Texas Southwestern Medical Center.
Molecular control of exocytosis.
Schwarz, T., Stanford University Medical Center. Genetic dis-
section of neurotransmitter release.
Tessier-Lavigne, M., University of California, San Francisco.
Regulators of axons.
Tully, T., Cold Spring Harbor Laboratory. Gentic analysis of
learning and memory.
INSTRUCTORS
Burtis, Kenneth, Ph.D., University of California, Davis
Carey, Michael, Ph.D., University of California, Los Angeles
Smale, Stephen, Ph.D.,University of California, Los Angeles
ASSISTANTS
Ellwood, Kate, University of California, Los Angeles
Kae lin, Christopher, University of California, Davis
Trinh, Le, University of California, Los Angeles
This course focused on the techniques used to study eukaryotic gene expression, particularly with
respect to transcriptional regulation. We examined the role of both cis- and trans-acting com-
ponents in this process. Regulation of gene expression by nuclear proteins was examined both by
in vitro transcription assays using cell-free extracts and by transfection of cloned DNA into mam-
malian tissue culture cells. Analytical techniques for these expression studies included primer ex-
tension, nuclease protection, and enzymatic assays for reporter proteins. Eukaryotic transcription
factors were expressed in E. coli and purified by affinity chromatography. Using these proteins,
students learned the techniques for detecting and characterizing the interaction between
regulatory DNA sequences and trans-acting protein factors, including mobility shift assays, DNase
footprinting, and methylation interference. Students also learned techniques for carrying out site-
directed mutagenesis of the sequences encoding trans-acting regulatory proteins as well as cis-
acting upstream regulatory elements. The two-hybrid technique in S. cerevisiae was employed to
examine protein-protein interactions involved in transcriptional activation. Experience with basic
recombinant DNA techniques is a prerequisite for admission to this course.
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Lectures by the instructors covered the theoretical aspects of the techniques used as well as
broader issues regarding strategies for investigating the regulation of gene expression in
eukaryotes. Guest lecturers discussed current problems in eukaryotic molecular biology as well as
technical approaches to their solution. Speakers included S. Bell, S. Burley, J. Conaway, S. Ghosh,
D. Gilmour, B. Graves, M. Green, R. Sen, B. Stillman, K. Struhl, and K. Yamamoto.
PARTICIPANTS
Bauer, A., B.S., I.M.P., Research Institute of Molecular
Pathology, Austria
Blemings, K., B.S., Ph.D., University of Wisconsin
Burczynski, M., B.S., University of Pennsylvania School of
Medicine
Garcia, J., B.S., M.S., Centro de Investigacion y de Estudios
Avanzados del Institute Politecnico Nacional, Mexico
Gaudet, P., B.S., Concordia University, Canada
Heller, R., B.S., M.D., University of Oxford, United Kingdom
Hur le, B., B.S., Universidad de Oviedo, Spain
Kamnert, I., B.S., University of Lund, Sweden
SEMINARS
Bell, S., Massachusetts Institute of Technology. Biochemical
characterization of the ORC proteins.
Burley, S., Rockefeller University. X-ray crystallographic
studies of eukaryotic transcription factors.
Burtis, K., University of California, Davis. Structure and func-
tion of the doublesex proteins of D. melanogaster.
Carey, M., University of California, Los Angles. Biochemical
mechanisms of eukaryotic gene activation.
Conway, J., Oklahoma Medical Research Foundation. Fac-
tors and mechanisms controlling elongation by RNA
polymerase II.
Freedman, L., Memorial Sloan-Kettering Institute. Transcrip-
tional activation and repression by nuclear hormone recep-
tors.
Ghosh, S., Yale Medical School. Differential regulation of NF-
KB by I-KBa and I-KB13.
Gill, G., Harvard Medical School. Multiprotein complexes in
transcriptional regulation.
Gilmour, D., Pennsylvania State University. In vivo and in
vitro analyses of the hsp70 heat shock gene promoter from
Drosophila.
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Karpenko, Oxano, B.S., Brown University
Kurie, J., B.A., M.D., M.D. Anderson Cancer Cen-
ter/University of Texas
Li, L., D.V.M., Ph.D., Rockefeller University
Penc, S., B.S., M.S., Ph.D., Harvard Medical School
Ronnov-Jessen, L., B.S., Ph.D., Rigshospitalet, Denmark
Samaras, S., B.S., Ph.D., Pennsylvania State University
Sokolowski, M., B.S., Karolinska Institute, Sweden
Ten Berge, D., B.S., M.S., The Netherlands Institute of Devel-
opmental Biology, The Netherlands
Graves, B., University of Utah. The Ets family of transcription
factors: Winged helix-turn-helix proteins displaying autoin-
hibition of DNA binding .
Green, M., University of Masschusetts. Analysis of TAFII
function in vivo.
Peterson, C., University of Massachusetts. Protein com-
plexes for remodeling chromatin.
Sen, R., Brandeis University. Factors regulating Ig gene ex-
pression.
Smale, S., University of California, Los Angeles. Regulation of
TATA-less genes in immature lymphocytes.
Stillman, B., Cold Spring Harbor Laboratory. Cell cycle con-
trol of genome replication.
Struhl, K., Harvard Medical School. Molecular mechanisms
of yeast transcriptional regulation.
Tanese, N., New York University. Transcriptional activation
mediated by the mammalian TFI ID complex.
Yamamoto, K., University of California, San Francisco. Sig-
naling and transcriptional regulation by intracellular recep-
tors.
Imaging Structure and Function in the Nervous System
July 24-August 13
INSTRUCTORS
Konnerth, Arthur, M.D., Ph.D., University of Saarland, Germany
Lanni, Frederick, Ph.D., Carnegie-Mellon University
Yuste, Rafael, M.D., Ph.D., Columbia University
ASSISTANTS
Cash, Syd, Columbia University
Eilers, Jens, University of Saarland, Germany
Laufer, Ilya, Columbia University
Vanni, Steven, Carnegie-Mellon University
Advances in light microscopy, digital image processing, and the development of a variety of pow-
erful fluorescent probes present expanding opportunities for visualizing and measuring the struc-
ture and function of neurons, synapses, and networks in the brain. This intensive laboratory and
lecture course provided participants with the theoretical and practical tools to utilize these emerg-
ing technologies. The primary emphasis of the course was on light microscopy, including fluores-
cence, differential interference contrast, confocal scanning, and 2-photon scanning excitation, as
well as the use of different types of electronic cameras and the application of digital processing to
enhance and analyze microscope images. Students learned the principles of light microscopy, the
use of calcium-sensitive probes (e.g., Fura-2, calcium green, and oregon BAPTA green), voltage-
sensitive dyes, photo-activated ("caged") compounds, GFP, exocytosis tracers, whole-cell patch-
clamp methods in brain slices, single-cell microinjection of fluorescent indicators, and other meth-
ods to explore the molecular determinants of neuronal function. The course used a variety of neural
systems, including living animals, brain slices (e.g., hippocampus, cerebellum, and neocortex),
and cultured cells. Applicants had a strong background in the neurosciences, physiology, or cell
biology.
Lecturers included G. Augustine, W. Betz, T. Bonhoeffer, M. Chalfie, H. Cline, W. Denk, P.
Forscher, S. Fraser, A. Grinvald, T. Hazelrigg, T. Inoue, L. Katz, J. Lichtman, R. Malinow, E. Neher,
D. O'Malley, W. Regehr, R. Tsien, W. Webb, and R. Wong.
PARTICIPANTS
Baumann, T., B.S., M.S., Ph.D., Oregon Health Sciences Uni-
versity
Colwell, C., B.S., Ph.D., University of California, Los Angeles
Dunlap, D., B.S., M.S., Ph.D., San Raffaele Scientific Institute,
Italy
Gomperts, S., B.S., University of California, San Francisco
Hazrati, L.-N., B.S., Ph.D., Ontario, Canada
Heuss, C., B.S., University of Zurich, Switzerland
SEMINARS
Augustine, G., Duke University. Calcium indicators.
Betz, W., University of Colorado. FM indicators.
Bonhoeffer, T., Max-Planck Institute, Germany. Development
of cortical maps.
Chalfie, M., Columbia University. Using green fluorescent
protein in C. elegans.
Cline, H., Cold Spring Harbor Laboratory. In vivo imaging of
retinotectal development.
Denk, W., Bell Laboratories, New Jersey. Applications of 2-
photon micros-copy.
Forscher, P., Yale University. High-resolution imaging of cel-
lular dynamics.
Fraser, S., California Institute of Technology. MRI micros-
copy.
Grinvald, A., Weizmann Institute of Science. Voltage-
sensitive dyes and intrinsic signals.
Hazelrigg, T., Columbia University. Using green fluorescent
protein in Drosophila.
Inoue, T., Universal Imaging Corporation. Video microscopy.
Katz, L., Duke University Medical Center. Uncaging
glutamate.
Konnerth, A., University of Saar, Germany. Dendritic imaging
Yeast Genetics
Huerta, P., B.S., M.S., Ph.D., Massachusetts Institute of
Technology
Ikeda, K., B.S., Ph.D., RIKEN, Japan
Kopp, D., B.S., Ph.D., University of Texas, Austin
Mombaerts, P., B.S., M.D., Ph.D., Rockefeller University
Protti, D., B.S., Ph.D., Max-Planck Institute, Germany
Walz, W., B.S., Ph.D., University of Saskatchewan, Canada
with confocal microscopy.
Lanni, F., Carnegie Mellon University. Microscopy basics.
Lichtman, J., Washington University. Confocal microscopy.
Malinow, R., Cold Spring Harbor Laboratory. Silent synapses
in development and plasticity.
Neher, E., Max-Planck Institute for Biophysical Chemistry,
Germany. ca++ buffers, buffered diffusion, and ca++
domains.
O'Malley, D., State University of New York, Stony Brook. Cal-
cium imaging in zebrafish.
Regehr, W., Harvard Medical School. Calcium dynamics.
Tsien, R., University of California, San Diego. Design of in-
dicators for ionic signals; caged compounds and the
mechanism of synaptic plasticity. Fluorescence imaging of
cAMP, protein trafficking, and gene expression.
Webb, W., Cornell University. Principles of 2-photon micro-
scopy.
Wong, R., Washington University School of Medicine. Imag-
ing multineuronal activity in the developing retina.
Yuste, R., Columbia University. Dendritic imaging with 2-
photon microscopy.
July 24-August 13
INSTRUCTORS
Adams, Alison, Ph.D., University of Arizona
Gottschling, Daniel, Ph.D., Fred Hutchinson Cancer Research Center
Kaiser, Chris, Ph.D., Massachusetts Institute of Technology
CO-INSTRUCTOR
Segev, Nava, University of Chicago
ASSISTANTS
Chen, Esther, Massachusetts Institute of Chicago
Meisinger, pia, University of Chicago
O'Dell, Johanna, University of Arizona
The major laboratory techniques used in the genetic analysis of yeast were studied, including the
isolation and characterization of mutants, tetrad analysis, complementation, and mitotic recombina-
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tion. Micromanipulation used in tetrad analysis were carried out by all students. Molecular genetic
techniques, including yeast transformation, gene replacement, analysis of gene fusions, and gen-
eration of mutations in cloned genes, were studied. Indirect immunofluorescence experiments were
done to identify the nucleus, microtubules, and other cellular components. Lectures that are funda-
mental aspects of yeast genetics were presented along with seminars given by outside speakers
on topics of current interest.
PARTICIPANTS
Adams, C., B.S., Ph.D., University of Bath, United Kingdom
Choi, J.H., B.S., M.S., St. John's University
Clarke, E., B.S., University of Oklahoma
Cox, G., B.A., M.D., Duke University Medical Center
Eisenstein, R., B.A., Ph.D., University of Wisconsin
Fisher, E., B.A., M.D., Ph.D., Mount Sinai School of Medicine
Hatsuzawa, K., B.S., Ph.D., Tokyo University of Pharmaceuti-
cal and Life Sciences, Japan
Lin, J., B.S., Ph.D., Cornell University
Liu, W.-M., B.A., M.S., Ph.D., Stanford University
SEMINARS
Adams, A., University of Arizona. The actin cytoskeleton of
yeast.
Botstein, D., Stanford University School of Medicine. Yeast
genetics in the postgenome era.
Fink, G., Whitehead Institute. Signal transduction and dimor-
phism.
Futcher, B., Cold Spring Harbor Laboratory. The yeast cell
cycle engine.
Gottschling, D., Fred Hutchinson Cancer Research Center.
Telomeric position effect: A handle on the chromosome.
Herskowitz, I., University of California, San Francisco. Cell
specialization and the life cycle of yeast.
Hieter, P., Johns Hopkins University. Chromosome segrega-
tion.
Kaiser, C., Massachusetts Institute of Technology. Regula-
tion of vesicle transport in the secretory pathway.
Meinke, M., B.S., Ph.D., St. John's University/ College of St.
Benedict, Minnesota
Mizuguchi, M., B.S., M.S., Ph.D., National Institutes of Health
Schultz, M., B.S., Ph.D., University of Alberta, Canada
Slayman, C., B.A., Ph.D., Yale University School of Medicine
Smits, G., B.S., University of Amsterdam, The Netherlands
Takagi, H., B.S., M.S., Ph.D., Fukui Prefectural University,
Japan
Tinker-Kulberg, R., B.S., Ph.D., University of California, San
Francisco
Mitchell, A., Columbia University. Regulation of entry into
meiosis.
Parker, R., University of Arizona. mRNA turnover in yeast.
Peterson, C., University of Massachusetts Medical Center.
Molecular machines for remodeling chromatin.
Petes, T., University of North Carolina. Genetic control of
genome stability in yeast.
Rose, M., Princeton University. Karyogamy and spindle pole
body function.
Segev, N., University of Chicago. GTPases in protein trans-
port.
Struhl, K., Harvard Medical School. Regulation of transcrip-
tion.
Wickner, R., National Institutes of Health. Yeast killer and
regulation of protein states.
Advanced Drosophila Genetics
July 30-August 12
INSTRUCTORS
Ashburner, Michael, Ph.D., University of Cambridge, United Kindom
Hawley, Scott, Ph.D., University of California, Davis
This intensive seminar course provided an introduction to the theory and practice of methods used
to manipulate the Drosophila genome. It was suitable for graduate students and researchers with
some experience with Drosophila who were interested in expanding their knowledge of the wide
range of genetic techniques now available for use with this organism. Topics covered included
chromosome mechanics, the design and execution of genetic screens, and the use of
transposable elements as genetic tools.
PARTICIPANTS
Adler, E., B.A., Ph.D., Institut de Biologie Physico-Chimique,
France
Bartsch, S., B.S., Swiss Federal Institute of Technology,
Zurich, Switzerland
Breuer, S., B.S., Philipps-Uniyersitat, Germany
Franc, N.C., B.S., CNRS, Institut de Biologie Moleculaire et
Cellulaire, France
De Young, K., B.S., National Institutes of Health
Dubois, L., B.S., Universite Paul Sabatier Toulouse,
France
Ekengren, S., B.S., M.S., Stockholm University, Sweden
Faye, I., B.S., Ph.D., Stockholm University, Sweden
Goldstein, D., B.S., Ph.D., Pennsylvania State University
264
Ip, T., B.S., Ph.D., University of Massachusetts Medical
Center
Khalsa, 0., B.A., Brown University
Luk, S.K.-S., B.S., M.S., Ph.D., Chinese University of Hong
Kong
Maggert, K., B.S., University of California, San Diego and the
Salk Institute
Neal, K., B.A., Ph.D., Emory University
Yan, R., B.S., Ph.D., Rockefeller University
Pearson, A., B.A., Massaschusetts Institute of Technology
Torres, S., B.S., Ph.D., Brown University
Walker, D., B.A., Iowa State University
Zwick, M., B.S., University of California, Davis
SEMINARS
Ashburner, M., University of Cambridge, United Kingdom. In-
troduction to Drosophila biology, phylogeny.
Fly Base-where to find information. Chromosomes,
cytogenetics, chromosome aberrations, mapping (genetic
and cytogenetic).
Cherbas, P., Indiana University. Somatic cell genetics.
Cline, T., University of California, Berkeley. Alternative to
brute force: Selective and sensitized genetic screens, and
their use in the genetic dissection of Drosophila sex
determination.
Engels, W., University of Wisconsin. P elements.
Ganetzky, B., University of Madison, Wisconsin.
Neurogenetics.
Go lic, K., University of Utah. Mosaic systems FRT/FLP.
Hawley, S., University of California, Davis. Genetics of
meiosis; methods of study and exploitation; distributive
pairing.
Hogness, D., Stanford University School of Medicine. The
Drosophila genome: Past, present, and future.
Lehmann, R., New York University Medical Center/Skirball In-
stitute. Genetic analysis of early Drosophila development.
Simpson, P., I.G.B.M.C., France. The achaete-scute complex
and the genetic control of bristle pattern.
Theurkauf, W., State University of New York, Stony Brook.
Genetic analysis of cytoskeletal function during oogenesis
and early embryogenesis.
Tully, T., Cold Spring Harbor Laboratory. Genetic dissection
of memory.
Advanced In Situ Hybridization and Immunocytochemistry
October 10-23
INSTRUCTORS
Hough, Paul, Ph.D., Brookhaven National Laboratory
Jacobson, Kenneth, Ph.D., University of North Carolina, Chapel Hill
Mastrangelo, Iris, Ph.D., Brookhaven National Laboratory
Hied, Thomas, Ph.D., National Institutes of Health
Spector, David, Ph.D., Cold Spring Harbor Laboratory
ASSISTANTS
Howard, Tamara, Cold Spring Harbor Laboratory
Navarre, Richard, University of North Carolina, Chapel Hill
Veldman, Timothy, National Institutes of Health
This course focused on specialized techniques in microscopy related to localizing DNA sequences
and proteins in cells and preparing DNA and DNA-protein spreads for microscopic examination.
The course emphasized the use of the latest equipment and techniques in epifluorescence micros-
copy, confocal laser scanning microscopy, electron microscopy, and digital image processing.
The aims of the course were designed to provide state-of-the-art technology and scientific ex-
pertise in the use of microscopic applications to address basic questions in genome organization
and cellular and molecular biology. The course was designed for the molecular biologist who is in
need of microscopic approaches and for the cell biologist who is not familiar with the practical ap-
plication of the advanced techniques presented in the course. Among the methods presented was
the preparation of tagged nucleic acid probes, fixation methods, detection of multiple DNA se-
quences in single nuclei or chromosome spreads, comparative genomic hybridization, spectral
karyotyping, use of a variety of reporter molecules and nonantibody fluorescent tags, and indirect
antibody labeling of multiple proteins in a single cell. In addition, molecular electron microscopy
was used to examine DNA-protein interactions. In each method, several experimental protocols
were presented allowing the students to assess the relative merits of each and to relate them to
their own research. Students were encouraged to bring nucleic acid or protein probes to the
course which were used in addition to those provided by the instructors. The laboratory portion of
the course was supplemented by invited lecturers who gave up-to-the-minute reports on current re-
search using the techniques presented in the course.
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PARTICIPANTS
Brisken, C., M.D., Whitehead Institute, Massachusetts
Chevret, E., B.S., M.S., Ph.D., Imperial Cancer Research
Fund, United Kingdom
Cone, R., M.D., Ph.D, University Hospital Zurich, Switzerland
Dow, J., M.D., Meharry Medical College, Tennessee
Florczyk, M., B.S., State University of New York, Stony Brook
Gaietta, G., B.A., Ph.D., University of California, San Diego
Horst, H., M.D., Ph.D., University Ulm, Germany
Juan, V., B.A., University of California, Santa Cruz
SEMINARS
Brinkley, W., Baylor College of Medicine. DNA/protein orga-
nization in the centromere-kinetochore complex of human
chromosomes: An integrated microscopy study.
Cremer, T., University of Heidelberg, Germany. Three-
dimensional organization of chromosome territories in the
interphase nucleus.
Deerinck, T., University of California, San Diego. Electron mi-
croscopy as a tool in cell and molecular biology.
Jay, D., Harvard University. Chromophore-assisted laser in-
activation of cellular proteins.
Jacobson, K., University of North Carolina. Basic introduction
to light microscopy and video microscopy. Fluorescence
microscopy and low light level cameras.
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Liva, S., B.S., University of California, Los Angeles
Mermoud, J., B.S., Ph.D., Yale University School of Medicine
Novakovic, S., M.S., M.D., Roche Bioscience, California
Reinert, B., B.S., M.S., Kansas State University
Tsai, C.-C., D.V.M., Ph.D., University of Washington, Seattle
Van Den Berghe, J., B.A., Ph.D., National University of
Singapore
Wang, G., B.S., Ph.D., Loma Linda University, California
Wimpee, B., B.S., University of Wisconsin, Milwaukee
Murray, J., University of Pennsylvania. Principles of confocal
microscopy and deconvolution techniques.
Ried, T., National Institutes of Health. Comparative genomic
hybridization.
Singer, R., University of Massachusetts Medical School.
Cytoplasmic organization of mRNA.
Spector, D., Cold Spring Harbor Laboratory. Im-
munocytochemistry. An integrated microscopic approach
to examining nuclear organization.
Waggoner, A., Amersham Life Sciences, Pittsburgh, Pennsyl-
vania. Development of fluorochromes and filters for fluores-
cence microscopy.
Macromolecular Crystallography
October 10-23
INSTRUCTORS
Furey, William, Ph.D., V.A. Medical Center
Gilliland, Gary, Ph.D., Center for Advanced Research in Biotechnology
McPherson, Alexander, Ph.D., University of California, Riverside
Pflugrath, James, Ph.D., Molecular Structure Corporation
ASSISTANT
Vasquez, Gregory, Center for Advanced Research in Biotechnology
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through
other methods. This "intensive" laboratory/computational course focused on the major techniques
used to determine the three-dimensional structures of macromolecules. It was designed for
scientists with a working knowledge of protein structure and function, but who are new to macro-
molecular crystallography. Topics covered included crystallization (proteins, nucleic acids, and
complexes), crystal characterization, X-ray sources and optics, crystal freezing, data collection,
data reduction, anomalous dispersion, multiple isomorphous replacement, phase determination,
solvent flattening, molecular replacement and averaging, electron density interpretation, structure
refinement, molecular graphics, molecular dynamics, and multidimensional NMR. Participants
learned through extensive hands-on experiments how to crystallize and determine a protein struc-
ture, along with lectures and informal discussions on the theory behind the techniques.
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PARTICIPANTS
Adler, M., B.A., M.S., Ph.D., Ber lex Biosience, California
Dutta, S., B.S., M.S., Boston University
Hanlon, N., B.S., Ph.D., University of Oxford, United Kingdom
Jovine, L., B.S., MRC Laboratory of Molecular Biology,
United Kingdom
Kulathila, R., B.S., Ciba-Geigy Corporation, New Jersey
Le, H., B.S., Ph.D., Schering-Plough Research Institute, New
Jersey
MacDonald, R., B.A., Ph.D., Northwestern University, Illinois
Monem, V., B.S., Ontario Cancer Institute, Canada
Persson, R., B.S., Lund University, Sweden
SEMINARS
Brunger, A., Yale University, HHMI. Accurate experimental
crystallographic phases by multiwavelength anomalous
dispersion.
Clore, G.M., National Institutes of Health. Structures of
protein-DNA complexes by NMR.
Doudna, J., Yale University. A high-resolution tour of a large
ribozyme domain.
Dyda, F., National Institutes of Health. Structure determina-
tion of HIV integrae core domain by combined MAD.
Fitzgerald, P., Merck Research Laboratories, Rahway, New
Jersey. From L-689, 502 to Crixivan: The use of structure in
the identification of an HIV protease drug.
Gilliland, G., Center for Advanced Research in Biotech-
Pruett, P., B.S., Ph.D., Florida State University
Saridakis, V., B.S., University of Montreal, Canada
Schapira, M., Ph.D., New York University/Skirball Institute
Takeda, S., B.S., Ph.D., Matsushita Electric Industrial Co.,
Japan
Tzartos, S., B.S., Ph.D., Hellenic Pasteur Institute, Greece
Van Pouderoyen, G., B.S., Ph.D., Netherlands Cancer In-
stitute
Zhang, M., B.S., Ph.D. , Dana-Farber Cancer Institute, Massa-
chusetts
nology, Rockville, Maryland. Glutathione S-transferase: In-
sight into catalysis, substrate specificity, and subunit inter-
actions from structural analyses.
Hendrickson, W., Columbia University, HHMI. Structural biol-
ogy of cellular responses to stress.
Joshua-Tor, L., Cold Spring Harbor Laboratory. The yeast
bleomycin hydrolase, Ga16-A nucleic-acid-binding
protease.
Sussman, J., Brookhaven National Laboratory, Upton, New
York. Acetylcholinesterase in 3D: New mysteries revealed
from the crystal structure.
Tronrud, D., University of Oregon. Strange density.
YACs in Structural and Biological Genome Analysis
October 10-23
INSTRUCTORS
Huxley, Clare, Ph.D., Imperial College School of Medicine at St. Mary's, United Kingdom
Reeves, Roger, Ph.D., Johns Hopkins University
COINSTRUCTOR
Church, Deanna, Ph.D., University of California, Irvine
ASSISTANTS
Cabin, Deborah, Johns Hopkins University
Clines, Greg, University of Texas Southwestern Medical Center
Mann, Katherine, Imperial College School of Medicine/St. Mary's Hospital, United Kingdom
This lab-based course was aimed at investigators using genetic and physical mapping to isolate
their gene of interest. It covered techniques involved in physical mapping, contig building, gene
isolation, and functional analysis of cloned DNA. Experiments included analysis and characteriza-
tion of large-insert clones (YACs, BACs, and PACs) by partial digestion and pulsed-field gel elec-
trophoresis; creation of nested derivatives of YACs by fragmentation at repeat sequences or exons;
end sequence rescue; contig building by STS content mapping; gene identification by cDNA se-
lection and exon trapping; manipulation of YAC DNA by homologous recombination for the intro-
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duction of mammalian selectable markers and specific mutations; and preparation of YAC DNA for
transfer into cells in tissue culture by lipofection and into transgenic mice by pronuclear injection.
There also were computer-based sessions on accessing data from the World Wide Web and using
databases. The practical component of the course was supplemented with lectures by invited
speakers who are prominent researchers in the field and who then spent time talking to the
participants. Participants presented their own research interests to serve as the basis for structured
discussions of how to apply current technologies to their specific research project.
PARTICIPANTS
Bartsch, D., B.S., Ph.D., Columbia University
Bullejos, M., B.S., Universidad de Granada, Spain
Galli, J., M.S., Ph.D., Karolinska Hospital, Sweden
Immervoll, T., B.S., Ph.D., GSF Research Center, Germany
Kokkinaki, M., B.S., University of Crete, Greece
Langford, G., B.S., Ph.D., Cambridge University, United
Kingdom
Lorenzi, H., B.S., Universidad de Buenos Aires, Argentina
Messiaen, L., B.S., M.S., Ph.D., University Hospital, Belgium
Meyer, A., B.S., Ph.D., Sandoz Pharma Ltd., Switzerland
Monyer, H., B.S., Ph.D., University of Heidelberg, Germany
Parmer, R., M.D., Ph.D., University of California, San Diego
Puranam, R., B.S., M.S., Ph.D., Duke University
Shiraki, T., B.A., M.S., Kyoto University, Japan
Takacs, L., M.D., Ph.D., AMgen, California
Williams, J., M.S., Ph.D., Louisiana State University Medical
Center
Yuan, B.-Z., M.D., Ph.D., National Institutes of Health
SEMINARS
Birren, B., Whitehead Institute/MIT Center For Genome Re-
search. Bacterial artificial chromosomes in genome analy-
sis.
Cabin, D., Johns Hopkins University School of Medicine.
Fundamentals of yeast genetics for genome analysis.
Clines, G., University of Texas Southwestern Medical Center,
Dallas. Gene identification by cDNA selection.
Church, D., University of California, Irvine. Molecular analysis
of the Cri du Chat region.
Green, E., National Institutes of Health, NCHGR. YAC-based
mapping of human chromosomes.
Friedman, J., Rockefeller University. Positional cloning of
obesity genes-The morning after.
Huxley, C., Imperial College, United Kingdom. Functional
analysis of mammalian DNA function by YAC transfer.
Reeves, R., Johns Hopkins University. From comparative
maps to compatative source.
Trask, B., University of Washington, Seattle. Genome analy-
sis through fluorescence in situ hybridization.
Wilson, R., Washington University School of Medicine, St.
Louis, Missouri. Genome analysis by large-scale DNA se-
quencing.
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Mouse Behavioral Analysis
October 25-November 7
INSTRUCTORS
Eichenbaum, Howard, Ph.D., Boston University
Morris, Richard, Ph.D., University of Edinburgh, United Kingdom
Silva, Alcino, Ph.D., Cold Spring Harbor Laboratory
ASSISTANT
Bourtchuladze Roussoudan, Ph.D., Columbia University
Kogan, Jeff, Cold Spring Harbor Laboratory
Wolfer, David, University of Zurich, Switzerland
This course was intended to provide a theoretical and experimental introduction to behavioral anal-
ysis in the mouse, with a focus on learning and memory. It was especially designed for geneticists,
molecular biologists, pharmacologists, and electrophysiologists with a need for hands-on introduc-
tion to behavioral analysis of the mouse. Additionally, the course covered the principles of using
mutant mice in behavioral studies, as well as the issues involved in integrating behavioral,
neuroanatomical, neurophysiological, and molecular findings. Among the methods presented were
the water maze, cued and contextual fear conditioning, inhibitory avoidance, natural/ethologically
relevant learning, open field behavior, and other activity tests. In addition, there were demonstra-
tions of several aspects in in vivo and in vitro electrophysiology (synaptic, single unit, and EEG
recordings).
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PARTICIPANTS
Episkopou, V., B.S., Ph.D., MRC Clinical Sciences Center,
United Kingdom
Freeman, T., B.S., University of Oxford, United Kingdom
Gass, P., M.D., Ph.p., German Cancer Research Center
Gianfranceschi, L., B.S., Scuola Norma le Superiore, Italy
Johnson, D., M.S., Ph.D., Oak Ridge National Laboratory,
Tennessee
Kuhn, R., B.S., Ph.D., University of Cologne, Germany
SEMINARS
Diamond, A., Kennedy Shriver Center, Waltham, Massachu-
setts. Human cognition-What is the value of mouse
models?
Jacobs, L., University of California, Berkeley. The natural
mouse.
Jaffard, R., C.N.R.S., URA 339, Talance, Fance. The hip-
pocampus-What is it good for?
Keverne, B., University of Cambridge, United Kingdom.
Beyond learning: What other behavioral issues could be
studied in the mouse?
LeDoux, J., New York University. Mechanisms that modulate
Computational Genomics
Paradee, W., B.S., Ph.D., Emory University, Georgia
Plasterk, R., B.S., Ph.D., Netherlands Cancer Institute
Schoepfer, R., B.S., Ph.D., University College London, United
Kingdom
Shin, H.-S., M.D., Ph.D., Pohan University of Science and
Technology, Korea
Sterneck, Esta, M.S., Ph.D., National Cancer Institute
Yukawa, K., M.D., Ph.D., Columbia University
emotion in the amygdala.
Malinow, R., Cold Spring Harbor Laboratory. Mechanisms of
hippocampal synaptic plasticity.
Pay lor, R., National Institutes of Health. Neurological tests in
mice.
Tonegawa, S., Massachusetts Institute of Technology. Gene
targeting and the study of learning and memory.
Wilson, M., Massachusetts Institute of Technology. Critical is-
sues in the integration of behavioral and electrophysiologi-
cal studies.
October 31-November 5
INSTRUCTORS
Pearson, William, Ph.D., University of Virginia, Charlottesville
Smith, Randall, Ph.D., SmithKline Beecham Pharmaceuticals
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This course presented a comprehensive overview of the theory and practice of computational
methods for gene identification and characterization from DNA sequence data. The course focused
on approaches to extracting the maximum amount of information from protein and DNA sequence
similarity through sequence database searches, statistical analysis, multiple sequence alignment,
and hidden Markov models (HMMs). Additional topics included gene recognition (exon/intron pre-
diction), identifying signals in unaligned sequences, and integration of genetic and sequence in-
formation in biological databases. The course combined lectures with hands-on exercises; stu-
dents were encouraged to pose challenging sequence analysis problems using their own data.
The course was taught using Unix workstations, and participants were expected to be comfortable
using the Unix operating system, programs, and a Unix text editor (programming knowledge was
not required). The course was designed for biologists seeking advanced training in biological se-
quence analysis, for computer core directors and staff for molecular biology or genetics resources,
and for scientists in other disciplines, such as computer scientists, who wished to survey current
research problems in biological sequence analysis.
PARTICIPANTS
Aaronson, J., B.A., M.S., Merck Research Laboratories, New
Jersey
Budarf, M., B.A., Ph.D., Children's Hospital of Philadelphia
Butler, B., B.A., Ph.D., Genetics Computer Group, Inc., Wis-
consin
Deng, Z., B.S., Ph.D., National Institutes of Health
Glusman, G., B.S., M.S., Weizmann Institute of Science, Is-
rael
Guffanti, A., B.S., Telethon Institute of Genetics and Medi-
cine, Italy
Hirakawa, M., B.S., M.S., Japan Information Center of Bio-
science and Technology
Juvik, G., B.S., M.S., Stanford University, California
Kupfer, K., B.S., Ph.D., University of Texas Southwestern
Medical Center
SEMINARS
Eddy, S., Washington University School of Medicine, St.
Louis, Missouri. Blocks, motifs, domains, and other protein
databases. Multiple sequence comparison with hidden
Markov models.
Gish, W., Washington University School of Medicine, St.
Louis, Missouri. Statistics of sequence similarity scores.
Searching databases with BLAST and friends. NCBI tools
for sequence analysis.
Kerlavage, A., The Institute for Genome Research, Rockville,
Maryland. Genome databases and genome informatics.
Whole genome insights.
Marr, T., Cold Spring Harbor Laboratory. Genome
McCombie, W.R., B.A., Ph.D., Cold Spring Harbor
Laboratory
Mishra, R., B.S., Harvard University Medical School
Mittur, A., B.S., University of Southern California
Peek, A., B.S., M.S., Rutgers University
Pelling, A., B.S., University of Portsmouth, United Kingdom
Richardson, J., B.A., M.S., Ph.D., The Jackson Laboratory
Rosenberg, M., M.S., Ph.D., Massachusetts General Hospital
Santiago-Blay, J., University of Chicago, Illinois
Soriano, N., B.S., CNRS, France
Wang, G., M.S., M.D., University of Alabama
Winkler R., Ph.D., University of Arizona
Zhu, Z., B.S., Ph.D., University of Massachusetts Medical
Center
topographer.
Pearson, W., University of Virginia. Introduction and over-
view. Protein evolution-biology. Practical issues in protein
sequence searching.
Smith, R., SmithKline Beecham Pharmaceuticals, King of
Prussia, Pennsylvania. Introduction to multiple sequence
comparison.
Stormo, G., University of Colorado. Identifying sites in un-
aligned sequences. Gene parsing.
Uberbacher, E., Oak Ridge National Laboratory. Analyzing
eukakryotic genes with GRAIL.
Molecular and Cell Biology of S. pombe and Other Yeasts
November 6-19
INSTRUCTORS
Chappell, Thomas, Ph.D., University College London, United Kingdom
Rachubinski, Richard, Ph.D., McMaster University, Canada
Young, Paul, Ph.D., Queens University, Canada
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ASSISTANT
Chua, Gordon, Queens University, Canada
Williams, Hazel, University College London, United Kingdom
Fission yeast is often chosen as a model system for studies of cell and molecular biology. This
course was designed to introduce the basic genetic, molecular, and cell biological techniques
necessary for investigators to adapt this system to their own laboratory/project. Topics included for-
mal genetics and tetrad dissection, cytology including fluorescent and immunological techniques,
transformation and gene replacement, plasmid recovery, and cell fractionation. Many of the experi-
ments exploited mutant strains affected in cell cycle or cytoskeleton. Against this background,
several other yeast systems of industrial or pathological interest were introduced. The Pichia sys-
tem was used for protein expression, Yarrowia for cell fractionation studies, and Candida for hyphal
transformation. In addition to the laboratory component, invited speakers addressed various
aspects of the biology of these systems.
PARTICIPANTS
Bezbaruah, S., B.S., Ph.D., University College London,
United Kingdom
Caviston, J., B.S., Fox Chase Cancer Center, Pennsylvania
Donald, A., B.S., Ph.D., Babraham Institute, United Kingdom
Drescher, R., B.S., M.S., University of Saarland, Germany
Fisher, R., B.A., M.D., Ph.D., University of California, San
Francisco
Grishchuk, K., M.D., University of Colorado
Hurtado, C.A.R., B.S., University of Sao Paulo, Brazil
SEMINARS
Chappell, T., University College London, United Kingdom.
Wandering along the secretory pathway of S. pombe.
Cregg, J., University of Oregon, Graduate Institute, Portland.
Development and general features of Pichia expression
system. Pichia as a model system for studying peroxisome
biogenesis.
Fink, G., Whitehead Institute, Cambridge, Massachusetts.
Dimorphism in yeast: A model for fungal development.
Leatherwood, J., State University of New York, Stony Brook.
Cell cycle regulation in S. pombe.
Kornacker, M., B.S., Ph.D., Bristol Myers Squibb, New Jersey
Kull, B., B.S., Ph.D., Max-Planck Institute, Germany
Nogi, Y., M.S., Ph.D., Saitama Medical School, Japan
Nose, H., B.S., Ph.D., Meiji Seika Kaisha, Ltd., Japan
Seno, G., B.S., M.S., Ph.D., Lilly Research Labs., Illinois
Severinov, K., M.S., Ph.D., Rockefeller University
Shida, M., B.S., Ph.D., National Research Council, Canada
Tohda, H., M.S., Asahi Glass Co., Ltd., Japan
Zhou, D., B.S., M.S., University of Alabama
McLeod, M., State University of New York, Brooklyn. Mating
type and meiosis in fission yeast. Role of ran kinases in
meiosis.
Rachubinski, P., University of Alberta, Edmonton, Canada.
Mutants of peroxisome assembly in Yarrowia lipolytica.
Waterham, H., University of Oregon, Graduate Institute, Port-
land. Laboratory seminars,
Young, P., Queens University, Kingston, Ontario, Canada.
Sodium transport and salt tolerance in fission yeast.
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Phage Display of Combinatorial Libraries
November 6-19
INSTRUCTORS
Barbas, Carlos, Ph.D., Scripps Research Institute
Burton, Dennis, Ph.D., Scripps Research Institute
Silverman, Gregg, Ph.D., University of California, San Diego
ASSISTANT
Briones, Amelia, University of Strasbourg, France
Fuller, Roberta, Scripps Research Institute
Nayak, Jayakar, University of California School of Medicine, San Diego
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for
the rapid production of antibodies from immune and nonimmune sources. This library/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and selection of desired antibodies from the library. Students learned the theoretical and
practical aspects of constructing combinatorial libraries from immune and nonimmune sources as
well as the construction of synthetic antibody libraries. Antibodies were selected from the library by
panning. Production, purification, and characterization of Fab fragments expressed in E. coli were
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also covered. The lecture series presented by a number of invited speakers focused on PCR of im-
munoglobulin genes, the biology of filamentous phage and the utility of surface expression librar-
ies, expression of antibodies in E. coli and mammalian cells, antibody structure and function,
catalytic antibodies, the whole biology of antibody activity, and recent results on the use of
antibodies in therapy.
PARTICIPANTS
Bazinet, C., B.A., Ph.D., St. John's University.
Cahill, D., B.S., Ph.D., Max-Planck Institute, Germany
Gottstein, C., M.D., University of Texas Southwestern Medi-
cal Center
Hong, H.J., B.S., Ph.D., Korea Research Institute
Massey, R., B.A., University of Nevada
Momany, C., B.A., Ph.D., Purdue University, W. Lafayette, In-
diana
Nathan, S., B.S., M.S., Ph.D., National University of Malaysia
Nilsson, L., M.S., Uppsala University, Sweden
Pasqualini, R., B.S., Ph.D., La Jolla Cancer Research Center,
California
SEMINARS
Kelsoe, G., University of Maryland School of Medicine. Biol-
ogy of an antibody response.
Lowman, H., Genentech, Inc., South San Francisco, Califor-
nia. Additivity and avidity in affinity maturation by phage
display.
Model, P., Rockefeller University. Biology of filamentous
phage.
Nestler, P., Cold Spring Harbor Laboratory. Combinatorial
chemistry.
Persson, M., Karolinska Hospital, Sweden. Eukaryotic ex-
Phelps, J., B.A., Amylin Pharmaceuticals, Inc., California
Probert, W., B.S., Ph.D., Centers for Disease Control and
Prevention, Colorado
Sompuram, S., B.S., M.S., Ph.D., Boston University School of
Medicine
Steel, J., B.S., M.S., Imperial Cancer Research Fund, United
Kingdom
Vazquez-Abad, D., B.S., M.D., University of Connecticut
Health Center
Warren-Stewart, L., B.S., M.S., Pfizer, Inc., Connecticut
Yano, S., M.S., Ph.D., Yamanouchi Pharmaceutical Co., Ltd.,
Japan
pression of human antibodies isolated by phage display.
Scanlan, T., University of California, San Francisco. Catalytic
antibody structure-function.
Scott, J., Simon Fraser University, Burnaby BC, Canada.
Phage-displayed peptide libraries: Their construction,
screening, and general use.
Siegel, D., University of Pennsylvania. Selection of anti-red
cell antibodies by phage display.
Wilson, I.A., Scripps Research Institute. Structural basis of
antibody-antigen recognition.
The Laboratory would like to acknowledge the generosity of the following companies who loaned
equipment and reagents to the various courses:
5 Prime 3 Prime
Arribion
Amersham
Amresco
Andotek
Applied Biosystems/P.E.
Axon Instruments
Beckman Instruments
Becton-Dickenson
Bio-101
Bio-Rad
Biometra
Bioptechs, Inc.
Boehringer Mannheim
Brinkman Instruments
Burleigh Instruments
Carl Zeiss
CBS Scientific
Chroma Technology
Codonics
Corning Costar
David Kopf Instruments
Denton Vacuum
Drummond Scientific
DuPont NEN
Epicentre Technologies Nikon
Fisher Scientific Novagen
FMC Novex
Fotodyne Optronics Engineering
Gatan Pel-Freeze
General Valve Pfanstiehl
Gibco/Life Technologies Pharmacia
Hamamatsu Photometrics
Hoefer Scientific Princeton Separation
Instrutech Promega
lnvitrogen Corp. Oiagen
lsomedix Inc. Replicatech
Kodak Savant Instruments
Kramer Scientific Corp. Scion Image
Laser Science Seikagaku
Leica Siskiyou Design
LP Industries Spectra Physics
Melles Griot Stratagene
Millipore Sutter Instruments
MJ Research Trikinetics
Modulation Optics, Inc. Tropix, Inc.
Molecular Bioproducts Universal Imaging
Morrell Instruments, Inc. Vector Labs
Narishige Vysis
New England Biolabs, Inc. Wallac
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SEMINARS
Invited Speaker Program
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present
their latest findings on a weekly basis. These seminars keep the CSHL staff current on the latest
developments and broaden their perspectives. Graduate students and postdoctoral fellows meet
with the seminar speakers for lunch immediately after the seminar, allowing an opportunity for the
exchange of ideas in an informal setting.
1996
January
Michael Lebl, Selectide Corporation. Combinatorial chem-
istry: From peptide to nonpeptide libraries. (Host: Peter
Nest ler)
Douglas Koshland, Carnegie Institution of Washington.
Yeast chromosome structure is not an oxymoron. (Host:
David Spector)
Sara Courtneidge, Sugen Inc. Src family kinases and the
cell cycle. (Host: Nick Tonks)
Joseph Schlessinger, New York University School of Medi-
cine. Cellular signaling by tyrosine phosphorylation. (Host:
Terri Grodzicker)
February
Allen Oliff, Merck Research Laboratories. Farnesyl trans-
ferase inhibitors as anticancer agents. (Host: Michael
Wig ler)
Michael Stern, Yale University. FGF signaling pathways and
cell migration guidance in C. elegans. (Host: Nick Tonks)
Gyorgy Buzsaki, Rutgers University, Center for Neuro-
science, Network oscillations, irregular bursts, and plas-
ticity in the hippocampal formation. (Host: Alcino Silva)
Derek van der Kooy, University of Toronto, Department of
Anatomy and Cell Biology. What should learning and
memory mutants look like? (Host: Michael Hengartner)
March
Robert Malenka, University of California, San Francisco.
Mechanisms of long-term depression in the hippocampus.
(Host: Roberto Malinow)
Rick Fidel, University of California, San Diego. Receptor-
mediated pathways controlling Dictyostelium develop-
ment. (Host: Hong Ma)
Ken Kemphues, Cornell University, Section of Genetics and
Development. Establishing polarity in the C. elegans em-
bryo: A PAR, of the story. (Host: Michael Hengartner)
Arnie Levine, Princeton University, Department of Molecular
Biology. The regulation of the p53 tumor suppressor gene.
(Host: Terri Grodzicker)
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April
Joseph Ecker, University of Pennsylvania, Department of
Biology. The ethylene gas signaling pathway in plants.
(Host: Hong Ma)
Steve Block, Princeton University, Department of Molecular
Biology. Nanometers and piconewtons: Using optical
tweezers to study biological motors. (Host: David Spector)
Yoshinori Watanabe, University of Tokyo, Department of
Biophysics and Biochemistry. An RNA-binding protein
Mei2 regulates the initiation and the process of meiosis in
fission yeast. (Host: Akila Mayeda)
James Wilson, University of Pennsylvania,
man Gene Therapy. Gene therapy for inherited diseases.
(Host: Ryuji Kobayashi)
October
Randy Shekman, Department of Molecular and Cell Biology,
University of California, Berkeley. Mechanism of cargo
capture early in the secretory pathway. (Host: Kim Arndt)
Alan Hall, MRC Laboratory for Molecular Cell Biology, Uni-
versity College, London. Regulation of the actin cytos-
keleton by RHO GTPases. (Host: Linda Van Aelst)
Ronald Plasterk, Netherlands Cancer Institute, Amsterdam.
G protein function in C. elegans. (Host: Michael Hengart-
ner)
November
Robert Tjian, University of California, Berkeley. Regulation of
transcription in animal cells: Activators, co-activators, and
the basal machinery. (Host: Terri Grodzicker)
December
Andrew McMahon, Harvard University. The role of cell sig-
naling in patterning the vertebrate embryo. (Host: Grigori
Enikolopov)
Timothy Bestor, Columbia University, Biology of genomic
methylation patterns. (Host: Xiaodong Cheng)
Howard Schulman, Stanford University, Department of
Neurobiology. Spatial and temporal regulation of CaM
kinase II: An enzyme with a memory? (Host: Robert
Malinow)
In-House Seminar Program
Cold Spring Harbor In-House Seminars were initiated to provide 'a semiformal avenue for communi-
cation between the various research groups at the Laboratory. They are particularly useful for re-
search personnel who have recently joined the Laboratory. The seminars also afford a necessary
opportunity for the graduate students and postgraduate staff to develop their skills in organizing,
presenting, and defending their research.
1996
January
Alcino Silva: Reverse genetics of learning and memory in
mice.
Patty Springer (Martienssen Lab): Gene-trap patterns in
Arabidopsis shoot development.
Mirjana Maletic-Savatic (Malinow Lab): Dendritic exocytosis:
A novel process linked to plasticity.
February
Michael Regulski (Tully Lab): NO: Genetic tools in Drosoph-
ila.
Rui-Ming Xu (Cheng Lab): The anatomy of casein kinase-1.
Hong Ma: To flower or not to flower: Functional analysis of
AGAMOUS.
Alain Verreault (Stillman Lab): How cells make chromo-
somes.
March
Dong Jing Zou (Cline Lab): The role of CaMKI I in visual sys-
tem development.
Michele Cleary (Herr Lab): The Oct-1 POU domain: Taking
on different shapes and different roles for regulating tran-
scription.
Sanders Williams (Visiting Scientist): Myocyte nuclear fac-
tor: A novel transcriptional regulator involved in control of
differentiation and proliferation of cells in the myogenic
lineage.
Andrew Flint (Tonks Lab): PTP1B, from structure to function.
Kathy O'Neill (Wig ler Lab): RAS's CAP from yeast to human.
April
Ulrich Grossniklaus: Sex or no Sex? The reproductivity biol-
ogy of flowering plants.
Marie Luce Vignais (Gilman Lab): A JAK-STAT pathway in
the PDGF response?
Yuri Lazebnik: Enemies within.
Maria Blasco (Greider Lab): Mouse as a model system for
the study of telomerase.
October
Scott Lowe: Tumor suppressor genes and cellular defense
mechanisms against cancer.
Michael Zhang (Marr Lab): Identification of protein-coding
regions in the human genome based on quadratic dis-
criminant analysis.
November
Winship Herr: Probing a biological machine in vivo: Genetic
analysis of the basal transcriptional apparatus.
Linda Van Aelst: Regulators and effectors of Rac function.
December
Karl Giese (Silva Lab): Learning/memory of mutant mice:
The next generation.
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UNDERGRADUATE RESEARCH
An important aspect of the summer program at the Laboratory is the participation of college un-
dergraduate students in active research projects under the supervision of full-time laboratory staff
members. The program was initiated in 1959. Since that year, 462 students have participated in
the course, and many have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental
principles of biology; (2) an increased awareness of experimental approaches to science; (3) a
deeper understanding of the major issues in the fields of biochemistry and genetics, and
molecular and cellular biology; and (4) a personal acquaintance with research, research workers,
and centers for study.
The following students, selected from over 280 applicants, took part in the program:
M. Nadeem All, Cambridge University
Advisor: Hollis Cline
Sponsor: Olney Foundation
NO and neuronal development.
Martha Betson, Cambridge University
Advisor: Linda Van Aelst
Sponsor: Frederica Von State Fund
Isolation of a full-length clone for POR3, a novel rac-binding
protein.
Casey Blegen, University of Wisconsin
Advisor: Kim Arndt
Sponsor: National Science Foundation
Isolation of high-copy suppressors of the growth defect
caused by overexpression of both SIT4 and SAP155.
Bilyana Georgieva, Mount Holyoke College
Advisor: Bruce Stillman
Sponsor: Burroughs Wellcome Fund
DNA replication: Construction and study of replication factor
C (RFC) conditional mutants.
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Jennifer Gervais, Yale University
Advisor: Gregory Hannon
Sponsor: Burroughs Wellcome Fund
The development of a gene-tagging retroviral technique
using p53 and its transcription factors as a model system.
Jarret Glasscock, University of Arizona
Advisor, Yi Zhong
Sponsor: National Science Foundation
CREB and the signal transduction pathway.
Michael Goller, Penn State University
Advisor: Dr. Yuri Lazebnik
Sponsor: Burroughs Wellcome Foundation
Characterization of apoptosis-relevant endonuclease ac-
tivity.
Christina Grozinger, McGill University
Advisor: Winship Herr
Sponsor: Garfield Foundation
Determination of human cellular proteins interacting with the
carboxyl terminus of HCF via the yeast two hybrid system.
Stephen Haggarty, University British Columbia
Advisor: Bruce Futcher
Sponsor: Libby Internship
G., progression and the molecular basis of Start in the cell
cycle of the yeast Saccharomyces cerevisiae.
Saul Kivimie, Tartus University
Advisor: Arne Stenlund
Sponsor: Glass Foundation
Interaction of papillomavirus El and E2 proteins at the viral
origin of replication.
Tracy Litzi, Cedar Crest College
Advisor: Erich Grotewold
Sponsor: National Science Foundation
PCR-based screening of a Mu grid in maize.
Valerie Maier, University of Glasgow
Advisor: Richard McCombie
Sponsor: Curtis S. Read Foundation
Expression pattern analysis of open reading frames identi-
fied by the Schizosaccharomyces pombe genome se-
quence project.
Jonathan Montagu, Oxford University
Advisor: Peter Nest ler
Sponsor: Shakespeare Internship
The search for a potent and selective inhibitor of PTP-1B.
Teresa Niccoli, Cambridge University
Advisor Adrian Krainer
Sponsor: Jephson Educational Trust
Analysis of PRP 18-binding properties.
Betty Nyein, Massachusetts Institute of Technology
Advisor: Jerry Yin
Sponsor: National Science Foundation
Characterization of the S162 mutation in CREB.
Viktoriya Paroder, SUNY, Stony Brook
Advisor: David Beach
Sponsor: National Science Foundation
Enrichment and isolation of cDNAs from a known region of a
chromosome.
Gera Ida Parvilus, Tuskegee University
Advisor Michael Hengartner
Sponsor: National Science Foundation
Temporal control of gene expression in the nervous system
of the nematode, C. elegans.
Govindan Ramanathan, Rochester Institute of Technology
Advisor Grigori Enikolopov
Sponsor: Mr. and Mrs. Cornelius N. Bliss III
No synthase in the development of Drosophila
melanogaster.
Gloria Jessica Sales, Florida International University
Advisor: Ryuji Kobayashi
Sponsor: National Science Foundation
Isolation and sequencing of endoprotease
Joshua Silverman, University of California, San Diego
Advisor: David Spector
Sponsor: Burroughs Wellcome
The study of structure-function relationships is one of the
fundamentals of modern molecular biology.
Nathan Springer, Southeast Missouri State University
Advisor: Rob Martienssen
Sponsor: Burroughs Wellcome
Molecular and developmental characterization of blade-
less2, a Maize leaf development mutant.
Audrey Wells, University of New Mexico
Advisor Timothy Tully
Sponsor: National Science Foundation
Development of molecular-genetic tools in Drosophila.
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NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to ac-
quire a greater knowledge and understanding of their environment. Through a series of special-
ized field courses, younger students can engage in introductory programs such as Nature Bugs,
Nature Detectives, and Nature Discovery, and older students can enroll in more advanced pro-
grams such as Marine Biology and Nature Photography.
During the summer of 1996, a total of 397 students participated in 28 courses within the pro-
gram. The classes were held outdoors, weather permitting, at the West Side School. The
Laboratory has equipped and maintains classroom and laboratory facilities as well as a darkroom
at West Side School. This facility is used as a base for the students' exploration of the local en-
vironment. Field classes are held on Laboratory grounds, St. John's Preserve, Fire Island National
Seashore, Caumsett State Park, the Cold Spring Harbor Fish Hatchery and Aquarium, as well as
other local preserves and sanctuaries.
In addition to the three, two-week sessions, the Adventure Education course meets on two Fri-
days for trips. The students go on a 10-mile bicycle hike to Sagamore Hill and a 12-mile canoe trip
on the Nissequogue River.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR
Amy Anderson, Cold Spring Harbor Laboratory
INSTRUCTORS
Alison Forte, B.S. in Marine Science, University of Rhode Island
Donna Pandaliano, M.S., Science Teacher, Valley Stream School District
Linda Payoski, M.S., Science Teacher, Uniondale School District
Marjorie Pizza, M.S., Science Teacher, Locust Valley School District
Brian Withers, Fine Arts Teacher, New York City School System
COURSES
Nature Bugs
Nature Detectives
Nature Discovery
Ecology Explorers
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Frogs, Flippers, and Fins
Pebble Pups
Freshwater Life
Seashore Life
Marine Biology
Nature Photography
Adventure Education

BANBURY CENTER
DIRECTOR'S REPORT
The year 1996 was a comparatively quiet one for Banbury Center, with 15 scientific meetings and
5 neurobiology courses, and the Conference Room being used on 12 other occasions. But the
range of topics was broad and the quality of the meetings was high. Of the 492 scientists who
came to the Center, 79 (16%) came from abroad, with scientists from the United Kingdom,
Germany, and France predominating. Of the participants from the United States, most came from
states with the highest concentrations of biomedical research institutions and companies, with four
states (California, Maryland, Massachusetts, and New York) accounting for more than 50% of
participants. Nevertheless, the geographical distribution was wide, with participants coming from
31 states. It is notable that no fewer than seven Nobel Laureates came to Banbury Center in 1996.
Another highlight of the year was, of course, the record snowfall of the 1995-1996 winter-73 in-
ches here on Long Island-and we were fortunate to escape serious disruption to the 1996 pro-
gram.
"Basic" Research
The 1996 meetings dealing with the molecular biology of the cell were outstanding in their
coverage of fascinating processes. Two dealt with DNA, albeit in very different contexts. In 1995,
Rich Roberts and Xiadong Cheng described the interaction of a DNA methylase enzyme with a
DNA molecule and showed that the cytosine base being methylated was "flipped" out of the double
helix in a totally unexpected way. The meeting, DNA Base "Flipping': How and Why, reviewed new
evidence that "base flipping" may be not be restricted to DNA methylases and may be a more gen-
eral mechanism used by other enzymes for interactions with DNA molecules.
Another novel process in the cell is the means by which it replicates telomeres, the ends of the
chromosomes. With the discovery of telomerase, the enzyme that makes telomeres, and data im-
plicating telomeres in cancer and aging, this is a very "hot" area of research. Telomeres and
Telomerase followed up on an historic Banbury Center meeting from 1994, and itself proved to
have been held at just the right moment.
In contrast to telomeres and telomerase (a relatively new area of research), Mechanisms of
Transcriptional Initiation discussed one of the oldest problems in molecular biology, namely, how
RNA molecules are made from the appropriate genes and at the appropriate times. This was an ex-
traordinary workshop, a veritable summit meeting of the world's leading researchers. The schedule
was also remarkable in being developed as the meeting progressed, with speakers limited to a few
minutes and a few slides. It was very effective, a tribute to the hard work of the organizers, session
chairs, and participants.
The remaining two meetings dealt with cells rather than molecules. Plant Reproductive Biology
covered a range of topics of special interest to those breeding and developing new strains of
plants. The meeting was a survey of recent research including processes such as cytoplasmic
male sterility, self-incompatibility, and apomixis. Animal mesenchyme cells are fascinating, being
involved in many developmental processes and having many different functions. The properties
and roles of these cells were examined in Cellular and Molecular Biology of Mesenchyme. It was a
great pleasure to work with Dan Marshak, a former scientist here at the Laboratory, in his new role
of Director of Research for Osiris Therapeutics, Inc.
Human Genetics
Just a few years ago, it was found that the genetic abnormality in Huntington's Disease was the
presence of triplet repeats in the gene, leading to tracts of glutamines in the Huntingtin protein.
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Conference Center (Photo by J. Witkowski)
Such mutations had never been observed before, and this remarkable finding has become even
more remarkable as other disorders with the same type of mutation have been discovered, all af-
fecting the nervous system. The Triplet Repeats and Polyglutamine Tracts meeting brought togeth-
er an eclectic group of scientists, not all of whom work on these disorders, to try to determine how
to move the research from the genetic level to the biochemical and cellular levels. We were espe-
cially pleased to have Max Perutz attend and tell us of his work on a special type of protein-protein
interaction.
Manic-depressive Illness: Evolutionary and Ethical Issues combined interesting scientific ques-
tions with societal issues. The scientific questions dealt with the adaptive advantages of mutations
that are highly deleterious yet relatively common and widespread. The societal issues relating to
the genetics of manic-depressive illness (MDI) are complicated by the apparent social benefits
derived from some individuals afflicted by the illness. The meeting discussed what is known of the
individual and social costs of MDI, and how these affect ethical questions regarding diagnosis.
Vaccines
In recent years, Banbury Center has been the site of several workshops on infectious diseases and
vaccines funded by the Albert B. Sabin Vaccine Foundation. The Foundation supported two further
meetings in 1996. AIDS Vaccine Initiative, held in March, reviewed the current state of affairs on
. developing an effective vaccine against HIV. This is a highly complex problem, in which economics
and political considerations appear to play a role at least as large as scientific research. Fortunate-
ly, the organizers and the Foundation were able to involve individuals across a broad spectrum of
interests who talked candidly about the difficulties involved.
The March meeting laid the groundwork for a second meeting in November, that was supported
also by the National Institute of Allergy and Infectious Diseases, on Case Studies in Vaccine Devel-
opment. Here participants analyzed in depth examples of vaccine development and produc-
tion-both successful and unsuccessful-with a view to learning what works and what is to be
avoided. It was a very interesting meeting, and instructive in dealing with real-life cases rather than
abstract models.
Neuroscience
Neurobiology continues to play a large part in the Banbury Center year. There are the neurobiology
courses in the summer, and in the autumn of 1996 there were also two neuroscience meetings.
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One meeting brought together studies of two rather different systems. On the one hand, glutamate
receptors are known to play key roles in nerve and synapse development, while on the other, there
is the phenomenon of synaptic plasticity in which synaptic activity produces long-lasting changes.
Plasticity of Glutamate Receptors examined whether new data on the functioning of glutamate
receptors can help in understanding the mechanisms underlying synaptic plasticity.
Synaptic plasticity may be important in learning and in the establishment of memory. Genetic
Approaches to Learning and Memory reviewed recent advances in finding genes involved in learn-
ing and memory. In addition, participants covered some of the social issues involved in the estab-
lishment of a new field of research; in this case, the use of transgenic mice to study the genetic
basis of learning and memory. These issues include developing fruitful relationships between two
groups of researchers-molecular biologists and neurophysiologists--that have not interacted be-
fore, and establishing methodological standards.
Biotechnology
This year, only one Banbury Center meeting was directly concerned with a biotechnology topic.
Some years ago, there was great optimism that DNA molecules could be used as therapeutic
agents. But while the DNA molecule is versatile, its properties are not what the molecular biologist
needs to modify gene expression in living cells. Modified Nucleic Acids: Chemistry and Applica-
tions examined the ways in which DNA molecules can be chemically modified so that they retain
their properties but are easier to get into cells and are more stable when they are there.
Participants included organic chemists-specialists at making new molecules-and molecular
biologists who are trying to use these compounds.
The Executives' Conference
This series of meetings has become legendary for the variety of topics covered, and for the ex-
traordinarily high quality of both scientist-speakers and executive-guests. This year's meeting was
no exception and perhaps had an added benefit in that the topic, Human Development, was un-
familiar to many at the meeting. Even more so than usual, we asked the participants to go on a long
intellectual journey with us: from patterning in the embryo, through human embryonic development
and the development of gender differences, to the fertilization and manipulation of human embryos
in vitro. I was delighted to have two long-time friends participate-Lewis Wolpert, who published
the seminal paper on pattern formation in embryos, and Robert Winston, who developed
preimplantation genetic testing, and who now, as Lord Winston, speaks in the House of Lords on
these issues.
"Education" for Nonscientists
Banbury Center has for many years held workshops on modern biomedical research for groups of
nonscientists, but this year, we did something rather special when some 20 federal and state
judges came to Banbury for a 10-day workshop on The Art of Judging: Perspectives of Science.
Funded by the Federal Judicial Center in Washington, D.C., this was a most interesting workshop,
covering not just genetics, but also statistics in the courtroom, risk assessment, and the history and
philosophy of science. A highlight of the meeting was a talk by Laurie Garrett based on her interna-
tional best seller, The Coming Plague. The workshop received very high ratings from the
participants and we expect that the Federal Judicial Center will return in 1997.
One of the most important and influential series of meetings ever held at Banbury Center was
that funded by the Alfred P. Sloan Foundation. Over a period of 12 years, the Sloan Foundation pro-
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vided funds to invite Congressional staff and science journalists to Banbury for workshops on
biomedical research that has an immediate impact on the public. These workshops were very high-
ly regarded by the participants and provided us with invaluable connections in organizations as
varied as the Congressional Research Service and the National Association of Science Writers.
Cold Spring Harbor Laboratory Public Affairs and Banbury Center decided that these workshops
were so valuable that we should do at least one more, and so the Science Journalists Workshop on
Genetics of Human Behavior took place in November. The entire meeting dealt with controversial
issues and we were fortunate in having the leading researchers come to us, including Dean Hamer,
who was the first to find an association between a genetic locus and male homosexuality.
Courses at Banbury Center
As usual, Banbury Center, during the summer months, was host to five courses, organized by the
Laboratory's Meetings Office: Genetic-Epidemiological Studies of Complex Diseases; Neurobiology
of Human Neurological Disease; Computational Neuroscience: Vision; Neurobiology: Brain Devel-
opment and Function; and Advanced Drosophila Genetics.
Other Meetings
Banbury Center is such a wonderful facility that we are glad to make it available to the local com-
munity. In 1996, the Center was used for one-day retreats by the Lloyd Harbor Conservation Board,
Cold Spring Harbor School District, Family Service League, and Huntington Hospital. In addition,
Susan Cooper of Public Affairs organized a Lloyd Harbor seminar for residents of the Village.
Banbury Center on the World Wide Web
The Internet, and particularly the World Wide Web (WWW), has become an indispensable tool for
all scientists, including myself. Through it, I can locate people; find out what research they do and
where it has been published; and send letters and invitations via e-mail to participants in our meet-
Robertson house (left) and Sammis Hall (right) provide housing accommodations at Banbury Center.
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ings. It was inevitable, then, that Banbury Center would have its own web site. Here, we publish our
annual report; provide descriptions of the Center and the style of our meetings; and important in-
formation such as maps and directions on how to reach us. A link to our web pages can be found
on the Laboratory's home page at www.cshl.org.
Funding
It is impossible to overstate the importance of the contributions made by members of the Cold
Spring Harbor Laboratory Corporate Sponsor Program to the Banbury Center. Funds from this Pro-
gram continue to be essential for a large part of the Banbury Center's activities and provide a firm
basis for the rest of our program. In 1996, there were seven meetings for Corporate Sponsors, an
increase due to the success of the Plant Associate Program that provided funds for a plant science
meeting on Plant Reproductive Biology. Other Corporate Sponsor meetings were Plasticity of
Glutamate Receptors; DNA Base "Flipping": How and Why; Telomeres and Telomerase; Triplet
Repeats and Polyglutamine Tracts; and Modified Nucleic Acids: Chemistry and Applications.
Companies in the biotechnology world continue to be important sponsors of meetings on topics
of special interest to them. All such proposals received must satisfy the same high standards of
scientific interest and relevance to the Laboratory's range of research and educational inter-
ests-we do not merely rent out the Conference Center-and the meetings are organized in the
same way as all our meetings. In 1996, Osiris Therapeutics funded the meeting on Cellular and
Molecular Biology of Mesenchyme, while Geron Corporation contributed to the meeting on
Telomeres and Telomerase.
J.P. Morgan, Inc. was again very generous in its support of the Executive Conference on
Human Development, enabling us to invite scientists of the highest caliber and providing a wonder-
ful ambience in which to listen to and ponder the very best of modern biomedical research.
Foundations and other nonprofit organizations made significant contributions to our year. Our
long association with three Foundations led to four meetings. The Albert B. Sabin Foundation sup-
ported the two meetings relating to vaccines: AIDS Vaccine Initiative and Case Studies in Vaccine
Development, the Charles A. Dana Foundation provided funds for Manic-depressive Illness: Evolu-
tionary and Ethical Issues; and the Hereditary Disease Foundation contributed to the meeting Tri-
plet Repeats and Polyglutamine Tracts. The meeting on Genetic Approaches to Learning and
Memory was funded by the Marie H. Robertson Memorial Fund for Neurobiology. Finally, the Feder-
al Judicial Center supported the fascinating meeting for federal and state judges.
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MEETINGS
Cellular and Molecular Biology of Mesenchyme
February 11-February 14
FUNDED BY
Osiris Therapeutics, Inc.
ARRANGED BY
D.R. Marshak, Osiris Therapeutics, Inc , Baltimore, Maryland
SESSION 1: Skeletal
Chairperson: D.K. Heinegard, University of Lund, Sweden
A.I. Caplan, Case Western Reserve University, Cleveland,
Ohio: The mesengenic process and its relationship of
skeletogenesis and hematopoesis.
D.J. Prockop, Thomas Jefferson University, Philadelphia,
Pennsylvania: Potential uses of marrow stromal cells for
therapy of genetic diseases of bones and cartilage.
M.W. Long, University of Michigan, Ann Arbor: Bone-marrow-
derived human osteoprogenitor cells.
G.A. Rodan, Merck Sharp and Dohme Research Labora-
tories, West Point, Pennsylvania: Osteoblast requirement
for osteoblast formation in culture.
D.K. Heinegard, University of Lund, Sweden: Macromole-
cule markers of chondrocyte and osteoblast development.
R. St-Arnaud, Shriners Hospital, Montreal, Quebec, Canada:
Abnormal bone development in mice with targeted muta-
tions in the gene for 25-hydroxyvitamin-D-24-hydroxylase.
B. DeCrombrugghe, M.D. Anderson Cancer Center, Hous-
ton, Texas: Approaches to chodrocyte and osteoblast dif-
ferential.
SESSION 2: Marrow
Chairperson: B. Torok-Storb, The Fred Hutchinson Cancer Research Center, Seattle,
Washington
C.I. Civin, The Johns Hopkins Oncology Center, Baltimore,
Maryland: Lessons from lymphohematopoiesis.
P.J. Quesenberry, University of Massachusetts Medical Cen-
ter, Worcester: Marrow stromal and cytokine regulation of
primitive marrow stem cells.
S.L. Gerson, Case Western Reserve University, Cleveland,
Ohio: Mesenchymal stem cells as a gene therapy target.
SESSION 3: Muscle
Chairperson: C. Ordahl, University of California, San Francisco
C. Ordahl, University of California, San Francisco: Early
skeletal muscle development.
E.N. Olson, University of Texas Southwestern Medical Cen-
ter, Dallas: bHLH factors as regulators of somatogenesis.
B. Wold, California Institute of Technology, Pasadena: Multi-
ple pathways to skeletal muscle.
L.A. Leinwand, University of Colorado at Boulder: Special-
ized function or redundancy in muscle gene families.
J.M. Leiden, The University of Chicago, Illinois: The role of
GATA-4 in cardiac myocyte differentiation.
H.M. Blau, Stanford University, California, Muscle-mediated
gene therapy.
M.A. Thiede, Osiris Therapeutics, Inc., Baltimore, Maryland:
Reinfusion of mesenchymal stem cells for stromal
reconstitution following lethal irradiation.
B. Torok-Storb, The Fred Hutchinson Cancer Research Cen-
ter, Seattle, Washington: Functional components of the
marrow microenvironment.
L.A. Leinwand, E.N. Olson, C. Ordahl
SESSION 4: Vasculature
Chairperson: W.H. Burgess, American Red Cross/Holland La
B. Christ, Anatomisches Institut, Freiburg, Germany: Devel-
opment of the embryonic vascular system.
W.H. Burgess, American Red Cross/Holland Laboratory,
Rockville Maryland: FGF-1 and mitogenic signal transduc-
tion: Targeting specificity.
D. Bowen-Pope, University of Washington, Seattle: Role
PDGF in connective tissue development and function.
boratory, Rockville, Maryland
L. Demer, University of California, Los Angeles: Pluripotent
mesenchymal cells in artery wall calcification.
R. Bucala, The Picower Institute for Medical Research, Man-
hasset, New York: Fibrocytes: A circulating cell population
involved in tissue repair.
SESSION 5: Connective Tissue/Neural Crest/Other
Chairperson: D.R. Marshak, Osiris Therapeutics, Inc., Baltimore
D.R. Marshak, Osiris Therapeutics, Inc., Baltimore, Mary-
land: Introductory remarks.
W.E. Wright, University of Texas Southwestern Medical Cen-
ter, Dallas: Telomeres, aging, and the senescence of stem
cells.
D.M. Noden, College of Veterinary Medicine, Cornell Univer-
sity, Ithaca, New York: Lineage analyses of craniofacial
mesenchymal populations.
J.M. Lauder, University of North Carolina, Chapel Hill:
Regulation of embryonic craniofacial mesenchyme differ-
entiation by serotonin.
, Maryland
H.C. Slavkin, National Institute of Dental Research, Be-
thesda, Maryland: Specifications for the cell images for
cartilage, bone and teeth.
M. Moos, Center for Biologics Evaluation & Research, Food
& Drug Administration, Rockville, Maryland: Biologist
meets bureaucrat: The interface between innovation and
regulation in contemporary therapeutics.
C. Ordahl, University of California, San Francisco: Closing
remarks.
Modified Nucleic Acids: Chemistry and Applications
March 17-March 20
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
M. Matteucci, Gilead Sciences, Inc., Foster City, California
P. Nelson, The Panum Institute, Copenhagen, Denmark
M.H. Caruthers, S. Gryaznov, P.P. Herdewijn
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SESSION 1: Modified Backbones
Chairperson: D. Cook, ISIS Pharmaceuticals, Inc.,
Carlsbad, California
M.H. Caruthers, University of Colorado, Boulder: Chemical
synthesis and biochemical studies with dithioate and
boranephosphate DNA.
A. Eschenmoser, Laboratorium fur Organische Chemie,
Zurich, Switzerland: Pyranosyl-RNA.
P.P. Herdewijn, Rega Institute, Leuven, Belgium: Backbone
modifications resulting in strong hybridizing oligonu-
cleotides.
B.R. Shaw, Duke University, Durham, North Carolina:
Properties of boronated nucleic acids.
S.A. Benner, ETH-Zentrum, Zurich, Switzerland: Modified
nucleobases; modified sugars; modified linkers.
SESSION 2: Novel Nucleobases
Chairperson: S. Benner, ETH-Zentrum, Zurich, Switzerland
F. See la, Universitat Osnabruck, Germany: The control of
DNA structure by modified purines.
D.E. Bergstrom, Purdue University, West Lafayette, Indiana:
Wild-card" bases: Design and synthesis.
E.T. Kool, University of Rochester, New York: Altering the
functional properties of DNA without modifying the back-
bone.
T.S. Widlanski, Indiana University, Bloomington: Expanding
the genetic backbone; synthesis of sulfonate-modified
nucleic acids and their interactions with polymerases.
M. Matteucci, Gilead Sciences, Inc., Foster City, California:
Covalent and noncovalent conformational restriction of
oligonucleotides.
M. Waring, University of Cambridge, United Kingdom:
Moving the purine 2-amino group around: Effects on se-
quence recognition and ligand binding.
SESSION 3: Functional Oligos
Chairperson: A. Eschenmoser, ETH-Zentrum, Zurich, Switzerland
R.L. Letsinger, Northwestern University, Evanston, Illinois:
Controlling properties of oliogonucleotides by chemical
modifications.
R.B. Meyer, Epoch Pharmaceuticals, Bothell, Washington:
Specific modification of genomic DNA with reactive
oligonucleotides.
J. Sun, INSERM, CNRS, Paris, France: Oligonucleotide-
directed triple helix formation: Stabilization and extension
of recognition sequences of triple helices.
SESSION 4: Physical Chemistry and Structure
Chairperson: R. Letsinger, Northwestern University, Evanston,
K.J. Breslauer, Rutgers University, Piscataway, New Jersey:
Nucleic acid hybridization, stability, and ligand-binding
properties: A thermodynamic perspective.
A. Graslund, Arrhenius Labs, Stockholm, Sweden: Stability
and dynamics of PNA/DNA complexes.
S.R. Jordan, Glaxo Wellcome, Research Triangle Park, North
Carolina: Crystal structure of PNA2: DNA triplex.
SESSION 5: Gene Therapeutic Leads
Chairperson: J. Feigon, University of California, Los Angeles
J. Summerton, Antivirals Inc., Corvallis, Oregon: Design,
preparation, and properties of morpholino antisense oligos.
S. Gryaznov, Lynx Therapeutics, Inc., Hayward, California:
Synthesis and physicochemical properties of oligonucle-
otide phosphoramidates.
P.E. Nielsen, The Panum Institute, Copenhagen, Denmark:
PNA (peptide nucleic acids). What have we learned and
where does it lead?
M. Frank-Kamenetskii, Boston University, Massachusetts:
Sequence-specific targeting of duplex DNA with peptide
nucleic acid (PNA).
D.H. Turner, University of Rochester, New York: Binding of
oligonucleotides to the catalytic site of a group I ribozyme.
O.D. Scharer, Harvard University, Cambridge, Massachu-
setts: The use of modified nucleic acids to study DNA
repair enzymes.
Illinois
J. Feigon, University of California, Los Angeles: Solution
structures of DNA triplexes containing modified
nucleotides.
S.M. Freier, ISIS Pharmaceuticals, Inc., Carlsbad, California:
Modified antisense oligonucleotides: Hybridization
pharmacokinetics and pharmacology.
P.D. Cook, ISIS Pharmaceuticals, Inc. Carlsbad, California:
Making drugs out of oligonucleotides.
S. Agrawal, Hybridon, Inc., Worcester, Massachusetts:
Antisense properties of oligonucleotide analogs.
H.E. Moser, Ciba-Geigy Ltd., Basel, Switzerland: Modified
antisense oligonucleotides: From structure to biological ac-
tivity in animals.
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AIDS Vaccine Initiative: The Sabin Foundation's Role
March 24-March 26
FUNDED BY
Albert B. Sabin Vaccine Foundation
ARRANGED BY
M.R. Hilleman, Merck Research Institute, West Point, Pennsylvania
M.L. Clements, The Johns Hopkins University, Baltimore, Maryland
SESSION 1: Challenges
Chairperson: M.R. Hilleman, Merck Research Institute, West Point, Pennsylvania
M. R. Hilleman, Merck Research Institute, West Point,
Pennsylvania: AIDS Vaccine Initiative: Challenges and
directions in targeted research.
R. Kurth, Paul-Ehrlich-Institut, Langen, Germany: Perspec-
tive of the European community.
SESSION 2: Identifying Obstacles and Opportunities in Research on HIV Vaccines
Facilitator: L.A. Miller, Intermedica, Inc., Norwalk, Connecticut
SESSION 3: Federal and Foundation Initiatives
Chairperson: D. Bolognesi, Duke University Medical Center,
J. Killen, NIAID, National Institutes of Health, Bethesda,
Maryland: Perspective of NIAID.
D. Bolognesi, Duke University Medical Center, Durham,
North Carolina: The problems that confront the evolution of
the Vaccine Initiative as seen from the OAR deliberations.
H.R. Shepherd, Albert B. Sabin Vaccine Foundation, New
Canaan, Connecticut and S.M. Shapero, Beverly Hills, Cali-
fornia: The role of foundations in the AIDS Vaccine Initia-
tive.
Durham, North Carolina
Panel and General Discussion: Future Roles of Govern-
ment and Foundations
Moderator: L.A. Miller, Intermedica, Inc., Norwalk, Con-
necticut
D. Henderson, Johns Hopkins University, Baltimore, Maryland
K.I. Shine, National Academy of Sciences, Washington, D.C.
J. Lederberg, The Rockefeller University, New York, New York
SESSION 4: How Can the Sabin Foundation Best Organize Its Efforts to Increase the Prob-
ability of Developing an Effective HIV Vaccine?
Chairperson: M.L. Clements, Johns Hopkins University School of Public Health, Baltimore,
Maryland
H.R. Shepherd, Albert B. Sabin Vaccine Foundation, New
Canaan, Connecticut: The resources of the Sabin Foun-
dation over the next three years.
Building a Consensus: Parts 1 and 2
Facilitator: L.A. Miller, Intermedica, Inc., Norwalk, Connecticut
M.L. Clements, Johns Hopkins University School of Public
Health, Baltimore, Maryland: Conclusions: Drawing up a
list of goals.
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DNA Base "Flipping": How and Why
April 7-April 10
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
X. Cheng, Cold Spring Harbor Laboratory
R.S. Lloyd, University of Texas Medical Branch, Galveston, Texas
SESSION 1: Biophysical Considerations of Base Flipping
Chairperson: D.J. Patel, Memorial Sloan-Kettering Cancer Center,
R.J. Roberts, New England BioLabs, Inc., Beverly, Massa-
chusetts: The origin of base flipping.
D.J. Patel, Memorial Sloan-Kettering Cancer Center, New
York, New York: Bulge and loop conformations in RNA.
M. Weiss, University of Chicago, Illinois: Florescence studies
of DNA bending. L.
D.G. Gorenstein, University of Texas Medical Branch, Gal-
SESSION 2: DNA Methyltransferases
Chairperson: X. Cheng, Cold Spring Harbor Laboratory
G. Schluckebier, Freie Universitat Berlin, Germany: Three- S.
dimensional structure of adenine specific DNA-
methyltransferases from Thermus aquaticus.
G.I. Verdine, Harvard University, Cambridge, Massachusetts: E.
Keepers of the code: Studies on proteins that decorate
and mend the genome.
X. Cheng, Cold Spring Harbor Laboratory: Hhal methyltrans-
ferase.
New York, New York
veston: NMR structure of a dG base flipping in a
benzo(a)pyrene diol epoxide duplex adduct.
. Goodman, University of Southern California, Los Angeles:
Evidence for the occurrence of ionized base mispairs dur-
ing DNA synthesis.
S. Beese, Duke University Medical Center, Durham, North
Carolina: Structure of DNA polymerise -DNA complexes.
Klimasauskas, Institute of Biotechnology, Vilnius,
Lithuania: Stopped-flow fluorescence studies of
methyltransferase-induced base-flipping in DNA.
Weinhold, Max-Planck-Institut fuer Molekulare Physiologie,
Dortmund, Germany: Evidence for a base flipping mechan-
ism by the adenine-specific DNA methyl-transferase from
Thermus aquaticus.
H.H Thorp, R.J. Roberts
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SESSION 3: DNA Repair Enzymes
Chairperson: R.S. Lloyd, University of Texas Medical Branch,
S. Wallace, University of Vermont, Burlington: Processing of
oxidative DNA base lesions.
J.A. Tainer, The Scripps Research Institute, La Jolla, Califor-
nia: Crystal structures and mutational analysis of DNA
base-excision repair enzymes: Structural basis for
specificity and catalysis.
R.P. Cunningham, State University of New York, Albany:
Novel motifs for substrate recognition by the repair enzyme
endonuclease III.
K. Morikawa, Protein Engineering Research Institute, Osaka,
Japan: Crystal structure of pyrimidine dimer excision-
SESSION 4: DNA Repair Enzymes
Chairperson: R.J. Roberts, New England BioLabs, Inc.,
Beverly, Massachusetts
R. Savva, University College London, United Kingdom: Fur-
ther investigations of the mode of action of uracil-DNA
glycosylase.
D.W. Mosbaugh, Oregon State University, Corvallis: Struc-
ture, function, and interaction of E. coli uracil-DNA
glycosylase with the Ugi protein.
B. Demple, Harvard University School of Public Health, Bos-
ton, Massachusetts: Is there a role for base flipping in AP
endonucleases?
A.-L. Lu-Chang, University of Maryland, Baltimore: Interac-
tion of mismatch-containing DNA with E. coli MutY and
mammalian MutY homologs.
T. Ellenberger, Harvard Medical School, Boston, Massachu-
setts: Crystal structure of E. coll.
Plant Reproductive Biology
Galveston
repair enzyme complexed with DNA: A novel flipping-out
mechanism.
H.-W. Park, Duke University Medical Center, Durham, North
Carolina: The structure of DNA photolyase: Insights into
substrate binding mode.
R.S. Lloyd, University of Texas Medical Branch, Galveston:
Mechanism of endonuclease V.
L. Grossman, The Johns Hopkins University, Baltimore,
Maryland: DNA structures induced by RNAP as 'start' sets
for DNA repairs.
SESSION 5: DNA Trans-actions
Chairperson: S.M. Linn, University of California, Berkeley
S.M. Linn, University of California, Berkeley: Other DNA
repair processes that might relate to base flipping.
H.H. Thorp, The University of North Carolina at Chapel Hill:
Detecting single base mismatches: Consequences of base
flipping.
P.C.E. Moody, University of Leicester, United Kingdom: Why
should 06-MeG-DNA methyltransferases flip?
D.B. Wig ley, University of Oxford, United Kingdom: 'Base
flipping' in DNA ligases.
P.S. Freemont, Imperial Cancer Research Fund, London,
United Kingdom: A DNA glucosyltransferase from T4
phage: Structure and function.
B.L. Bass, HHMI, University of Utah, Salt Lake City: Double-
stranded RNA adenosine deaminase.
April 21-April 24
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
R. Pruitt, Harvard University, Cambridge, Massachusetts
SESSION 1: Male Reproductive Development I
Chairperson: P.S. Schnable, Iowa State University, Ames
R. Pruitt, Harvard University, Cambridge, Massachusetts:
Genetic analysis of reproduction in Arabidopsis.
M.C. Albertsen, Pioneer Hi-Bred International, Inc., Johnston,
Iowa: Cloning and characterizing male fertility genes in
maize.
S. McCormick, Plant Gene Expression Center, Albany, Cali-
fornia: Cell division mutations in Arabidopsis pollen devel-
opment.
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D. Twell, University of Leicester, United Kingdom: Gene
regulation and cell determination in male gametophyte de-
velopment.
W.Z. Cande, University of California, Berkeley: Chromosome
behavior during meiotic prophase in maize meiocytes.
S.H. Strauss, Oregon State University, Corvallis: Floral
homeotic genes as tools for engineering complete
reproductive sterility in Populus and other forest trees.
SESSION 2: Male Reproductive Development II
Chairperson: M. Albertsen, Pioneer Hi-Bred International, Johnston, Iowa
D. Preuss, University of Chicago, Illinois: An Arabidopsis
mutant defective in pollen tube guidance exhibits self-
sterility.
C.S. Levings III, North Carolina State University, Raleigh:
The Texas male-sterile cytoplasm of maize.
P.S. Schnable, Iowa State University, Ames: Fertility restora-
tion of cytoplasmic male sterility: Molecular analysis of
the r2 restorer of cmsT maize.
S. Mackenzie, Purdue University, West Lafayette, Indiana:
Tissue-specific expression of a mitochondria! sequence
influences pollen development in cms bean.
M. Hanson, Cornell University, Ithaca, New York: Cytoplas-
mic male sterility in Petunia.
SESSION 3: Female Reproductive Development
Chairperson: H. Dickinson, University of Oxford, United Kingdom
J.L. Bowman, University of California, Davis: Molecular
genetics of carpel development.
J.A. Verbeke, University of Arizona, Tucson: Fusion events
during gynoecium development.
C.S. Gasser, University of California, Davis: Genetic analysis
of ovule development.
U. Grossniklaus, Cold Spring Harbor Laboratory: Enhancer
detection as a tool to study reproductive development in
Arabidopsis.
of Reproductive Systems
Chairperson: U. Grossniklaus, Cold Spring Harbor Laboratory
C.F. Crane, Texas A&M University, College Station: Develop-
mental implications of apomixis.
R. Bicknell, Crop & Food Research Ltd., Christchurch, New
Zealand: Development of Hieracium as a model system to
study apomixis.
A.M. Chaudhury, CSIRO Division of Plant Industry, Australia:
Fertilization-independent seed development.
S.C. De Vries, Agricultural University Wageningen, The
Netherlands: Signal transduction in the early plant embryo.
SESSION 5: Self-incompatibility/Fertilization
Chairperson: A.M. Chaudhury, CSIRO, Canberra City, Australia
H. Dickson, University of Oxford, United Kingdom: Defensin-
like proteins in the pollen coating of Brassica.
J.B. Nasrallah, Cornell University, Ithaca, New York: Self-
incompatibility in Brassica.
F.C.H. Franklin, University of Birmingham, United Kingdom:
Self-incompatibility in Papauer rhoeas: Progress toward
elucidation of the molecular basis of pollen-pistil recogni-
tion.
T.-H. Kao, Pennsylvania State University, University Park:
Role of Petunia receptor kinase PRK1 in pollen and embryo
sac development.
S.H. Strauss
J.M. Herr, Jr., University of South Carolina, Columbia: A new
perspective of ovule and female gametophyte evolution.
A. Ray, University of Rochester, New York: Floral initiation
and ovule development.
R. Fischer, University of California, Berkeley: Control of ovule
development in Arabidopsis.
U. Goodenough, Washington University, St. Louis, Missouri:
Why and how have sex genes evolved?
J.A. Banks, Purdue University, West Lafayette, Indiana:
Mechanisms of sex determination in homosporous ferns;
alternation of generations.
E. Lord, University of California, Riverside: Pollination as a
case of cell adhesion and cell movement.
W.E. Friedman, University of Colorado, Boulder: Comparative
and phylogenetic approaches to reconstructing the evolu-
tion of plant reproductive patterns.
S.D. Russell, University of Oklahoma, Norman: Structural
considerations in angiosperm fertilization.
C. Dumas, Ecole Norma le Superieure, Lyon, France: How to
investigate fertilization in flowering plants.
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Triplet Repeats and Polyglutamine Tracts
May 5-May 8
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program and the Hereditary
Disease Foundation
ARRANGED BY
D. Housman, Massachusetts Institute of Technology, Cambridge
D. Nelson, Baylor College of Medicine, Houston, Texas
A. Tobin, University of California, Los Angeles
N.S. Wexler, College of Physicians & Surgeons of Columbia University, New York, New York
SESSION 1: Clinical Presentation
N.S. Wexler, College of Physicians & Surgeons of Columbia
University, New York, New York
SESSION 2: Triplet Repeat Diseases
A.B. Young, Massachusetts General Hospital, Boston: Inter-
action of polyglutamines with mitochondria! import proteins
or leader sequences.
J.F. Gusella, Massachusetts General Hospital, Charlestown:
Huntington's disease.
C. Ross, The Johns Hopkins University, Baltimore,
HD, DRPLA.
J.M. Vance, Duke University Medical Center, Durham, North
Carolina: Similarities of the GAG trinculeotides and the
uniqueness of the nervous system in neurogenetics.
SESSION 3: Polyglutamine Tracts
M. Perutz, MRC Laboratory of Molecular Biology, Cam-
bridge, United Kingdom: Incorporation of glutamine
repeats in a small protein causes irreversible association
into oligomers.
K. Stott, MRC Laboratory of Molecular Biology, Cambridge,
C. Ross, N.S. Wexler, S. Fields
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D.L. Nelson, Baylor College of Medicine, Houston, Texas:
Fragile X syndrome update.
P. Patel, Baylor College of Medicine, Houston, Texas: The
Friedreich's ataxia intronic GAA expansion: What does it
do?
K. Taneja, University
cester: Detection of triplet repeats by in situ hybridization.
Discussion: Triplet repeat disorders.
United Kingdom: The oligomerization mechanism of a model
protein with engineered glutamine repeats.
C.T. Caskey, Merck Research Laboratories, Merck & Co.,
Inc., West Point, Pennsylvania: New date on triplet binding
proteins.
SESSION 4: Protein-Protein Interactions
S. Fields, University of Washington, Seattle: Yeast hybrid
methods to analyze protein-protein and RNA-protein inter-
actions.
T. Dawson, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Expansion of polyglutamine repeat
in Huntington leads to abnormal proteins interactions in-
volving calmodulin.
J.R. Burke, Duke University Medical Center, Durham, North
Carolina: Possible roles for GAPDH in polyglutamine
repeat diseases.
B. Koshy, Baylor College of Medicine, Houston, Texas: Char-
acterization of ataxia-1 and its interactions with GAPDH.
R. Brent, Massachusetts General Hospital, Boston: Assigning
functions to proteins by mapping connections.
Discussion: Where next in studying protein-protein interac-
tions?
SESSION 6: Cell Death
N. Heintz, HHMI, Rockefeller University, New York, New
York: Cell death and the cell cycle.
S. Lowe, Cold Spring Harbor Laboratory: Modulation of
apoptosis in tumor development and cancer therapy.
M. Hengartner, Cold Spring Harbor Laboratory: Programmed
cell death in C. elegans nervous system.
H. Dudek, Children's Hospital, Boston, Massachusetts: Sig-
nal transduction pathways and the regulation of neuronal
survival and death.
Discussion: What do cell death studies offer research on tri-
plet repeat diseases?
SESSION 5: Mouse Models
J.-L. Mandel, IGBMC, Illkirch, France: Progress in construc-
tion of cellular or mouse models of Huntington's disease.
G. Bates, Guy's Hospital, London, United Kingdom: Trans-
genic models. Phenotype observed in mice transgenic for
the Huntington's disease mutation.
M.E. MacDonald, Massachusetts General Hospital, Char-
lestown: Making models of the unstable Huntington's dis-
ease CAG repeat in the mouse.
D.E. Merry, University of Pennsylvania School of Medicine,
Philadelphia: Androgen receptor transgenic mice: At-
tempts at creating a mouse model for spinal and bulbar
muscular atrophy.
Discussion: Future developments using transgenic models.
SESSION 7: Looking for Therapies
G.D. Yancopoulos, Regeneron Pharmaceuticals, Inc., Tar-
rytown, New York: Neurotrophic factors and neurogenera-
tive disease.
A. Tobin, University of California, Los Angeles: Round Table
Discussion: How to move from 'basic' research to
'therapeutic' research?
N.S. Wexler, College of Physicians & Surgeons of Columbia
University, New York, New York
L.J. DeGennaro, Wyeth-Ayerst Research, Princeton, New
Jersey
C.T. Caskey, Merck Research Laboratories, Merck & Co.,
Inc., West Point, Pennsylvania
G.D. Yancopoulos, Regeneron Pharmaceuticals, Inc., Tar-
rytown, New York
Plasticity of Glutamate Receptors: Cellular and
Molecular Mechanisms
October 6-October 9
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
R. Malinow, Cold Spring Harbor Laboratory
R.L. Huganir, HHMI, Johns Hopkins University School of Medicine, Baltimore, Maryland
SESSION 1: Formation of a Model Synapse: The Neuromuscular Junction
Chairperson: R.L. Huganir, HHMI, Johns Hopkins University School of Medicine, Balti-
more, Maryland
S.C. Froehner, University of North Carolina School of Medi-
cine, Chapel Hill: Syntrophins: Modular adaptor proteins
in synaptic signaling.
J.R. Fallon, Brown University, Providence, Rhode Island:
Regulation of synaptic structure.
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M.L. Mayer, R.L. Huganir,
G.L. Westbrook, R.A. Nicoli
SESSION 2: Structure and Function of Glutamate Receptors
Chairperson: R. Malinow, Cold Spring Harbor Laboratory
R.W. Gereau, The Salk Institute for Biological Studies, San
Diego, California: Mechanism of desensitization of
mGluR5.
P.H. Seeburg, University of Heidelberg, Germany: Genetic
regulation of glutamate receptor properties.
M. Mishina, University of Tokyo, Japan: Synaptic plasticity in
mutant mice lacking glutamate receptor channels.
SESSION 3: Physiological Properties of Glutamate Receptors
Chairperson: R.A. Nicoll, University of California, San Francisco
S.G. Cull-Candy, University College London, United King-
dom: Single-channel diversity and dependence on subunit
composition in the cerebellum.
M.L. Mayer, LCMN, NICHD, National Institutes of Health,
Bethesda, Maryland: Permeation and block in GIuR chan-
nels.
R.W. Tsien, Stanford University School of Medicine, Califor-
nia: Understanding the quantal response at glutamater-gic
synapses between hippocampal neurons.
S. Nakanishi, Kyoto University Faculty of Medicine, Japan:
Distinct signaling calcium of different metabotropic recep-
tor subtypes.
M. Hollmann, Max Planck Institute for Experimental Medicine,
Gottingen, Germany: Functional domains and topology of
glutamate receptors.
G.L. Westbrook, Vollum Institute, Oregon Health Sciences
University, Portland: Intracellular regulation of NMDA
receptors.
C.E. Jahr, Vollum Institute, Oregon Health Sciences Univer-
sity, Portland: Regulation of glutamate channel activation at
synapses.
SESSION 4: Regulation of Glutamate Receptor Function
Chairperson: R.C. Malenka, University of California, San Francisco
R.L. Huganir, HHMI, Johns Hopkins University School of
Medicine, Baltimore, Maryland: Regulation of glutamate
receptors by protein phosphorylation.
M.W. Salter, Hospital for Sick Children, Toronto, Canada:
NMDA receptor for regulation by tyrosine phosphorylation.
T.R. Soder ling, Vollum Institute, Oregon Health Sciences Uni-
versity, Portland: Regulation of glutamate receptors by
Cam-Kinase II.
SESSION 5: Synaptic Structure and Localization of Glutamate Receptors
Chairperson: P.H. Seeburg, University of Heidelberg, Germany
P. Somogyi, Oxford University, United Kingdom: Location of K.M. Harris, Children's Hospital, Boston, Massachusetts:
glutamate receptors in relation to transmitter release sites. Structural diversity of hippocampal glutamatergic
R.J. Wenthold, NIDCD, National Institutes of Health, Bethes- synapses.
da, Maryland: Distribution and targeting at glutamate M.H. Sheng, HHMI, Massachusetts General Hospital, Bos-
receptors in neurons. ton: Molecular organization of glutamatergic synapses.
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SESSION 6: Plasticity at Excitatory Synapses I
Chairperson: S.G. Cull-Candy, University College London, United Kingdom
G.L. Collingridge, University of Bristol School of Medical
Sciences, United Kingdom: Glutamate receptors and LTP
in the hippocampus.
D.M. Kullmann, Institute of Neurology, London, United King-
dom: Long-term potentiation of AMPA and NMDA receptor-
mediated signals in the hippocampus.
R. Malinow, Cold Spring Harbor Laboratory: Silent synaps-
es: Electrophysiological and cell biological studies.
H. Cline, Cold Spring Harbor Laboratory: Parallel mecha-
nisms underlying 'development' and 'plasticity' of synaptic
connections.
R.C. Malenka, University of California, San Francisco:
Bidirectional control of synaptic strength.
D.W. Choi, Washington University School of Medicine, St.
Louis, Missouri: mGIuR modulation of excitotoxic neuronal
death.
SESSION 7: Plasticity of Excitatory Synapses II
Chairperson: S.C. Froehner, University of North Carolina School of Medicine, Chapel Hill
R.A. Nicoll, University of California, San Francisco: The role
of metabotropic glutamate receptors in hippocampal
mossy fiber transmission.
T. Takahashi, Brain Research Institute, Tokyo, Japan: Mech-
anisms underlying short-term and long-term synaptic
modulation induced by presynaptic glutamate receptors.
D.J. Linden, Johns Hopkins University School of Medicine,
Baltimore, Maryland: A protein-synthesis-dependent late
phase of cerebella long-term depression.
SESSION 8: Global Mechanisms
Chairperson: M.L. Mayer, LCMN, NICHD, National Institutes of Health, Bethesda,
Maryland
M.F. Bear, HHMI, Brown University, Providence, Rhode Is-
land: Bidirectional synaptic plasticity and its regulation in
the cerebral cortex.
J.E. Lisman, Brandeis University, Waltham, Massachusetts: A
new role for NMDA channels in memory recall.
The Art of Judging: Perspectives of Science
October 10-October 15
FUNDED BY
The Judiciary Leadership Development Council, The Federal Judicial Center,
and Cold Spring Harbor Laboratory
ARRANGED BY
J.A. Apple, The Federal Judicial Center, Washington, D.C.
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
J.D. Watson, Cold Spring Harbor Laboratory: Frontiers of ge-
netic research.
SESSION 2
P. Galison, Harvard University, Cambridge, Massachusetts:
Science in the 20th century.
R. Meserve, Covington & Burling, Washington, D.C.: Science
issues in the courtroom.
SESSION 3
P. Reilly, Shriver Center for Mental Retardation, Waltham,
Massachusetts: Special policy issues involving DNA and
genetic engineering.
D. Hull, Northwestern University, Chicago, Illinois: The pro-
cess of science: The system of rewards.
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SESSION 4
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: DNA and the Human Genome Project.
D. Wilkinson, Princeton University, New Jersey: Evidence, er-
rors, and proof in science: Cosmology as a paradigm.
SESSION 5
D. Mick los and Mark Bloom, DNA Learning Center, Cold
Spring Harbor Laboratory: Visit to Cold Spring Harbor
Laboratory and personal DNA experiments.
SESSION 6
L. Moses, Stanford University Medical School, California:
Statistics and probability in science.
M. Weinberg, The Weinberg Group, Washington, D.C.: Is-
sues of science and industry.
S.A. Schaffer, New York University, New York: Research in-
tegrity and scientific misconduct.
SESSION 7
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory: Eugenics.
J. Foran, Risk Science Institute, Washington, D.C.: Causation
and risk assessment in science.
SESSION 8
M. Gallo, Robert Wood Johnson Medical School, Piscataway,
New Jersey: Toxicology and the environment.
L. Garrett, Newsday, Melville, New York: Viruses and
plagues.
SESSION 9
J.W. Hicks, Alabama Department of Forensic Sciences,
Birmingham: Science and criminal investigations.
P.M. Eisenberger, Princeton University, New Jersey: Role of
universities in science and technology in 21st century.
Manic-depressive Illness: Evolutionary and Ethical Issues
October 20-October 23
FUNDED BY
Charles A. Dana Foundation
ARRANGED BY
K.R. Jamison, The Johns Hopkins School of Medicine, Baltimore, Maryland
R. Cook-Deegan, National Academy of Science, Washington, D.C.
LL Hall, National Alliance for the Mentally III, Arlington, Virginia
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Overview of Manic-depressive Illness; Status of Genetic Studies; Individual
and Social Costs of Manic-depressive Illness
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Co-Chairpersons: P.C. Whybrow, University of Pennsylvania, Philadelphia, and
L.L. Hall, National Alliance for the Mentally III, Arlington, Virginia
K.R. Jamison, The Johns Hopkins School of Medicine, Balti- R.J. Wyatt, National Institute of Mental Health, Washington,
more, Maryland: Overiew of manic-depressive illness: Its D.C.: Economic costs.
cost and benefits. L. Andrews, Chicago-Kent College of Law, Illinois: Risks and
R.J. De Paulo, The Johns Hopkins School of Medicine, Balti- benefits of genetic information (to individuals and their
more, Maryland: Status of genetic studies. families).
T. Ricke, National Depressive and Manic-Depressive Associ-
ation, Chicago, Illinois: Family costs.
SESSION 2: Adaptive Value of Manic-depressive Illness
Chairperson: S.H. Barondes, University of California, San Francisco
R. Richards, University of California, San Francisco: Creativ-
ity in manic-depressives and their first-degree relatives.
D.R. Wilson, University of Cincinnati, Ohio: Evolutionary ad-
vantages of mood instability.
P. Gilbert, Kingsway Hospital, Derby, United Kingdom:
Evolutionary perspectives on depression.
SESSION 3: Evolutionary Biology: Perspectives from Other Conditions
Chairperson: R. Cook-Deegan, National Academy of Science, Washington, D.C.
R.M. Neese, University of Michigan Medical School, Ann Ar-
bor: Disease in general, including sickle cell, thalas-
semia-malaria, and CF-cholera.
D. Hamer, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland: Homosexuality: The findings.
C. Burr, Atlantic Monthly, Washington, D.C.: Homosexuality:
The implications.
L.M. Silver, Princeton University, New Jersey: Genetics of
complex behavioral traits (in mouse).
SESSION 4: Evolutionary Perspectives on Manic-depressive Illness: Implications
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Focused discussion: What's at stake?
Leaders: P.C. Whybrow, University of Pennsylvania, Philadelphia, and
L.L. Hall, National Alliance for the Mentally III, Arlington, Virginia
Focused discussion: Does manic-depression have adaptive value?
Leader: S.H. Barondes, University of California, San Francisco
Focused discussion: Is there a tradeoff between social benefit and individual harm?
SESSION 5: Development of Consensus Statement
Co-Chairpersons: R. Cook-Deegan, National Academy of Sciences, Washington, D.C.,
and K.R. Jamison, The Johns Hopkins School of Medicine, Baltimore, Maryland
C. Burr, R.J. De Paulo
D. Hamer
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J.P. Morgan & Co. Incorporated/Cold Spring Harbor Laboratory
Executive Conference on Human Development
October 25-October 27
ARRANGED BY
J.D. Watson, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
L. Wolpert, University College and Middlesex Hospital Medi-
cal School, London, United Kingdom: How embryos de-
velop.
SESSION 2
B. Hogan, Vanderbilt University Medical School, Nashville,
Tennessee: Human development from conception to birth.
D. Page, Whitehead Institute, Massachusetts Institute of
Technology, Cambridge: Genes and sex.
J. Hall, University of British Columbia, Vancouver, Canada:
When development goes awry.
SESSION 3
R. Rosenfeld, Oregon Health Sciences University, Portland:
Human growth and maturation. Significance, biology, and
therapeutic interventions.
SESSION 4
A. Silva, Cold Spring Harbor Laboratory: Studying learning
and memory.
T. Marr, Cold Spring Harbor Laboratory: Genetics and
manic-depressive illness.
SESSION 5
M. Hines, University of California, Los Angeles: Developmen-
tal differences between the sexes.
R. Winston, Royal Postgraduate Medical School, London,
United Kingdom: Controlling human development: Ethical
issues.
D. Page, G. Milne
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Telomeres and Telomerase
November 3-November 6
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program with additional
support from Geron Corporation
ARRANGED BY
T. de Lange, The Rockefeller University, New York, New York
C. Greider, Cold Spring Harbor Laboratory
SESSION 1: Telomere Length Regulation I
Chairperson: C. Greider, Cold Spring Harbor Laboratory
E.H. Blackburn, University of California, San Francisco: Yeast
and other telomerases.
T.R. Cech, HHMI, University of Colorado, Boulder: Purifica-
tion of Euplotes telomerase.
V. Lundblad, Baylor College of Medicine: EST1, EST2, EST3,
and EST4/CDC13: In vivo regulators of yeast telomerase.
SESSION 2: Telomere Length Regulation II
Chairperson: T.R. Cech, HHMI, University of Colorado, Boulder
R. Wel linger, University of Sherbrooke, Canada: Studies on
the terminal DNA structure of eukaryotic telomeres.
K.W. Runge, Cleveland Clinic Foundation Research Institute,
Ohio: Telomere length regulation in Saccharo-myces
cereyisiae.
V.A. Zakian, Princeton University, New Jersey: Telomere
maintenance in Saccharomyces.
A.J. Lustig, Tulane Medical Center, New Orleans, Louisiana:
A novel mechanism for telomere size control in yeast.
D.M. Shore, University of Geneva, Switzerland: Telomere
length regulation by Rap1 protein in yeast.
C. Price, University of Nebraska, Lincoln: Coordination of G
and C strand synthesis during de novo telomere addition.
T. de Lange, Rockefeller University, New York, New York:
Mammalian telomeric proteins and telomere length control.
SESSION 3: Telomerase
Chairperson: E.H. Blackburn, University of California, San Francisco
K. Collins, University of California, Berkeley: Architecture of
the telomerase RNP.
D.E. Shippen, Texas A&M University, College Station: DNA
recognition and synthesis by ciliate and plant telomer-
ases.
D. Romero, University of Minnesota, Minneapolis: The fidel-
ity of Paramecium telomerase in vivo.
F. Muller, University of Fribourg, Switzerland: Telomeres in
nematodes.
F. Ishikawa, Tokyo Institute of Technology, Yokohama,
Japan: Cloning of a mammalian telomerase component
gene.
SESSION 4: Drosophila Telomeres
Chairperson: C.S. Newton, UMDNJ-New Jersey Medical School, Newark
M.-L. Pardue, Massachusetts Institute of Technology, Cam-
bridge: The Drosophila telomere: The relationship be-
tween telomeres and transposable elements.
H. Biessmann, University of California, Irvine: Drosophila
and mosquito telomeres.
T.R. Cech, M.-L. Pardue
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SESSION 5: Telomeric Chromatin
Chairperson: T.D. Pates, University of North Carolina, Chapel
D. Rhodes, MRC Laboratory of Molecular Biology, Cam-
bridge, United Kingdom: The crystal structure of the DNA-
binding domain of yeast Rapt in complex with telomeric
DNA.
S. Schultz, University of Colorado, Boulder: Structure of the
0. nova telomere binding protein complexed with ssDNA.
J.P. Langmore, Biophysics Research Division, University of
Michigan, Ann Arbor: Functional studies of vertebrate
model telomeres in vitro, and determination of the
covalent terminal structure of telomeres from mortal and
immortal human cells.
SESSION 6: Telomeres and Telomerase in Cancer and Aging
Chairperson: V.A. Zakian, Princeton University, New Jersey
C. Greider, Cold Spring Harbor Laboratory: Telomerase in
mouse models.
R.R. Reddel, Children's Medical Research Institute, Went-
worthville, Australia: Lengthening of telomeres in human
cell lines without detectable telomerase activity.
J.W. Shay, University of Texas Southwestern Medical Center,
Dallas: Telomerase and cancer: Diagnostic, prognostic,
and therapeutic implications.
J.K. McDougall, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Viral gene expression and telomer-
ase activation.
Hill
D. Gottschling, Fred Hutchinson Cancer Research Center,
Seattle: Waiting 'til the end: Silent chromatin regulates the
time of telomeric DNA replication.
C.S. Newton, UMDNJ-New Jersey Medical School, Newark:
Telomeric inactivation of a yeast chromosomal DNA
replication origin.
J. Berman, University of Minnesota, St. Paul: The organiza-
tion of telomeres and telomere-associated proteins in yeast
nuclei.
C.B. Harley, Geron Corporation, Menlo Park, California:
Telomere loss and cell aging.
S. Bacchetti, McMaster University, Hamilton, Ontario, Cana-
da: Reprogramming of telomerase and alteration of telo-
meres in human cells by mutated telomerase RNA
templates.
W.E. Wright, University of Texas Southwestern Medical Cen-
ter, Dallas: G-rich overhang in human telomeres.
Science Journalists Workshop on Genetics of Human Behavior
November 7-November 9
FUNDED BY
Cold Spring Harbor Laboratory
ARRANGED BY
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Human Behavior
M.G. McInnis, Johns Hopkins Hospital, Baltimore, Maryland:
Psychiatric disorders as aberrant behavior.
D. Goldman, NIAAA, National Institutes of Health, Rockville,
Maryland: Biological and genetic approaches to under-
standing alcoholism.
M. Linnoila, NIAAA, National Institutes of Health, Bethesda,
Maryland: Biological and genetic approaches to under-
standing aggressive behavior.
D. Hamer, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland: Genetic analyses of homo-
sexuality.
T. Tully, Cold Spring Harbor Laboratory: Genetic studies of
learning and memory.
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: The new human genetics.
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D. Goldman, M. Linnoila
SESSION 2: DNA Experiment
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory: DNA fingerprinting using PCR.
Case Studies in Vaccine Development
November 17-November 20
FUNDED BY
Albert B. Sabin Vaccine Foundation and the
National Institute of Allergy
and Infectious Diseases
ARRANGED BY
R.G. Douglas, Merck & Co., Inc., Whitehouse Station, New Jersey
B. Gel lin, NIAID, National Institutes of Health, Bethesda, Maryland
SESSION 1: Orientation and Objectives
R.G. Douglas, Merck & Co., Inc., Whitehouse Station, New
Jersey and E.K. Marcuse, University of Washington,
Seattle: NVAC and the Future Vaccine Subcommittee:
Mandate and mission.
B.G. Gel lin, National Institutes of Health, Bethesda, Mary-
land: Case studies in vaccine development: Concept and
goal of the workshop.
R.G. Douglas, Merck & Co., Inc., Whitehouse Station, New
Jersey: The vaccine R&D "system."
L. Galambos and J.E. Sewell, The Johns Hopkins University,
Baltimore, Maryland: Perspectives on networks: Lessons
learned from other industries.
SESSION 2: Case Studies in Vaccine Development I
Ty21 a
Introduction: M.M. Levine, University of Maryland, Balti-
more
SESSION 3: Case Studies in Vaccine Development II
Rotavirus vaccine
Introduction: S. Plotkin, Pasteur Merieux Connaught,
Marnes la Coquette, France (via teleconference)
Varicella vaccine
Introduction: A. Gershon, College of Physicians &
Surgeons of Columbia University, New York, New York
SESSION 4: Case Studies in Vaccine Development III
RSV vaccine
Introduction: C. Hellman, National Institutes of Health,
Bethesda, Maryland
Hib vaccine
Introduction: J.I. Ward, UCLA Center for Vaccine Research,
Torrance, California
R.G. Douglas, B. Gel lin
SESSION 5: Case Studies in Vaccine Development IV
Hepatitis vaccines
Introduction: M.R. Hilleman, Merck Research Labora-
tories, West Point, Pennsylvania
Cold-adapted influenza vaccine
Introduction: P.F. Wright, Vanderbilt Medical Center, Nash-
ville, Tennessee
SESSION 6
The vaccine R&D fabric: Common and uncommon
threads
Discussion Leader: R.G.Douglas, Merck & Co., Inc.,
Whitehouse Station, New Jersey
The vaccine R&D fabric: A view from the outside
Discussion Leaders: L Galambos and J.E. Sewell, The
Johns Hopkins University, Baltimore, Maryland
SESSION 7
Lessons learned and lessons taught: Strengthening the
vaccine R&D system
Discussion Leaders: B.G. Gellin and R. Rabinovich, Na-
tional Institutes of Health, Bethesda, Maryland, and
P.K. Russell, The Johns Hopkins University, Baltimore,
Maryland
R.G. Douglas, Merck & Co., Inc., Whitehouse Station, New
Jersey: Closing remarks,
Genetic Approaches to Learning and Memory
December 8-December 11
FUNDED BY
Marie H. Robertson Memorial Fund for Neurobiology
ARRANGED BY
E.R. Kandel, College of Physicians & Surgeons of Columbia University, New York, New York
A. Silva, Cold Spring Harbor Laboratory
S. Tonegawa, Massachusetts Institute of Technology, Cambridge
SESSION 1: Calcium Calmodulin Kinase and Plasticity
Chairperson: E.R. Kandel, College of Physicians & Surgeons of Columbia University, New
York, New York
K.P. Giese, Cold Spring Harbor Laboratory: The role of the
autophosphorylation at T286 of a-CaMKII.
M.R. Mayford, College of Physicians & Surgeons of Columbia
University, New York, New York: Regulated genetic con-
trol of synoptic plasticity, learning, and memory.
K. Fox, University of Wales, Cardiff, United Kingdom: The
role of a-CaMKII in barrel cortex plasticity.
M.P. Stryker, University of California, San Francisco:
Plasticity mechanisms responsible for cortical develop-
ment: Comparison of findings in vivo and in vitro in mouse
visual cortex.
J.O. McNamara, Duke University Medical Center, Durham,
North Carolina: Kindling: An NMDA receptor-dependent
plasticity of mammalian nervous system.
SESSION 2: Genetics, Synapses, and Learning
Chairperson: S. Nakanishi, Kyoto University Faculty of Medicine, Japan
T.C. Sudhof, University of Texas Southwestern Medical Cen- S. Tonegawa, Massachusetts Institute of Technology, Cam-
ter at Dallas: Mechanisms of neurotransmitter release. bridge: NMDA receptor-dependent synoptic plasticity is
H. Thoenen, Max Planck Institute for Psychiatry, Martinsried, needed for spatial memory study with CAI-restricted
Germany: Gene targeting and virus-medicate gene trans- knockout mice.
fer in the analysis of neuronal plasticity. M.A. Wilson, Massachusetts Institute of Technology, Cam-
H.-S. Shin, Pohang University of Science and Technology, bridge: Dissecting the role of hippocampal plasticity in
Pohang, Republic of Korea: IP3 Kinase mutation, LTP, spatial representations using region-specific genetic
and learning. knockouts.
P.F. Chapman, University of Wales, Cardiff, United Kingdom:
Behavioral and physiological analyses of a transgenic Round Table Discussion: Genetics and cognition: What will
model of Alzheimer's disease. we need to make the connection?
J.S. Takahashi, Northwestern University, Evanston, Illinois: Introduced by: M.P. Stryker, University of California, San
Forward genetic approaches to learning and memory in Francisco
the mouse.
H.-P. Lipp, University of Zurich, Switzerland: Biological
relevance of behavioral effects observed in knockout
mice: Natural selection studies.
SESSION 3: LTP and Beyond
Chairperson: S. Tonegawa, Massachusetts Institute of Technology, Cambridge
A. Silva, Cold Spring Harbor Laboratory: Plasticity, spikes,
and learning.
R. Morris, UMDS Guy's Hospital, London, United Kingdom:
Selective inhibition of LTP in the dentate gyrus in vivo
does not affect spatial learning in mice lacking Thy-1.
E.G. Abel, College of Physicians & Surgeons of Columbia
University, New York: Genes important for long-term
memory.
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D.R. Storm, University of Washington, Seattle: Role of the
adenylyl cyclases and cAMP for learning and memory.
T.J. O'Dell, University of California, Los Angeles: The role of
protein kinase A and modulatory neurotransmitters in low
frequency stimulation-induced LTP.
isieuronai mecnanisms and Behavior
Chairperson: S.F. Heinemann, The Salk Institute, San Diego,
S. Nakanishi, Kyoto University, Japan: Glutamate receptor
function in neuronal plasticity.
S.G.N. Grant, University of Edinburgh, United Kingdom:
Postsynaptic tyrosine kinase signaling.
R.F. Lathe, University of Edinburgh, United Kingdom: Genes
selectively expressed in hippocampus.
S. Itohara, Kyoto University, Japan: Astrocytes and neuronal
plasticity.
M. Picciotto, Yale University School of Medicine, New Haven,
Connecticut: Pharmacological and behavioral ef-
California
fects of a mutation in the high-affinity receptor for nicotine.
E.R. Kandel, College of Physicians & Surgeons of Columbia
University, New York, New York: Genes, synapses, and
long-term memory.
Round Table Discussion: Genetic background and the
study of behavior.
Introduced by: T. Tully, Cold Spring Harbor Laboratory
R.F. Lathe, S. Tonegawa
SESSION 5: Ion Channels and Learning
Chairperson: H. Thoenen, Max Planck Institute for Psychiatry, Martinsreid, Germany
P.A. Slesinger, University of California, San Francisco: Ge-
netic manipulations of G protein-gated inwardly rectifying
potassium channels.
S.F. Heinemann, The Salk Institute, San Diego, California:
Mutations in glutamate receptor genes.
1. Roder, Samuel Lunenfeld Research Institute, Toronto,
Canada: Behavioral LTP analysis of various GluR knock-
outs.
lound Table Discussion: Genetic background of ES cells.
produced by: The Jackson Laboratory, Bar Harbor, Maine
Mechanisms of Transcriptional Initiation
December 14-December 17
FUNDED BY
Cold Spring Harbor Laboratory
ARRANGED BY
W. Herr, Cold Spring Harbor Laboratory
R. Kingston, Massachusetts General Hospital, Boston
K. Yamamoto, University of California, San Francisco
TOPIC: What are the functional targets of activators?
SESSION 1: Activator Targets: GTFs and Holoenzyme I
Chairpersons: R. Losick, Harvard University, Cambridge, Massachusetts and
T. Maniatis, Harvard University, Cambridge, Massachusetts
SESSION 2: Activator Targets: TAFs
Chairpersons: C. Gross, University of California, San Francisco and
B. Stillman, Cold Spring Harbor Laboratory
TOPIC: What is the mechanism of activator function? I
SESSION 3: Chromatin: Transcriptional Activation and Modification
Chairpersons: E. O'Shea, University of California, San Francisco and
R. Treisman, Imperial Cancer Research Fund, London, United Kingdom
SESSION 4: Stabilization and lsomerization of the Preinitiation Complex
Chairpersons: S. Adhya, National Cancer Institute, Bethesda, Maryland and
A. Hochschild, Harvard Medical School, Boston, Massachusetts
TOPIC: What is the mechanism of activator function? II
SESSION 5: Promoter Clearance, Elongation, and Phosphorylation
Chairperson: K. Yamamoto, University of California, San Francisco
SUMMARY AND OVERVIEW
T. Maniatis, Harvard University, Cambridge, Massachusetts
Introduced by: E. Simpson, The Jackson Laboratory, Bar
Harbor, Maine
M. Ptashne
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DNA LEARNING CENTER
David A. Mick los, Director
Mark V. Bloom, Assistant Director
Susan M. Lauter, Creative Director
Judy Cumella Korabik, Program Coordinator
Amy Cross, Program Assistant
Melissa A.G. Hewitt, Laboratory Instructor
Diane Esposito, Laboratory Instructor
Flavio Della Seta, Laboratory Instructor
Andrew M. Morotti, Laboratory Instructor
Scott Bronson, Laboratory Instructor
Michael Greenberg, Laboratory Instructor
Joan Alexander, Laboratory Instructor
In 1989, we first brought local 5th and 6th grade students into our 8io2000
Teaching Laboratory for a summer genetics camp, entitled Fun With DNA. That
educational experiment tested the notion of whether or not young students are
capable of understanding the Gene Age that they will inherit. The answer can be
found in our 1996 visitation statistics-for the first time, middle school students
(grades 5-8) replaced high school students as the DNALC's largest clientele for
lab instruction.
A 1990 grant from the National Science Foundation supported our first
organized effort to train middle-school faculty. A 1991 grant from the Hearst
Foundation allowed us to recruit elementary educators Jane Conigliaro and
Diane Jedlicka and to begin to rigorously implement programs for Long Island
schools. Our first goal was to establish a substantial summer camp program, in-
cluding Fun With DNA and its follow-up, World of Enzymes. Portledge School was
added as a summer camp site to provide easier access for students from Nas-
sau County. With later support from the Howard Hughes Medical Institute and the
Barker Welfare Foundation, summer camps were conducted for minority students
from Manhattan at the American Museum of Natural History and A. Phillip
Randolph High School.
Genetics as a Model for Whole Learning was initiated in 1992, as the umbrella
for our middle school activities. The program provides DNALC staff support to
help school systems implement a selection of laboratories from the Fun With DNA
and World of Enzymes camps. The object is to train 5th and 6th grade classroom
teachers to use genetics as the hub of an across-discipline network to link
science with math, social studies, current events, and language arts. Genetics as
a Model for Whole Learning incorporates numerous educational features that are
compatible with national and local science standards:
age-appropriate instruction according to cognitive development
principles from current research on learning and memory
progressive sequencing of activities (constructivism)
discovery approach accommodates a variety of learning styles (visual,
auditory, tactile)
interdisciplinary approach accommodates multiple intelligence types
cooperative learning and problem solving
active learning and creative behaviors
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metaphorical and associative learning
science as a way of looking at the world and solving problems
skills and strategies for life-long learning
the museum as a school
research technology and equipment
applying content expertise to analysis of current issues and ethical
decision-making
introducing new career opportunities
Thus far, we have implemented the program in 12 member districts of the
Curriculum Study Program. The logistics of setting up and running independent
Genetics as a Model for Whole Learning programs at so many distant sites is ex-
tremely complex. DNA Learning Center staff meet with the district administrators
and classroom teachers to design a customized program-ranging from in-
tensive instruction for several classes to a briefer exposure for all students in a
grade level. DNA Learning Center staff then provide 10-15 days of faculty train-
ing and in-school instruction. Over a 2-3 year period, teachers become comfort-
able with the curriculum and implement their own customized units, typically cul-
minating with a laboratory field trip to the DNALC. Equipment and supplies for
several different laboratories are transported between schools. Logistics became
even more complex this year, when we added ten elementary/middle schools in
Community School District 29, near Kennedy Airport, and Corlears Junior High
School in Chinatown. All tolled, the 1996 program involved 5045 students and
138 teachers in 38 schools.
Above: Andrew Morotti instructs stu-
dents in the Genetics as a Model for
Whole Learning Program. Right:
Students examine fruit fly mutations
with a compound microscope.
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An Historic Opportunity to Resynthesize Early Biology Education
The response to Genetics as a Model for Whole Learning has been almost over-
whelming. Word of the program is now spreading in the New York metropolitan
area, and we have a waiting list of districts interested in joining the program when
space becomes available. The program is also attracting the interest of
educators in other parts of the country. With donations from Tom White, Research
Vice President of Roche Molecular Systems, Jane Conigliaro has conducted Fun
With DNA and World of Enzymes camps for the Point Arena School District in
Mendocino County, California. High school faculty trained through our National
Science Foundation Leadership Institute (1993-1995) have provided in-service
training in genetics for approximately 1000 elementary/middle school faculty and
initiated summer camp programs in several states.
The demand for high-quality science instruction for younger students was fur-
ther accelerated by the long-awaited publication this year of the National Science
Education Standards. This document challenges school districts nationwide to
provide all precollege students with hands-on, minds-on experiences that en-
courage critical thinking in science. The Science Standards, in combination with
two educational trends, should specifically focus attention on the 6th grade as
the major objective in the battle to build a genetically literate populace. First,
school restructuring is moving 6th grade classes out of the elementary school
and into the middle school. With this move, 6th grade teachers, accustomed to
teaching all subjects with the same class all day, now are forced to specialize by
content area. Some must make the conversion to science teacher, even though
the typical K-6 certification received by most teachers has virtually no science re-
quirements. Second, the New York City School Board recently decreed that life
science should be moved to the 6th grade, followed by physical science in the
7th grade and earth science in the 8th.
We are thus seeing in the nation's largest metropolitan area a whole genera-
tion of 6th grade teachers who need retraining for their new roles as life science
teachers. This is an historic opportunity to start afresh with an entirely new cur-
riculum that views life processes through the lens of genetics. This would im-
mediately bring early biology education into line with modern research. Students
rising into high school with higher expectations in biology would, in turn, force
more sweeping changes in entrenched high school curricula. Genetics as a
Model for Whole Learning takes a large step in this direction and at the same
time builds upon former classroom teachers' strengths in reading and across-
discipline integration.
Renewed Support from the Hearst Foundation
With this opportunity ahead of us, we were pleased to receive news at year's end
of a $100,000 grant from the Hearst Foundation to support the further expansion
of Genetics as a Model for Whole Learning. Hearst support will be used to take
the curriculum from its current photocopied notebook form to a published text. In
addition to hands-on laboratories and supporting discussion, the formalized cur-
riculum will include a fully elaborated "case study" of human growth hormone,
based on our exhibit, Story of a Gene. A teacher's guide will include student
learning objectives, content connections, lab prep, and answers to questions.
The lab text will be augmented by multimedia learning materials, including the
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Genetic Computer Arcade and Internet-accessible support. The DNA Learning
Center's track record for producing articulate, well-timed, and user-friendly
texts-plus established contacts in the publishing industry-should help us to
identify a suitable publishing partner.
With formalization of the curriculum, we will be prepared to initiate a national
training program based on dissemination methods developed with National
Science Foundation support over the last decade. Teacher training will utilize our
nationwide network of university and precollege collaborators with whom we have
organized teacher training in the past and who are committed to modeling new
approaches to genetics instruction. We will especially target institutions that have
received precollege education grants from the Howard Hughes Medical Institute,
which encourages collaborations between grantees. Piggybacking onto estab-
lished precollege programs makes cost-effective use of existing infrastructures
for reaching teachers, interacting with school decision-makers, and providing
ongoing teacher follow-up and support. Hearst support will also be used to foster
linkages between high schools with existing laboratory programs and
elementary/middle schools that are implementing Genetics as a Model for Whole
Learning. In this way, elementary through high school faculty can collaborate to
establish sequenced instruction that incorporates hands-on learning about
genetics at several stages in child and adolescent development.
Strategic Alliances to Reach to Minority and Disadvantaged Students
We have always been honest about our efforts to contribute solutions to the prob-
lems of providing excellent science education for minority and disadvantaged
students. Our location among wealthy villages of Long Island's "Gold Coast" puts
the largest numbers of needy students at least a half-hour commute from our
center. To defeat this distance problem, we have attempted to develop strategic
alliances that allow us to have a presence in less affluent areas of metropolitan
New York. In 1996, we initiated key collaborations to better reach minority and
disadvantaged students in Brooklyn and Queens-the two boroughs of New York
City that are physically located on Long Island.
Especially satisfying has been the development of a close collaboration with
Dr. Mort Slater, who directs Gateway to Higher Education, a program of the City
University of New York Medical School, to stimulate minority achievement in
science. Dr. Slater operates student science enrichment programs serving 1500
students at five New York City High Schools: Brooklyn Technical, Erasmus Hall,
Jamaica, Fort Richmond, Queens Gateway, and John F. Kennedy. Dr. Slater's
uncanny ability to find ways around the arcane bureaucracy of New York City
Public Schools is the perfect complement to our content expertise in modern biol-
ogy. Thus, working together with Principal Lee McCaskill, Assistant Principal
Andrea Canner, and Science Teacher Judy Cohen, we have been able to estab-
lish a modern DNA Laboratory at Brooklyn Tech. One of New York City's three
specialized science high schools with competitive admission, Brooklyn Tech has
recently begun to broaden its scope beyond its traditional engineering emphasis.
The DNA Laboratory will immediately upgrade biology instruction, allowing imple-
mentation of the recommended molecular genetics laboratories in seven Ad-
vanced Placement Biology classes in spring 1997 and a molecular genetics elec-
tive in the 1997-1998 academic year.
Equally important has been a growing collaboration with Community School
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District 29, a public school system in Queens serving 25,000 students in grades
K-8. Located immediately to the north of Kennedy Airport, District 29 serves a
population that is 95% minority, where two thirds of students are eligible for lunch
assistance and 31% have limited English proficiency. Working closely with Su-
perintendent Celestine Miller, Director of Funded Programs Ellen Schlesinger,
and Supervisor of Science Diane Erhlich, we began the large-scale implementa-
tion of Genetics as a Model for Whole Learning. The initial year's program in-
volved 24 days of in-school instruction and 30 field trips to the DNALC that in-
volved 1000 students. Again joining forces with Dr. Slater, we intend to establish
a genetics laboratory at the district's new Gifted and Talented Academy for Arts
and Sciences at Intermediate School 59. The new laboratories at Brooklyn Tech
and IS59 will provide a large-scale test of integrated genetics instruction devel-
oped and tested in the mini-districts of Long Island's north shore. The labora-
tories will serve as satellite learning centers from which we can extend student
enrichment and faculty development to schools throughout Brooklyn and
Queens.
Students from Community School
District 29 during a visit to the
Learning Center.
We have devoted considerable resources to Central Islip School District, lo-
cated in the middle of Long Island. With a population composed of equal parts
Black, Hispanic, and White students, Central Islip represents the changing face
of urban America. Here, we have assisted science teacher Jerry Watkins to de-
velop an advanced biology program that mirrors those offered by larger or
wealthier districts. Jerry offers a molecular genetics elective during the academic
year and a summer research program. In 1996, he also taught two sessions of
DNA Science at the American Museum of Natural History. At the middle school
level, Lynn Casdia continues to teach summer camps based on Fun With DNA
and World of Enzymes.
Our Bio2000 Laboratory Has Reached Capacity
We have always considered the Bio2000 Laboratory the heart of our operation. It
was the first space renovated and opened for student instruction in spring 1988,
six months in advance of our official opening. It has remained in continuous oper-
ation since that time, even during major building renovations that closed the re-
mainder of the public facilities in 1993-1994. We began operation with a morning
lab session for high school students, which became fully booked within a year.
An afternoon session was added for middle school students in 1991. This year, a
30% increase was achieved by adding a second afternoon session on Monday
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and Friday. Now, with double or triple booking virtually every school day between
October 1 and June 15, we can honestly say that the Bio2000 Laboratory has
reached saturation. Although we can likely increase in-school instruction consid-
erably over the next year, this will be extremely hard on staff and will also in-
crease demand for field trips to the DNALC. Thus, further significant expansion of
laboratory experiences must await the hoped-for BioMedia Addition to the south
of our building.
The DNALC teaching facilities were also fully occupied throughout the sum-
mer months. Laboratory workshops were offered at four levels: Fun With DNA
(5th to 8th grade), World of Enzymes (6th to 8th grade), DNA Science (9th to 12th
grade), and Advanced DNA Science (10th to 12th grade). Sue Lauter initiated a
new course, Introduction to Computer Design, held in the BioMedia Laboratory.
Demand for summer instruction remained high, with 338 students participating at
courses held at the DNALC, as well as in the Beckman teaching labs on the main
CSHL campus and at Portledge School in Locust Valley. Support from the
Howard Hughes Medical Institute and the Barker Welfare Foundation allowed us
to extend opportunities for 99 students to attend courses conducted at venues in
New York City: the American Museum of Natural History and A. Philip Randolph
High School. Significantly, minority students composed 40% of summer
workhsop participants.
It is also worth noting that during 1996, we saw our 100,000th visitor. Al-
though this would be a yearly or even quarterly statistic for a large science cen-
ter, the numbers alone do not tell the whole story. We are extremely proud of the
fact that more than half of our clientele has received an intensive laboratory expe-
rience that goes well beyond the standard museum visit. A student lab exposure
at the DNALC averages two hours, whereas off-site instruction averages six
hours per student. Workshops average 30 hours of instruction.
With the opening of our own World Wide Web site (http://darwin.cshl.org), we
can now count 'virtual" visitors among our clientele. By year's end, the site was
receiving about 10,000 'hits" per month, including visitors from more than 50
countries. We quickly deployed substantial animations of molecular genetic pro-
cesses, using newly-released Shockwave compression software. The current
animations, showing DNA analysis by polymerase chain reaction and Southern
blotting, are the most popular stops at our site. These animations are a unique
resource for understanding dynamic molecular events and cannot be found else-
where. We intend to greatly expand our animation gallery in 1997.
DNA Learning Center Visitation 1988-1996
1988 1989 1990 1991 1992 1993 1994 1995 1996 Total
Student Labs (on-site) 2,031 3,753 3,758 4,248 4,624 3,422 3,961 4,682 6,088 36,567
Student Labs (off-site) 291 435 1,305 1,434 2,328 5,045 10,838
Teacher Labs 58 278 270 234 270 254 302 379 302 2,357
Student Workshops 32 13 24 176 234 351 361 503 437 2,131
Teacher Workshops 496 285 314 333 441 249 177 101 151 2,547
Lab Subtotal 2,617 4,329 4,366 5,282 6,004 5,581 6,235 7,993 12,023 54,430
Student Lectures 553 449 660 600 1,000 734 575 520 575 5,666
Exhibit/L1 Discovery 3,231 2,547 2,964 1,480 848 6,416 9,943 10,366 10,122 47,917
Total 6,401 7,325 7,990 7,362 7,852 12,731 16,753 18,879 22,720 108,013
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Cablevision's multimedia production, Long Island Discovery, continued as a
popular attraction, drawing more than 10,000 viewers. The 12th annual Great Mo-
ments in DNA Science Honors Student Seminar Series drew 575 local students
and teachers. Speakers and topics were:
Jan Witkowski, CSHL: The New Human Genetics.
Robert DeSalle, American Museum of Natural History: The Science of
Jurassic Park.
Scott Lowe, CSHL: Cancer and Cell Suicide.
Teacher Training Workshops Bear Brunt of Shift in NSF Funding
With support from the National Science Foundation (NSF) and the Howard
Hughes Medical Institute, we continued our effort to make human DNA finger-
printing by polymerase chain reaction (PCR) practical for widespread use in biol-
ogy classes. The Human Genome Diversity-Student Allele Database is a mini-lab
unit based on an experiment from our Laboratory DNA Science book that allows
students to examine their own DNA polymorphisms. During the academic year,
Mark Bloom and collaborator John Kruper (now at Allegheny College) introduced
the unit to 98 college faculty through a series of four NSF-sponsored workshops
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The precursor of the pub-
lished text, DNA Science,
used in 1987. The Vector
Van, pictured "on-the-road,'
transported all equipment
and supplies necessary to
instruct the DNA Science
curriculum.
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held at the United States Military Academy (West Point, NY); Howard University
(Washington, DC); City Lab (Boston University, MA); and Morehouse College (At-
lanta, GA).
The program is based on an Alu insertion polymorphism, an example of a
"jumping gene" that has amplified itself to over 500,000 copies in the human
genome. A small subset of Alu insertions have occurred recently in our evolution-
ary past and can be used as biological clocks to study human origins. Students
can use their own allelic data to conduct a case study in population genetics.
The data can be manipulated using Student Allele Database software developed
by the DNALC and the University of Chicago. Accessible via the Internet, the Stu-
dent Allele Database allows students to tabulate Alu insertion data, test Hardy-
Weinberg equilibrium, and compare two populations by contingency Chi-square
and genetic distance. The database includes Alu allele frequencies from relic
populations around the world and from nearly 900 students who have performed
the experiment at the DNALC. Additional data sets are being added by the
classes of faculty trained through the NSF program.
The DNALC continued its international leadership in 1996, conducting
teacher workshops in Australia and Italy. In January, Dave Mick los traveled to
Melbourne to conduct a DNA Science Workshop that drew 50 secondary
teachers from throughout Victoria, Australia. The course was jointly organized by
Suzanne Cory, director of the Walter and Eliza Hall Institute, and James Pittard,
Chairman of the Microbiology Department at the University of Melbourne. A May
course on "DNA Amplification and Genetic Diversity," sponsored by the Porto
Conte Foundation, introduced the Student Allele Database project to 20
secondary teachers from the Naples area. The workshop was organized by our
collaborator Marcel lo Siniscalco and Giuseppe Martini, of the International In-
stitute of Genetics and Biophysics.
It was with some nostalgia that Dave Mick los conducted DNA Science In-
stitutes at Eastern Mennonite University (Harrisonburg, VA) and the University of
Alaska (Fairbanks), concluding a 10-year NSF training program for high school
biology teachers. DNA Science is the nation's longest-running training program
in molecular genetics for high school faculty and has been in continuous opera-
tion since its founding in 1985. DNALC staff have instructed more than 1500 fac-
ulty at institutes in 38 states and Puerto Rico, and an estimated 2000 additional
faculty nationwide have been trained by other academic groups using the DNA
Science curriculum. Thus, there is good reason to believe that the DNA Science
curriculum has been the major training mechanism to introduce precollege biol-
ogy teachers to DNA manipulation techniques. But this achievement seemed for
naught when we received word at year's end that, after two successive proposal
attempts, NSF would not renew support for the DNA Science program. We were
very lucky to have maintained NSF support over an entire decade, considering
that 3-5-year funding is the norm. The DNALC's high school training was always
an anomaly in the NSF portfolio-we were the only program funded explicitly to
take faculty training to distant sites in other states. In that sense, we always led a
fragile existence.
The DNALC's training programs developed in an era when NSF supported
training programs were operated by individual investigators at major universities
and research institutions. However, several years ago, NSF initiated a major pro-
gram of "systemic initiatives"-multi-million dollar awards to state and urban edu-
cation authorities. While the theory of improving science education within a whole
school system is attractive, many see these as essentially redundant entitlement
funding to educational bureaucracies that have shown little ability to innovate or
improve themselves. By year's end, NSF had even gone to the extreme measure
of rescinding funds for initiatives in the District of Columbia, Florida, and North
Carolina. NSF cited a "crisis in leadership" in these school systems, but many see
the systemic program as a leadership failure at NSF.
However history ultimately judges the systemic initiatives, the net effect has
been to virtually eliminate funding of innovative, independent programs. Further-
more, representatives from systemic initiatives have become the dominant voice
in NSF panels that review prospective grant proposals. The tenor of current
reviews is antipathetic to programs, such as ours, that deal with advanced topics
or appeal to well-prepared teachers. Even so, we are among the few genetics
education programs in the nation that has managed to maintain a reasonable
level of federal funding during this difficult period.
Corporate Advisory Board Is Key to Our Continued Success
Five years ago, funding from the NSF and other federal agencies contributed
nearly half of DNALC operating revenues. Federal funding dropped to 25% of
1996 costs. Thankfully, over the last several years, the DNALC has expanded
funding from its local educational activities and from Long Island contributors to
cover about half of annual operating costs. This strong base of local support al-
lows us to weather periodic changes in federal funding and explore new grant
opportunities. The Corporate Advisory Board (CAB) has become the key element
of our local funding picture, involving an ever-growing number of local com-
panies in the DNALC's mission to educate local students. CAB members include
individual philanthropists and business leaders representing a range of Long Is-
land companies.
The year began with the good news that John Leahy had assumed the CAB
chairmanship. John is Senior Vice President at Chase Manhattan Bank, a long-
time supporter of CSHL. Under the leadership of John and CSHL Special
Projects Coordinator Laura Hundt, the DNALC annual fund drive reached
$147,000, a 10% increase over 1995. Horst Saalbach and golf committee mem-
John Leahy Addresses CAB
members and guests at
Long Island Business Night
in October.
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bers organized the third annual golf tournament, held at Piping Rock Club on
June 18th, which contributed $83,500 toward the annual fund goal. The golf com-
mittee included Vincent Adimando, Andrew Ackerman, Howard Blankmann,
Gerald Brennan, G. Morgan Browne, Richard Catalano, Clark Gillies, Arthur
Herman, John Kean, and William Keen. Long Island Business Night, on October
6th, was another highlight of the calendar as CAB members and guests were en-
tertained by CSHL President James Watson and his wife Elizabeth at their home,
Ballybung.
Opening of McClintock Exhibit Completes DNALC Renovation
On September 20th, we opened a new exhibit, "World of Barbara McClintock,' to
commemorate the life and work of Cold Spring Harbor Laboratory's most
celebrated female scientist. The opening marked the completion of our long-term
effort to remodel our 1925 school building as a modern science center.
The exhibit recreates Barbara's laboratory in the basement of Demerec Build-
ing at the time of her death in 1992. Since she was frugal and relied on little
scientific equipment other than a microscope, her laboratory contained items that
spanned her entire career at Cold Spring Harbor. Many articles date to her first
laboratory in the Mouse House (now McClintock Laboratory), in which she
worked until 1953. A timeline chronicles her childhood in Hartford and Brooklyn,
her education at Cornell, and her scientific work at the California Institute of Tech-
nology and the University of Missouri, as well as Cold Spring Harbor. Her Nobel-
winning discovery of transposable genetic elements is described in a computer
animation. Her 1983 Nobel prize is displayed, along with her Nobel Lecture-one
of the few videotapes of her available.
The McClintock gallery is painted to simulate the
cinder block walls in the Demerec building laboratory
in which she worked. The life model was commissioned
from Third Dimension, Ltd., in Vancouver.
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The most eye-catching, and controversial, part of the exhibit is a life model of
Barbara, based on a photograph from 1947, six years after she came to Cold
Spring Harbor as a summer guest. She is portrayed at work in front of her micro-
scope, which was, in a real sense, her world: 'You know, when I look at a cell, I
get down in that cell and look around. I found that the more I worked with them,
the bigger and bigger [the chromosomes] got. And when I was working with
them, I wasn't outside, I was down there. I was part of the system. I was right
down there and everything got big. I was even able to see the integral parts of
the chromosome-actually, everything was there. It surprised me, because I ac-
tually felt as if I were right down there and these things were my friends.'
Staff and Interns
In summer, we were sorry to say good-bye to part-time laboratory instructor
Flavio Della Seta, who finished his postdoctoral stay in Kim Arndt's lab and
returned to his faculty position at the University of Nancy. With the expansion of
off-site instruction under the Genetics as a Model for Whole Learning Program,
Diane Jedlicka and Malissa Hewitt had to cease instructing high school classes
in the Bio2000 Laboratory. To fill this void, we were lucky to obtain the assistance
of three additional part-time Laboratory Instructors-Joan Alexander, Scott
Bronson, and Michael Greenberg. Joan, who has worked in several CSHL labs, is
presently an associate scientist at Amp licon, a new biotechnology company con-
cerned with identifying genes involved in human breast tumors. Scott is a re-
search associate and Mike is a postdoctoral fellow in the laboratory of Jacek
Skowronski, which investigates the role of the Nef protein in HIV pathogenesis.
Andrew Morotti joined the full-time staff in September as Laboratory In-
structor, providing key support to the rapidly growing laboratory program.
Andrew was a natural choice for the position, having worked all summer as an in-
structional intern for the Fun With DNA and World of Enzymes summer camps. In
addition to teaching middle school labs, both at the DNALC and at participating
schools, he also aided Mark Bloom in managing our growing number of high
school interns. Andrew has a biology degree from SUNY Plattsburgh. Amy Cross
began a part-time position as Program Assistant in August-helping with the
complicated scheduling of visits to the DNALC and introducing students to the
multimedia program Long Island Discovery and the Story of a Gene Exhibit. A
1996 graduate of SUNY Geneseo, Amy previously worked for Friends Academy
in Locust Valley as a counselor and assistant office manager. Andrew and Amy
also helped fill the large administrative hole left when Sue Lauter took maternity
leave in September. Sue gave birth to twins, Casey and Martin, on November
14th.
Intern Trevor Carlson (Central Islip High School) contributed heavily to the de-
velopment of the DNALC home page on the World Wide Web, including Shock-
wave animations and an interactive bulletin board. The laboratory instructional
staff was ably assisted by high school interns Stacey Trotter (Walt Whitman High
School), Salley Ann Gibney (Cold Spring Harbor High School), Rachael Neumann
(Syosset High School), and Trevor Sammis (Huntington High School). Jermel
Watkins, now the senior intern, continued to work part-time at the DNALC while
studying pre-med at the New York Institute of Technology. In fall, we bid farewell
to Stacey, who began her freshman year at Cornell University and to Salley, who
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began her freshman year at Johns Hopkins University. Newcomers Hana Mizuno
(Cold Spring Harbor High School), Mera Goodman (Walt Whitman High School),
Karin Glaizer (Portledge School), Gerry DeGregoris (Chaminade High School),
and Dan Gibson (Cold Spring Harbor High School) joined the staff in fall, 1996,
and assisted with the laboratory instruction program. The new interns, together
with Rachael and Trevor, began to formulate plans for carrying out independent
research projects in addition to their intern work. Assisting at Fun With DNA sum-
mer camps were lab aides Ali Chaudry (Walt Whitman High School), Todd Rebori
(Walt Whitman High School), Jennifer Kosinski (Roslyn High School), Paul Tanck
(Massapequa High School), and Kim Bronson (who is married to Laboratory In-
structor, Scott Bronson).
Staff Associates Jerry Watkins, of Central Islip High School, and Twana
Adams, of Bronx Alternative School, instructed minority workshops hosted at the
American Museum of Natural History in Manhattan and at A. Philip Randolph
High School in Harlem. Jerry Watkins, father of DNALC intern Jermel, is a gradu-
ate of the DNA Science Workshop and the NSF Leadership Institute. In addition
to instructing two DNA Science Workshops at the Museum of Natural History,
Jerry also taught student workshops in his home district, Central Islip. A resident
and community organizer, Twana taught Fun With DNA summer camps at A.
Philip Randolph High School, with support from Michael Gordon, a teacher at
Choir Academy of Harlem.
1996 Workshops, Meetings, and Collaborations
January 15-19
January 17
January 19
February 10
February 23-25
March 2-3
March 15-16
March 16-17
March 20
March 22
March 28-29
March 30
April 2
April 10
April 11
April 17
April 18
April 23
April 25
April 27-29
May 2
May 6
May 10
May 15
May 20-21
May 28
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DNA Science Workshop, Walter and Eliza Hall Institute and University of Melbourne, Australia
Laboratory for Women In Science and Engineering Program, SUNY Stony Brook, DNALC
Corporate Advisory Board Meeting, Banbury Center
Laboratory for Corporate Advisory Board and Cold Spring Harbor Laboratory Association Direc-
tors, DNALC
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database,
USMA, West Point, New York
National Science Foundation Follow-up Workshop, DNA Science, Bates College, Lewiston, Maine
National Science Foundation Grant Review, Washington D.C.
National Science Foundation Follow-up Workshop, DNA Science, University of Kansas, Lawrence
Meeting at American Philosophical Society, Philadelphia, Pennsylvania
Benjamin/Cummings Strategies Workshop, Valencia Community College, Orlando, Florida
National Science Teachers Association Meeting, Philadelphia, Pennsylvania
Benjamin/Cummings Strategies Workshop, Pasadena Community College, California
Meeting at The Center for Occupational Research and Development, Waco, Texas
Community School District 29 Meeting, Rosedale, New York
Site visit by Rob Kelly, Computer Associates, and Peter Goldsmith, Long Island Association
Corporate Advisory Board Meeting, DNALC
Great Moments in DNA Science, Honors Students Seminar, CSHL
Great Moments In DNA Science, Honors Students Seminar, DNALC
Biotech Conference, Harrisonburg High School, Harrisonburg, Virginia
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database,
Howard University, Washington D.C.
Site visit by BBC Photographers, Great Britain
Great Moments in DNA Science, Honors Students Seminar, CSHL
Site visit by Bruce Curtis, National Geographic
Computer Associates Meeting, Islandia, New York
Corporate Advisory Board Meeting, Chase Bank Regional Headquarters, Melville, New York
DNA Amplification and Genetic Diversity Workshop, International Institute of Genetics and
Biophysics, Naples, Italy
Site visit by Ellen Potter, Salk Institute
June 6
June 8
June 10
June 14
June 17
June 24-28
June 24-July 2
June 27
July 1-12
July 8-12
July 12
July 15-19
July 22-26
July 29-Aug 1
July 29-Aug 2
August 1
August 5-9
August 5-13
August 8
August 12-15
August 19-23
August 19-27
August 26-29
August 26-30
September 5
September 17
September 20
September 25
October 7
October 12-14
October 16
October 18
October 18-19
October 21
October 22
October 23-25
October 26
Oct 30-Nov 1
November 2
November 9
November 9-11
November 13
November 14
Site visit by John Reiher, The Center for Occupational Research and Development
Seminar at Southern Mississippi University, Hattiesburg
Brooklyn Technical High School Meeting, Brooklyn, New York
Site visit by Anika Rohl, Swedish Medical Research Council
National Science Foundation Workshop, DNA Science, University of Alaska, Fairbanks
Access Excellence Summit, San Francisco, California
Fun With DNA Workshop, Port ledge School, Locust Valley, New York
DNA Science Minority Workshop, Central Islip, New York
Advanced DNA Science Workshop, DNALC
Corporate Advisory Board Meeting, DNALC
Advanced DNA Science Minority Workshop, Central Islip, New York
DNA Science Workshop, DNALC
Site visit by Keith Mc Kenney, The Institute for Genomic Research
National Science Foundation Workshop, DNA Science, Harrisonburg, Virginia
Howard Hughes/Barker Welfare Foundation Minority Workshop, DNA Science, American Museum
of Natural History, New York, New York
Fun With DNA Workshop, DNALC
Fun With DNA Workshop, Port ledge School, Locust Valley, New York
DNA Science Workshop, DNALC
Howard Hughes/Barker Welfare Foundation Minority Workshop, DNA Science, American Museum
of Natural History, New York, New York
Introduction to Computer Design Workshop, DNALC
Howard Hughes/Barker Welfare Foundation Minority Workshop, Fun With DNA, A. Philip Randolph
High School, New York, New York
World of Enzymes Workshop, DNALC
Howard Hughes/Barker Welfare Minority Workshop, DNA Science, American Museum of Natural
History, New York, New York
Site visit by Robert Frehse, Hearst Foundation
Fun With DNA, DNALC
Howard Hughes/Barker Welfare Foundation Minority Workshop, Advanced DNA Science,
American Museum of Natural History, New York, New York
Site visit by New York Senator Kemp Hannon
Fun With DNA Workshop, DNALC
DNA Science Workshop, DNALC
Howard Hughes/Barker Welfare Foundation Minority Workshop, World of Enzymes, American
Museum of Natural History, New York, New York
Advanced DNA Science Workshop, Beckman Neuroscience Center, CSHL
World of Enzymes Workshop, DNALC
Introduction to Computer Design Workshop, DNALC
Site visit by Dorothy Dart and Ray Geste land, University of Utah Genome Center
Community School District 29 Meeting, DNALC
World of Barbara McClintock Exhibit Opening, DNALC
Site visit by Steven Olson, Howard Hughes Medical Institute
Site visit by Lorraine LaFemina, Long Island Business News
Seminar for Federal Judicial Center, DNALC and Banbury Center
Corporate Advisory Board Meeting, DNALC
Site visit by Agneta Levinovitz, Nobel Forum
National Association of Biology Teachers Convention, Charlotte, North Carolina
Site visit by Dr. Nancy Douzines and Brooke Mahoney, The Rauch Foundation, and Linda
Fransciscovitch, US Trust Company
Meeting at The Institute of Genomic Research, Rockville, Maryland
Howard Hughes Medical Institute Program Directors' Meeting, Bethesda, Maryland
Association of Science and Technology Centers Conference, Pittsburgh, Pennsylvania
National Science Teachers Association Meeting, Atlanta, Georgia
Seminar for Metropolitan Association of College and University Biologists, Paramus, New Jersey
Laboratory for Journalists Workshop-Genetics of Human Behavior, DNALC
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database,
Boston University, Massachusetts
Seminar for Cornell University Medical College Program in Regional Genetics, CSHL
Corporate Advisory Board Meeting, DNALC
Site visit by Nancy Hutchison, Fred Hutchinson Cancer Center
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November 20
November 25
December 6
December 10
December 13-15
December 16
Site visit by Frederica Jarco, Greenwall Foundation
National Marfan Foundation Meeting, DNALC
Site visit by Paul Fetters, Howard Hughes Medical Institute
Introduction to Forensic Uses of DNA Fingerprinting, seminar for law enforcement and legal
communities, DNALC
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database,
Morehouse College, Atlanta, Georgia
Site visit by Jane Block, Pall Corporation, and Jim Shaw, Newsday
Sites of Major Faculty Workshops 1985-1996
Key: High School College Middle School
ALABAMA University of Alabama, Tuscaloosa 1987-1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA University of California, Davis 1986
San Francisco State University 1991
University of California, Northridge 1993
COLORADO Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
DISTRICT OF COLUMBIA Howard University 1992, 1996
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991, 1996
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986, 1987
University of Chicago 1992
INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
MASSACHUSETTS Beverly High School 1986
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Boston University 1994, 1996
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990, 1991
MISSOURI Washington University, St. Louis 1989
NEW HAMPSHIRE St. Paul's School, Concord 1986, 1987
NEVADA University of Nevada, Reno 1992
NEW YORK Albany High School 1987
Bronx High School of Science 1987
Columbia University, New York 1993
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Cold Spring Harbor High School 1985, 1987
DeWitt Middle School, Ithaca 1991, 1993
DNA Learning Center 1988-1995
DNA Learning Center 1990, 1992, 1995
DNA Learning Center 1990-1992
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987-1990
Titusville Middle School, Poughkeepsie 1991, 1993
Wheatley School, Old Westbury 1985
U.S. Military Academy, West Point 1996
NORTH CAROLINA North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA School of Science and Mathematics, Oklahoma City 1994
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
UTAH University of Utah, Salt Lake City 1993
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
WASHINGTON University of Washington, Seattle 1993
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and
University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Pureto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SWEDEN Kristineberg Marine Research Station, Fiskeb8ckskil 1995
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1996 PUBLICATIONS
General Books
Protein Kinesis: The Dynamics of Protein Trafficking
and Stability
Symposia on Quantitative Biology LX
Vaccines 96: Molecular Approaches to the Control of
Infectious Diseases
F. Brown, E. Norrby, D. Burton, and J. Mekalanos (eds.)
The Eighth Day of Creation: Makers of the Revolution in
Biology, Expanded Edition
H.F. Judson
Discovering Molecular Genetics: Solutions Manual &
Workbook
J.H. Miller
CSHL Monograph Series
DNA Replication in Eukaryotic Cells
M.L. DePamphilis (ed.)
Epigenetic Mechanisms of Gene Regulation
V.E.A. Russo, A.A. Martienssen, and A.D. Riggs (eds.)
Cancer Surveys Series
Vol. 26, Skin Cancer
I.M. Leigh, J.A. Newton Bishop, and M.L. Kripke (eds.)
Vol. 27: Cell Signalling
P. Parker and T. Pawson (eds.)
Vol. 28: Genetic Instability in Cancer
T. Lindahl (ed.)
Journals
Genes & Development (Volume 10, 24 issues)
T. Grodzicker and N. Hastie (eds.)
Genome Research (Volume 6, 12 issues)
A. Chakravarti, R. Gibbs, E. Green, R. Myers, and
M. Boguski (eds.)
Learning & Memory (Volume 3, 6 issues)
J.H. Byrne (ed.)
Videotapes
On Becoming a Scientist
Promise & Perils of Biotechnology: Genetic Testing
Other
The Lab Manual Source Book
CSHL Annual Report 1995
Banbury Center Annual Report 1995
Administration and Financial Annual Report 1995
Abstract/program books for 16 CSHL meetings
COLD SPRING HARBOR LABORATORY PRESS
The year was one of considerable achievement in the creation of assets and sales of existing publi-
cations. All three journals built a stronger subscription base. A new edition of The Cold Spring Har-
bor Laboratory Manual Source Book was published and by the year's end had become the basis of
a new company formed to capitalize on the potential of the directory and its online companion,
BioSupplyNet. Nine new books and two new videotapes were published, bringing the total titles in
print to over 220. However, publication of six new book titles, including the most important of the
year, could not be completed by year's end and despite the backlist's strong performance there
was a considerable shortfall in book sales. Journal income reached a record total overall but soft
advertising sales in the first half-year and higher costs resulting from staff disabilities reduced the
anticipated surplus. The Press thus showed an overall operating loss. A comprehensive response to
the factors underlying this result was already underway by the year's end.
Books and Electronic Media
No new laboratory manuals were published this year, as work continued on the development of a
bumper crop of new techniques publications for future release. Of the eleven books and
videotapes published during the year (see opposite for the complete list), two titles were added to
the monograph series that has brought distinction to our program since the early 1970s. DNA
Replication in Eukaryotic Cells, orchestrated singlehandedly by editor Mel DePamphlis, had three
goals: to help teachers of molecular biology synthesize the enormous amount of new information
available on the topic; to provide workers in the field with a summary of progress; and to help other
investigators relate DNA replication to other biological problems such as cell cycle control and cell
death. Its forty chapters divided neatly into concepts, proteins and systems, and we anticipate fu-
ture editions in which selected parts of this material are made available for teachers and students.
Epigenetic Mechanisms of Gene Replication, edited by Enzo Russo, Rob Martienssen, and Arthur
Riggs, was dedicated to Barbara McClintock, forever associated with Cold Spring Harbor, where
she discovered transposable genetic elements. By the end of her long life, she had seen the study
of epigenetic mechanisms she pioneered move from the shadows of uncertainty to the status of a
respected discipline. The book's 35 chapters provided, for the first time, a survey of such mechan-
isms in mammalian, plant, insect, fungal, and microbial systems.
It also gave us much satisfaction to release in a new edition Horace Freeland Judson's classic
history of the birth of molecular biology, The Eighth Day of Creation. First published in 1978 and un-
available in the U.S. for many years, it is one of the best popular accounts of any aspect of science
ever published, the product of Judson's graceful writing and his journalist's tenacity in getting to
the heart of a great story. Our handsomely designed new edition corrects some minor errors in the
original and extends it with additional essays on Rosalind Franklin and Erwin Chargaff and a new
epilogue on the development of molecular biology since 1970. The book's reappearance has been
warmly welcomed.
It is also worth noting the appearance of, perhaps, the last two in a series of educational
videotapes conceived by staff at the University of California San Francisco. On Becoming A
Scientist, The Promise and Perils of Biotechnology, and last year's Stories from the Scientists were
produced by a group of Bay Area teachers and university staff as a follow-up to UCSF's hugely
popular 1992 symposium on the social implications of molecular genetics, Winding Your Way
Through DNA, which the Press also distributed on videotape. Created with care and clarity, and
showing science and scientists in action in a truthful way, all these productions have been popular
with educators at many levels and have been recognized with awards, such as this year's Golden
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Eagle and Golden Apple, won by Stories from the Scientists, and the Bronze Apple won by Promise
and Perils. The coordinator of the series at UCSF throughout our collaboration was Valli Thayer
McDougle, now retired from her position, with whom it was always a pleasure to work and to whom
the lion's share of credit for this inspiring series must go.
Our history, The Cells of the Body, written by Sir Henry Harris, was selected by CHOICE maga-
zine, a publication of the Association of College and Research Libraries, for its list of Outstanding
Academic Books for 1996.
Journal Publishing
For the first time in several years, the journal department had none of the challenges of a new title
launch or a doubled publication frequency to deal with. But significant progress was made towards
electronic distribution of journal content, starting in March with the addition of abstracts from all the
current issues to the journals' World Wide Web pages. By year's end, agreement had been
reached with High Wire Press of Stanford University to publish the full text of all the Cold Spring
Harbor journals online, starting in late 1997. High Wire's list of client publishers now encompasses
many of the most important journals in cellular and molecular biology and their clustering under
one virtual roof gives added point to many interesting questions about the future of journals in a
wired world.
The geographically far-flung editors of Genome Research took enthusiastic advantage of anoth-
er form of networked information, namely a journal-specific, web-based intranet used to inspect
and comment on submitted papers and their reviews. This prototype system, devised by Managing
Editor Judy Cuddihy and the staff of Sheridan Electronic Systems, proved robust and scalable and
will be adapted for use with our other journals, saving time and the expense of sending papers for
review around the world by courier.
Genome Research ended its first full year of monthly publication with a healthy 12% increase in
institutional subscriptions, more than justifying the decision to reposition our established PCR tech-
nology journal in genome science. The journal's manuscript submission rate grew steadily through-
out the year and the journal's editors, Mark Boguski, Aravinda Chakravarti, Richard Gibbs, Eric
Green, and Richard Myers, responded bravely to the increased workload and the need for con-
stantly advancing standards. By the end of the year, however, all concerned agreed that it was
time the journal had a full-time editor at Cold Spring Harbor to help make the selection process
more efficient and to create additional types of editorial content that would enhance the journal's
appeal to individual subscribers.
Learning and Memory, a new addition to our journal family in mid-1994, maintained its subscrip-
tion base in its second full year of publication. The flow of manuscripts strengthened, and the year
was notable for the appearance of an outstanding double issue on longterm potentiation and its
meaning. The journal is steadily achieving recognition in the neuroscience community, a difficult
process given the competition from more established journals and the fledgling stage of much
molecular analysis of learning and memory. Its future is in the capable hands of Jack Byrne, who
took over as editor this year. The journal has a niche and a foundation for eventual success, but it
will not come overnight.
Genes & Development, on the other hand, is now an established winner. Its reputation was un-
derlined by a further increase in the impact factor calculated by the Institute for Scientific Informa-
tion, which placed it sixth in the roster of most cited journals in all biology. The journal's editors,
Terri Grodzicker and Nick Hastie, facing increased demand to publish in the journal, responded by
continuing to raise the standard required for acceptance. The year's 24 issues stretched the scope
of the journal into newer areas of cellular biology, and the activities of Michele Cleary, and later Kim
Gavin, resulted in the appearance of more commissioned reviews. The reward, with the aid of well-
targeted marketing, was a 5% increase in circulation-no small achievement for a journal in its
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ninth year in a marketplace undergoing great upheaval.
Advertising sales were soft in the first half of the year but picked up well in the third quarter with
the arrival of Marcie Ebenstein as Advertising Sales Manager. She began an overhaul of the sales
department's operations in order to rebuild this important source of income for the journal program.
The Laboratory Manual Source Book
In March, the 1996 edition of this directory of laboratory products and their suppliers was distrib-
uted free of charge to more than 50,000 scientists worldwide. The cost of distribution was borne by
the product advertising space, sold vigorously by Joan Boyce, the project manager. This was the
second annual edition of the Source Book, more comprehensive in all respects than the first. The
expanded databases were incorporated within BioSupplyNet, a searchable web site that extended
the information in the print directory with technical specifications, special pricing offers, and other
user-oriented data. The Source Book and its interactive equivalent grew from the laboratory manual
publishing program and, as they evolved, the project's potential basis for systems of advanced
marketing and electronic commerce seemed ever more intriguing. The development of these capa-
bilities, however, clearly required technical expertise that we did not have, and an investment that
the Press could not sustain. Fortunately, we did have access to the Harris and Harris Group, a
Manhattan-based business development company wise in the commercial exploitation of ideas
and technology from academic institutions. With the help of its principals, a new company was
formed in October to purchase and develop the Source Book and its web site. Owned jointly by the
Laboratory and its investors, BioSupplyNet Incorporated has an experienced entrepreneur, Lyle
Brecht, as its President, Joan Boyce as Vice-President, and the Source Book's ex-Press core staff
as its first employees.
The company's first challenge was to create a 1997 print directory so comprehensive that it
would become the standard for science and its associated vendors. The second was to in-
corporate into the web site the technical sophistication necessary to surge ahead of competitors in
search capability and delivery of advanced marketing information. As the year ended, the staff had
risen to eight, and both tasks were well underway. A joint marketing agreement with the Press was
negotiated by which all purchasers of Cold Spring Harbor manuals would continue to get free
copies of the Source Book.
Marketing and Distribution
This year's marketing activities centered on the well-tried strategies of direct mail, meeting exhibits,
and journal advertising, but incorporated additional activities on an exploratory basis. The direct
mail program centered on a widely distributed Genes, Cells, and Proteins catalog, two issues of the
New Book Titles newsletter, and a variety of title-specific brochures. The journals received particu-
lar attention through a well-targeted approach to specific academic libraries and reduced price of-
fers to individuals via several different routes. Both strategies had notable success. In addition,
some telemarketing was done to obtain specific types of information.
The Press exhibit stand appeared at the seven major scientific society meetings of the year and
several smaller, more specific conferences. This is another important marketing channel which in-
troduces the Press to many young scientists and to hopeful authors and others with ideas for future
publications.
The Cold Spring Harbor meetings and courses offer similar opportunities in more intimate sur-
roundings. The campus bookstore, in the past operated by the Press in cramped surroundings,
reopened in April in new and spacious quarters under the management of the college division of
Barnes and Noble, Inc. Visitors benefited from a much expanded range of books, software, clo-
thing, and other items, with room and expanded hours in which to browse.
The web site at www.cshl.org, which opened two years ago as a marketing tool for the Press
and the meetings and courses program, was redesigned to reflect other aspects of the Laboratory.
Its function for the Press remained unchanged-a keyword-searchable catalog allied with detailed
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announcements of new books and journal issues, sample chapters from forthcoming titles, and the
opportunity to purchase electronically. But an important shift in emphasis occurred this year with
our decision not to release a complete catalog of publications in print. The online catalog is now
definitive, to be recommended to any customers seeking backlist information, and much care is
taken to ensure that it is complete, up-to-date, and entirely accurate in all respects.
To service book orders and journal subscriptions acquired by these various means, our Fulfill-
ment and Dispatch Department continued to rely on its now drastically outmoded computer system
while actively seeking an alternative with the kind of functionality needed by an operation of our
size. Towards the year's end, one promising software prototype did well in early tests, suggesting
that it might be possible early in 1997 to install a new client-server based system that would offer
unprecedented flexibility and control together with the kind of financial and marketing analysis on
the fly that is impossible with the current equipment.
New Projects
During the year, agreement was reached with authors and editors about the creation of more than
20 new publishing projects, in print and in electronic media. These projects included manuals,
monographs, advanced textbooks, and essays. And many conversations took place about other
possibilities in a variety of media, as publishers, scientists, and others pooled their ideas about like-
ly styles of scientific communication in the next century.
Staff changes
The publishing program continued to benefit from the commitment of its staff to high quality at
every level and in every function. The list of staff members in December 1996 is given at the back
of this volume, and grateful thanks is extended to each one of them. But special mention must be
made of the heads of the departments of the Press, Nancy Ford, Judy Cuddihy, Ingrid Benirschke,
Nancy Hodson, and Guy Keyes, whose management skills, ideas, and advice were essential to the
workings of the organization.
During the year, we welcomed several new members of staff: Marcie Ebenstein as Advertising
Sales Manager, Kim Gavin as Assistant Editor of Genes & Development, Kaaren Janssen as Pro-
ject Managing Editor, Val Pakaluk as Editorial Secretary, and Liz Powers as Assistant to the Direc-
tor. We bade farewell to Michele Cleary, Eileen Paetz, Laura Terwilliger, and Teresa Tiganis, wish-
ing them well for the future. And we prepared to say goodbye to Nancy Ford who in December an-
nounced her intention to retire in January, after 24 years' distinguished service to the Laboratory.
During this period she developed the publications program with taste, intelligence, and dedication,
working with an extraordinary cadre of leading scientists to create some of the landmark publica-
tions in the nascent science of molecular biology.
Nancy built into the publishing program many of the elements we value most: insistent ac-
curacy, elegant design, and warm relationships with the authors and editors who bring us their
special expertise. Those values remain intact, now the preserve of others with equal commit-
ment-a legacy to be very proud of. We began the new year with the intention of restructuring the
organization of the Press to increase efficiency, raise productivity, and improve financial manage-
ment. Our challenge is to attain these goals without losing sight of the characteristics that have
defined publishing at Cold Spring Harbor for the past quarter century.
John R. Inglis
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FINANCE
FINANCIAL STATEMENTS
STATEMENT OF FINANCIAL POSITION
December 31, 1996
With comparative amounts for 1995
Assets: 1996 1995
Cash and cash equivalents $ 12,959,798 13,459,548
Investments 123,682,720 94,979,330
Accounts receivable:
Publications 489,932 601,297
Other 191,162 358,430
Grants receivable 2,251,645 3,028,747
Contributions receivable 3,518,165 500,000
Publications inventory 1,426,118 1,394,720
Prepaid expenses and other assets 1,308,461 2,078,234
Investment in employee residences 2,370,943 1,825,641
Land, buildings, and equipment:
Land and improvements 9,037,008 7,588,532
Buildings 60,467,671 59,706,386
Furniture, fixtures, and equipment 4,310,386 4,239,740
Laboratory equipment 11,721,056 10,554,994
Library books and periodicals 365,630 365,630
Construction in progress 1,103,850 190,382
87,005,601 82,645,664
Less accumulated depreciation and amortization (27,354,072) (24,634,265)
Land, buildings, and equipment, net 59,651,529 58,011,399
Total assets $ 207,850,473 176,237,346
Liabilities and Net Assets:
Accounts payable and accrued expenses $ 1,470,007 949,079
Notes payable 864,961 667,520
Bonds payable 30,000,000 30,000,000
Deferred revenue 5,715,510 5,351,669
Total liabilities 38,050,478 36,968,268
Net Assets:
Unrestricted
General operating 6,030,181 5,693,880
Designated:
For research program 1,150,000 1,150,000
Capital expenditures 34,540,515 34,010,961
Board designated endowment 63,334,506 49,544,118
Total unrestricted 105,055,202 90,398,959
Temporarily restricted 1,269,123 470,000
Permanently restricted 63,475,670 48,400,119
Total net assets 169,799,995 139,269,078
Total liabilities and net assets $ 207,850,473 176,237,346
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STATEMENT OF ACTIVITIES
Year Ended December 31, 1996
With comparative amounts for 1995
Unrestricted
Temporarily
Restricted
Permanently
Restricted
1996
Total
1995
Total
Revenue and other support:
Public support (contributions
and nongovernment grant awards) $ 9,639,448 1,179,123 3,537,198 14,355,769 11,191,359
Government grant awards 13,756,042 - 13,756,042 12,105,851
Indirect cost allowances 9,817,300 9,817,300 9,007,870
Other revenue:
Program fees 1,948,793 1,948,793 1,773,800
Rental income 443,934 443,934 435,555
Publications sales 4,804,744 - 4,804,744 5,119,484
Dining services 2,080,803 - 2,080,803 1,983,219
Rooms and apartments 1,639,324 - 1,639,324 1,664,609
Royalty & licensing fees 464,652 464,652 1,222,390
Gain on sale of investments, net 5,911,392 - 8,771,350 14,682,742 4,410,605
Net decrease in unrealized gains
on investments (1,985,032) - (3,550,771) (5,535,803) -
Investment income-
interest and dividends 6,258,338 6,258,338 6,903,504
Recovery of valuation allowance - 522,774
Miscellaneous 109,733 109,733 134,334
Total other revenue 21,676,681 5,220,579 26,897,260 24,170,274
Net assets released from restrictions:
Expiration of time restrictions 380,000 (380,000)
Total revenue and support 55,269,471 799,123 8,757,777 64,826,371 56,475,354
Expenses:
Program services:
Research 16,658,074 - - 16,658,074 15,837,311
Summer programs
(meetings and courses)
5,730,064 - - 5,730,064 5,201,484
Publications 5,031,983 - - 5,031,983 5,078,559
Banbury Center conferences 457,033 - 457,033 920,781
DNA Learning Center programs 278,473 - - 278,473 486,367
Total program services 28,155,627 - - 28,155,627 27,524,502
Supporting services:
Direct research support 1,325,133 - - 1,325,133 1,243,713
Library 658,967 - - 658,967 591,520
Operation and maintenance of plant 5,721,030 - - 5,721,030 5,514,513
General and administrative 4,824,906 - - 4,824,906 4,655,785
Dining services 1,907,328 - - 1,907,328 1,814,174
Interest 1,385,706 - 1,385,706 1,526,387
Depreciation and amortization 2,988,112 - - 2,988,112 2,820,555
Total supporting services 18,811,182 - - 18,811,182 18,166,647
Total expenses $ 46,966,809 - - 46,966,809 45,691,149
Change in net assets before
cumulative effects of changes
in accounting principles $ 8,302,662 799,123 8,757,777 17,859,562 10,784,205
Cumulative effects of changes in accounting
for investments and contributions 6,353,581 - 6,317,774 12,671,355 1,560,000
Change in net assets 14,656,243 799,123 15,075,551 30,530,917 12,344,205
Net assets at beginning of year 90,398,959 470,000 48,400,119 139,269,078 126,924,873
Net assets at end of year $ 105,055,202 1,269,123 63,475,670 169,799,995 139,269,078
COMPARATIVE OPERATING HISTORY 1992-1996
(Dollars in Thousands)
1992 1993 1994 1995 1996
Income:
Main Lab:
Grants & contracts $ 16,800 18,136 19,293 19,653 20,879
Indirect cost reimbursement 8,388 8,383 8,460 8,881 9,704
Other 5,520 6,049 6,808 7,461 7,859
CSH Press 3,709 4,319 4,390 5,119 4,805
Banbury Center 1,104 1,281 1,569 1,732 1,214
DNA Learning Center 822 796 824 954 754
Total income 36,343 38,964 41,344 43,800 45,215
Expenses:
Main Lab:
Grants & contracts 16,800 18,136 19,293 19,653 20,879
Operation & maintenance of plant 4,241 4,777 5,141 5,266 5,446
General & administrative 2,634 2,785 2,909 3,329 3,438
Other 4,141 4,385 4,847 4,959 5,367
CSH Press 3,548 4,134 4,309 5,079 5,032
Banbury Center 1,070 1,226 1,498 1,643 1,225
DNA Learning Center 843 768 798 958 781
Total expenses 33,277 36,211 38,795 40,887 42,168
Excess before depreciation and
(designation) release of funds 3,066 2,753 2,549 2,913 3,047
Depreciation (2,358) (2,522) (2,668) (2,821) (2,988)
(Designation) release of funds (1) (600) 0 200 0 0
Net operating excess $ 108 231 81 92 59
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(1) Funds designated to underwrite future direct and indirect expenses of the neuroscience and other research programs.
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COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31, 1996
Auxiliary Activities 18.4 %
Corporate Contributions and Grants 3.9 %
Interest and Miscellaneous 1.4 %
,Royalty and Licensing Fees 2.5 %
ill ill 666,14411111111k
11111111111111111111
Endowments and Board
Designated Funds 12.5 %Federal Grants 37.7 %
Foundation and Private
Contributions and Grants 23.6 %
FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the DNA Learning Center receive a substan-
tial portion of their funding through grants from the Federal Government and through grants, capital
gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 1996.
GRANTS January 1, 1996-December 31, 1996
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 1996 Funding'
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Dr. Herr 1/92 -12/96 3,672,396
Dr. Marr 6/95 -5/98 766,537
Dr. Stillman 8/90 -7/00 2,635,553
Dr. Tully 5/96 -4/99 671,011 *
Research Support Dr. Arndt 1/95 -12/97 284,642
Dr. Beach 5/94 -2/99 302,858
Dr. Beach 4/93 -3/97 196,726
Dr. Beach 8/95 -5/00 263,349
Dr. Cheng 4/93 -3/97 207,626
Dr. Cheng 9/95 -8/97 50,000
Dr. Cline 12/95 -11/98 276,020
Dr. Enikolopov 9/94 -8/98 212,009
Dr. Futcher 4/93 -3/97 276,020
Dr. Futcher 1/91 -12/99 162,055
Dr. Greider 12/94 -11/98 294,246
Dr. Greider 8/91 -7/01 280,651
Dr. Helfman 4/94 -3/98 298,503
Dr. Helfman 8/93 -5/98 237,628
Dr. Hengartner 5/95 -4/00 224,355
Dr. Hernandez 7/87 -6/00 141,450
Dr. Hernandez 9/91 -8/96 183,445
Dr. Herr 3/92 -2/96 81,128
Dr. Herr 8/96 -7/00 199,979 *
Dr. Hirano 5/96 -4/00 231,981 *
Dr. Joshua-Tor 8/96 -7/99 231,446 *
Dr. Krainer 7/94 -6/98 335,762
Dr. Malinow 5/94 -4/97 118,300
Dr. Malinow 4/95 -2/98 256,523
Dr. Mathews 2/92 -8/96 146,529
Dr. Mathews 9/93 -8/98 249,761
Dr. Mathews 9/94 -9/97 33,567
Dr. McCombie 4/94 -3/97 439,941
Dr. Skowronski 12/93 -11/97 342,751
Dr. Spector 4/95 -3/99 317,328
Dr. Silva 7/95 -6/00 250,286
Dr. Stillman 7/83 -5/97 454,173
Dr. Tonks 8/91 -5/96 454,002
Dr. Tully 4/94 -3/97 340,595
Dr. Tully 8/96 -6/00 266,643 *
Dr. Wig ler 7/95 -4/99 1,828,181
Dr. Yin 9/96 -8/99 254,600 *
Dr. Zhong 2/96 -1/97 232,122 *
Equipment Dr. Kobayashi 5/96 -5/97 203,000 *
New Grants Awarded in 1996
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1996 Funding+
Fellowships Dr. Bolwig 1/96 -12/96 29,900*
Dr. Dai 8/94 -10/97 31,200
Dr. DeZazzo 1/95 -12/96 32,500
Dr. Dubnau 7/96 -6/99 22,608*
Dr. Edwards 9/95 -8/98 23,700
Dr. Gu 4/96 -11/96 15,800*
Dr. Le 2/96-1/99 23,700*
Dr. Mainen 10/95 -9/97 23,700
Dr. O'Gara 12/95 -12/97 28,600
Dr. Schneider 7/96 -7/97 28,600*
Dr. Zhang 9/92 -8/97 103,533
Training Support Training in Cancer Cell Biology
and Tumor Virology
7/94 -2/99 217,089
Course Support Advanced Bacterial Genetics 5/93 -4/98 58,511
Cancer Research Center Workshops 4/92 -3/97 250,757
Neurobiology Short-term Training 5/82 -4/97 142,341
CSHL Analysis of Large DNA Molecules 4/91 -3/01 105,510
Essential Computational Genomics for 1991 -1998 38,931
Molecular Biologists
Advanced In Situ Hybridization
and Immunocytochemistry
1992 -1997 52,879
Molecular Biology and Development
of Xenopus laevis
4/96 -3/99 10,000*
Automated Genome Sequencing 4/95 -3/98 71,127
Meeting Support Genome Mapping and Sequencing 4/90 -3/99 23,067*
Zebrafish Development and Genetics 4/95 -3/97 11,000
61st Symposium: Function and Dysfunction
in the Nervous System
4/96 -3/97 15,000'
Cancer Genetics and Tumor Suppressor 7/96 -6/97 10,000*
Genes
Conference on the Cell Cycle 5/96 -5/97 5,000'
Conference on Mouse Molecular Genetics 7/96 -6/97 14,850*
Conference on Gene Therapy 7/96 -6/97 26,000*
Molecular Biology of Hepatitis B Virus 8/96 -8/97 5,500
NATIONAL SCIENCE FOUNDATION
Program Project Drs. Martienssen/McCombie 9/96 -8/99 1,420,000*
Research Support Dr. Cline 9/96 -8/99 100,000 *
Dr. Colasanti 9/96 -8/99 110,000*
Dr. Grotewold 11/94 -10/98 122,188
Dr. Ma 5/94 -4/97 135,500
Dr. Ma 8/94 -7/98 110,000
Dr. Martienssen 8/94 -7/97 150,000
Dr. Peunova 9/95 -8/98 94,000
Fellowship Support Dr. Springer 12/93 -11/96 30,170
Training Support Undergraduate Research 6/91 -5/97 50,000
Program
Course Support Arabidopsis Molecular Genetics 6/94 -5/97 60,000
Molecular Biology and Development
of Xenopus laevis
4/96 -3/97 30,000*
Macromolecular Crystallography 8/94 -7/97 26,720
Computational Neuroscience: Vision 7/96 -12/96 10,000*
Molecular Genetics of Fission Yeast 9/94 -8/99 39,450
New Grants Awarded in 1996
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1996 Funding'
Meeting Support The Biology of Heat Shock 4/96 -3/97 3,000*
Zebrafish Development and 3/96 -2/97 6,500*
Genetics
Learning and Memory 9/96 -8/97 10,189*
The Cell Cycle 5/96 -4/97 3,000*
Mouse Molecular Genetics 8/96 -7/97 8,000*
DEPARTMENT OF ENERGY
Research Support Dr. Marr 7/94 -2/97 228,425
Meeting Support Molecular Genetics of Bacteria and 7/96 -7/97 8,625 *
Phage
The lojap Gene in Maize 8/91 -2/98 94,000
Course Support Macromolecular Crystallography 9/94 -12/96 14,240
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Ma 9/94 -9/97 43,573
Drs. Ma/McCombie 9/96 -8/98 50,000
Dr. Martienssen 9/94 -9/97 65,113
Drs. McCombie/Martienssen 6/95 -6/98 75,628
Dr. Sundaresan 7/95 -8/97 70,000
UNITED STATES DEPARTMENT OF ARMY
Research Support Dr. Futcher 6/94 -6/99 215,364
Dr. Hannon 9/96 -8/00 150,000
Dr. Wig ler 7/94 -8/98 200,000
Fellowship Support Dr. Hong-Xiang Liu 12/96 -11/99 41,743*
NONFEDERAL GRANTS
Research Support
American Cancer Society Dr. Enikolopov 7/95 -6/97 79,145
Dr. Ma 7/94 -6/97 30,000
Dr. Ma 1/95 -12/96 90,000
Dr. Wig ler, Professorship 1986 -2012 50,000
Dr. Wigler, Supply Allowance 1986 -1996 10,000*
American Heart Association Dr. Helfman 7/91 -6/96 18,606
Amplicon Corporation Dr. Wigler 6/94 -5/97 404,000
Arnold & Mabel Beckman Dr. Joshua-Tor 7/96 -6/98 100,000*
Foundation Dr. Silva 7/95 -6/96 94,501
Calbiochem-Novabiochem Dr. Krainer 2/96 -1/98 40,000'
Foundation
Council for Tobacco Research Dr. Arndt 7/95 -6/97 79,500
Dr. Helfman 7/91 -6/97 80,000
Dr. Tonks 1/95 -12/97 90,102
Charles A. Dana Foundation Dr. Marr 1/96 -12/97 171,396*
Donaldson Charitable Trust Dr. Hengartner 7/96 -6/98 62,500 *
The Eppley Foundation for Dr. Cline 7/96 -6/97 15,000*
Research, Inc.
* New Grants Awarded in 1996
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1996 Funding+
Geron Corporation Dr. Greider 2/94 -1/97 206,075
Institute of Molecular
Agrobiology Dr. Sundaresan 2/96 -1/97 42,275
Irving A Hansen Dr. Tonks 8/95 -7/97 10,000
Memorial Foundation
Lita Annenberg Hazen Neurobiology Support 12/96 -11/97 200,000
Foundation
Helen Hoffritz Foundation Dr. Cline 12/96 -11/97 20,000
ISIS Pharmaceuticals Dr. Spector 6/93 -6/97 60,000*
Esther A. & Joseph Klingenstein Dr. Cline 6/95 -6/96 17,658
Fund, Inc. Dr. Enkolopov 7/94 -6/98 40,000
Dr. Silva 7/93 -6/96 12,008
Robert Leet and Clara Guthrie Dr. Cline 7/94 -6/96 37,062
Patterson Trust
L.I. Breast Cancer Action Dr. Wig ler 1996 45,000 *
Coalition
Lucille P. Markey Charitable Neurobiology Support 7/90 -6/97 500,000
Trust
Mathers Charitable Foundation Neurobiology Research 1/95 -12/97 253,500
Support/Dr. Mal inow
The McKnight Endowment Fund for Dr. Silva 7/95 -6/98 50,000
Neuroscience Dr. Yin 7/96 -6/99 50,000
Mellam Family Foundation Dr. Tonks 12/96 -11/00 50,000 *
Memorial-Sloan Kettering (NIH) Dr. Kobayashi 9/94 -7/97 181,700
Dr. Tonks 9/94 -7/97 193,265
Dr. Wig ler 9/95 -8/98 266,889
John Merck Fund Dr. Silva 5/95 -4/97 60,000
NYU Consortium (NIH) Dr. Kobayashi 5/92 -4/97 77,569
Nanoprobes, Inc. Dr. Spector 30,234*
National Down Syndrome Dr. Cline 7/95 -6/97 25,000
Society
N.A.T.O. Dr. Nest ler 1/96 -12/98 5,406
Neurofibromatosis Foundation Dr. Silva 7/96 -6/97 50,000 *
Pew Charitable Trust Dr. Hirano 7/96 -6/00 50,000
Dr. Krainer 7/94 -6/96 59,358
Dr. Lazebnik 7/95 -6/99 50,760
Dr. Zhong 7/94 -6/98 50,672
Pioneer Hi-Bred International Dr. Colasanti 6/96 -5/98 80,000
Lauri Strauss Leukemia Dr. Tonks 5/95 -4/96 15,000
Foundation, Felix Schnyder
Memorial Fund
Swartz Foundation Dr. Stillman 12/96 -11/97 77,274
Volkswagen Foundation Dr. Silva 7/96 -6/99 32,808
Westvaco, Inc. Drs. Martienssen/McCombie 5/96 -4/97 670,826
Whitehall Foundation Dr. Silva 9/93 -8/96 4,882
Dr. Zhong 1/94 -12/96 40,000
Equipment Support
Arrow Electronics Equipment 2/96 -12/96 20,000
Ira De Camp Foundation Equipment 7/94 -6/97 300,000
Estate of Mildred Becker Equipment 6/96 -5/97 100,000
Oliver S. and Jennie R. Donaldson Equipment 12/96 -11/97 100,000 *
Charitable Trust
Edwin Marks Equipment 6/96 -5/97 65,760 *
William and Maude Pritchard Equipment 12/96 -11/96 225,000 *
Charitable Trust
Estate of H. Turner Slocum Equipment 3/96 -2/97 5,000"
New Grants Awarded in 1996
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1996 Funding+
Fellowships
Rita Allen Foundation Dr. Hengartner 9/94 -8/99 30,000
American Cancer Society Dr. Ellison 7/95 -6/98 26,000
Dr. Kass-Eisler 11/96 -10/99 24,000
American Heart Association Dr. Berthier 7/96 -6/98 30,000
Cancer Research Fund of the Dr. Conklin 11/93 -10/96 26,788
Damon Runyon-Walter Winchell Dr. Liang 9/94 -8/97 34,000
Foundation Dr. Weinreich 1/94 -12/96 34,000
CSHL Association Fellowships 4/95 -9/97 270,135
Jane Coffin Childs Dr. Mirzayan 7/93 -6/96 14,626
Dr. Verreault 10/94 -9/97 29,500
Demerec-Kaufmann Dr. Grotewold 6/95 -5/96 5,000
Hollaender Fellowship
Deutsche Forschungs-
gemeinscheft
Dr. Lorenz 6/96 -11/97 22,400*
Eton Student Internship Dr. Hoffman 8/95 -7/96 3,000
Fundacion Ramon Areces Dr. Mendez 10/96 -9/98 6,000
Glaxo Research Institute Fellowship Support 1/94 -12/96 100,000
Goldring International Fellowship Support 7/94 -6/97 30,000
Group, Inc.
Human Frontier Dr. Desnoyers 5/96 -4/97 17,150*
Science Program Dr. Donovan 6/95 -5/97 35,400
Dr. Grossniklaus 11/94 -10/96 7,734
Dr. Hamaguchi 8/94 -7/96 30,263
Dr. lizuka 6/96 -5/97 38,660
Dr. Misteli 10/95 -9/97 32,000
Dr. Steiner 4/94 -3/96 8,350
Japan Society for Promotion
of Science
Dr. Hayashi 4/96 -3/98 40,000
Jikei University School of Dr. Nakamura 2/96 -3/97 36,000
Medicine
Leukemia Society Dr. Autexier 7/95 -12/96 32,340
Dr. Blasco 7/96 -6/99 31,320
Dr. Serrano 7/95 -12/96 32,340
Dr. Rong Li 7/94 -9/96 22,680
Dr. Tansey 7/96 -6/99 31,320
Ministerio de Education y Dr. Losada 10/96 -10/98 5,400'
Cultura (Spain)
Andrew Seligson Memorial Fellowship Support 9/90 -5/97 35,000
Fellowship
Wellcome Trust Dr. Sanders 1/96 -12/97 13,700 *
Dr. Zaman 8/96 -7/98 20,253 *
Wendt Fellowships Neurobiology Fellowship Support 1/94 -12/96 50,000
Training Support
Cornelius N. Bliss Memorial CSHL Summer Undergraduate Program 1996 4,500
Fund
Ira Hershkowitz CSHL Summer Undergraduate Program 1996 100
Jephson Educational CSHL Summer Undergraduate Program 1996 7,500
Howard Hughes Medical Graduate Student Support 1994 -1996 26,000
Institute
David & Stephanie Kaback CSHL Summer Undergraduate Program 1996 500*
Angus McIntyre CSHL Summer Undergraduate Program 1996 100*
Qosina Corporation CSHL Summer Undergraduate Program 1996 25
Share -It -Now CSHL Summer Undergraduate Program 1996 500 '
Foundation
New Grants Awarded in 1996
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1996 Funding+
Nathan Springer
D.J. Sutherland
Course Support
Asgrow Seed Company
Grass Foundation
Holden's Foundation Seeds, Inc.
Howard Hughes Medical Institute
Esther A. & Joseph Klingenstein
Fund, Inc.
Monsanto Company
Pioneer Hi-Breed
Meeting Support
Abbott Laboratories
Affinity Bioreagents, Inc.
American Cyanamid Company
Amgen, Inc.
Apo llon, Inc.
Bayer Corporation
Bayer Corporation
Beckman Instruments, Inc
Behringerwerke AG, Marburg/
Germany-Beohringer, Ingelheim
GmbH, Ingelheim/Germany
Churchill Livingstone
Clontech Laboratories, Inc.
Dupont Merck Pharmaceutical
Company
Gen Hunter Corporation
Genomyx Corporation
Glaxo Wellcome, Inc.
Hoffman-LaRoche Laboratories
F. Hoffman-LaRoche
Heidie Meisendothen
ICN Phrmaceuticals, Inc.
Merck & Company, Inc.
Merck Research Laboratories
Micro Video Instruments, Inc.
Millennium Pharmaceuticals
Novagen, Inc.
Novo Nordisk A/S
Oxnard Foundation
New Grants Awarded in 1996
+ Includes direct and indirect cost
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CSHL Summer Undergraduate Program
CSHL Summer Undergraduate Program
Plant Breeding Course
Scholarships
Plant Breeding Course
Advanced Neurobiology Courses
Advanced Neurobiology Courses
Plant Breeding Course
Plant Breeding Course
Hepatitus B Virus Meeting
Molecular Chaperones and the Heat-
shock Response Meeting
Molecular Approaches to the
Control of Infectious Diseases
Molecular Chaperones and the Heat-
shock Response Meeting
Hepatitus B Virus Meeting
Hepatitus B Virus Meeting
Molecular Chaperones and the Heat-
shock Response Meeting
Differential Display and Related
Techniques for Gene Discovery
Hepatitus B Virus Meeting
Molecular Chaperones and the Heat-
shock Response Meeting
Differential Display and Related
Techniques for Gene Discovery
61st Symposium: Function and
Dysfunction in the Nervous System
Differential Display and Related
Techniques for Gene Discovery
Differential Display and Related
Techniques for Gene Discovery
Hepatitus B Virus Meeting
Hepatitus B Virus Meeting
Molecular Chaperones and the Heat-
shock Response Meeting
Perspectives on the Zebrafish Genome
Translational Control Meeting
Hepatitus B Virus Meeting
Differential Display and Related
Techniques for Gene Discovery
Perspectives on the Zebrafish Genome
Differential Display and Related
Techniques for Gene Discovery
Translational Control Meeting
Molecular Chaperones and the Heat-
shock Response Meeting
Utrophin Meeting
1996 369 *
1996
3/94 -3/96
5/94 -4/97
3/95 -3/96
1991-1999
5/94 -4/97
3/95 -3/96
3/95 -3/96
1/96 -12/96
1/96 -12/96
4/96 -3/97
1/96 -12/96
1/96 -12/96
1/96 -12/96
1/96 -12/96
10/96 -9/97
1/96 -12/96
1/96 -12/96
10/96 -9/97
3/96 -12/96
10/96 -9/97
10/96 -9/97
300 *
2,000"
15,000*
1,000*
275,000
60,000
1,000 *
1,000*
1,000 *
1,000 *
15,000 *
3,000*
1,000 *
1,008 *
2,000*
5,000 *
1,954*
500*
1,000 *
1,000 *
2,000 *
5,000 *
1/96 -12/96 1,000*
1/96 -12/96 1,575*
1/96 -12/96 500*
4/96 -3/97 100'
1/96 -12/96 2,000*
1/96 -12/96 1,000
10/96 -9/97 1,000 "
4/96 -3/97 300 *
10/96 -9/97 1,500'
1/96 -12/96 500*
1/96 -12/96 3,000*
11/96 -10/99 20,000*
Grantor Program/Principal Investigator Duration of Grant 1996 Funding'
Pharmacia Biotech Molecular Approaches to the 4/96 -3/97 12,000 *
Control of Infectious Diseases
Promega Corporation Translational Control Meeting 1/96 -12/96 1,500*
Qiagen, Inc. Differential Display and Related 10/96 -9/97 2,000'
Techniques for Gene Discovery
Ribogene, Inc. Translational Control Meeting 1/96 -12/96 10,000*
Schering Plough Research Hepatitus B Virus Meeting 1/96 -12/96 2,000*
SmithKline Beecham Differential Display and Related 10/96 -9/97 1,000*
Pharmaceuticals Techniques for Gene Discovery
Society for Developmental Perspectives on the Zebrafish Genome 4/96 -3/97 2,500*
Biology
Stress Gen Biotechnologies
Corporation
Molecular Chaperones and the Heat-
shock Response Meeting
1/96 -12/96 5,000'
The Company of Biologists Perspectives on the Zebrafish Genome 4/96 -3/97 4,669 *
Limited
BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant 1996 Funding+
FEDERAL SUPPORT
The Federal Judicial Center Seminar for State and Federal Judges 1996 25,239 *
NONFEDERAL SUPPORT
Meeting Support
Charles A. Dana Foundation Research on the Genetic Basis of 1996 23,000 *
Manic Depressive Illness
Geron Corporation Telomeres 1996 1,500 *
Hereditary Diseases Triple Repeats and Polyglutamine Tracts 1996 10,000 *
Foundation
The Esther A. & Joseph Neuroscience Conference 1996 27,307 *
Klingenstein Fund, Inc.
Osiris Therapeutics, Inc. Mesenchyme 1996 31,999 *
Marie H. Robertson Memorial Learning and Memory 1996 9,920 *
Fund for Neurobiology
Albert B. Sabin Vaccine Sabin HIV 1996 35,249 *
Foundation
New Grants Awarded in 1996
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1996 Funding+
FEDERAL GRANTS
NATIONAL SCIENCE FOUNDATION A Two-Part Program to Develop and Support 4/93 -6/97 124,417
Nationwide Corps of Human and Molecular
Genetics Resource Teachers at the
Secondary Level, David Mick los
A Novel Mechanism for Introducing 4/95 -4/98 73,261
Human Genome Research in Freshman
Biology, Mark Bloom
NONFEDERAL GRANTS
Barker-Welfare Foundation Middle School Biology Camp/ 6/95 -6/97 8,650
American Museum of Natural History
Genentech, Inc. Story of a Gene Exhibit 4/95 -4/97 14,747
Howard Hughes Medical Institute Precollege Science Education Initiative
for Biomedical Research Institutions
7/94 -8/99 82,681
Porto Conte Foundation DNA Amplification and Genetic Diversity 2/96 -2/97 20,000 *
The following schools each awarded a grant in 1996 for the Genetics as a Model for Whole Learning Program:
China Town School District 1
Community School District 29
Great Neck Union Free School District
Half Hollow Hills Central School District
Plainedge Union Free School District
South Huntington Union Free School District
Syosset Central School District
$5,500
$18,400
$8,900
$5,000
$900
$9,600
$9,900
The following schools awarded a grant for Curriculum Study in 1996
of $950:
Commack Union Free School District
East Meadow Union Free School District
Garden City Union Free School District
Great Neck Public Schools
Half Hollow Hills Central School District
Harborfields Central School District
Herricks Union Free School District
Island Trees Union Free School District
Jericho Union Free School District
Lawrence Union Free School District
Locust Valley Central School District
of $1,500:
West Hempstead
of $2,000:
Hicksville Union Free School District
Long Beach School District
New Grants Awarded in 1996
+ Includes direct and indirect cost
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Massapequa Union Free School District
North Shore Central School District
Oyster Bay -East Norwich Central School District
Plainedge Union Free School District
Plainview-Old Bethpage Central School District
Port ledge School
Port Washington Union Free School District
Ramaz School
Roslyn Public School
Sachem Central School District
South Huntington Union Free School District
Syosset Central School District
Cold Spring Harbor Laboratory is a nonprofit research and educational institution
chartered by the University of the State of New York. Less than half (44.1%) of our
annual support is derived from Federal grants and contracts, and thus we rely
heavily on support from the private sector: foundations, corporations, and individu-
als. Contributions from the private sector are tax exempt under the provisions of
Section 501(c)(3) of the Internal Revenue Code. In addition, the Laboratory has
been designated a "public charity" and therefore may receive funds resulting from
the termination of "private foundations."
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities: You can generally deduct the full amount of the gift on your income
tax return, and, of course, you need pay no capital gains tax on the stock's ap-
preciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring Har-
bor Laboratory.
(2) Deliver the stock certificates to your broker with instructions to open an ac-
count for Cold Spring Harbor Laboratory and hold the securities in that ac-
count pending instructions from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Com-
ptroller, Cold Spring Harbor Laboratory, One Bungtown Road, Post Office
Box 100, Cold Spring Harbor, New York 11724. In a separate envelope,
send an executed stock power.
Pooled Income Funds: Combine gifts from a number of donors in a pool for at-
tractive investment and tax purposes.
Appreciated real estate or personal property: Sizable tax benefits can result
from such donations; the Laboratory can use some in its program and can sell
others.
Life insurance and charitable remainder trusts can be structured to suit the
donor's specific desires as to extent, timing, and tax needs.
Bequests: Most wills probably need to be updated. Designating Cold Spring Har-
bor Laboratory as beneficiary ensures that a bequest will be utilized as specified
for continuing good.
Conversion of private foundation to "public" status on termination: This may
be done by creating a separate fund within Cold Spring Harbor Laboratory
whereby the assets of the private foundation are accounted for as a separate
fund and used for the purposes specified by the donor. Alternatively, the private
foundation can be established as a supporting organization of Cold Spring Har-
bor Laboratory.
For additional information, please contact the Director of Development, Cold Spring Harbor
Laboratory, One Bungtown Road, Post Office Box 100, Cold Spring Harbor, NY 11724, or
call 516-367-8840.
CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 1996-December 31, 1996
Contributions of $5,000 and above, exclusive of Annual Fund
In 1996, the Laboratory received significant support in the form of capital and program contribu-
tions from individuals, foundations, and corporations.
Anderson Group, Inc.
Arrow Electronics, Inc.
Banbury Fund
Arnold & Mabel Beckman Foundation
Charles A. Dana Foundation
Mr. and Mrs. Charles F. Dolan
Oliver S. & Jenny R. Donaldson Charitable Trust
Eppley Foundation for Research, Inc.
Robert L. Garland
Goldring Family Foundation
Mr. and Mrs. John S. Grace
Grass Foundation
Mrs. Oliver R. Grace
The John A. Hartford Foundation, Inc.
Lita Annenberg Hazen Foundation
Helen Hoffritz Foundation
J. P. Morgan and Co. Inc.
David L. Luke III
Lucille P. Markey Charitable Trust
Mr. and Mrs. Edwin S. Marks
G. Harold & Leila Y. Mathers
Charitable Foundation
Marjorie A. and William L. Matheson
Charitable Trust
Total $6,731,224
McKnight Endowment Fund for Neuroscience
Mellam Family Foundation
Mr. and Mrs. William R. Miller
National Neurofibromatosis
Foundation, Inc.
New York Community Trust
Mrs. Edward J. Nouri
1 in 9: The Long Island Breast Cancer
Action Coalition
Oxnard Foundation
Pew Charitable Trust
Pioneer Hi-Bred International, Inc.
William and Maude Pritchard
Charitable Trust
Estate of Eric Ridder
Mr. and Mrs. Thomas A. Saunders III
Mr. and Mrs. Alan Seligson
Estate of H. Turner Slocum
Mr. and Mrs. Douglas Soref
Laurie S. Strauss Leukemia Foundation
Swartz Foundation
Volkswagen Foundation
Henry Wilmerding
CHILD CARE CENTER CAPITAL CAMPAIGN
January 1, 1996-December 31, 1996
Contributions of $1,000 and above, exclusive of Annual Fund
Anonymous
Dr. and Mrs. Robert Arnstein
Mr. and Mrs. Harry Brooks
Catherine D. Brown
G. Morgan Browne
Mary Ann Charlston
Dr. and Mrs. Bayard D. Clarkson
Mrs. Robert L. Clarkson, Jr.
Mr. and Mrs. John P. Cleary
Mr. and Mrs. Robert E. Cooper
Mr. and Mrs. Peter 0. Crisp
George W. Cutting, Jr.
Mrs. Richard Danzinger
Mr. and Mrs. David H. Deming
Mr. and Mrs. Donald L. Deming
The Dickey Family
Dvirka & Bartilucci
Mr. and Mrs. Robert L. Forbes
Mr. and Mrs. George S. Franklin
Total $ 691,639
Mr. and Mrs. Robert A Gay
Mr. and Mrs. Edward H. Gerry
Mrs. Augustin S. Hart, Jr.
Mr. and Mrs. Landon Hilliard Ill
Mr. and Mrs. John Hogerton
Patricia S. Huntington
Hyde and Watson Foundation
David H. Koch Charitable Foundation
Mr. and Mrs. Edward Lamont
Mr. and Mrs. James M. Large, Jr.
Mrs. Henry Lewis Ill
Mr. and Mrs. Robert D. Lindsay
Mr. and Mrs. Robert V. Lindsay
Mrs. John H. Livingston
David L. Luke Ill
Caroline M. Macomber
Mr. and Mrs. Edwin S. Marks
Mr. and Mrs. William B. Matteson
Richard and Mary McAdoo
Arthur C. Merrill
Mr. and Mrs. Robert G. Merrill
Mr. and Mrs. David Mick los
Mr. and Mrs. Francis W. Murray Ill
Mr. and Mrs. Adams H. Nickerson
Anita H. Page
Mr. and Mrs. Walter H. Page
Dr. and Mrs. David B. Pall
Mr. and Mrs. Howard Phipps, Jr.
Thomas T. Richmond
Mr. and Mrs. Peter G. Schiff
Mr. and Mrs. Peter 0. A. Solbert
Dr. and Mrs. Bruce Stillman
Mrs. Donald A. Straus
Mrs. David S. Taylor
Dr. and Mrs. James D. Watson
The Weezie Foundation
Mr. and Mrs. Henry Wendt
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ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
That this was the 13th year of the Cold Spring Harbor Laboratory Corporate Sponsor Program is a
testimony to both the farsightedness of its corporate members and the continuing high standards
of the meetings supported by the Program. There were 35 member companies in 1996, drawn from
a wide spectrum of the modern biomedical world, but having the common purpose of promoting
research through supporting meetings. The Laboratory's meetings program-in Grace Auditorium
and at the Banbury Center-continues to be the premier series of meetings on molecular biology
and molecular genetics. It is the firm financial support provided by the Corporate Sponsor Program
that enables us to plan ahead and to hold meetings on topics that are timely and important.
The members of the Program receive special privileges in acknowledgment of their contribu-
tions: All on-site fees are waived for eight representatives of each company at our meetings. Three
of these scientists may attend meetings at Banbury Center, where attendance is otherwise only by
invitation of the organizers. Corporate Sponsors receive gratis copies of Cold Spring Harbor
Laboratory Press publications, including the journals Genes & Development, Learning & Memory,
and Genome Research. Grace Auditorium is made available to Corporate Sponsor Program mem-
bers for special meetings.
Corporate Sponsors are acknowledged in all relevant publications, including the books of ab-
stracts given to every CSHL meeting participant. Names of the sponsoring companies are listed on
the posters describing the meetings which are mailed to approximately 7,000 scientists throughout
the world.
Alza Corporation
American Cyanamid Company
Amgen Inc.
BASF Bioresearch Corporation
Becton Dickinson and Company
Boehringer Mannheim Corporation
Bristol-Myers Squibb Company
Chiron Corporation
Chugai Research Institute
for Molecular Medicine, Inc.
Diagnostic Products Corporation
The Du Pont Merck
Pharmaceutical Company
346
Forest Laboratories, Inc.
Genentech, Inc.
Hoechst Marion Roussel, Inc.
Hoffmann-La Roche Inc.
Johnson & Johnson
Kirin Brewery, Ltd.
Kyowa Hakko Kogyo Co., Ltd.
Life Technologies, Inc.
Eli Lilly and Company
Merck Genome Research Institute
Monsanto Company
Oncogene Science, Inc.
Pall Corporation
The Perkin-Elmer Corporation,
Applied Biosystems Division
Pfizer Inc.
Pharmacia & Upjohn, Inc.
Pioneer Hi-Bred International, Inc.
Research Genetics, Inc.
Sandoz
Schering-Plough Corporation
Sumitomo Pharmaceuticals Co., Ltd.
Westvaco Corporation
Wyeth-Ayerst Research
Zeneca Group PLC
DNALC Corporate Advisory Board Annual Fund
An important objective of the Corporate Advisory Board of the DNA Learning Center is to provide a
sustainable level of annual funding for the Learning Center's programs. As a means of reaching
this objective, the Board conducts an Annual Fund and an Annual Golf Tourament with the pro-
ceeds to benefit the DNA Learning Center.
John J. Leahy, Chairman
Gary E. Frashier, Vice Chairman
Michael Aboff
Andrew D. Ackerman
Rocco S. Barrese, Esq.
Howard M. Blankman
Thomas J. Calabrese
Edward A. Chernoff
Paul Czeladnicki, Esq.
Robert E. Diller
ANNUAL FUND CONTRIBUTORS
CORPORATE BENEFACTOR
Luitpold Pharmaceuticals, Inc.
CORPORATE PATRONS
Chase Manhattan Bank
Laurie J. Landeau, V.M.D.
Motors & Armatures, Inc.
Pall Corporation
Price Waterhouse LLP
CORPORATE ASSOCIATES
ADEMCO
Anonymous
Louis and Virginia Clemente
Foundation, Inc.
KPMG Peat Marwick LLP
Meenan Oil Co., L.P.
Oncogene Science, Inc.
CORPORATE FRIENDS +.
Avis
Brinkmann Instruments, Inc.
Dilworth & Barrese
Fa la Direct Marketing
Ferran Brothers Inc.
Horace and Amy Hagedorn
Harweb Foundation
Arthur D. Herman
Corporate Benefactors, $10,000 or more
Corporate Patrons, $5,000 or more
4. Corporate Associates, $2,500 or more
ir.f. Corporate Friends, $1,000 or more
Friends of the DNALC, $50 or more
Total $77,295
Candido Fuentes, M.D.
Arthur D. Herman
John Kean
Laurie J. Landeau, V.M.D.
Ralf Lange
Lilo Leeds
James Mattutat
Patricia Petersen
Howard Blankman Incorporated
Gerard and Lilo Leeds
Rivkin, Radler & Kremer
William D. Roche
The Schiff Foundation
Super Millwork, Inc.
United States Trust Company
of New York
FRIENDS OF THE DNALC
Aboff's Inc.
John and Carole Aksak
Americana at Manhasset
Mr. and Mrs. Joseph Angel lo
Berger's Wholesale Meats
Chandra Bhansali
Mr. and Mrs. George A. Bourne
Rosemary Bourne
Mr. and Mrs. B. Bronfman
Chiropractic & Wellness
Education Center
James and Lenore Conenello
Robert and Lydia Cox
Ms. Deborah Davidson
Richard Galant & Aileen Jacobson
The Gewirtzmans
Mr. and Mrs. Joseph C. Grasso
I. Janvey & Sons, Inc.
MEMORIAL GIFT CONTRIBUTOR TO DNALC
Daniel Gale Agency, Inc
IN MEMORY OF
Maurice Leahy
William Roche
Wendy Vander Poel Russell
Horst Saalbach
Peter G. Schiff
Charles R. Schueler
Paul A. Vermylen, Jr.
Lawrence J. Waldman
Raymond A. Walters, Ph.D.
J.W. Hirschfeld Agency, Inc.
James and Lisa Mattutat
MSC Industrial Supply Company
Nortech Laboratories, Inc.
Precise Corporate Printing Inc.
George A. Roche
Mr. and Mrs. Jay Russ
Schneider, Kleinick, Weitz,
Damashek & Shoot
Dr. Roberta Schroder
and Michael Schroder
Brian Shore, Architect
Kelly Smith
Stebel & Paseltiner, P.C.
Mr. and Mrs. Paul Strohmenger
Telecommunications Reports
International, Inc.
Gregory, Marguerite and
Danielle Tumminio
Mr. and Mrs. Jesse Waldinger
Craig Weschke
Windemere Development Corp.
W.T. Hickey Corp.
Dr. and Mrs. Joel Yohai
OTHER CONTRIBUTORS
Mr. and Mrs. Gerard DeGregoris, Jr.
Steven M. Jaeger, Esq.
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GOLF TOURNAMENT SPONSORS
Major Corporate Sponsor
J.P. Morgan & Co. Inc.
Corporate Sponsors
Cablevision
Chase Manhattan Bank
Festo Corporation
Luitpold Pharmaceuticals,
Inc.
Cocktail Party and Buffet Sponsor
Hoffmann & Baron
Gold Sponsors
Badge Insurance Agency
Barnes & Noble Bookstores
Brinkmann Instruments
Chase Manhattan Bank
Daniel Gale Agency
Dilworth & Barrese
Ernst & Young LLP
Hoffmann & Baron
International Scientific
Communications
J.P. Morgan & Co. Inc.
Kean Development Company,
Inc.
KPMG Peat Marwick LLP
Luitpold Pharmaceuticals, Inc.
Nassau County Industrial
Development Agency
Northwood Ventures
NYNEX
Oncogene Science, Inc.
Price Waterhouse LLP
Sprint
U.S Trust Company
Silver Sponsors
Great Eastern Printing Company
Holmes Protection of L.I., Inc.
International Scientific
Communications
ITT Hartford
Margolin, Winer, & Evens LLP
Mr. David Massimilla
Shearman & Sterling
Village Green Service Center
VWR Scientific Products
Bronze Sponsors
Aboff's Inc
A.D. Herman Construction Co.,
Inc.
Applied Biosystems
Cortel Business Systems, Inc.
Holmes Protection of L.I., Inc.
Mr. Joseph Nidzyn
Tee & Green Sponsors
A.D. Herman Construction, Co.,
Inc.
Alliant Foodservice
Barnes & Noble Bookstores
Blackman Plumbing/Heating/
Cooling Supplies
Burt Building Materials Corp.
Daniel Gale Agency
Dvirka & Bartilucci
Epoch 5 Marketing
Fisher Scientific
Hilltop Computing
Howard Blankman Inc
ITT Hartford
Lawrence, Same & Lawrence
Metre Health
North Country Supply
Northwood Ventures
Price Waterhouse LLP
Stirling Creek Associates
Commemorative Journal
Sponsors
A&B Graphics
Abel Grenier, Inc.
ADJO Contracting Corp.
AFG Contracting, Inc.
American Stair Builders, Inc.
Applied Microbiology, Inc.
Berger's Wholesale Meats
Centerbrook Architects
Daniel Gale Agency
Total $ 83,409
Enzo Biochem
Fate Direct Marketing, Inc.
Farrell, Fritz, Caemmerer,
Cleary, Barnosky &
Armentano, P.C.
Feraco, Inc.
Financial Medical Systems
Fleet Bank
Dr. Candido Fuentes
Huntington Business
Products Center
Innovir Labs
International Bioimmune Systems
KPMG Peat Marwick LLP
Long Beach Medical Center
Margolin & Margolin
Mortgage Lending of
America, Inc.
New York Biotechnology
Association
Oncogene Science, Inc.
Port Dock and Stone Corp.
Price Waterhouse LLP
Racanelli Construction Co., Inc.
U.S. Trust Company
Validation Review Associates,
Inc.
Vittorio Auto Body and
Collision Corp.
Weitz and Luxenberg
Windemere Development Corp.
Other Contributors
Abbott Laboratories
Badge Insurance Agency
Breakfast Productions
Buckhurst, Fish & Jacquemart
The Country Printer
Curran & Connors, Inc.
Gerard Klauer Mattison
& Co., L.L.C.
Guild Agency, Inc.
J.D. Posillico, Inc.
KAM Home
Improvements Corp.
Total DNA Learning Center Annual Fund $ 160,704
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Lufthansa
Mr. David L. Luke III
N&S Electrical Supply
Parker, Chapin, Flattau
& Klimpl, LLP
Mr. William D. Roche
Mrs. William F. Russell
Uniflex, Inc
W.T. Hickey Corp.
Raffle Prizes
Aboff's Inc.
All Island Cleaning Service
American Airlines
Angelina's Ristorante
Arizona Beverage
Barney's Restaurant
Cablevision
Canterbury Ales
Capriccio Restaurant
Clare Rose
Ecco Environmental Control Company
Enterprise Rent-A-Car
Festo Corporation
Mr. Clark Gillies
Harborview Automotive
Arthur Herman
Huntington Business Products Centre
Inn on the Harbor
Kean Development Company, Inc.
Kean Landscaping, Inc.
L&L Camera, Inc.
Long Island Golfer Magazine
Main St. Nursery
MMS & N
National Arts Club Dining Room
Oyster Bay Frame Shop
Piccolo Restaurant
Price Waterhouse LLP
Scarsella's Florist
Spinnaker Travel, Ltd.
Trattoria Grasso
Village Green Service Center
Winebow, Inc., Ltd.
Zip Limousine
Cold Spring Harbor Laboratory Association (CSHLA)
Officers
Mr. John P. Cleary, President
Mrs. James M. Large, Vice President
Mrs. Harry A. Brooks, Secretary/Treasurer
Directors
Mrs. Joseph S. Augusciak
Nicholas Barilucci
Mrs. Thomas J. Calabrese
Mrs. Harry G. Charlston
David C. Clark
David H. Deming
Mrs. John J. Genovese
John S. Grace
Mrs. Joyce Green
President's Report
Coe Kerr
Antoine C. Kemper, Jr.
Alan M. Kisner, M.D.
Mrs. George N. Lindsay
Robert L. Marcus
Edward F. McCann II
Mrs. Robert G. Merrill
Mrs. Vincent Nesi
Gerald D. Olin
Philip M. Satow
Mrs. Thomas A. Saunders Ill
Mrs. Peter G. Schiff
Mrs. Douglas S. Soref
James L. Spingarn
Bruce Stillman, Ph.D.
James D. Watson, Ph.D.
George W. Cutting, Honorary
Director
As the primary support volunteer arm of the Laboratory, the Association places great emphasis
upon creating new friends while maintaining solid relationships with our old friends. To this end, in
1996, members of the Association made a significant effort to reach out to persons and organiza-
tions, explaining the Laboratory's mission and cultivating interest in the myriad activities here.
Our year began with the annual meeting on February 4. Dr. Allen Oliff, executive director for
cancer research at Merck Research Laboratory, was the guest speaker. His talk, Anti-Cancer
Agents Directed against Oncogene Targets, was delivered with enthusiasm and erudition. He also
conveyed a sense of renewed hope for significant progress in the fight against cancer. Three
directors retired; namely, Jane Greenberg, Donald Kent, M.D., and Douglas Rogers. Their unselfish
service to the Laboratory is appreciated greatly. In addition, new directors were elected at this
meeting, including Trudy Calabrese, Tony Kemper, and Cathy Soref.
On June 2, the annual Dorcas Cummings Lecture was sponsored by the Association. A high
point of the Association's activities, our guest speaker was V. S. Ramachandran, M.D., Ph.D.,
professor of neuroscience at the University of California, San Diego. He discussed Illusions of Body
Image in Neurology: What They Reveal About Human Nature. This stimulating and thought-
provoking lecture was delivered to an enthusiastic full house. At the dinner parties held subsequent
to the lecture, Dr. Ramachandran's talk dominated the conversation. His talk demonstrated clearly
that great strides are being made in neuroscience research. The dinner parties were hosted by
members of the Association and other friends of the Laboratory. Visiting scientists as well as the
Lab's own scientists attended these parties-clearly an enjoyable evening. The Association wishes
to express its special thanks to each of the hosts:
Mr. and Mrs. Henry Babcock, Jr.
Mr. and Mrs. Nicholas Bartilucci
Mr. and Mrs. Thomas Calabrese
Mr. and Mrs. David Clark
Mr. and Mrs. John Cleary
Mr. and Mrs. John J. Genovese
Mr. and Mrs. John Grace
Mr. and Mrs. Antoine Kemper, Jr.
Mr. and Mrs. Coe Kerr
Mr. and Mrs. Townsend Knight
Mrs. Mary D. Lindsay
Mr. and Mrs. Robert Lindsay
Mr. and Mrs. David Luke Ill
Mr. and Mrs. Robert Merrill
Mr. and Mrs. Robert O'Connor
Mr. and Mrs. James Pirtle
Mrs. Wendy Russell
Mr. and Mrs. Peter G. Schiff
Mr. and Mrs. Douglas Soref
Mr. and Mrs. James Spingarn
Mr. and Mrs. John Stephenson
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Drs. Cynthia MacKay and Peter Gouras at macular degeneration lecture; Dr. Xiaodong Cheng greets
Eastwoods School student; museum curator David Grimaldi at lecture on amber.
In September, the Association commenced its major membership drive and annual giving ef-
fort. The results of our effort were in excess of $604,000 from 663 members. This is a good result,
notwithstanding the fact that it fell short of last year's total. The annual membership drive competed
with two other major fundraising efforts which were conducted concurrently: the Emanuel Ax Gala
and the Mary D. Lindsay Child Care Center Capital Campaign. The Emanuel Ax Gala was chaired
by Lola Grace who, with her committee, organized a "standing room only" evening of music and
dinner. The concert netted in excess of $135,000, truly a magnificent achievement. In addition, the
Child Care Center Capital Campaign was commenced and, as of December 31st, had raised in
cash or pledges, in excess of $620,000. This campaign is being led by the vice-president of the
Association, Carol Large, who is to be commended for the great success to date. Of the funds
raised for the Child Care Center, $458,000 were raised from members of the Cold Spring Harbor
Laboratory Association. Thus, in the year 1996, the members of the Association have contributed
more than $1 million to various projects of the Laboratory, a feat to be applauded.
In addition to our annual fund drive, a number of other activities took place in the fall. On Sep-
tember 24, Jennifer Jordan, a trusts and estates partner of Cadwalader, Wickersham & Taft, gave
the second informative and thought-provoking estate-planning seminar. On October 13, Drs.
Cynthia J. MacKay and Peter Gouras, of Columbia-Presbyterian Hospital, discussed macular
degeneration, a leading cause of blindness in adults. They explained their current research in
retinal cell transplants, which hopefully will lead to a new treatment for this terrible affliction. On No-
vember 17, Dr. David Grimaldi, curator and chairman of the Department of Entomology at the
American Museum of Natural History, spoke to a well-attended audience on Amber: A Scientific
Renaissance. His lecture held interest from many perspectives for both adults and youngsters,
giving a great history of amber as well as tracing its use in jewelry.
Thanks also go to Owen and Bernadette Smith for hosting this year's major donor cocktail party
on November 24. The evening was brightened by a sampling of Owen's cooking skills. On Decem-
ber 13 the Association sponsored the annual holiday tree lighting, which included caroling and
holiday treats. The children had a wonderful time placing their homemade ornaments on the beauti-
ful tree.
Throughout the year, a number of initiatives were developed by Association directors and mem-
bers. These programs are on-going and involve new areas of interest; specifically, the Next Gener-
ation Initiative, a program designed to cultivate the interest of younger members of our community
in the life of the Laboratory. This effort held a wonderful evening on January 18, with talks by Bruce
Stillman and Tim Tully, followed by dinner parties at committee member's homes-a very successful
evening. Another program that is currently on-going is the establishment of a relationship between
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schools in the area and the Laboratory. Programs have commenced that involve teachers, stu-
dents, and parents from local schools to foster interest in scientific research. It is hoped that
through this medium, significant contacts between scientists and students will be made.
It is with particular pleasure that I acknowledge the significant contribution given to the
Laboratory during the past six years by Ed McCann and Alan Kisner, who have now stepped down
as directors of the Association. In addition, our thanks also to Joyce Green, Lauri Genovese, and
Bob Marcus, who served as directors of the Association and have retired. Each one of these
people gave their time unselfishly and helped in many ways to further the mission of the Laboratory
and its Association. For this we are very grateful. Special thanks goes to Jean Houghton, who has
served enthusiastically as our staff director, and also to the other members of the Laboratory's De-
velopment Office, who support the day-to-day efforts of the Association.
February 1997 John P. Cleary
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Mr. and Mrs. Guy A. Fritts
Mr. and Mrs. Clarence E. Galston
Mr. and Mrs. John S. Grace
Sarah R. Hadden
Mrs. F. Bailey Hall
Mrs. Albert L. Hoffman
Mrs. Gilbert W. Kahn
Mr. and Mrs. Thomas J. Kelly
Mrs. James Knott
Dr. Marcela V. Lara and
Dr. Esteban R. Lara
Mrs. Bayard H. Megear
Mr. Richard W. Meyer
Mr. and Mrs. John P. Morgan
Mr. and Mrs. Timothy Murawski
Mr. and Mrs. Mike O'Neill
Dr. Monroe L. Levin
Ms. Audrey Marantz
Ms. Ines Piraino de Radic
Mr. Aaron Rosenthal
Memorials and In Honor Totals $ 4,865
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Mrs. R. Brinkley Smithers
Mr. and Mrs. Edson W. Spencer
Oliver Stanton
Mrs. Ruth Stanton
The Stebbins Fund, Inc.
Tilles Investment Company
The Times Mirror Foundation
Union Pacific Corporation
Whitehall Foundation, Inc.
The William Ewing Foundation
The William H. Donner Foundation
Jacques Winter
The Zankel Fund
William R. Russell
Bette Schechter
Mr. Fred Stein
Mr. and Mrs. Ed Ward L. Palmer
Mr. and Mrs. Sterling Pile, Jr.
Mrs. Barbara Powers
Mr. and Mrs. Joseph Rizza, Jr.
Mr. Richard H. Robinson
Baron Franz Schager
Miss Frida Scharman
Dr. Kay H. Sato
Mr. Edward Shorin
Mr. and Mrs. Julian C. Stanley
Judith Steers
Mrs. David S. Taylor
U.S. Trust Company
Mr. and Mrs. Eugene D. Wadsworth
Mrs. Sherwood Waldron
Mrs. Taggart Whipple
Mrs. Theodore F. Whitmarsh
President's Council
The President's Council supports our program of Cold Spring Harbor Fellows, a
position created in 1986. Cold Spring Harbor Fellows are exceptionally talented,
young scientists who already show the capacity for high-level, independent
research while in pursuit of their doctoral degrees.
CONTRIBUTORS
Christopher Alafi
Abraham Appel
Peter L. Bloom
James T. Conneen
Michel David-Weill
Frederick Frank
Leo A. Guthart
Charles E. Harris
Walter B. Kissinger
Victor Niederhoffer
Donald A. Pels
George B. Rathmann
Hubert J.P. Schoemaker
James H. Simons
Sigi Ziering
Total $ 286,046
Undergraduate Research Program/Partners for the Future
The goal of the Laboratory's two student intern programs, the Undergraduate Research Program
for select college students and the Partners for the Future Program for top regional high school stu-
dents, is to produce future research scientists and to encourage awareness among young people
in general.
CONTRIBUTORS
Emanuel Ax Fund
Cornelius N. Bliss Memorial Fund
Burroughs Wellcome Fund
Cablevisions Systems Corp.
Dr. Ira Herskowitz
Jephson Educational Trust
David B. Kaback
Angus McIntyre
The Olney Fund
Qosina Corp.
Share -It- Now -Foundation
Nathan Springer
Donald J. Sutherland
Total $ 1,155,446
Total All Annual Funds $ 2,943,624
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LABORATORY STAFF
James D. Watson, President
Bruce W. Stillman, Director
Winship Herr, Asst. Director
G. Morgan Browne, Administrative Director
John P. Maroney, Asst. Administrative Director
William D. Keen, Comptroller
Terri I. Grodzicker, Asst. Director for Academic Affairs
Jan A. Witkowski, Director of Banbury Center
David A. Micklos, Director of DNA Learning Center
John R. Inglis, Executive Director of CSHL Press
David J. Stewart, Director of Meetings and Courses
Faculty
David Beach *
Xiaodong Cheng
Holly Cline
Joseph Colasanti
Grigori Enikolopov
Bruce Futcher
Carol Greider
Ueli Grossniklaus
Erich Grotewold
Gregory Hannon
David Helfman
Michael Hengartner
Nouria Hernandez*
Tatsuya Hirano
Leemor Joshua-Tor
Ryuji Kobayashi
Adrian Krainer
Yuri Lazebnik
Hong Ma
Roberto Malinow
Thomas Marr
Robert Martienssen
Akila Mayeda
W. Richard McCombie
H. Peter Nest ler
Natalia Peunova
Alcino Silva
Jacek Skowronski
David Spector
Arne Stenlund
Masafumi Tanaka
Nicholas Tonks
Tim Tully
Linda Van Aelst
Shou Waga
Michael Wig ler
Rui Ming Xu
Jerry Yin
Michael Qiwei Zhang
Yi Zhong
Cold Spring Harbor
Fellows
Ulrich Grossniklaus
(Until 7/1/96)
Scott Lowe (Until 5/1/96)
Adjunct Faculty
Scott Powers
Craig Ogata *
Genetics Research Unit
Carnegie Institution
of Washington
Alfred D. Hershey
Visiting Scientists
Daniel Bush**
Ai-Ping Dong
Konstantin Galactionov
Masaaki Hamaguchi
Satoshi Kida
Boris Kuzin
Roberta Maestro
Marjana Maletic-Savatic
Elly Nedivi
Vladimir Scheinker
Clifford Yen
Postdoctoral Fellows
Marcia Belvin
Anton Bennett
Christine Berthier
Maria Blasco
Gert Bolwig
Stephen Brand
Steve Buck
Mary Byrne
Javier Caceres
Jean-Philippe Vielle Calzada
Amancio Carnero
James Chong
Douglas Conklin
Gerhard Cullmann
Mark Curtis
Kang Dai
Nei lay Dedhia
Robert Del Vecchio
Serge Desnoyers
James Dezazzo
Dennis Dong
Joseph Donovan
Andrea Doseff
Joshua Dubnau
James Edwards
Viola Ellison
Hua-Ying Fan
Howard Fearnhead
Nikolai Federov
Paul Frankland
Andrew Garton
Karl Giese
Weimin Gong
Derek Gordon
Michael Greenberg
Bing Guo
Hui-Fu Guo
Michael Gutch
Frances Hannan
Yasunori Hayashi
R. William Henry
Masumi Hidaka
Craig Hinkley
David Horowitz
John Horton
Hai Huang
Sui Huang
Masayoshi lizuka
Arthur Johnson
Christopher Jones
Alyson Kass-Eisler
Keiji Kimura
Jeffrey Kogan
Thillai Koothan
Peter Krasnov
Siyuan Le
Chun Liang
Wen-Chuan (Athena) Lin
Dehua Liu
Hong-Xiang Liu
Ruiping Liu
Yi Liu
Yu Liu
Martin Lock
Muhammed Lodhi
Peter Lorenz
Ana Losada
Robert Lucito
Zachary Mainen
Salim Mamajiwalla
Mireya Marin
Juan Mendez
Caroline Mirzayan
Thomas Misteli
Vivek Mittal*
Michael Murray
Michael Myers
Mariko Nakamura
Margaret O'Gara
Bong-Kyeong Oh
Shannon Pendergrast*
Pablo Rabinowicz
Indrani Rajan
Baskar Ramamurthy
Michael Regulski
Cyril Sanders
Brandt Schneider
Manuel Serrano
Gavin Sherlock
Keiichi Shibahara
Mona Spector
Patricia Springer
Yuri Stasiv
Peiqing Sun*
William Tansey
Tony Tiganis
Alain Verreault
Jonathan Wallach
Jing (Jenny) Wang
Qizhi Wang
Yung-Chih (Judy) Wang
Michael Weinreich
Mee-Wa Wong*
Nicholas Wright
Gang-Yi Wu
Ming Yang
Shahid Zaman
Shaohui Zhang
Xujia Zhang
Xuemei Zhao
Jianlong Zhou
Dong-Jing Zou
Graduate Students
Robert Babb
Nicholas Carpino
*Funding provided by Howard Hughes Medical Institute
On Sabbatical at CSHL
Staff as of December 1996
Ofelia Carvalho
Kenneth Chang
Degui (Charlie) Chen
Grace Chen
Jeffrey Christensen
Lavina Faleiro
Ethan Ford
Richard Freiman
Eric Gillitzer
Tina Gumienny
Ying Han
Daniel Hoeppner
Chong (Chris) Huang
John lafrate
Tracy Kuhlman
Kenneth La Montagne
Arlinda Lee
Benjamin Lee
Qiong Liu
Michele Mc Donough
Troy Messick
Paul Mintz
James Moore
Debra Morrison
Shirley Pinto
Julia Polyakova
Alex Rai
Hai Rao
Patrick Reilly
Jose Rodriguez
Peter Rubinelli
Ahmed Samatar
Andrew Samuelson
Meenakshi Selvakumar
Setareh Sepehri
Andrew (Mark) Settles
Jian Sheng
Aneil Shirke
Michael Stebbins
Javor Stolarov
Tomasz (Tomek) Swigut
Suzanne Tharin
Tzu-Ling Tseng
Hua Tu
Terrence Vale
Thomas Volpe
Herman Wijnen
Qiang Wu
Qinghong Yang
Xiaohong (Helena) Yang
Lee Zou
Howard Hughes Medical
Institute Employes
Support Staff
Susan Allan
Graceann Bartilucci
Xiao (Joan) Chen
Beicong Ma
Carol Sekunda
Judi Smith
Lin Ying Xie
Research Associates
Carmelita Bautista
Georgia Binns
Lisa Manche
Linda Rodgers
Lab Facility Managers
Maria Coronesi
Diane Esposito
Spencer Tep lin
Laboratory Manager
Linda Hiesiger
Technical Programmers
Steven Cozza
David Cuddihy
Ryutaro Iwasaki
Moira Mallison
Jacqueline Salit
Adam Tracy
Secretaries
Sadie Arana
Patricia Bird
Idee Mallardi
Carol Marcincuk
Barbara Matusik
Lorraine Mclnerny
Jane Reader
Madeline Wisnewski
Research Assistants
Thomas Bridges
Charlotte Hunt-Grubbe
Laboratory Technicians
Deborah Aufiero
Scott Bronson
Anthony Buglino
Barry Burbach
Yow-Ning Chang
Tong Chen
Jodi Coblentz
Martha Daddario
Nancy Dawkins-Pisani
Melissa de Is Bastide
Ping Dong
Margaret Falkowski
Lidia Gnoj
Tina Gottsman
Susan Granat
Jill Grossman
Aliyah Hameed
Amy Hasegawa
Jill Hemish
Michiko Hirano
Mari lu Hoeppner
Tamara Howard
Yi Hu
Santosh John
Nancy Kaplan
Paul Kearney
James Keller
Martine Lessard
Jianping Liu
Lin Luo
Thomas Malone
Jennifer Mc Cann
Mila Mc Currach
Robert McGuirk
Irina Miloslayskaia
Elizabeth O'Connor
Ronnie Packer
Nora Poppito
Michael Riggs
Julie Rosenbaum
Simone Salghetti
Kristen Schutz
Rosemarie Sherlock
Nadim Shohdy
Stephanie Smith
Ashita Solanki
Yu ling Sun
Brian Svedberg
Sally Till
Alla Triger
Jennifer Troge
Klara Velinzon
Miho Waga
Kimberly Wanat
Patricia Wendel
Regina Whitaker
Jeanne Wiggins
Yifan Xu
Christina Yordan
Zhuang Yuan
Ying Zhang
Hong Zhou
Media Makers/
Laboratory Aides
Esteban Araya
June Blanchford
Patricia Brady
Jack Brodsky
Rodney Chisum
Nathalie Castiaux
Janice Douglas
Corine Driessens
Salvador Henriquez
Robin Kirchner
Christine Maurel
Vincent Meschan
Margaret Wallace
Xiu-Xia Zhang
DEPARTMENTS
Art
Michael Ockler
James Duffy
Philip Renna
Jessica Viccaro
Information Services
Gerald Latter,
Anthony Alicata
James Bense
Patrick Monardo
Robert Pace
William Palafox
Barbara Peters
Lee Wilbur
CSHL Press
Acquisition
Elizabeth Powers
Editorial/Production Books
Nancy Ford
Janet Argentine
Patricia Barker
Dorothy Brown
Mary Cozza
Maryliz Dickerson
Joan Ebert
Elaine Gaveglia
Kaaren Janssen
Annette Kirk
Lee Martin
Elizabeth Ritcey
Inez Sialiano
Susan Schaefer
Mary Smith
Editiorial/Production
Journals
Judy Cuddihy
Nadine Dumser
Kimberly Gavin
Cynthia Grimm
Kristin Kraus
Doris Lawrence
Valerie Pakaluk
'Funding provided by Howard Hughes Medical Institute
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Fullfilment/Distribution
Guy Keyes
Kathleen Cirone
Gabriella Horvath
Jacqueline Matura
Walter McKenna
Sharon Story
Barbara Terry
Finance
Nancy Hodson
Marketing
Ingrid Benirschke
James Suddaby
Advertising Sales
Marcie Ebenstein
Teresa Tiganis
Public Affairs
DevelopmenVLibrary
Susan Cooper
Clare Bunce
Laura Hyman
Public Affairs
Margot Bennett
Edward Campodonico
Marlene Emmons
Wendy Goldstein
Lynn Hardin
Herb Parsons
Development
Sherrie Hammond
Gordon Hargraves
Jean Houghton
Laura Hundt
Andrew Scott
Julie Sutherland
Cathie Wardell
Library
Margaret Henderson
Leigh Johnson
Wanda Stolen
Claudia Zago
Accounting
Amy Anderson
Sharon Bense
Jennifer Blovsky
Guy Cozza
Kathleen Didie
Karen Fabian
Mary Ellen Goldstein
Patricia Maroney
Alison McDermott
Carlos Mendez
Mary Ann Miceli
Patricia Urena
Noreen Vance
Barbara Wang
Grants
Susan Schultz
Wendy Crowley
Maureen Davies
Carol DuPree
Mary Horton
Patricia Kurfess
William Mahoney
Dee McKeon
Personnel
Cheryl Sinclair
Marjorie Berko
Jan Eisenman
Kim Gronachan
Patricia Howard
Barbara Purcell
Merilyn Simkins
Food Service
James Hope
Keven Adler
Jaime Bonilla
Francis Bowdren
Guidetta Carino
Wiliam Carmona
Michael Corral
Joan Doxey
Julie Ehrlich
Karen Farrell
Alec Firestone
Katherine Hamas
Oscar Lastra
Renee Le Strange
Maureen Morrow
Ronald Padden
Victor Ramones
Mauricio Rodriguez
Victoria Sharpe
Cathy Van Deurs
Leslie Wenzel
Keith Wieczorek
Meetings/Courses
Michael Glaessgen
James Koziol
Michela McBride
Andrew Mendelsohn
Margaret Stellabotte
Andrea Stephenson
Diane Tighe
Nancy Weeks
Purchasing
Philip Lembo
Margaret Brock
Carol Brower
Lorraine Byers
Susan De Angelo
Bruce Fahlbusch
Patricia Hinton-Stenko
Edith Kappenberg
Susan Rose
Central Administration
Maureen Berejka
Barry Braunstein
Delia King
Roberta Salant
Banbury Center
Katya Davey
Eleanor Sidorenko
Beatrice Toliver
DNA Learning Center
Joan Alexander
Mark Bloom
Jane Conigliaro
Amy Cross
Judy Cumella-Korabik
Diane Esposito
Michael Greenberg
Melissa Hewitt
Diane Jedlicka
Susan Laufer
Andrew Morotti
Lisa Shepherd
Facilities
Arthur Brings
Jack Richards
Peter Stahl
Leslie Allen
Margaret Chellis
Marlene Rubino
Frank Russo
Charles Schneider
Carpentry and Painting
Peter Schwind
Michael Demers
John Meyer
Joseph Pirnak
Peter Rohde
Benjamin Veneable
Harry Wozniak
Electrical and Mechanical
Louis Jagoda
Russell Allen
Greg Beal
Robert Collins
Jeffrey Goldblum
Environmental Health
and Safety
Christopher Hubert
Randal Jones
Bill Kearney
John Pisciotta
Equipment Design
Fabrication and Repair
Gus Dulis
Cliff Sutkevich
Gary Montemurro
George Newell
Grounds
Daniel Miller
William Bishop
Vincent Carey
Joseph Ellis
Lawrence Giordano
Edward Haab
Steven Kuzminski
Christopher McEvoy
John Nolan
Andrew Sauer
Stanley Schwarz
Dariusz Slodkowski
Harris Research
Support Facility
Lisa Bianco
Charlene De Poto
Ha lina Swidzinski
Ryszard Swidzinski
Housekeeping
Steven Tang
David Bonilla
Elizabeth Botti
Dessie Carter
Ming-Kai Chan
Stephen Gay
Jose Hernandez
George Leedham
Susanne MacPherson
Patricia Mc Adams
Dora Merlino
Guido Mosquera
Mary Muno
Wayne Pay
*Funding provided by Howard Hughes Medical Institute
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Ronald Romani
Claudia Schmid
Danuta Slodkowska
William Suescun
Jaroslaw Swi dzi n ski
Yew Teo
Plumbing
Lane Smith
Keith Spooner
Security
Robert Gensel
Frank Carberry
Randy Wilfong
Shipping and Receiving
Christopher Oravitz
Daniel Jusino
Joe Marcel lo
Curtis Williams
Uplands Farm
Timothy Mulligan
Research Staff
Departures
during 1996
Faculty
Kim Arndt
Peter Barker
Michael Mathews
Venkatesan Sundaresan
Akiya Watakabe
Staff Associates
Shobha Gunnery
Visiting Scientists
Ronald Pruzan
R. Sanders Williams**
Sr. Fellow
Chantal Autexier
Post Doctoral Fellows
Mikael Berg
Karen Buchkovich
Hui-Zhi Cai
Maureen Caligiuri
Flavio Della Seta
Catherine Flanagan
Andrew Flint
Mario Gimona
Qing Gu
Akemi Hanamura
Kyoko Hidaka
Masumi Hidaka
Johannes Hofmann
Yan-Fen Hu
James Hudson
Christopher Jones
Paul Kaufman
Rong Li
Huey Jane Liao
Mingsong Liu
May Luke
Renu Mital
Yukiko Mizukami
Koji Okamoto
Tsafrira Pe'ery
Frank Pessler
Y. Ramanathan
Juhan Sedman
Barbara Steiner
Constance Temm
Henry Tobin
Marie-Luce Vignais
Wei Wen
Angus Wilson
Scott Woody
Graduate Students
Charles Di Como
Dezhi Liao
Kathy O'Neill
Hai Rao
Cynthia Sadowski
Deborah Taylor
Terrence Vale
Qinghong Yang
On Sabbatical at CSHL
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